SAMPLE_ID	PATIENT_ID	CANCER_TYPE	SAMPLE_TYPE	SAMPLE_CLASS	METASTATIC_SITE	PRIMARY_SITE	CANCER_TYPE_DETAILED	GENE_PANEL	OTHER_SAMPLE_ID	OTHER_PATIENT_ID	SEX	SO_COMMENTS	SAMPLE_COVERAGE	TUMOR_PURITY
P-0000012-T03-IM3	P-0000012	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0002	DMP0002	Female			
P-0000012-T02-IM3	P-0000012	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0001	DMP0001	Female			
P-0000015-T01-IM3	P-0000015	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0003	DMP0003	Female			
P-0000004-T01-IM3	P-0000004	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0004	DMP0004	Female			
P-0000024-T01-IM3	P-0000024	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0005	DMP0005	Female			
P-0000026-T01-IM3	P-0000026	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0006	DMP0006	Female			
P-0000034-T01-IM3	P-0000034	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0007	DMP0007	Male			
P-0000025-T01-IM3	P-0000025	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0008	DMP0008	Female			
P-0000037-T01-IM3	P-0000037	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0038	DMP0038	Male			
P-0000033-T01-IM3	P-0000033	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT341	DMP0010	DMP0010	Female			
P-0000028-T01-IM3	P-0000028	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP0011	DMP0011	Female			
P-0000029-T01-IM3	P-0000029	Colorectal Cancer	Metastasis	Tumor	Pelvis	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0012	DMP0012	Female			
P-0000143-T01-IM3	P-0000143	Mesothelioma	Metastasis	Tumor	Pelvis	Testis	Testicular Mesothelioma	IMPACT341	DMP0139	DMP0139	Male			
P-0000039-T01-IM3	P-0000039	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0014	DMP0014	Male			
P-0000036-T01-IM3	P-0000036	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0016	DMP0016	Female			
P-0000030-T01-IM3	P-0000030	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0017	DMP0017	Female			
P-0000053-T01-IM3	P-0000053	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0018	DMP0018	Female			
P-0000042-T01-IM3	P-0000042	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0019	DMP0019	Male			
P-0000047-T01-IM3	P-0000047	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0020	DMP0020	Male			
P-0000044-T01-IM3	P-0000044	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0021	DMP0021	Female			
P-0000041-T01-IM3	P-0000041	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0023	DMP0023	Female			
P-0000071-T01-IM3	P-0000071	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0024	DMP0024	Male			
P-0000069-T01-IM3	P-0000069	Endometrial Cancer	Metastasis	Tumor	Rectosigmoid Colon	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0025	DMP0025	Female			
P-0000067-T01-IM3	P-0000067	Ovarian Cancer	Metastasis	Tumor	Cervix	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0026	DMP0026	Female			
P-0000056-T01-IM3	P-0000056	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0027	DMP0027	Male			
P-0000055-T01-IM3	P-0000055	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP0028	DMP0028	Female			
P-0000060-T01-IM3	P-0000060	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0029	DMP0029	Female			
P-0000066-T01-IM3	P-0000066	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0030	DMP0030	Female			
P-0000058-T01-IM3	P-0000058	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0031	DMP0031	Female			
P-0000061-T01-IM3	P-0000061	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP0032	DMP0032	Female			
P-0000057-T01-IM3	P-0000057	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0033	DMP0033	Female			
P-0000063-T01-IM3	P-0000063	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0034	DMP0034	Male			
P-0000068-T01-IM3	P-0000068	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0035	DMP0035	Male			
P-0000065-T01-IM3	P-0000065	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0036	DMP0036	Female			
P-0000059-T01-IM3	P-0000059	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0037	DMP0037	Female			
P-0000037-T02-IM3	P-0000037	Hepatocellular Carcinoma	Metastasis	Tumor	Liver	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0009	DMP0009	Male			
P-0000062-T01-IM3	P-0000062	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0039	DMP0039	Male			
P-0000073-T01-IM3	P-0000073	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP0040	DMP0040	Female			
P-0004046-T01-IM3	P-0004046	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0041	DMP0041	Male			
P-0003942-T01-IM3	P-0003942	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0042	DMP0042	Male			
P-0003930-T01-IM3	P-0003930	Esophagogastric Carcinoma	Metastasis	Tumor	Omentum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0043	DMP0043	Male			
P-0003944-T01-IM3	P-0003944	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0044	DMP0044	Male			
P-0003915-T01-IM3	P-0003915	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0045	DMP0045	Male			
P-0003983-T01-IM3	P-0003983	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0046	DMP0046	Male			
P-0003977-T01-IM3	P-0003977	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0048	DMP0048	Female			
P-0003914-T01-IM3	P-0003914	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0049	DMP0049	Male			
P-0004043-T01-IM3	P-0004043	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0050	DMP0050	Male			
P-0003981-T01-IM3	P-0003981	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0051	DMP0051	Male			
P-0004031-T01-IM3	P-0004031	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0052	DMP0052	Female			
P-0003961-T01-IM3	P-0003961	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0053	DMP0053	Female			
P-0000138-T02-IM3	P-0000138	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0125	DMP0125	Female			
P-0003922-T01-IM3	P-0003922	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0055	DMP0055	Female			
P-0003958-T01-IM3	P-0003958	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0056	DMP0056	Female			
P-0003974-T01-IM3	P-0003974	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0057	DMP0057	Female			
P-0000146-T01-IM3	P-0000146	Soft Tissue Sarcoma	Metastasis	Tumor	Small Bowel	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP0058-R	DMP0058-R	Male			
P-0004002-T01-IM3	P-0004002	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT341	DMP0059	DMP0059	Male			
P-0003940-T01-IM3	P-0003940	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0060	DMP0060	Female			
P-0004005-T01-IM3	P-0004005	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0061	DMP0061	Female			
P-0003936-T01-IM3	P-0003936	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0062	DMP0062	Female			
P-0004050-T01-IM3	P-0004050	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0063	DMP0063	Male			
P-0000550-T04-IM3	P-0000550	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0065		Female			
P-0003985-T01-IM3	P-0003985	Breast Carcinoma	Metastasis	Tumor	Omentum	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0066	DMP0066	Female			
P-0003994-T01-IM3	P-0003994	Germ Cell Tumor	Metastasis	Tumor	Lung	Mediastinum	Mixed Germ Cell Tumor	IMPACT341	DMP0067	DMP0067	Male			
P-0004023-T01-IM3	P-0004023	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0068	DMP0068	Female			
P-0004001-T01-IM3	P-0004001	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0069	DMP0069	Female			
P-0003916-T01-IM3	P-0003916	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0071	DMP0071	Male			
P-0003954-T01-IM3	P-0003954	Small Cell Lung Cancer	Metastasis	Tumor	Skin	Lung	Small Cell Lung Cancer	IMPACT341	DMP0072	DMP0072	Male			
P-0003932-T01-IM3	P-0003932	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0073	DMP0073	Female			
P-0003943-T01-IM3	P-0003943	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP0074	DMP0074	Female			
P-0003973-T01-IM3	P-0003973	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0075	DMP0075	Female			
P-0003935-T01-IM3	P-0003935	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0076	DMP0076	Male			
P-0003978-T01-IM3	P-0003978	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP0077	DMP0077	Male			
P-0004006-T01-IM3	P-0004006	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP0078	DMP0078	Male			
P-0000079-T01-IM3	P-0000079	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0079	DMP0079	Male			
P-0000102-T02-IM3	P-0000102	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0080	DMP0080	Female			
P-0000082-T01-IM3	P-0000082	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0083	DMP0083	Male			
P-0000086-T01-IM3	P-0000086	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0084	DMP0084	Male			
P-0000075-T01-IM3	P-0000075	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0085	DMP0085	Female			
P-0000084-T01-IM3	P-0000084	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0086	DMP0086	Male			
P-0000085-T02-IM3	P-0000085	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0087	DMP0087	Male			
P-0000076-T01-IM3	P-0000076	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0088	DMP0088	Female			
P-0000077-T01-IM3	P-0000077	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0089	DMP0089	Female			
P-0000080-T01-IM3	P-0000080	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Undifferentiated Carcinoma	IMPACT341	DMP0090	DMP0090	Female			
P-0000081-T01-IM3	P-0000081	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0091	DMP0091	Female			
P-0000093-T01-IM3	P-0000093	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0092	DMP0092	Female			
P-0000092-T01-IM3	P-0000092	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0093	DMP0093	Female			
P-0000098-T01-IM3	P-0000098	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0094	DMP0094	Female			
P-0000096-T01-IM3	P-0000096	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0095	DMP0095	Male			
P-0000112-T01-IM3	P-0000112	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0096	DMP0096	Male			
P-0000108-T01-IM3	P-0000108	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP0097	DMP0097	Male			
P-0000121-T01-IM3	P-0000121	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0098	DMP0098	Male			
P-0008213-T01-IM3	P-0008213	Leukemia	Primary	Tumor	Not Applicable	Bone Marrow	Chronic Myelogenous Leukemia	IMPACT341	DMP0099	DMP0099	Female			
P-0000110-T01-IM3	P-0000110	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0100	DMP0100	Male			
P-0000113-T01-IM3	P-0000113	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0101	DMP0101	Female			
P-0000117-T01-IM3	P-0000117	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0102	DMP0102	Male			
P-0000107-T01-IM3	P-0000107	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0103	DMP0103	Female			
P-0000119-T01-IM3	P-0000119	Colorectal Cancer	Metastasis	Tumor	Ovary	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0104	DMP0104	Female			
P-0000115-T01-IM3	P-0000115	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0105	DMP0105	Female			
P-0000122-T01-IM3	P-0000122	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT341	DMP0106	DMP0106	Female			
P-0000105-T01-IM3	P-0000105	Endometrial Cancer	Metastasis	Tumor	Kidney	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0107	DMP0107	Female			
P-0000118-T01-IM3	P-0000118	Sex Cord Stromal Tumor	Metastasis	Tumor	Kidney	Ovary	Granulosa Cell Tumor	IMPACT341	DMP0108	DMP0108	Female			
P-0000106-T01-IM3	P-0000106	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0109	DMP0109	Female			
P-0000103-T01-IM3	P-0000103	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph Node	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0110	DMP0110	Male			
P-0000114-T01-IM3	P-0000114	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0111	DMP0111	Female			
P-0000120-T01-IM3	P-0000120	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0112	DMP0112	Female			
P-0000116-T01-IM3	P-0000116	Uterine Sarcoma	Metastasis	Tumor	Diaphragm	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0113	DMP0113	Female			
P-0000104-T01-IM3	P-0000104	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0114	DMP0114	Female			
P-0000125-T01-IM3	P-0000125	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0115	DMP0115	Female			
P-0000133-T01-IM3	P-0000133	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0116	DMP0116	Female			
P-0001325-T01-IM3	P-0001325	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Small Cell Carcinoma	IMPACT341	DMP1330	DMP1330	Male			
P-0000126-T01-IM3	P-0000126	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0118	DMP0118	Female			
P-0000131-T01-IM3	P-0000131	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0119	DMP0119	Female			
P-0000141-T01-IM3	P-0000141	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Mucinous Ovarian Cancer	IMPACT341	DMP0120	DMP0120	Female			
P-0000135-T01-IM3	P-0000135	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP0121	DMP0121	Female			
P-0000127-T02-IM3	P-0000127	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0122	DMP0122	Male			
P-0000127-T01-IM3	P-0000127	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0123	DMP0123	Male			
P-0000137-T01-IM3	P-0000137	Cervical Cancer	Metastasis	Tumor	Pelvis	Cervix	Gastric Type Mucinous Carcinoma	IMPACT341	DMP0124	DMP0124	Female			
P-0000138-T01-IM3	P-0000138	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0054	DMP0054	Female			
P-0000129-T01-IM3	P-0000129	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0126	DMP0126	Female			
P-0000136-T01-IM3	P-0000136	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0127	DMP0127	Female			
P-0000132-T01-IM3	P-0000132	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP0128	DMP0128	Female			
P-0000123-T01-IM3	P-0000123	Germ Cell Tumor	Metastasis	Tumor	Chest Wall	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0129	DMP0129	Male			
P-0000142-T01-IM3	P-0000142	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP0130	DMP0130	Female			
P-0000134-T01-IM3	P-0000134	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP0131	DMP0131	Female			
P-0000130-T01-IM3	P-0000130	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0132	DMP0132	Male			
P-0000153-T01-IM3	P-0000153	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0133	DMP0133	Female			
P-0000144-T01-IM3	P-0000144	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0134	DMP0134	Male			
P-0000145-T01-IM3	P-0000145	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0135	DMP0135	Female			
P-0000149-T01-IM3	P-0000149	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0137	DMP0137	Female			
P-0000149-T02-IM3	P-0000149	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0136	DMP0136	Female			
P-0000154-T01-IM3	P-0000154	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0138	DMP0138	Male			
P-0000286-T01-IM3	P-0000286	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0265	DMP0265	Female			
P-0000152-T01-IM3	P-0000152	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0141	DMP0141	Female			
P-0000156-T01-IM3	P-0000156	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0142	DMP0142	Female			
P-0000151-T01-IM3	P-0000151	Germ Cell Tumor	Metastasis	Tumor	Kidney	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0143	DMP0143	Male			
P-0000148-T01-IM3	P-0000148	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP0172	DMP0172	Female			
P-0000158-T01-IM3	P-0000158	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0145	DMP0145	Female			
P-0000157-T01-IM3	P-0000157	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP0146	DMP0146	Female			
P-0000155-T01-IM3	P-0000155	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0147	DMP0147	Female			
P-0000147-T01-IM3	P-0000147	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0148	DMP0148	Female			
P-0000162-T01-IM3	P-0000162	Germ Cell Tumor	Metastasis	Tumor	Stomach	Testis	Seminoma	IMPACT341	DMP0149	DMP0149	Male			
P-0000178-T01-IM3	P-0000178	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0150	DMP0150	Male			
P-0000165-T01-IM3	P-0000165	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0151	DMP0151	Female			
P-0000167-T02-IM3	P-0000167	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0152	DMP0152	Female			
P-0000167-T01-IM3	P-0000167	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0153	DMP0153	Female			
P-0000163-T01-IM3	P-0000163	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0155	DMP0155	Female			
P-0000163-T02-IM3	P-0000163	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0154	DMP0154	Female			
P-0000174-T01-IM3	P-0000174	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0156	DMP0156	Female			
P-0000159-T01-IM3	P-0000159	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0157	DMP0157	Female			
P-0000180-T01-IM3	P-0000180	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0158	DMP0158	Female			
P-0000168-T01-IM3	P-0000168	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0159	DMP0159	Male			
P-0000171-T01-IM3	P-0000171	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Vulva	Yolk Sac Tumor	IMPACT341	DMP0160	DMP0160	Female			
P-0000170-T01-IM3	P-0000170	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0161	DMP0161	Male			
P-0000161-T01-IM3	P-0000161	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0162	DMP0162	Male			
P-0000160-T01-IM3	P-0000160	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Mixed Mucinous Carcinoma	IMPACT341	DMP0163	DMP0163	Female			
P-0000088-T01-IM3	P-0000088	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Bladder Urothelial Carcinoma	IMPACT341	DMP0165	DMP0165	Male			
P-0000187-T01-IM3	P-0000187	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0166	DMP0166	Female			
P-0000181-T01-IM3	P-0000181	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0167	DMP0167	Male			
P-0000183-T01-IM3	P-0000183	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0168	DMP0168	Female			
P-0000185-T01-IM3	P-0000185	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Mucinous Ovarian Cancer	IMPACT341	DMP0169	DMP0169	Female			
P-0000184-T01-IM3	P-0000184	Bladder Cancer	Primary	Tumor	Not Applicable	Urethra	Urethral Squamous Cell Carcinoma	IMPACT341	DMP0170	DMP0170	Male			
P-0000182-T01-IM3	P-0000182	Hepatocellular Carcinoma	Metastasis	Tumor	Peritoneum	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0171	DMP0171	Male			
P-0000148-T02-IM3	P-0000148	Ovarian Cancer	Metastasis	Tumor	Spleen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP0144	DMP0144	Female			
P-0000189-T01-IM3	P-0000189	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0173	DMP0173	Male			
P-0000188-T01-IM3	P-0000188	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0174	DMP0174	Female			
P-0000186-T01-IM3	P-0000186	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0175	DMP0175	Male			
P-0000201-T01-IM3	P-0000201	Breast Carcinoma	Metastasis	Tumor	Neck	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0176	DMP0176	Female			
P-0000203-T01-IM3	P-0000203	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0177	DMP0177	Male			
P-0000190-T01-IM3	P-0000190	Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Small Cell Lung Cancer	IMPACT341	DMP0178	DMP0178	Female			
P-0000195-T01-IM3	P-0000195	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0179	DMP0179	Female			
P-0000198-T01-IM3	P-0000198	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Kidney	Biphasic Malignant Neoplasm	IMPACT341	DMP0180		Male			
P-0001687-T01-IM3	P-0001687	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Small Cell Carcinoma	IMPACT341	DMP1564	DMP1564	Male			
P-0000202-T01-IM3	P-0000202	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0182	DMP0182	Male			
P-0000199-T01-IM3	P-0000199	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0183	DMP0183	Female			
P-0000193-T01-IM3	P-0000193	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0184	DMP0184	Female			
P-0000205-T01-IM3	P-0000205	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0185	DMP0185	Female			
P-0000191-T01-IM3	P-0000191	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0186	DMP0186	Female			
P-0000196-T01-IM3	P-0000196	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0187	DMP0187	Female			
P-0000204-T01-IM3	P-0000204	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1449	DMP1449	Female			
P-0000211-T01-IM3	P-0000211	Biliary Cancer	Metastasis	Tumor	Chest Wall	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0189	DMP0189	Male			
P-0000206-T01-IM3	P-0000206	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Salivary Carcinoma	IMPACT341	DMP0190	DMP0190	Female			
P-0000212-T01-IM3	P-0000212	Ovarian Cancer	Metastasis	Tumor	Bowel	Ovary	Mucinous Ovarian Cancer	IMPACT341	DMP0191	DMP0191	Female			
P-0000219-T01-IM3	P-0000219	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0192	DMP0192	Female			
P-0000208-T01-IM3	P-0000208	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0193	DMP0193	Female			
P-0000214-T01-IM3	P-0000214	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0194	DMP0194	Female			
P-0000216-T01-IM3	P-0000216	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1378	DMP1378	Female			
P-0000218-T01-IM3	P-0000218	Hepatocellular Carcinoma	Metastasis	Tumor	Liver	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0196	DMP0196	Female			
P-0000215-T01-IM3	P-0000215	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0197	DMP0197	Female			
P-0000207-T01-IM3	P-0000207	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0198	DMP0198	Female			
P-0000210-T01-IM3	P-0000210	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Cervical Squamous Cell Carcinoma	IMPACT341	DMP0199	DMP0199	Female			
P-0000228-T01-IM3	P-0000228	Hepatocellular Carcinoma	Metastasis	Tumor	Bone	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0200	DMP0200	Male			
P-0000225-T01-IM3	P-0000225	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0201	DMP0201	Male			
P-0000223-T01-IM3	P-0000223	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP0202	DMP0202	Female			
P-0000227-T01-IM3	P-0000227	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Bone	Clear Cell Odontogenic Carcinoma	IMPACT341	DMP0203	DMP0203	Female			
P-0000226-T01-IM3	P-0000226	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Sinonasal	Alveolar Rhabdomyosarcoma	IMPACT341	DMP0204	DMP0204	Male			
P-0000221-T01-IM3	P-0000221	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0205	DMP0205	Male			
P-0000222-T01-IM3	P-0000222	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0206	DMP0206	Male			
P-0000220-T01-IM3	P-0000220	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0207	DMP0207	Female			
P-0000230-T01-IM3	P-0000230	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0208	DMP0208	Female			
P-0000224-T01-IM3	P-0000224	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0209	DMP0209	Female			
P-0000231-T01-IM3	P-0000231	Non-Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Lung Adenocarcinoma	IMPACT341	DMP0210	DMP0210	Female			
P-0000232-T01-IM3	P-0000232	Ewing Sarcoma	Primary	Tumor	Not Applicable	Chest Wall	Ewing Sarcoma	IMPACT341	DMP0211	DMP0211	Male			
P-0000235-T01-IM3	P-0000235	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0212	DMP0212	Male			
P-0000242-T02-IM3	P-0000242	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0214	DMP0214	Female			
P-0000242-T01-IM3	P-0000242	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0213	DMP0213	Female			
P-0000234-T01-IM3	P-0000234	Breast Carcinoma	Metastasis	Tumor	Muscle	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0215	DMP0215	Female			
P-0000244-T01-IM3	P-0000244	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0216	DMP0216	Female			
P-0000239-T01-IM3	P-0000239	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0217	DMP0217	Male			
P-0000233-T01-IM3	P-0000233	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0218	DMP0218	Female			
P-0000246-T01-IM3	P-0000246	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Ovary	Mixed Germ Cell Tumor	IMPACT341	DMP0219	DMP0219	Female			
P-0000247-T01-IM3	P-0000247	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0220	DMP0220	Female			
P-0000237-T01-IM3	P-0000237	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0221	DMP0221	Male			
P-0000236-T01-IM3	P-0000236	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0222	DMP0222	Female			
P-0000238-T01-IM3	P-0000238	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0223	DMP0223	Male			
P-0000241-T01-IM3	P-0000241	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0224	DMP0224	Female			
P-0000245-T01-IM3	P-0000245	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0225	DMP0225	Female			
P-0000333-T01-IM3	P-0000333	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0296	DMP0296	Female			
P-0000250-T01-IM3	P-0000250	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0228	DMP0228	Female			
P-0000260-T01-IM3	P-0000260	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0229	DMP0229	Female			
P-0000252-T01-IM3	P-0000252	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0230	DMP0230	Female			
P-0000266-T01-IM3	P-0000266	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0232	DMP0232	Female			
P-0000263-T01-IM3	P-0000263	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0233	DMP0233	Female			
P-0000261-T01-IM3	P-0000261	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Seminoma	IMPACT341	DMP0234	DMP0234	Male			
P-0000259-T01-IM3	P-0000259	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0236	DMP0236	Female			
P-0000274-T01-IM3	P-0000274	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0237	DMP0237	Female			
P-0000271-T01-IM3	P-0000271	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0238	DMP0238	Female			
P-0000272-T01-IM3	P-0000272	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP0239	DMP0239	Male			
P-0000270-T01-IM3	P-0000270	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0240	DMP0240	Female			
P-0000276-T01-IM3	P-0000276	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0241	DMP0241	Female			
P-0000277-T01-IM3	P-0000277	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Oral Cavity	Squamous versus Mucoepidermoid	IMPACT341	DMP0242	DMP0242	Female			
P-0000269-T01-IM3	P-0000269	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP0243	DMP0243	Female			
P-0000279-T01-IM3	P-0000279	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0244	DMP0244	Male			
P-0000268-T01-IM3	P-0000268	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0245	DMP0245	Male			
P-0000275-T01-IM3	P-0000275	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0246	DMP0246	Female			
P-0000278-T01-IM3	P-0000278	Breast Carcinoma	Metastasis	Tumor	Uterus	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0247	DMP0247	Female			
P-0000273-T01-IM3	P-0000273	Cancer of Unknown Primary	Metastasis	Tumor	Muscle	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0248	DMP0248	Female			
P-0000267-T01-IM3	P-0000267	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0249	DMP0249	Female			
P-0000290-T01-IM3	P-0000290	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0250	DMP0250	Male			
P-0000281-T01-IM3	P-0000281	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2000	DMP2000	Male			
P-0000288-T01-IM3	P-0000288	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0252	DMP0252	Female			
P-0000280-T01-IM3	P-0000280	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0253	DMP0253	Female			
P-0000284-T01-IM3	P-0000284	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0254	DMP0254	Male			
P-0000292-T01-IM3	P-0000292	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0255	DMP0255	Female			
P-0000282-T01-IM3	P-0000282	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0256	DMP0256	Female			
P-0000289-T01-IM3	P-0000289	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0257	DMP0257	Male			
P-0000287-T01-IM3	P-0000287	Germ Cell Tumor	Metastasis	Tumor	Brain	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0258	DMP0258	Male			
P-0000083-T01-IM3	P-0000083	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0259	DMP0259	Male			
P-0000291-T01-IM3	P-0000291	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0260	DMP0260	Female			
P-0000425-T01-IM3	P-0000425	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0372	DMP0372	Male			
P-0000293-T01-IM3	P-0000293	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Basaloid Carcinoma	IMPACT341	DMP0262	DMP0262	Female			
P-0000283-T01-IM3	P-0000283	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0263	DMP0263	Male			
P-0000095-T01-IM3	P-0000095	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT341	DMP0264	DMP0264	Male			
P-0000332-T01-IM3	P-0000332	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Sarcomatoid Type	IMPACT341	DMP0295	DMP0295	Female			
P-0000299-T01-IM3	P-0000299	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341	DMP0266	DMP0266	Male			
P-0000306-T01-IM3	P-0000306	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Bowel	Gastrointestinal Stromal Tumor	IMPACT341	DMP0267	DMP0267	Male			
P-0000295-T01-IM3	P-0000295	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0268	DMP0268	Female			
P-0000302-T01-IM3	P-0000302	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0269	DMP0269	Male			
P-0000308-T01-IM3	P-0000308	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0270	DMP0270	Male			
P-0000307-T01-IM3	P-0000307	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Bladder Urothelial Carcinoma	IMPACT341	DMP0271	DMP0271	Female			
P-0000298-T01-IM3	P-0000298	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0272	DMP0272	Male			
P-0000300-T01-IM3	P-0000300	Esophagogastric Carcinoma	Metastasis	Tumor	Colon	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0273	DMP0273	Female			
P-0000309-T01-IM3	P-0000309	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP0274	DMP0274	Female			
P-0000303-T01-IM3	P-0000303	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0275	DMP0275	Female			
P-0000296-T01-IM3	P-0000296	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0276	DMP0276	Female			
P-0000301-T01-IM3	P-0000301	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0277	DMP0277	Male			
P-0000460-T01-IM3	P-0000460	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0416	DMP0416	Female			
P-0000313-T01-IM3	P-0000313	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Acinic Cell Carcinoma	IMPACT341	DMP0280	DMP0280	Male			
P-0000314-T01-IM3	P-0000314	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP0281	DMP0281	Male			
P-0000317-T01-IM3	P-0000317	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0282	DMP0282	Female			
P-0000323-T01-IM3	P-0000323	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0283	DMP0283	Female			
P-0000326-T01-IM3	P-0000326	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0285	DMP0285	Male			
P-0000319-T01-IM3	P-0000319	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Larynx	Larynx Squamous Cell Carcinoma	IMPACT341	DMP0286	DMP0286	Male			
P-0000322-T01-IM3	P-0000322	Gestational Trophoblastic Disease	Metastasis	Tumor	Lung	Uterus	Choriocarcinoma	IMPACT341	DMP0287	DMP0287	Female			
P-0000140-T01-IM3	P-0000140	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT341	DMP0117	DMP0117	Male			
P-0000315-T01-IM3	P-0000315	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0289	DMP0289	Male			
P-0000325-T01-IM3	P-0000325	Anal Cancer	Metastasis	Tumor	Liver	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP0290	DMP0290	Female			
P-0000316-T01-IM3	P-0000316	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0291	DMP0291	Female			
P-0000324-T01-IM3	P-0000324	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0292	DMP0292	Female			
P-0000043-T02-IM3	P-0000043	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0293	DMP0293	Female			
P-0000335-T01-IM3	P-0000335	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0294	DMP0294	Female			
P-0000368-T01-IM3	P-0000368	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0324	DMP0324	Male			
P-0000506-T01-IM3	P-0000506	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0456	DMP0456	Male			
P-0000336-T01-IM3	P-0000336	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0297	DMP0297	Male			
P-0000337-T01-IM3	P-0000337	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0298	DMP0298	Female			
P-0000339-T01-IM3	P-0000339	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0299	DMP0299	Female			
P-0000334-T01-IM3	P-0000334	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0300	DMP0300	Female			
P-0000329-T01-IM3	P-0000329	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0301	DMP0301	Female			
P-0000327-T01-IM3	P-0000327	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0302	DMP0302	Male			
P-0000340-T01-IM3	P-0000340	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0303	DMP0303	Male			
P-0000328-T01-IM3	P-0000328	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0305	DMP0305	Male			
P-0004012-T01-IM3	P-0004012	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0468	DMP0468	Male			
P-0000346-T01-IM3	P-0000346	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0307	DMP0307	Female			
P-0000342-T01-IM3	P-0000342	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0308	DMP0308	Male			
P-0000341-T01-IM3	P-0000341	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0309	DMP0309	Female			
P-0000352-T01-IM3	P-0000352	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0310	DMP0310	Female			
P-0000343-T01-IM3	P-0000343	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0311	DMP0311	Female			
P-0000351-T01-IM3	P-0000351	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0312	DMP0312	Male			
P-0000349-T01-IM3	P-0000349	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0313	DMP0313	Male			
P-0000347-T01-IM3	P-0000347	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP0315	DMP0315	Female			
P-0000353-T01-IM3	P-0000353	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0316	DMP0316	Female			
P-0000345-T01-IM3	P-0000345	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0317	DMP0317	Female			
P-0000344-T01-IM3	P-0000344	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0318	DMP0318	Male			
P-0000348-T01-IM3	P-0000348	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0319	DMP0319	Male			
P-0000365-T01-IM3	P-0000365	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Pelvis	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0320	DMP0320	Male			
P-0000363-T01-IM3	P-0000363	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0321	DMP0321	Male			
P-0000361-T01-IM3	P-0000361	Soft Tissue Sarcoma	Metastasis	Tumor	Larynx	Thyroid	Ossifying Fibromyxoid Tumor	IMPACT341	DMP0322	DMP0322	Male			
P-0000360-T01-IM3	P-0000360	Biliary Cancer	Metastasis	Tumor	Chest Wall	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0323	DMP0323	Male			
P-0000543-T01-IM3	P-0000543	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0504	DMP0504	Male			
P-0000369-T01-IM3	P-0000369	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0325	DMP0325	Female			
P-0000555-T01-IM3	P-0000555	Thyroid Cancer	Metastasis	Tumor	Trachea	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0510	DMP0510	Male			
P-0000366-T01-IM3	P-0000366	Ovarian Cancer	Metastasis	Tumor	Vagina	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0327	DMP0327	Female			
P-0000357-T01-IM3	P-0000357	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0328	DMP0328	Female			
P-0000367-T01-IM3	P-0000367	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP0329	DMP0329	Female			
P-0000355-T01-IM3	P-0000355	Uterine Sarcoma	Metastasis	Tumor	Chest Wall	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0330	DMP0330	Female			
P-0000364-T01-IM3	P-0000364	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0331	DMP0331	Male			
P-0000356-T01-IM3	P-0000356	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0332	DMP0332	Female			
P-0000362-T01-IM3	P-0000362	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0333	DMP0333	Female			
P-0000358-T01-IM3	P-0000358	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0334	DMP0334	Female			
P-0000374-T01-IM3	P-0000374	Salivary Carcinoma	Metastasis	Tumor	Lung	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0336	DMP0336	Female			
P-0000383-T01-IM3	P-0000383	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0337	DMP0337	Male			
P-0000378-T01-IM3	P-0000378	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0338	DMP0338	Male			
P-0000888-T01-IM3	P-0000888	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT341	DMP0835	DMP0835	Male			
P-0001899-T01-IM3	P-0001899	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT341	DMP1794	DMP1794	Male			
P-0000382-T01-IM3	P-0000382	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0341	DMP0341	Female			
P-0000380-T01-IM3	P-0000380	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0343	DMP0343	Female			
P-0000370-T01-IM3	P-0000370	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0344	DMP0344	Female			
P-0000372-T01-IM3	P-0000372	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Testis	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0345	DMP0345	Male			
P-0000381-T01-IM3	P-0000381	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0346	DMP0346	Female			
P-0000384-T01-IM3	P-0000384	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0348	DMP0348	Female			
P-0000387-T01-IM3	P-0000387	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP0349	DMP0349	Female			
P-0000398-T01-IM3	P-0000398	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0350	DMP0350	Female			
P-0000388-T01-IM3	P-0000388	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0351	DMP0351	Male			
P-0000397-T01-IM3	P-0000397	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0352	DMP0352	Female			
P-0000394-T01-IM3	P-0000394	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0353	DMP0353	Male			
P-0000386-T01-IM3	P-0000386	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Bladder Urothelial Carcinoma	IMPACT341	DMP0354	DMP0354	Male			
P-0002375-T01-IM3	P-0002375	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT341	DMP2103	DMP2103	Male			
P-0000392-T01-IM3	P-0000392	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0356	DMP0356	Female			
P-0000395-T01-IM3	P-0000395	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0357	DMP0357	Male			
P-0000390-T01-IM3	P-0000390	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0358	DMP0358	Male			
P-0000402-T01-IM3	P-0000402	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0359	DMP0359	Female			
P-0000411-T01-IM3	P-0000411	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0360	DMP0360	Female			
P-0000404-T01-IM3	P-0000404	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0361	DMP0361	Female			
P-0000403-T01-IM3	P-0000403	Ovarian Cancer	Metastasis	Tumor	Bowel	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0362	DMP0362	Female			
P-0000412-T01-IM3	P-0000412	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0363	DMP0363	Female			
P-0000408-T01-IM3	P-0000408	Esophagogastric Carcinoma	Metastasis	Tumor	Brain	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0364	DMP0364	Male			
P-0000406-T01-IM3	P-0000406	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0365	DMP0365	Male			
P-0000400-T01-IM3	P-0000400	Bladder Cancer	Primary	Tumor	Not Applicable	Urethra	Urethral Adenocarcinoma	IMPACT341	DMP0366	DMP0366	Female			
P-0000197-T01-IM3	P-0000197	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0181	DMP0181	Male			
P-0000410-T01-IM3	P-0000410	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0368	DMP0368	Male			
P-0000407-T01-IM3	P-0000407	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0369	DMP0369	Female			
P-0000405-T01-IM3	P-0000405	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0370	DMP0370	Male			
P-0000409-T01-IM3	P-0000409	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0371	DMP0371	Female			
P-0000876-T01-IM3	P-0000876	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0818	DMP0818	Male			
P-0000419-T01-IM3	P-0000419	Biliary Cancer	Metastasis	Tumor	Liver	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0373	DMP0373	Male			
P-0000423-T02-IM3	DMP0374	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0374	DMP0374	Male			
P-0000423-T01-IM3	P-0000423	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Plasmacytoid/Signet Ring Cell Bladder Carcinoma	IMPACT341	DMP0375	DMP0375	Male			
P-0000420-T01-IM3	P-0000420	Anal Cancer	Metastasis	Tumor	Lymph Node	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP0376	DMP0376	Female			
P-0000413-T01-IM3	P-0000413	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0377	DMP0377	Female			
P-0000421-T01-IM3	P-0000421	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP0378	DMP0378	Male			
P-0000426-T01-IM3	P-0000426	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0379	DMP0379	Female			
P-0000417-T01-IM3	P-0000417	Esophagogastric Carcinoma	Metastasis	Tumor	Soft Tissue	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0380	DMP0380	Female			
P-0000890-T01-IM3	P-0000890	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0825	DMP0825	Male			
P-0000418-T01-IM3	P-0000418	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0382	DMP0382	Male			
P-0000414-T01-IM3	P-0000414	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0383	DMP0383	Female			
P-0000422-T01-IM3	P-0000422	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1410	DMP1410	Female			
P-0000428-T01-IM3	P-0000428	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0385	DMP0385	Female			
P-0000432-T01-IM3	P-0000432	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0386	DMP0386	Female			
P-0000438-T01-IM3	P-0000438	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0387	DMP0387	Female			
P-0000435-T01-IM3	P-0000435	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0388	DMP0388	Female			
P-0000439-T01-IM3	P-0000439	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0389	DMP0389	Female			
P-0000180-T02-IM3	P-0000180	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0390	DMP0390	Female			
P-0000433-T01-IM3	P-0000433	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP0391	DMP0391	Male			
P-0000427-T01-IM3	P-0000427	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0392	DMP0392	Female			
P-0000434-T01-IM3	P-0000434	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0393	DMP0393	Male			
P-0000436-T01-IM3	P-0000436	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph Node	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0394	DMP0394	Female			
P-0000318-T01-IM3	P-0000318	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0288	DMP0288	Male			
P-0000445-T01-IM3	P-0000445	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0396	DMP0396	Female			
P-0000452-T01-IM3	P-0000452	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Cervical Squamous Cell Carcinoma	IMPACT341	DMP0397	DMP0397	Female			
P-0000447-T01-IM3	P-0000447	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0398	DMP0398	Female			
P-0000456-T01-IM3	P-0000456	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0399	DMP0399	Male			
P-0000457-T01-IM3	P-0000457	Bladder Cancer	Metastasis	Tumor	Adrenal Gland	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0400	DMP0400	Female			
P-0000377-T01-IM3	P-0000377	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0943	DMP0943	Male			
P-0000373-T01-IM3	P-0000373	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0340	DMP0340	Male			
P-0000454-T01-IM3	P-0000454	Head and Neck Carcinoma	Metastasis	Tumor	Abdomen	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP0403	DMP0403	Male			
P-0000446-T01-IM3	P-0000446	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0404	DMP0404	Male			
P-0000451-T01-IM3	P-0000451	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0405	DMP0405	Female			
P-0000450-T01-IM3	P-0000450	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Yolk Sac Tumor	IMPACT341	DMP0406	DMP0406	Male			
P-0000448-T01-IM3	P-0000448	Endometrial Cancer	Metastasis	Tumor	Rectum	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0407	DMP0407	Female			
P-0000443-T01-IM3	P-0000443	Germ Cell Tumor	Metastasis	Tumor	Brain	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0408	DMP0408	Male			
P-0000391-T01-IM3	P-0000391	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0355	DMP0355	Male			
P-0000444-T01-IM3	P-0000444	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0410	DMP0410	Male			
P-0000453-T01-IM3	P-0000453	Cervical Cancer	Metastasis	Tumor	Lymph Node	Cervix	Endocervical Adenocarcinoma	IMPACT341	DMP0411	DMP0411	Female			
P-0000455-T01-IM3	P-0000455	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP0412	DMP0412	Female			
P-0000440-T01-IM3	P-0000440	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0413	DMP0413	Female			
P-0000462-T01-IM3	P-0000462	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0414	DMP0414	Female			
P-0000464-T01-IM3	P-0000464	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0415	DMP0415	Female			
P-0000889-T01-IM3	P-0000889	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0826	DMP0826	Female			
P-0000472-T01-IM3	P-0000472	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0417	DMP0417	Female			
P-0000467-T01-IM3	P-0000467	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0418	DMP0418	Female			
P-0000459-T01-IM3	P-0000459	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0419	DMP0419	Male			
P-0000471-T01-IM3	P-0000471	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0420	DMP0420	Female			
P-0000458-T01-IM3	P-0000458	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0421	DMP0421	Male			
P-0000461-T01-IM3	P-0000461	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT341	DMP0422	DMP0422	Male			
P-0000468-T01-IM3	P-0000468	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0423	DMP0423	Female			
P-0000469-T01-IM3	P-0000469	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0424	DMP0424	Female			
P-0000466-T01-IM3	P-0000466	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0425	DMP0425	Female			
P-0000465-T01-IM3	P-0000465	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0426	DMP0426	Female			
P-0000463-T01-IM3	P-0000463	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0427	DMP0427	Male			
P-0000401-T01-IM3	P-0000401	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0367	DMP0367	Male			
P-0000431-T01-IM3	P-0000431	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0395	DMP0395	Male			
P-0000485-T01-IM3	P-0000485	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0430	DMP0430	Male			
P-0000483-T01-IM3	P-0000483	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0431	DMP0431	Female			
P-0000474-T01-IM3	P-0000474	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0432	DMP0432	Female			
P-0000473-T01-IM3	P-0000473	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0433	DMP0433	Female			
P-0000476-T01-IM3	P-0000476	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Ependymoma	IMPACT341	DMP0434	DMP0434	Female			
P-0000481-T01-IM3	P-0000481	Esophagogastric Carcinoma	Metastasis	Tumor	Bowel	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0435	DMP0435	Male			
P-0000475-T01-IM3	P-0000475	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Yolk Sac Tumor	IMPACT341	DMP0436	DMP0436	Male			
P-0000478-T01-IM3	P-0000478	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0437	DMP0437	Female			
P-0000482-T01-IM3	P-0000482	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0438	DMP0438	Female			
P-0000486-T01-IM3	P-0000486	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP0439	DMP0439	Female			
P-0000480-T01-IM3	P-0000480	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Axilla	Sweat Gland Carcinoma (Apocrine Eccrine Carcinoma)	IMPACT341	DMP0440	DMP0440	Male			
P-0000477-T01-IM3	P-0000477	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Atypical Lung Carcinoid	IMPACT341	DMP0441	DMP0441	Female			
P-0000491-T01-IM3	P-0000491	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP0442	DMP0442	Male			
P-0000490-T01-IM3	P-0000490	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0443	DMP0443	Female			
P-0000488-T01-IM3	P-0000488	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0444	DMP0444	Male			
P-0000499-T01-IM3	P-0000499	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0445	DMP0445	Female			
P-0000497-T01-IM3	P-0000497	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Spindle Cell Rhabdomyosarcoma	IMPACT341	DMP0446	DMP0446	Male			
P-0000500-T01-IM3	P-0000500	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0447	DMP0447	Male			
P-0000495-T01-IM3	P-0000495	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0448	DMP0448	Female			
P-0000494-T01-IM3	P-0000494	Cancer of Unknown Primary	Metastasis	Tumor	Neck	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0449	DMP0449	Male			
P-0000376-T01-IM3	P-0000376	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Ovarian Carcinosarcoma	IMPACT341	DMP0450	DMP0450	Female			
P-0000396-T01-IM3	P-0000396	Head and Neck Carcinoma	Metastasis	Tumor	Brain	Oropharynx	Head and Neck Squamous Cell Carcinoma of Unknown Primary	IMPACT341	DMP0451	DMP0451	Female			
P-0000399-T01-IM3	P-0000399	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Skin Cancer, Non-Melanoma	IMPACT341	DMP0452	DMP0452	Female			
P-0000501-T01-IM3	P-0000501	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1395	DMP1395	Male			
P-0000511-T01-IM3	P-0000511	Colorectal Cancer	Metastasis	Tumor	Chest Wall	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0454	DMP0454	Female			
P-0000513-T01-IM3	P-0000513	Bladder Cancer	Primary	Tumor	Not Applicable	Urethra	Bladder Urothelial Carcinoma	IMPACT341	DMP0455	DMP0455	Male			
P-0000902-T01-IM3	P-0000902	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0829	DMP0829	Male			
P-0000510-T01-IM3	P-0000510	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0457	DMP0457	Male			
P-0000507-T01-IM3	P-0000507	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0458	DMP0458	Female			
P-0000508-T01-IM3	P-0000508	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0459	DMP0459	Female			
P-0000904-T01-IM3	P-0000904	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP0846	DMP0846	Male			
P-0000502-T01-IM3	P-0000502	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0461	DMP0461	Male			
P-0000503-T01-IM3	P-0000503	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0462	DMP0462	Male			
P-0000449-T01-IM3	P-0000449	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0401	DMP0401	Male			
P-0000442-T01-IM3	P-0000442	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0402	DMP0402	Male			
P-0000441-T01-IM3	P-0000441	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0409	DMP0409	Male			
P-0000249-T02-IM3	P-0000249	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0466	DMP0466	Female			
P-0004010-T01-IM3	P-0004010	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0467	DMP0467	Female			
P-0001007-T01-IM3	P-0001007	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0928	DMP0928	Female			
P-0004045-T01-IM3	P-0004045	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0469	DMP0469	Female			
P-0003955-T01-IM3	P-0003955	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0470	DMP0470	Male			
P-0004019-T01-IM3	P-0004019	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0471	DMP0471	Male			
P-0004044-T01-IM3	P-0004044	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0472	DMP0472	Male			
P-0000479-T01-IM3	P-0000479	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0428	DMP0428	Male			
P-0000484-T01-IM3	P-0000484	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0429	DMP0429	Male			
P-0003951-T01-IM3	P-0003951	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0475	DMP0475	Male			
P-0000504-T01-IM3	P-0000504	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0463	DMP0463	Male			
P-0003964-T01-IM3	P-0003964	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0477	DMP0477	Male			
P-0000416-T01-IM3	P-0000416	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0478	DMP0478	Female			
P-0000527-T01-IM3	P-0000527	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0479	DMP0479	Female			
P-0000524-T01-IM3	P-0000524	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0480	DMP0480	Male			
P-0000526-T01-IM3	P-0000526	Colorectal Cancer	Metastasis	Tumor	Ovary	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0481	DMP0481	Female			
P-0000522-T01-IM3	P-0000522	Breast Carcinoma	Metastasis	Tumor	Scalp	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0482	DMP0482	Female			
P-0000519-T01-IM3	P-0000519	Breast Carcinoma	Metastasis	Tumor	Retroperitoneum	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0483	DMP0483	Female			
P-0000515-T01-IM3	P-0000515	Cancer of Unknown Primary	Metastasis	Tumor	Uterus	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0484	DMP0484	Female			
P-0000429-T01-IM3	P-0000429	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP0485	DMP0485	Male			
P-0000525-T01-IM3	P-0000525	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0486	DMP0486	Female			
P-0000518-T01-IM3	P-0000518	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0487	DMP0487	Female			
P-0000509-T01-IM3	P-0000509	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0464	DMP0464	Male			
P-0000517-T01-IM3	P-0000517	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0489	DMP0489	Female			
P-0000514-T01-IM3	P-0000514	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0490	DMP0490	Female			
P-0000520-T01-IM3	P-0000520	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0491	DMP0491	Male			
P-0000516-T01-IM3	P-0000516	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0492	DMP0492	Male			
P-0000523-T01-IM3	P-0000523	Esophagogastric Carcinoma	Metastasis	Tumor	Adrenal Gland	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0493	DMP0493	Male			
P-0000531-T01-IM3	P-0000531	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0494	DMP0494	Female			
P-0003925-T01-IM3	P-0003925	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0465	DMP0465	Male			
P-0001813-T01-IM3	P-0001813	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1676	DMP1676	Male			
P-0000530-T01-IM3	P-0000530	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0498	DMP0498	Female			
P-0000535-T01-IM3	P-0000535	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0499	DMP0499	Female			
P-0001041-T01-IM3	P-0001041	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP0966	DMP0966	Female			
P-0000536-T01-IM3	P-0000536	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0501	DMP0501	Male			
P-0000532-T01-IM3	P-0000532	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0502	DMP0502	Female			
P-0000538-T01-IM3	P-0000538	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0503	DMP0503	Male			
P-0000546-T01-IM3	P-0000546	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0511	DMP0511	Male			
P-0000542-T01-IM3	P-0000542	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0505	DMP0505	Female			
P-0000557-T01-IM3	P-0000557	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0506	DMP0506	Male			
P-0000552-T01-IM3	P-0000552	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0507	DMP0507	Male			
P-0000554-T01-IM3	P-0000554	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0508	DMP0508	Female			
P-0000544-T01-IM3	P-0000544	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0509	DMP0509	Male			
P-0001384-T01-IM3	P-0001384	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP1268	DMP1268	Female			
P-0000581-T01-IM3	P-0000581	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Biphasic Type	IMPACT341	DMP0539	DMP0539	Male			
P-0000134-T02-IM3	P-0000134	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP0512	DMP0512	Female			
P-0000547-T01-IM3	P-0000547	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0513	DMP0513	Female			
P-0000553-T01-IM3	P-0000553	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph Node	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0514	DMP0514	Male			
P-0000561-T01-IM3	P-0000561	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0515	DMP0515	Female			
P-0000569-T01-IM3	P-0000569	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0516	DMP0516	Female			
P-0000564-T01-IM3	P-0000564	Soft Tissue Sarcoma	Metastasis	Tumor	Retroperitoneum	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT341	DMP0517	DMP0517	Male			
P-0000563-T01-IM3	P-0000563	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0518	DMP0518	Male			
P-0000562-T01-IM3	P-0000562	Colorectal Cancer	Metastasis	Tumor	Abdomen	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0519	DMP0519	Female			
P-0000570-T01-IM3	P-0000570	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0520	DMP0520	Male			
P-0003945-T01-IM3	P-0003945	Prostate Cancer	Metastasis	Tumor	Bladder Neck	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0473	DMP0473	Male			
P-0000566-T01-IM3	P-0000566	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP0522	DMP0522	Female			
P-0000571-T01-IM3	P-0000571	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0523	DMP0523	Female			
P-0000558-T01-IM3	P-0000558	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0524	DMP0524	Female			
P-0000350-T01-IM3	P-0000350	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP0525	DMP0525	Female			
P-0000584-T01-IM3	P-0000584	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0526	DMP0526	Female			
P-0000574-T01-IM3	P-0000574	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0527	DMP0527	Female			
P-0000583-T01-IM3	P-0000583	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP0528	DMP0528	Female			
P-0000576-T01-IM3	P-0000576	Uterine Sarcoma	Metastasis	Tumor	Bowel	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0529	DMP0529	Female			
P-0000579-T01-IM3	P-0000579	Soft Tissue Sarcoma	Metastasis	Tumor	Neck	Sinonasal	Rhabdomyosarcoma	IMPACT341	DMP0530	DMP0530	Male			
P-0000572-T01-IM3	P-0000572	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0531	DMP0531	Male			
P-0000580-T01-IM3	P-0000580	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT341	DMP0532	DMP0532	Female			
P-0000578-T01-IM3	P-0000578	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0533	DMP0533	Female			
P-0000575-T01-IM3	P-0000575	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP0534	DMP0534	Female			
P-0000582-T01-IM3	P-0000582	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Eye	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0535	DMP0535	Female			
P-0000376-T02-IM3	P-0000376	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Ovarian Carcinosarcoma	IMPACT341	DMP0536	DMP0536	Female			
P-0000573-T01-IM3	P-0000573	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0537	DMP0537	Male			
P-0000585-T01-IM3	P-0000585	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0538	DMP0538	Female			
P-0000593-T01-IM3	P-0000593	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0551	DMP0551	Male			
P-0000586-T01-IM3	P-0000586	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Hypopharynx	Head and Neck Squamous Cell Carcinoma of Unknown Primary	IMPACT341	DMP0540	DMP0540	Male			
P-0000597-T01-IM3	P-0000597	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0541	DMP0541	Female			
P-0000590-T01-IM3	P-0000590	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0542	DMP0542	Female			
P-0000588-T01-IM3	P-0000588	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0543	DMP0543	Female			
P-0000589-T01-IM3	P-0000589	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT341	DMP0544	DMP0544	Male			
P-0000592-T01-IM3	P-0000592	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0545	DMP0545	Female			
P-0000596-T01-IM3	P-0000596	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT341	DMP0546	DMP0546	Male			
P-0000591-T01-IM3	P-0000591	Cancer of Unknown Primary	Metastasis	Tumor	Heart	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0547	DMP0547	Male			
P-0003908-T01-IM3	P-0003908	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0474	DMP0474	Male			
P-0000587-T01-IM3	P-0000587	Hepatocellular Carcinoma	Metastasis	Tumor	Bone	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0549	DMP0549	Male			
P-0000598-T01-IM3	P-0000598	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT341	DMP0550	DMP0550	Male			
P-0000741-T01-IM3	P-0000741	Mesothelioma	Metastasis	Tumor	Diaphragm	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0686	DMP0686	Male			
P-0000489-T01-IM3	P-0000489	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Minor Salivary Gland	Salivary Carcinoma	IMPACT341	DMP0552	DMP0552	Male			
P-0000595-T01-IM3	P-0000595	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0553	DMP0553	Female			
P-0000594-T01-IM3	P-0000594	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0554	DMP0554	Male			
P-0000599-T01-IM3	P-0000599	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0555	DMP0555	Female			
P-0000613-T01-IM3	P-0000613	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0556	DMP0556	Female			
P-0000605-T01-IM3	P-0000605	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0557	DMP0557	Female			
P-0000604-T01-IM3	P-0000604	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0558	DMP0558	Male			
P-0000614-T01-IM3	P-0000614	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0559	DMP0559	Female			
P-0000606-T01-IM3	P-0000606	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0560	DMP0560	Female			
P-0000612-T01-IM3	P-0000612	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0561	DMP0561	Female			
P-0000607-T01-IM3	P-0000607	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0562	DMP0562	Female			
P-0003939-T01-IM3	P-0003939	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0476	DMP0476	Male			
P-0000616-T01-IM3	P-0000616	Colorectal Cancer	Metastasis	Tumor	Skin	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1585	DMP1585	Female			
P-0000521-T01-IM3	P-0000521	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0488	DMP0488	Male			
P-0000541-T01-IM3	P-0000541	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0496	DMP0496	Male			
P-0000617-T01-IM3	P-0000617	Breast Carcinoma	Metastasis	Tumor	Peritoneum	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0567	DMP0567	Female			
P-0000602-T01-IM3	P-0000602	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0568	DMP0568	Female			
P-0000611-T01-IM3	P-0000611	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0569	DMP0569	Male			
P-0000609-T01-IM3	P-0000609	Soft Tissue Sarcoma	Metastasis	Tumor	Bladder	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT341	DMP0570	DMP0570	Male			
P-0000621-T01-IM3	P-0000621	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0571	DMP0571	Male			
P-0000618-T01-IM3	P-0000618	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0572	DMP0572	Male			
P-0000627-T01-IM3	P-0000627	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP0573	DMP0573	Female			
P-0000622-T01-IM3	P-0000622	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0574	DMP0574	Female			
P-0000624-T01-IM3	P-0000624	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0575	DMP0575	Female			
P-0000625-T01-IM3	P-0000625	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0576	DMP0576	Female			
P-0000628-T01-IM3	P-0000628	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0577	DMP0577	Male			
P-0000626-T01-IM3	P-0000626	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0578	DMP0578	Female			
P-0000620-T01-IM3	P-0000620	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0579	DMP0579	Female			
P-0000623-T01-IM3	P-0000623	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0580	DMP0580	Female			
P-0000619-T01-IM3	P-0000619	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0581	DMP0581	Male			
P-0000630-T01-IM3	P-0000630	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0582	DMP0582	Female			
P-0000629-T01-IM3	P-0000629	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0583	DMP0583	Female			
P-0000633-T01-IM3	P-0000633	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0584	DMP0584	Female			
P-0000641-T01-IM3	P-0000641	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0585	DMP0585	Male			
P-0000632-T01-IM3	P-0000632	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0586	DMP0586	Male			
P-0000643-T01-IM3	P-0000643	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0587	DMP0587	Female			
P-0000645-T01-IM3	P-0000645	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0588	DMP0588	Female			
P-0000642-T01-IM3	P-0000642	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0589	DMP0589	Male			
P-0000637-T01-IM3	P-0000637	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0590	DMP0590	Female			
P-0000639-T01-IM3	P-0000639	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0591	DMP0591	Male			
P-0000635-T01-IM3	P-0000635	Colorectal Cancer	Metastasis	Tumor	Lung	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0592	DMP0592	Male			
P-0000560-T01-IM3	P-0000560	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0521	DMP0521	Male			
P-0000636-T01-IM3	P-0000636	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0594	DMP0594	Female			
P-0000644-T01-IM3	P-0000644	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0595	DMP0595	Female			
P-0000638-T01-IM3	P-0000638	Breast Carcinoma	Metastasis	Tumor	Heart	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0596	DMP0596	Female			
P-0000634-T01-IM3	P-0000634	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP0597	DMP0597	Female			
P-0000649-T01-IM3	P-0000649	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0598	DMP0598	Female			
P-0000651-T01-IM3	P-0000651	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0599	DMP0599	Female			
P-0000657-T01-IM3	P-0000657	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0600	DMP0600	Male			
P-0000653-T01-IM3	P-0000653	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341	DMP0601	DMP0601	Male			
P-0000658-T01-IM3	P-0000658	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0602	DMP0602	Female			
P-0000656-T01-IM3	P-0000656	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0603	DMP0603	Female			
P-0000600-T01-IM3	P-0000600	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0548	DMP0548	Male			
P-0000615-T01-IM3	P-0000615	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0563	DMP0563	Male			
P-0000603-T01-IM3	P-0000603	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0565	DMP0565	Male			
P-0000650-T01-IM3	P-0000650	Germ Cell Tumor	Metastasis	Tumor	Brain	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0607	DMP0607	Male			
P-0000648-T01-IM3	P-0000648	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Teratoma	IMPACT341	DMP0608	DMP0608	Male			
P-0000654-T01-IM3	P-0000654	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP0609	DMP0609	Male			
P-0000652-T01-IM3	P-0000652	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Angiosarcoma	IMPACT341	DMP0610	DMP0610	Female			
P-0000661-T01-IM3	P-0000661	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0611	DMP0611	Female			
P-0000670-T01-IM3	P-0000670	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0612	DMP0612	Female			
P-0000663-T01-IM3	P-0000663	Germ Cell Tumor	Metastasis	Tumor	Liver	Retroperitoneum	Mixed Germ Cell Tumor	IMPACT341	DMP0613	DMP0613	Male			
P-0000664-T01-IM3	P-0000664	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0614	DMP0614	Male			
P-0000665-T01-IM3	P-0000665	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Seminoma	IMPACT341	DMP0615	DMP0615	Male			
P-0000667-T01-IM3	P-0000667	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0616	DMP0616	Female			
P-0000666-T01-IM3	P-0000666	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0617	DMP0617	Female			
P-0000671-T01-IM3	P-0000671	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP0618	DMP0618	Female			
P-0001358-T02-IM3	P-0001358	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP1545	DMP1545	Male			
P-0000673-T01-IM3	P-0000673	Soft Tissue Sarcoma	Metastasis	Tumor	Diaphragm	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0620	DMP0620	Female			
P-0000674-T01-IM3	P-0000674	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0621	DMP0621	Female			
P-0000669-T01-IM3	P-0000669	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0622	DMP0622	Female			
P-0000660-T01-IM3	P-0000660	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Follicular Dendritic Cell Sarcoma	IMPACT341	DMP0623	DMP0623	Male			
P-0000610-T01-IM3	P-0000610	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0566	DMP0566	Male			
P-0000668-T01-IM3	P-0000668	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341	DMP0625	DMP0625	Female			
P-0000640-T01-IM3	P-0000640	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0593	DMP0593	Male			
P-0000687-T01-IM3	P-0000687	Colorectal Cancer	Metastasis	Tumor	Ovary	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0627	DMP0627	Female			
P-0000688-T01-IM3	P-0000688	Cervical Cancer	Metastasis	Tumor	Ovary	Cervix	Gastric Type Mucinous Carcinoma	IMPACT341	DMP0628	DMP0628	Female			
P-0000677-T01-IM3	P-0000677	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0629	DMP0629	Male			
P-0000680-T01-IM3	P-0000680	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Myxofibrosarcoma	IMPACT341	DMP0630	DMP0630	Female			
P-0000684-T01-IM3	P-0000684	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0631	DMP0631	Female			
P-0000689-T01-IM3	P-0000689	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0632	DMP0632	Male			
P-0000682-T01-IM3	P-0000682	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0633	DMP0633	Male			
P-0000659-T01-IM3	P-0000659	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0604	DMP0604	Male			
P-0000679-T01-IM3	P-0000679	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP0635	DMP0635	Female			
P-0000685-T01-IM3	P-0000685	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0636	DMP0636	Male			
P-0000681-T01-IM3	P-0000681	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0637	DMP0637	Female			
P-0000678-T01-IM3	P-0000678	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0638	DMP0638	Male			
P-0000686-T01-IM3	P-0000686	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT341	DMP0639	DMP0639	Male			
P-0000676-T01-IM3	P-0000676	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0640	DMP0640	Female			
P-0000702-T01-IM3	P-0000702	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0641	DMP0641	Female			
P-0000704-T01-IM3	P-0000704	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0642	DMP0642	Female			
P-0000693-T01-IM3	P-0000693	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Small Bowel	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0643	DMP0643	Male			
P-0000694-T01-IM3	P-0000694	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0644	DMP0644	Male			
P-0000698-T01-IM3	P-0000698	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP0645	DMP0645	Female			
P-0000696-T01-IM3	P-0000696	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT341	DMP0646	DMP0646	Female			
P-0000697-T01-IM3	P-0000697	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP0647	DMP0647	Female			
P-0000699-T01-IM3	P-0000699	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0648	DMP0648	Male			
P-0000703-T01-IM3	P-0000703	Colorectal Cancer	Metastasis	Tumor	Omentum	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0649	DMP0649	Male			
P-0000692-T01-IM3	P-0000692	Sex Cord Stromal Tumor	Primary	Tumor	Not Applicable	Testis	Testicular Sex Cord Stromal Tumor, Unclassified	IMPACT341	DMP0650	DMP0650	Male			
P-0001866-T01-IM3	P-0001866	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP1747	DMP1747	Female			
P-0000690-T01-IM3	P-0000690	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP0652	DMP0652	Female			
P-0000695-T01-IM3	P-0000695	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0653	DMP0653	Male			
P-0000710-T01-IM3	P-0000710	Chondroblastoma	Primary	Tumor	Not Applicable	Bone	Chondroblastoma	IMPACT341	DMP0654	DMP0654	Female			
P-0000718-T01-IM3	P-0000718	Chondrosarcoma	Primary	Tumor	Not Applicable	Buttock	Myxoid Chondrosarcoma	IMPACT341	DMP0655	DMP0655	Male			
P-0000717-T01-IM3	P-0000717	Salivary Carcinoma	Metastasis	Tumor	Pleura	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0656	DMP0656	Male			
P-0000709-T01-IM3	P-0000709	Cancer of Unknown Primary	Metastasis	Tumor	Ovary	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0657	DMP0657	Female			
P-0000705-T01-IM3	P-0000705	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0658	DMP0658	Male			
P-0000713-T01-IM3	P-0000713	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0659	DMP0659	Female			
P-0000716-T01-IM3	P-0000716	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0660	DMP0660	Male			
P-0000706-T01-IM3	P-0000706	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0661	DMP0661	Male			
P-0000714-T01-IM3	P-0000714	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0662	DMP0662	Female			
P-0000711-T01-IM3	P-0000711	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0663	DMP0663	Female			
P-0000708-T01-IM3	P-0000708	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Bone	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP0664	DMP0664	Male			
P-0000707-T01-IM3	P-0000707	Germ Cell Tumor	Metastasis	Tumor	Adrenal Gland	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0665	DMP0665	Male			
P-0000720-T01-IM3	P-0000720	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT341	DMP0666	DMP0666	Female			
P-0000655-T01-IM3	P-0000655	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0605	DMP0605	Male			
P-0000730-T01-IM3	P-0000730	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0668	DMP0668	Male			
P-0000719-T01-IM3	P-0000719	Ewing Sarcoma	Primary	Tumor	Not Applicable	Neck	Ewing Sarcoma	IMPACT341	DMP0669	DMP0669	Female			
P-0000647-T01-IM3	P-0000647	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0606	DMP0606	Male			
P-0000379-T02-IM3	P-0000379	Chondrosarcoma	Metastasis	Tumor	Bone	Soft Tissue	Myxoid Chondrosarcoma	IMPACT341	DMP0671	DMP0671	Male			
P-0000731-T01-IM3	P-0000731	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341	DMP0672	DMP0672	Female			
P-0000726-T01-IM3	P-0000726	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0673	DMP0673	Female			
P-0000723-T01-IM3	P-0000723	Ewing Sarcoma	Primary	Tumor	Not Applicable	Flank	Ewing Sarcoma	IMPACT341	DMP0674	DMP0674	Female			
P-0000724-T01-IM3	P-0000724	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Adenocarcinoma	IMPACT341	DMP0675	DMP0675	Female			
P-0000728-T01-IM3	P-0000728	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Liver	Skin	Merkel Cell Carcinoma	IMPACT341	DMP0676	DMP0676	Female			
P-0000722-T01-IM3	P-0000722	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0677	DMP0677	Male			
P-0000729-T01-IM3	P-0000729	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0678	DMP0678	Male			
P-0000721-T01-IM3	P-0000721	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0679	DMP0679	Female			
P-0000737-T01-IM3	P-0000737	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0680	DMP0680	Female			
P-0000738-T01-IM3	P-0000738	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0681	DMP0681	Male			
P-0000732-T01-IM3	P-0000732	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0682	DMP0682	Male			
P-0000733-T01-IM3	P-0000733	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Blood Vessel	Intimal Sarcoma	IMPACT341	DMP0683	DMP0683	Male			
P-0000743-T01-IM3	P-0000743	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT341	DMP0684	DMP0684	Female			
P-0000740-T01-IM3	P-0000740	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341	DMP0685	DMP0685	Female			
P-0000750-T01-IM3	P-0000750	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0698	DMP0698	Male			
P-0000736-T01-IM3	P-0000736	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0687	DMP0687	Female			
P-0000746-T01-IM3	P-0000746	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0688	DMP0688	Male			
P-0000742-T01-IM3	P-0000742	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0689	DMP0689	Male			
P-0000744-T01-IM3	P-0000744	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0690	DMP0690	Female			
P-0000739-T01-IM3	P-0000739	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0691	DMP0691	Male			
P-0000745-T01-IM3	P-0000745	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0692	DMP0692	Female			
P-0000735-T01-IM3	P-0000735	Thymic Tumor	Metastasis	Tumor	Lymph Node	Thymus	Thymic Carcinoma	IMPACT341	DMP0693	DMP0693	Male			
P-0000760-T01-IM3	P-0000760	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0694	DMP0694	Male			
P-0000672-T01-IM3	P-0000672	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0624	DMP0624	Male			
P-0000748-T01-IM3	P-0000748	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP0696	DMP0696	Male			
P-0000757-T01-IM3	P-0000757	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0697	DMP0697	Female			
P-0000824-T01-IM3	P-0000824	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0764	DMP0764	Female			
P-0000759-T01-IM3	P-0000759	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0699	DMP0699	Male			
P-0000758-T01-IM3	P-0000758	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0700	DMP0700	Male			
P-0000756-T01-IM3	P-0000756	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0701	DMP0701	Female			
P-0000749-T01-IM3	P-0000749	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP0702	DMP0702	Male			
P-0000747-T01-IM3	P-0000747	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0703	DMP0703	Male			
P-0000751-T01-IM3	P-0000751	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0704	DMP0704	Male			
P-0000754-T01-IM3	P-0000754	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0705	DMP0705	Female			
P-0000761-T01-IM3	P-0000761	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP0706	DMP0706	Female			
P-0000771-T01-IM3	P-0000771	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP0707	DMP0707	Male			
P-0000525-T02-IM3	P-0000525	Breast Carcinoma	Metastasis	Tumor	Cervix	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0708	DMP0708	Female			
P-0000766-T01-IM3	P-0000766	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0709	DMP0709	Male			
P-0000762-T01-IM3	P-0000762	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0710	DMP0710	Male			
P-0000763-T01-IM3	P-0000763	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0711	DMP0711	Female			
P-0000769-T01-IM3	P-0000769	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0712	DMP0712	Male			
P-0000767-T01-IM3	P-0000767	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT341	DMP0713	DMP0713	Female			
P-0000770-T01-IM3	P-0000770	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Metaplastic Carcinosarcoma	IMPACT341	DMP0714	DMP0714	Female			
P-0000768-T01-IM3	P-0000768	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP0715	DMP0715	Male			
P-0000772-T01-IM3	P-0000772	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0716	DMP0716	Female			
P-0000764-T01-IM3	P-0000764	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Chest Wall	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0717	DMP0717	Male			
P-0000765-T01-IM3	P-0000765	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0718	DMP0718	Female			
P-0000779-T01-IM3	P-0000779	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Back	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP0719	DMP0719	Male			
P-0000775-T01-IM3	P-0000775	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Major Salivary Gland	High-Grade Salivary Gland Carcinoma	IMPACT341	DMP0720	DMP0720	Female			
P-0000784-T01-IM3	P-0000784	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT341	DMP0721	DMP0721	Male			
P-0000776-T01-IM3	P-0000776	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0722	DMP0722	Female			
P-0000783-T01-IM3	P-0000783	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP0723	DMP0723	Male			
P-0000780-T01-IM3	P-0000780	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP0724	DMP0724	Female			
P-0000782-T01-IM3	P-0000782	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0725	DMP0725	Male			
P-0000778-T01-IM3	P-0000778	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0726	DMP0726	Female			
P-0000100-T02-IM3	P-0000100	Germ Cell Tumor	Metastasis	Tumor	Pelvis	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0727	DMP0727	Male			
P-0000785-T01-IM3	P-0000785	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0728	DMP0728	Female			
P-0000786-T01-IM3	P-0000786	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0729	DMP0729	Female			
P-0000777-T01-IM3	P-0000777	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0730	DMP0730	Female			
P-0000774-T01-IM3	P-0000774	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT341	DMP0731	DMP0731	Male			
P-0002058-T01-IM3	P-0002058	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP1818	DMP1818	Female			
P-0000796-T01-IM3	P-0000796	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP0733	DMP0733	Male			
P-0000798-T01-IM3	P-0000798	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0734	DMP0734	Female			
P-0000802-T01-IM3	P-0000802	Colorectal Cancer	Metastasis	Tumor	Pelvis	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0735	DMP0735	Female			
P-0000789-T01-IM3	P-0000789	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0736	DMP0736	Female			
P-0000797-T01-IM3	P-0000797	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2068	DMP2068	Male			
P-0000787-T01-IM3	P-0000787	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0738	DMP0738	Female			
P-0000790-T01-IM3	P-0000790	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0739	DMP0739	Male			
P-0000795-T01-IM3	P-0000795	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0740	DMP0740	Female			
P-0000791-T01-IM3	P-0000791	Germ Cell Tumor	Metastasis	Tumor	Abdomen	Testis	Seminoma	IMPACT341	DMP0741	DMP0741	Male			
P-0000792-T01-IM3	P-0000792	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0742	DMP0742	Male			
P-0002076-T01-IM3	P-0002076	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP1833	DMP1833	Female			
P-0000788-T01-IM3	P-0000788	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP0745	DMP0745	Female			
P-0000799-T01-IM3	P-0000799	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP0746	DMP0746	Male			
P-0000812-T01-IM3	P-0000812	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP0747	DMP0747	Male			
P-0000813-T01-IM3	P-0000813	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341	DMP0748	DMP0748	Male			
P-0000815-T01-IM3	P-0000815	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Chondroblastic Osteosarcoma	IMPACT341	DMP0749	DMP0749	Male			
P-0000804-T01-IM3	P-0000804	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0750	DMP0750	Female			
P-0000803-T01-IM3	P-0000803	Soft Tissue Sarcoma	Local Recurrence	Tumor	Pelvis	Testis	Well-Differentiated Liposarcoma	IMPACT341	DMP0751	DMP0751	Male			
P-0000805-T01-IM3	P-0000805	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0752	DMP0752	Female			
P-0000816-T01-IM3	P-0000816	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0753	DMP0753	Female			
P-0000808-T01-IM3	P-0000808	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0754	DMP0754	Female			
P-0000807-T01-IM3	P-0000807	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0755	DMP0755	Male			
P-0000811-T01-IM3	P-0000811	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0756	DMP0756	Male			
P-0000814-T01-IM3	P-0000814	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0757	DMP0757	Female			
P-0000806-T01-IM3	P-0000806	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0758	DMP0758	Female			
P-0000809-T01-IM3	P-0000809	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0759	DMP0759	Female			
P-0000818-T01-IM3	P-0000818	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0760	DMP0760	Male			
P-0000830-T01-IM3	P-0000830	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0761	DMP0761	Female			
P-0000831-T01-IM3	P-0000831	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0762	DMP0762	Male			
P-0000823-T01-IM3	P-0000823	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Seminoma	IMPACT341	DMP0763	DMP0763	Male			
P-0001027-T01-IM3	P-0001027	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0935	DMP0935	Male			
P-0000825-T01-IM3	P-0000825	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0765	DMP0765	Female			
P-0000821-T01-IM3	P-0000821	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Skin Basal Cell Carcinoma	IMPACT341	DMP0766	DMP0766	Male			
P-0000826-T01-IM3	P-0000826	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Chest Wall	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0767	DMP0767	Male			
P-0000675-T01-IM3	P-0000675	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0626	DMP0626	Male			
P-0000827-T01-IM3	P-0000827	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0769	DMP0769	Female			
P-0000822-T01-IM3	P-0000822	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0770	DMP0770	Male			
P-0000829-T01-IM3	P-0000829	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP0771	DMP0771	Male			
P-0000820-T01-IM3	P-0000820	Breast Carcinoma	Metastasis	Tumor	Pelvis	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0772	DMP0772	Female			
P-0000819-T01-IM3	P-0000819	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0773	DMP0773	Male			
P-0000846-T01-IM3	P-0000846	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP0774	DMP0774	Male			
P-0000837-T01-IM3	P-0000837	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Breast Angiosarcoma	IMPACT341	DMP0775	DMP0775	Female			
P-0000840-T01-IM3	P-0000840	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0776	DMP0776	Female			
P-0000845-T01-IM3	P-0000845	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Bone	Synovial Sarcoma	IMPACT341	DMP0777	DMP0777	Male			
P-0000839-T01-IM3	P-0000839	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0778	DMP0778	Female			
P-0000848-T01-IM3	P-0000848	Chondrosarcoma	Metastasis	Tumor	Forehead	Clivus	Chondrosarcoma	IMPACT341	DMP0779	DMP0779	Male			
P-0000841-T01-IM3	P-0000841	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0780	DMP0780	Female			
P-0000683-T01-IM3	P-0000683	Prostate Cancer	Metastasis	Tumor	Urethra	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0634	DMP0634	Male			
P-0000838-T01-IM3	P-0000838	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0782	DMP0782	Female			
P-0000675-T02-IM3	P-0000675	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT341	DMP0667	DMP0667	Male			
P-0000843-T01-IM3	P-0000843	Colorectal Cancer	Metastasis	Tumor	Lung	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP0784	DMP0784	Female			
P-0002212-T01-IM3	P-0002212	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP2090	DMP2090	Male			
P-0000864-T01-IM3	P-0000864	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0786	DMP0786	Female			
P-0000870-T01-IM3	P-0000870	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0787	DMP0787	Male			
P-0000872-T01-IM3	P-0000872	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0788	DMP0788	Male			
P-0000866-T01-IM3	P-0000866	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Buttock	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0789	DMP0789	Female			
P-0000863-T01-IM3	P-0000863	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Alveolar Soft Part Sarcoma	IMPACT341	DMP0790	DMP0790	Male			
P-0000862-T01-IM3	P-0000862	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0791	DMP0791	Female			
P-0000871-T01-IM3	P-0000871	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0792	DMP0792	Female			
P-0000867-T01-IM3	P-0000867	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0793	DMP0793	Male			
P-0000865-T01-IM3	P-0000865	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP0794	DMP0794	Female			
P-0000868-T01-IM3	P-0000868	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0795	DMP0795	Female			
P-0000869-T01-IM3	P-0000869	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0796	DMP0796	Male			
P-0000849-T01-IM3	P-0000849	Soft Tissue Sarcoma	Metastasis	Tumor	Peritoneum	Bowel	Clear Cell Sarcoma	IMPACT341	DMP0797	DMP0797	Female			
P-0000852-T01-IM3	P-0000852	Melanoma	Metastasis	Tumor	Lung	Eye	Uveal Melanoma	IMPACT341	DMP0798	DMP0798	Male			
P-0000853-T01-IM3	P-0000853	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0799	DMP0799	Female			
P-0000860-T01-IM3	P-0000860	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0800	DMP0800	Female			
P-0000851-T01-IM3	P-0000851	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Neck	Alveolar Soft Part Sarcoma	IMPACT341	DMP0801	DMP0801	Male			
P-0000854-T01-IM3	P-0000854	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP0802	DMP0802	Male			
P-0000859-T01-IM3	P-0000859	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Chest Wall	Angiosarcoma	IMPACT341	DMP0803	DMP0803	Male			
P-0000856-T01-IM3	P-0000856	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0804	DMP0804	Male			
P-0000858-T01-IM3	P-0000858	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0806	DMP0806	Female			
P-0000855-T01-IM3	P-0000855	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0807	DMP0807	Male			
P-0000850-T01-IM3	P-0000850	Breast Sarcoma	Metastasis	Tumor	Axilla	Breast	Breast Angiosarcoma	IMPACT341	DMP0808	DMP0808	Female			
P-0000861-T01-IM3	P-0000861	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0809	DMP0809	Female			
P-0000883-T01-IM3	P-0000883	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP0810	DMP0810	Male			
P-0000820-T02-IM3	P-0000820	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0811	DMP0811	Female			
P-0000878-T01-IM3	P-0000878	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Neuroendocrine Carcinoma	IMPACT341	DMP0812	DMP0812	Female			
P-0000884-T01-IM3	P-0000884	Histiocytosis	Primary	Tumor	Not Applicable	Eyelid	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT341	DMP0813	DMP0813	Male			
P-0000873-T01-IM3	P-0000873	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pancreas	Lung	Lung Adenocarcinoma	IMPACT341	DMP0814	DMP0814	Male			
P-0000880-T01-IM3	P-0000880	Bladder Cancer	Metastasis	Tumor	Colon	Bladder	Plasmacytoid/Signet Ring Cell Bladder Carcinoma	IMPACT341	DMP0815	DMP0815	Female			
P-0000877-T01-IM3	P-0000877	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0816	DMP0816	Male			
P-0000874-T01-IM3	P-0000874	Colorectal Cancer	Metastasis	Tumor	Brain	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0817	DMP0817	Female			
P-0002233-T01-IM3	P-0002233	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP2159	DMP2159	Male			
P-0000875-T01-IM3	P-0000875	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0819	DMP0819	Male			
P-0000881-T01-IM3	P-0000881	Soft Tissue Sarcoma	Metastasis	Tumor	Kidney	Lower Extremity	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0820	DMP0820	Female			
P-0000879-T01-IM3	P-0000879	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP0821	DMP0821	Female			
P-0000887-T01-IM3	P-0000887	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0822	DMP0822	Female			
P-0000885-T01-IM3	P-0000885	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0823	DMP0823	Female			
P-0000886-T01-IM3	P-0000886	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0000240-T01-IM3	P-0000240	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0226	DMP0226	Female			
P-0000354-T01-IM3	P-0000354	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0306	DMP0306	Male			
P-0000891-T01-IM3	P-0000891	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0827	DMP0827	Male			
P-0000896-T01-IM3	P-0000896	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP0828	DMP0828	Male			
P-0000359-T01-IM3	P-0000359	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0326	DMP0326	Female			
P-0000895-T01-IM3	P-0000895	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT341	DMP0830	DMP0830	Male			
P-0000900-T01-IM3	P-0000900	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0831	DMP0831	Male			
P-0000892-T01-IM3	P-0000892	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0832	DMP0832	Male			
P-0000899-T01-IM3	P-0000899	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0833	DMP0833	Male			
P-0000901-T01-IM3	P-0000901	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0834	DMP0834	Female			
P-0000725-T01-IM3	P-0000725	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0670	DMP0670	Male			
P-0000893-T01-IM3	P-0000893	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP0836	DMP0836	Male			
P-0000898-T01-IM3	P-0000898	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT341	DMP0837	DMP0837	Male			
P-0000894-T01-IM3	P-0000894	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT341	DMP0838	DMP0838	Male			
P-0000897-T01-IM3	P-0000897	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341	DMP0839	DMP0839	Female			
P-0000911-T01-IM3	P-0000911	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0840	DMP0840	Male			
P-0000321-T02-IM3	P-0000321	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Undifferentiated Carcinoma	IMPACT341	DMP0841	DMP0841	Female			
P-0000908-T01-IM3	P-0000908	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0842	DMP0842	Male			
P-0000915-T01-IM3	P-0000915	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0843	DMP0843	Male			
P-0000914-T01-IM3	P-0000914	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP0844	DMP0844	Male			
P-0000905-T01-IM3	P-0000905	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Spindle Cell Rhabdomyosarcoma	IMPACT341	DMP0845	DMP0845	Male			
P-0000415-T01-IM3	P-0000415	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0381	DMP0381	Female			
P-0000907-T01-IM3	P-0000907	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0847	DMP0847	Female			
P-0000755-T01-IM3	P-0000755	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0695	DMP0695	Male			
P-0000910-T01-IM3	P-0000910	Salivary Carcinoma	Metastasis	Tumor	Liver	Major Salivary Gland	Mucoepidermoid Carcinoma	IMPACT341	DMP0850	DMP0850	Female			
P-0000903-T01-IM3	P-0000903	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0851	DMP0851	Male			
P-0000906-T01-IM3	P-0000906	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0852	DMP0852	Male			
P-0000916-T01-IM3	P-0000916	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0853	DMP0853	Male			
P-0000923-T01-IM3	P-0000923	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Myoepithelial Carcinoma	IMPACT341	DMP0854	DMP0854	Female			
P-0000928-T01-IM3	P-0000928	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341	DMP0855	DMP0855	Male			
P-0000919-T01-IM3	P-0000919	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0856	DMP0856	Male			
P-0000926-T01-IM3	P-0000926	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0857	DMP0857	Female			
P-0000927-T01-IM3	P-0000927	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP0858	DMP0858	Female			
P-0000917-T01-IM3	P-0000917	Cancer of Unknown Primary	Metastasis	Tumor	Sigmoid Colon	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0859	DMP0859	Male			
P-0000925-T01-IM3	P-0000925	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP0860	DMP0860	Female			
P-0000920-T01-IM3	P-0000920	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0861	DMP0861	Female			
P-0000153-T02-IM3	P-0000153	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0862	DMP0862	Female			
P-0000924-T01-IM3	P-0000924	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP0863	DMP0863	Female			
P-0000922-T01-IM3	P-0000922	Melanoma	Metastasis	Tumor	Adrenal Gland	Skin	Cutaneous Melanoma	IMPACT341	DMP0864	DMP0864	Male			
P-0000929-T01-IM3	P-0000929	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pancreas	Lung	Lung Adenocarcinoma	IMPACT341	DMP0866	DMP0866	Male			
P-0000918-T01-IM3	P-0000918	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0867	DMP0867	Male			
P-0000938-T01-IM3	P-0000938	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0868	DMP0868	Male			
P-0000933-T01-IM3	P-0000933	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0869	DMP0869	Female			
P-0000943-T01-IM3	P-0000943	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP0870	DMP0870	Female			
P-0000932-T01-IM3	P-0000932	Biliary Cancer	Metastasis	Tumor	Pelvis	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0871	DMP0871	Male			
P-0000936-T01-IM3	P-0000936	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0872	DMP0872	Male			
P-0000533-T01-IM3	P-0000533	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0500	DMP0500	Female			
P-0000940-T01-IM3	P-0000940	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Transverse Colon	Colon Adenocarcinoma	IMPACT341	DMP0874	DMP0874	Female			
P-0000939-T01-IM3	P-0000939	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Skin Basal Cell Carcinoma	IMPACT341	DMP0875	DMP0875	Female			
P-0000691-T01-IM3	P-0000691	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0768	DMP0768	Male			
P-0000942-T01-IM3	P-0000942	Hepatocellular Carcinoma	Metastasis	Tumor	Peritoneum	Liver	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0877	DMP0877	Male			
P-0000842-T01-IM3	P-0000842	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0781	DMP0781	Male			
P-0000930-T01-IM3	P-0000930	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP0879	DMP0879	Male			
P-0000944-T01-IM3	P-0000944	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0880	DMP0880	Female			
P-0000950-T01-IM3	P-0000950	Small Bowel Cancer	Primary	Tumor	Not Applicable	Duodenum-Jejunum	Small Bowel Adenocarcinoma	IMPACT341	DMP0881	DMP0881	Male			
P-0000950-T02-IM3	P-0000950	Small Bowel Cancer	Metastasis	Tumor	Lung	Small Bowel	Small Bowel Adenocarcinoma	IMPACT341	DMP0882	DMP0882	Male			
P-0000947-T01-IM3	P-0000947	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0883	DMP0883	Female			
P-0000951-T01-IM3	P-0000951	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0884	DMP0884	Male			
P-0000958-T01-IM3	P-0000958	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT341	DMP0885	DMP0885	Female			
P-0000957-T01-IM3	P-0000957	Salivary Carcinoma	Metastasis	Tumor	Eye	Minor Salivary Gland	Salivary Duct Carcinoma	IMPACT341	DMP0886	DMP0886	Female			
P-0000956-T01-IM3	P-0000956	Small Bowel Cancer	Metastasis	Tumor	Omentum	Jejunum	Small Bowel Adenocarcinoma	IMPACT341	DMP0887	DMP0887	Female			
P-0000952-T01-IM3	P-0000952	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0888	DMP0888	Female			
P-0000948-T01-IM3	P-0000948	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0889	DMP0889	Female			
P-0000946-T01-IM3	P-0000946	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0890	DMP0890	Female			
P-0000976-T01-IM3	P-0000976	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0902	DMP0902	Female			
P-0000949-T01-IM3	P-0000949	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0892	DMP0892	Male			
P-0000978-T01-IM3	P-0000978	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP0893	DMP0893	Female			
P-0000979-T01-IM3	P-0000979	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0894	DMP0894	Female			
P-0000984-T01-IM3	P-0000984	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0895	DMP0895	Female			
P-0000977-T01-IM3	P-0000977	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0896	DMP0896	Male			
P-0000987-T01-IM3	P-0000987	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0897	DMP0897	Male			
P-0000982-T01-IM3	P-0000982	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0898	DMP0898	Female			
P-0000817-T01-IM3	P-0000817	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Back	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0899	DMP0899	Male			
P-0000985-T01-IM3	P-0000985	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0900	DMP0900	Female			
P-0000988-T01-IM3	P-0000988	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0901	DMP0901	Male			
P-0001018-T01-IM3	P-0001018	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0926	DMP0926	Female			
P-0000980-T01-IM3	P-0000980	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0903	DMP0903	Male			
P-0000995-T01-IM3	P-0000995	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP0904	DMP0904	Male			
P-0000999-T01-IM3	P-0000999	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP0905	DMP0905	Male			
P-0001002-T01-IM3	P-0001002	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Bone	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP0906	DMP0906	Female			
P-0001003-T01-IM3	P-0001003	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0907	DMP0907	Female			
P-0000989-T01-IM3	P-0000989	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0908	DMP0908	Female			
P-0000994-T01-IM3	P-0000994	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP0909	DMP0909	Female			
P-0000997-T01-IM3	P-0000997	Colorectal Cancer	Metastasis	Tumor	Abdomen	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1531	DMP1531	Male			
P-0000991-T01-IM3	P-0000991	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0911	DMP0911	Female			
P-0001000-T01-IM3	P-0001000	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Alveolar Soft Part Sarcoma	IMPACT341	DMP0912	DMP0912	Male			
P-0001001-T01-IM3	P-0001001	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP0913	DMP0913	Male			
P-0000998-T01-IM3	P-0000998	Non-Small Cell Lung Cancer	Metastasis	Tumor	Skin	Lung	Atypical Lung Carcinoid	IMPACT341	DMP0914	DMP0914	Female			
P-0000993-T01-IM3	P-0000993	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0915	DMP0915	Male			
P-0000992-T01-IM3	P-0000992	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0916	DMP0916	Male			
P-0001012-T01-IM3	P-0001012	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0917	DMP0917	Male			
P-0001005-T01-IM3	P-0001005	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP0918	DMP0918	Female			
P-0001014-T01-IM3	P-0001014	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Seminoma	IMPACT341	DMP0919	DMP0919	Male			
P-0001009-T01-IM3	P-0001009	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0920	DMP0920	Male			
P-0001013-T01-IM3	P-0001013	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT341	DMP0921	DMP0921	Male			
P-0001017-T01-IM3	P-0001017	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0922	DMP0922	Male			
P-0001011-T01-IM3	P-0001011	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0923	DMP0923	Female			
P-0001008-T01-IM3	P-0001008	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0924	DMP0924	Female			
P-0001010-T01-IM3	P-0001010	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP0925	DMP0925	Female			
P-0001015-T01-IM3	P-0001015	Thyroid Cancer	Metastasis	Tumor	Liver	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP0931	DMP0931	Female			
P-0001004-T01-IM3	P-0001004	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0927	DMP0927	Male			
P-0001294-T01-IM3	P-0001294	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1205	DMP1205	Female			
P-0001016-T01-IM3	P-0001016	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Uterus	Embryonal Rhabdomyosarcoma	IMPACT341	DMP0929	DMP0929	Female			
P-0001520-T01-IM3	P-0001520	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1414	DMP1414	Male			
P-0001714-T01-IM3	P-0001714	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1597	DMP1597	Female			
P-0001019-T01-IM3	P-0001019	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT341	DMP0932	DMP0932	Male			
P-0001023-T01-IM3	P-0001023	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0933	DMP0933	Female			
P-0001031-T01-IM3	P-0001031	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP0934	DMP0934	Female			
P-0001110-T01-IM3	P-0001110	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP1020	DMP1020	Male			
P-0001026-T01-IM3	P-0001026	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Small Cell Osteosarcoma	IMPACT341	DMP0936	DMP0936	Male			
P-0001759-T01-IM3	P-0001759	Thyroid Cancer	Metastasis	Tumor	Brain	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1636	DMP1636	Female			
P-0001029-T01-IM3	P-0001029	Melanoma	Metastasis	Tumor	Liver	Foot	Acral Melanoma	IMPACT341	DMP0938	DMP0938	Male			
P-0001034-T01-IM3	P-0001034	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP0939	DMP0939	Female			
P-0000847-T01-IM3	P-0000847	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0783	DMP0783	Male			
P-0001030-T01-IM3	P-0001030	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP0941	DMP0941	Female			
P-0001020-T01-IM3	P-0001020	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP0942	DMP0942	Male			
P-0000912-T01-IM3	P-0000912	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0849	DMP0849	Male			
P-0000962-T01-IM3	P-0000962	Uterine Sarcoma	Metastasis	Tumor	Retroperitoneum	Soft Tissue	Uterine Perivascular Epithelioid Cell Tumor	IMPACT341	DMP0944	DMP0944	Female			
P-0000965-T01-IM3	P-0000965	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0945	DMP0945	Female			
P-0000973-T01-IM3	P-0000973	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0946	DMP0946	Female			
P-0000969-T01-IM3	P-0000969	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0947	DMP0947	Female			
P-0001800-T01-IM3	P-0001800	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1657	DMP1657	Female			
P-0000972-T01-IM3	P-0000972	Chondrosarcoma	Metastasis	Tumor	Diaphragm	Rib	Myxoid Chondrosarcoma	IMPACT341	DMP0949	DMP0949	Male			
P-0000960-T01-IM3	P-0000960	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0950	DMP0950	Male			
P-0000970-T01-IM3	P-0000970	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP0952	DMP0952	Female			
P-0000968-T01-IM3	P-0000968	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Anus	Anorectal Mucosal Melanoma	IMPACT341	DMP0953	DMP0953	Male			
P-0000646-T02-IM3	P-0000646	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP0954	DMP0954	Male			
P-0000961-T01-IM3	P-0000961	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0955	DMP0955	Male			
P-0001048-T01-IM3	P-0001048	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP0957	DMP0957	Male			
P-0001038-T01-IM3	P-0001038	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP0958	DMP0958	Female			
P-0001046-T01-IM3	P-0001046	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP0959	DMP0959	Female			
P-0001042-T01-IM3	P-0001042	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP0960	DMP0960	Male			
P-0001044-T01-IM3	P-0001044	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP0961	DMP0961	Female			
P-0001037-T01-IM3	P-0001037	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0962	DMP0962	Female			
P-0001047-T01-IM3	P-0001047	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP0963	DMP0963	Male			
P-0001040-T01-IM3	P-0001040	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0964	DMP0964	Male			
P-0001910-T01-IM3	P-0001910	Thyroid Cancer	Metastasis	Tumor	Esophagus	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1811	DMP1811	Male			
P-0001052-T01-IM3	P-0001052	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP0967	DMP0967	Female			
P-0001043-T01-IM3	P-0001043	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0968	DMP0968	Female			
P-0001039-T01-IM3	P-0001039	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Peritoneum	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0969	DMP0969	Male			
P-0000903-T02-IM3	P-0000903	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP0970	DMP0970	Male			
P-0001035-T01-IM3	P-0001035	Soft Tissue Sarcoma	Local Recurrence	Tumor	Scalp	Scalp	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0971	DMP0971	Male			
P-0001055-T01-IM3	P-0001055	Soft Tissue Sarcoma	Metastasis	Tumor	Kidney	Brain	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP0973	DMP0973	Female			
P-0001060-T01-IM3	P-0001060	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT341	DMP0974	DMP0974	Female			
P-0001061-T01-IM3	P-0001061	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP0975	DMP0975	Female			
P-0001058-T01-IM3	P-0001058	Gestational Trophoblastic Disease	Metastasis	Tumor	Lung	Mediastinum	Choriocarcinoma	IMPACT341	DMP0976	DMP0976	Male			
P-0001054-T01-IM3	P-0001054	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1572	DMP1572	Female			
P-0001063-T01-IM3	P-0001063	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT341	DMP0978	DMP0978	Female			
P-0001053-T01-IM3	P-0001053	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341	DMP0979	DMP0979	Male			
P-0001051-T01-IM3	P-0001051	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Ependymoma	IMPACT341	DMP0980	DMP0980	Male			
P-0001049-T01-IM3	P-0001049	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341	DMP0981	DMP0981	Male			
P-0001050-T01-IM3	P-0001050	Ovarian Cancer	Metastasis	Tumor	Bowel	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP0982	DMP0982	Female			
P-0001057-T01-IM3	P-0001057	Cervical Cancer	Metastasis	Tumor	Small Bowel	Cervix	Gastric Type Mucinous Carcinoma	IMPACT341	DMP0983	DMP0983	Female			
P-0001056-T01-IM3	P-0001056	Soft Tissue Sarcoma	Metastasis	Tumor	Soft Tissue	Groin	Dedifferentiated Liposarcoma	IMPACT341	DMP0984	DMP0984	Male			
P-0001076-T01-IM3	P-0001076	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP0985	DMP0985	Female			
P-0000931-T01-IM3	P-0000931	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0876	DMP0876	Male			
P-0001077-T01-IM3	P-0001077	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP0987	DMP0987	Male			
P-0001070-T01-IM3	P-0001070	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP0988	DMP0988	Male			
P-0001073-T01-IM3	P-0001073	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP0989	DMP0989	Female			
P-0001074-T01-IM3	P-0001074	Bladder Cancer	Metastasis	Tumor	Prostate	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP0990	DMP0990	Male			
P-0001081-T01-IM3	P-0001081	Melanoma	Metastasis	Tumor	Ovary	Skin	Cutaneous Melanoma	IMPACT341	DMP0991	DMP0991	Female			
P-0001083-T01-IM3	P-0001083	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lymph Node	Epitheloid Sarcoma	IMPACT341	DMP0992	DMP0992	Male			
P-0001082-T01-IM3	P-0001082	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP0993	DMP0993	Female			
P-0001087-T01-IM3	P-0001087	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP0994	DMP0994	Female			
P-0001088-T01-IM3	P-0001088	Soft Tissue Sarcoma	Metastasis	Tumor	Small Bowel	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341	DMP0995	DMP0995	Male			
P-0001079-T01-IM3	P-0001079	Colorectal Cancer	Local Recurrence	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP0996	DMP0996	Male			
P-0001089-T01-IM3	P-0001089	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP0997	DMP0997	Male			
P-0001090-T01-IM3	P-0001090	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Spindle Cell Rhabdomyosarcoma	IMPACT341	DMP0998	DMP0998	Male			
P-0001085-T01-IM3	P-0001085	Endometrial Cancer	Metastasis	Tumor	Vagina	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP0999	DMP0999	Female			
P-0001078-T01-IM3	P-0001078	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1000	DMP1000	Female			
P-0001086-T01-IM3	P-0001086	Ovarian Cancer	Metastasis	Tumor	Kidney	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1001	DMP1001	Female			
P-0001080-T01-IM3	P-0001080	Ovarian Cancer	Metastasis	Tumor	Heart	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1002	DMP1002	Female			
P-0001084-T01-IM3	P-0001084	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1003	DMP1003	Male			
P-0000921-T01-IM3	P-0000921	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1004	DMP1004	Female			
P-0001101-T01-IM3	P-0001101	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Neck	Synovial Sarcoma	IMPACT341	DMP1005	DMP1005	Male			
P-0001093-T01-IM3	P-0001093	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1006	DMP1006	Male			
P-0001094-T01-IM3	P-0001094	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP1007	DMP1007	Female			
P-0001100-T01-IM3	P-0001100	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1008	DMP1008	Male			
P-0001097-T01-IM3	P-0001097	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1009	DMP1009	Female			
P-0001096-T01-IM3	P-0001096	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1010	DMP1010	Male			
P-0000935-T01-IM3	P-0000935	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0878	DMP0878	Male			
P-0001098-T01-IM3	P-0001098	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1012	DMP1012	Male			
P-0001099-T01-IM3	P-0001099	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1013	DMP1013	Female			
P-0001095-T01-IM3	P-0001095	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Smooth Muscle Tumor of Uncertain Malignant Potential	IMPACT341	DMP1014	DMP1014	Female			
P-0001091-T01-IM3	P-0001091	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP1015	DMP1015	Female			
P-0000937-T01-IM3	P-0000937	Chordoma	Primary	Tumor	Not Applicable	Bone	Chordoma	IMPACT341	DMP1016	DMP1016	Male			
P-0000941-T01-IM3	P-0000941	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1017	DMP1017	Male			
P-0000955-T01-IM3	P-0000955	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1018	DMP1018	Female			
P-0000945-T01-IM3	P-0000945	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP1019	DMP1019	Male			
P-0001103-T01-IM3	P-0001103	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP1022	DMP1022	Male			
P-0001107-T01-IM3	P-0001107	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Rectum	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT341	DMP1021	DMP1021	Female			
P-0001178-T01-IM3	P-0001178	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP1094	DMP1094	Male			
P-0001104-T01-IM3	P-0001104	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP2136	DMP2136	Female			
P-0001111-T01-IM3	P-0001111	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Condroblastic Osteosarcoma	IMPACT341	DMP1024	DMP1024	Female			
P-0001113-T01-IM3	P-0001113	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT341	DMP1025	DMP1025	Female			
P-0001102-T01-IM3	P-0001102	Small Bowel Cancer	Metastasis	Tumor	Skin	Jejunum	Small Bowel Adenocarcinoma	IMPACT341	DMP1026	DMP1026	Male			
P-0001112-T01-IM3	P-0001112	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1027	DMP1027	Female			
P-0001106-T01-IM3	P-0001106	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1028	DMP1028	Male			
P-0001021-T01-IM3	P-0001021	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0940	DMP0940	Male			
P-0001105-T01-IM3	P-0001105	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1030	DMP1030	Female			
P-0001109-T01-IM3	P-0001109	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Synovial Sarcoma	IMPACT341	DMP1031	DMP1031	Female			
P-0000963-T01-IM3	P-0000963	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1032	DMP1032	Female			
P-0001123-T01-IM3	P-0001123	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1033	DMP1033	Female			
P-0001117-T01-IM3	P-0001117	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1034	DMP1034	Male			
P-0001118-T01-IM3	P-0001118	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1035	DMP1035	Female			
P-0001120-T01-IM3	P-0001120	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pleura	Synovial Sarcoma	IMPACT341	DMP1036	DMP1036	Male			
P-0001739-T01-IM3	P-0001739	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP1616	DMP1616	Male			
P-0001125-T01-IM3	P-0001125	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Myxofibrosarcoma	IMPACT341	DMP1038	DMP1038	Female			
P-0001115-T01-IM3	P-0001115	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1039	DMP1039	Female			
P-0001124-T01-IM3	P-0001124	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP1040	DMP1040	Female			
P-0001121-T01-IM3	P-0001121	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1041	DMP1041	Female			
P-0001136-T01-IM3	P-0001136	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1042	DMP1042	Male			
P-0001129-T01-IM3	P-0001129	Chondrosarcoma	Primary	Tumor	Not Applicable	Upper Extremity	Myxoid Chondrosarcoma	IMPACT341	DMP1043	DMP1043	Male			
P-0001138-T01-IM3	P-0001138	Pancreatic Cancer	Metastasis	Tumor	Lymph Node	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1044	DMP1044	Female			
P-0000377-T02-IM3	P-0000377	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2166	DMP2166	Male			
P-0001131-T01-IM3	P-0001131	Non-Small Cell Lung Cancer	Metastasis	Tumor	Uterus	Lung	Lung Adenocarcinoma	IMPACT341	DMP1046	DMP1046	Female			
P-0001137-T01-IM3	P-0001137	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1047	DMP1047	Male			
P-0001130-T01-IM3	P-0001130	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1048	DMP1048	Female			
P-0001498-T02-IM3	P-0001498	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1814	DMP1814	Male			
P-0001071-T01-IM3	P-0001071	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0986	DMP0986	Male			
P-0001149-T01-IM3	P-0001149	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1062	DMP1062	Female			
P-0001140-T01-IM3	P-0001140	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1063	DMP1063	Female			
P-0001144-T01-IM3	P-0001144	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1064	DMP1064	Male			
P-0001146-T01-IM3	P-0001146	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT341	DMP1065	DMP1065	Female			
P-0001155-T01-IM3	P-0001155	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1066	DMP1066	Male			
P-0001154-T01-IM3	P-0001154	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1067	DMP1067	Male			
P-0001092-T01-IM3	P-0001092	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1011	DMP1011	Male			
P-0001156-T01-IM3	P-0001156	Breast Carcinoma	Metastasis	Tumor	Retroperitoneum	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1069	DMP1069	Female			
P-0001161-T01-IM3	P-0001161	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1070	DMP1070	Female			
P-0001151-T01-IM3	P-0001151	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1071	DMP1071	Female			
P-0001152-T01-IM3	P-0001152	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1072	DMP1072	Female			
P-0001157-T01-IM3	P-0001157	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1073	DMP1073	Male			
P-0001158-T01-IM3	P-0001158	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1074	DMP1074	Male			
P-0001150-T01-IM3	P-0001150	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1075	DMP1075	Female			
P-0001108-T01-IM3	P-0001108	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1029	DMP1029	Male			
P-0001170-T01-IM3	P-0001170	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1077	DMP1077	Male			
P-0001173-T01-IM3	P-0001173	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Heart	Intimal Sarcoma	IMPACT341	DMP1078	DMP1078	Female			
P-0001164-T01-IM3	P-0001164	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	High-Grade Endometrial Stromal Sarcoma	IMPACT341	DMP1079	DMP1079	Female			
P-0001174-T01-IM3	P-0001174	Melanoma	Metastasis	Tumor	In-transit	Nailbed	Acral Melanoma	IMPACT341	DMP1080	DMP1080	Female			
P-0001171-T01-IM3	P-0001171	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP1081	DMP1081	Male			
P-0001163-T01-IM3	P-0001163	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1082	DMP1082	Female			
P-0001168-T01-IM3	P-0001168	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1083	DMP1083	Female			
P-0001166-T01-IM3	P-0001166	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1084	DMP1084	Female			
P-0001165-T01-IM3	P-0001165	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1085	DMP1085	Female			
P-0001175-T01-IM3	P-0001175	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1086	DMP1086	Female			
P-0001182-T01-IM3	P-0001182	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Metaplastic Carcinosarcoma	IMPACT341	DMP1087	DMP1087	Female			
P-0001181-T01-IM3	P-0001181	Germ Cell Tumor	Metastasis	Tumor	Neck	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1088	DMP1088	Male			
P-0001184-T01-IM3	P-0001184	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1089	DMP1089	Female			
P-0001179-T01-IM3	P-0001179	Melanoma	Primary	Tumor	Not Applicable	Vagina	Genitourinary Mucosal Melanoma	IMPACT341	DMP1090	DMP1090	Female			
P-0001917-T01-IM3	P-0001917	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	DMP1781	DMP1781	Male			
P-0001183-T01-IM3	P-0001183	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1092	DMP1092	Female			
P-0001180-T01-IM3	P-0001180	Esophagogastric Carcinoma	Metastasis	Tumor	Breast	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1093	DMP1093	Female			
P-0002402-T01-IM3	P-0002402	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	DMP2223	DMP2223	Male			
P-0001176-T01-IM3	P-0001176	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Myoepithelial Carcinoma	IMPACT341	DMP1095	DMP1095	Female			
P-0001032-T01-IM3	P-0001032	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1096	DMP1096	Female			
P-0001185-T01-IM3	P-0001185	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1097	DMP1097	Male			
P-0001191-T01-IM3	P-0001191	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Angiosarcoma	IMPACT341	DMP1098	DMP1098	Female			
P-0001128-T01-IM3	P-0001128	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1045	DMP1045	Male			
P-0001189-T01-IM3	P-0001189	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1100	DMP1100	Male			
P-0001186-T01-IM3	P-0001186	Head and Neck Carcinoma	Metastasis	Tumor	Bone	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP1101	DMP1101	Male			
P-0001188-T01-IM3	P-0001188	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1102	DMP1102	Male			
P-0001190-T01-IM3	P-0001190	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1103	DMP1103	Male			
P-0001192-T01-IM3	P-0001192	Colorectal Cancer	Metastasis	Tumor	Lung	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1104	DMP1104	Male			
P-0001193-T01-IM3	P-0001193	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1105	DMP1105	Female			
P-0001199-T01-IM3	P-0001199	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1106	DMP1106	Female			
P-0001200-T01-IM3	P-0001200	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1107	DMP1107	Male			
P-0001205-T01-IM3	P-0001205	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Hemangiopericytoma of the Central Nervous System	IMPACT341	DMP1108	DMP1108	Male			
P-0001196-T01-IM3	P-0001196	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1109	DMP1109	Female			
P-0001194-T01-IM3	P-0001194	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1110	DMP1110	Male			
P-0001197-T01-IM3	P-0001197	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1111	DMP1111	Female			
P-0001198-T01-IM3	P-0001198	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Eye	Poorly Differentiated Epitheloid Neoplasm	IMPACT341	DMP1112	DMP1112	Male			
P-0001201-T01-IM3	P-0001201	Salivary Carcinoma	Metastasis	Tumor	Lung	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1113	DMP1113	Female			
P-0001195-T01-IM3	P-0001195	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341	DMP1114	DMP1114	Male			
P-0001141-T01-IM3	P-0001141	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1061	DMP1061	Male			
P-0001153-T01-IM3	P-0001153	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1068	DMP1068	Male			
P-0000964-T01-IM3	P-0000964	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1076	DMP1076	Male			
P-0001217-T01-IM3	P-0001217	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Upper Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1119	DMP1119	Female			
P-0001222-T01-IM3	P-0001222	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP1120	DMP1120	Male			
P-0001215-T01-IM3	P-0001215	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1121	DMP1121	Male			
P-0001211-T01-IM3	P-0001211	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1122	DMP1122	Female			
P-0001214-T01-IM3	P-0001214	Salivary Carcinoma	Primary	Tumor	Not Applicable	Minor Salivary Gland	Mucoepidermoid Carcinoma	IMPACT341	DMP1123	DMP1123	Female			
P-0000715-T03-IM3	P-0000715	Thyroid Cancer	Metastasis	Tumor	Liver	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1836	DMP1836	Female			
P-0001219-T01-IM3	P-0001219	Histiocytosis	Metastasis	Tumor	Omentum	Diffuse	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT341	DMP1125	DMP1125	Male			
P-0001209-T01-IM3	P-0001209	Cancer of Unknown Primary	Metastasis	Tumor	Bone	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1126	DMP1126	Male			
P-0001208-T01-IM3	P-0001208	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1127	DMP1127	Male			
P-0001212-T01-IM3	P-0001212	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1128	DMP1128	Female			
P-0001210-T01-IM3	P-0001210	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Seminoma	IMPACT341	DMP1129	DMP1129	Male			
P-0001187-T01-IM3	P-0001187	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1099	DMP1099	Male			
P-0001218-T01-IM3	P-0001218	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1131	DMP1131	Female			
P-0001220-T01-IM3	P-0001220	Salivary Carcinoma	Metastasis	Tumor	Liver	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1132	DMP1132	Male			
P-0001963-T01-IM3	P-0001963	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1889	DMP1889	Female			
P-0001236-T01-IM3	P-0001236	Cancer of Unknown Primary	Metastasis	Tumor	Breast	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1134	DMP1134	Female			
P-0001227-T01-IM3	P-0001227	Colorectal Cancer	Primary	Tumor	Not Applicable	Hepatic Flexure	Colon Adenocarcinoma	IMPACT341	DMP1135	DMP1135	Male			
P-0001237-T01-IM3	P-0001237	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1136	DMP1136	Male			
P-0001226-T01-IM3	P-0001226	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1137	DMP1137	Female			
P-0001232-T01-IM3	P-0001232	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP1138	DMP1138	Male			
P-0001235-T01-IM3	P-0001235	Small Bowel Cancer	Primary	Tumor	Not Applicable	Jejunum	Small Bowel Adenocarcinoma	IMPACT341	DMP1139	DMP1139	Male			
P-0001229-T01-IM3	P-0001229	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Eye	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP1140	DMP1140	Male			
P-0001206-T01-IM3	P-0001206	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1115	DMP1115	Male			
P-0001231-T01-IM3	P-0001231	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1142	DMP1142	Male			
P-0001233-T01-IM3	P-0001233	Ewing Sarcoma	Primary	Tumor	Not Applicable	Leg	Ewing Sarcoma	IMPACT341	DMP1143	DMP1143	Female			
P-0001223-T01-IM3	P-0001223	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1144	DMP1144	Male			
P-0001228-T01-IM3	P-0001228	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1145	DMP1145	Female			
P-0001225-T01-IM3	P-0001225	Salivary Carcinoma	Metastasis	Tumor	Pleura	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1146	DMP1146	Male			
P-0001240-T01-IM3	P-0001240	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP1147	DMP1147	Female			
P-0002002-T01-IM3	P-0002002	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP1939	DMP1939	Female			
P-0001248-T01-IM3	P-0001248	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1149	DMP1149	Female			
P-0001243-T01-IM3	P-0001243	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1150	DMP1150	Female			
P-0001202-T01-IM3	P-0001202	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1117	DMP1117	Male			
P-0001238-T01-IM3	P-0001238	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1152	DMP1152	Male			
P-0001239-T01-IM3	P-0001239	Salivary Carcinoma	Metastasis	Tumor	Lung	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1153	DMP1153	Male			
P-0001250-T01-IM3	P-0001250	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341	DMP1154	DMP1154	Male			
P-0001251-T01-IM3	P-0001251	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT341	DMP1155	DMP1155	Female			
P-0001204-T01-IM3	P-0001204	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1118	DMP1118	Male			
P-0001221-T01-IM3	P-0001221	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1130	DMP1130	Male			
P-0001230-T01-IM3	P-0001230	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1141	DMP1141	Male			
P-0001253-T01-IM3	P-0001253	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1159	DMP1159	Female			
P-0001258-T01-IM3	P-0001258	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1160	DMP1160	Female			
P-0001265-T01-IM3	P-0001265	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT341	DMP1161	DMP1161	Female			
P-0001257-T01-IM3	P-0001257	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1162	DMP1162	Female			
P-0001259-T01-IM3	P-0001259	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1163	DMP1163	Male			
P-0001247-T01-IM3	P-0001247	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1151	DMP1151	Male			
P-0001261-T01-IM3	P-0001261	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Omentum	Colon	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP1165	DMP1165	Female			
P-0001260-T01-IM3	P-0001260	Esophagogastric Carcinoma	Metastasis	Tumor	Omentum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1166	DMP1166	Female			
P-0001255-T01-IM3	P-0001255	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341	DMP1167	DMP1167	Female			
P-0001263-T01-IM3	P-0001263	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1168	DMP1168	Female			
P-0001275-T01-IM3	P-0001275	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1169	DMP1169	Male			
P-0001267-T01-IM3	P-0001267	Sex Cord Stromal Tumor	Primary	Tumor	Not Applicable	Ovary	Sertoli-Leydig Cell Tumor	IMPACT341	DMP1170	DMP1170	Female			
P-0001276-T01-IM3	P-0001276	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1171	DMP1171	Male			
P-0001242-T01-IM3	P-0001242	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1156	DMP1156	Male			
P-0001279-T01-IM3	P-0001279	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP1173	DMP1173	Female			
P-0001266-T01-IM3	P-0001266	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Upper Extremity	Synovial Sarcoma	IMPACT341	DMP1174	DMP1174	Male			
P-0001273-T01-IM3	P-0001273	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP1175	DMP1175	Male			
P-0002145-T01-IM3	P-0002145	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341	DMP2017	DMP2017	Female			
P-0001272-T01-IM3	P-0001272	Ovarian Cancer	Metastasis	Tumor	Diaphragm	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1177	DMP1177	Female			
P-0001278-T01-IM3	P-0001278	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1178	DMP1178	Female			
P-0001269-T01-IM3	P-0001269	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1179	DMP1179	Female			
P-0001268-T01-IM3	P-0001268	Bladder Cancer	Metastasis	Tumor	Pelvis	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1180	DMP1180	Male			
P-0001288-T01-IM3	P-0001288	Chordoma	Primary	Tumor	Not Applicable	Muscle	Chordoma	IMPACT341	DMP1181	DMP1181	Male			
P-0001282-T01-IM3	P-0001282	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT341	DMP1182	DMP1182	Male			
P-0001289-T01-IM3	P-0001289	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1184	DMP1184	Female			
P-0001284-T01-IM3	P-0001284	Ovarian Cancer	Metastasis	Tumor	Diaphragm	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1185	DMP1185	Female			
P-0001285-T01-IM3	P-0001285	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1186	DMP1186	Female			
P-0001286-T01-IM3	P-0001286	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1187	DMP1187	Female			
P-0001281-T01-IM3	P-0001281	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1188	DMP1188	Male			
P-0001287-T01-IM3	P-0001287	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1189	DMP1189	Female			
P-0001283-T01-IM3	P-0001283	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1190	DMP1190	Female			
P-0001290-T01-IM3	P-0001290	Breast Carcinoma	Metastasis	Tumor	Retroperitoneum	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1191	DMP1191	Female			
P-0001242-T02-IM3	P-0001242	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1157	DMP1157	Male			
P-0000966-T01-IM3	P-0000966	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1158	DMP1158	Male			
P-0001295-T01-IM3	P-0001295	Colorectal Cancer	Metastasis	Tumor	Brain	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1194	DMP1194	Female			
P-0001296-T01-IM3	P-0001296	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1195	DMP1195	Female			
P-0001306-T01-IM3	P-0001306	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1196	DMP1196	Female			
P-0001292-T01-IM3	P-0001292	Biliary Cancer	Metastasis	Tumor	Liver	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1197	DMP1197	Male			
P-0001305-T01-IM3	P-0001305	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1198	DMP1198	Female			
P-0001298-T01-IM3	P-0001298	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1199	DMP1199	Male			
P-0001301-T01-IM3	P-0001301	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1200	DMP1200	Male			
P-0001302-T01-IM3	P-0001302	Colorectal Cancer	Metastasis	Tumor	Ovary	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1201	DMP1201	Female			
P-0001299-T01-IM3	P-0001299	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1202	DMP1202	Male			
P-0001304-T01-IM3	P-0001304	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP1203	DMP1203	Female			
P-0001293-T01-IM3	P-0001293	Cancer of Unknown Primary	Metastasis	Tumor	Scalp	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1204	DMP1204	Male			
P-0002150-T01-IM3	P-0002150	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP2025	DMP2025	Female			
P-0001300-T01-IM3	P-0001300	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1206	DMP1206	Female			
P-0001303-T01-IM3	P-0001303	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1207	DMP1207	Female			
P-0001318-T01-IM3	P-0001318	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1208	DMP1208	Female			
P-0001308-T01-IM3	P-0001308	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1209	DMP1209	Female			
P-0001312-T01-IM3	P-0001312	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1210	DMP1210	Female			
P-0001311-T01-IM3	P-0001311	Nerve Sheath Tumor	Metastasis	Tumor	Diaphragm	Fallopian Tube	Malignant Biphasic Neoplasm	IMPACT341	DMP1211	DMP1211	Female			
P-0001317-T01-IM3	P-0001317	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1212	DMP1212	Male			
P-0001309-T01-IM3	P-0001309	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1213	DMP1213	Female			
P-0001314-T01-IM3	P-0001314	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1214	DMP1214	Female			
P-0001307-T01-IM3	P-0001307	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1215	DMP1215	Male			
P-0001310-T01-IM3	P-0001310	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1216	DMP1216	Female			
P-0001315-T01-IM3	P-0001315	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1217	DMP1217	Male			
P-0001316-T01-IM3	P-0001316	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1219	DMP1219	Male			
P-0001127-T02-IM3	P-0001127	Non-Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1220	DMP1220	Male			
P-0001262-T01-IM3	P-0001262	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1164	DMP1164	Male			
P-0001172-T02-IM3	P-0001172	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1222	DMP1222	Female			
P-0001274-T01-IM3	P-0001274	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1172	DMP1172	Male			
P-0001338-T01-IM3	P-0001338	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1224	DMP1224	Female			
P-0001336-T01-IM3	P-0001336	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1225	DMP1225	Male			
P-0001339-T01-IM3	P-0001339	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1226	DMP1226	Male			
P-0001340-T01-IM3	P-0001340	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT341	DMP1227	DMP1227	Male			
P-0001342-T01-IM3	P-0001342	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Angiomyolipoma	IMPACT341	DMP1228	DMP1228	Female			
P-0001335-T01-IM3	P-0001335	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1229	DMP1229	Female			
P-0001331-T01-IM3	P-0001331	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1230	DMP1230	Female			
P-0001341-T01-IM3	P-0001341	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1231	DMP1231	Female			
P-0000505-T01-IM3	P-0000505	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1192	DMP1192	Male			
P-0001297-T01-IM3	P-0001297	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1193	DMP1193	Male			
P-0000857-T01-IM3	P-0000857	Chondrosarcoma	Metastasis	Tumor	Soft Tissue	Lower Extremity	Extraskeletal Myxoid Chondrosarcoma	IMPACT341	DMP1234	DMP1234	Male			
P-0001036-T01-IM3	P-0001036	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Ovarian Seromucinous Borderline Tumor	IMPACT341	DMP1235	DMP1235	Female			
P-0001345-T01-IM3	P-0001345	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Upper Extremity	Epitheloid Sarcoma	IMPACT341	DMP1236	DMP1236	Female			
P-0001343-T01-IM3	P-0001343	Soft Tissue Sarcoma	Metastasis	Tumor	Paracaval	Retroperitoneum	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1237	DMP1237	Male			
P-0001350-T01-IM3	P-0001350	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1238	DMP1238	Female			
P-0001356-T01-IM3	P-0001356	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1239	DMP1239	Female			
P-0001352-T01-IM3	P-0001352	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Metaplastic Carcinosarcoma	IMPACT341	DMP1240	DMP1240	Female			
P-0001355-T01-IM3	P-0001355	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1241	DMP1241	Female			
P-0001351-T01-IM3	P-0001351	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1242	DMP1242	Female			
P-0001346-T01-IM3	P-0001346	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1243	DMP1243	Female			
P-0001354-T01-IM3	P-0001354	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1244	DMP1244	Male			
P-0001347-T01-IM3	P-0001347	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1245	DMP1245	Male			
P-0001348-T01-IM3	P-0001348	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP1246	DMP1246	Male			
P-0001348-T02-IM3	P-0001348	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1247	DMP1247	Male			
P-0001365-T01-IM3	P-0001365	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1249	DMP1249	Male			
P-0001372-T01-IM3	P-0001372	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1250	DMP1250	Female			
P-0001371-T01-IM3	P-0001371	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1251	DMP1251	Male			
P-0001362-T01-IM3	P-0001362	Thymic Tumor	Metastasis	Tumor	Bone	Thymus	Thymic Carcinoma	IMPACT341	DMP1252	DMP1252	Female			
P-0001367-T01-IM3	P-0001367	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1253	DMP1253	Female			
P-0001369-T01-IM3	P-0001369	Renal Cell Carcinoma	Metastasis	Tumor	Small Bowel	Kidney	Papillary Renal Cell Carcinoma	IMPACT341	DMP1254	DMP1254	Female			
P-0001361-T01-IM3	P-0001361	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP1255	DMP1255	Male			
P-0001364-T01-IM3	P-0001364	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Perivascular Epithelioid Cell Tumor	IMPACT341	DMP1256	DMP1256	Female			
P-0001366-T01-IM3	P-0001366	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1257	DMP1257	Female			
P-0001363-T01-IM3	P-0001363	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1258	DMP1258	Male			
P-0001368-T01-IM3	P-0001368	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1259	DMP1259	Male			
P-0001370-T01-IM3	P-0001370	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1260	DMP1260	Male			
P-0001359-T01-IM3	P-0001359	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1261	DMP1261	Female			
P-0000990-T02-IM3	P-0000990	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1221	DMP1221	Male			
P-0001385-T01-IM3	P-0001385	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP1263	DMP1263	Female			
P-0001375-T01-IM3	P-0001375	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1264	DMP1264	Female			
P-0001387-T01-IM3	P-0001387	Non-Small Cell Lung Cancer	Metastasis	Tumor	Heart	Lung	Lung Adenocarcinoma	IMPACT341	DMP1265	DMP1265	Male			
P-0001380-T01-IM3	P-0001380	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1266	DMP1266	Female			
P-0001376-T01-IM3	P-0001376	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP1267	DMP1267	Female			
P-0002141-T01-IM3	P-0002141	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP2027	DMP2027	Male			
P-0001383-T01-IM3	P-0001383	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1269	DMP1269	Female			
P-0001377-T01-IM3	P-0001377	Ewing Sarcoma	Primary	Tumor	Not Applicable	Chest Wall	Ewing Sarcoma	IMPACT341	DMP1270	DMP1270	Male			
P-0001337-T01-IM3	P-0001337	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1223	DMP1223	Male			
P-0001373-T01-IM3	P-0001373	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Myoepithelial Carcinoma	IMPACT341	DMP1273	DMP1273	Male			
P-0001374-T01-IM3	P-0001374	Vulvar Carcinoma	Primary	Tumor	Not Applicable	Vulva	Squamous Cell Carcinoma of the Vulva	IMPACT341	DMP1274	DMP1274	Female			
P-0001381-T01-IM3	P-0001381	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341	DMP1275	DMP1275	Male			
P-0001391-T01-IM3	P-0001391	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1276	DMP1276	Male			
P-0001392-T01-IM3	P-0001392	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1277	DMP1277	Female			
P-0001400-T01-IM3	P-0001400	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1278	DMP1278	Female			
P-0001397-T01-IM3	P-0001397	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1279	DMP1279	Female			
P-0001395-T01-IM3	P-0001395	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1280	DMP1280	Female			
P-0001388-T01-IM3	P-0001388	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1281	DMP1281	Male			
P-0001393-T01-IM3	P-0001393	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1282	DMP1282	Male			
P-0001389-T01-IM3	P-0001389	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1283	DMP1283	Female			
P-0001403-T01-IM3	P-0001403	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1284	DMP1284	Female			
P-0001406-T01-IM3	P-0001406	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1285	DMP1285	Female			
P-0001332-T01-IM3	P-0001332	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1232	DMP1232	Male			
P-0001402-T01-IM3	P-0001402	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1287	DMP1287	Female			
P-0001409-T01-IM3	P-0001409	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1288	DMP1288	Male			
P-0001410-T01-IM3	P-0001410	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Gastric Wall	Gastrointestinal Stromal Tumor	IMPACT341	DMP1289	DMP1289	Male			
P-0001405-T01-IM3	P-0001405	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341	DMP1290	DMP1290	Female			
P-0001411-T01-IM3	P-0001411	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1291	DMP1291	Female			
P-0001404-T01-IM3	P-0001404	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Teratoma	IMPACT341	DMP1292	DMP1292	Male			
P-0001408-T01-IM3	P-0001408	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1293	DMP1293	Male			
P-0001425-T01-IM3	P-0001425	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1294	DMP1294	Female			
P-0002221-T01-IM3	P-0002221	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341	DMP2088	DMP2088	Female			
P-0001420-T01-IM3	P-0001420	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1296	DMP1296	Female			
P-0001419-T01-IM3	P-0001419	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1297	DMP1297	Female			
P-0001424-T01-IM3	P-0001424	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1298	DMP1298	Female			
P-0001332-T02-IM3	P-0001332	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1233	DMP1233	Male			
P-0001421-T01-IM3	P-0001421	Ovarian Cancer	Metastasis	Tumor	Cecum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1300	DMP1300	Female			
P-0000964-T02-IM3	P-0000964	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1262	DMP1262	Male			
P-0001415-T01-IM3	P-0001415	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1302	DMP1302	Female			
P-0001412-T01-IM3	P-0001412	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1303	DMP1303	Male			
P-0001422-T01-IM3	P-0001422	Salivary Carcinoma	Metastasis	Tumor	Bone	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1304	DMP1304	Female			
P-0001417-T01-IM3	P-0001417	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1305	DMP1305	Female			
P-0001416-T01-IM3	P-0001416	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Pleura	Skin	Skin Adnexal Carcinoma	IMPACT341	DMP1306	DMP1306	Female			
P-0001423-T01-IM3	P-0001423	Soft Tissue Sarcoma	Metastasis	Tumor	Abdomen	Brain	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP1307	DMP1307	Male			
P-0001432-T01-IM3	P-0001432	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT341	DMP1308	DMP1308	Female			
P-0001433-T01-IM3	P-0001433	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1309	DMP1309	Male			
P-0001430-T01-IM3	P-0001430	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1310	DMP1310	Male			
P-0001440-T01-IM3	P-0001440	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1311	DMP1311	Female			
P-0001428-T01-IM3	P-0001428	Colorectal Cancer	Metastasis	Tumor	Lung	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1312	DMP1312	Male			
P-0001438-T01-IM3	P-0001438	Soft Tissue Sarcoma	Local Recurrence	Tumor	Pelvis	Pelvis	Leiomyosarcoma	IMPACT341	DMP1313	DMP1313	Male			
P-0001429-T01-IM3	P-0001429	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1314	DMP1314	Male			
P-0001439-T01-IM3	P-0001439	Uterine Sarcoma	Metastasis	Tumor	Brain	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1315	DMP1315	Female			
P-0001427-T01-IM3	P-0001427	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1316	DMP1316	Female			
P-0001437-T01-IM3	P-0001437	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1317	DMP1317	Female			
P-0001435-T01-IM3	P-0001435	Germ Cell Tumor	Metastasis	Tumor	Soft Tissue	Testis	Teratoma	IMPACT341	DMP1318	DMP1318	Male			
P-0001436-T01-IM3	P-0001436	Osteosarcoma	Primary	Tumor	Not Applicable	Chest Wall	Osteoblastic Osteosarcoma	IMPACT341	DMP1319	DMP1319	Male			
P-0001431-T01-IM3	P-0001431	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Stromal Tumor	IMPACT341	DMP1320	DMP1320	Male			
P-0000064-T02-IM3	P-0000064	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP1321	DMP1321	Female			
P-0001382-T01-IM3	P-0001382	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1271	DMP1271	Male			
P-0001326-T01-IM3	P-0001326	Glioma	Primary	Tumor	Not Applicable	Brain	High-Grade Glioma, NOS	IMPACT341	DMP1323	DMP1323	Female			
P-0001324-T01-IM3	P-0001324	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1324	DMP1324	Male			
P-0001327-T01-IM3	P-0001327	Salivary Carcinoma	Metastasis	Tumor	Lung	Minor Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1325	DMP1325	Female			
P-0001322-T01-IM3	P-0001322	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1326	DMP1326	Male			
P-0001328-T01-IM3	P-0001328	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341	DMP1327	DMP1327	Female			
P-0001321-T01-IM3	P-0001321	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1328	DMP1328	Male			
P-0001330-T01-IM3	P-0001330	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1329	DMP1329	Male			
P-0001407-T01-IM3	P-0001407	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1286	DMP1286	Male			
P-0001320-T01-IM3	P-0001320	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1331	DMP1331	Male			
P-0001323-T01-IM3	P-0001323	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1332	DMP1332	Male			
P-0001413-T01-IM3	P-0001413	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1299	DMP1299	Male			
P-0001426-T01-IM3	P-0001426	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1301	DMP1301	Male			
P-0001447-T01-IM3	P-0001447	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1335	DMP1335	Female			
P-0001444-T01-IM3	P-0001444	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Acral Melanoma	IMPACT341	DMP1336	DMP1336	Male			
P-0001453-T01-IM3	P-0001453	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Bladder Urothelial Carcinoma	IMPACT341	DMP1337	DMP1337	Male			
P-0001329-T01-IM3	P-0001329	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1322	DMP1322	Male			
P-0000966-T02-IM3	P-0000966	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1333	DMP1333	Male			
P-0001451-T01-IM3	P-0001451	Salivary Carcinoma	Primary	Tumor	Not Applicable	Lung	Adenoid Cystic Carcinoma	IMPACT341	DMP1340	DMP1340	Female			
P-0000655-T02-IM3	P-0000655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1334	DMP1334	Male			
P-0001452-T01-IM3	P-0001452	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1342	DMP1342	Female			
P-0001442-T01-IM3	P-0001442	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1343	DMP1343	Male			
P-0001450-T01-IM3	P-0001450	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1344	DMP1344	Female			
P-0001443-T01-IM3	P-0001443	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1345	DMP1345	Male			
P-0001448-T01-IM3	P-0001448	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Mediastinum	Pleomorphic Liposarcoma	IMPACT341	DMP1346	DMP1346	Male			
P-0001441-T01-IM3	P-0001441	Breast Carcinoma	Metastasis	Tumor	Bowel	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1347	DMP1347	Female			
P-0001454-T01-IM3	P-0001454	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1348	DMP1348	Male			
P-0001464-T01-IM3	P-0001464	Uterine Sarcoma	Metastasis	Tumor	Rectosigmoid Colon	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1349	DMP1349	Female			
P-0001461-T01-IM3	P-0001461	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1350	DMP1350	Male			
P-0001467-T01-IM3	P-0001467	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Unknown	Head and Neck Squamous Cell Carcinoma of Unknown Primary	IMPACT341	DMP1351	DMP1351	Female			
P-0001457-T01-IM3	P-0001457	Ovarian Cancer	Metastasis	Tumor	Paracolic Gutter	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1352	DMP1352	Female			
P-0001463-T01-IM3	P-0001463	Cervical Cancer	Metastasis	Tumor	Peritoneum	Cervix	Cervical Squamous Cell Carcinoma	IMPACT341	DMP1353	DMP1353	Female			
P-0001445-T01-IM3	P-0001445	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1338	DMP1338	Male			
P-0001458-T01-IM3	P-0001458	Hepatocellular Carcinoma	Metastasis	Tumor	Lung	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP1355	DMP1355	Male			
P-0001460-T01-IM3	P-0001460	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP1356	DMP1356	Female			
P-0001468-T01-IM3	P-0001468	Endometrial Cancer	Metastasis	Tumor	Vagina	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP1357	DMP1357	Female			
P-0001465-T01-IM3	P-0001465	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Soft Tissue	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP1358	DMP1358	Male			
P-0001456-T01-IM3	P-0001456	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP1359	DMP1359	Female			
P-0001469-T01-IM3	P-0001469	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1360	DMP1360	Female			
P-0001459-T01-IM3	P-0001459	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1361	DMP1361	Female			
P-0001481-T01-IM3	P-0001481	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1362	DMP1362	Female			
P-0001478-T01-IM3	P-0001478	Ovarian Cancer	Metastasis	Tumor	Pelvis	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP1363	DMP1363	Female			
P-0001471-T01-IM3	P-0001471	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1364	DMP1364	Female			
P-0001482-T01-IM3	P-0001482	Chondrosarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Extraskeletal Myxoid Chondrosarcoma	IMPACT341	DMP1365	DMP1365	Male			
P-0001483-T01-IM3	P-0001483	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1366	DMP1366	Female			
P-0001473-T01-IM3	P-0001473	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1367	DMP1367	Female			
P-0001472-T01-IM3	P-0001472	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1368	DMP1368	Female			
P-0001475-T01-IM3	P-0001475	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1369	DMP1369	Female			
P-0001479-T01-IM3	P-0001479	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Low-Grade Fibromyxoid Sarcoma	IMPACT341	DMP1370	DMP1370	Male			
P-0001470-T01-IM3	P-0001470	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1371	DMP1371	Female			
P-0001485-T01-IM3	P-0001485	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT341	DMP1372	DMP1372	Male			
P-0001474-T01-IM3	P-0001474	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1373	DMP1373	Female			
P-0001484-T01-IM3	P-0001484	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1374	DMP1374	Female			
P-0001488-T01-IM3	P-0001488	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1375	DMP1375	Female			
P-0001489-T01-IM3	P-0001489	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1376	DMP1376	Female			
P-0001491-T01-IM3	P-0001491	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1377	DMP1377	Female			
P-0000216-T02-IM3	P-0000216	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0195	DMP0195	Female			
P-0001203-T01-IM3	P-0001203	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1379	DMP1379	Female			
P-0001241-T01-IM3	P-0001241	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1677	DMP1677	Female			
P-0001114-T02-IM3	P-0001114	Breast Carcinoma	Metastasis	Tumor	Mediastinum	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1381	DMP1381	Female			
P-0001487-T01-IM3	P-0001487	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1382	DMP1382	Male			
P-0001059-T02-IM3	P-0001059	Penile Cancer	Primary	Tumor	Not Applicable	Penis	Penile Squamous Cell Carcinoma	IMPACT341	DMP1383	DMP1383	Male			
P-0001446-T01-IM3	P-0001446	Prostate Cancer	Metastasis	Tumor	Kidney	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1339	DMP1339	Male			
P-0001497-T01-IM3	P-0001497	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Seromucinous Carcinoma	IMPACT341	DMP1385	DMP1385	Female			
P-0001496-T01-IM3	P-0001496	Biliary Cancer	Metastasis	Tumor	Liver	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1386	DMP1386	Male			
P-0001494-T01-IM3	P-0001494	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1387	DMP1387	Male			
P-0001503-T01-IM3	P-0001503	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1388	DMP1388	Female			
P-0001499-T01-IM3	P-0001499	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1389	DMP1389	Male			
P-0001495-T01-IM3	P-0001495	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1390	DMP1390	Male			
P-0001502-T01-IM3	P-0001502	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1391	DMP1391	Male			
P-0001505-T01-IM3	P-0001505	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1392	DMP1392	Female			
P-0001501-T01-IM3	P-0001501	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1393	DMP1393	Female			
P-0001417-T02-IM3	P-0001417	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1394	DMP1394	Female			
P-0000501-T02-IM3	P-0000501	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP0453	DMP0453	Male			
P-0001511-T01-IM3	P-0001511	Anal Cancer	Metastasis	Tumor	Liver	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP1396	DMP1396	Male			
P-0001506-T01-IM3	P-0001506	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1397	DMP1397	Male			
P-0001518-T01-IM3	P-0001518	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP1398	DMP1398	Male			
P-0001510-T01-IM3	P-0001510	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1399	DMP1399	Male			
P-0001516-T01-IM3	P-0001516	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1400	DMP1400	Female			
P-0001513-T01-IM3	P-0001513	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1401	DMP1401	Female			
P-0001514-T01-IM3	P-0001514	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1402	DMP1402	Female			
P-0001509-T01-IM3	P-0001509	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP1403	DMP1403	Female			
P-0001507-T01-IM3	P-0001507	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1404	DMP1404	Female			
P-0001515-T01-IM3	P-0001515	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1405	DMP1405	Female			
P-0001517-T01-IM3	P-0001517	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT341	DMP1406	DMP1406	Male			
P-0001512-T01-IM3	P-0001512	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1407	DMP1407	Female			
P-0001508-T01-IM3	P-0001508	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1408	DMP1408	Female			
P-0001519-T01-IM3	P-0001519	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1409	DMP1409	Male			
P-0000422-T02-IM3	P-0000422	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP0384	DMP0384	Female			
P-0001526-T01-IM3	P-0001526	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1411	DMP1411	Male			
P-0001532-T01-IM3	P-0001532	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1412	DMP1412	Female			
P-0001529-T01-IM3	P-0001529	Cancer of Unknown Primary	Metastasis	Tumor	Umbilical Cord	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1413	DMP1413	Male			
P-0000512-T01-IM3	P-0000512	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0460	DMP0460	Female			
P-0001533-T01-IM3	P-0001533	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1415	DMP1415	Male			
P-0001531-T01-IM3	P-0001531	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1416	DMP1416	Male			
P-0001523-T01-IM3	P-0001523	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP1417	DMP1417	Male			
P-0001525-T01-IM3	P-0001525	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1418	DMP1418	Male			
P-0001524-T01-IM3	P-0001524	Cancer of Unknown Primary	Metastasis	Tumor	Pleura	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1419	DMP1419	Male			
P-0001530-T01-IM3	P-0001530	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT341	DMP1420	DMP1420	Male			
P-0001521-T01-IM3	P-0001521	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Epithelioid Angiosarcoma	IMPACT341	DMP1421	DMP1421	Male			
P-0001522-T01-IM3	P-0001522	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP1422	DMP1422	Male			
P-0001527-T01-IM3	P-0001527	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341	DMP1423	DMP1423	Male			
P-0001104-T02-IM3	P-0001104	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1023	DMP1023	Female			
P-0001542-T01-IM3	P-0001542	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1425	DMP1425	Male			
P-0001539-T01-IM3	P-0001539	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1426	DMP1426	Female			
P-0001534-T01-IM3	P-0001534	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1427	DMP1427	Male			
P-0001548-T01-IM3	P-0001548	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP1428	DMP1428	Female			
P-0001545-T01-IM3	P-0001545	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1429	DMP1429	Female			
P-0001543-T01-IM3	P-0001543	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1430	DMP1430	Male			
P-0001547-T01-IM3	P-0001547	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1431	DMP1431	Female			
P-0001540-T01-IM3	P-0001540	Osteosarcoma	Primary	Tumor	Not Applicable	Forearm	Osteosarcoma	IMPACT341	DMP1432	DMP1432	Female			
P-0001536-T01-IM3	P-0001536	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1433	DMP1433	Female			
P-0001538-T01-IM3	P-0001538	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1434	DMP1434	Male			
P-0001544-T01-IM3	P-0001544	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Synovial Sarcoma	IMPACT341	DMP1435	DMP1435	Male			
P-0001449-T01-IM3	P-0001449	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1341	DMP1341	Male			
P-0001554-T01-IM3	P-0001554	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1437	DMP1437	Female			
P-0001550-T01-IM3	P-0001550	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1438	DMP1438	Female			
P-0001553-T01-IM3	P-0001553	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1439	DMP1439	Female			
P-0001560-T01-IM3	P-0001560	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT341	DMP1440	DMP1440	Male			
P-0001561-T01-IM3	P-0001561	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1441	DMP1441	Female			
P-0001557-T01-IM3	P-0001557	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Larynx	Larynx Squamous Cell Carcinoma	IMPACT341	DMP1442	DMP1442	Male			
P-0001551-T01-IM3	P-0001551	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1443	DMP1443	Female			
P-0001558-T01-IM3	P-0001558	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1444	DMP1444	Female			
P-0001555-T01-IM3	P-0001555	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP1445	DMP1445	Female			
P-0001549-T01-IM3	P-0001549	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1446	DMP1446	Female			
P-0001559-T01-IM3	P-0001559	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1447	DMP1447	Female			
P-0001556-T01-IM3	P-0001556	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Meningioma	IMPACT341	DMP1448	DMP1448	Male			
P-0000204-T02-IM3	P-0000204	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0188	DMP0188	Female			
P-0001571-T01-IM3	P-0001571	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1450	DMP1450	Female			
P-0001568-T01-IM3	P-0001568	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1451	DMP1451	Female			
P-0001570-T01-IM3	P-0001570	Ovarian Cancer	Metastasis	Tumor	Cul-de-sac	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1452	DMP1452	Female			
P-0001572-T01-IM3	P-0001572	Uterine Sarcoma	Metastasis	Tumor	Bone	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1453	DMP1453	Female			
P-0001573-T01-IM3	P-0001573	Melanoma	Primary	Tumor	Not Applicable	Anus	Anorectal Mucosal Melanoma	IMPACT341	DMP1454	DMP1454	Female			
P-0001566-T01-IM3	P-0001566	Breast Carcinoma	Metastasis	Tumor	Stomach	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1455	DMP1455	Female			
P-0001569-T01-IM3	P-0001569	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1456	DMP1456	Female			
P-0001564-T01-IM3	P-0001564	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1457	DMP1457	Female			
P-0001462-T01-IM3	P-0001462	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1354	DMP1354	Male			
P-0001565-T01-IM3	P-0001565	Endometrial Cancer	Metastasis	Tumor	Liver	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP1459	DMP1459	Female			
P-0001562-T01-IM3	P-0001562	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1460	DMP1460	Male			
P-0001224-T02-IM3	P-0001224	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1461	DMP1461	Female			
P-0001621-T01-IM3	P-0001621	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1462	DMP1462	Female			
P-0001616-T01-IM3	P-0001616	Ovarian Cancer	Metastasis	Tumor	Bladder	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1463	DMP1463	Female			
P-0001623-T01-IM3	P-0001623	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1464	DMP1464	Female			
P-0001622-T01-IM3	P-0001622	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1465	DMP1465	Male			
P-0001613-T01-IM3	P-0001613	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1466	DMP1466	Female			
P-0001625-T01-IM3	P-0001625	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1467	DMP1467	Male			
P-0001620-T01-IM3	P-0001620	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1468	DMP1468	Female			
P-0001624-T01-IM3	P-0001624	Adrenocortical Carcinoma	Metastasis	Tumor	Lung	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP1469	DMP1469	Male			
P-0001619-T01-IM3	P-0001619	Anal Cancer	Metastasis	Tumor	Heart	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP1470	DMP1470	Male			
P-0001618-T01-IM3	P-0001618	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1471	DMP1471	Female			
P-0001627-T01-IM3	P-0001627	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1472	DMP1472	Female			
P-0001638-T01-IM3	P-0001638	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1473	DMP1473	Female			
P-0001635-T01-IM3	P-0001635	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1474	DMP1474	Female			
P-0001640-T01-IM3	P-0001640	Colorectal Cancer	Primary	Tumor	Not Applicable	Splenic Flexure	Colon Adenocarcinoma	IMPACT341	DMP1475	DMP1475	Male			
P-0001493-T01-IM3	P-0001493	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1384	DMP1384	Male			
P-0001537-T01-IM3	P-0001537	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1436	DMP1436	Male			
P-0001637-T01-IM3	P-0001637	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1478	DMP1478	Female			
P-0001629-T01-IM3	P-0001629	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1479	DMP1479	Female			
P-0001563-T01-IM3	P-0001563	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1458	DMP1458	Male			
P-0001634-T01-IM3	P-0001634	Ovarian Cancer	Metastasis	Tumor	Spleen	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1481	DMP1481	Female			
P-0001633-T01-IM3	P-0001633	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1482	DMP1482	Female			
P-0001628-T01-IM3	P-0001628	Cancer of Unknown Primary	Metastasis	Tumor	Adrenal Gland	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1483	DMP1483	Female			
P-0001631-T01-IM3	P-0001631	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1484	DMP1484	Female			
P-0001632-T01-IM3	P-0001632	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1485	DMP1485	Female			
P-0001582-T01-IM3	P-0001582	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1486	DMP1486	Male			
P-0001575-T01-IM3	P-0001575	Ovarian Cancer	Metastasis	Tumor	Paracolic Gutter	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1487	DMP1487	Female			
P-0001577-T01-IM3	P-0001577	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1488	DMP1488	Female			
P-0001574-T01-IM3	P-0001574	Cancer of Unknown Primary	Metastasis	Tumor	Bone	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1489	DMP1489	Male			
P-0001578-T01-IM3	P-0001578	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1490	DMP1490	Male			
P-0001580-T01-IM3	P-0001580	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1491	DMP1491	Female			
P-0001579-T01-IM3	P-0001579	Wilms Tumor	Primary	Tumor	Not Applicable	Kidney	Wilms Tumor	IMPACT341	DMP1492	DMP1492	Male			
P-0001576-T01-IM3	P-0001576	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1493	DMP1493	Female			
P-0001104-T03-IM3	P-0001104	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1424	DMP1424	Female			
P-0001434-T01-IM3	P-0001434	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP1495	DMP1495	Female			
P-0001398-T01-IM3	P-0001398	Anal Cancer	Metastasis	Tumor	Lymph Node	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP1496	DMP1496	Male			
P-0001583-T01-IM3	P-0001583	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1497	DMP1497	Male			
P-0001594-T01-IM3	P-0001594	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1498	DMP1498	Female			
P-0001591-T01-IM3	P-0001591	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1499	DMP1499	Male			
P-0001598-T01-IM3	P-0001598	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Sinonasal	Sinonasal Squamous Cell Carcinoma	IMPACT341	DMP1500	DMP1500	Male			
P-0001595-T01-IM3	P-0001595	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1501	DMP1501	Female			
P-0001597-T01-IM3	P-0001597	Small Bowel Cancer	Primary	Tumor	Not Applicable	Small Bowel	Small Bowel Cancer	IMPACT341	DMP1502	DMP1502	Female			
P-0001589-T01-IM3	P-0001589	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1503	DMP1503	Female			
P-0001596-T01-IM3	P-0001596	Soft Tissue Sarcoma	Local Recurrence	Tumor	Kidney	Retroperitoneum	Dedifferentiated Sarcoma	IMPACT341	DMP1504	DMP1504	Female			
P-0001585-T01-IM3	P-0001585	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1505	DMP1505	Female			
P-0001390-T01-IM3	P-0001390	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1506	DMP1506	Male			
P-0001603-T01-IM3	P-0001603	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT341	DMP1507	DMP1507	Male			
P-0001602-T01-IM3	P-0001602	Germ Cell Tumor	Metastasis	Tumor	Pelvis	Ovary	Yolk Sac Tumor	IMPACT341	DMP1508	DMP1508	Female			
P-0001605-T01-IM3	P-0001605	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1509	DMP1509	Female			
P-0001608-T01-IM3	P-0001608	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1510	DMP1510	Female			
P-0001610-T01-IM3	P-0001610	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1511	DMP1511	Male			
P-0001612-T01-IM3	P-0001612	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP1512	DMP1512	Male			
P-0001611-T01-IM3	P-0001611	Cancer of Unknown Primary	Metastasis	Tumor	Brain	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1513	DMP1513	Female			
P-0001600-T01-IM3	P-0001600	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1514	DMP1514	Female			
P-0001607-T01-IM3	P-0001607	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1515	DMP1515	Female			
P-0001609-T01-IM3	P-0001609	Ampullary Carcinoma	Metastasis	Tumor	Liver	Ampulla of Vater	Ampullary Carcinoma	IMPACT341	DMP1516	DMP1516	Male			
P-0001601-T01-IM3	P-0001601	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1517	DMP1517	Male			
P-0001604-T01-IM3	P-0001604	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1518	DMP1518	Female			
P-0001606-T01-IM3	P-0001606	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1519	DMP1519	Female			
P-0001169-T01-IM3	P-0001169	Meningothelial Tumor	Primary	Tumor	Not Applicable	Bone	Meningioma	IMPACT341	DMP1520	DMP1520	Female			
P-0001645-T01-IM3	P-0001645	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1521	DMP1521	Male			
P-0001648-T01-IM3	P-0001648	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1522	DMP1522	Female			
P-0001649-T01-IM3	P-0001649	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1524	DMP1524	Male			
P-0001646-T01-IM3	P-0001646	Melanoma	Metastasis	Tumor	Stomach	Skin	Cutaneous Melanoma	IMPACT341	DMP1525	DMP1525	Female			
P-0001642-T01-IM3	P-0001642	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341	DMP1526	DMP1526	Female			
P-0001641-T01-IM3	P-0001641	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1527	DMP1527	Female			
P-0001643-T01-IM3	P-0001643	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1528	DMP1528	Female			
P-0001652-T01-IM3	P-0001652	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Sclerosing Epithelioid Fibrosarcoma	IMPACT341	DMP1529	DMP1529	Female			
P-0001647-T01-IM3	P-0001647	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1530	DMP1530	Male			
P-0000997-T02-IM3	P-0000997	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0910	DMP0910	Male			
P-0001660-T01-IM3	P-0001660	Salivary Carcinoma	Metastasis	Tumor	Bone	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP1532	DMP1532	Female			
P-0001662-T01-IM3	P-0001662	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1533	DMP1533	Male			
P-0001659-T01-IM3	P-0001659	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP1534	DMP1534	Male			
P-0001657-T01-IM3	P-0001657	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1535	DMP1535	Male			
P-0001658-T01-IM3	P-0001658	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1536	DMP1536	Male			
P-0001653-T01-IM3	P-0001653	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP1537	DMP1537	Female			
P-0001663-T01-IM3	P-0001663	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Teratoma	IMPACT341	DMP1538	DMP1538	Male			
P-0001661-T01-IM3	P-0001661	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1539	DMP1539	Female			
P-0001654-T01-IM3	P-0001654	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1540	DMP1540	Female			
P-0001656-T01-IM3	P-0001656	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP1541	DMP1541	Male			
P-0001664-T01-IM3	P-0001664	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1542	DMP1542	Female			
P-0001655-T01-IM3	P-0001655	Cervical Cancer	Metastasis	Tumor	Lymph Node	Cervix	Cervical Adenosquamous Carcinoma	IMPACT341	DMP1543	DMP1543	Female			
P-0001424-T02-IM3	P-0001424	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1544	DMP1544	Female			
P-0000662-T01-IM3	P-0000662	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0619	DMP0619	Male			
P-0001365-T02-IM3	P-0001365	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1546	DMP1546	Male			
P-0001675-T01-IM3	P-0001675	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341	DMP1547	DMP1547	Male			
P-0001665-T01-IM3	P-0001665	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1548	DMP1548	Female			
P-0001679-T01-IM3	P-0001679	Melanoma	Metastasis	Tumor	Adrenal Gland	Rectum	Anorectal Mucosal Melanoma	IMPACT341	DMP1549	DMP1549	Male			
P-0001672-T01-IM3	P-0001672	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1550	DMP1550	Female			
P-0001670-T01-IM3	P-0001670	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1551	DMP1551	Male			
P-0001673-T01-IM3	P-0001673	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1552	DMP1552	Female			
P-0001678-T01-IM3	P-0001678	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1553	DMP1553	Male			
P-0001676-T01-IM3	P-0001676	Colorectal Cancer	Metastasis	Tumor	Ovary	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1554	DMP1554	Female			
P-0000700-T01-IM3	P-0000700	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0651	DMP0651	Male			
P-0001677-T01-IM3	P-0001677	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1556	DMP1556	Female			
P-0001669-T01-IM3	P-0001669	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT341	DMP1557	DMP1557	Male			
P-0001667-T01-IM3	P-0001667	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP1558	DMP1558	Female			
P-0001686-T01-IM3	P-0001686	Melanoma	Primary	Tumor	Not Applicable	Vulva	Genitourinary Mucosal Melanoma	IMPACT341	DMP1559	DMP1559	Female			
P-0001690-T01-IM3	P-0001690	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1560	DMP1560	Male			
P-0001692-T01-IM3	P-0001692	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1561	DMP1561	Male			
P-0001685-T02-IM3	P-0001685	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1570	DMP1570	Male			
P-0001681-T01-IM3	P-0001681	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Serous Borderline Ovarian Tumor, Micropapillary	IMPACT341	DMP1563	DMP1563	Female			
P-0001630-T01-IM3	P-0001630	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1476	DMP1476	Male			
P-0001683-T01-IM3	P-0001683	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1565	DMP1565	Female			
P-0001639-T01-IM3	P-0001639	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1477	DMP1477	Male			
P-0001680-T01-IM3	P-0001680	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1567	DMP1567	Female			
P-0001682-T01-IM3	P-0001682	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP1568	DMP1568	Male			
P-0001688-T01-IM3	P-0001688	Cervical Cancer	Metastasis	Tumor	Pelvis	Cervix	Cervical Squamous Cell Carcinoma	IMPACT341	DMP1569	DMP1569	Female			
P-0001685-T01-IM3	P-0001685	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1562	DMP1562	Male			
P-0001680-T02-IM3	P-0001680	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Cervical Squamous Cell Carcinoma	IMPACT341	DMP1571	DMP1571	Female			
P-0001054-T02-IM3	P-0001054	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Cecum	Colon Adenocarcinoma	IMPACT341	DMP0977	DMP0977	Female			
P-0001696-T01-IM3	P-0001696	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1573	DMP1573	Female			
P-0001702-T01-IM3	P-0001702	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1574	DMP1574	Female			
P-0001701-T01-IM3	P-0001701	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1575	DMP1575	Female			
P-0001636-T01-IM3	P-0001636	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1480	DMP1480	Male			
P-0001695-T01-IM3	P-0001695	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1577	DMP1577	Female			
P-0001700-T01-IM3	P-0001700	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Endometrioid Ovarian Cancer	IMPACT341	DMP1578	DMP1578	Female			
P-0001705-T01-IM3	P-0001705	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Merkel Cell Carcinoma	IMPACT341	DMP1579	DMP1579	Male			
P-0001703-T01-IM3	P-0001703	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1580	DMP1580	Female			
P-0001699-T01-IM3	P-0001699	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1581	DMP1581	Female			
P-0001706-T01-IM3	P-0001706	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT341	DMP1582	DMP1582	Male			
P-0001684-T01-IM3	P-0001684	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1566	DMP1566	Male			
P-0001704-T01-IM3	P-0001704	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1584	DMP1584	Male			
P-0000616-T02-IM3	P-0000616	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP0564	DMP0564	Female			
P-0002415-T01-IM3	P-0002415	Mesothelioma	Metastasis	Tumor	Lymph Node	Pleura	Pleural Mesothelioma	IMPACT341	DMP2247	DMP2247	Male			
P-0001720-T01-IM3	P-0001720	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1587	DMP1587	Male			
P-0001694-T01-IM3	P-0001694	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1576	DMP1576	Male			
P-0001713-T01-IM3	P-0001713	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1589	DMP1589	Female			
P-0001711-T01-IM3	P-0001711	Soft Tissue Sarcoma	Metastasis	Tumor	Blood Vessel	Lower Extremity	Leiomyosarcoma	IMPACT341	DMP1590	DMP1590	Male			
P-0001708-T01-IM3	P-0001708	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP1591	DMP1591	Female			
P-0001710-T01-IM3	P-0001710	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP1592	DMP1592	Male			
P-0001718-T01-IM3	P-0001718	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1593	DMP1593	Female			
P-0001716-T01-IM3	P-0001716	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT341	DMP1594	DMP1594	Male			
P-0001709-T01-IM3	P-0001709	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1595	DMP1595	Male			
P-0001715-T01-IM3	P-0001715	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1596	DMP1596	Female			
P-0000539-T02-IM3	P-0000539	Thyroid Cancer	Metastasis	Tumor	Liver	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0732	DMP0732	Female			
P-0001707-T01-IM3	P-0001707	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1598	DMP1598	Male			
P-0001726-T01-IM3	P-0001726	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1599	DMP1599	Male			
P-0001722-T01-IM3	P-0001722	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1600	DMP1600	Male			
P-0001730-T01-IM3	P-0001730	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1601	DMP1601	Female			
P-0001723-T01-IM3	P-0001723	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341	DMP1602	DMP1602	Male			
P-0001731-T01-IM3	P-0001731	Glioma	Primary	Tumor	Not Applicable	Brain	High-Grade Glioma, NOS	IMPACT341	DMP1603	DMP1603	Male			
P-0001729-T01-IM3	P-0001729	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1604	DMP1604	Male			
P-0001721-T01-IM3	P-0001721	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1605	DMP1605	Female			
P-0001724-T01-IM3	P-0001724	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1606	DMP1606	Male			
P-0001725-T01-IM3	P-0001725	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT341	DMP1607	DMP1607	Female			
P-0001727-T01-IM3	P-0001727	Chordoma	Primary	Tumor	Not Applicable	Pelvis	Chordoma	IMPACT341	DMP1608	DMP1608	Male			
P-0001732-T01-IM3	P-0001732	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1609	DMP1609	Female			
P-0001733-T01-IM3	P-0001733	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1610	DMP1610	Male			
P-0001736-T01-IM3	P-0001736	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1611	DMP1611	Male			
P-0001737-T01-IM3	P-0001737	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Medullary Carcinoma	IMPACT341	DMP1612	DMP1612	Male			
P-0001734-T01-IM3	P-0001734	Colorectal Cancer	Primary	Tumor	Not Applicable	Hepatic Flexure	Colon Adenocarcinoma	IMPACT341	DMP1613	DMP1613	Female			
P-0000836-T01-IM3	P-0000836	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0785	DMP0785	Female			
P-0001741-T01-IM3	P-0001741	Cancer of Unknown Primary	Metastasis	Tumor	Abdomen	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1615	DMP1615	Female			
P-0000023-T01-IM3	P-0000023	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT341	DMP0015	DMP0015	Male			
P-0001740-T01-IM3	P-0001740	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT341	DMP1617	DMP1617	Male			
P-0001744-T01-IM3	P-0001744	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Nose	Nasal Squamous Cell Carcinoma	IMPACT341	DMP1618	DMP1618	Male			
P-0001743-T01-IM3	P-0001743	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP1619	DMP1619	Female			
P-0001749-T01-IM3	P-0001749	Germ Cell Tumor	Primary	Tumor	Liver	Testis	Seminoma	IMPACT341	DMP1620	DMP1620	Male			
P-0001738-T01-IM3	P-0001738	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Mucinous Tubular Spindle Cell Carcinoma	IMPACT341	DMP1621	DMP1621	Male			
P-0001745-T01-IM3	P-0001745	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1622	DMP1622	Female			
P-0001742-T01-IM3	P-0001742	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1623	DMP1623	Male			
P-0001746-T01-IM3	P-0001746	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1624	DMP1624	Male			
P-0001747-T01-IM3	P-0001747	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1625	DMP1625	Female			
P-0001535-T01-IM3	P-0001535	Thymic Tumor	Metastasis	Tumor	Mediastinum	Thymus	Thymoma	IMPACT341	DMP1626	DMP1626	Female			
P-0001755-T01-IM3	P-0001755	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1627	DMP1627	Male			
P-0001752-T01-IM3	P-0001752	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1628	DMP1628	Female			
P-0001753-T01-IM3	P-0001753	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Papillary Renal Cell Carcinoma	IMPACT341	DMP1629	DMP1629	Male			
P-0001754-T01-IM3	P-0001754	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1630	DMP1630	Female			
P-0001756-T01-IM3	P-0001756	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT341	DMP1631	DMP1631	Male			
P-0001758-T01-IM3	P-0001758	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1632	DMP1632	Female			
P-0001750-T01-IM3	P-0001750	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1633	DMP1633	Female			
P-0001757-T01-IM3	P-0001757	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1634	DMP1634	Female			
P-0001751-T01-IM3	P-0001751	Breast Carcinoma	Metastasis	Tumor	Epidural	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1635	DMP1635	Female			
P-0000934-T01-IM3	P-0000934	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP0873	DMP0873	Male			
P-0001760-T01-IM3	P-0001760	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Metaplastic Carcinosarcoma	IMPACT341	DMP1637	DMP1637	Female			
P-0001615-T01-IM3	P-0001615	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Myxoid Leiomyosarcoma	IMPACT341	DMP1638	DMP1638	Female			
P-0001614-T01-IM3	P-0001614	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1639	DMP1639	Female			
P-0001777-T01-IM3	P-0001777	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1640	DMP1640	Female			
P-0001784-T01-IM3	P-0001784	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1641	DMP1641	Female			
P-0001783-T01-IM3	P-0001783	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341	DMP1642	DMP1642	Female			
P-0001779-T01-IM3	P-0001779	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Renal Neuroendocrine Tumor	IMPACT341	DMP1643	DMP1643	Male			
P-0001787-T01-IM3	P-0001787	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1644	DMP1644	Female			
P-0001782-T01-IM3	P-0001782	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1645	DMP1645	Female			
P-0001788-T01-IM3	P-0001788	Melanoma	Metastasis	Tumor	Liver	Skin	Uveal Melanoma	IMPACT341	DMP1646	DMP1646	Female			
P-0001781-T01-IM3	P-0001781	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1647	DMP1647	Female			
P-0001698-T01-IM3	P-0001698	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1583	DMP1583	Male			
P-0001775-T01-IM3	P-0001775	Adrenocortical Carcinoma	Metastasis	Tumor	Lung	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP1649	DMP1649	Female			
P-0001780-T01-IM3	P-0001780	Uterine Sarcoma	Metastasis	Tumor	Skin	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1650	DMP1650	Female			
P-0001778-T01-IM3	P-0001778	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1651	DMP1651	Male			
P-0001717-T01-IM3	P-0001717	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1588	DMP1588	Male			
P-0001798-T01-IM3	P-0001798	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1653	DMP1653	Female			
P-0001791-T01-IM3	P-0001791	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1654	DMP1654	Female			
P-0001801-T01-IM3	P-0001801	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1655	DMP1655	Female			
P-0001799-T01-IM3	P-0001799	Ovarian Cancer	Metastasis	Tumor	Cul-de-sac	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1656	DMP1656	Female			
P-0001234-T01-IM3	P-0001234	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP1133	DMP1133	Male			
P-0001776-T01-IM3	P-0001776	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1648	DMP1648	Male			
P-0001797-T01-IM3	P-0001797	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1659	DMP1659	Female			
P-0001794-T01-IM3	P-0001794	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Larynx	Larynx Squamous Cell Carcinoma	IMPACT341	DMP1660	DMP1660	Male			
P-0001796-T01-IM3	P-0001796	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1661	DMP1661	Female			
P-0001793-T01-IM3	P-0001793	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1662	DMP1662	Female			
P-0001790-T01-IM3	P-0001790	Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Small Cell Lung Cancer	IMPACT341	DMP1663	DMP1663	Female			
P-0001805-T01-IM3	P-0001805	Bladder Cancer	Metastasis	Tumor	Prostate	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1665	DMP1665	Male			
P-0001802-T01-IM3	P-0001802	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1666	DMP1666	Male			
P-0001810-T01-IM3	P-0001810	Salivary Carcinoma	Metastasis	Tumor	Skin	Trachea	Adenoid Cystic Carcinoma	IMPACT341	DMP1667	DMP1667	Male			
P-0001809-T01-IM3	P-0001809	Sex Cord Stromal Tumor	Metastasis	Tumor	Bladder	Ovary	Granulosa Cell Tumor	IMPACT341	DMP1668	DMP1668	Female			
P-0001807-T01-IM3	P-0001807	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1669	DMP1669	Male			
P-0001811-T01-IM3	P-0001811	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1670	DMP1670	Female			
P-0001803-T01-IM3	P-0001803	Penile Cancer	Metastasis	Tumor	Skin	Penis	Penile Squamous Cell Carcinoma	IMPACT341	DMP1671	DMP1671	Male			
P-0001814-T01-IM3	P-0001814	Uterine Sarcoma	Metastasis	Tumor	Sigmoid Colon	Uterus	Uterine Myxoid Leiomyosarcoma	IMPACT341	DMP1672	DMP1672	Female			
P-0001808-T01-IM3	P-0001808	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1673	DMP1673	Male			
P-0001812-T01-IM3	P-0001812	Small Bowel Cancer	Metastasis	Tumor	Peritoneum	Small Bowel	Small Bowel Adenocarcinoma	IMPACT341	DMP1674	DMP1674	Male			
P-0001806-T01-IM3	P-0001806	Hepatocellular Carcinoma	Metastasis	Tumor	Adrenal Gland	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1675	DMP1675	Male			
P-0001813-T02-IM3	DMP1676	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP0497	DMP0497	Male			
P-0001241-T02-IM3	P-0001241	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1380	DMP1380	Female			
P-0001818-T01-IM3	P-0001818	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1678	DMP1678	Female			
P-0001827-T01-IM3	P-0001827	Chondrosarcoma	Primary	Tumor	Not Applicable	Pelvis	Chondrosarcoma	IMPACT341	DMP1679	DMP1679	Female			
P-0001826-T01-IM3	P-0001826	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1680	DMP1680	Female			
P-0000828-T02-IM3	P-0000828	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1652	DMP1652	Male			
P-0001824-T01-IM3	P-0001824	Biliary Cancer	Metastasis	Tumor	Peritoneum	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1682	DMP1682	Male			
P-0001820-T01-IM3	P-0001820	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1683	DMP1683	Female			
P-0001825-T01-IM3	P-0001825	Uterine Sarcoma	Metastasis	Tumor	Stomach	Uterus	Uterine Epithelioid Leiomyosarcoma	IMPACT341	DMP1684	DMP1684	Female			
P-0001823-T01-IM3	P-0001823	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1685	DMP1685	Female			
P-0001830-T01-IM3	P-0001830	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1686	DMP1686	Female			
P-0001819-T01-IM3	P-0001819	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1687	DMP1687	Male			
P-0001821-T01-IM3	P-0001821	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Epithelioid Leiomyosarcoma	IMPACT341	DMP1688	DMP1688	Female			
P-0001828-T01-IM3	P-0001828	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1689	DMP1689	Female			
P-0001816-T01-IM3	P-0001816	Pheochromocytoma	Primary	Tumor	Not Applicable	Adrenal Gland	Pheochromocytoma	IMPACT341	DMP1690	DMP1690	Male			
P-0001795-T01-IM3	P-0001795	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1658	DMP1658	Male			
P-0001817-T01-IM3	P-0001817	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1692	DMP1692	Female			
P-0001835-T01-IM3	P-0001835	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP1693	DMP1693	Male			
P-0001832-T01-IM3	P-0001832	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1694	DMP1694	Female			
P-0001834-T01-IM3	P-0001834	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1695	DMP1695	Male			
P-0001842-T01-IM3	P-0001842	Germ Cell Tumor	Metastasis	Tumor	Vas deferens	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1696	DMP1696	Male			
P-0001837-T01-IM3	P-0001837	Non-Small Cell Lung Cancer	Metastasis	Tumor	Heart	Lung	Lung Adenocarcinoma	IMPACT341	DMP1697	DMP1697	Female			
P-0001838-T01-IM3	P-0001838	Uterine Sarcoma	Metastasis	Tumor	Liver	Uterus	Undifferentiated Uterine Sarcoma	IMPACT341	DMP1698	DMP1698	Female			
P-0001836-T01-IM3	P-0001836	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1699	DMP1699	Female			
P-0001839-T01-IM3	P-0001839	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1700	DMP1700	Female			
P-0001841-T01-IM3	P-0001841	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP1701	DMP1701	Male			
P-0001833-T01-IM3	P-0001833	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1702	DMP1702	Male			
P-0001840-T01-IM3	P-0001840	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1703	DMP1703	Female			
P-0001931-T01-IM3	P-0001931	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1704	DMP1704	Male			
P-0001929-T01-IM3	P-0001929	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341	DMP1705	DMP1705	Male			
P-0001935-T01-IM3	P-0001935	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1706	DMP1706	Female			
P-0001932-T01-IM3	P-0001932	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1707	DMP1707	Female			
P-0001927-T01-IM3	P-0001927	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1708	DMP1708	Male			
P-0001930-T01-IM3	P-0001930	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT341	DMP1709	DMP1709	Female			
P-0001937-T01-IM3	P-0001937	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT341	DMP1710	DMP1710	Male			
P-0001928-T01-IM3	P-0001928	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1711	DMP1711	Male			
P-0001934-T01-IM3	P-0001934	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1712	DMP1712	Female			
P-0001926-T01-IM3	P-0001926	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP1713	DMP1713	Male			
P-0001936-T01-IM3	P-0001936	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Clear Cell Carcinoma	IMPACT341	DMP1714	DMP1714	Female			
P-0001925-T01-IM3	P-0001925	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1715	DMP1715	Female			
P-0001933-T01-IM3	P-0001933	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1716	DMP1716	Female			
P-0001855-T01-IM3	P-0001855	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1717	DMP1717	Male			
P-0001848-T01-IM3	P-0001848	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1718	DMP1718	Female			
P-0001852-T01-IM3	P-0001852	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1719	DMP1719	Female			
P-0001850-T01-IM3	P-0001850	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1720	DMP1720	Male			
P-0001844-T01-IM3	P-0001844	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT341	DMP1722	DMP1722	Male			
P-0001849-T01-IM3	P-0001849	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP1723	DMP1723	Female			
P-0001856-T01-IM3	P-0001856	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1724	DMP1724	Male			
P-0001851-T01-IM3	P-0001851	Adrenocortical Carcinoma	Metastasis	Tumor	Pancreas	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341	DMP1725	DMP1725	Male			
P-0001854-T01-IM3	P-0001854	Germ Cell Tumor	Metastasis	Tumor	Pelvis	Testis	Seminoma	IMPACT341	DMP1726	DMP1726	Male			
P-0001829-T01-IM3	P-0001829	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1681	DMP1681	Male			
P-0001847-T01-IM3	P-0001847	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1728	DMP1728	Female			
P-0001857-T01-IM3	P-0001857	Appendiceal Cancer	Metastasis	Tumor	Abdominal Wall	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT341	DMP1729	DMP1729	Male			
P-0001846-T01-IM3	P-0001846	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1730	DMP1730	Female			
P-0001843-T01-IM3	P-0001843	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1731	DMP1731	Female			
P-0001766-T01-IM3	P-0001766	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1732	DMP1732	Female			
P-0001773-T01-IM3	P-0001773	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT341	DMP1733	DMP1733	Male			
P-0001761-T01-IM3	P-0001761	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1734	DMP1734	Female			
P-0001764-T01-IM3	P-0001764	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1735	DMP1735	Female			
P-0001822-T01-IM3	P-0001822	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1691	DMP1691	Male			
P-0001762-T01-IM3	P-0001762	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1737	DMP1737	Female			
P-0001763-T01-IM3	P-0001763	Cancer of Unknown Primary	Metastasis	Tumor	Spleen	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1738	DMP1738	Female			
P-0001767-T01-IM3	P-0001767	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1739	DMP1739	Female			
P-0001769-T01-IM3	P-0001769	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1740	DMP1740	Male			
P-0001845-T01-IM3	P-0001845	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1727	DMP1727	Male			
P-0001693-T02-IM3	P-0001693	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1742	DMP1742	Female			
P-0002137-T01-IM3	P-0002137	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Medullary Thyroid Cancer	IMPACT341	DMP2316	DMP2316	Male			
P-0001862-T01-IM3	P-0001862	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1744	DMP1744	Female			
P-0001768-T01-IM3	P-0001768	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1736	DMP1736	Male			
P-0001865-T01-IM3	P-0001865	Soft Tissue Sarcoma	Local Recurrence	Tumor	Lung	Lung	Angiosarcoma	IMPACT341	DMP1746	DMP1746	Male			
P-0001028-T01-IM3	P-0001028	Thyroid Cancer	Metastasis	Tumor	Trachea	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP0937	DMP0937	Male			
P-0001867-T01-IM3	P-0001867	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1748	DMP1748	Male			
P-0001871-T01-IM3	P-0001871	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1749	DMP1749	Female			
P-0001860-T01-IM3	P-0001860	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1750	DMP1750	Female			
P-0001869-T01-IM3	P-0001869	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT341	DMP1751	DMP1751	Male			
P-0001870-T01-IM3	P-0001870	Soft Tissue Sarcoma	Local Recurrence	Tumor	Retroperitoneum	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP1752	DMP1752	Male			
P-0001864-T01-IM3	P-0001864	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1753	DMP1753	Male			
P-0001858-T01-IM3	P-0001858	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1754	DMP1754	Female			
P-0001872-T01-IM3	P-0001872	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Myoepithelial Carcinoma	IMPACT341	DMP1755	DMP1755	Female			
P-0001863-T01-IM3	P-0001863	Soft Tissue Sarcoma	Metastasis	Tumor	Upper Extremity	Breast	Angiosarcoma	IMPACT341	DMP1756	DMP1756	Female			
P-0001774-T01-IM3	P-0001774	Prostate Cancer	Metastasis	Tumor	Prostate	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1741	DMP1741	Male			
P-0001874-T01-IM3	P-0001874	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1758	DMP1758	Female			
P-0001879-T01-IM3	P-0001879	Pancreatic Cancer	Metastasis	Tumor	Abdomen	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1759	DMP1759	Female			
P-0001886-T01-IM3	P-0001886	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1760	DMP1760	Male			
P-0001882-T01-IM3	P-0001882	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1761	DMP1761	Male			
P-0001877-T01-IM3	P-0001877	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1762	DMP1762	Female			
P-0001880-T01-IM3	P-0001880	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1763	DMP1763	Male			
P-0001883-T01-IM3	P-0001883	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1764	DMP1764	Female			
P-0001875-T01-IM3	P-0001875	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1766	DMP1766	Female			
P-0001885-T01-IM3	P-0001885	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Hemangiopericytoma of the Central Nervous System	IMPACT341	DMP1767	DMP1767	Male			
P-0001878-T01-IM3	P-0001878	Soft Tissue Sarcoma	Metastasis	Tumor	Hip	Lower Extremity	Leiomyosarcoma	IMPACT341	DMP1768	DMP1768	Male			
P-0001861-T01-IM3	P-0001861	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1745	DMP1745	Male			
P-0001859-T01-IM3	P-0001859	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1757	DMP1757	Male			
P-0001881-T01-IM3	P-0001881	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP1771	DMP1771	Male			
P-0001919-T01-IM3	P-0001919	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Back	Dermatofibrosarcoma Protuberans	IMPACT341	DMP1772	DMP1772	Female			
P-0001915-T01-IM3	P-0001915	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1773	DMP1773	Female			
P-0001922-T01-IM3	P-0001922	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1774	DMP1774	Male			
P-0001918-T01-IM3	P-0001918	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP1775	DMP1775	Male			
P-0001914-T01-IM3	P-0001914	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341	DMP1776	DMP1776	Female			
P-0001920-T01-IM3	P-0001920	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1777	DMP1777	Male			
P-0001912-T01-IM3	P-0001912	Head and Neck Carcinoma	Metastasis	Tumor	Liver	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP1778	DMP1778	Male			
P-0001921-T01-IM3	P-0001921	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341	DMP1779	DMP1779	Male			
P-0001924-T01-IM3	P-0001924	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Duodenum	Gastrointestinal Stromal Tumor	IMPACT341	DMP1780	DMP1780	Male			
P-0001126-T01-IM3	P-0001126	Mesothelioma	Metastasis	Tumor	Bowel	Umbilical Mass	Peritoneal Mesothelioma	IMPACT341	DMP1037	DMP1037	Female			
P-0001923-T01-IM3	P-0001923	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1782	DMP1782	Male			
P-0001916-T01-IM3	P-0001916	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1783	DMP1783	Female			
P-0001913-T01-IM3	P-0001913	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1784	DMP1784	Female			
P-0001741-T02-IM3	P-0001741	Cancer of Unknown Primary	Metastasis	Tumor	Trachea	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1785	DMP1785	Female			
P-0001735-T01-IM3	P-0001735	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1786	DMP1786	Female			
P-0001887-T01-IM3	P-0001887	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1787	DMP1787	Female			
P-0001888-T01-IM3	P-0001888	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1788	DMP1788	Female			
P-0001891-T01-IM3	P-0001891	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1789	DMP1789	Male			
P-0001897-T01-IM3	P-0001897	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP1790	DMP1790	Male			
P-0001884-T01-IM3	P-0001884	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1769	DMP1769	Male			
P-0001889-T01-IM3	P-0001889	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1792	DMP1792	Female			
P-0001892-T01-IM3	P-0001892	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT341	DMP1793	DMP1793	Male			
P-0001876-T01-IM3	P-0001876	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1770	DMP1770	Male			
P-0001896-T01-IM3	P-0001896	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT341	DMP1795	DMP1795	Female			
P-0001894-T01-IM3	P-0001894	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1796	DMP1796	Female			
P-0001893-T01-IM3	P-0001893	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Carcinoid	IMPACT341	DMP1797	DMP1797	Female			
P-0001898-T01-IM3	P-0001898	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1798	DMP1798	Female			
P-0001890-T01-IM3	P-0001890	Brain Cancer, NOS	Primary	Tumor	Not Applicable	Brain	Brain Cancer, NOS	IMPACT341	DMP1799	DMP1799	Male			
P-0001692-T02-IM3	P-0001692	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Abdomen	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP1800	DMP1800	Male			
P-0001771-T01-IM3	P-0001771	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1801	DMP1801	Female			
P-0001902-T01-IM3	P-0001902	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1802	DMP1802	Female			
P-0001908-T01-IM3	P-0001908	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1803	DMP1803	Female			
P-0001907-T01-IM3	P-0001907	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1804	DMP1804	Female			
P-0001904-T01-IM3	P-0001904	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1805	DMP1805	Female			
P-0001911-T01-IM3	P-0001911	Ovarian Cancer	Metastasis	Tumor	Rectosigmoid Colon	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1807	DMP1807	Female			
P-0001903-T01-IM3	P-0001903	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Hypopharynx	Hypopharyngeal Squamous Cell Carcinoma	IMPACT341	DMP1808	DMP1808	Male			
P-0001906-T01-IM3	P-0001906	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1809	DMP1809	Female			
P-0001909-T01-IM3	P-0001909	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1810	DMP1810	Male			
P-0000967-T01-IM3	P-0000967	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP0948	DMP0948	Male			
P-0001901-T01-IM3	P-0001901	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT341	DMP1812	DMP1812	Female			
P-0001895-T01-IM3	P-0001895	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1791	DMP1791	Male			
P-0001216-T01-IM3	P-0001216	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1124	DMP1124	Male			
P-0001804-T01-IM3	P-0001804	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341	DMP1815	DMP1815	Female			
P-0002060-T01-IM3	P-0002060	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341	DMP1816	DMP1816	Male			
P-0001246-T01-IM3	P-0001246	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1148	DMP1148	Female			
P-0001541-T01-IM3	P-0001541	Thyroid Cancer	Metastasis	Tumor	Thigh	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1614	DMP1614	Male			
P-0001941-T02-IM3	P-0001941	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1819	DMP1819	Female			
P-0002064-T01-IM3	P-0002064	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1820	DMP1820	Female			
P-0002057-T01-IM3	P-0002057	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1821	DMP1821	Male			
P-0002066-T01-IM3	P-0002066	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Larynx	Pleomorphic Rhabdomyosarcoma	IMPACT341	DMP1822	DMP1822	Male			
P-0002056-T01-IM3	P-0002056	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1823	DMP1823	Female			
P-0002063-T01-IM3	P-0002063	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP1824	DMP1824	Female			
P-0002059-T01-IM3	P-0002059	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1825	DMP1825	Male			
P-0002073-T01-IM3	P-0002073	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP1826	DMP1826	Male			
P-0002069-T01-IM3	P-0002069	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1827	DMP1827	Male			
P-0002071-T01-IM3	P-0002071	Pancreatic Cancer	Metastasis	Tumor	Lymph Node	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1828	DMP1828	Female			
P-0002068-T01-IM3	P-0002068	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1829	DMP1829	Female			
P-0002070-T01-IM3	P-0002070	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1830	DMP1830	Male			
P-0002072-T01-IM3	P-0002072	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1831	DMP1831	Male			
P-0002077-T01-IM3	P-0002077	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1832	DMP1832	Male			
P-0001853-T01-IM3	P-0001853	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1721	DMP1721	Male			
P-0002075-T01-IM3	P-0002075	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1834	DMP1834	Male			
P-0002078-T01-IM3	P-0002078	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1835	DMP1835	Male			
P-0001868-T01-IM3	P-0001868	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1743	DMP1743	Male			
P-0001402-T02-IM3	P-0001402	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT341	DMP1837	DMP1837	Female			
P-0002080-T01-IM3	P-0002080	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Transverse Colon	Colon Adenocarcinoma	IMPACT341	DMP1838	DMP1838	Male			
P-0002083-T01-IM3	P-0002083	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1839	DMP1839	Female			
P-0002091-T01-IM3	P-0002091	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1840	DMP1840	Female			
P-0002081-T01-IM3	P-0002081	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1841	DMP1841	Female			
P-0002084-T01-IM3	P-0002084	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT341	DMP1842	DMP1842	Female			
P-0002079-T01-IM3	P-0002079	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP1843	DMP1843	Male			
P-0002085-T01-IM3	P-0002085	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1844	DMP1844	Female			
P-0002087-T01-IM3	P-0002087	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1845	DMP1845	Male			
P-0002082-T01-IM3	P-0002082	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1846	DMP1846	Female			
P-0002088-T01-IM3	P-0002088	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1847	DMP1847	Female			
P-0002092-T01-IM3	P-0002092	Anal Cancer	Primary	Tumor	Not Applicable	Rectum	Anal Squamous Cell Carcinoma	IMPACT341	DMP1848	DMP1848	Male			
P-0001528-T02-IM3	P-0001528	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1849	DMP1849	Male			
P-0002094-T01-IM3	P-0002094	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT341	DMP1850	DMP1850	Male			
P-0002095-T01-IM3	P-0002095	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1851	DMP1851	Female			
P-0002102-T01-IM3	P-0002102	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1852	DMP1852	Male			
P-0002097-T01-IM3	P-0002097	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1853	DMP1853	Male			
P-0002100-T01-IM3	P-0002100	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1854	DMP1854	Female			
P-0002098-T01-IM3	P-0002098	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT341	DMP1855	DMP1855	Male			
P-0002093-T01-IM3	P-0002093	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1856	DMP1856	Male			
P-0002105-T01-IM3	P-0002105	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1857	DMP1857	Male			
P-0002096-T01-IM3	P-0002096	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1858	DMP1858	Female			
P-0001859-T02-IM3	P-0001859	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1813	DMP1813	Male			
P-0002103-T01-IM3	P-0002103	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP1860	DMP1860	Female			
P-0001135-T02-IM3	P-0001135	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP1861	DMP1861	Male			
P-0002111-T01-IM3	P-0002111	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Myxofibrosarcoma	IMPACT341	DMP1862	DMP1862	Female			
P-0002106-T01-IM3	P-0002106	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1863	DMP1863	Female			
P-0002118-T01-IM3	P-0002118	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1864	DMP1864	Female			
P-0002107-T01-IM3	P-0002107	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1865	DMP1865	Female			
P-0002108-T01-IM3	P-0002108	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Myoepithelial Carcinoma	IMPACT341	DMP1866	DMP1866	Female			
P-0002120-T01-IM3	P-0002120	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT341	DMP1867	DMP1867	Male			
P-0002109-T01-IM3	P-0002109	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1868	DMP1868	Female			
P-0002116-T01-IM3	P-0002116	Ovarian Cancer	Metastasis	Tumor	Pelvis	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1869	DMP1869	Female			
P-0002119-T01-IM3	P-0002119	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1870	DMP1870	Female			
P-0002110-T01-IM3	P-0002110	Ovarian Cancer	Metastasis	Tumor	Umbilical Area	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP1871	DMP1871	Female			
P-0002115-T01-IM3	P-0002115	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP1872	DMP1872	Female			
P-0002117-T01-IM3	P-0002117	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1873	DMP1873	Female			
P-0001948-T01-IM3	P-0001948	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Rectum	Follicular Dendritic Cell Sarcoma	IMPACT341	DMP1874	DMP1874	Male			
P-0001945-T01-IM3	P-0001945	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1875	DMP1875	Female			
P-0001944-T01-IM3	P-0001944	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1876	DMP1876	Female			
P-0001947-T01-IM3	P-0001947	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Mesentery	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341	DMP1877	DMP1877	Male			
P-0001949-T01-IM3	P-0001949	Colorectal Cancer	Metastasis	Tumor	Pelvis	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1878	DMP1878	Male			
P-0001946-T01-IM3	P-0001946	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Ossifying Fibromyxoid Tumor	IMPACT341	DMP1879	DMP1879	Male			
P-0001940-T01-IM3	P-0001940	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1880	DMP1880	Female			
P-0001952-T01-IM3	P-0000886	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1881		Female			
P-0001941-T01-IM3	P-0001941	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1882	DMP1882	Female			
P-0000175-T03-IM3	P-0000175	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1883	DMP1883	Female			
P-0001962-T01-IM3	P-0001962	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1884	DMP1884	Female			
P-0001965-T01-IM3	P-0001965	Ovarian Cancer	Metastasis	Tumor	Fallopian Tube	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1885	DMP1885	Female			
P-0001959-T01-IM3	P-0001959	Cervical Cancer	Metastasis	Tumor	Liver	Cervix	Combined Endocervical Adenocarcinoma and Small Cell Carcinoma of the Cervix	IMPACT341	DMP1886	DMP1886	Female			
P-0001957-T01-IM3	P-0001957	Breast Carcinoma	Metastasis	Tumor	Fallopian Tube	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1887	DMP1887	Female			
P-0002061-T01-IM3	P-0002061	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP1817	DMP1817	Male			
P-0001956-T01-IM3	P-0001956	Embryonal Tumor	Primary	Tumor	Not Applicable	Abdomen	Neuroblastoma	IMPACT341	DMP1890	DMP1890	Male			
P-0001967-T01-IM3	P-0001967	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1893	DMP1893	Female			
P-0001968-T01-IM3	P-0001968	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1891	DMP1891	Male			
P-0001964-T01-IM3	P-0001964	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP1894	DMP1894	Male			
P-0001954-T01-IM3	P-0001954	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT341	DMP1895	DMP1895	Female			
P-0001955-T01-IM3	P-0001955	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1896	DMP1896	Female			
P-0001966-T01-IM3	P-0001966	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	Ovarian Cancer, Other	IMPACT341	DMP1897	DMP1897	Female			
P-0000835-T02-IM3	P-0000835	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Angiosarcoma	IMPACT341	DMP1898	DMP1898	Male			
P-0001977-T01-IM3	P-0001977	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP1899	DMP1899	Male			
P-0001973-T01-IM3	P-0001973	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Bowel	Gastrointestinal Stromal Tumor	IMPACT341	DMP1900	DMP1900	Female			
P-0001982-T01-IM3	P-0001982	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT341	DMP1901	DMP1901	Female			
P-0001975-T01-IM3	P-0001975	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341	DMP1902	DMP1902	Male			
P-0001978-T01-IM3	P-0001978	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT341	DMP1904	DMP1904	Female			
P-0001980-T01-IM3	P-0001980	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT341	DMP1905	DMP1905	Male			
P-0001974-T01-IM3	P-0001974	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1906	DMP1906	Male			
P-0001971-T01-IM3	P-0001971	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341	DMP1907	DMP1907	Female			
P-0001983-T01-IM3	P-0001983	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP1908	DMP1908	Male			
P-0001976-T01-IM3	P-0001976	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1909	DMP1909	Female			
P-0001979-T01-IM3	P-0001979	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1910	DMP1910	Female			
P-0001970-T01-IM3	P-0001970	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1911	DMP1911	Female			
P-0001972-T01-IM3	P-0001972	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP1912	DMP1912	Male			
P-0001994-T01-IM3	P-0001994	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP1913	DMP1913	Female			
P-0001990-T01-IM3	P-0001990	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1914	DMP1914	Female			
P-0001991-T01-IM3	P-0001991	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1915	DMP1915	Female			
P-0001995-T01-IM3	P-0001995	Pineal Tumor	Metastasis	Tumor	Brain	Brain	Pineal Parenchymal Tumor of Intermediate Differentiation	IMPACT341	DMP1917	DMP1917	Female			
P-0001992-T01-IM3	P-0001992	Ovarian Cancer	Metastasis	Tumor	Rectum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1918	DMP1918	Female			
P-0001986-T01-IM3	P-0001986	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1919	DMP1919	Female			
P-0001984-T01-IM3	P-0001984	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1920	DMP1920	Female			
P-0001987-T01-IM3	P-0001987	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341	DMP1921	DMP1921	Male			
P-0001989-T01-IM3	P-0001989	Uterine Sarcoma	Metastasis	Tumor	Liver	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP1922	DMP1922	Female			
P-0001997-T01-IM3	P-0001997	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Bone	Schwannoma	IMPACT341	DMP1924	DMP1924	Female			
P-0001999-T01-IM3	P-0001999	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Ovary	Angiosarcoma	IMPACT341	DMP1925	DMP1925	Female			
P-0001988-T01-IM3	P-0001988	Glioma	Primary	Tumor	Not Applicable	Brain	Pilocytic Astrocytoma	IMPACT341	DMP1926	DMP1926	Male			
P-0001985-T01-IM3	P-0001985	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1927	DMP1927	Female			
P-0002101-T01-IM3	P-0002101	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1859	DMP1859	Male			
P-0002013-T01-IM3	P-0002013	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP1929	DMP1929	Male			
P-0002003-T01-IM3	P-0002003	Nerve Sheath Tumor	Metastasis	Tumor	Eye	Bone	Melanotic Schwannoma	IMPACT341	DMP1930	DMP1930	Female			
P-0002001-T01-IM3	P-0002001	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP1931	DMP1931	Female			
P-0002006-T01-IM3	P-0002006	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1932	DMP1932	Female			
P-0002008-T01-IM3	P-0002008	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Skin	Angiosarcoma	IMPACT341	DMP1933	DMP1933	Male			
P-0002010-T01-IM3	P-0002010	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP1934	DMP1934	Female			
P-0002012-T01-IM3	P-0002012	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Synovial Sarcoma	IMPACT341	DMP1935	DMP1935	Male			
P-0002004-T01-IM3	P-0002004	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Dedifferentiated Carcinoma	IMPACT341	DMP1936	DMP1936	Female			
P-0002014-T01-IM3	P-0002014	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1937	DMP1937	Female			
P-0002000-T01-IM3	P-0002000	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1938	DMP1938	Female			
P-0002172-T01-IM3	P-0002172	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341	DMP2049	DMP2049	Female			
P-0002011-T01-IM3	P-0002011	Germ Cell Tumor	Primary	Tumor	Not Applicable	Ovary	Mixed Germ Cell Tumor	IMPACT341	DMP1940	DMP1940	Female			
P-0002005-T01-IM3	P-0002005	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	Hemangioblastoma	IMPACT341	DMP1941	DMP1941	Male			
P-0002009-T01-IM3	P-0002009	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1942	DMP1942	Female			
P-0000335-T02-IM3	P-0000335	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1943	DMP1943	Female			
P-0002021-T01-IM3	P-0002021	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP1944	DMP1944	Female			
P-0002019-T01-IM3	P-0002019	Melanoma	Metastasis	Tumor	Spleen	Eye	Uveal Melanoma	IMPACT341	DMP1946	DMP1946	Male			
P-0002024-T01-IM3	P-0002024	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1947	DMP1947	Male			
P-0002020-T01-IM3	P-0002020	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Leiomyosarcoma	IMPACT341	DMP1948	DMP1948	Male			
P-0002022-T01-IM3	P-0002022	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1949	DMP1949	Male			
P-0002025-T01-IM3	P-0002025	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1950	DMP1950	Female			
P-0002023-T01-IM3	P-0002023	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1951	DMP1951	Female			
P-0002018-T01-IM3	P-0002018	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Unknown	Melanoma of Unknown Primary	IMPACT341	DMP1952	DMP1952	Female			
P-0002017-T01-IM3	P-0002017	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1953	DMP1953	Female			
P-0002015-T01-IM3	P-0002015	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP1954	DMP1954	Female			
P-0001681-T02-IM3	P-0001681	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	Serous Borderline Ovarian Tumor, Micropapillary	IMPACT341	DMP1955	DMP1955	Female			
P-0002036-T01-IM3	P-0002036	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1956	DMP1956	Female			
P-0002032-T01-IM3	P-0002032	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1957	DMP1957	Male			
P-0002038-T01-IM3	P-0002038	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1958	DMP1958	Female			
P-0002026-T01-IM3	P-0002026	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1959	DMP1959	Male			
P-0002030-T01-IM3	P-0002030	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341	DMP1960	DMP1960	Male			
P-0002039-T01-IM3	P-0002039	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP1961	DMP1961	Female			
P-0002028-T01-IM3	P-0002028	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP1962	DMP1962	Female			
P-0002029-T01-IM3	P-0002029	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Upper Tract Urothelial Carcinoma	IMPACT341	DMP1963	DMP1963	Male			
P-0002033-T01-IM3	P-0002033	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1964	DMP1964	Female			
P-0002037-T01-IM3	P-0002037	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Ampullary Carcinoma	IMPACT341	DMP1965	DMP1965	Male			
P-0002034-T01-IM3	P-0002034	Soft Tissue Sarcoma	Metastasis	Tumor	Trachea	Chest Wall	Synovial Sarcoma	IMPACT341	DMP1966	DMP1966	Female			
P-0002027-T01-IM3	P-0002027	Esophagogastric Carcinoma	Metastasis	Tumor	Bone	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1967	DMP1967	Male			
P-0002035-T01-IM3	P-0002035	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1968	DMP1968	Female			
P-0002031-T01-IM3	P-0002031	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP1969	DMP1969	Female			
P-0002048-T01-IM3	P-0002048	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP1970	DMP1970	Female			
P-0002044-T01-IM3	P-0002044	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP1971	DMP1971	Male			
P-0002052-T01-IM3	P-0002052	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT341	DMP1972	DMP1972	Female			
P-0002041-T01-IM3	P-0002041	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1973	DMP1973	Female			
P-0002047-T01-IM3	P-0002047	Hepatocellular Carcinoma	Metastasis	Tumor	Rectum	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP1974	DMP1974	Female			
P-0002045-T01-IM3	P-0002045	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Salivary Gland	High-Grade Salivary Gland Carcinoma	IMPACT341	DMP1975	DMP1975	Female			
P-0002049-T01-IM3	P-0002049	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1976	DMP1976	Female			
P-0002050-T01-IM3	P-0002050	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP1977	DMP1977	Male			
P-0002042-T01-IM3	P-0002042	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP1978	DMP1978	Male			
P-0002046-T01-IM3	P-0002046	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1979	DMP1979	Male			
P-0002051-T01-IM3	P-0002051	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP1980	DMP1980	Male			
P-0002053-T01-IM3	P-0002053	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1981	DMP1981	Female			
P-0002054-T01-IM3	P-0002054	Cancer of Unknown Primary	Metastasis	Tumor	Chest Wall	Unknown	Cancer of Unknown Primary	IMPACT341	DMP1982	DMP1982	Female			
P-0002043-T01-IM3	P-0002043	Glioma	Primary	Tumor	Not Applicable	Brain	Oligoastrocytoma	IMPACT341	DMP1983	DMP1983	Male			
P-0001244-T02-IM3	P-0001244	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1928	DMP1928	Male			
P-0002251-T01-IM3	P-0002251	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1985	DMP1985	Male			
P-0002237-T01-IM3	P-0002237	Breast Carcinoma	Metastasis	Tumor	Scalp	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1986	DMP1986	Female			
P-0002250-T01-IM3	P-0002250	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Soft Tissue	Embryonal Rhabdomyosarcoma	IMPACT341	DMP1987	DMP1987	Male			
P-0002244-T01-IM3	P-0002244	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1988	DMP1988	Female			
P-0002248-T01-IM3	P-0002248	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1989	DMP1989	Female			
P-0002241-T01-IM3	P-0002241	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1990	DMP1990	Female			
P-0002245-T01-IM3	P-0002245	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1991	DMP1991	Female			
P-0002242-T01-IM3	P-0002242	Ovarian Cancer	Metastasis	Tumor	Liver	Fallopian Tube	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1992	DMP1992	Female			
P-0002249-T01-IM3	P-0002249	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP1993	DMP1993	Female			
P-0002247-T01-IM3	P-0002247	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP1994	DMP1994	Female			
P-0002240-T01-IM3	P-0002240	Ewing Sarcoma	Metastasis	Tumor	Lung	Chest Wall	Ewing Sarcoma	IMPACT341	DMP1995	DMP1995	Male			
P-0002238-T01-IM3	P-0002238	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP1996	DMP1996	Male			
P-0002239-T01-IM3	P-0002239	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP1997	DMP1997	Female			
P-0002243-T01-IM3	P-0002243	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP1998	DMP1998	Female			
P-0002242-T02-IM3	P-0002242	Ovarian Cancer	Primary	Tumor	Not Applicable	Fallopian Tube	High-Grade Serous Ovarian Cancer	IMPACT341	DMP1999	DMP1999	Female			
P-0000281-T02-IM3	P-0000281	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP0251	DMP0251	Male			
P-0002129-T01-IM3	P-0002129	Breast Carcinoma	Metastasis	Tumor	Pterygoid Palatine Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2001	DMP2001	Female			
P-0002134-T01-IM3	P-0002134	Nerve Sheath Tumor	Metastasis	Tumor	Lung	Neck	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP2002	DMP2002	Female			
P-0002124-T01-IM3	P-0002124	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2003	DMP2003	Female			
P-0002132-T01-IM3	P-0002132	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2004	DMP2004	Male			
P-0002125-T01-IM3	P-0002125	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP2005	DMP2005	Male			
P-0002122-T01-IM3	P-0002122	Ovarian Cancer	Metastasis	Tumor	Lung	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2006	DMP2006	Female			
P-0002135-T01-IM3	P-0002135	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP2007	DMP2007	Female			
P-0002126-T01-IM3	P-0002126	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP2008	DMP2008	Male			
P-0002127-T01-IM3	P-0002127	Non-Small Cell Lung Cancer	Metastasis	Tumor	Breast	Lung	Atypical Lung Carcinoid	IMPACT341	DMP2009	DMP2009	Male			
P-0002128-T01-IM3	P-0002128	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP2010	DMP2010	Female			
P-0002121-T01-IM3	P-0002121	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT341	DMP2011	DMP2011	Male			
P-0001684-T02-IM3	P-0001684	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP1984	DMP1984	Male			
P-0002133-T01-IM3	P-0002133	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2013	DMP2013	Female			
P-0002143-T01-IM3	P-0002143	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP2015	DMP2015	Female			
P-0002138-T01-IM3	P-0002138	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341	DMP2016	DMP2016	Female			
P-0000285-T01-IM3	P-0000285	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP0261	DMP0261	Male			
P-0002136-T01-IM3	P-0002136	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Mixed Ovarian Carcinoma	IMPACT341	DMP2018	DMP2018	Female			
P-0002142-T01-IM3	P-0002142	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP2019	DMP2019	Female			
P-0002146-T01-IM3	P-0002146	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Plasmacytoid/Signet Ring Cell Bladder Carcinoma	IMPACT341	DMP2020	DMP2020	Male			
P-0002140-T01-IM3	P-0002140	Small Bowel Cancer	Metastasis	Tumor	Ovary	Jejunum	Small Bowel Cancer	IMPACT341	DMP2021	DMP2021	Female			
P-0002123-T01-IM3	P-0002123	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2012	DMP2012	Male			
P-0000320-T01-IM3	P-0000320	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP0279	DMP0279	Male			
P-0002139-T01-IM3	P-0002139	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2024	DMP2024	Female			
P-0000800-T01-IM3	P-0000800	Thyroid Cancer	Metastasis	Tumor	Mediastinum	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP0743	DMP0743	Male			
P-0002144-T01-IM3	P-0002144	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2026	DMP2026	Female			
P-0000954-T01-IM3	P-0000954	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP0891	DMP0891	Male			
P-0002155-T01-IM3	P-0002155	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP2029	DMP2029	Male			
P-0002164-T01-IM3	P-0002164	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP2030	DMP2030	Male			
P-0002161-T01-IM3	P-0002161	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP2031	DMP2031	Male			
P-0002154-T01-IM3	P-0002154	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341	DMP2032	DMP2032	Female			
P-0002157-T01-IM3	P-0002157	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT341	DMP2033	DMP2033	Female			
P-0002160-T01-IM3	P-0002160	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP2034	DMP2034	Male			
P-0002159-T01-IM3	P-0002159	Histiocytosis	Primary	Tumor	Not Applicable	Soft Tissue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT341	DMP2035	DMP2035	Female			
P-0002153-T01-IM3	P-0002153	Non-Small Cell Lung Cancer	Metastasis	Tumor	Neck	Lung	Lung Adenocarcinoma	IMPACT341	DMP2036	DMP2036	Male			
P-0002156-T01-IM3	P-0002156	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2037	DMP2037	Male			
P-0002163-T01-IM3	P-0002163	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2038	DMP2038	Female			
P-0002151-T01-IM3	P-0002151	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2039	DMP2039	Female			
P-0002152-T01-IM3	P-0002152	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2040	DMP2040	Male			
P-0002162-T01-IM3	P-0002162	Anal Cancer	Metastasis	Tumor	Liver	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP2041	DMP2041	Female			
P-0002171-T01-IM3	P-0002171	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2042	DMP2042	Male			
P-0002178-T01-IM3	P-0002178	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2043	DMP2043	Female			
P-0002168-T01-IM3	P-0002168	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Acinic Cell Carcinoma	IMPACT341	DMP2044	DMP2044	Female			
P-0002166-T01-IM3	P-0002166	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP2046	DMP2046	Male			
P-0002167-T01-IM3	P-0002167	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2047	DMP2047	Male			
P-0001006-T01-IM3	P-0001006	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP0930	DMP0930	Male			
P-0002176-T01-IM3	P-0002176	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2050	DMP2050	Female			
P-0002179-T01-IM3	P-0002179	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341	DMP2051	DMP2051	Female			
P-0002175-T01-IM3	P-0002165	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Foot	Acral Melanoma	IMPACT341	DMP2052		Male			
P-0002174-T01-IM3	P-0002174	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP2053	DMP2053	Female			
P-0002169-T01-IM3	P-0002169	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT341	DMP2054	DMP2054	Male			
P-0002182-T01-IM3	P-0002182	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Skin	Cutaneous Melanoma	IMPACT341	DMP2055	DMP2055	Female			
P-0002188-T01-IM3	P-0002188	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2056	DMP2056	Female			
P-0002189-T01-IM3	P-0002189	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP2059	DMP2059	Male			
P-0002187-T01-IM3	P-0002187	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2060	DMP2060	Male			
P-0002185-T01-IM3	P-0002185	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Neck	Oropharynx Squamous Cell Carcinoma	IMPACT341	DMP2061	DMP2061	Male			
P-0002184-T01-IM3	P-0002184	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT341	DMP2062	DMP2062	Female			
P-0002191-T01-IM3	P-0002191	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP2063	DMP2063	Female			
P-0002192-T01-IM3	P-0002192	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341	DMP2064	DMP2064	Female			
P-0002186-T01-IM3	P-0002186	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP2065	DMP2065	Male			
P-0002183-T01-IM3	P-0002183	Biliary Cancer	Metastasis	Tumor	Gallbladder	Lung	Gallbladder Cancer	IMPACT341	DMP2066	DMP2066	Male			
P-0002181-T01-IM3	P-0002181	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP2067	DMP2067	Male			
P-0000797-T02-IM3	P-0000797	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP0737	DMP0737	Male			
P-0002148-T01-IM3	P-0002148	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT341	DMP2069	DMP2069	Female			
P-0002149-T01-IM3	P-0002149	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2022	DMP2022	Male			
P-0002206-T01-IM3	P-0002206	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2070	DMP2070	Male			
P-0002203-T01-IM3	P-0002203	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341	DMP2072	DMP2072	Male			
P-0002202-T01-IM3	P-0002202	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2073	DMP2073	Female			
P-0002199-T01-IM3	P-0002199	Bladder Cancer	Metastasis	Tumor	Pelvis	Bladder	Bladder Adenocarcinoma	IMPACT341	DMP2074	DMP2074	Male			
P-0002208-T01-IM3	P-0002208	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT341	DMP2075	DMP2075	Male			
P-0002198-T01-IM3	P-0002198	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341	DMP2076	DMP2076	Male			
P-0002195-T01-IM3	P-0002195	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Heart	Leiomyosarcoma	IMPACT341	DMP2077	DMP2077	Male			
P-0002194-T01-IM3	P-0002194	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2078	DMP2078	Female			
P-0002205-T01-IM3	P-0002205	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341	DMP2079	DMP2079	Female			
P-0002207-T01-IM3	P-0002207	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2080	DMP2080	Male			
P-0002197-T01-IM3	P-0002197	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT341	DMP2082	DMP2082	Male			
P-0002200-T01-IM3	P-0002200	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341	DMP2083	DMP2083	Female			
P-0002215-T01-IM3	P-0002215	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT341	DMP2084	DMP2084	Male			
P-0001280-T01-IM3	P-0001280	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP1176	DMP1176	Male			
P-0001418-T01-IM3	P-0001418	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP1295	DMP1295	Female			
P-0002216-T01-IM3	P-0002216	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341	DMP2087	DMP2087	Male			
P-0001671-T01-IM3	P-0001671	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP1555	DMP1555	Female			
P-0002218-T01-IM3	P-0002218	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341	DMP2089	DMP2089	Female			
P-0002204-T01-IM3	P-0002204	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP2081	DMP2081	Female			
P-0002222-T01-IM3	P-0002222	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2091	DMP2091	Female			
P-0002213-T01-IM3	P-0002213	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP2092	DMP2092	Female			
P-0002219-T01-IM3	P-0002219	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP2093	DMP2093	Male			
P-0002211-T01-IM3	P-0002211	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT341	DMP2094	DMP2094	Female			
P-0002209-T01-IM3	P-0002209	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341	DMP2095	DMP2095	Male			
P-0002196-T01-IM3	P-0002196	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2071	DMP2071	Male			
P-0002214-T01-IM3	P-0002214	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Adenoid Cystic Carcinoma	IMPACT341	DMP2097	DMP2097	Male			
P-0002374-T01-IM3	P-0002374	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2098	DMP2098	Female			
P-0002366-T01-IM3	P-0002366	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2099	DMP2099	Female			
P-0002370-T01-IM3	P-0002370	Thymic Tumor	Metastasis	Tumor	Mediastinum	Thymus	Thymoma	IMPACT341	DMP2100	DMP2100	Female			
P-0002363-T01-IM3	P-0002363	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2101	DMP2101	Female			
P-0002369-T01-IM3	P-0002369	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2102	DMP2102	Female			
P-0002223-T01-IM3	P-0002223	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2096	DMP2096	Male			
P-0002367-T01-IM3	P-0002367	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341	DMP2105	DMP2105	Male			
P-0002376-T01-IM3	P-0002376	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2106	DMP2106	Male			
P-0002364-T01-IM3	P-0002364	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2107	DMP2107	Male			
P-0002373-T01-IM3	P-0002373	Ovarian Cancer	Metastasis	Tumor	Colon	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2108	DMP2108	Female			
P-0001993-T01-IM3	P-0001993	Pancreatic Cancer	Metastasis	Tumor	Lymph Node	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2109	DMP2109	Male			
P-0002384-T01-IM3	P-0002384	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2110	DMP2110	Female			
P-0002378-T01-IM3	P-0002378	Soft Tissue Sarcoma	Local Recurrence	Tumor	Retroperitoneum	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT341	DMP2111	DMP2111	Female			
P-0002383-T01-IM3	P-0002383	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Colon	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP2112	DMP2112	Male			
P-0002391-T01-IM3	P-0002391	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2113	DMP2113	Male			
P-0002390-T01-IM3	P-0002390	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2114	DMP2114	Female			
P-0002386-T01-IM3	P-0002386	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP2115	DMP2115	Female			
P-0002380-T01-IM3	P-0002380	Melanoma	Metastasis	Tumor	Axilla	Skin	Cutaneous Melanoma	IMPACT341	DMP2116	DMP2116	Female			
P-0002377-T01-IM3	P-0002377	Hepatocellular Carcinoma	Metastasis	Tumor	Diaphragm	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP2118	DMP2118	Female			
P-0002388-T01-IM3	P-0002388	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2119	DMP2119	Female			
P-0002387-T01-IM3	P-0002387	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2120	DMP2120	Female			
P-0002382-T01-IM3	P-0002382	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2121	DMP2121	Male			
P-0002379-T01-IM3	P-0002379	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	DMP2122	DMP2122	Female			
P-0002393-T01-IM3	P-0002393	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP2124	DMP2124	Male			
P-0002398-T01-IM3	P-0002398	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2125	DMP2125	Male			
P-0002397-T01-IM3	P-0002397	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2126	DMP2126	Male			
P-0002392-T01-IM3	P-0002392	Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Melanoma	IMPACT341	DMP2127	DMP2127	Male			
P-0002394-T01-IM3	P-0002394	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2128	DMP2128	Male			
P-0002401-T01-IM3	P-0002401	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Yolk Sac Tumor	IMPACT341	DMP2129	DMP2129	Male			
P-0002400-T01-IM3	P-0002400	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2130	DMP2130	Female			
P-0002396-T01-IM3	P-0002396	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2131	DMP2131	Female			
P-0002395-T01-IM3	P-0002395	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT341	DMP2132	DMP2132	Male			
P-0002399-T01-IM3	P-0002399	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2133	DMP2133	Female			
P-0002054-T02-IM3	P-0002054	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP2134	DMP2134	Female			
P-0002149-T02-IM3	P-0002149	Prostate Cancer	Metastasis	Tumor	Urethra	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2135	DMP2135	Male			
P-0001104-T05-IM3	P-0001104	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP1494	DMP1494	Female			
P-0001062-T02-IM3	P-0001062	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Synovial Sarcoma	IMPACT341	DMP2137	DMP2137	Male			
P-0002040-T01-IM3	P-0002040	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Metaplastic Carcinosarcoma	IMPACT341	DMP2138	DMP2138	Female			
P-0004028-T01-IM3	P-0004028	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2139	DMP2139	Female			
P-0004007-T02-IM3	P-0004007	Colorectal Cancer	Metastasis	Tumor	Sigmoid Colon	Colon	Colon Adenocarcinoma	IMPACT341	DMP2140	DMP2140	Male			
P-0003946-T01-IM3	P-0003946	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP2141	DMP2141	Female			
P-0004021-T01-IM3	P-0004021	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2142	DMP2142	Female			
P-0003912-T01-IM3	P-0003912	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2143	DMP2143	Male			
P-0004038-T01-IM3	P-0004038	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2144	DMP2144	Female			
P-0003990-T01-IM3	P-0003990	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT341	DMP2145	DMP2145	Male			
P-0003927-T01-IM3	P-0003927	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP2146	DMP2146	Female			
P-0004008-T01-IM3	P-0004008	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP2147	DMP2147	Male			
P-0003913-T01-IM3	P-0003913	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2148	DMP2148	Female			
P-0003941-T01-IM3	P-0003941	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2149	DMP2149	Female			
P-0004007-T01-IM3	DMP2150	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2150	DMP2150	Male			
P-0001364-T02-IM3	P-0001364	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Rectum	Perivascular Epithelioid Cell Tumor	IMPACT341	DMP2151	DMP2151	Female			
P-0002234-T01-IM3	P-0002234	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP2205	DMP2205	Female			
P-0002227-T01-IM3	P-0002227	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2153	DMP2153	Female			
P-0002228-T01-IM3	P-0002228	Breast Carcinoma	Local Recurrence	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2154	DMP2154	Female			
P-0002226-T01-IM3	P-0002226	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Uterine Sarcoma, Other	IMPACT341	DMP2155	DMP2155	Female			
P-0002231-T01-IM3	P-0002231	Soft Tissue Sarcoma	Metastasis	Tumor	Abdomen	Pelvis	Leiomyosarcoma	IMPACT341	DMP2156	DMP2156	Female			
P-0002236-T01-IM3	P-0002236	Embryonal Tumor	Metastasis	Tumor	Brain	Adrenal Gland	Neuroblastoma	IMPACT341	DMP2157	DMP2157	Male			
P-0002229-T01-IM3	P-0002229	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2158	DMP2158	Female			
P-0002210-T01-IM3	P-0002210	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP2085	DMP2085	Female			
P-0002232-T01-IM3	P-0002232	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2160	DMP2160	Female			
P-0002224-T01-IM3	P-0002224	Glioma	Primary	Tumor	Not Applicable	Brain	High-Grade Glioma, NOS	IMPACT341	DMP2161	DMP2161	Male			
P-0002225-T01-IM3	P-0002225	Non-Small Cell Lung Cancer	Metastasis	Tumor	Neck	Lung	Poorly Differentiated Cancer	IMPACT341	DMP2162	DMP2162	Male			
P-0002235-T01-IM3	P-0002235	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341	DMP2163	DMP2163	Female			
P-0002230-T01-IM3	P-0002230	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP2164	DMP2164	Female			
P-0002134-T02-IM3	P-0002134	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Neck	Malignant Peripheral Nerve Sheath Tumor	IMPACT341	DMP2165	DMP2165	Female			
P-0000377-T03-IM3	P-0000377	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP0339	DMP0339	Male			
P-0002254-T01-IM3	P-0002254	Glioma	Primary	Tumor	Not Applicable	Brain	Low-Grade Glioma, NOS	IMPACT341	DMP2167	DMP2167	Female			
P-0002262-T01-IM3	P-0002262	Soft Tissue Sarcoma	Metastasis	Tumor	Pleura	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341	DMP2168	DMP2168	Male			
P-0001177-T01-IM3	P-0001177	Mesothelioma	Metastasis	Tumor	Appendix	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP1091	DMP1091	Female			
P-0002258-T01-IM3	P-0002258	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Vulva	Embryonal Rhabdomyosarcoma	IMPACT341	DMP2170	DMP2170	Female			
P-0002255-T01-IM3	P-0002255	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341	DMP2171	DMP2171	Female			
P-0002259-T01-IM3	P-0002259	Chordoma	Primary	Tumor	Not Applicable	Pituitary Mass	Chordoma	IMPACT341	DMP2172	DMP2172	Female			
P-0002264-T01-IM3	P-0002264	Renal Cell Carcinoma	Metastasis	Tumor	Ovary	Kidney	Renal Neuroendocrine Tumor	IMPACT341	DMP2173	DMP2173	Female			
P-0002220-T01-IM3	P-0002220	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP2086	DMP2086	Female			
P-0002257-T01-IM3	P-0002257	Ovarian Cancer	Metastasis	Tumor	Colon	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT341	DMP2175	DMP2175	Female			
P-0002252-T01-IM3	P-0002252	Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Small Cell Lung Cancer	IMPACT341	DMP2176	DMP2176	Female			
P-0002253-T01-IM3	P-0002253	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341	DMP2177	DMP2177	Male			
P-0001961-T01-IM3	P-0001961	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2178	DMP2178	Female			
P-0002269-T01-IM3	P-0002269	Osteosarcoma	Metastasis	Tumor	Pelvis	Bone	Osteosarcoma	IMPACT341	DMP2179	DMP2179	Male			
P-0002272-T01-IM3	P-0002272	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP2180	DMP2180	Female			
P-0002267-T01-IM3	P-0002267	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT341	DMP2181	DMP2181	Male			
P-0002275-T01-IM3	P-0002275	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2182	DMP2182	Female			
P-0002278-T01-IM3	P-0002278	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT341	DMP2183	DMP2183	Female			
P-0002265-T01-IM3	P-0002265	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2184	DMP2184	Male			
P-0002266-T01-IM3	P-0002266	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP2185	DMP2185	Male			
P-0002274-T01-IM3	P-0002274	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2186	DMP2186	Male			
P-0002276-T01-IM3	P-0002276	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Small Bowel	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT341	DMP2187	DMP2187	Female			
P-0002268-T01-IM3	P-0002268	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT341	DMP2188	DMP2188	Female			
P-0002277-T01-IM3	P-0002277	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341	DMP2189	DMP2189	Male			
P-0002273-T01-IM3	P-0002273	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2190	DMP2190	Male			
P-0002270-T01-IM3	P-0002270	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP2191	DMP2191	Male			
P-0001785-T02-IM3	P-0001785	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2192	DMP2192	Female			
P-0002284-T01-IM3	P-0002284	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT341	DMP2193	DMP2193	Female			
P-0002285-T01-IM3	P-0002285	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2194	DMP2194	Female			
P-0002290-T01-IM3	P-0002290	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP2195	DMP2195	Male			
P-0002291-T01-IM3	P-0002291	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Colon Adenocarcinoma	IMPACT341	DMP2196	DMP2196	Female			
P-0002287-T01-IM3	P-0002287	Cancer of Unknown Primary	Metastasis	Tumor	Chest Wall	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2197	DMP2197	Female			
P-0002283-T01-IM3	P-0002283	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Dermatofibroma	IMPACT341	DMP2198	DMP2198	Male			
P-0002280-T01-IM3	P-0002280	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP2199	DMP2199	Female			
P-0002286-T01-IM3	P-0002286	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341	DMP2200	DMP2200	Female			
P-0002281-T01-IM3	P-0002281	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP2201	DMP2201	Female			
P-0002288-T01-IM3	P-0002288	Ovarian Cancer	Metastasis	Tumor	Kidney	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341	DMP2202	DMP2202	Female			
P-0002279-T01-IM3	P-0002279	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2203	DMP2203	Female			
P-0002289-T01-IM3	P-0002289	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2204	DMP2204	Male			
P-0002234-T02-IM3	P-0002234	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT341	DMP2152	DMP2152	Female			
P-0001436-T02-IM3	P-0001436	Osteosarcoma	Metastasis	Tumor	Soft Tissue	Chest Wall	Osteoblastic Osteosarcoma	IMPACT341	DMP2206	DMP2206	Male			
P-0002297-T01-IM3	P-0002297	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2207	DMP2207	Female			
P-0002305-T01-IM3	P-0002305	Melanoma	Primary	Tumor	In-transit	Skin	Acral Melanoma	IMPACT341	DMP2208	DMP2208	Male			
P-0002304-T01-IM3	P-0002304	Prostate Cancer	Primary	Tumor	Testis	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2209	DMP2209	Male			
P-0002303-T01-IM3	P-0002303	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2210	DMP2210	Male			
P-0002296-T01-IM3	P-0002296	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Small Cell Carcinoma	IMPACT341	DMP2211	DMP2211	Male			
P-0002302-T01-IM3	P-0002302	Ovarian Cancer	Metastasis	Tumor	Pelvis	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2212	DMP2212	Female			
P-0002295-T01-IM3	P-0002295	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP2213	DMP2213	Female			
P-0002298-T01-IM3	P-0002298	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341	DMP2214	DMP2214	Female			
P-0002299-T01-IM3	P-0002299	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP2215	DMP2215	Female			
P-0002294-T01-IM3	P-0002294	Glioma	Primary	Tumor	Not Applicable	Brain	High-Grade Glioma, NOS	IMPACT341	DMP2216	DMP2216	Female			
P-0002301-T01-IM3	P-0002301	Soft Tissue Sarcoma	Local Recurrence	Tumor	Retroperitoneum	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341	DMP2217	DMP2217	Female			
P-0002292-T01-IM3	P-0002292	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP2218	DMP2218	Male			
P-0002293-T01-IM3	P-0002293	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP2219	DMP2219	Female			
P-0002413-T01-IM3	P-0002413	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT341	DMP2220	DMP2220	Male			
P-0002409-T01-IM3	P-0002409	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT341	DMP2222	DMP2222	Female			
P-0001712-T01-IM3	P-0001712	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT341	DMP1586	DMP1586	Female			
P-0002406-T01-IM3	P-0002406	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2224	DMP2224	Male			
P-0002404-T01-IM3	P-0002404	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341	DMP2225	DMP2225	Male			
P-0002414-T01-IM3	P-0002414	Small Bowel Cancer	Primary	Tumor	Not Applicable	Small Bowel	Small Bowel Adenocarcinoma	IMPACT341	DMP2226	DMP2226	Male			
P-0002403-T01-IM3	P-0002403	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2227	DMP2227	Female			
P-0002407-T01-IM3	P-0002407	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2228	DMP2228	Female			
P-0002405-T01-IM3	P-0002405	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Kidney	Sweat gland	Sweat Gland Adenocarcinoma	IMPACT341	DMP2230	DMP2230	Male			
P-0002408-T01-IM3	P-0002408	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2231	DMP2231	Male			
P-0002412-T01-IM3	P-0002412	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	DMP2232	DMP2232	Male			
P-0002016-T01-IM3	P-0002016	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2233	DMP2233	Male			
P-0002423-T01-IM3	P-0002423	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2234	DMP2234	Male			
P-0002420-T01-IM3	P-0002420	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2235	DMP2235	Female			
P-0002416-T01-IM3	P-0002416	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2236	DMP2236	Female			
P-0002422-T01-IM3	P-0002422	Melanoma	Primary	Tumor	Not Applicable	Urethra	Genitourinary Mucosal Melanoma	IMPACT341	DMP2237	DMP2237	Female			
P-0002419-T01-IM3	P-0002419	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP2238	DMP2238	Male			
P-0002424-T01-IM3	P-0002424	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Squamous Cell Carcinoma, NOS	IMPACT341	DMP2239	DMP2239	Male			
P-0002417-T01-IM3	P-0002417	Cancer of Unknown Primary	Metastasis	Tumor	Pelvis	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2240	DMP2240	Female			
P-0002425-T01-IM3	P-0002425	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2241	DMP2241	Male			
P-0002428-T01-IM3	P-0002428	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2242	DMP2242	Male			
P-0002426-T01-IM3	P-0002426	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2243	DMP2243	Female			
P-0002421-T01-IM3	P-0002421	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2244	DMP2244	Female			
P-0002418-T01-IM3	P-0002418	Melanoma	Metastasis	Tumor	Abdomen	Skin	Cutaneous Melanoma	IMPACT341	DMP2245	DMP2245	Female			
P-0002427-T01-IM3	P-0002427	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341	DMP2246	DMP2246	Male			
P-0002307-T01-IM3	P-0002307	Mesothelioma	Primary	Tumor	Not Applicable	Endometrium	Peritoneal Mesothelioma	IMPACT341	DMP2272	DMP2272	Female			
P-0002217-T02-IM3	P-0002217	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2248	DMP2248	Male			
P-0002432-T01-IM3	P-0002432	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2249		Male			
P-0002442-T01-IM3	P-0002442	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2250		Male			
P-0002430-T01-IM3	P-0002430	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP2251		Female			
P-0002429-T01-IM3	P-0002429	Melanoma	Primary	Tumor	Not Applicable	Spinal Cord	Primary CNS Melanoma	IMPACT341	DMP2252		Male			
P-0002436-T01-IM3	P-0002436	Anal Cancer	Primary	Tumor	Not Applicable	Rectum	Anal Squamous Cell Carcinoma	IMPACT341	DMP2253		Male			
P-0002434-T01-IM3	P-0002434	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2254		Female			
P-0002437-T01-IM3	P-0002437	Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Melanoma	IMPACT341	DMP2255		Female			
P-0002440-T01-IM3	P-0002440	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT341	DMP2256		Female			
P-0002438-T01-IM3	P-0002438	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2257		Male			
P-0002439-T01-IM3	P-0002439	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2258		Male			
P-0002441-T01-IM3	P-0002441	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP2259		Female			
P-0002431-T01-IM3	P-0002431	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2260		Male			
P-0002433-T01-IM3	P-0002433	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT341	DMP2261		Male			
P-0002443-T01-IM3	P-0002443	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2262		Female			
P-0002435-T01-IM3	P-0002435	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2263		Female			
P-0002314-T01-IM3	P-0002314	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2264	DMP2264	Male			
P-0002315-T01-IM3	P-0002315	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341	DMP2265	DMP2265	Female			
P-0002309-T01-IM3	P-0002309	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341	DMP2266	DMP2266	Male			
P-0002306-T01-IM3	P-0002306	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2267	DMP2267	Male			
P-0002312-T01-IM3	P-0002312	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2268	DMP2268	Female			
P-0002318-T01-IM3	P-0002318	Soft Tissue Sarcoma	Metastasis	Tumor	Peritoneum	Retroperitoneum	Leiomyosarcoma	IMPACT341	DMP2269	DMP2269	Female			
P-0002317-T01-IM3	P-0002317	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341	DMP2270	DMP2270	Female			
P-0002313-T01-IM3	P-0002313	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341	DMP2271	DMP2271	Female			
P-0002348-T01-IM3	P-0002348	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT341	DMP2297	DMP2297	Female			
P-0000257-T01-IM3	P-0000257	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT341	DMP2273	DMP2273	Male			
P-0002308-T01-IM3	P-0002308	Germ Cell Tumor	Metastasis	Tumor	Omentum	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP2274	DMP2274	Male			
P-0002319-T01-IM3	P-0002319	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Extrahepatic Cholangiocarcinoma	IMPACT341	DMP2275	DMP2275	Male			
P-0002311-T01-IM3	P-0002311	Bladder Cancer	Metastasis	Tumor	Pelvis	Bladder	Bladder Urothelial Carcinoma	IMPACT341	DMP2276	DMP2276	Male			
P-0002316-T01-IM3	P-0002316	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341	DMP2277	DMP2277	Male			
P-0002332-T01-IM3	P-0002332	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT341	DMP2278	DMP2278	Female			
P-0002333-T01-IM3	P-0002333	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2279	DMP2279	Male			
P-0002326-T01-IM3	P-0002326	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Dedifferentiated Liposarcoma	IMPACT341	DMP2280	DMP2280	Male			
P-0002327-T01-IM3	P-0002327	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2281	DMP2281	Female			
P-0002325-T01-IM3	P-0002325	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP2282	DMP2282	Female			
P-0002321-T01-IM3	P-0002321	Colorectal Cancer	Metastasis	Tumor	Ovary	Cecum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP2283	DMP2283	Female			
P-0002328-T01-IM3	P-0002328	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Sinonasal	Head and Neck Neuroendocrine Carcinoma	IMPACT341	DMP2284	DMP2284	Male			
P-0002331-T01-IM3	P-0002331	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP2285	DMP2285	Male			
P-0002329-T01-IM3	P-0002329	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2286	DMP2286	Male			
P-0002323-T01-IM3	P-0002323	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2288	DMP2288	Male			
P-0002322-T01-IM3	P-0002322	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT341	DMP2289	DMP2289	Female			
P-0002320-T01-IM3	P-0002320	Non-Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Lung Adenocarcinoma	IMPACT341	DMP2290	DMP2290	Male			
P-0002330-T01-IM3	P-0002330	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT341	DMP2291	DMP2291	Male			
P-0002340-T01-IM3	P-0002340	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341	DMP2292	DMP2292	Female			
P-0002345-T01-IM3	P-0002345	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341	DMP2293	DMP2293	Female			
P-0002334-T01-IM3	P-0002334	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2294	DMP2294	Male			
P-0002338-T01-IM3	P-0002338	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2295	DMP2295	Female			
P-0002337-T01-IM3	P-0002337	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341	DMP2296	DMP2296	Female			
P-0002260-T01-IM3	P-0002260	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	DMP2169	DMP2169	Male			
P-0002336-T01-IM3	P-0002336	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2298	DMP2298	Female			
P-0002344-T01-IM3	P-0002344	Gestational Trophoblastic Disease	Metastasis	Tumor	Adrenal Gland	Uterus	Choriocarcinoma	IMPACT341	DMP2299	DMP2299	Female			
P-0002342-T01-IM3	P-0002342	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Inflammatory Myofibroblastic Tumor	IMPACT341	DMP2300	DMP2300	Male			
P-0002339-T01-IM3	P-0002339	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341	DMP2301	DMP2301	Female			
P-0002343-T01-IM3	P-0002343	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341	DMP2302	DMP2302	Female			
P-0002341-T01-IM3	P-0002341	Penile Cancer	Metastasis	Tumor	Lymph Node	Penis	Penile Squamous Cell Carcinoma	IMPACT341	DMP2303	DMP2303	Male			
P-0002335-T01-IM3	P-0002335	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341	DMP2304	DMP2304	Male			
P-0002362-T01-IM3	P-0002362	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2305	DMP2305	Female			
P-0002354-T01-IM3	P-0002354	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Oral Cavity	Alveolar Soft Part Sarcoma	IMPACT341	DMP2306	DMP2306	Male			
P-0002359-T01-IM3	P-0002359	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341	DMP2307	DMP2307	Female			
P-0002360-T01-IM3	P-0002360	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341	DMP2308	DMP2308	Female			
P-0002361-T01-IM3	P-0002361	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT341	DMP2309	DMP2309	Female			
P-0002356-T01-IM3	P-0002356	Uterine Sarcoma	Metastasis	Tumor	Liver	Uterus	Uterine Leiomyosarcoma	IMPACT341	DMP2310	DMP2310	Female			
P-0002351-T01-IM3	P-0002351	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341	DMP2311	DMP2311	Female			
P-0002357-T01-IM3	P-0002357	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341	DMP2312	DMP2312	Female			
P-0002353-T01-IM3	P-0002353	Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Melanoma	IMPACT341	DMP2313	DMP2313	Female			
P-0002358-T01-IM3	P-0002358	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	DMP2314	DMP2314	Male			
P-0002273-T02-IM3	P-0002273	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	DMP2315	DMP2315	Male			
P-0002263-T01-IM3	P-0002263	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP2174	DMP2174	Male			
P-0000217-T01-IM3	P-0000217	Anal Cancer	Metastasis	Tumor	Lung	Anus	Anal Squamous Cell Carcinoma	IMPACT341	DMP2317	DMP2317	Male			
P-0001325-T02-IM5	P-0001325	Prostate Cancer	Metastasis	Tumor	Flank	Prostate	Prostate Small Cell Carcinoma	IMPACT410			Male			
P-0001998-T01-IM3	P-0001998	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Synovial Sarcoma	IMPACT341	DMP1923		Female			
P-0002347-T01-IM3	P-0002347	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female			
P-0002389-T02-IM3	P-0002389	Vulvar Carcinoma	Primary	Tumor	Not Applicable	Vagina	Mucinous Adenocarcinoma of the Vulva	IMPACT341			Female			
P-0002398-T02-IM3	P-0002398	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male			
P-0002444-T01-IM3	P-0002444	Cancer of Unknown Primary	Metastasis	Tumor	Muscle	Unknown	Cancer of Unknown Primary	IMPACT341			Male			
P-0002445-T01-IM3	P-0002445	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female			
P-0002446-T01-IM3	P-0002446	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male			
P-0002451-T01-IM3	P-0002451	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002452-T01-IM3	P-0002452	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female			
P-0002453-T01-IM3	P-0002453	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male			
P-0002454-T01-IM3	P-0002454	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341			Male			
P-0002455-T01-IM3	P-0002455	Colorectal Cancer	Metastasis	Tumor	Pelvis	Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341			Female			
P-0002456-T01-IM3	P-0002456	Melanoma	Primary	Tumor	Not Applicable	Esophagus	Head and Neck Mucosal Melanoma	IMPACT341			Female			
P-0002461-T01-IM3	P-0002461	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT341			Female			
P-0002463-T01-IM3	P-0002463	Colorectal Cancer	Metastasis	Tumor	Vagina	Colon	Colon Adenocarcinoma	IMPACT341			Female			
P-0002464-T01-IM3	P-0002464	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT341			Male			
P-0002467-T01-IM3	P-0002467	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341			Female			
P-0002470-T01-IM3	P-0002470	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341			Male			
P-0002471-T01-IM3	P-0002471	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Female			
P-0002472-T01-IM3	P-0002472	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male			
P-0002473-T01-IM3	P-0002473	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002474-T01-IM3	P-0002474	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341			Male			
P-0002475-T01-IM3	P-0002475	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341			Female			
P-0002476-T01-IM3	P-0002476	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bowel	Dedifferentiated Liposarcoma	IMPACT341			Female			
P-0002477-T01-IM3	P-0002477	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Bowel	Gastrointestinal Stromal Tumor	IMPACT341			Male			
P-0002478-T01-IM3	P-0002478	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female			
P-0002479-T01-IM3	P-0002479	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT341			Female			
P-0002480-T01-IM3	P-0002480	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male			
P-0002481-T01-IM3	P-0002481	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT341			Male			
P-0002482-T01-IM3	P-0002482	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT341			Female			
P-0002483-T01-IM3	P-0002483	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Female			
P-0002485-T01-IM3	P-0002485	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Male			
P-0002486-T01-IM3	P-0002486	Salivary Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Adenoid Cystic Carcinoma	IMPACT341			Female			
P-0002487-T01-IM3	P-0002487	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT341			Female			
P-0002488-T01-IM3	P-0002488	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341			Male			
P-0002489-T01-IM3	P-0002489	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002490-T01-IM3	P-0002490	Melanoma	Primary	Tumor	Not Applicable	Unknown	Melanoma of Unknown Primary	IMPACT341			Male			
P-0002491-T01-IM3	P-0002491	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002492-T01-IM3	P-0002492	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT341			Female			
P-0002493-T01-IM3	P-0002493	Hepatocellular Carcinoma	Metastasis	Tumor	Lung	Liver	Hepatoblastoma	IMPACT341			Male			
P-0002495-T01-IM3	P-0002495	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Male			
P-0002507-T01-IM3	P-0002507	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT341			Female			
P-0002509-T01-IM3	P-0002509	Cancer of Unknown Primary	Metastasis	Tumor	Brain	Unknown	Cancer of Unknown Primary	IMPACT341			Female			
P-0002510-T01-IM3	P-0002510	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT341			Female			
P-0002511-T01-IM3	P-0002511	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002512-T01-IM3	P-0002512	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341			Male			
P-0002514-T01-IM3	P-0002514	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002515-T01-IM3	P-0002515	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT341			Male			
P-0002516-T01-IM3	P-0002516	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male			
P-0002517-T01-IM3	P-0002517	Melanoma	Metastasis	Tumor	Heart	Skin	Uveal Melanoma	IMPACT341			Male			
P-0002519-T01-IM3	P-0002519	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Pancreas	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT341			Male			
P-0002526-T01-IM3	P-0002526	Ovarian Cancer	Metastasis	Tumor	Colon	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female			
P-0002527-T01-IM3	P-0002527	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female			
P-0002529-T01-IM3	P-0002529	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male			
P-0002531-T01-IM3	P-0002531	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002548-T01-IM3	P-0002548	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male			
P-0002549-T01-IM3	P-0002549	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Female			
P-0002553-T01-IM3	P-0002553	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Mucinous Stomach Adenocarcinoma	IMPACT341			Female			
P-0002555-T01-IM3	P-0002555	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Synovial Sarcoma	IMPACT341			Male			
P-0002557-T01-IM3	P-0002557	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002558-T01-IM3	P-0002558	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Female			
P-0002562-T01-IM3	P-0002562	Breast Carcinoma	Metastasis	Tumor	Neck	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002563-T01-IM3	P-0002563	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341			Male			
P-0002565-T01-IM3	P-0002565	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT341			Female			
P-0002566-T01-IM3	P-0002566	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002567-T01-IM3	P-0002567	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002573-T01-IM3	P-0002573	Ovarian Cancer	Metastasis	Tumor	Lung	Ovary	Endometrioid Ovarian Cancer	IMPACT341			Female			
P-0003400-T01-IM5	P-0003400	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male			
P-0003425-T01-IM5	P-0003425	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female			
P-0002130-T02-IM3	P-0002130	Soft Tissue Sarcoma	Metastasis	Tumor	Not Applicable	Retroperitoneum	Fibrosarcoma	IMPACT341			Male			
P-0002466-T01-IM3	P-0002466	Mesothelioma	Metastasis	Tumor	Chest Wall	Pleura	Pleural Mesothelioma	IMPACT341			Male			
P-0002007-T01-IM3	P-0002007	Histiocytosis	Primary	Tumor	Not Applicable	Bone	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT341			Female			
P-0002458-T01-IM3	P-0002458	Pancreatic Cancer	Metastasis	Tumor	Ovary	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Female			
P-0002460-T01-IM3	P-0002460	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341			Male			
P-0002462-T01-IM3	P-0002462	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341			Male			
P-0002465-T01-IM3	P-0002465	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	GE Junction	Esophagogastric Adenocarcinoma	IMPACT341			Male			
P-0002468-T01-IM3	P-0002468	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT341			Female			
P-0002469-T01-IM3	P-0002469	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341			Male			
P-0001396-T01-IM3	P-0001396	Breast Carcinoma	Metastasis	Tumor	Back	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female			
P-0002457-T01-IM3	P-0002457	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT341			Male			
P-0002499-T01-IM3	P-0002499	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male			
P-0002505-T01-IM3	P-0002505	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Neuroendocrine Tumors	IMPACT341			Male			
P-0002533-T01-IM3	P-0002533	Germ Cell Tumor	Metastasis	Tumor	Diaphragm	Testis	Mixed Germ Cell Tumor	IMPACT341			Male			
P-0004475-T01-IM5	P-0004475	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male			
P-0000027-T01-IM3	P-0000027	Mesothelioma	Primary	Tumor	Not Applicable	Lung	Pleural Mesothelioma, Epithelioid Type	IMPACT341	DMP0013	DMP0013	Female			
P-0002190-T01-IM3	P-0002190	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteoblastic Osteosarcoma	IMPACT341	DMP2058	DMP2058	Female			
P-0002410-T01-IM3	P-0002410	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341	DMP2221	DMP2221	Male			
P-0002449-T01-IM3	P-0002449	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341			Female			
P-0004262-T02-IM5	P-0004262	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female			
P-0004842-T02-IM5	P-0004842	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male			
P-0002523-T01-IM3	P-0002523	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002524-T01-IM3	P-0002524	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002551-T01-IM3	P-0002551	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002559-T01-IM3	P-0002559	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female			
P-0002564-T01-IM3	P-0002564	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male			
P-0002086-T01-IM3	P-0002086	Germ Cell Tumor	Metastasis	Tumor	Liver	Mediastinum	Yolk Sac Tumor	IMPACT341			Male			
P-0002170-T01-IM3	P-0002170	Ewing Sarcoma	Metastasis	Tumor	Chest Wall	Bone	Ewing Sarcoma	IMPACT341	DMP2045	DMP2045	Female			
P-0001338-T02-IM3	P-0001338	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	N/A		Female			
P-0002385-T01-IM3	P-0002385	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341	DMP2123	DMP2123	Female			
P-0002450-T01-IM3	P-0002450	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT341	N/A	N/A	Female			
P-0002459-T01-IM3	P-0002459	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT341	N/A	N/A	Female			
P-0002530-T01-IM3	P-0002530	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341	N/A	N/A	Female			
P-0002177-T01-IM3	P-0002177	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2048	DMP2048	Female			
P-0002447-T01-IM3	P-0002447	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Cancer, NOS	IMPACT341	N/A	N/A	Female			
P-0005491-T01-IM5	P-0005491	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410	N/A	N/A	Female		401	20
P-0000320-T02-IM3	P-0000320	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	N/A		Male		587	NA
P-0001040-T02-IM3	P-0001040	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341	N/A		Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	224	NA
P-0002193-T01-IM3	P-0002193	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Larynx	Larynx Squamous Cell Carcinoma	IMPACT341	DMP2057	DMP2057	Male		946	50
P-0002411-T01-IM3	P-0002411	Head and Neck Carcinoma	Metastasis	Tumor	Neck	Unknown	Head and Neck Squamous Cell Carcinoma of Unknown Primary	IMPACT341	DMP2229	DMP2229	Male		936	40
P-0002484-T01-IM3	P-0002484	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341	N/A	N/A	Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	456	NA
P-0002520-T01-IM3	P-0002520	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT341	N/A	N/A	Male		388	50
P-0002522-T01-IM3	P-0002522	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	N/A	N/A	Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	227	20
P-0002525-T01-IM3	P-0002525	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Stromal Tumor	IMPACT341	N/A	N/A	Female		400	50
P-0002528-T01-IM3	P-0002528	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341	N/A	N/A	Male		487	50
P-0002532-T01-IM3	P-0002532	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	N/A	N/A	Male		156	30
P-0002552-T01-IM3	P-0002552	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT341	N/A	N/A	Female	Note: Copy number profile is suggestive of broad copy number losses on  Chromosome 14, 22 and Chromosome arms 1p, 3q, 16p, 19q	1016	80
P-0002556-T01-IM3	P-0002556	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341	N/A	N/A	Female		633	60
P-0002569-T01-IM3	P-0002569	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341	N/A	N/A	Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	534	20
P-0005615-T02-IM5	P-0005615	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The PTEN exon8 mutations occur on different alleles.       Note: A comparison of variant frequencies suggests the PTEN p.Y336* and TP53 p.S376fs  mutations are subclonal.	1015	30
P-0005657-T01-IM5	P-0005657	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	677	30
P-0002159-T02-IM5	P-0002159	Histiocytosis	Primary	Tumor	Not Applicable	Soft Tissue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410	DMP2035		Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	791	30
P-0005968-T01-IM5	P-0005968	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410	N/A	N/A	Female	Note: A comparison of variant frequencies suggests the PIK3CA  p.R88Q mutation is subclonal.	240	30
P-0003208-T01-IM5	P-0003208	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT410	N/A	N/A	Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p)	515	70
P-0005697-T02-IM5	P-0005697	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	N/A	N/A	Male	Note: The ZFHX3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	620	80
P-0002832-T01-IM3	P-0002832	Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Melanoma	IMPACT341	N/A	N/A	Male		962	40
P-0005875-T01-IM5	P-0005875	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Papillary Renal Cell Carcinoma	IMPACT410	N/A	N/A	Male		958	90
P-0006281-T01-IM5	P-0006281	Bladder Cancer	Metastasis	Tumor	Soft Tissue	Bladder	Bladder Urothelial Carcinoma	IMPACT410	N/A	N/A	Male	Note: The NOTCH1 exon18 mutations all occur in cis (same allele).	233	10
P-0006293-T01-IM5	P-0006293	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410	N/A	N/A	Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome  1 and chromosome arm 14q	517	80
P-0005753-T02-IM5	P-0005753	Renal Cell Carcinoma	Metastasis	Tumor	Soft Tissue	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		424	80
P-0003918-T01-IM3	P-0003918	Breast Carcinoma	Primary	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1052	DMP1052	Female		859	NA
P-0003929-T01-IM3	P-0003929	Germ Cell Tumor	Primary	Tumor	Brain	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT341	DMP1056	DMP1056	Male		695	NA
P-0003933-T01-IM3	P-0003933	Breast Carcinoma	Primary	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1055	DMP1055	Female		839	NA
P-0003947-T01-IM3	P-0003947	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1059	DMP1059	Female		736	NA
P-0003948-T01-IM3	P-0003948	Soft Tissue Sarcoma	Primary	Tumor	Testis	Soft Tissue	Leiomyosarcoma	IMPACT341	DMP1053	DMP1053	Male		503	NA
P-0003959-T01-IM3	P-0003959	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Orbit	Embryonal Rhabdomyosarcoma	IMPACT341	DMP1050	DMP1050	Female		741	NA
P-0003960-T01-IM3	P-0003960	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341	DMP1060	DMP1060	Female		445	NA
P-0003963-T01-IM3	P-0003963	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Seminoma	IMPACT341	DMP1049	DMP1049	Male		895	NA
P-0003980-T01-IM3	P-0003980	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Undifferentiated Uterine Sarcoma	IMPACT341	DMP1058	DMP1058	Female		647	NA
P-0003982-T01-IM3	P-0003982	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341	DMP1057	DMP1057	Female		247	NA
P-0004015-T01-IM3	P-0004015	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT341	DMP1054	DMP1054	Male		601	NA
P-0004018-T01-IM3	P-0004018	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341	DMP1051	DMP1051	Male		644	NA
P-0006541-T02-IM5	P-0006541	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p.	749	80
P-0000066-T02-IM5	P-0000066	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	677	30
P-0000114-T02-IM3	P-0000114	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341			Female		409	60
P-0000192-T02-IM3	P-0000192	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	744	20
P-0000208-T02-IM5	P-0000208	Non-Small Cell Lung Cancer	Metastasis	Tumor	Subcutaneous Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female		442	40
P-0000209-T02-IM3	P-0000209	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: The CDKN2B,  CDKN2Ap16INK4A, and CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmation by another method suggested, if clinically indicated.	798	50
P-0000228-T03-IM5	P-0000228	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	697	20
P-0000247-T02-IM5	P-0000247	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the PIK3CA p.E545A mutation is subclonal.	660	50
P-0000247-T03-IM5	P-0000247	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1301	50
P-0000253-T02-IM5	P-0000253	Ewing Sarcoma	Metastasis	Tumor	Lung	Bone	Ewing Sarcoma	IMPACT410			Male		683	50
P-0000258-T02-IM5	P-0000258	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph node	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 2.	745	90
P-0000282-T02-IM5	P-0000282	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		1197	30
P-0000350-T02-IM3	P-0000350	Renal Cell Carcinoma	Metastasis	Tumor	Ovary	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosomes 7, 17 and Chromosome arms 16q and 20q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18	841	30
P-0000375-T02-IM5	P-0000375	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		866	50
P-0000377-T04-IM5	P-0000377	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		834	30
P-0000386-T02-IM5	P-0000386	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		169	70
P-0000444-T02-IM5	P-0000444	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male		889	40
P-0000470-T02-IM5	P-0000470	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Variants in TET1 gene indicates the presence of sub-clones      Note: The IDH2,BLM,PDGFRA,KIT,KDR,and FAT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	569	50
P-0000509-T02-IM5	P-0000509	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1022	70
P-0000514-T02-IM5	P-0000514	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low sequencing depth of coverage of 102X, negative results should be interpreted with caution.	102	10
P-0000525-T03-IM5	P-0000525	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ARID5B copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1008	60
P-0000532-T02-IM5	P-0000532	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Variants in IGF1R gene indicates the presence of sub-clones	688	50
P-0000553-T02-IM5	P-0000553	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample (analyzed with 341 gene MSK-IMPACT panel) and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample where applicable.	813	20
P-0000595-T02-IM5	P-0000595	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		592	60
P-0000623-T02-IM5	P-0000623	Salivary Carcinoma	Metastasis	Tumor	Lung	Parotid Gland	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes	402	70
P-0000624-T02-IM5	P-0000624	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1435	70
P-0000628-T02-IM5	P-0000628	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		971	NA
P-0000640-T02-IM5	P-0000640	Prostate Cancer	Primary	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 10q23-10q26, 11q21-11q23, and 22q  Note: The ACVR1, ATM, BCL10, BIRC3, BMPR1A, CBL, CHEK2, CRKL, EP300, EPHA7, ERCC5, ETV6, FGFR2, MAPK1, MLL, MRE11A, NF2, PGR, RAD21, SDHAF2, SDHD, SMARCB1, SUFU, TCF7L2 and YAP1 copy number losses falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The AR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	695	30
P-0000640-T03-IM5	P-0000640	Prostate Cancer	Metastasis	Tumor	Spine	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		404	70
P-0000655-T03-IM5	P-0000655	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The KRAS p.Q61K is present at low variant allele frequency. Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	989	10
P-0000657-T02-IM5	P-0000657	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The PALB2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	802	50
P-0000663-T02-IM5	P-0000663	Germ Cell Tumor	Metastasis	Tumor	Lung	Retroperitoneum	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	459	10
P-0000681-T02-IM5	P-0000681	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EIF4A2 exon8 mutations all occur in cis (same allele).          Note: The FGFR4, NSD1, FLT4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	817	60
P-0000689-T02-IM5	P-0000689	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		966	80
P-0000690-T02-IM5	P-0000690	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		650	40
P-0000690-T03-IM5	P-0000690	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		748	30
P-0000758-T02-IM5	P-0000758	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		454	60
P-0000793-T02-IM5	P-0000793	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Poorly Differentiated Carcinoma	IMPACT410			Male		578	60
P-0000839-T02-IM5	P-0000839	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.	1311	80
P-0000842-T02-IM5	P-0000842	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q13-13q14, 15q13-15q21, 16q23-16q24 and  17p12-17p13	395	20
P-0000879-T02-IM5	P-0000879	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		573	40
P-0000883-T02-IM5	P-0000883	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and 19p.	783	20
P-0000909-T03-IM3	P-0000909	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		461	NA
P-0000913-T03-IM5	P-0000913	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		771	35
P-0000952-T02-IM5	P-0000952	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		1214	50
P-0000978-T02-IM5	P-0000978	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The APC exon 16 p.Q1480fs and p.G1499fs mutations all occur in cis (same allele).	839	40
P-0000982-T02-IM5	P-0000982	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		856	60
P-0001010-T02-IM5	P-0001010	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 100X, negative results should be interpreted with caution.	100	80
P-0001047-T02-IM5	P-0001047	Esophagogastric Carcinoma	Metastasis	Tumor	Omentum	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male	Note: The MLL3 p.R1197T and p.K1207N exon23 mutations all occur in cis (same allele).	970	30
P-0001114-T03-IM5	P-0001114	Breast Carcinoma	Metastasis	Tumor	Pericardium	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	632	20
P-0001204-T02-IM5	P-0001204	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		630	30
P-0001219-T02-IM5	P-0001219	Histiocytosis	Primary	Tumor	Not Applicable	Blood	Histiocytosis	IMPACT410			Male		853	NA
P-0001219-T03-IM5	P-0001219	Histiocytosis	Primary	Tumor	Not Applicable	Tongue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	832	20
P-0001232-T02-IM5	P-0001232	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	947	50
P-0001242-T03-IM5	P-0001242	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q including MYC.    Note: Low sequencing depth of coverage of 124X, negative results should be interpreted with caution.	124	20
P-0001254-T02-IM3	P-0001254	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	704	50
P-0001300-T02-IM5	P-0001300	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The matched normal was sequenced previously using the 341 gene panel, for which HLA-A and NUP93 were not covered. The variants in these genes may represent germline SNPs.	633	60
P-0001303-T02-IM3	P-0001303	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341			Female		741	30
P-0001303-T03-IM5	P-0001303	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		964	80
P-0001315-T02-IM5	P-0001315	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Skin	Duodenum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 13q,14q ,15q and 22q.	1023	90
P-0001319-T02-IM5	P-0001319	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		452	10
P-0001319-T03-IM5	P-0001319	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		506	30
P-0001342-T02-IM5	P-0001342	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Angiomyolipoma	IMPACT410			Female		525	80
P-0001347-T02-IM5	P-0001347	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1030	20
P-0001357-T02-IM5	P-0001357	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		755	NA
P-0001394-T02-IM5	P-0001394	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	675	20
P-0001396-T02-IM5	P-0001396	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	311	10
P-0001401-T02-IM3	P-0001401	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Gallbladder	Gastrointestinal Neuroendocrine Tumors	IMPACT341			Male		125	20
P-0001420-T02-IM5	P-0001420	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 1p, 4q, 9p and 14q     Note: The TNFRSF14 and  TGFBR1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	865	40
P-0001432-T02-IM5	P-0001432	Embryonal Tumor	Metastasis	Tumor	Not Applicable	Brain	Neuroblastoma	IMPACT410			Female		684	10
P-0001449-T02-IM5	P-0001449	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		807	50
P-0001454-T02-IM5	P-0001454	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	570	NA
P-0001495-T02-IM5	P-0001495	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The MLL  exon27 mutations all occur in cis (same allele).	964	60
P-0001500-T02-IM5	P-0001500	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		804	30
P-0001505-T02-IM3	P-0001505	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: The AURKA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	217	20
P-0001516-T02-IM5	P-0001516	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1577	10
P-0001528-T03-IM5	P-0001528	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		769	NA
P-0001546-T02-IM5	P-0001546	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		690	20
P-0001552-T02-IM5	P-0001552	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	764	90
P-0001586-T02-IM5	P-0001586	Esophagogastric Carcinoma	Metastasis	Tumor	Brain	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the ERBB2 p.D769H mutation is on the amplified allele.	877	20
P-0001598-T02-IM5	P-0001598	Head and Neck Carcinoma	Metastasis	Tumor	Eyelid	Orbit	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p 10q and 11q.	652	60
P-0001599-T03-IM5	P-0001599	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	627	30
P-0001613-T02-IM5	P-0001613	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		816	50
P-0001631-T02-IM5	P-0001631	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		1036	60
P-0001642-T02-IM5	P-0001642	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 122X, negative results should be interpreted with caution.	122	60
P-0001642-T03-IM5	P-0001642	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 118X, negative results should be interpreted with caution.	118	40
P-0001688-T02-IM5	P-0001688	Cervical Cancer	Metastasis	Tumor	Pelvis	Cervix	Cervical Squamous Cell Carcinoma	IMPACT410			Female		959	20
P-0001697-T02-IM3	P-0001697	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		247	NA
P-0001699-T02-IM5	P-0001699	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female		1012	40
P-0001728-T02-IM5	P-0001728	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The TP53 mutations occur on different alleles.	955	80
P-0001747-T02-IM5	P-0001747	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The AKT2 and CCNE1  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. Note: The SOX17 exon2 p.L124fs and p.R142del mutations all occur in cis (same allele). Note: The RET exon17 mutations occur on different alleles.	1030	20
P-0001785-T03-IM5	P-0001785	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female		981	30
P-0001835-T02-IM3	P-0001835	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosomes 1p, 3p, 8, 13q, 14q, 18q and 22q.	417	30
P-0001840-T02-IM5	P-0001840	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TP53 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	547	40
P-0001843-T02-IM5	P-0001843	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The SPEN, FGFR4 and NSD1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	938	40
P-0001876-T02-IM5	P-0001876	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	379	20
P-0001884-T02-IM5	P-0001884	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	651	10
P-0001904-T02-IM5	P-0001904	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		401	20
P-0001913-T02-IM5	P-0001913	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colorectal Adenocarcinoma	IMPACT410			Female		628	20
P-0001942-T03-IM3	P-0001942	Cervical Cancer	Primary	Tumor	Not Applicable	Vagina	Gastric Type Mucinous Carcinoma	IMPACT341			Female	Note: Due to patients prior aplastic anemia status post bone marrow transplant, variant calling is performed unmatched	192	30
P-0001943-T02-IM5	P-0001943	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		268	50
P-0001996-T01-IM3	P-0001996	Esophagogastric Carcinoma	Metastasis	Tumor	Brain	Stomach	Stomach Adenocarcinoma	IMPACT341	DMP1916	DMP1916	Male		320	20
P-0002015-T02-IM5	P-0002015	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		948	60
P-0002055-T02-IM5	P-0002055	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Follicular Thyroid Cancer	IMPACT410			Female		446	70
P-0002071-T02-IM5	P-0002071	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		821	60
P-0002091-T02-IM5	P-0002091	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		570	20
P-0002099-T02-IM3	P-0002099	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	410	40
P-0002119-T02-IM5	P-0002119	Biliary Cancer	Metastasis	Tumor	Breast	Bile Duct	Cholangiocarcinoma	IMPACT410			Female		183	40
P-0002123-T02-IM5	P-0002123	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1031	20
P-0002131-T02-IM5	P-0002131	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.      Note: Low sequencing depth of coverage of 182X, negative results should be interpreted with caution.	182	40
P-0002159-T01-IM5	P-0002159	Histiocytosis	Primary	Tumor	Not Applicable	Soft Tissue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	791	30
P-0002203-T02-IM3	P-0002203	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT341			Male		446	60
P-0002208-T02-IM5	P-0002208	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Variants in CARD11, DICER1, and PPP2R1A  genes indicates the presence of sub-clones	783	30
P-0002208-T03-IM5	P-0002208	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		636	30
P-0002221-T02-IM5	P-0002221	Thyroid Cancer	Metastasis	Tumor	Mediastinum	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 11q, 16q, and 22q.	1035	80
P-0002225-T02-IM5	P-0002225	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p.	1232	30
P-0002253-T02-IM5	P-0002253	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		551	30
P-0002256-T02-IM5	P-0002256	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Sarcoma, Other	IMPACT410			Female		771	60
P-0002273-T03-IM5	P-0002273	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	764	10
P-0002294-T02-IM5	P-0002294	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The number and pattern of mutations is consistent with a hypermutator phenotype arising as a resistance mechanism to temozolomide or similar agents	758	80
P-0002308-T02-IM3	P-0002308	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	638	60
P-0002310-T01-IM3	P-0002310	Ovarian Cancer	Metastasis	Tumor	Perigastric nodules	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female		700	40
P-0002324-T01-IM3	P-0002324	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341	DMP2287	DMP2287	Female		652	40
P-0002326-T02-IM5	P-0002326	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Inguinal Canal	Dedifferentiated Liposarcoma	IMPACT410			Male		741	60
P-0002328-T02-IM5	P-0002328	Miscellaneous Brain Tumor	Metastasis	Tumor	Nasopharynx	Brain	High-Grade Neuroepithelial Tumor	IMPACT410			Male		523	40
P-0002349-T02-IM5	P-0002349	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	653	70
P-0002368-T02-IM3	P-0002368	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: The GATA3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	451	20
P-0002381-T01-IM3	P-0002381	Ependymomal Tumor	Primary	Tumor	Not Applicable	Spinal Cord	Myxopapillary Ependymoma	IMPACT341	DMP2117	DMP2117	Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	377	NA
P-0002386-T02-IM5	P-0002386	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female		692	50
P-0002417-T02-IM5	P-0002417	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 17q23-25.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 7q34-36 ,10q23-26 and 19q13	918	30
P-0002448-T02-IM3	P-0002448	Osteosarcoma	Metastasis	Tumor	Lung	humerus	Osteosarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	526	60
P-0002449-T02-IM5	P-0002449	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 1, 2, 6, 10, 13, 17, X and Chromosome arm 11q	395	90
P-0002461-T02-IM5	P-0002461	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female	Note: The CCND2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	694	30
P-0002463-T02-IM5	P-0002463	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		675	10
P-0002506-T02-IM5	P-0002506	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The MET and EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	891	20
P-0002508-T01-IM3	P-0002508	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Scalp	Basal Cell Carcinoma	IMPACT341			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.    Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	82	60
P-0002512-T02-IM5	P-0002512	Colorectal Cancer	Metastasis	Tumor	Chest Wall	Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT410			Male	Note: The RICTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The SMAD2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	901	80
P-0002513-T02-IM5	P-0002513	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		398	80
P-0002537-T02-IM5	P-0002537	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		669	50
P-0002568-T01-IM3	P-0002568	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Male		699	40
P-0002570-T01-IM3	P-0002570	Cervical Cancer	Metastasis	Tumor	Ovary	Cervix	Endocervical Adenocarcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p and 11q.	458	20
P-0002571-T01-IM3	P-0002571	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		863	30
P-0002572-T01-IM3	P-0002572	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	760	60
P-0002574-T01-IM3	P-0002574	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Male		252	40
P-0002575-T01-IM3	P-0002575	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	99	40
P-0002576-T02-IM5	P-0002576	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		250	60
P-0002577-T01-IM3	P-0002577	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT341			Female		720	40
P-0002578-T01-IM3	P-0002578	Embryonal Tumor	Primary	Tumor	Not Applicable	Brain	Neuroblastoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q.	672	50
P-0002579-T01-IM3	P-0002579	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male		761	30
P-0002580-T01-IM3	P-0002580	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		735	50
P-0002581-T01-IM3	P-0002581	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	940	10
P-0002581-T02-IM5	P-0002581	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	395	30
P-0002582-T01-IM3	P-0002582	Breast Carcinoma	Metastasis	Tumor	Bladder	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341			Female		1114	30
P-0002583-T01-IM3	P-0002583	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Acinar not ductal	495	40
P-0002584-T01-IM3	P-0002584	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		1056	20
P-0002585-T01-IM3	P-0002585	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		269	40
P-0002586-T01-IM3	P-0002586	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Adenocarcinoma	IMPACT341			Male		1027	40
P-0002587-T01-IM3	P-0002587	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT341			Female		626	50
P-0002588-T01-IM3	P-0002588	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Myxofibrosarcoma	IMPACT341			Male		197	50
P-0002589-T01-IM3	P-0002589	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341			Female		364	40
P-0002590-T01-IM3	P-0002590	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Dermatofibrosarcoma Protuberans	IMPACT341			Male	Broad loss in 21q. PDGFB and COL1A1 genes  not in the panel.	445	60
P-0002591-T01-IM3	P-0002591	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Borad loss of 13q including BRCA2. Include note for 3p and 11q as well.	731	30
P-0002592-T01-IM3	P-0002592	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Hypopharynx	Hypopharynx Squamous Cell Carcinoma	IMPACT341			Male		779	30
P-0002593-T01-IM3	P-0002593	Breast Carcinoma	Metastasis	Tumor	Right Supraclavicular Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		727	30
P-0002594-T01-IM3	P-0002594	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	GE Junction	Gastrointestinal Stromal Tumor	IMPACT341			Female		444	50
P-0002594-T02-IM5	P-0002594	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Not Applicable	Liver	Gastrointestinal Stromal Tumor	IMPACT410			Female		1022	80
P-0002595-T01-IM3	P-0002595	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT341			Female		787	20
P-0002596-T01-IM3	P-0002596	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copt number gain suggestive of the presence of i(12p).	302	30
P-0002597-T02-IM5	P-0002597	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		194	30
P-0002599-T01-IM3	P-0002599	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		322	20
P-0002601-T01-IM3	P-0002601	Germ Cell Tumor	Metastasis	Tumor	Mediastinum	Testis	Mixed Germ Cell Tumor	IMPACT341			Male		268	20
P-0002602-T01-IM3	P-0002602	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT341			Female		521	50
P-0002603-T01-IM3	P-0002603	Head and Neck Carcinoma	Metastasis	Tumor	Not Applicable	Trachea	Head and Neck Squamous Cell Carcinoma	IMPACT341			Male		587	30
P-0002604-T01-IM3	P-0002604	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT341			Female		561	40
P-0002604-T02-IM5	P-0002604	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: Variants in  LATS1, MLL3 and NCOR1 genes indicate the presence of sub-clones	517	30
P-0002605-T01-IM3	P-0002605	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341			Female		648	20
P-0002606-T01-IM3	P-0002606	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		537	80
P-0002607-T01-IM3	P-0002607	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Plasmacytoid/Signet Ring Cell Bladder Carcinoma	IMPACT341			Male		563	40
P-0002608-T01-IM3	P-0002608	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT341			Male		384	60
P-0002609-T01-IM3	P-0002609	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT341			Female		403	30
P-0002610-T01-IM3	P-0002610	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		535	30
P-0002611-T01-IM3	P-0002611	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT341			Female		464	NA
P-0002612-T01-IM3	P-0002612	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		511	NA
P-0002613-T01-IM3	P-0002613	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	712	NA
P-0002614-T01-IM3	P-0002614	Bladder Cancer	Metastasis	Tumor	Lung	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Male		552	30
P-0002614-T02-IM5	P-0002614	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: The EGFR exon18 mutations all occur in cis (same allele).	421	70
P-0002615-T01-IM3	P-0002615	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Female		359	50
P-0002615-T02-IM5	P-0002615	Renal Cell Carcinoma	Metastasis	Tumor	Pleura	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 4, 9, 14 and 18 as well as Chromosome arms 2q, 3p (including VHL and BAP1), 17p.	410	60
P-0002616-T01-IM3	P-0002616	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341			Male		583	30
P-0002617-T01-IM3	P-0002617	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	375	10
P-0002617-T02-IM5	P-0002617	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The 8q copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	299	40
P-0002619-T01-IM3	P-0002619	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341			Male		362	30
P-0002620-T01-IM3	P-0002620	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341			Male	Note: The PTPN11 exon3 mutations occur in trans on different alleles.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 2q, 16p and 19q.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and 12p.	741	40
P-0002621-T02-IM5	P-0002621	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female	Note: The MGA  exon 4 mutations all occur in cis (same allele).        Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 6 and 11.	77	60
P-0002622-T01-IM3	P-0002622	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		611	30
P-0002622-T02-IM5	P-0002622	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1115	NA
P-0002624-T01-IM3	P-0002624	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	377	30
P-0002625-T01-IM3	P-0002625	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: The FOXA1 exon2 mutations all occur in cis on the same allele.	516	60
P-0002626-T01-IM3	P-0002626	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: Assessment of the copy number profile is limited by increased background noise.	186	20
P-0002627-T01-IM3	P-0002627	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q	1535	70
P-0002629-T01-IM3	P-0002629	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Squamous Cell Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	730	30
P-0002630-T01-IM3	P-0002630	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female		726	30
P-0002631-T01-IM3	P-0002631	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		592	30
P-0002632-T01-IM3	P-0002632	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Medullary Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	171	20
P-0002632-T02-IM5	P-0002632	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Medullary Carcinoma	IMPACT410			Male		450	40
P-0002633-T01-IM3	P-0002633	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		249	60
P-0002634-T01-IM3	P-0002634	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Assessment of the copy number profile is limited by increased background noise, negative results should be interpreted with caution.	201	20
P-0002635-T01-IM3	P-0002635	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Male		703	30
P-0002636-T01-IM3	P-0002636	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copt number gain suggestive of the presence of i(12p).	485	30
P-0002637-T01-IM3	P-0002637	Non-Small Cell Lung Cancer	Metastasis	Tumor	Abdomen	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341			Male		1086	50
P-0002638-T01-IM3	P-0002638	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT341			Female		1022	NA
P-0002639-T01-IM3	P-0002639	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: The TP53 exon5 mutations all occur in cis on the same allele.	760	30
P-0002640-T01-IM3	P-0002640	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 10q, 11q, 16q and  22q	195	40
P-0002641-T01-IM3	P-0002641	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT341			Female		1287	NA
P-0002642-T01-IM3	P-0002642	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Buttock	Myxoid/Round-Cell Liposarcoma	IMPACT341			Male	Note: MSK-IMPACT test panel does not cover FUS nor DDIT3 gene.	534	NA
P-0002643-T01-IM3	P-0002643	Ovarian Cancer	Metastasis	Tumor	Pleural Fluid	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	1113	NA
P-0002645-T01-IM3	P-0002645	Ovarian Cancer	Metastasis	Tumor	Diaphragm	Ovary	Mucinous Ovarian Cancer	IMPACT341			Female		528	30
P-0002646-T01-IM3	P-0002646	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 9, 13, 14, 15, and Chromosome arms 9q, 17p	885	20
P-0002647-T01-IM3	P-0002647	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341			Male	Note: The FAT1 and PALB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and Chromosome arm 6q	866	NA
P-0002647-T02-IM5	P-0002647	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q , 10q ,16p and 18q .    Note: The GATA3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	816	60
P-0002648-T01-IM3	P-0002648	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p	745	NA
P-0002648-T02-IM5	P-0002648	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female	Note: The KRAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	750	20
P-0002649-T01-IM3	P-0002649	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: The CDH1 exon16 mutations all occur in cis on the same allele.	226	50
P-0002650-T01-IM3	P-0002650	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	522	50
P-0002651-T01-IM3	P-0002651	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Male		494	50
P-0002652-T01-IM3	P-0002652	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q, 16p  Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 18 and 22 and Chromosome arms proximal 1p, 6q, 9p, 11q, and 16q	635	30
P-0002654-T01-IM3	P-0002654	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341			Male	Note: Despite low tumor purity, copy number profile is suggestive of broad copy number losses on Chromosome arm 3p, 8p.   Note: Despite low tumor purity, copy number profile is suggestive of broad copy number gains on Chromosome arm 5p, 7q.	515	30
P-0002655-T01-IM3	P-0002655	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Cancer, NOS	IMPACT341			Female		868	50
P-0002656-T01-IM3	P-0002656	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	556	20
P-0002657-T01-IM3	P-0002657	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests thePIK3CA p.G364R mutation is subclonal.	608	50
P-0002658-T01-IM3	P-0002658	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	259	60
P-0002659-T01-IM3	P-0002659	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results for copy number changes should be interpreted with caution.	651	20
P-0002660-T01-IM3	P-0002660	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Epithelial Tumor	IMPACT341			Female		930	60
P-0002661-T01-IM3	P-0002661	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	557	20
P-0002662-T01-IM3	P-0002662	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Synovial Sarcoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 12q and 20q    Note: MSK-IMPACT test panel does not cover SYT gene.	715	60
P-0002663-T01-IM3	P-0002663	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Male		572	20
P-0002664-T01-IM3	P-0002664	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Mucinous Ovarian Cancer	IMPACT341			Female		749	40
P-0002665-T01-IM3	P-0002665	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT341			Male		243	50
P-0002666-T01-IM3	P-0002666	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT341			Male	Note: Due to marginal sample quality, all negative results should be interpreted with caution.	103	20
P-0002667-T01-IM3	P-0002667	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		660	40
P-0002668-T01-IM3	P-0002668	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	523	60
P-0002669-T01-IM3	P-0002669	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341			Male		316	30
P-0002670-T01-IM3	P-0002670	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	423	20
P-0002671-T01-IM3	P-0002671	Colorectal Cancer	Primary	Tumor	Not Applicable	Splenic Flexure	Colon Adenocarcinoma	IMPACT341			Female		577	30
P-0002672-T01-IM3	P-0002672	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 10, 13, 14, 15, 21, 22	597	30
P-0002674-T01-IM3	P-0002674	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT341			Female		715	30
P-0002675-T01-IM3	P-0002675	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT341			Male		548	30
P-0002677-T01-IM3	P-0002677	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Male		128	30
P-0002679-T01-IM3	P-0002679	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q including RB1	530	30
P-0002680-T01-IM3	P-0002680	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	small bowel	Gastrointestinal Stromal Tumor	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 9, 14, 15, 18, 22 and Chromosome arm 1p.	425	40
P-0002682-T01-IM3	P-0002682	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 16p  Note: Copy number profile is suggestive of broad copy number losses on Chromosome 17 and Chromosome arms 15q, 16q and 18q. However, due to noisy copy number profile smaller copy number events may not be detected.	251	30
P-0002683-T01-IM3	P-0002683	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	420	30
P-0002684-T01-IM3	P-0002684	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	272	30
P-0002685-T01-IM3	P-0002685	Soft Tissue Sarcoma	Primary	Tumor	Pelvis	Pelvis	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341			Female		543	60
P-0002687-T01-IM3	P-0002687	Cervical Cancer	Metastasis	Tumor	Lymph Node	Cervix	Endocervical Adenocarcinoma	IMPACT341			Female		286	20
P-0002688-T02-IM3	P-0002688	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: The CCND3, VEGFA, and ARID2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	726	50
P-0002689-T01-IM3	P-0002689	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Squamous Cell Carcinoma	IMPACT341			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	378	30
P-0002691-T01-IM3	P-0002691	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests the ARID2  E47fs mutation is subclonal.	340	60
P-0002692-T01-IM3	P-0002692	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	625	30
P-0002694-T02-IM3	P-0002694	Non-Small Cell Lung Cancer	Metastasis	Tumor	LYMPH NODE	LUNG	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	639	20
P-0002695-T01-IM3	P-0002695	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female		723	60
P-0002696-T01-IM3	P-0002696	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	750	20
P-0002697-T01-IM3	P-0002697	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	liver	Hepatocellular Carcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	394	60
P-0002698-T01-IM3	P-0002698	Soft Tissue Sarcoma	Metastasis	Tumor	Pleura	Neck	Synovial Sarcoma	IMPACT341			Male	Note: MSK-IMPACT test panel does not cover SYT gene.	625	30
P-0002700-T01-IM3	P-0002700	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: The FGF4, FGF9 and FGF19 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	317	30
P-0002701-T01-IM3	P-0002701	Chordoma	Metastasis	Tumor	Skin	Bone	Chordoma	IMPACT341			Male		331	70
P-0002702-T01-IM3	P-0002702	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Cecum	Colon Adenocarcinoma	IMPACT341			Female		796	30
P-0002703-T01-IM3	P-0002703	Salivary Carcinoma	Metastasis	Tumor	Bone	Bone	Myoepithelial Carcinoma	IMPACT341			Male		726	80
P-0002704-T01-IM3	P-0002704	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	191	20
P-0002705-T01-IM3	P-0002705	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	671	40
P-0002706-T01-IM3	P-0002706	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT341			Female		504	40
P-0002707-T01-IM3	P-0002707	Non-Small Cell Lung Cancer	Metastasis	Tumor	RP LN	lung	Lung Adenocarcinoma	IMPACT341			Female		554	60
P-0002707-T03-IM5	P-0002707	Non-Small Cell Lung Cancer	Metastasis	Tumor	Abdomen	Lung	Lung Adenocarcinoma	IMPACT410			Female		1087	50
P-0002708-T01-IM3	P-0002708	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341			Female	Note: Low sequencing depth of coverage of 105X, negative results should be interpreted with caution.	105	40
P-0002709-T01-IM3	P-0002709	Non-Small Cell Lung Cancer	Metastasis	Tumor	Abdomen	Lung	Large Cell Lung Carcinoma	IMPACT341			Female		465	40
P-0002710-T01-IM3	P-0002710	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Stomach Adenocarcinoma	IMPACT341			Male		195	20
P-0002712-T01-IM3	P-0002712	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The MDM2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	844	20
P-0002713-T01-IM3	P-0002713	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		657	30
P-0002714-T01-IM3	P-0002714	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q	827	40
P-0002715-T01-IM3	P-0002715	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Male	Note: The GATA3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	846	20
P-0002716-T01-IM3	P-0002716	Mesothelioma	Metastasis	Tumor	Lymph Node	Pleura	Pleural Mesothelioma	IMPACT341			Male		700	30
P-0002716-T02-IM5	P-0002716	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	612	NA
P-0002717-T01-IM3	P-0002717	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT341			Female		743	20
P-0002718-T01-IM3	P-0002718	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Male		816	30
P-0002719-T01-IM3	P-0002719	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	liver	Hepatocellular Carcinoma	IMPACT341			Male		451	50
P-0002720-T01-IM3	P-0002720	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT341			Male		588	30
P-0002721-T01-IM3	P-0002721	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341			Male		233	20
P-0002722-T01-IM3	P-0002722	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	487	20
P-0002723-T01-IM3	P-0002723	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	GE Junction	Gastrointestinal Neuroendocrine Tumors	IMPACT341			Male	Note: Low sequencing depth of coverage of 59X, negative results should be interpreted with caution.	59	50
P-0002724-T01-IM3	P-0002724	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	885	40
P-0002725-T01-IM3	P-0002725	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	461	20
P-0002726-T01-IM3	P-0002726	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	1107	60
P-0002728-T01-IM3	P-0002728	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male		660	30
P-0002729-T01-IM3	P-0002729	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341			Female		531	40
P-0002730-T01-IM3	P-0002730	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male		835	30
P-0002731-T02-IM5	P-0002731	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		776	70
P-0002732-T01-IM3	P-0002732	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	413	30
P-0002733-T01-IM3	P-0002733	Biliary Cancer	Metastasis	Tumor	Peritoneum	Gallbladder	Gallbladder Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	831	20
P-0002734-T01-IM3	P-0002734	Ependymomal Tumor	Primary	Tumor	Not Applicable	Bone	Ependymoma	IMPACT341			Male	Note: The MDM2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	623	20
P-0002735-T01-IM3	P-0002735	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution. If clinically indicated, please submit another tumor block.	938	20
P-0002736-T01-IM3	P-0002736	Hepatocellular Carcinoma	Metastasis	Tumor	Mediastinum	Liver	Fibrolamellar Carcinoma	IMPACT341			Female		670	40
P-0002737-T02-IM5	P-0002737	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		450	40
P-0002738-T01-IM3	P-0002738	Non-Small Cell Lung Cancer	Metastasis	Tumor	Paratracheal mass	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341			Female		263	30
P-0002738-T02-IM5	P-0002738	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female		352	30
P-0002739-T01-IM3	P-0002739	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		189	20
P-0002740-T01-IM3	P-0002740	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		271	20
P-0002741-T01-IM3	P-0002741	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Male		676	30
P-0002743-T01-IM3	P-0002743	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Male		703	50
P-0002744-T01-IM3	P-0002744	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		150	20
P-0002745-T01-IM3	P-0002745	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Head and Neck Squamous Cell Carcinoma	IMPACT341			Female		374	20
P-0002746-T01-IM3	P-0002746	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Larynx	Larynx Squamous Cell Carcinoma	IMPACT341			Male		260	60
P-0002747-T01-IM3	P-0002747	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	614	20
P-0002750-T02-IM3	P-0002750	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	mandible	Head and Neck Squamous Cell Carcinoma	IMPACT341			Male	Note: Variants in XXX gene indicates the presence of sub-clones	697	50
P-0002751-T01-IM3	P-0002751	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Female		91	20
P-0002752-T01-IM3	P-0002752	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Female		104	30
P-0002753-T01-IM3	P-0002753	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT341			Male		546	30
P-0002754-T01-IM3	P-0002754	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female		697	40
P-0002755-T01-IM3	P-0002755	Salivary Carcinoma	Primary	Tumor	Not Applicable	salivary	Salivary Duct Carcinoma	IMPACT341			Female		840	30
P-0002755-T02-IM3	P-0002755	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	salivary	Salivary Duct Carcinoma	IMPACT341			Female		644	50
P-0002756-T01-IM3	P-0002756	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		275	20
P-0002756-T02-IM5	P-0002756	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		869	40
P-0002757-T01-IM3	P-0002757	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Blood Vessel	Intimal Sarcoma	IMPACT341			Female		1533	20
P-0002758-T01-IM3	P-0002758	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Male		112	30
P-0002759-T01-IM3	P-0002759	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT341			Male		422	20
P-0002761-T01-IM3	P-0002761	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		626	50
P-0002762-T02-IM5	P-0002762	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Upper Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	258	40
P-0002763-T01-IM3	P-0002763	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT341			Female	Note: MSK-IMPACT test panel does not cover STAT6 nor NAB2 genes.	353	50
P-0002764-T01-IM3	P-0002764	Chondrosarcoma	Primary	Tumor	Not Applicable	Bone	Chondrosarcoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 15q, 16p and Chromosomes 2, 5, 8 and 18.	466	40
P-0002765-T01-IM3	P-0002765	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341			Male		507	NA
P-0002766-T01-IM3	P-0002766	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Female		757	NA
P-0002767-T01-IM3	P-0002767	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q including ERBB2.         Note: The NBN, MYC and RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	600	40
P-0002769-T01-IM3	P-0002769	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Female		663	NA
P-0002770-T01-IM3	P-0002770	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Rectum	Rectal Adenocarcinoma	IMPACT341			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	171	20
P-0002771-T01-IM3	P-0002771	Ovarian Cancer	Metastasis	Tumor	Pelvic wall	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	442	30
P-0002772-T01-IM3	P-0002772	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3, chromosome arm 18q and focal loss on chromosome arm 1q21 - 1q31.	454	40
P-0002773-T01-IM3	P-0002773	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	618	20
P-0002775-T01-IM3	P-0002775	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		439	50
P-0002776-T01-IM3	P-0002776	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT341			Female		661	50
P-0002777-T01-IM3	P-0002777	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		771	30
P-0002778-T01-IM3	P-0002778	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341			Male		618	40
P-0002779-T01-IM3	P-0002779	Small Bowel Cancer	Primary	Tumor	Not Applicable	Jejunum	Small Bowel Cancer	IMPACT341			Male		407	30
P-0002781-T01-IM3	P-0002781	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	2q, 13, 17p loss	368	20
P-0002782-T01-IM3	P-0002782	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT341			Female		724	30
P-0002784-T01-IM3	P-0002784	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341			Female		712	30
P-0002786-T01-IM3	P-0002786	Mesothelioma	Metastasis	Tumor	Chest Wall	Pleura	Pleural Mesothelioma	IMPACT341			Male		545	30
P-0002787-T01-IM3	P-0002787	Head and Neck Carcinoma	Metastasis	Tumor	Liver	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT341			Male		622	30
P-0002788-T01-IM3	P-0002788	Colorectal Cancer	Metastasis	Tumor	Abdomen	Ascending Colon	Colon Adenocarcinoma	IMPACT341			Male		571	40
P-0002789-T01-IM3	P-0002789	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		520	30
P-0002791-T01-IM3	P-0002791	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT341			Female		769	30
P-0002792-T01-IM3	P-0002792	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male		504	60
P-0002793-T02-IM3	P-0002793	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests the  NRAS p.G12D mutation is subclonal.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 9p, 11q and chromosome X.	688	50
P-0002794-T01-IM3	P-0002794	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT341			Female		213	20
P-0002794-T02-IM5	P-0002794	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Lung and 30%	738	NA
P-0002795-T01-IM3	P-0002795	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male	Note: The KIT copy number profile is suggestive of multiple copies (duplications) of exon 13 . Confirmatory testing by an alternate method is suggested, if clinically indicated.	669	20
P-0002796-T01-IM3	P-0002796	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		281	20
P-0002797-T01-IM3	P-0002797	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341			Male		543	40
P-0002798-T01-IM3	P-0002798	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 8q and 17q.	751	60
P-0002799-T01-IM3	P-0002799	Germ Cell Tumor	Primary	Tumor	Not Applicable	mediastinal (carcinomasarcoma)	Mixed Germ Cell Tumor	IMPACT341			Female		423	60
P-0002800-T01-IM3	P-0002800	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		590	20
P-0002801-T01-IM3	P-0002801	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT341			Male		747	30
P-0002802-T01-IM3	P-0002802	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	454	20
P-0002803-T01-IM3	P-0002803	Ovarian Cancer	Metastasis	Tumor	Bladder	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	536	20
P-0002804-T01-IM3	P-0002804	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT341			Male		876	30
P-0002805-T01-IM3	P-0002805	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Papillary Renal Cell Carcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	988	40
P-0002806-T01-IM3	P-0002806	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Male		613	20
P-0002807-T01-IM3	P-0002807	Uterine Sarcoma	Metastasis	Tumor	Pelvic Mass	Uterus	Uterine Epithelioid Leiomyosarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 13q	606	60
P-0002808-T01-IM3	P-0002808	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	lung	Lung Squamous Cell Carcinoma	IMPACT341			Female		789	40
P-0002809-T01-IM3	P-0002809	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Squamous Cell Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	583	20
P-0002810-T01-IM3	P-0002810	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Pancreatobiliary Ampullary Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	644	20
P-0002811-T01-IM3	P-0002811	Soft Tissue Sarcoma	Metastasis	Tumor	Lower Extremity	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 7p.    Note: MSK-IMPACT test panel does not cover DDIT3 or FUS genes.	716	50
P-0002812-T01-IM3	P-0002812	Uterine Sarcoma	Metastasis	Tumor	Para-aortic mass	Uterus	Uterine Epithelioid Leiomyosarcoma	IMPACT341			Female		251	40
P-0002813-T01-IM3	P-0002813	Breast Carcinoma	Metastasis	Tumor	Omentum	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	261	20
P-0002814-T01-IM3	P-0002814	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q including GNAS.	328	30
P-0002815-T01-IM3	P-0002815	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 19q.	474	30
P-0002816-T01-IM3	P-0002816	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 11 and Chromosome arm 13q.	723	70
P-0002817-T01-IM3	P-0002817	Uterine Sarcoma	Metastasis	Tumor	Liver	Uterus	Uterine Leiomyosarcoma	IMPACT341			Female		656	60
P-0002818-T01-IM3	P-0002818	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	HG NET	Head and Neck Neuroendocrine Carcinoma	IMPACT341			Female	Note: The RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	528	NA
P-0002819-T01-IM3	P-0002819	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Testis	Leiomyosarcoma	IMPACT341			Male	Note: Variants in TP53 gene indicates the presence of sub-clones	739	60
P-0002820-T01-IM3	P-0002820	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	499	20
P-0002821-T01-IM3	P-0002821	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT341			Female		232	20
P-0002822-T01-IM3	P-0002822	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).  Note: The KDR and EPHA5 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	647	40
P-0002823-T01-IM3	P-0002823	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	574	20
P-0002824-T01-IM3	P-0002824	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	736	NA
P-0002825-T01-IM3	P-0002825	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	593	20
P-0002825-T02-IM5	P-0002825	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the ASXL2 p.R312fs mutation is subclonal.	361	20
P-0002826-T01-IM3	P-0002826	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT341			Female		777	40
P-0002827-T01-IM3	P-0002827	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	432	20
P-0002828-T01-IM3	P-0002828	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.      Note: The PRKAR1A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	509	20
P-0002829-T01-IM3	P-0002829	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT341			Female		629	30
P-0002830-T01-IM3	P-0002830	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	339	20
P-0002833-T01-IM3	P-0002833	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		617	30
P-0002835-T01-IM3	P-0002835	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	1130	NA
P-0002836-T01-IM3	P-0002836	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome X and Chromosome arms 9p and 10q.	756	40
P-0002838-T02-IM5	P-0002838	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		326	20
P-0002838-T03-IM5	P-0002838	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		791	10
P-0002839-T01-IM3	P-0002839	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	712	50
P-0002840-T01-IM3	P-0002840	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		966	30
P-0002840-T02-IM3	P-0002840	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	add back BAP1 p.R227C	. This is a met from Run15-003  Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	767
P-0002841-T01-IM3	P-0002841	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		846	30
P-0002842-T01-IM3	P-0002842	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		725	20
P-0002843-T01-IM3	P-0002843	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Male		712	40
P-0002843-T02-IM5	P-0002843	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		653	40
P-0002844-T01-IM3	P-0002844	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341			Female		597	30
P-0002845-T01-IM3	P-0002845	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT341			Male	Note: The KRAS exon4 mutations all occur in cis on the same allele.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	546	20
P-0002847-T01-IM3	P-0002847	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		330	30
P-0002848-T01-IM3	P-0002848	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	728	20
P-0002852-T01-IM3	P-0002852	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests the FBXW7 R479X mutation is subclonal.	568	30
P-0002853-T01-IM3	P-0002853	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p31-1p32 and 3p21-3p22	577	50
P-0002854-T01-IM3	P-0002854	Head and Neck Carcinoma	Metastasis	Tumor	Bone	Oral Cavity	Oropharynx Squamous Cell Carcinoma	IMPACT341			Male		798	30
P-0002855-T01-IM3	P-0002855	Colorectal Cancer	Primary	Tumor	Not Applicable	Splenic Flexure	Colon Adenocarcinoma	IMPACT341			Female		739	20
P-0002856-T01-IM3	P-0002856	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341			Female		376	20
P-0002858-T01-IM3	P-0002858	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		111	60
P-0002860-T01-IM3	P-0002860	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and chromosome arm 6q.	814	40
P-0002862-T01-IM3	P-0002862	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		1107	30
P-0002863-T01-IM3	P-0002863	Chordoma	Metastasis	Tumor	Subcutaneous Tissue	Bone	Chordoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: The MLL exon12 mutations all occur in cis on the same allele.	611	50
P-0002864-T01-IM3	P-0002864	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Male		766	20
P-0002866-T01-IM3	P-0002866	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female		611	30
P-0002867-T01-IM3	P-0002867	Cancer of Unknown Primary	Metastasis	Tumor	Chest Wall	Unknown	Cancer of Unknown Primary	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	556	20
P-0002868-T02-IM5	P-0002868	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	531	30
P-0002870-T01-IM3	P-0002870	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female		771	70
P-0002872-T01-IM3	P-0002872	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT341			Female		615	20
P-0002874-T01-IM3	P-0002874	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	1045	40
P-0002875-T01-IM3	P-0002875	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Papillary Thyroid Cancer	IMPACT341			Male		473	70
P-0002878-T01-IM3	P-0002878	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Female		556	30
P-0002880-T01-IM3	P-0002880	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		528	30
P-0002882-T01-IM3	P-0002882	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Sinonasal	Rhabdomyosarcoma	IMPACT341			Male	Note: MSK-IMPACT test panel does not cover the PAX3, PAX7 and FHKR genes.	786	20
P-0002883-T01-IM3	P-0002883	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophagogastric Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	191	30
P-0002883-T02-IM5	P-0002883	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		1085	20
P-0002884-T01-IM3	P-0002884	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT341			Male		618	20
P-0002885-T01-IM3	P-0002885	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	784	90
P-0002886-T01-IM3	P-0002886	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		667	30
P-0002887-T01-IM3	P-0002887	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female		748	40
P-0002888-T01-IM3	P-0002888	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Male		594	60
P-0002889-T01-IM3	P-0002889	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Non-Seminomatous Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	451	20
P-0002891-T01-IM3	P-0002891	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	297	60
P-0002892-T01-IM3	P-0002892	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	602	70
P-0002894-T01-IM3	P-0002894	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		663	50
P-0002895-T01-IM3	P-0002895	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	181	20
P-0002897-T01-IM3	P-0002897	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		159	40
P-0002898-T01-IM3	P-0002898	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		389	30
P-0002898-T02-IM5	P-0002898	Prostate Cancer	Primary	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 16q, 17p and 18q    Note: The EPHA7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	576	80
P-0002899-T01-IM3	P-0002899	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT341			Female	Note: MSK-IMPACT test panel does not cover the DDIT3 nor FUS genes.	728	30
P-0002900-T01-IM3	P-0002900	Miscellaneous Neuroepithelial Tumor	Primary	Tumor	Not Applicable	Brain	Rosette-forming Glioneuronal Tumor of the Fourth Ventricle	IMPACT341			Male		473	20
P-0002901-T01-IM3	P-0002901	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		364	60
P-0002901-T03-IM5	P-0002901	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		350	60
P-0002903-T01-IM3	P-0002903	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341			Female		290	40
P-0002905-T01-IM3	P-0002905	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		430	20
P-0002906-T01-IM3	P-0002906	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT341			Female		750	40
P-0002908-T01-IM3	P-0002908	Pancreatic Cancer	Metastasis	Tumor	Lymph Node	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT341			Male	Note: Low sequencing depth of coverage of 75X, negative results should be interpreted with caution.	75	50
P-0002909-T01-IM3	P-0002909	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		368	20
P-0002911-T01-IM3	P-0002911	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT341			Female		446	70
P-0002912-T01-IM3	P-0002912	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		509	NA
P-0002913-T01-IM3	P-0002913	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT341			Male		740	90
P-0002914-T01-IM3	P-0002914	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341			Male		522	50
P-0002915-T01-IM3	P-0002915	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		609	20
P-0002916-T01-IM3	P-0002916	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female		549	NA
P-0002916-T02-IM5	P-0002916	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		598	20
P-0002917-T01-IM3	P-0002917	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		200	30
P-0002919-T01-IM3	P-0002919	Soft Tissue Sarcoma	Metastasis	Tumor	Para-aortic Mass	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT341			Female		741	90
P-0002920-T01-IM3	P-0002920	Salivary Carcinoma	Metastasis	Tumor	Liver	Salivary Duct	Salivary Duct Carcinoma	IMPACT341			Female		735	30
P-0002920-T02-IM5	P-0002920	Salivary Carcinoma	Metastasis	Tumor	Liver	Salivary Gland	Salivary Carcinoma	IMPACT410			Female		1087	30
P-0002922-T01-IM3	P-0002922	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		799	70
P-0002936-T01-IM3	P-0002936	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Male		635	30
P-0002937-T01-IM3	P-0002937	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT341			Male		508	20
P-0002939-T01-IM3	P-0002939	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Sinonasal	Sinonasal Squamous Cell Carcinoma	IMPACT341			Male		654	30
P-0002940-T01-IM3	P-0002940	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Unclassified Renal Cell Carcinoma	IMPACT341			Male		532	20
P-0002941-T01-IM3	P-0002941	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Male		677	20
P-0002942-T01-IM3	P-0002942	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		616	20
P-0002943-T01-IM3	P-0002943	Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Small Cell Lung Cancer	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	456	NA
P-0002944-T01-IM3	P-0002944	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT341			Male		381	20
P-0002945-T01-IM3	P-0002945	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT341			Female		987	30
P-0002946-T01-IM3	P-0002946	Miscellaneous Neuroepithelial Tumor	Primary	Tumor	Not Applicable	Bone	Paraganglioma	IMPACT341			Female		443	50
P-0002948-T02-IM5	P-0002948	Salivary Carcinoma	Metastasis	Tumor	Lymph node	Parotid	Salivary Duct Carcinoma	IMPACT410			Female	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	456	20
P-0002949-T01-IM3	P-0002949	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	658	20
P-0002950-T01-IM3	P-0002950	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		680	50
P-0002951-T01-IM3	P-0002951	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male	Note: Variants in HGF gene indicates the presence of sub-clones	737	30
P-0002952-T01-IM3	P-0002952	Chordoma	Primary	Tumor	Not Applicable	Bone	Chordoma	IMPACT341			Female	Note: Variants in AR gene indicates the presence of sub-clones	410	50
P-0002953-T01-IM3	P-0002953	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests the ARID5B p.E589X mutation is subclonal.    Note: The BAP1 exon9 mutations occur in trans on different alleles	781	30
P-0002954-T01-IM3	P-0002954	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		480	20
P-0002955-T01-IM3	P-0002955	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	462	50
P-0002956-T01-IM3	P-0002956	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female		703	50
P-0002957-T01-IM3	P-0002957	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female		349	30
P-0002958-T01-IM3	P-0002958	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		356	70
P-0002959-T01-IM3	P-0002959	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		252	20
P-0002959-T02-IM5	P-0002959	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		654	60
P-0002960-T01-IM3	P-0002960	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT341			Male		578	20
P-0002961-T01-IM3	P-0002961	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	424	30
P-0002962-T01-IM3	P-0002962	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: The BRCA2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	803	60
P-0002963-T01-IM3	P-0002963	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT341			Male	Note: Copy number profile shows no evidence of 1p and 19q loss.	666	70
P-0002964-T01-IM3	P-0002964	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of a fragmented genome..	537	70
P-0002964-T02-IM3	P-0002964	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Cancer of Unknown Primary	IMPACT341			Male	Note: This tumor sample is not clonally related to the sample tested in M15-126.   Note: The MYOD1 exon1 mutations all occur in cis on the same allele.        Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	515	30
P-0002965-T01-IM3	P-0002965	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Male	Note: The SOX2 and FGFR1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	970	20
P-0002967-T01-IM3	P-0002967	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT341			Male		310	60
P-0002969-T01-IM3	P-0002969	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pancreas	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: A comparison of variant frequencies suggests the RFWD2 (p.R273I), FH (p.G346C) and SPEN (p.A1061G) mutations are subclonal.	462	20
P-0002970-T01-IM3	P-0002970	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		1087	30
P-0002971-T01-IM3	P-0002971	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	673	20
P-0002971-T02-IM5	P-0002971	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		623	50
P-0002972-T01-IM3	P-0002972	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Mediastinum	Pleomorphic Liposarcoma	IMPACT341			Female		809	50
P-0002974-T01-IM3	P-0002974	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		967	70
P-0002975-T01-IM3	P-0002975	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: The 17q arm copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	346	50
P-0002975-T02-IM5	P-0002975	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		385	40
P-0002976-T01-IM3	P-0002976	Renal Cell Carcinoma	Metastasis	Tumor	Abdomen	Kidney	Renal Clear Cell Carcinoma	IMPACT341			Male		359	80
P-0002977-T01-IM3	P-0002977	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT341			Female	Note: MSK-IMPACT test panel does not cover TFE3 or ASPL gene.	351	50
P-0002978-T02-IM5	P-0002978	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Acinic Cell Carcinoma	IMPACT410			Female		672	30
P-0002978-T03-IM5	P-0002978	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Salivary Carcinoma, Other	IMPACT410			Female	Note: The BLM and IGF1R copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	628	90
P-0002978-T04-IM5	P-0002978	Salivary Carcinoma	Metastasis	Tumor	Chest Wall	Salivary Gland	Salivary Carcinoma, Other	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	1186	30
P-0002979-T01-IM3	P-0002979	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Renal Angiomyolipoma	IMPACT341			Female		721	30
P-0002979-T02-IM3	P-0002979	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Angiomyolipoma	IMPACT341			Female	Note: A comparison of variant frequencies suggests the RB1 I768fs mutation is subclonal.	420	60
P-0002981-T01-IM3	P-0002981	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT341			Female		538	70
P-0002981-T02-IM5	P-0002981	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		834	70
P-0002982-T01-IM3	P-0002982	Ovarian Cancer	Metastasis	Tumor	Chest Wall	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT341			Female		392	50
P-0002983-T01-IM3	P-0002983	Thymic Tumor	Metastasis	Tumor	Lung	Thymus	Thymoma	IMPACT341			Male		1142	80
P-0002984-T01-IM3	P-0002984	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q and Xp.	637	50
P-0002985-T01-IM3	P-0002985	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Female		690	60
P-0002986-T01-IM3	P-0002986	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT341			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	62	20
P-0002987-T01-IM3	P-0002987	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	567	80
P-0002989-T01-IM3	P-0002989	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	961	30
P-0002990-T01-IM3	P-0002990	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		702	70
P-0002990-T02-IM5	P-0002990	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome X and 8q including MYC.	779	60
P-0002991-T01-IM3	P-0002991	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		870	NA
P-0002992-T01-IM3	P-0002992	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Adrenal Gland	Neuroblastoma	IMPACT341			Female		916	70
P-0002993-T01-IM3	P-0002993	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Nailbed	Acral Melanoma	IMPACT341			Male		257	60
P-0002994-T01-IM3	P-0002994	Colorectal Cancer	Metastasis	Tumor	Pelvis	Rectum	Rectal Adenocarcinoma	IMPACT341			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	570	20
P-0002995-T01-IM3	P-0002995	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT341			Female	drop all below 40%	705	70
P-0002996-T01-IM3	P-0002996	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	655	NA
P-0002996-T02-IM3	P-0002996	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	704	20
P-0002997-T01-IM3	P-0002997	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		327	30
P-0002998-T01-IM3	P-0002998	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Auditory Canal	Head and Neck Squamous Cell Carcinoma	IMPACT341			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	607	60
P-0002999-T01-IM3	P-0002999	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: A comparison of variant frequencies suggests the EGFR p.R252H mutation is subclonal.	468	70
P-0003000-T01-IM3	P-0003000	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: The KDM6A exon20 mutations all occur in cis on the same allele.	800	40
P-0003001-T01-IM3	P-0003001	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		410	20
P-0003002-T01-IM3	P-0003002	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		556	70
P-0003003-T01-IM3	P-0003003	Renal Cell Carcinoma	Metastasis	Tumor	Abdomen	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT341			Male		672	60
P-0003004-T01-IM3	P-0003004	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	731	20
P-0003005-T01-IM3	P-0003005	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	697	20
P-0003006-T01-IM3	P-0003006	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	680	20
P-0003007-T01-IM3	P-0003007	Cancer of Unknown Primary	Metastasis	Tumor	Abdomen	Unknown	Cancer of Unknown Primary	IMPACT341			Male		687	50
P-0003008-T01-IM3	P-0003008	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Female		254	30
P-0003010-T01-IM3	P-0003010	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	718	20
P-0003011-T01-IM3	P-0003011	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male		692	20
P-0003014-T01-IM3	P-0003014	Endometrial Cancer	Metastasis	Tumor	Retroperitoneum	Uterus	Uterine Endometrioid Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	871	20
P-0003016-T01-IM3	P-0003016	Head and Neck Carcinoma	Metastasis	Tumor	Neck	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	609	20
P-0003017-T01-IM3	P-0003017	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT341			Female		839	50
P-0003018-T01-IM3	P-0003018	Gestational Trophoblastic Disease	Primary	Tumor	Not Applicable	Testis	Choriocarcinoma	IMPACT341			Male		1055	60
P-0003019-T01-IM3	P-0003019	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	590	60
P-0003020-T01-IM3	P-0003020	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT341			Female	Note: A comparison of variant frequencies suggests the SMARCD1, PBRM1 and CDKN2Ap16INK4A mutations are subclonal.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 including ETV1.	260	60
P-0003021-T01-IM3	P-0003021	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		191	30
P-0003022-T01-IM3	P-0003022	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Evidence for i(12p) can not be derived from the copy number profile.	435	50
P-0003023-T01-IM3	P-0003023	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	741	50
P-0003024-T01-IM3	P-0003024	Bladder Cancer	Metastasis	Tumor	Subcutaneous Tissue	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male	Note: The ERBB3 exon28 mutations occur in trans on different alleles	569	60
P-0003025-T01-IM3	P-0003025	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	484	50
P-0003025-T02-IM5	P-0003025	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	718	10
P-0003026-T01-IM3	P-0003026	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	532	20
P-0003027-T01-IM3	P-0003027	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	601	20
P-0003028-T01-IM3	P-0003028	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	577	20
P-0003029-T01-IM3	P-0003029	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		884	30
P-0003030-T01-IM3	P-0003030	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Variants in ARID2 and BRCA2 genes indicates the presence of sub-clones	567	50
P-0003031-T01-IM5	P-0003031	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: The KDM6A exon21 mutations all occur in cis (same allele).	363	90
P-0003032-T01-IM5	P-0003032	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	572	20
P-0003033-T01-IM5	P-0003033	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The CCND1, FGF19, FGF3 and FGF4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	562	30
P-0003033-T02-IM5	P-0003033	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		596	50
P-0003034-T01-IM5	P-0003034	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1021	NA
P-0003035-T01-IM5	P-0003035	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Descending Colon	Colon Adenocarcinoma	IMPACT410			Female		820	40
P-0003036-T01-IM5	P-0003036	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Chest Wall	Synovial Sarcoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover SYT gene.	746	90
P-0003037-T01-IM5	P-0003037	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	644	30
P-0003039-T01-IM5	P-0003039	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		668	60
P-0003040-T01-IM5	P-0003040	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.    Note: The ERBB3 and GLI1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	791	70
P-0003041-T01-IM5	P-0003041	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1096	NA
P-0003042-T01-IM5	P-0003042	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q including MYC.	184	30
P-0003043-T01-IM5	P-0003043	Soft Tissue Sarcoma	Metastasis	Tumor	Small Bowel	Abdomen	Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	712	80
P-0003044-T01-IM3	P-0003044	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	471	80
P-0003045-T01-IM3	P-0003045	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q	478	90
P-0003046-T01-IM3	P-0003046	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT341			Male		526	30
P-0003047-T01-IM3	P-0003047	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT341			Male		874	50
P-0003048-T01-IM3	P-0003048	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT341			Male	Note: A comparison of variant frequencies suggests the PIK3R2 splicing mutation is subclonal.	334	40
P-0003049-T01-IM3	P-0003049	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Trachea	Head and Neck Squamous Cell Carcinoma	IMPACT341			Male	Note: A comparison of variant frequencies suggests the MST1 P76L mutation is subclonal.	398	30
P-0003050-T01-IM3	P-0003050	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT341			Female		510	50
P-0003051-T01-IM3	P-0003051	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT341			Male		458	20
P-0003052-T01-IM3	P-0003052	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male		382	40
P-0003053-T01-IM3	P-0003053	Head and Neck Carcinoma	Metastasis	Tumor	Lymph node	Neck	Head and Neck Squamous Cell Carcinoma	IMPACT341			Female		582	50
P-0003054-T01-IM3	P-0003054	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female	Note: Copy number profile is suggestive of a fragmented genome..	806	70
P-0003055-T01-IM3	P-0003055	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT341			Male		885	50
P-0003056-T01-IM3	P-0003056	Salivary Carcinoma	Metastasis	Tumor	Brain	Sinonasal	Adenoid Cystic Carcinoma	IMPACT341			Female		237	80
P-0003057-T01-IM3	P-0003057	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		652	NA
P-0003058-T01-IM3	P-0003058	Soft Tissue Sarcoma	Primary	Tumor	Retroperitoneum	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT341			Female		283	20
P-0003059-T01-IM3	P-0003059	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341			Female		703	30
P-0003060-T01-IM3	P-0003060	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Synovial Sarcoma	IMPACT341			Male	Note: MSK-IMPACT test panel does not cover SYT gene.	759	80
P-0003061-T01-IM3	P-0003061	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	236	40
P-0003062-T01-IM3	P-0003062	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT341			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	643	90
P-0003063-T01-IM3	P-0003063	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		714	20
P-0003064-T01-IM3	P-0003064	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Adrenal Gland	Neuroblastoma	IMPACT341			Male		801	60
P-0003064-T02-IM5	P-0003064	Embryonal Tumor	Primary	Tumor	Not Applicable	Flank	Neuroblastoma	IMPACT410			Male		1002	90
P-0003065-T01-IM3	P-0003065	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT341			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q	333	30
P-0003066-T01-IM3	P-0003066	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT341			Female		586	60
P-0003067-T01-IM3	P-0003067	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	852	20
P-0003068-T01-IM5	P-0003068	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		653	80
P-0003069-T01-IM5	P-0003069	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Female		355	40
P-0003070-T01-IM5	P-0003070	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		609	30
P-0003071-T01-IM5	P-0003071	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		796	30
P-0003072-T01-IM5	P-0003072	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		733	20
P-0003073-T01-IM5	P-0003073	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		544	60
P-0003075-T01-IM5	P-0003075	Thyroid Cancer	Metastasis	Tumor	Paratracheal	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	439	40
P-0003077-T01-IM5	P-0003077	Colorectal Cancer	Metastasis	Tumor	Brain	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	881	60
P-0003078-T01-IM5	P-0003078	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		670	40
P-0003079-T01-IM5	P-0003079	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		722	60
P-0003080-T01-IM5	P-0003080	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		691	40
P-0003096-T01-IM5	P-0003096	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		875	20
P-0003097-T01-IM5	P-0003097	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: The NEGR1 and MALT1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p21 including BAP1.	440	90
P-0003098-T01-IM5	P-0003098	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT410			Female		348	NA
P-0003099-T01-IM5	P-0003099	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Male		646	90
P-0003100-T01-IM5	P-0003100	Germ Cell Tumor	Metastasis	Tumor	Mediastinum	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	589	30
P-0003101-T01-IM5	P-0003101	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		461	NA
P-0003102-T01-IM5	P-0003102	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		135	NA
P-0003103-T01-IM5	P-0003103	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male	Note: The WT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	509	70
P-0003104-T01-IM5	P-0003104	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure induced damage.	627	NA
P-0003105-T01-IM5	P-0003105	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male		717	30
P-0003106-T01-IM5	P-0003106	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Larynx	Larynx Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	805	NA
P-0003107-T01-IM5	P-0003107	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR exon18 mutations all occur in cis (same allele).	904	50
P-0003108-T01-IM5	P-0003108	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		701	90
P-0003109-T01-IM5	P-0003109	Uterine Sarcoma	Metastasis	Tumor	Scalp	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		294	NA
P-0003110-T01-IM5	P-0003110	Colorectal Cancer	Metastasis	Tumor	Lung	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The ASXL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	636	40
P-0003111-T01-IM5	P-0003111	Salivary Carcinoma	Metastasis	Tumor	Lung	Perineal	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover NFIB nor MYB genes    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 12q and 17p.	414	90
P-0003112-T01-IM5	P-0003112	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	747	10
P-0003113-T01-IM5	P-0003113	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Endometrial Stromal Sarcoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 66X, negative results should be interpreted with caution.	65	NA
P-0003114-T01-IM5	P-0003114	Mastocytosis	Metastasis	Tumor	Not Applicable	Unknown	Systemic Mastocytosis	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	599	NA
P-0003116-T01-IM5	P-0003116	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		784	30
P-0003116-T02-IM5	P-0003116	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	771	NA
P-0003117-T01-IM5	P-0003117	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		611	70
P-0003118-T01-IM5	P-0003118	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		375	60
P-0003119-T01-IM5	P-0003119	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	951	30
P-0003120-T01-IM5	P-0003120	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female		265	70
P-0003122-T01-IM5	P-0003122	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Pancreatobiliary Ampullary Carcinoma	IMPACT410			Female	Pancreatic adenocarcinoma	581	50
P-0003123-T01-IM5	P-0003123	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Heart	Intimal Sarcoma	IMPACT410			Female		590	NA
P-0003124-T01-IM5	P-0003124	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Colon Adenocarcinoma	IMPACT410			Male		616	30
P-0003125-T01-IM5	P-0003125	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		348	60
P-0003126-T01-IM5	P-0003126	Ependymomal Tumor	Primary	Tumor	Not Applicable	Spinal cord	Ependymoma	IMPACT410			Male		518	70
P-0003127-T01-IM5	P-0003127	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	474	NA
P-0003128-T01-IM5	P-0003128	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		673	90
P-0003129-T01-IM5	P-0003129	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	601	40
P-0003130-T01-IM5	P-0003130	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		576	20
P-0003131-T01-IM5	P-0003131	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		618	NA
P-0003132-T01-IM5	P-0003132	Non-Small Cell Lung Cancer	Metastasis	Tumor	Epidural	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: The MGA exon3 mutations all occur in cis (same allele).	620	30
P-0003133-T01-IM5	P-0003133	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		744	50
P-0003134-T01-IM5	P-0003134	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Variants in POLE and SUZ12 genes indicate the presence of sub-clones	716	60
P-0003135-T01-IM5	P-0003135	Appendiceal Cancer	Metastasis	Tumor	Omentum	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Male	repeat sample	517	10
P-0003135-T03-IM5	P-0003135	Appendiceal Cancer	Metastasis	Tumor	Omentum	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	506	10
P-0003136-T01-IM5	P-0003136	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Cecum	Colon Adenocarcinoma	IMPACT410			Male		85	20
P-0003137-T01-IM5	P-0003137	Cancer of Unknown Primary	Metastasis	Tumor	Omentum	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	629	10
P-0003139-T01-IM5	P-0003139	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		655	60
P-0003139-T02-IM5	P-0003139	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		918	70
P-0003140-T01-IM5	P-0003140	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p.	662	70
P-0003141-T01-IM5	P-0003141	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		334	50
P-0003142-T01-IM5	P-0003142	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		684	80
P-0003144-T01-IM5	P-0003144	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Upper Extremity	Dedifferentiated Liposarcoma	IMPACT410			Female		684	90
P-0003145-T01-IM5	P-0003145	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	598	10
P-0003146-T01-IM5	P-0003146	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female	Note: The TSC1 exon 7 mutations all occur in cis on the same allele.	614	20
P-0003147-T01-IM5	P-0003147	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		689	70
P-0003149-T01-IM5	P-0003149	Embryonal Tumor	Metastasis	Tumor	Para-tracheal	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	1020	90
P-0003150-T01-IM5	P-0003150	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		221	60
P-0003150-T02-IM5	P-0003150	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		299	60
P-0003152-T01-IM5	P-0003152	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	537	20
P-0003153-T01-IM5	P-0003153	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: The MALT1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	492	80
P-0003154-T01-IM5	P-0003154	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	617	10
P-0003155-T01-IM5	P-0003155	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male		436	20
P-0003156-T01-IM5	P-0003156	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The RICTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	529	60
P-0003157-T01-IM5	P-0003157	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The SETD2 exon21 mutations all occur in cis (same allele).	765	30
P-0003158-T01-IM5	P-0003158	Mesothelioma	Primary	Tumor	Not Applicable	Peri-colic gutter	Peritoneal Mesothelioma	IMPACT410			Female		487	20
P-0003159-T01-IM5	P-0003159	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		639	50
P-0003160-T01-IM5	P-0003160	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		583	60
P-0003161-T01-IM5	P-0003161	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Eyelid	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	683	20
P-0003162-T01-IM5	P-0003162	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 14q and 15q.	642	90
P-0003164-T01-IM5	P-0003164	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Male	Note: The  PDGFRA , KIT and KDR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	624	70
P-0003165-T01-IM5	P-0003165	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of copy number loss on Chromosome arm 9p21-24.	745	60
P-0003166-T02-IM5	P-0003166	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		974	40
P-0003167-T01-IM5	P-0003167	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	695	40
P-0003168-T01-IM5	P-0003168	Histiocytosis	Primary	Tumor	Not Applicable	Epidural	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	190	10
P-0003169-T01-IM5	P-0003169	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		525	10
P-0003170-T01-IM5	P-0003170	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  7  Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 6 and 10	900	90
P-0003171-T01-IM5	P-0003171	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male		587	70
P-0003172-T01-IM5	P-0003172	Breast Carcinoma	Metastasis	Tumor	Pelvis	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	697	80
P-0003174-T01-IM5	P-0003174	Germ Cell Tumor	Primary	Tumor	Not Applicable	Ovary	Mature Teratoma	IMPACT410			Female		586	40
P-0003175-T01-IM5	P-0003175	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Female		449	40
P-0003176-T01-IM5	P-0003176	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		531	80
P-0003177-T01-IM5	P-0003177	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		520	50
P-0003178-T01-IM5	P-0003178	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: A comparison of variant frequencies suggests the PTEN R130* and PIK3CA H1047R  mutations are subclonal.	854	60
P-0003179-T01-IM5	P-0003179	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		546	40
P-0003179-T02-IM5	P-0003179	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PTPRT and NCOA3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	814	60
P-0003180-T01-IM5	P-0003180	Soft Tissue Sarcoma	Metastasis	Tumor	Sigmoid Colon	Retroperitoneum	Leiomyosarcoma	IMPACT410			Male		719	70
P-0003181-T01-IM5	P-0003181	Prostate Cancer	Metastasis	Tumor	Chest Wall	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male		855	70
P-0003181-T02-IM5	P-0003181	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male		301	60
P-0003182-T01-IM5	P-0003182	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Parotid	Shoulder	Basal Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	390	30
P-0003183-T01-IM5	P-0003183	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the BRAF D594V, NF1 N1563* and TP53 R196* mutations are subclonal.    Note: The PTEN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	720	40
P-0003184-T01-IM5	P-0003184	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The CXCR4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	225	20
P-0003185-T01-IM5	P-0003185	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		728	80
P-0003186-T01-IM5	P-0003186	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Adenocarcinoma	IMPACT410			Female		675	20
P-0003187-T01-IM5	P-0003187	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	734	10
P-0003187-T02-IM5	P-0003187	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		663	20
P-0003188-T01-IM5	P-0003188	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: The RAF1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	829	40
P-0003190-T01-IM5	P-0003190	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		661	20
P-0003191-T01-IM5	P-0003191	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		313	30
P-0003192-T01-IM5	P-0003192	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		764	40
P-0003193-T01-IM5	P-0003193	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Carcinoid	IMPACT410			Female		499	70
P-0003194-T01-IM5	P-0003194	Ovarian Cancer	Metastasis	Tumor	Lymph node	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		587	30
P-0003195-T01-IM5	P-0003195	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		406	60
P-0003196-T01-IM5	P-0003196	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		730	30
P-0003197-T01-IM5	P-0003197	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male		598	70
P-0003198-T02-IM5	P-0003198	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Due to marginal sample quality, all negative results should be interpreted with caution.	251	30
P-0003199-T01-IM5	P-0003199	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		533	40
P-0003200-T01-IM5	P-0003200	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	671	30
P-0003201-T01-IM5	P-0003201	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		375	20
P-0003202-T01-IM5	P-0003202	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	763	20
P-0003203-T01-IM5	P-0003203	Salivary Carcinoma	Metastasis	Tumor	Bone	Major Salivary Gland	Myoepithelial Carcinoma	IMPACT410			Male		752	80
P-0003204-T01-IM5	P-0003204	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		218	60
P-0003205-T01-IM5	P-0003205	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		751	40
P-0003205-T02-IM5	P-0003205	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		541	40
P-0003206-T01-IM5	P-0003206	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		614	60
P-0003207-T01-IM5	P-0003207	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		266	60
P-0003209-T01-IM5	P-0003209	Colorectal Cancer	Metastasis	Tumor	Liver	Splenic Flexure	Colon Adenocarcinoma	IMPACT410			Male	Note: The TP53 exon5 mutations occur in trans on different alleles	715	70
P-0003210-T01-IM5	P-0003210	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female		719	20
P-0003211-T01-IM5	P-0003211	Colorectal Cancer	Metastasis	Tumor	Ovary	Cecum	Colon Adenocarcinoma	IMPACT410			Female		817	80
P-0003212-T01-IM5	P-0003212	Hepatocellular Carcinoma	Metastasis	Tumor	Adrenal Gland	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome 6 and 7 and Chromosome arm 1q and 8q  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 8p and 17p	556	70
P-0003213-T01-IM5	P-0003213	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		451	80
P-0003214-T01-IM5	P-0003214	Biliary Cancer	Metastasis	Tumor	Lymph Node	Bile Duct	Cholangiocarcinoma	IMPACT410			Male		292	50
P-0003216-T01-IM5	P-0003216	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		673	80
P-0003217-T01-IM5	P-0003217	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Leiomyosarcoma	IMPACT410			Female		671	70
P-0003218-T01-IM5	P-0003218	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	200	30
P-0003219-T01-IM5	P-0003219	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	553	40
P-0003220-T01-IM5	P-0003220	Bladder Cancer	Metastasis	Tumor	Lung	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female		261	40
P-0003221-T01-IM5	P-0003221	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		476	70
P-0003222-T01-IM5	P-0003222	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The NOTCH3 and BRD4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	765	40
P-0003223-T01-IM5	P-0003223	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		310	30
P-0003223-T02-IM5	P-0003223	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: The IL10, IKBKE, and MDM4  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	479	80
P-0003224-T01-IM5	P-0003224	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1, FGF3, FGF4 and FGF19 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	528	30
P-0003225-T01-IM5	P-0003225	Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Melanoma	IMPACT410			Female		639	90
P-0003226-T01-IM5	P-0003226	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		459	20
P-0003227-T01-IM5	P-0003227	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	169	30
P-0003228-T01-IM5	P-0003228	Soft Tissue Sarcoma	Metastasis	Tumor	Transverse Colon	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arm 13q	434	40
P-0003229-T01-IM5	P-0003229	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Male		550	60
P-0003230-T01-IM5	P-0003230	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	230	30
P-0003231-T01-IM5	P-0003231	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	506	20
P-0003232-T01-IM5	P-0003232	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Spindle Cell Rhabdomyosarcoma	IMPACT410			Female		581	60
P-0003233-T01-IM5	P-0003233	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 74X, negative results should be interpreted with caution.	74	60
P-0003234-T01-IM5	P-0003234	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: There are several structural rearrangement events involving DOT1L gene that may impact gene function.	719	40
P-0003235-T01-IM5	P-0003235	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Scalp	Merkel Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.  Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1p, 5p and 19p  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 10q, 11p and 17p	516	80
P-0003236-T01-IM5	P-0003236	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	804	30
P-0003237-T01-IM5	P-0003237	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	203	20
P-0003238-T01-IM5	P-0003238	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9 and Chromosome arm 14q	600	50
P-0003239-T01-IM5	P-0003239	Salivary Carcinoma	Primary	Tumor	Not Applicable	Lacrimal	Salivary Duct Carcinoma	IMPACT410			Male		184	40
P-0003240-T01-IM5	P-0003240	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		739	60
P-0003241-T01-IM5	P-0003241	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	384	70
P-0003243-T01-IM5	P-0003243	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 68X, negative results should be interpreted with caution.    Note: EGFR T790M mutation is detected with manual review of the data, however due to low coverage of the sample it is below reporting threshold.   Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	68	40
P-0003244-T01-IM5	P-0003244	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: The CDKN2B and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	833	40
P-0003245-T01-IM5	P-0003245	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	279	30
P-0003246-T01-IM5	P-0003246	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	333	80
P-0003247-T01-IM5	P-0003247	Non-Small Cell Lung Cancer	Metastasis	Tumor	RUQ	Lung	Lung Adenocarcinoma	IMPACT410			Female		597	20
P-0003248-T01-IM5	P-0003248	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	512	10
P-0003249-T01-IM5	P-0003249	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Heart	Intimal Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  segment 12q13-15	760	90
P-0003250-T01-IM5	P-0003250	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		572	50
P-0003253-T01-IM5	P-0003253	Small Bowel Cancer	Metastasis	Tumor	Peritoneum	Ileum	Small Bowel Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	209	10
P-0003255-T01-IM5	P-0003255	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		531	40
P-0003256-T01-IM5	P-0003256	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome  arms 1q and 17q	564	50
P-0003257-T01-IM5	P-0003257	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: The BLM exon3 mutations all occur in cis (same allele).  Note: The MLL2 exon22 mutations all occur in cis (same allele).	918	30
P-0003258-T01-IM5	P-0003258	Colorectal Cancer	Metastasis	Tumor	Ovary	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		530	20
P-0003259-T01-IM5	P-0003259	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		565	50
P-0003260-T01-IM5	P-0003260	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female		234	40
P-0003260-T02-IM5	P-0003260	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Colon	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18	480	40
P-0003261-T01-IM5	P-0003261	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The SETD2 exon3 and MLL3 exon 31 mutations all occur in cis (same allele).	625	40
P-0003263-T01-IM5	P-0003263	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		174	80
P-0003264-T01-IM5	P-0003264	Embryonal Tumor	Metastasis	Tumor	Pelvis	Retroperitoneum	Neuroblastoma	IMPACT410			Female		789	40
P-0003265-T01-IM5	P-0003265	Breast Carcinoma	Metastasis	Tumor	Subcutaneous Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		833	60
P-0003266-T01-IM5	P-0003266	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	1p and 19q note	562	30
P-0003267-T01-IM5	P-0003267	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	High-Grade Endometrial Stromal Sarcoma	IMPACT410			Female	Add back TSC2 intragenic.	518	80
P-0003268-T01-IM5	P-0003268	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		227	50
P-0003269-T01-IM5	P-0003269	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	1p and 19q note	571	30
P-0003270-T02-IM5	P-0003270	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	387	10
P-0003271-T01-IM5	P-0003271	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male		103	30
P-0003272-T01-IM5	P-0003272	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Neck	Odontogenic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12.	724	70
P-0003273-T01-IM5	P-0003273	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		304	60
P-0003273-T03-IM5	P-0003273	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	The ERBB2 p.V777L mutation frequency suggests that the mutation is on the amplified allele.      Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p36.32-1p22.3, 6q, 7q, 11q13.1,11q14.2-11q24.2, and 17p.	84	70
P-0003275-T01-IM5	P-0003275	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		689	20
P-0003276-T01-IM5	P-0003276	Non-Small Cell Lung Cancer	Metastasis	Tumor	Iliac	Lung	Lung Adenocarcinoma	IMPACT410			Female		700	50
P-0003277-T01-IM5	P-0003277	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Nose	Basal Cell Carcinoma	IMPACT410			Male		320	30
P-0003278-T01-IM5	P-0003278	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The NKX2-1 and FOXOA1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	589	50
P-0003279-T01-IM5	P-0003279	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		652	60
P-0003280-T01-IM5	P-0003280	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Female		523	40
P-0003281-T01-IM5	P-0003281	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		736	60
P-0003282-T01-IM5	P-0003282	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		566	60
P-0003283-T01-IM5	P-0003283	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		102	30
P-0003285-T01-IM5	P-0003285	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		703	30
P-0003286-T01-IM5	P-0003286	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		744	30
P-0003287-T01-IM5	P-0003287	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms  2q and 3q  Note: Copy number profile is suggestive of broad copy number losses on Chromosome 15 and  Chromosome arms 1p, 14q, 18q and 22q	846	NA
P-0003290-T01-IM5	P-0003290	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female		439	NA
P-0003291-T01-IM5	P-0003291	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Breast	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female		362	50
P-0003292-T01-IM5	P-0003292	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		409	30
P-0003293-T01-IM5	P-0003293	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Female		674	50
P-0003294-T01-IM5	P-0003294	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	286	30
P-0003295-T01-IM5	P-0003295	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Mediastinum	Well-Differentiated Liposarcoma	IMPACT410			Male		540	20
P-0003296-T01-IM5	P-0003296	Soft Tissue Sarcoma	Metastasis	Tumor	Bile Duct	Liver	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Male		779	70
P-0003297-T01-IM5	P-0003297	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		702	40
P-0003298-T01-IM5	P-0003298	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		689	40
P-0003299-T01-IM5	P-0003299	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	554	40
P-0003300-T01-IM5	P-0003300	Histiocytosis	Primary	Tumor	Not Applicable	Skull Base	Langerhans Cell Histiocytosis	IMPACT410			Female		796	20
P-0003301-T01-IM5	P-0003301	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		738	10
P-0003302-T01-IM5	P-0003302	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	238	20
P-0003303-T01-IM5	P-0003303	Non-Small Cell Lung Cancer	Metastasis	Tumor	Paratracheal	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	543	40
P-0003306-T01-IM5	P-0003306	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		425	30
P-0003307-T01-IM5	P-0003307	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	663	60
P-0003308-T01-IM5	P-0003308	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female		472	60
P-0003310-T01-IM5	P-0003310	Histiocytosis	Primary	Tumor	Not Applicable	Pericarnium	Langerhans Cell Histiocytosis	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	525	10
P-0003310-T02-IM5	P-0003310	Histiocytosis	Primary	Tumor	Not Applicable	Bone	Langerhans Cell Histiocytosis	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	647	10
P-0003313-T01-IM5	P-0003313	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	655	20
P-0003314-T01-IM5	P-0003314	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		573	30
P-0003315-T01-IM5	P-0003315	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Yolk Sac Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	736	30
P-0003316-T01-IM5	P-0003316	Non-Small Cell Lung Cancer	Metastasis	Tumor	Forehead	Lung	Lung Adenocarcinoma	IMPACT410			Female		402	40
P-0003317-T01-IM5	P-0003317	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	713	10
P-0003317-T02-IM5	P-0003317	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		632	30
P-0003319-T01-IM5	P-0003319	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		450	50
P-0003320-T01-IM5	P-0003320	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Hypopharynx	Hypopharynx Squamous Cell Carcinoma	IMPACT410			Male		613	30
P-0003325-T01-IM5	P-0003325	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Scalp	Merkel Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p, 4q, 5q, 9p and 17.	575	70
P-0003326-T01-IM5	P-0003326	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	416	10
P-0003327-T01-IM5	P-0003327	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Male		642	60
P-0003328-T01-IM5	P-0003328	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Synovial Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p, 3, 10 and 14.  Note: MSK-IMPACT test panel does not cover the SYT gene.	655	70
P-0003329-T01-IM5	P-0003329	Biliary Cancer	Metastasis	Tumor	Omentum	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	593	10
P-0003330-T01-IM5	P-0003330	Thyroid Cancer	Metastasis	Tumor	Lymph Node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		571	50
P-0003331-T01-IM5	P-0003331	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		410	20
P-0003332-T01-IM5	P-0003332	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		451	90
P-0003333-T01-IM5	P-0003333	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12p and loss on 3p.	260	80
P-0003335-T01-IM5	P-0003335	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female	tumor type??	173	90
P-0003338-T01-IM5	P-0003338	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Sinonasal	Olfactory Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	342	70
P-0003339-T01-IM5	P-0003339	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Variants in CIC gene indicates the presence of sub-clones    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 19q .	282	70
P-0003340-T01-IM5	P-0003340	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 2p. 3p, 7p , 12p and Chromosome X.	196	60
P-0003342-T01-IM5	P-0003342	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		415	NA
P-0003343-T01-IM5	P-0003343	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	79	60
P-0003345-T01-IM5	P-0003345	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		641	40
P-0003346-T01-IM5	P-0003346	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	371	70
P-0003347-T01-IM5	P-0003347	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		684	50
P-0003348-T01-IM5	P-0003348	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female		314	30
P-0003349-T01-IM5	P-0003349	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	223	40
P-0003350-T01-IM5	P-0003350	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		716	60
P-0003351-T01-IM5	P-0003351	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	751	10
P-0003352-T01-IM5	P-0003352	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		698	60
P-0003353-T01-IM5	P-0003353	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The FOXA1 exon2 mutations occur in trans (different alleles).	255	40
P-0003354-T01-IM5	P-0003354	Bladder Cancer	Metastasis	Tumor	Retroperitoneum	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		485	40
P-0003355-T01-IM5	P-0003355	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 22q.	617	50
P-0003356-T01-IM5	P-0003356	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	598	20
P-0003357-T01-IM5	P-0003357	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	99	30
P-0003358-T01-IM5	P-0003358	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 9p, 14q , 16q and 22q.    Note: The CDKN2Ap16INK4A exon2 and CDKN2Ap14ARF exon2 mutations all occur in cis (same allele).	795	90
P-0003359-T01-IM5	P-0003359	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	506	70
P-0003360-T01-IM5	P-0003360	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 22q.	793	80
P-0003361-T01-IM5	P-0003361	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT410			Female		553	20
P-0003362-T01-IM5	P-0003362	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9p.	593	90
P-0003363-T01-IM5	P-0003363	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Female		328	30
P-0003364-T01-IM5	P-0003364	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female		650	20
P-0003365-T01-IM5	P-0003365	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		576	30
P-0003366-T01-IM5	P-0003366	Renal Cell Carcinoma	Metastasis	Tumor	Soft Tissue	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		576	60
P-0003367-T01-IM5	P-0003367	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		570	60
P-0003368-T01-IM5	P-0003368	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		743	20
P-0003370-T01-IM5	P-0003370	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	677	10
P-0003372-T01-IM5	P-0003372	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		497	50
P-0003373-T01-IM5	P-0003373	Bladder Cancer	Metastasis	Tumor	Urethra	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		491	40
P-0003374-T01-IM5	P-0003374	Head and Neck Carcinoma	Metastasis	Tumor	Lymph node	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT410			Male		884	30
P-0003375-T01-IM5	P-0003375	Breast Carcinoma	Metastasis	Tumor	Epidural	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		617	20
P-0003376-T02-IM5	P-0003376	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		123	40
P-0003377-T01-IM5	P-0003377	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The GRIN2A, ERCC4 and SOCS1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	671	30
P-0003381-T01-IM5	P-0003381	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		387	40
P-0003382-T01-IM5	P-0003382	Thyroid Cancer	Metastasis	Tumor	Chest	Thyroid	Medullary Thyroid Cancer	IMPACT410			Female		778	60
P-0003383-T01-IM5	P-0003383	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		823	30
P-0003385-T02-IM5	P-0003385	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Blood Vessel	Head and Neck Neuroendocrine Carcinoma	IMPACT410			Female		147	30
P-0003388-T01-IM5	P-0003388	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		627	40
P-0003389-T01-IM5	P-0003389	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 52X, negative results should be interpreted with caution.  Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	52	60
P-0003390-T01-IM5	P-0003390	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		201	60
P-0003391-T01-IM5	P-0003391	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		105	30
P-0003392-T01-IM5	P-0003392	Glioma	Primary	Tumor	Not Applicable	Brain	Oligoastrocytoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 83X, negative results should be interpreted with caution.	83	80
P-0003393-T01-IM5	P-0003393	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		494	30
P-0003394-T01-IM5	P-0003394	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20%). Negative results should be interpreted with caution.	563	20
P-0003395-T01-IM5	P-0003395	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		441	30
P-0003396-T01-IM5	P-0003396	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9q21.2-31.2	538	60
P-0003397-T01-IM5	P-0003397	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	530	10
P-0003398-T01-IM5	P-0003398	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT410			Male	Note: The EED copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	409	40
P-0003401-T01-IM5	P-0003401	Melanoma	Metastasis	Tumor	Lung	Rectum	Anorectal Mucosal Melanoma	IMPACT410			Female		644	30
P-0003402-T01-IM5	P-0003402	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The GATA2 exon6 mutations all occur in cis (same allele).	288	30
P-0003403-T01-IM5	P-0003403	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		759	60
P-0003404-T01-IM5	P-0003404	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	498	10
P-0003405-T01-IM5	P-0003405	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male		461	60
P-0003406-T01-IM5	P-0003406	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		412	60
P-0003407-T01-IM5	P-0003407	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20%). Negative results should be interpreted with caution.    Note: The NCOR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	558	20
P-0003408-T01-IM5	P-0003408	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9	314	70
P-0003409-T01-IM5	P-0003409	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	402	10
P-0003410-T01-IM5	P-0003410	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	568	40
P-0003410-T02-IM5	P-0003410	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	562	60
P-0003411-T01-IM5	P-0003411	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Female		422	60
P-0003412-T01-IM5	P-0003412	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	359	20
P-0003413-T01-IM5	P-0003413	Salivary Carcinoma	Primary	Tumor	Not Applicable	Pelvis	Myoepithelial Carcinoma	IMPACT410			Male	Note: The SMARCB1 exon4 mutations all occur in cis (same allele).	458	80
P-0003414-T01-IM5	P-0003414	Mesothelioma	Primary	Tumor	Not Applicable	Lung	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	437	30
P-0003415-T01-IM5	P-0003415	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Heart	Intimal Sarcoma	IMPACT410			Female	Note: The KDM6A copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The CDKN1B copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	345	30
P-0003416-T02-IM5	P-0003416	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Duodenum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 14q, 15q and 22q.	864	30
P-0003417-T01-IM5	P-0003417	Renal Cell Carcinoma	Metastasis	Tumor	Soft Tissue	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		546	30
P-0003419-T02-IM5	P-0003419	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	763	NA
P-0003421-T01-IM5	P-0003421	Glioma	Primary	Tumor	Not Applicable	Brain	Ganglioglioma	IMPACT410			Female		532	60
P-0003422-T01-IM5	P-0003422	Non-Small Cell Lung Cancer	Metastasis	Tumor	Colon	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	301	20
P-0003423-T01-IM5	P-0003423	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Gain in 17q amplicon does not include ERBB2	423	60
P-0003424-T01-IM5	P-0003424	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		580	60
P-0003426-T01-IM5	P-0003426	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	199	10
P-0003428-T01-IM5	P-0003428	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the TERT P308fs mutation is subclonal.	407	60
P-0003429-T01-IM5	P-0003429	Bladder Cancer	Metastasis	Tumor	Liver	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		387	20
P-0003430-T01-IM5	P-0003430	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.	717	50
P-0003431-T01-IM5	P-0003431	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The RAD51B, TSHR and DICER1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	737	30
P-0003432-T01-IM5	P-0003432	Esophagogastric Carcinoma	Metastasis	Tumor	manubrium	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	146	70
P-0003433-T01-IM5	P-0003433	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The ABL1 exon11 mutations all occur in cis (same allele).	636	60
P-0003434-T01-IM5	P-0003434	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The BAP1 p.M1I mutation disrupts translation start. It is uncertain if this mutation is inactivating.	174	30
P-0003435-T01-IM5	P-0003435	Soft Tissue Sarcoma	Metastasis	Tumor	Spleen	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: The DICER1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	640	80
P-0003436-T01-IM5	P-0003436	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 9p.	300	30
P-0003437-T01-IM5	P-0003437	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		861	20
P-0003438-T01-IM5	P-0003438	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		692	70
P-0003439-T01-IM5	P-0003439	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		254	30
P-0003440-T01-IM5	P-0003440	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover SYT gene.	736	70
P-0003441-T01-IM5	P-0003441	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	197	NA
P-0003442-T02-IM5	P-0003442	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	578	80
P-0003443-T01-IM5	P-0003443	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	530	10
P-0003444-T01-IM5	P-0003444	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The 12p copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	831	60
P-0003445-T01-IM5	P-0003445	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		509	60
P-0003446-T01-IM5	P-0003446	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		608	30
P-0003447-T01-IM5	P-0003447	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 179X, negative results should be interpreted with caution.	179	30
P-0003448-T01-IM5	P-0003448	Mesothelioma	Primary	Tumor	Not Applicable	Lung	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	383	30
P-0003449-T01-IM5	P-0003449	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 166X, negative results should be interpreted with caution.	166	80
P-0003450-T01-IM5	P-0003450	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	715	70
P-0003451-T01-IM5	P-0003451	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	689	70
P-0003453-T01-IM5	P-0003453	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		898	60
P-0003455-T02-IM5	P-0003455	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	384	10
P-0003456-T01-IM5	P-0003456	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10p.	537	80
P-0003457-T01-IM5	P-0003457	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p including SDHB	479	80
P-0003458-T02-IM5	P-0003458	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		536	80
P-0003459-T01-IM5	P-0003459	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	521	10
P-0003460-T01-IM5	P-0003460	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		268	NA
P-0003461-T02-IM5	P-0003461	Biliary Cancer	Metastasis	Tumor	Pelvis	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 16p	354	40
P-0003462-T01-IM5	P-0003462	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	450	40
P-0003463-T02-IM5	P-0003463	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: The chromosome arm 11q and chromosome 18  copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	388	80
P-0003464-T02-IM5	P-0003464	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	429	50
P-0003465-T01-IM5	P-0003465	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	223	20
P-0003466-T01-IM5	P-0003466	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: The RASA1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	811	20
P-0003467-T01-IM5	P-0003467	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		232	80
P-0003468-T01-IM5	P-0003468	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The TP63 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	596	10
P-0003468-T02-IM5	P-0003468	Prostate Cancer	Primary	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The PTEN, TP63, FOXP1 and RYBP copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	382	60
P-0003469-T01-IM5	P-0003469	Salivary Carcinoma	Metastasis	Tumor	Liver	Nasopharynx	Salivary Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 18.      Note: Copy number profile is suggestive of broad copy number loss on Chromosomes 6, 10, 11, X and chromosome arms 13q and 22q.	524	40
P-0003470-T01-IM5	P-0003470	Sellar Tumor	Primary	Tumor	Not Applicable	Bladder	Granular Cell Tumor	IMPACT410			Female		512	40
P-0003471-T01-IM5	P-0003471	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The SDHA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	721	80
P-0003472-T01-IM5	P-0003472	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female		826	40
P-0003473-T01-IM5	P-0003473	Biliary Cancer	Metastasis	Tumor	Omentum	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	505	10
P-0003474-T01-IM5	P-0003474	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		684	30
P-0003475-T01-IM5	P-0003475	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		462	60
P-0003476-T01-IM5	P-0003476	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.      Note: The IDH2, BLM and IGF1R copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	680	90
P-0003477-T01-IM5	P-0003477	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophageal Adenocarcinoma	IMPACT410			Male		649	30
P-0003478-T01-IM5	P-0003478	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		507	20
P-0003479-T01-IM5	P-0003479	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR, INHBA, ETV1,PMS2 and RAC1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	695	30
P-0003480-T01-IM5	P-0003480	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		508	30
P-0003481-T01-IM5	P-0003481	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	269	NA
P-0003482-T01-IM5	P-0003482	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		361	70
P-0003483-T01-IM5	P-0003483	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	571	10
P-0003484-T01-IM5	P-0003484	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Rhabdomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	561	60
P-0003485-T01-IM5	P-0003485	Cervical Cancer	Metastasis	Tumor	Neck	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female	The HISTs  CNV were decided to be dropped during the sign out.	286	80
P-0003486-T01-IM5	P-0003486	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female	deceased patient	574	60
P-0003487-T01-IM5	P-0003487	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		839	30
P-0003488-T01-IM5	P-0003488	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	222	90
P-0003489-T01-IM5	P-0003489	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		697	20
P-0003490-T01-IM5	P-0003490	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 15q,  17q and 22q.	511	50
P-0003491-T01-IM5	P-0003491	Appendiceal Cancer	Metastasis	Tumor	Liver	Appendix	Malignant Carcinoid of the Appendix	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18.   Note: The YES1 PIK3C3 SMAD2 SMAD4 MALT1 PMAIP1 BCL2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	418	90
P-0003492-T01-IM5	P-0003492	Embryonal Tumor	Primary	Tumor	Not Applicable	Maxilla	Olfactory Neuroblastoma	IMPACT410			Male		707	70
P-0003493-T01-IM5	P-0003493	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18 and chromosome arms 16q and 17p.	521	80
P-0003494-T01-IM5	P-0003494	Chondrosarcoma	Metastasis	Tumor	Lung	Bone	Mesenchymal Chondrosarcoma	IMPACT410			Male		865	50
P-0003496-T01-IM5	P-0003496	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Lower Extremity	Leiomyosarcoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	205	40
P-0003498-T01-IM5	P-0003498	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: The ATRX exon22 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of a fragmented genome..	772	50
P-0003500-T01-IM5	P-0003500	Salivary Carcinoma	Metastasis	Tumor	Lymph node	Parotid	Salivary Duct Carcinoma	IMPACT410			Male		1001	60
P-0003501-T01-IM5	P-0003501	Colorectal Cancer	Metastasis	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20 and arm 8q.	737	20
P-0003502-T01-IM5	P-0003502	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		386	70
P-0003503-T01-IM5	P-0003503	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		121	60
P-0003504-T01-IM5	P-0003504	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome Xq25	899	70
P-0003504-T02-IM5	P-0003504	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	463	10
P-0003505-T01-IM5	P-0003505	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		555	NA
P-0003506-T01-IM5	P-0003506	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	521	50
P-0003507-T01-IM5	P-0003507	Bladder Cancer	Metastasis	Tumor	Pubic bone	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FAT1 and FBXW7 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	804	40
P-0003508-T01-IM5	P-0003508	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		570	30
P-0003509-T01-IM5	P-0003509	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		541	20
P-0003510-T01-IM5	P-0003510	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		454	30
P-0003511-T01-IM5	P-0003511	Prostate Cancer	Primary	Tumor	Prostate bed	Primary	Prostate Adenocarcinoma	IMPACT410			Male		624	30
P-0003511-T02-IM5	P-0003511	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The AR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	483	10
P-0003511-T03-IM5	P-0003511	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		633	30
P-0003512-T01-IM5	P-0003512	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Female	Note: The IGF1R and BLM copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	409	80
P-0003513-T01-IM5	P-0003513	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colon Adenocarcinoma	IMPACT410			Female	Note: The SOX9 exon3 mutations all occur in cis (same allele).	369	20
P-0003514-T01-IM5	P-0003514	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		732	40
P-0003515-T01-IM5	P-0003515	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Rectum	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Female	Note: The  BCL2L11, PARK2, FANCC, PTCH1, TGFBR1, KLF4, and KDM6A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 21q	640	50
P-0003516-T01-IM5	P-0003516	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	512	10
P-0003517-T01-IM5	P-0003517	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	723	NA
P-0003518-T01-IM5	P-0003518	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q11-13.	485	30
P-0003519-T01-IM5	P-0003519	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	409	10
P-0003520-T01-IM5	P-0003520	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Small Bowel	Cecum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	741	90
P-0003521-T02-IM5	P-0003521	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Male		443	40
P-0003522-T01-IM5	P-0003522	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	781	70
P-0003523-T01-IM5	P-0003523	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		277	60
P-0003523-T02-IM5	P-0003523	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TP53 exon5 mutations occur on different alleles.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	719	30
P-0003524-T01-IM5	P-0003524	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		503	30
P-0003525-T01-IM5	P-0003525	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	476	10
P-0003526-T01-IM5	P-0003526	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Stomach	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male		663	90
P-0003527-T01-IM5	P-0003527	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	487	40
P-0003528-T01-IM5	P-0003528	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ESR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	682	40
P-0003529-T01-IM5	P-0003529	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The MSH6 exon2 mutations all occur in cis (same allele).  Note: The TP53 exon8 mutations occur in trans (different alleles).	592	70
P-0003530-T01-IM5	P-0003530	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	48	NA
P-0003531-T01-IM5	P-0003531	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	736	60
P-0003532-T01-IM5	P-0003532	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome region 12q12 to 12q14.1.	592	60
P-0003533-T01-IM5	P-0003533	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13.	541	10
P-0003533-T03-IM5	P-0003533	Germ Cell Tumor	Metastasis	Tumor	Spleen	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male		798	20
P-0003534-T01-IM5	P-0003534	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		642	60
P-0003535-T01-IM5	P-0003535	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	921	80
P-0003536-T01-IM5	P-0003536	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		914	20
P-0003536-T02-IM5	P-0003536	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 20q12 and 20q13.	841	50
P-0003537-T02-IM5	P-0003537	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		575	40
P-0003538-T01-IM5	P-0003538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	632	60
P-0003538-T02-IM5	P-0003538	Prostate Cancer	Primary	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The AR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	614	10
P-0003539-T01-IM5	P-0003539	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The FGFR4 NSD1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	595	30
P-0003540-T01-IM5	P-0003540	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	409	20
P-0003541-T01-IM5	P-0003541	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		572	30
P-0003543-T01-IM5	P-0003543	Esophagogastric Carcinoma	Metastasis	Tumor	Neck	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Male		433	50
P-0003544-T01-IM5	P-0003544	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		447	40
P-0003545-T01-IM5	P-0003545	Chordoma	Primary	Tumor	Not Applicable	Brain	Chordoma	IMPACT410			Male		464	60
P-0003546-T01-IM5	P-0003546	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of multiple chromosome arm level losses and gains.   Note: Copy number profile is different than clear cell component (M15-2056)	647	20
P-0003546-T02-IM5	P-0003546	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		574	80
P-0003547-T01-IM5	P-0003547	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		558	30
P-0003548-T01-IM5	P-0003548	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Female	Note: The BAP1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	816	70
P-0003550-T01-IM5	P-0003550	Cancer of Unknown Primary	Metastasis	Tumor	Soft Tissue	Not Available	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	451	10
P-0003551-T01-IM5	P-0003551	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TP53 exon5 mutations all occur in cis (same allele).	405	10
P-0003552-T01-IM5	P-0003552	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		508	30
P-0003553-T01-IM5	P-0003553	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The RICTOR, SDHA, and TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	535	30
P-0003554-T01-IM5	P-0003554	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female		419	80
P-0003555-T01-IM5	P-0003555	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		621	60
P-0003556-T01-IM5	P-0003556	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		393	30
P-0003557-T01-IM5	P-0003557	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		419	60
P-0003558-T01-IM5	P-0003558	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The CDKN2B,  CDKN2Ap16INK4A  and CDKN2Ap14ARF  copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	303	10
P-0003559-T01-IM5	P-0003559	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	682	10
P-0003560-T01-IM5	P-0003560	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 17p.    Note: The PTPRT exon18 mutations all occur in cis (same allele).	480	70
P-0003561-T01-IM5	P-0003561	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		315	40
P-0003562-T01-IM5	P-0003562	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		629	90
P-0003563-T01-IM5	P-0003563	Non-Small Cell Lung Cancer	Metastasis	Tumor	Skin	Lung	Lung Carcinoid	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p, 6q, 9p, 11q, 16q and chromosome 20.	667	70
P-0003564-T01-IM5	P-0003564	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male		408	40
P-0003565-T01-IM5	P-0003565	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	718	10
P-0003566-T01-IM5	P-0003566	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	394	20
P-0003567-T01-IM5	P-0003567	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	420	70
P-0003568-T01-IM5	P-0003568	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p, 9 and 14.	386	60
P-0003569-T01-IM5	P-0003569	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		393	40
P-0003570-T01-IM5	P-0003570	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		380	90
P-0003571-T01-IM5	P-0003571	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		211	30
P-0003572-T01-IM5	P-0003572	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		576	30
P-0003573-T01-IM5	P-0003573	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		728	10
P-0003573-T02-IM5	P-0003573	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		456	60
P-0003575-T01-IM5	P-0003575	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	512	60
P-0003576-T01-IM5	P-0003576	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	668	40
P-0003577-T01-IM5	P-0003577	Cancer of Unknown Primary	Metastasis	Tumor	Abdomen	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	468	20
P-0003578-T01-IM5	P-0003578	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Mediastinum	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		750	60
P-0003579-T01-IM5	P-0003579	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		515	90
P-0003580-T01-IM5	P-0003580	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	705	20
P-0003581-T01-IM5	P-0003581	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: TheWT1, PNRC1, EPHA7, PRDM1 and FYN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	588	60
P-0003582-T01-IM5	P-0003582	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		425	30
P-0003583-T01-IM5	P-0003583	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample will be initiated.	399	40
P-0003583-T02-IM5	P-0003583	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		744	20
P-0003584-T01-IM5	P-0003584	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		513	20
P-0003586-T01-IM5	P-0003586	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The NKX2-1 and FOXA1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.     Note: The SMAD4, NPM1, FGFR4, NSD1, and FLT4 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	542	80
P-0003587-T01-IM5	P-0003587	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT410			Female		337	60
P-0003589-T02-IM5	P-0003589	Gestational Trophoblastic Disease	Metastasis	Tumor	Lung	Testis	Choriocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p.	400	70
P-0003590-T01-IM5	P-0003590	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1p.    Note: The RASA1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	448	NA
P-0003591-T01-IM5	P-0003591	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		281	50
P-0003592-T01-IM5	P-0003592	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		404	60
P-0003592-T02-IM5	P-0003592	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		646	50
P-0003593-T01-IM5	P-0003593	Adrenocortical Carcinoma	Metastasis	Tumor	Bone	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male		642	30
P-0003594-T01-IM5	P-0003594	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	538	10
P-0003595-T01-IM5	P-0003595	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		478	70
P-0003596-T01-IM5	P-0003596	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		313	20
P-0003597-T01-IM5	P-0003597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		218	60
P-0003597-T02-IM5	P-0003597	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome X.	514	60
P-0003598-T01-IM5	P-0003598	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female		326	NA
P-0003598-T02-IM5	P-0003598	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 10 and 14q	961	50
P-0003599-T01-IM5	P-0003599	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		603	60
P-0003600-T01-IM5	P-0003600	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		589	NA
P-0003601-T01-IM5	P-0003601	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		272	60
P-0003602-T01-IM5	P-0003602	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		459	40
P-0003602-T02-IM5	P-0003602	Ampullary Carcinoma	Metastasis	Tumor	Liver	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18.	531	30
P-0003603-T01-IM5	P-0003603	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q24 including MYC.	554	50
P-0003604-T01-IM5	P-0003604	Cancer of Unknown Primary	Metastasis	Tumor	Brain	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: The CDKN2A,  CDKN2Ap14ARF and CDKN2Ap16INK4A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	735	30
P-0003605-T01-IM5	P-0003605	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	481	30
P-0003606-T01-IM5	P-0003606	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	280	NA
P-0003607-T01-IM5	P-0003607	Bladder Cancer	Metastasis	Tumor	Lymph node	Urethra	Urethral Squamous Cell Carcinoma	IMPACT410			Male		675	40
P-0003608-T01-IM5	P-0003608	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	236	40
P-0003609-T01-IM5	P-0003609	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Male		285	60
P-0003610-T01-IM5	P-0003610	Head and Neck Carcinoma	Metastasis	Tumor	Skin	Skin	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		490	60
P-0003611-T01-IM5	P-0003611	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		589	30
P-0003612-T01-IM5	P-0003612	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male		469	60
P-0003613-T01-IM5	P-0003613	Small Bowel Cancer	Metastasis	Tumor	Peritoneum	Small Bowel	Small Bowel Cancer	IMPACT410			Male		160	20
P-0003614-T01-IM5	P-0003614	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Low sequencing depth of coverage of 93X, negative results should be interpreted with caution.	93	80
P-0003615-T01-IM5	P-0003615	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT410			Female		397	80
P-0003616-T01-IM5	P-0003616	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		142	60
P-0003617-T01-IM5	P-0003617	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Extrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	430	20
P-0003618-T01-IM5	P-0003618	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Male		389	30
P-0003619-T01-IM5	P-0003619	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		472	80
P-0003620-T01-IM5	P-0003620	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		474	80
P-0003620-T02-IM5	P-0003620	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: The PTEN exon6 mutations all occur in cis (same allele).    Note: The MITF copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The SMAD3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	726	70
P-0003621-T01-IM5	P-0003621	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		479	60
P-0003622-T01-IM5	P-0003622	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		583	60
P-0003623-T01-IM5	P-0003623	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	185	10
P-0003624-T01-IM5	P-0003624	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ERBB2 copy number gain falls below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	615	10
P-0003625-T01-IM5	P-0003625	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The GATA2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	455	70
P-0003626-T01-IM5	P-0003626	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	575	30
P-0003627-T01-IM5	P-0003627	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	516	NA
P-0003628-T01-IM5	P-0003628	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		788	40
P-0003630-T01-IM5	P-0003630	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		179	30
P-0003630-T02-IM5	P-0003630	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		453	40
P-0003631-T01-IM5	P-0003631	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		462	30
P-0003632-T01-IM5	P-0003632	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		561	40
P-0003633-T01-IM5	P-0003633	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	711	50
P-0003634-T01-IM5	P-0003634	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		731	90
P-0003635-T01-IM5	P-0003635	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 20q      Note: Copy number profile is suggestive of a fragmented genome..      Note: The SRC, TOP1, PTPRT, and NCOA3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	667	50
P-0003636-T01-IM5	P-0003636	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Low sequencing depth of coverage of 88X, negative results should be interpreted with caution.	88	70
P-0003637-T01-IM5	P-0003637	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		344	60
P-0003639-T01-IM5	P-0003639	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Scalp	Angiosarcoma	IMPACT410			Male	1q gain, 1p loss 7ploss  and 10qloss  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,7p and 10q and broad copy number gain on 1q .	450	50
P-0003640-T01-IM5	P-0003640	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	490	10
P-0003641-T01-IM5	P-0003641	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		311	30
P-0003642-T01-IM5	P-0003642	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 158X, negative results should be interpreted with caution.	158	30
P-0003643-T01-IM5	P-0003643	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		471	30
P-0003644-T01-IM5	P-0003644	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	701	10
P-0003645-T01-IM5	P-0003645	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 147x, negative results should be interpreted with caution.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	147	60
P-0003646-T01-IM5	P-0003646	Salivary Carcinoma	Primary	Tumor	Not Applicable	Parotid	Salivary Duct Carcinoma	IMPACT410			Female	Note: The AURKA  exon 3 mutations all occur in cis (same allele).	728	40
P-0003647-T01-IM5	P-0003647	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	766	70
P-0003648-T01-IM5	P-0003648	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MDM2 and YES1  copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	729	NA
P-0003649-T01-IM5	P-0003649	Salivary Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MYB or NIFB genes.	329	30
P-0003650-T01-IM5	P-0003650	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		640	20
P-0003651-T01-IM5	P-0003651	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13 and 22.	480	60
P-0003652-T01-IM5	P-0003652	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 118X, negative results should be interpreted with caution.	118	20
P-0003653-T01-IM5	P-0003653	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Due to marginal sample quality, all negative results should be interpreted with caution.  Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	370	10
P-0003654-T01-IM5	P-0003654	Non-Small Cell Lung Cancer	Metastasis	Tumor	Retroperitoneum	Lung	Lung Adenocarcinoma	IMPACT410			Female		652	20
P-0003655-T01-IM5	P-0003655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		591	70
P-0003656-T02-IM5	P-0003656	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		188	30
P-0003658-T01-IM5	P-0003658	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Muscle	Embryonal Rhabdomyosarcoma	IMPACT410			Female		606	60
P-0003658-T02-IM5	P-0003658	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Mediastinum	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The SOCS1 exon2 mutations ( p.H87fs and  p.R92G )all occur in cis (same allele).	623	10
P-0003659-T01-IM5	P-0003659	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover TFE3 gene.	292	60
P-0003660-T01-IM5	P-0003660	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male		649	20
P-0003661-T01-IM5	P-0003661	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		696	40
P-0003662-T01-IM5	P-0003662	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	595	10
P-0003664-T01-IM5	P-0003664	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		863	20
P-0003665-T01-IM5	P-0003665	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	590	80
P-0003666-T01-IM5	P-0003666	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		693	30
P-0003667-T01-IM5	P-0003667	Sellar Tumor	Primary	Tumor	Not Applicable	Brain	Pituicytoma	IMPACT410			Male		563	70
P-0003668-T01-IM5	P-0003668	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bladder	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		703	80
P-0003669-T01-IM5	P-0003669	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female		416	40
P-0003670-T01-IM5	P-0003670	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		662	30
P-0003671-T01-IM5	P-0003671	Renal Cell Carcinoma	Metastasis	Tumor	Soft Tissue	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		385	60
P-0003672-T01-IM5	P-0003672	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Female		473	60
P-0003673-T01-IM5	P-0003673	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		220	60
P-0003674-T01-IM5	P-0003674	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male		617	40
P-0003676-T01-IM5	P-0003676	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		170	70
P-0003677-T01-IM5	P-0003677	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		654	70
P-0003678-T01-IM5	P-0003678	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	621	10
P-0003679-T01-IM5	P-0003679	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Stomach Adenocarcinoma	IMPACT410			Male		615	40
P-0003681-T01-IM5	P-0003681	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		490	50
P-0003682-T01-IM5	P-0003682	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		454	20
P-0003683-T01-IM5	P-0003683	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	528	20
P-0003684-T01-IM5	P-0003684	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	566	20
P-0003686-T01-IM5	P-0003686	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Angiosarcoma	IMPACT410			Male		634	30
P-0003687-T01-IM5	P-0003687	Endometrial Cancer	Metastasis	Tumor	Liver	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		590	70
P-0003688-T01-IM5	P-0003688	Soft Tissue Sarcoma	Primary	Tumor	Muscle	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male	Note: The FLT4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	671	30
P-0003689-T01-IM5	P-0003689	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	103	20
P-0003690-T01-IM5	P-0003690	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		129	60
P-0003691-T01-IM5	P-0003691	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Female		484	60
P-0003692-T01-IM5	P-0003692	Cancer of Unknown Primary	Metastasis	Tumor	Mesentery	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: The ERBB3, GLI and CDK4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	387	60
P-0003693-T01-IM5	P-0003693	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		676	60
P-0003693-T02-IM5	P-0003693	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The previously reported  PTPRD p.Q1718* variant is observed at a low frequency.	851	10
P-0003694-T01-IM5	P-0003694	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		342	70
P-0003695-T01-IM5	P-0003695	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		294	30
P-0003696-T01-IM5	P-0003696	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Female		433	30
P-0003698-T02-IM5	P-0003698	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		473	20
P-0003699-T01-IM5	P-0003699	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Female		521	80
P-0003700-T01-IM5	P-0003700	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The MAP2K1 exon6 mutations all occur in cis (same allele).	834	60
P-0003701-T01-IM5	P-0003701	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		498	50
P-0003702-T02-IM5	P-0003702	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		191	20
P-0003703-T01-IM5	P-0003703	Melanoma	Primary	Tumor	Not Applicable	Vagina	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		326	60
P-0003704-T01-IM5	P-0003704	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male		289	60
P-0003706-T01-IM5	P-0003706	Melanoma	Primary	Tumor	Not Applicable	Vagina	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		240	60
P-0003707-T01-IM5	P-0003707	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male	Adrenal cortical neoplasm	136	70
P-0003708-T01-IM5	P-0003708	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Serous Borderline Ovarian Tumor	IMPACT410			Female		584	80
P-0003709-T01-IM5	P-0003709	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		667	30
P-0003710-T01-IM5	P-0003710	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		481	60
P-0003711-T01-IM5	P-0003711	Head and Neck Carcinoma	Metastasis	Tumor	Neck	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		566	10
P-0003712-T01-IM5	P-0003712	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		621	30
P-0003713-T01-IM5	P-0003713	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		356	30
P-0003714-T01-IM5	P-0003714	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		361	60
P-0003715-T01-IM5	P-0003715	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		443	10
P-0003716-T01-IM5	P-0003716	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		418	70
P-0003717-T01-IM5	P-0003717	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		556	30
P-0003718-T01-IM5	P-0003718	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	319	10
P-0003719-T01-IM5	P-0003719	Bladder Cancer	Metastasis	Tumor	Retroperitoneum	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		594	70
P-0003720-T01-IM5	P-0003720	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		481	20
P-0003721-T01-IM5	P-0003721	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		658	20
P-0003722-T01-IM5	P-0003722	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		673	30
P-0003723-T01-IM5	P-0003723	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		207	30
P-0003724-T01-IM5	P-0003724	Soft Tissue Sarcoma	Metastasis	Tumor	Muscle	Lower Extremity	Synovial Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p   Note: Copy number profile is suggestive of broad copy number gains on Chromosomes 7, 12 and chromosome arm Xp.    Note: MSK-IMPACT test panel does not cover SYT gene.	653	50
P-0003725-T01-IM5	P-0003725	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		483	20
P-0003726-T01-IM5	P-0003726	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	650	70
P-0003727-T01-IM5	P-0003727	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		424	40
P-0003728-T01-IM5	P-0003728	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		477	80
P-0003729-T01-IM5	P-0003729	Mesothelioma	Primary	Tumor	Not Applicable	Testis	Testicular Mesothelioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.    Note: The AURKA and GNAS copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	577	30
P-0003730-T01-IM5	P-0003730	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	716	10
P-0003731-T01-IM5	P-0003731	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Vagina	Embryonal Rhabdomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	843	50
P-0003732-T01-IM5	P-0003732	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		642	30
P-0003733-T01-IM5	P-0003733	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		581	30
P-0003734-T01-IM5	P-0003734	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by low tumor purity.	433	10
P-0003735-T01-IM5	P-0003735	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		429	NA
P-0003736-T01-IM5	P-0003736	Biliary Cancer	Metastasis	Tumor	Peritoneum	Gallbladder	Gallbladder Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	503	10
P-0003737-T01-IM5	P-0003737	Biliary Cancer	Metastasis	Tumor	Lung	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	633	70
P-0003738-T02-IM5	P-0003738	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	859	70
P-0003739-T01-IM5	P-0003739	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Scalp	Angiosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	449	20
P-0003740-T01-IM5	P-0003740	Bladder Cancer	Metastasis	Tumor	Ovary	Bladder	Urachal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18q.    Note: The PIK3C3 and MALT1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	383	60
P-0003741-T01-IM5	P-0003741	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		231	30
P-0003742-T01-IM5	P-0003742	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		520	50
P-0003743-T01-IM5	P-0003743	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		632	NA
P-0003744-T01-IM5	P-0003744	Ovarian Cancer	Metastasis	Tumor	Lymph node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		477	30
P-0003745-T02-IM5	P-0003745	Gestational Trophoblastic Disease	Primary	Tumor	Not Applicable	Testis	Choriocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	691	10
P-0003746-T01-IM5	P-0003746	Soft Tissue Sarcoma	Primary	Tumor	Sigmoid Colon	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Female		360	60
P-0003747-T01-IM5	P-0003747	Hepatocellular Carcinoma	Metastasis	Tumor	Lymph Node	Liver	Fibrolamellar Carcinoma	IMPACT410			Female		470	50
P-0003748-T01-IM5	P-0003748	Ovarian Cancer	Metastasis	Tumor	Uterus	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		307	10
P-0003749-T01-IM5	P-0003749	Melanoma	Primary	Tumor	Not Applicable	Oral Cavity	Head and Neck Mucosal Melanoma	IMPACT410			Male		436	50
P-0003750-T01-IM5	P-0003750	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		695	70
P-0003751-T01-IM5	P-0003751	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		623	30
P-0003752-T02-IM5	P-0003752	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	152	20
P-0003753-T01-IM5	P-0003753	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	588	10
P-0003754-T01-IM5	P-0003754	Uterine Sarcoma	Metastasis	Tumor	Ureter and Pelvic Wall	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		444	70
P-0003755-T01-IM5	P-0003755	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		484	10
P-0003756-T01-IM5	P-0003756	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		385	10
P-0003757-T01-IM5	P-0003757	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		750	30
P-0003758-T01-IM5	P-0003758	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Small Cell Carcinoma	IMPACT410			Male		561	40
P-0003759-T01-IM5	P-0003759	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	557	10
P-0003760-T01-IM5	P-0003760	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Female		681	60
P-0003761-T01-IM5	P-0003761	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		506	80
P-0003762-T01-IM5	P-0003762	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MLL and ERBB2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	663	30
P-0003762-T02-IM5	P-0003762	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		981	70
P-0003763-T01-IM5	P-0003763	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		477	30
P-0003764-T01-IM5	P-0003764	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9q, 22q and Xp.	613	60
P-0003765-T01-IM5	P-0003765	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Angiosarcoma	IMPACT410			Male		520	20
P-0003766-T01-IM5	P-0003766	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		745	60
P-0003767-T01-IM5	P-0003767	Endometrial Cancer	Metastasis	Tumor	Peritoneum	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		729	20
P-0003770-T01-IM5	P-0003770	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Mucinous Tubular Spindle Cell Carcinoma	IMPACT410			Male		426	50
P-0003770-T02-IM5	P-0003770	Renal Cell Carcinoma	Metastasis	Tumor	Vena cava	Kidney	Renal Mucinous Tubular Spindle Cell Carcinoma	IMPACT410			Male		668	50
P-0003770-T03-IM5	P-0003770	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Renal Mucinous Tubular Spindle Cell Carcinoma	IMPACT410			Male		552	40
P-0003771-T01-IM5	P-0003771	Soft Tissue Sarcoma	Primary	Tumor	Lung	Lung	Angiosarcoma	IMPACT410			Male		465	50
P-0003772-T01-IM5	P-0003772	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		445	60
P-0003773-T01-IM5	P-0003773	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		716	60
P-0003774-T01-IM5	P-0003774	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		676	30
P-0003775-T01-IM5	P-0003775	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatoblastoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	670	30
P-0003776-T01-IM5	P-0003776	Leukemia	Primary	Tumor	Not Applicable	Lymph node	Chronic Lymphocytic Leukemia	IMPACT410			Male		664	50
P-0003777-T01-IM5	P-0003777	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	477	60
P-0003778-T01-IM5	P-0003778	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		542	30
P-0003779-T01-IM5	P-0003779	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: PTPRT gain is an intragenic amplification involving exons 1-9. Its functional significance is not determined.	353	20
P-0003780-T01-IM5	P-0003780	Colorectal Cancer	Metastasis	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		755	10
P-0003781-T01-IM5	P-0003781	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	808	NA
P-0003782-T01-IM5	P-0003782	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	708	10
P-0003783-T01-IM5	P-0003783	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: A comparison of variant frequencies suggests the EGFR A289T mutation is subclonal.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 10q	671	70
P-0003784-T01-IM5	P-0003784	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		537	50
P-0003785-T01-IM5	P-0003785	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	739	20
P-0003786-T01-IM5	P-0003786	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 119X, negative results should be interpreted with caution.	119	20
P-0003787-T01-IM5	P-0003787	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		636	10
P-0003788-T01-IM5	P-0003788	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Wide range of variant frequencies suggests the presence of multiple sub-clones	462	70
P-0003789-T01-IM5	P-0003789	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		670	20
P-0003790-T01-IM5	P-0003790	Bladder Cancer	Metastasis	Tumor	Lymph node	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		526	20
P-0003790-T02-IM5	P-0003790	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		596	20
P-0003791-T01-IM5	P-0003791	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colon Adenocarcinoma	IMPACT410			Male		785	20
P-0003792-T01-IM5	P-0003792	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q, including MYC	822	60
P-0003793-T01-IM5	P-0003793	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		647	60
P-0003794-T01-IM5	P-0003794	Endometrial Cancer	Metastasis	Tumor	Liver	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: The POLE copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	723	30
P-0003795-T01-IM5	P-0003795	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		557	30
P-0003796-T01-IM5	P-0003796	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		802	10
P-0003797-T01-IM5	P-0003797	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Female		300	40
P-0003798-T01-IM5	P-0003798	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	237	20
P-0003799-T01-IM5	P-0003799	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	510	20
P-0003799-T02-IM5	P-0003799	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male		1019	60
P-0003801-T01-IM5	P-0003801	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		409	50
P-0003802-T01-IM5	P-0003802	Endometrial Cancer	Metastasis	Tumor	Peritoneum	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1p	637	30
P-0003803-T01-IM5	P-0003803	Cancer of Unknown Primary	Metastasis	Tumor	Bladder	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	680	60
P-0003804-T01-IM5	P-0003804	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 11q and 22q12.1-13.2	575	70
P-0003805-T01-IM5	P-0003805	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7	570	50
P-0003806-T01-IM5	P-0003806	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		468	50
P-0003807-T01-IM5	P-0003807	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	555	10
P-0003808-T01-IM5	P-0003808	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		196	50
P-0003809-T01-IM5	P-0003809	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	583	10
P-0003810-T01-IM5	P-0003810	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The RAD51 and MGA copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	663	40
P-0003811-T01-IM5	P-0003811	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		381	30
P-0003812-T01-IM5	P-0003812	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	535	10
P-0003813-T01-IM5	P-0003813	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		608	20
P-0003814-T01-IM5	P-0003814	Bladder Cancer	Primary	Tumor	Not Applicable	Urethra	Urethral Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	556	30
P-0003816-T01-IM5	P-0003816	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		686	30
P-0003817-T01-IM5	P-0003817	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	656	10
P-0003818-T01-IM5	P-0003818	Ovarian Cancer	Metastasis	Tumor	Cecum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		489	20
P-0003819-T01-IM5	P-0003819	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		844	40
P-0003820-T01-IM5	P-0003820	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of copy number loss on Chromosome 9p21-9p24 and 6q23.	595	40
P-0003821-T01-IM5	P-0003821	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Major Salivary Gland	Salivary Duct Carcinoma	IMPACT410			Male		485	30
P-0003823-T01-IM5	P-0003823	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 9 and Chromosome arms 5q, 11p, 17p and 18q	235	60
P-0003824-T01-IM5	P-0003824	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		344	70
P-0003825-T01-IM5	P-0003825	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q	714	80
P-0003826-T01-IM5	P-0003826	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Plasmacytoid/Signet Ring Cell Bladder Carcinoma	IMPACT410			Male	Note: The AR exon1 mutations occur in trans (different alleles).    Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	942	40
P-0003827-T01-IM5	P-0003827	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		206	10
P-0003828-T01-IM5	P-0003828	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Skin Adnexal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	152	40
P-0003829-T01-IM5	P-0003829	Ovarian Cancer	Metastasis	Tumor	Lymph node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	607	40
P-0003830-T01-IM5	P-0003830	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1p34.2-32.3	273	40
P-0003831-T01-IM5	P-0003831	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female		515	40
P-0003832-T01-IM5	P-0003832	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 79X, negative results should be interpreted with caution.	79	30
P-0003833-T01-IM5	P-0003833	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q	369	30
P-0003834-T01-IM5	P-0003834	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male		444	30
P-0003835-T01-IM5	P-0003835	Soft Tissue Sarcoma	Primary	Tumor	Upper Extremity	Upper Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		534	70
P-0003836-T01-IM5	P-0003836	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 7q and 17.	484	20
P-0003838-T01-IM5	P-0003838	Renal Cell Carcinoma	Metastasis	Tumor	Muscle	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p and 9.	452	40
P-0003838-T02-IM5	P-0003838	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p and 9.	464	40
P-0003839-T01-IM5	P-0003839	Colorectal Cancer	Metastasis	Tumor	Abdomen	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	637	40
P-0003840-T01-IM5	P-0003840	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		477	70
P-0003841-T01-IM5	P-0003841	Bladder Cancer	Metastasis	Tumor	Abdomen	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		608	60
P-0003842-T01-IM5	P-0003842	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Leg	Merkel Cell Carcinoma	IMPACT410			Female		563	20
P-0003843-T01-IM5	P-0003843	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		630	20
P-0003843-T02-IM5	P-0003843	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		286	20
P-0003844-T01-IM5	P-0003844	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.      Note: Low sequencing depth of coverage of 145X, negative results should be interpreted with caution.	145	10
P-0003845-T01-IM5	P-0003845	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Female		463	40
P-0003846-T01-IM5	P-0003846	Small Bowel Cancer	Primary	Tumor	Not Applicable	Small Bowel	Small Bowel Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: The MITF, FOXP1, RYBP and SHQ1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	590	10
P-0003847-T01-IM5	P-0003847	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		339	30
P-0003848-T01-IM5	P-0003848	Bladder Cancer	Metastasis	Tumor	Lymph node	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	675	10
P-0003849-T01-IM5	P-0003849	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	365	10
P-0003850-T01-IM5	P-0003850	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10.	806	70
P-0003851-T01-IM5	P-0003851	Soft Tissue Sarcoma	Metastasis	Tumor	Lower Extremity	Bone	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7q36.	732	60
P-0003852-T01-IM5	P-0003852	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The EZH2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	541	30
P-0003853-T01-IM5	P-0003853	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The CDKN2B,  CDKN2Ap16INK4A  and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	478	40
P-0003854-T01-IM5	P-0003854	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	450	10
P-0003854-T02-IM5	P-0003854	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The RNF43 and RAD51C copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	580	40
P-0003855-T01-IM5	P-0003855	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Female		377	20
P-0003856-T01-IM5	P-0003856	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The NBN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	329	70
P-0003857-T01-IM5	P-0003857	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male		524	40
P-0003858-T01-IM5	P-0003858	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The ATM exon60 mutations all occur in cis (same allele).    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	540	10
P-0003859-T01-IM5	P-0003859	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	332	10
P-0003860-T01-IM5	P-0003860	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		440	50
P-0003861-T01-IM5	P-0003861	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	427	20
P-0003862-T01-IM5	P-0003862	Soft Tissue Sarcoma	Primary	Tumor	Lymph Node	Breast	Angiosarcoma	IMPACT410			Female		760	30
P-0003863-T01-IM5	P-0003863	Non-Small Cell Lung Cancer	Metastasis	Tumor	Colon	Lung	Lung Adenocarcinoma	IMPACT410			Female		562	60
P-0003864-T01-IM5	P-0003864	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: The SH2B3  exon 2  mutations all occur in cis (same allele).   Note: The RAD52, CCND2, and ETV6 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	684	70
P-0003865-T01-IM5	P-0003865	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The PIC3CA and SOX2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	612	50
P-0003866-T01-IM5	P-0003866	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		292	50
P-0003866-T02-IM5	P-0003866	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		734	50
P-0003867-T01-IM5	P-0003867	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		748	60
P-0003868-T01-IM5	P-0003868	Melanoma	Metastasis	Tumor	Adrenal Gland	Skin	Cutaneous Melanoma	IMPACT410			Male		632	80
P-0003869-T01-IM5	P-0003869	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		643	40
P-0003870-T01-IM5	P-0003870	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A, and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion.	759	30
P-0003871-T01-IM5	P-0003871	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	607	90
P-0003872-T01-IM5	P-0003872	Melanoma	Metastasis	Tumor	Abdomen	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	675	60
P-0003873-T01-IM5	P-0003873	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		708	70
P-0003874-T01-IM5	P-0003874	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: The RAC1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	855	30
P-0003875-T01-IM5	P-0003875	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female		457	70
P-0003876-T01-IM5	P-0003876	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: The GNAS and AURKA  copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	933	50
P-0003877-T01-IM5	P-0003877	Breast Carcinoma	Metastasis	Tumor	Stomach	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		502	40
P-0003878-T01-IM5	P-0003878	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 18q and 21q.	474	60
P-0003879-T01-IM5	P-0003879	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The SDHA and TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	889	20
P-0003880-T01-IM5	P-0003880	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		808	40
P-0003881-T01-IM5	P-0003881	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male		747	40
P-0003882-T01-IM5	P-0003882	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		426	30
P-0003884-T01-IM5	P-0003884	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		904	60
P-0003885-T01-IM5	P-0003885	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		666	10
P-0003886-T01-IM5	P-0003886	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: The NF1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	692	20
P-0003888-T01-IM5	P-0003888	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	79	20
P-0003889-T01-IM5	P-0003889	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		672	40
P-0003890-T01-IM5	P-0003890	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q.	724	20
P-0003891-T01-IM5	P-0003891	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	619	60
P-0003892-T01-IM5	P-0003892	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		655	30
P-0003893-T01-IM5	P-0003893	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		293	40
P-0003894-T01-IM5	P-0003894	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	434	20
P-0003895-T01-IM5	P-0003895	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male		440	40
P-0003898-T01-IM5	P-0003898	Biliary Cancer	Metastasis	Tumor	Pleura	Bile Duct	Cholangiocarcinoma	IMPACT410			Male	Note: PHOX2B, MDM2 (missense) and MAP2K1 variants indicate the presence of sub-clones	378	80
P-0003899-T01-IM5	P-0003899	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Acral Melanoma	IMPACT410			Male	Note: The EP300 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	904	60
P-0003900-T01-IM5	P-0003900	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		433	60
P-0003901-T01-IM5	P-0003901	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	600	20
P-0003902-T01-IM5	P-0003902	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	355	10
P-0003903-T01-IM5	P-0003903	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	796	70
P-0003909-T01-IM5	P-0003909	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		268	20
P-0003911-T01-IM5	P-0003911	Bladder Cancer	Metastasis	Tumor	Liver	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female		451	70
P-0003920-T01-IM5	P-0003920	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Variants in ERBB2  (p.S310F)and MLL (p.R3744*) gene indicates the presence of sub-clones	584	50
P-0003921-T01-IM5	P-0003921	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	739	70
P-0003926-T01-IM5	P-0003926	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		391	20
P-0003928-T01-IM5	P-0003928	Head and Neck Carcinoma	Metastasis	Tumor	Sinonasal	Oral Cavity	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		408	50
P-0003934-T01-IM5	P-0003934	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Follicular Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 18.	616	50
P-0003934-T02-IM5	P-0003934	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Follicular Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 18.	817	60
P-0003934-T03-IM5	P-0003934	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Follicular Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 18.	788	50
P-0003937-T01-IM5	P-0003937	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male		394	40
P-0003937-T02-IM5	P-0003937	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male		510	60
P-0003938-T01-IM5	P-0003938	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		328	40
P-0003949-T01-IM5	P-0003949	Chordoma	Primary	Tumor	Not Applicable	Bone	Chordoma	IMPACT410			Female	Note: The MLL2 and SMARCD1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.   Note: The MLL2 - MON2 rearrangement could be a result of the copy number gain seen in MLL2.	438	60
P-0003950-T01-IM5	P-0003950	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		437	70
P-0003953-T01-IM5	P-0003953	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Epithelioid Hemangioendothelioma	IMPACT410			Male		345	50
P-0003958-T02-IM5	P-0003958	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		909	60
P-0003962-T02-IM5	P-0003962	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male		483	80
P-0003962-T03-IM5	P-0003962	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male		242	80
P-0003965-T01-IM5	P-0003965	Pheochromocytoma	Metastasis	Tumor	Epidural	Adrenal Gland	Pheochromocytoma	IMPACT410			Male		307	30
P-0003966-T01-IM5	P-0003966	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		532	50
P-0003967-T01-IM5	P-0003967	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		481	20
P-0003968-T01-IM5	P-0003968	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.  Note: Variants in SYK and NOTCH1 genes indicates the presence of sub-clones	632	80
P-0003970-T01-IM5	P-0003970	Non-Small Cell Lung Cancer	Metastasis	Tumor	Breast	Lung	Lung Adenocarcinoma	IMPACT410			Female		481	40
P-0003970-T02-IM5	P-0003970	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Female		866	30
P-0003971-T02-IM5	P-0003971	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 102X, negative results should be interpreted with caution.	102	30
P-0003972-T01-IM5	P-0003972	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Male	Note: The SPOP copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	533	10
P-0003984-T01-IM5	P-0003984	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	337	10
P-0003986-T01-IM5	P-0003986	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	405	30
P-0003987-T01-IM5	P-0003987	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		422	70
P-0003993-T01-IM5	P-0003993	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		602	30
P-0003995-T01-IM5	P-0003995	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	87	10
P-0003996-T01-IM5	P-0003996	Cancer of Unknown Primary	Metastasis	Tumor	Abdomen	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	301	10
P-0003998-T01-IM5	P-0003998	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	639	50
P-0003999-T01-IM5	P-0003999	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		570	20
P-0004000-T01-IM5	P-0004000	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p	486	20
P-0004011-T01-IM5	P-0004011	Colorectal Cancer	Metastasis	Tumor	Omentum	Colon	Colon Adenocarcinoma	IMPACT410			Male		431	10
P-0004014-T01-IM5	P-0004014	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		236	30
P-0004016-T01-IM5	P-0004016	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Poorly Differentiated Carcinoma	IMPACT410			Male	Note: Variants in STAT5B and RBM10 gene indicates the presence of sub-clones	290	40
P-0004017-T01-IM5	P-0004017	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT410			Female	Note: The TP53  exon5 mutations occur in different alleles.	429	20
P-0004020-T01-IM5	P-0004020	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		693	20
P-0004025-T01-IM5	P-0004025	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		561	20
P-0004026-T01-IM5	P-0004026	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		522	50
P-0004027-T01-IM5	P-0004027	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p/19q	393	60
P-0004029-T01-IM5	P-0004029	Sex Cord Stromal Tumor	Metastasis	Tumor	Liver	Ovary	Granulosa Cell Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	519	60
P-0004029-T02-IM5	P-0004029	Sex Cord Stromal Tumor	Metastasis	Tumor	Spleen	Ovary	Granulosa Cell Tumor	IMPACT410			Female		521	5
P-0004030-T01-IM5	P-0004030	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male	Note: The STK11 exon8 mutations all occur in cis (same allele).	443	30
P-0004032-T01-IM5	P-0004032	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Ganglioglioma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	166	30
P-0004034-T01-IM5	P-0004034	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		290	60
P-0004035-T01-IM5	P-0004035	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The SOX2 and BRAF copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	623	70
P-0004039-T01-IM5	P-0004039	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	113	30
P-0004040-T02-IM5	P-0004040	Endometrial Cancer	Metastasis	Tumor	Liver	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	661	20
P-0004041-T01-IM5	P-0004041	Chondrosarcoma	Primary	Tumor	Not Applicable	Acetabulum	Chondrosarcoma	IMPACT410			Male		449	50
P-0004042-T01-IM5	P-0004042	Soft Tissue Sarcoma	Primary	Tumor	Pelvis	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm Xp.        Note: The ESR1 and NF2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	607	80
P-0004046-T02-IM5	P-0004046	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Poorly Differentiated Carcinoma of the Stomach	IMPACT410			Male		865	20
P-0004047-T01-IM5	P-0004047	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male		605	60
P-0004048-T01-IM5	P-0004048	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The MITF copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	422	40
P-0004051-T01-IM5	P-0004051	Colorectal Cancer	Metastasis	Tumor	Abdomen	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		342	30
P-0004052-T01-IM5	P-0004052	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.     Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	99	70
P-0004054-T01-IM5	P-0004054	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		437	50
P-0004055-T01-IM5	P-0004055	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Major Salivary Gland	Salivary Duct Carcinoma	IMPACT410			Male		619	60
P-0004056-T01-IM5	P-0004056	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome Xq25.      Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	614	60
P-0004057-T01-IM5	P-0004057	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.        Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.     Note: The FLCN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	670	70
P-0004058-T01-IM5	P-0004058	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of copy number loss on Chromosome 6p22.      Note: The ESR1 and FGFR1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	273	20
P-0004059-T01-IM5	P-0004059	Histiocytosis	Primary	Tumor	Not Applicable	Chest	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Female	Note: Low sequencing depth of coverage of 78X, negative results should be interpreted with caution.	78	10
P-0004060-T01-IM5	P-0004060	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		687	50
P-0004061-T02-IM5	P-0004061	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 19p.        Note: The H3F3C,PIK3C2G,KRAS,ETV6,CDKN1B,NEGR1,FUBP1,EPHA7  copy number loss fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	716	50
P-0004062-T01-IM5	P-0004062	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Appendix	Follicular Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of copy number loss on Chromosome 10q23-25 and Chromosome 15q26.    Note: The EPHA7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory FISH is suggested, if clinically indicated.	734	50
P-0004063-T01-IM5	P-0004063	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		224	30
P-0004064-T01-IM5	P-0004064	Bladder Cancer	Metastasis	Tumor	Bone	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: ERBB2 p.D227H extracellular domain variant frequency suggests that the mutant allele is amplified.	389	50
P-0004065-T01-IM5	P-0004065	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The CCND1 exon3 mutations all occur in cis (same allele).      Note: The RICTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	690	20
P-0004066-T01-IM5	P-0004066	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		483	10
P-0004066-T02-IM5	P-0004066	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pericardium	Lung	Lung Adenocarcinoma	IMPACT410			Male		839	10
P-0004067-T01-IM5	P-0004067	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p.	739	40
P-0004068-T01-IM5	P-0004068	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and 8q.	604	50
P-0004069-T01-IM5	P-0004069	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	579	20
P-0004070-T02-IM5	P-0004070	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		575	50
P-0004071-T01-IM5	P-0004071	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8, 18 and 21.	565	60
P-0004072-T01-IM5	P-0004072	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Variants in MAP2K1 gene indicates the presence of sub-clones	807	NA
P-0004073-T01-IM5	P-0004073	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	633	40
P-0004074-T01-IM5	P-0004074	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	553	20
P-0004075-T01-IM5	P-0004075	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The CDK12, ERBB2 and RARA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	709	40
P-0004076-T01-IM5	P-0004076	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		530	20
P-0004077-T01-IM5	P-0004077	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Female		614	50
P-0004078-T01-IM5	P-0004078	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Female		399	60
P-0004079-T01-IM5	P-0004079	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 7q.	699	20
P-0004080-T01-IM5	P-0004080	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	670	50
P-0004081-T01-IM5	P-0004081	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		645	30
P-0004082-T01-IM5	P-0004082	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Embryonal Rhabdomyosarcoma	IMPACT410			Male	Note: The HRAS and  IGF2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	673	50
P-0004083-T01-IM5	P-0004083	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		787	30
P-0004084-T01-IM5	P-0004084	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		433	10
P-0004085-T01-IM5	P-0004085	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		481	40
P-0004086-T01-IM5	P-0004086	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	552	30
P-0004087-T01-IM5	P-0004087	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	650	70
P-0004088-T01-IM5	P-0004088	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	1208	10
P-0004089-T01-IM5	P-0004089	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		622	70
P-0004090-T01-IM5	P-0004090	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	691	70
P-0004091-T01-IM5	P-0004091	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The PIK3CG and MET  copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	990	40
P-0004092-T01-IM5	P-0004092	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.      Note: The  GRIN2A  exon4 mutations all occur in cis (same allele).      Note: Copy number profile is suggestive of a fragmented genome..    Note: The MYC  copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	814	50
P-0004093-T01-IM5	P-0004093	Vaginal Cancer	Primary	Tumor	Not Applicable	Vulva	Squamous Cell Carcinoma of the Vulva	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	710	10
P-0004094-T01-IM5	P-0004094	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	727	10
P-0004095-T01-IM5	P-0004095	Gestational Trophoblastic Disease	Primary	Tumor	Not Applicable	Uterus	Choriocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	705	10
P-0004096-T01-IM5	P-0004096	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	318	10
P-0004097-T01-IM5	P-0004097	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Chondroblastic Osteosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	618	10
P-0004098-T01-IM5	P-0004098	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Oral Cavity	Mantle Cell Lymphoma	IMPACT410			Male		530	60
P-0004099-T01-IM5	P-0004099	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		652	40
P-0004100-T01-IM5	P-0004100	Meningothelial Tumor	Primary	Tumor	Not Applicable	Bone	Solitary Fibrous Tumor of the Central Nervous System	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	670	30
P-0004101-T01-IM5	P-0004101	Miscellaneous Neuroepithelial Tumor	Metastasis	Tumor	Epidural	Retroperitoneum	Paraganglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 6p, 14 and  17p.	649	50
P-0004102-T01-IM5	P-0004102	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q.	330	60
P-0004103-T01-IM5	P-0004103	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	691	20
P-0004104-T01-IM5	P-0004104	Breast Carcinoma	Metastasis	Tumor	Neck	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		511	40
P-0004105-T01-IM5	P-0004105	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		658	20
P-0004106-T01-IM5	P-0004106	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p34-1p22.	654	20
P-0004107-T01-IM5	P-0004107	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Pelvis	Leiomyosarcoma	IMPACT410			Female		680	70
P-0004108-T01-IM5	P-0004108	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	466	20
P-0004109-T01-IM5	P-0004109	Melanoma	Metastasis	Tumor	In-transit	Skin	Acral Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	364	20
P-0004110-T01-IM5	P-0004110	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		793	40
P-0004111-T01-IM5	P-0004111	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Male		580	30
P-0004112-T01-IM5	P-0004112	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Lower Extremity	Leiomyosarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	603	70
P-0004113-T01-IM5	P-0004113	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		737	30
P-0004114-T01-IM5	P-0004114	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The BCL2L1 and CRKL copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	685	NA
P-0004115-T01-IM5	P-0004115	Pancreatic Cancer	Metastasis	Tumor	Bile Duct	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		441	NA
P-0004116-T01-IM5	P-0004116	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	678	60
P-0004117-T01-IM5	P-0004117	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR exon19 mutations all occur in cis (same allele).	734	40
P-0004118-T01-IM5	P-0004118	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.	385	60
P-0004119-T01-IM5	P-0004119	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 10q.	816	50
P-0004120-T01-IM5	P-0004120	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		587	20
P-0004121-T01-IM5	P-0004121	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	576	30
P-0004121-T02-IM5	P-0004121	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		694	50
P-0004122-T01-IM5	P-0004122	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		802	30
P-0004123-T01-IM5	P-0004123	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	651	20
P-0004124-T01-IM5	P-0004124	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	691	10
P-0004125-T01-IM5	P-0004125	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		512	40
P-0004126-T01-IM5	P-0004126	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Sinonasal	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	475	NA
P-0004127-T01-IM5	P-0004127	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		515	50
P-0004128-T01-IM5	P-0004128	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Blood Vessel	Intimal Sarcoma	IMPACT410			Female		242	20
P-0004129-T01-IM5	P-0004129	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		486	30
P-0004129-T02-IM5	P-0004129	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6q23-26.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p.	1051	40
P-0004130-T01-IM5	P-0004130	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Auditory Canal	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		1031	40
P-0004130-T02-IM5	P-0004130	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Auditory Canal	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		531	60
P-0004131-T01-IM5	P-0004131	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	741	20
P-0004132-T01-IM5	P-0004132	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Male		573	40
P-0004133-T01-IM5	P-0004133	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The FGFR1 and MRE11A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	775	20
P-0004135-T01-IM5	P-0004135	Gestational Trophoblastic Disease	Primary	Tumor	Not Applicable	Mediastinum	Choriocarcinoma	IMPACT410			Female		574	30
P-0004136-T01-IM5	P-0004136	Endometrial Cancer	Metastasis	Tumor	Vagina	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	574	50
P-0004137-T01-IM5	P-0004137	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		480	20
P-0004138-T01-IM5	P-0004138	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		566	30
P-0004139-T01-IM5	P-0004139	Vaginal Cancer	Primary	Tumor	Not Applicable	Vagina	Squamous Cell Carcinoma of the Vulva	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	670	10
P-0004140-T01-IM5	P-0004140	Colorectal Cancer	Metastasis	Tumor	Abdomen	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		627	50
P-0004140-T02-IM5	P-0004140	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	578	10
P-0004141-T01-IM5	P-0004141	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	633	30
P-0004142-T01-IM5	P-0004142	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 9q and 12q.	725	60
P-0004143-T01-IM5	P-0004143	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Epithelioid Hemangioendothelioma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Low sequencing depth of coverage of 184X, negative results should be interpreted with caution.	184	10
P-0004144-T01-IM5	P-0004144	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	490	10
P-0004145-T01-IM5	P-0004145	Chondrosarcoma	Metastasis	Tumor	Blood Vessel	Pelvis	Chondrosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	542	20
P-0004146-T01-IM5	P-0004146	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		710	40
P-0004147-T01-IM5	P-0004147	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		659	70
P-0004148-T01-IM5	P-0004148	Soft Tissue Sarcoma	Metastasis	Tumor	Jejunum	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male		527	40
P-0004149-T01-IM5	P-0004149	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.  Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	517	20
P-0004150-T01-IM5	P-0004150	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		527	40
P-0004151-T01-IM5	P-0004151	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		728	50
P-0004152-T01-IM5	P-0004152	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	708	60
P-0004153-T01-IM5	P-0004153	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	638	50
P-0004154-T01-IM5	P-0004154	Small Bowel Cancer	Primary	Tumor	Not Applicable	Ileum	Small Bowel Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	688	40
P-0004155-T01-IM5	P-0004155	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	438	10
P-0004157-T01-IM5	P-0004157	Nerve Sheath Tumor	Metastasis	Tumor	Soft Tissue	Colon	Malignant Peripheral Nerve Sheath Tumor	IMPACT410			Female		708	50
P-0004158-T01-IM5	P-0004158	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	493	20
P-0004159-T01-IM5	P-0004159	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		744	10
P-0004160-T01-IM5	P-0004160	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.         Note: Low sequencing depth of coverage of 143X, negative results should be interpreted with caution.	143	10
P-0004161-T01-IM5	P-0004161	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Uterus	Small Bowel	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q including SMAD4.	668	60
P-0004162-T01-IM5	P-0004162	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		828	30
P-0004163-T01-IM5	P-0004163	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosomes 5, 12 and 18.	527	70
P-0004164-T01-IM5	P-0004164	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	High-Grade Endometrial Stromal Sarcoma	IMPACT410			Female		902	50
P-0004165-T01-IM5	P-0004165	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		318	50
P-0004166-T01-IM5	P-0004166	Cervical Cancer	Metastasis	Tumor	Ascites	Cervix	Gastric Type Mucinous Carcinoma	IMPACT410			Female		267	70
P-0004167-T01-IM5	P-0004167	Ovarian Cancer	Metastasis	Tumor	Vagina	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9, 18  and 22q.	501	60
P-0004168-T01-IM5	P-0004168	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The IDH2, BLM, TOP1 and PTPRT  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	704	50
P-0004169-T01-IM5	P-0004169	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		720	40
P-0004170-T01-IM5	P-0004170	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		673	30
P-0004172-T01-IM5	P-0004172	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	715	10
P-0004173-T01-IM5	P-0004173	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The PTEN exon5 p.F145fs and p.Q149* mutations occur on different alleles.      Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	327	20
P-0004174-T01-IM5	P-0004174	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	609	20
P-0004175-T01-IM5	P-0004175	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		724	20
P-0004176-T01-IM5	P-0004176	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	839	20
P-0004177-T01-IM5	P-0004177	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Male		788	50
P-0004178-T01-IM5	P-0004178	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		480	30
P-0004179-T01-IM5	P-0004179	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Rectum	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Male		529	40
P-0004180-T01-IM5	P-0004180	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: Low sequencing depth of coverage of 172X, negative results should be interpreted with caution.	172	70
P-0004181-T01-IM5	P-0004181	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	814	40
P-0004182-T01-IM5	P-0004182	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		433	50
P-0004183-T01-IM5	P-0004183	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		519	60
P-0004183-T02-IM5	P-0004183	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1007	30
P-0004184-T01-IM5	P-0004184	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	327	20
P-0004185-T01-IM5	P-0004185	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		285	30
P-0004186-T01-IM5	P-0004186	Salivary Carcinoma	Primary	Tumor	Not Applicable	Orbit	Adenoid Cystic Carcinoma	IMPACT410			Male		636	20
P-0004187-T01-IM5	P-0004187	Breast Carcinoma	Metastasis	Tumor	Stomach	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		714	70
P-0004189-T01-IM5	P-0004189	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		568	30
P-0004190-T01-IM5	P-0004190	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Female		855	60
P-0004191-T01-IM5	P-0004191	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Mixed Mucinous Carcinoma	IMPACT410			Female		531	40
P-0004193-T01-IM5	P-0004193	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 7q and 16q.	512	70
P-0004194-T01-IM5	P-0004194	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		688	20
P-0004195-T01-IM5	P-0004195	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	304	60
P-0004196-T01-IM5	P-0004196	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		390	60
P-0004197-T01-IM5	P-0004197	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female		710	60
P-0004198-T01-IM5	P-0004198	Soft Tissue Sarcoma	Primary	Tumor	Lower Extremity	Lower Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	546	80
P-0004199-T01-IM5	P-0004199	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Groin	Epithelioid Sarcoma	IMPACT410			Female		697	60
P-0004200-T01-IM5	P-0004200	Chondrosarcoma	Primary	Tumor	Not Applicable	Leg	Chondrosarcoma	IMPACT410			Male		635	30
P-0004201-T01-IM5	P-0004201	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		667	50
P-0004202-T01-IM5	P-0004202	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	639	10
P-0004203-T01-IM5	P-0004203	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		701	50
P-0004204-T01-IM5	P-0004204	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: The INHBA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	578	70
P-0004205-T01-IM5	P-0004205	Renal Cell Carcinoma	Metastasis	Tumor	Brain	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	234	60
P-0004206-T01-IM5	P-0004206	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		695	30
P-0004207-T01-IM5	P-0004207	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		804	30
P-0004208-T01-IM5	P-0004208	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the ARID5B p.K494fs mutation is subclonal.    Note: The MDM2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	751	30
P-0004209-T01-IM5	P-0004209	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		574	40
P-0004210-T01-IM5	P-0004210	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		594	50
P-0004211-T01-IM5	P-0004211	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the MAX p.L46W and CTNNB1 p.D32N mutations are subclonal.	731	40
P-0004212-T01-IM5	P-0004212	Renal Cell Carcinoma	Metastasis	Tumor	Pleura	Kidney	Collecting Duct Renal Cell Carcinoma	IMPACT410			Female	Note: The YES1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	544	70
P-0004213-T01-IM5	P-0004213	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q including MYC and RECQL4.	603	60
P-0004214-T01-IM5	P-0004214	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		373	70
P-0004215-T01-IM5	P-0004215	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The CCND1, FGF19, FGF4, FGF3 and YES1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	450	30
P-0004216-T01-IM5	P-0004216	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female		384	30
P-0004217-T01-IM5	P-0004217	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Sacrum	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT gene.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,3p and 11.	606	70
P-0004218-T01-IM5	P-0004218	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The  CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	547	60
P-0004219-T01-IM5	P-0004219	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		515	30
P-0004220-T01-IM5	P-0004220	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Variants in CBL  gene indicates the presence of sub-clones	301	20
P-0004221-T01-IM5	P-0004221	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		426	30
P-0004222-T01-IM5	P-0004222	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male		647	10
P-0004223-T01-IM5	P-0004223	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Low sequencing depth of coverage of 145X, negative results should be interpreted with caution.	145	20
P-0004224-T01-IM5	P-0004224	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		799	80
P-0004225-T01-IM5	P-0004225	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Variants in EGFR  gene indicates the presence of sub-clones    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and 17q deletion.	809	80
P-0004226-T01-IM5	P-0004226	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		473	30
P-0004227-T01-IM5	P-0004227	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	549	30
P-0004228-T01-IM5	P-0004228	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 193X, negative results should be interpreted with caution.	193	40
P-0004229-T01-IM5	P-0004229	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Angiosarcoma	IMPACT410			Female		487	50
P-0004230-T01-IM5	P-0004230	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: The GNAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	703	30
P-0004231-T01-IM5	P-0004231	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		951	60
P-0004231-T02-IM5	P-0004231	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		610	50
P-0004232-T01-IM5	P-0004232	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		496	40
P-0004233-T01-IM5	P-0004233	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the TP53 p.S127F and SMARCA4 p.E1577Q mutations are subclonal.    Note: The MAPK1, SMARCB1 and CHEK2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1173	80
P-0004234-T01-IM5	P-0004234	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Well-Differentiated Liposarcoma	IMPACT410			Female		846	60
P-0004235-T01-IM5	P-0004235	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 2p and 15p.	372	70
P-0004236-T01-IM5	P-0004236	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Female		321	50
P-0004237-T01-IM5	P-0004237	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 147X, negative results should be interpreted with caution.	147	50
P-0004238-T01-IM5	P-0004238	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	447	30
P-0004240-T01-IM5	P-0004240	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female		714	30
P-0004241-T01-IM5	P-0004241	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..      Note: The PHOX2B, FGFR3, PDGFRA, and KIT copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	543	50
P-0004242-T01-IM5	P-0004242	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		403	70
P-0004243-T01-IM5	P-0004243	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	358	70
P-0004244-T01-IM5	P-0004244	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		555	20
P-0004245-T01-IM5	P-0004245	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and Chromosome arm 22q.	761	40
P-0004246-T01-IM5	P-0004246	Breast Carcinoma	Metastasis	Tumor	Bladder	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		531	50
P-0004247-T01-IM5	P-0004247	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		725	30
P-0004248-T01-IM5	P-0004248	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		360	30
P-0004248-T02-IM5	P-0004248	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	516	30
P-0004249-T01-IM5	P-0004249	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	624	40
P-0004250-T01-IM5	P-0004250	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1217	30
P-0004251-T01-IM5	P-0004251	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		363	30
P-0004252-T01-IM5	P-0004252	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT410			Male	Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	511	30
P-0004253-T01-IM5	P-0004253	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		475	60
P-0004255-T01-IM5	P-0004255	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		356	30
P-0004256-T01-IM5	P-0004256	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		190	50
P-0004257-T01-IM5	P-0004257	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and broad copy number loss on Chromosome 9.	1135	70
P-0004257-T02-IM5	P-0004257	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and broad copy number loss on Chromosome 9.	638	70
P-0004258-T01-IM5	P-0004258	Ovarian Cancer	Metastasis	Tumor	Lymph node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	549	10
P-0004259-T01-IM5	P-0004259	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 12q	397	50
P-0004260-T01-IM5	P-0004260	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		512	20
P-0004260-T02-IM5	P-0004260	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		456	40
P-0004261-T01-IM5	P-0004261	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		307	40
P-0004262-T01-IM5	P-0004262	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q including FLT1, FLT3 and BRCA2.	667	30
P-0004263-T01-IM5	P-0004263	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Spindle Cell Carcinoma of the Lung	IMPACT410			Female	Note: A comparison of variant frequencies suggests the RIT1 S19* mutation is subclonal.	489	70
P-0004264-T01-IM5	P-0004264	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	746	10
P-0004265-T01-IM5	P-0004265	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female		565	80
P-0004266-T01-IM5	P-0004266	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Female	Note: The BRD4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The CDKN2B,  CDKN2Ap16INK4A and  CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	648	40
P-0004267-T01-IM5	P-0004267	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Pleomorphic Liposarcoma	IMPACT410			Female		512	80
P-0004268-T01-IM5	P-0004268	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male		456	80
P-0004269-T01-IM5	P-0004269	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		514	60
P-0004270-T01-IM5	P-0004270	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		374	50
P-0004270-T02-IM5	P-0004270	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1056	90
P-0004271-T01-IM5	P-0004271	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		422	60
P-0004272-T01-IM5	P-0004272	Melanoma	Metastasis	Tumor	Bone	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		510	60
P-0004273-T01-IM5	P-0004273	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		596	70
P-0004274-T01-IM5	P-0004274	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		848	60
P-0004275-T01-IM5	P-0004275	Melanoma	Primary	Tumor	Not Applicable	Sinonasal	Head and Neck Mucosal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and 8q .	382	70
P-0004276-T01-IM5	P-0004276	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	587	20
P-0004277-T01-IM5	P-0004277	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		302	40
P-0004278-T01-IM5	P-0004278	Non-Small Cell Lung Cancer	Primary	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The PIK3CG exon11 mutations occur on different alleles.  Note: The APC  exon16  mutations all occur in cis (same allele).	143	60
P-0004279-T01-IM5	P-0004279	Non-Small Cell Lung Cancer	Primary	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	minor more than 2%, high vf!!	544	40
P-0004280-T01-IM5	P-0004280	Anal Cancer	Metastasis	Tumor	Lymph node	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..  Note: The YAP1 and AKT2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	268	30
P-0004281-T01-IM5	P-0004281	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		519	60
P-0004283-T01-IM5	P-0004283	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 153X, negative results should be interpreted with caution.	153	40
P-0004284-T01-IM5	P-0004284	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		581	50
P-0004285-T01-IM5	P-0004285	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		471	60
P-0004286-T01-IM5	P-0004286	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		590	20
P-0004287-T01-IM5	P-0004287	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	495	70
P-0004288-T01-IM5	P-0004288	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		381	50
P-0004289-T01-IM5	P-0004289	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1, FGF4, FGF19, FGF3 and GNAS copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	353	20
P-0004290-T03-IM5	P-0004290	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	20
P-0004291-T01-IM5	P-0004291	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Colon	Malignant Peripheral Nerve Sheath Tumor	IMPACT410			Female	Note: The GATA3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	656	60
P-0004292-T01-IM5	P-0004292	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		233	70
P-0004293-T01-IM5	P-0004293	Breast Carcinoma	Metastasis	Tumor	Omentum	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: The CDK12, ERBB2 and RARA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	516	40
P-0004294-T01-IM5	P-0004294	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		569	40
P-0004295-T01-IM5	P-0004295	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: The FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The ARID1A, CDKN2B, CDKN2Ap14ARF and CDKN2Ap16INK4A	copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	505
P-0004298-T01-IM5	P-0004298	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The PDGFRA and EGFR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	704	50
P-0004300-T01-IM5	P-0004300	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Low tumor content (approximately 10% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	473	10
P-0004301-T01-IM5	P-0004301	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number results do not suggest a ERBB2 gain.	616	70
P-0004302-T01-IM5	P-0004302	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the KIT p.Q575del mutation is subclonal.	289	40
P-0004303-T01-IM5	P-0004303	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 10% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	888	50
P-0004304-T01-IM5	P-0004304	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	339	60
P-0004305-T01-IM5	P-0004305	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10q and 14.	1225	50
P-0004306-T01-IM5	P-0004306	Chondrosarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Extraskeletal Myxoid Chondrosarcoma	IMPACT410			Female		368	40
P-0004307-T01-IM5	P-0004307	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		227	50
P-0004308-T01-IM5	P-0004308	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low sequencing depth of coverage of 151X, negative results should be interpreted with caution.	151	30
P-0004309-T01-IM5	P-0004309	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		508	50
P-0004310-T01-IM5	P-0004310	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		232	50
P-0004311-T01-IM5	P-0004311	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Variants in PTEN M198*  indicates the presence of sub-clones	387	50
P-0004312-T01-IM5	P-0004312	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		388	40
P-0004313-T01-IM5	P-0004313	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,19q and 15q.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.	694	60
P-0004314-T01-IM5	P-0004314	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	634	60
P-0004315-T01-IM5	P-0004315	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The KRAS exon2 mutations occur on different alleles.	686	20
P-0004316-T01-IM5	P-0004316	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		118	60
P-0004317-T01-IM5	P-0004317	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		510	40
P-0004318-T01-IM5	P-0004318	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	578	10
P-0004319-T01-IM5	P-0004319	Miscellaneous Neuroepithelial Tumor	Primary	Tumor	Not Applicable	Brain	Astroblastoma	IMPACT410			Female		716	50
P-0004320-T01-IM5	P-0004320	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT410			Male		609	60
P-0004322-T01-IM5	P-0004322	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	568	20
P-0004323-T01-IM5	P-0004323	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		623	20
P-0004324-T01-IM5	P-0004324	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		360	10
P-0004325-T01-IM5	P-0004325	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	671	20
P-0004326-T01-IM5	P-0004326	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		839	30
P-0004327-T01-IM5	P-0004327	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The TP53 exon 6  mutations occur on different alleles.	334	40
P-0004328-T01-IM5	P-0004328	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		494	30
P-0004329-T01-IM5	P-0004329	Cancer of Unknown Primary	Metastasis	Tumor	Pelvis	Unknown	Cancer of Unknown Primary	IMPACT410			Male		496	50
P-0004330-T01-IM5	P-0004330	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		523	50
P-0004331-T01-IM5	P-0004331	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female		456	50
P-0004333-T01-IM5	P-0004333	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Angiosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	458	20
P-0004334-T01-IM5	P-0004334	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 5q11-22, 11q,  12q12-14, 13q	531	50
P-0004335-T01-IM5	P-0004335	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	560	20
P-0004336-T01-IM5	P-0004336	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	729	10
P-0004337-T01-IM5	P-0004337	Sex Cord Stromal Tumor	Metastasis	Tumor	Abdomen	Ovary	Steroid Cell Tumor, NOS	IMPACT410			Female		308	40
P-0004338-T01-IM5	P-0004338	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The PDGFRA exon5 mutations all occur in cis (same allele).   A comparison of variant frequencies suggests these mutations are subclonal and occur on the non-amplified allele.	538	40
P-0004339-T01-IM5	P-0004339	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		680	50
P-0004340-T01-IM5	P-0004340	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		412	40
P-0004341-T01-IM5	P-0004341	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q including MYC.	492	40
P-0004342-T01-IM5	P-0004342	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		265	40
P-0004343-T01-IM5	P-0004343	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	426	20
P-0004344-T01-IM5	P-0004344	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: EML4-ALK fusion assessment is equivocal by MSK-IMPACT. Confirmatory assessment via FISH is recommended.	628	30
P-0004345-T01-IM5	P-0004345	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		497	40
P-0004346-T01-IM5	P-0004346	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		196	30
P-0004347-T01-IM5	P-0004347	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		329	60
P-0004348-T01-IM5	P-0004348	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: The BRAF exon 15 mutations all occur in cis (same allele).	439	60
P-0004349-T01-IM5	P-0004349	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Female		533	50
P-0004350-T01-IM5	P-0004350	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		257	30
P-0004351-T01-IM5	P-0004351	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	762	10
P-0004352-T01-IM5	P-0004352	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	637	20
P-0004353-T01-IM5	P-0004353	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	282	10
P-0004354-T01-IM5	P-0004354	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		459	60
P-0004355-T01-IM5	P-0004355	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	277	40
P-0004356-T01-IM5	P-0004356	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Signet Ring Cell Type of the Appendix	IMPACT410			Female	Note: The KIT, PDGFRA, KDR and EPHA5 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	782	30
P-0004357-T01-IM5	P-0004357	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	769	70
P-0004358-T01-IM5	P-0004358	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female		763	20
P-0004359-T01-IM5	P-0004359	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		919	50
P-0004360-T01-IM5	P-0004360	Ovarian Cancer	Metastasis	Tumor	Pelvis	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	190	60
P-0004361-T01-IM5	P-0004361	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	793	20
P-0004361-T02-IM5	P-0004361	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		411	20
P-0004362-T01-IM5	P-0004362	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		226	30
P-0004363-T01-IM5	P-0004363	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Mucinous Colorectal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	543	10
P-0004364-T01-IM5	P-0004364	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	581	30
P-0004364-T02-IM5	P-0004364	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		566	40
P-0004364-T03-IM5	P-0004364	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	584	40
P-0004365-T01-IM5	P-0004365	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Salivary Gland	Mantle Cell Lymphoma	IMPACT410			Female		886	80
P-0004366-T01-IM5	P-0004366	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		759	30
P-0004367-T01-IM5	P-0004367	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		760	50
P-0004368-T01-IM5	P-0004368	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Variants in ATRX K1801R gene indicates the presence of sub-clones	486	40
P-0004369-T01-IM5	P-0004369	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		549	40
P-0004370-T01-IM5	P-0004370	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,4q,13q and 19q.	634	50
P-0004371-T01-IM5	P-0004371	Salivary Carcinoma	Metastasis	Tumor	Liver	Sinonasal	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Variants in ETV1 R301L gene indicates the presence of sub-clones	804	80
P-0004372-T01-IM5	P-0004372	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	640	20
P-0004373-T01-IM5	P-0004373	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	575	70
P-0004374-T01-IM5	P-0004374	Cancer of Unknown Primary	Metastasis	Tumor	Epidural	Unknown	Cancer of Unknown Primary	IMPACT410			Female		470	20
P-0004375-T01-IM5	P-0004375	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		676	20
P-0004376-T01-IM5	P-0004376	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		676	40
P-0004377-T01-IM5	P-0004377	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosomes 5, 12, 16 and 20.      Note: The STK11 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The NKX3-1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	389	60
P-0004378-T01-IM5	P-0004378	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	856	10
P-0004379-T01-IM5	P-0004379	Endometrial Cancer	Metastasis	Tumor	Chest Wall	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		650	50
P-0004380-T01-IM5	P-0004380	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	200	20
P-0004381-T01-IM5	P-0004381	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The AXIN2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	445	40
P-0004382-T01-IM5	P-0004382	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		471	30
P-0004383-T01-IM5	P-0004383	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Merkel Cell Carcinoma	IMPACT410			Female	Note: The BRCA2, FOXO1, RB1, EPHA5 and FAM175A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	553	60
P-0004384-T01-IM5	P-0004384	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MAP3K1 and PLK2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	608	70
P-0004385-T01-IM5	P-0004385	Soft Tissue Sarcoma	Primary	Tumor	Forehead	Forehead	Angiosarcoma	IMPACT410			Female		840	30
P-0004386-T01-IM5	P-0004386	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		744	40
P-0004387-T01-IM5	P-0004387	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	57	20
P-0004389-T01-IM5	P-0004389	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		508	60
P-0004391-T01-IM5	P-0004391	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Parotid	Sebaceous Carcinoma	IMPACT410			Female		637	10
P-0004392-T01-IM5	P-0004392	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		455	40
P-0004393-T01-IM5	P-0004393	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		788	30
P-0004394-T01-IM5	P-0004394	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male		568	60
P-0004395-T01-IM5	P-0004395	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The ERBB3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	510	50
P-0004396-T01-IM5	P-0004396	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		503	50
P-0004397-T01-IM5	P-0004397	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		236	40
P-0004398-T01-IM5	P-0004398	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	479	30
P-0004399-T01-IM5	P-0004399	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		904	50
P-0004400-T01-IM5	P-0004400	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		423	50
P-0004401-T01-IM5	P-0004401	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	480	40
P-0004402-T01-IM5	P-0004402	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		494	40
P-0004403-T01-IM5	P-0004403	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		368	10
P-0004404-T01-IM5	P-0004404	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 11q,16q and 22q.	609	80
P-0004405-T01-IM5	P-0004405	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Prostate	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Male		477	60
P-0004406-T01-IM5	P-0004406	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		510	50
P-0004407-T01-IM5	P-0004407	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Male		461	50
P-0004408-T01-IM5	P-0004408	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Upper Extremity	Pleomorphic Liposarcoma	IMPACT410			Male		400	60
P-0004409-T01-IM5	P-0004409	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Adrenal Gland	Angiosarcoma	IMPACT410			Male		499	30
P-0004410-T01-IM5	P-0004410	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male		332	40
P-0004411-T01-IM5	P-0004411	Soft Tissue Sarcoma	Primary	Tumor	Lung	Abdomen	Leiomyosarcoma	IMPACT410			Female		656	40
P-0004412-T01-IM5	P-0004412	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Variants in ROS1 gene indicates the presence of sub-clones	264	30
P-0004413-T01-IM5	P-0004413	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		497	80
P-0004414-T01-IM5	P-0004414	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	514	20
P-0004415-T01-IM5	P-0004415	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Arm	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.	650	70
P-0004416-T01-IM5	P-0004416	Head and Neck Carcinoma	Metastasis	Tumor	Bone	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		585	30
P-0004417-T01-IM5	P-0004417	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	245	30
P-0004418-T01-IM5	P-0004418	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.  Note: Low sequencing depth of coverage of 178X, negative results should be interpreted with caution.	178	10
P-0004419-T01-IM5	P-0004419	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		136	50
P-0004420-T01-IM5	P-0004420	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		258	20
P-0004421-T01-IM5	P-0004421	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		593	40
P-0004423-T01-IM5	P-0004423	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	660	70
P-0004424-T01-IM5	P-0004424	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the PIK3CA (p.E542K), FGFR3 (p.S249C), and MED12 (p. P22T)  mutations are subclonal.	979	70
P-0004425-T01-IM5	P-0004425	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Axilla	Skin	Merkel Cell Carcinoma	IMPACT410			Male		302	30
P-0004426-T01-IM5	P-0004426	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		506	70
P-0004427-T01-IM5	P-0004427	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		733	70
P-0004428-T01-IM5	P-0004428	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female		209	60
P-0004429-T01-IM5	P-0004429	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	390	50
P-0004430-T01-IM5	P-0004430	Thyroid Cancer	Metastasis	Tumor	Soft Tissue	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		254	30
P-0004431-T01-IM5	P-0004431	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		693	50
P-0004432-T01-IM5	P-0004432	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		581	50
P-0004433-T01-IM5	P-0004433	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		972	10
P-0004434-T01-IM5	P-0004434	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: The MYC and RAD21 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	718	50
P-0004435-T01-IM5	P-0004435	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		583	40
P-0004436-T01-IM5	P-0004436	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		836	40
P-0004437-T01-IM5	P-0004437	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: The TERT  mutations all occur in cis (same allele).	323	50
P-0004438-T01-IM5	P-0004438	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		500	20
P-0004439-T01-IM5	P-0004439	Salivary Carcinoma	Metastasis	Tumor	Soft Tissue	Sinonasal	Salivary Adenocarcinoma	IMPACT410			Female		1100	20
P-0004440-T01-IM5	P-0004440	Mesothelioma	Metastasis	Tumor	Pelvis	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Female		1234	30
P-0004441-T01-IM5	P-0004441	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The APC exon16 mutations occur on different alleles.	746	30
P-0004442-T01-IM5	P-0004442	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		305	30
P-0004444-T01-IM5	P-0004444	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FGFR3 exon7 mutations all occur in cis (same allele).	596	30
P-0004445-T01-IM5	P-0004445	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Serous Borderline Ovarian Tumor	IMPACT410			Female		655	30
P-0004446-T01-IM5	P-0004446	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		491	30
P-0004447-T01-IM5	P-0004447	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		707	20
P-0004448-T01-IM5	P-0004448	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		612	50
P-0004449-T01-IM5	P-0004449	Small Bowel Cancer	Metastasis	Tumor	Abdomen	Jejunum	Small Bowel Cancer	IMPACT410			Female	Note: The SDHA, TERT and CDK6 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	351	10
P-0004450-T01-IM5	P-0004450	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CASP8 exon8 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 7q and 12p.	509	40
P-0004451-T01-IM5	P-0004451	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Female		603	40
P-0004452-T01-IM5	P-0004452	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The ARID1A copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	618	10
P-0004453-T01-IM5	P-0004453	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female		580	60
P-0004454-T01-IM5	P-0004454	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The KDM5A, RAD52 and CCND2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The FBXW7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	466	NA
P-0004455-T01-IM5	P-0004455	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		669	20
P-0004456-T01-IM5	P-0004456	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Follicular Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17p.	655	70
P-0004457-T01-IM5	P-0004457	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p.        Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q.      Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.    Note: The ALOX12B and AURKB copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	586	70
P-0004458-T01-IM5	P-0004458	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		475	80
P-0004459-T01-IM5	P-0004459	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	283	20
P-0004460-T01-IM5	P-0004460	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		590	30
P-0004462-T01-IM5	P-0004462	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		372	70
P-0004463-T01-IM5	P-0004463	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		566	30
P-0004464-T01-IM5	P-0004464	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Skin	Non-Hodgkin Lymphoma	IMPACT410			Male	run unmatched	959	10
P-0004466-T01-IM5	P-0004466	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		344	60
P-0004467-T01-IM5	P-0004467	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: The NOTHC4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	482	40
P-0004468-T01-IM5	P-0004468	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	575	50
P-0004472-T01-IM5	P-0004472	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		201	30
P-0004473-T01-IM5	P-0004473	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: The CIC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The AKT2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17q11-17q21.	844	60
P-0004474-T01-IM5	P-0004474	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The TMPRSS2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1179	20
P-0004476-T01-IM5	P-0004476	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MRE11A exon 4 mutations all occur in cis (same allele).	301	50
P-0004477-T01-IM5	P-0004477	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	507	50
P-0004478-T02-IM5	P-0004478	Small Bowel Cancer	Metastasis	Tumor	Lung	Duodenum	Small Bowel Cancer	IMPACT410			Male	Note: The AURKA and GNAS copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	683	30
P-0004481-T01-IM5	P-0004481	Embryonal Tumor	Metastasis	Tumor	Bone Marrow	Adrenal Gland	Neuroblastoma	IMPACT410			Male		841	30
P-0004482-T01-IM5	P-0004482	Prostate Cancer	Primary	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.	696	60
P-0004483-T01-IM5	P-0004483	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 122X, negative results should be interpreted with caution.        Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.      Note: The YES1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	122	70
P-0004484-T01-IM5	P-0004484	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.	272	50
P-0004486-T01-IM5	P-0004486	Colorectal Cancer	Primary	Tumor	Lymph node	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		798	60
P-0004488-T01-IM5	P-0004488	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		655	40
P-0004489-T01-IM5	P-0004489	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	484	40
P-0004491-T01-IM5	P-0004491	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female	Note: The  EGFR p.A289W mutation frequency suggests that it is on the amplified allele.Note: The FH copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	935	40
P-0004492-T01-IM5	P-0004492	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	701	40
P-0004493-T01-IM5	P-0004493	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	562	50
P-0004494-T01-IM5	P-0004494	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		462	40
P-0004495-T01-IM5	P-0004495	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The PGR, YAP1, BIRC3 and H3F3C copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	959	30
P-0004497-T01-IM5	P-0004497	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Mantle Cell Lymphoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number results by alternate methods is suggested if clinically indicated.	876	40
P-0004497-T02-IM5	P-0004497	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Axilla	Mantle Cell Lymphoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number results by alternate methods is suggested if clinically indicated.	816	60
P-0004498-T01-IM5	P-0004498	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Male		574	40
P-0004499-T01-IM5	P-0004499	Soft Tissue Sarcoma	Metastasis	Tumor	Brain	Breast	Leiomyosarcoma	IMPACT410			Female		570	60
P-0004500-T01-IM5	P-0004500	Cancer of Unknown Primary	Metastasis	Tumor	Skin	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q .	567	40
P-0004501-T01-IM5	P-0004501	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		709	20
P-0004502-T01-IM5	P-0004502	Colorectal Cancer	Primary	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	440	40
P-0004503-T01-IM5	P-0004503	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		780	60
P-0004504-T01-IM5	P-0004504	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		396	50
P-0004505-T01-IM5	P-0004505	Osteosarcoma	Metastasis	Tumor	Lung	Leg	Osteosarcoma	IMPACT410			Male	Note: The NF1, CDKN2B, CDKN2Ap16INK4A and CDKN2Ap16INK4A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	468	70
P-0004506-T01-IM5	P-0004506	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	571	50
P-0004507-T01-IM5	P-0004507	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		281	60
P-0004508-T01-IM5	P-0004508	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MLL2 p.R4468fs and p.L4462_L4466delinsQ mutations all occur in cis (same allele).	890	30
P-0004509-T01-IM5	P-0004509	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Abdomen	Abdomen	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 2p, 14q, 15q, 18q and 22q.	689	60
P-0004510-T01-IM5	P-0004510	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1368	50
P-0004511-T01-IM5	P-0004511	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		564	30
P-0004512-T01-IM5	P-0004512	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Soft Tissue	Leiomyosarcoma	IMPACT410			Female		628	60
P-0004513-T01-IM5	P-0004513	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female		677	60
P-0004514-T01-IM5	P-0004514	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		696	40
P-0004515-T01-IM5	P-0004515	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the ATRX p.R444* mutation is subclonal.	809	40
P-0004516-T01-IM5	P-0004516	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	578	20
P-0004516-T02-IM5	P-0004516	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5.	1060	60
P-0004517-T01-IM5	P-0004517	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		726	50
P-0004518-T01-IM5	P-0004518	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	more than 4% minor, threshold set at 10	447	40
P-0004519-T01-IM5	P-0004519	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The RHOA exon5 mutations all occur in cis (same allele).	567	10
P-0004520-T01-IM5	P-0004520	Biliary Cancer	Metastasis	Tumor	Lung	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		776	30
P-0004521-T01-IM5	P-0004521	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	889	40
P-0004522-T01-IM5	P-0004522	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	107	40
P-0004523-T01-IM5	P-0004523	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		850	30
P-0004524-T01-IM5	P-0004524	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	663	40
P-0004526-T01-IM5	P-0004526	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	718	30
P-0004527-T01-IM5	P-0004527	Melanoma	Metastasis	Tumor	In-transit	Foot	Acral Melanoma	IMPACT410			Female		256	60
P-0004528-T01-IM5	P-0004528	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		226	30
P-0004529-T01-IM5	P-0004529	Melanoma	Primary	Tumor	Not Applicable	Nasopharynx	Head and Neck Mucosal Melanoma	IMPACT410			Female		722	50
P-0004530-T01-IM5	P-0004530	Ovarian Cancer	Metastasis	Tumor	Paracolic Gutter	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	742	30
P-0004531-T01-IM5	P-0004531	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q	677	50
P-0004532-T01-IM5	P-0004532	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		309	40
P-0004533-T01-IM5	P-0004533	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	514	10
P-0004535-T01-IM5	P-0004535	Biliary Cancer	Metastasis	Tumor	Lung	Bile Duct	Cholangiocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 180X, negative results should be interpreted with caution.	180	40
P-0004536-T01-IM5	P-0004536	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Male		742	40
P-0004537-T01-IM5	P-0004537	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		538	30
P-0004538-T01-IM5	P-0004538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		698	30
P-0004539-T01-IM5	P-0004539	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		682	30
P-0004540-T01-IM5	P-0004540	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		802	50
P-0004541-T01-IM5	P-0004541	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Male		573	30
P-0004542-T01-IM5	P-0004542	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	735	20
P-0004543-T01-IM5	P-0004543	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male		304	50
P-0004544-T01-IM5	P-0004544	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..    Note: The XPO1, MSH2, and MSH6 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	880	40
P-0004545-T01-IM5	P-0004545	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: The STAG2 exon6 mutations all occur in cis (same allele).	953	40
P-0004546-T01-IM5	P-0004546	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	527	10
P-0004547-T01-IM5	P-0004547	Biliary Cancer	Primary	Tumor	Peritoneum	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		564	20
P-0004548-T01-IM5	P-0004548	Uterine Sarcoma	Metastasis	Tumor	Liver	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT410			Female		873	40
P-0004549-T01-IM5	P-0004549	Colorectal Cancer	Metastasis	Tumor	Peritoneal Fluid	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The KDM5A,CDK8,FLT3,FLT1,FGFR1 and MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	633	30
P-0004550-T01-IM5	P-0004550	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	659	30
P-0004551-T01-IM5	P-0004551	Esophagogastric Carcinoma	Metastasis	Tumor	Falciform Ligament	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	872	10
P-0004552-T01-IM5	P-0004552	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		689	40
P-0004553-T01-IM5	P-0004553	Cancer of Unknown Primary	Metastasis	Tumor	Abdomen	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	776	20
P-0004554-T01-IM5	P-0004554	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		646	40
P-0004555-T01-IM5	P-0004555	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	274	30
P-0004556-T01-IM5	P-0004556	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	739	20
P-0004557-T01-IM5	P-0004557	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	455	20
P-0004558-T01-IM5	P-0004558	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	595	40
P-0004559-T01-IM5	P-0004559	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Peripheral T-Cell Lymphoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	636	40
P-0004560-T01-IM5	P-0004560	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Stomach	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		641	40
P-0004561-T01-IM5	P-0004561	Renal Cell Carcinoma	Metastasis	Tumor	Brain	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		583	40
P-0004562-T01-IM5	P-0004562	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 155X, negative results should be interpreted with caution.	155	60
P-0004563-T01-IM5	P-0004563	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	689	20
P-0004564-T01-IM5	P-0004564	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The CCND1, FGF19, FGF4, FGF3 and PAK1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	857	40
P-0004565-T01-IM5	P-0004565	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	223	50
P-0004566-T01-IM5	P-0004566	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Variants in PIK3CA gene indicates the presence of sub-clones	696	50
P-0004567-T01-IM5	P-0004567	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.      Note: The BRCA2 exon11 mutations all occur in cis (same allele).	712	20
P-0004568-T01-IM5	P-0004568	Ovarian Cancer	Metastasis	Tumor	Lung	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		698	40
P-0004569-T01-IM5	P-0004569	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Adrenal Gland	Neuroblastoma	IMPACT410			Female		994	40
P-0004570-T01-IM5	P-0004570	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Atypical Meningioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p,  7p14-7p22, 11q23-11q24, 19p13.2- 19p13.3, and Chromosome 22.        Note: The JAK3 and PIK3R2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	582	60
P-0004571-T01-IM5	P-0004571	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	547	10
P-0004572-T01-IM5	P-0004572	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	447	40
P-0004573-T01-IM5	P-0004573	Cervical Cancer	Metastasis	Tumor	Lung	Cervix	Cervical Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	726	10
P-0004574-T01-IM5	P-0004574	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	879	40
P-0004576-T01-IM5	P-0004576	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		556	50
P-0004577-T01-IM5	P-0004577	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	169	50
P-0004578-T01-IM5	P-0004578	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p/19q.	553	50
P-0004580-T01-IM5	P-0004580	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	562	40
P-0004584-T01-IM5	P-0004584	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		758	20
P-0004585-T01-IM5	P-0004585	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Peripheral T-Cell Lymphoma	IMPACT410			Male		725	20
P-0004588-T01-IM5	P-0004588	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		756	10
P-0004589-T01-IM5	P-0004589	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ERBB2 and RARA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	618	30
P-0004590-T01-IM5	P-0004590	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The LATS2, CDK8, FLT1, FLT3 and BRCA2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	685	70
P-0004591-T01-IM5	P-0004591	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	602	40
P-0004592-T01-IM5	P-0004592	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low sequencing depth of coverage of 99X, negative results should be interpreted with caution.	99	40
P-0004593-T01-IM5	P-0004593	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The RASA1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	230	50
P-0004594-T01-IM5	P-0004594	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		358	40
P-0004595-T01-IM5	P-0004595	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	323	60
P-0004596-T01-IM5	P-0004596	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Sarcoma, Other	IMPACT410			Female		529	90
P-0004597-T01-IM5	P-0004597	Cancer of Unknown Primary	Metastasis	Tumor	Pelvis	Unknown	Cancer of Unknown Primary	IMPACT410			Male		390	30
P-0004597-T02-IM5	P-0004597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		775	20
P-0004598-T01-IM5	P-0004598	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		568	60
P-0004599-T01-IM5	P-0004599	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 103X, negative results should be interpreted with caution.	103	40
P-0004600-T01-IM5	P-0004600	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1047	40
P-0004600-T02-IM5	P-0004600	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the HIST1H3D exon2 mutation is subclonal.	420	40
P-0004601-T01-IM5	P-0004601	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	352	10
P-0004602-T01-IM5	P-0004602	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	688	30
P-0004603-T01-IM5	P-0004603	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		553	80
P-0004604-T01-IM5	P-0004604	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Groin	Epithelioid Sarcoma	IMPACT410			Female		620	50
P-0004605-T01-IM5	P-0004605	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		651	40
P-0004606-T01-IM5	P-0004606	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	880	50
P-0004607-T02-IM5	P-0004607	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR p.L858R mutation frequency suggests that the mutation might occur on the amplified allele.	571	50
P-0004607-T03-IM5	P-0004607	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		857	30
P-0004608-T01-IM5	P-0004608	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1072	20
P-0004609-T01-IM5	P-0004609	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		557	60
P-0004610-T01-IM5	P-0004610	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Mediastinum	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		887	50
P-0004611-T01-IM5	P-0004611	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1026	30
P-0004612-T01-IM5	P-0004612	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		454	30
P-0004613-T01-IM5	P-0004613	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	1007	40
P-0004614-T01-IM5	P-0004614	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Basal Cell Carcinoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	520	20
P-0004615-T01-IM5	P-0004615	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		514	60
P-0004616-T01-IM5	P-0004616	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Male		760	40
P-0004617-T01-IM5	P-0004617	Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Small Cell Lung Cancer	IMPACT410			Male		729	30
P-0004618-T01-IM5	P-0004618	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	652	20
P-0004618-T02-IM5	P-0004618	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: The MLL2 exon34 p.E2911K and p.G2889E mutations all occur in cis (same allele).	1125	40
P-0004619-T01-IM5	P-0004619	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		583	30
P-0004620-T01-IM5	P-0004620	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 15q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and Chromsome 12.	1215	60
P-0004621-T01-IM5	P-0004621	Germ Cell Tumor	Metastasis	Tumor	Lung	Testis	Seminoma	IMPACT410			Male		321	50
P-0004622-T01-IM5	P-0004622	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	356	40
P-0004622-T02-IM5	P-0004622	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		706	40
P-0004623-T01-IM5	P-0004623	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT410			Female	Note: Variants in PIK3CA and IGF1R genes indicate the presence of sub-clones      Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.     Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	508	50
P-0004625-T01-IM5	P-0004625	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Assessment of the copy number profile is  precluded by increased background noise.	752	40
P-0004626-T01-IM5	P-0004626	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	513	10
P-0004627-T01-IM5	P-0004627	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		608	40
P-0004629-T01-IM5	P-0004629	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		582	30
P-0004630-T01-IM5	P-0004630	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	471	40
P-0004631-T01-IM5	P-0004631	Ovarian Cancer	Metastasis	Tumor	Pleura	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	580	50
P-0004632-T01-IM5	P-0004632	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	652	30
P-0004633-T01-IM5	P-0004633	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		720	40
P-0004634-T01-IM5	P-0004634	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		700	30
P-0004635-T01-IM5	P-0004635	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Angiosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q14-11q23.	300	50
P-0004636-T01-IM5	P-0004636	Mesothelioma	Metastasis	Tumor	Lymph Node	Pleura	Pleural Mesothelioma	IMPACT410			Male		620	50
P-0004637-T01-IM5	P-0004637	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	358	40
P-0004638-T01-IM5	P-0004638	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Female		331	60
P-0004639-T01-IM5	P-0004639	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Spleen	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A, and  CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	756	40
P-0004640-T01-IM5	P-0004640	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	225	10
P-0004641-T01-IM5	P-0004641	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male		950	50
P-0004642-T01-IM5	P-0004642	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q31-1q44.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p, 5q32-5q35, 10, and 17p.	796	40
P-0004643-T01-IM5	P-0004643	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		365	30
P-0004644-T01-IM5	P-0004644	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		605	40
P-0004645-T01-IM5	P-0004645	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14q.	722	50
P-0004646-T01-IM5	P-0004646	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The NBN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	486	30
P-0004647-T01-IM5	P-0004647	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		533	40
P-0004648-T01-IM5	P-0004648	Appendiceal Cancer	Metastasis	Tumor	Stomach	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	738	10
P-0004649-T01-IM5	P-0004649	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	648	20
P-0004650-T01-IM5	P-0004650	Melanoma	Metastasis	Tumor	Liver	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: The JUN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	809	40
P-0004651-T01-IM5	P-0004651	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Abdomen	Gastrointestinal Stromal Tumor	IMPACT410			Male		589	50
P-0004652-T01-IM5	P-0004652	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	678	20
P-0004653-T01-IM5	P-0004653	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		1045	40
P-0004654-T01-IM5	P-0004654	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		743	40
P-0004655-T01-IM5	P-0004655	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1142	20
P-0004656-T01-IM5	P-0004656	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	681	20
P-0004657-T01-IM5	P-0004657	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Low sequencing depth of coverage of 172X, negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	172	50
P-0004657-T02-IM5	P-0004657	Soft Tissue Sarcoma	Primary	Tumor	Retroperitoneum	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male		638	60
P-0004658-T01-IM5	P-0004658	Non-Small Cell Lung Cancer	Metastasis	Tumor	Epidural	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	440	20
P-0004659-T01-IM5	P-0004659	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The SPEN exon11 mutations all occur in cis (same allele).	421	30
P-0004660-T01-IM5	P-0004660	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		723	50
P-0004661-T01-IM5	P-0004661	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		752	50
P-0004662-T02-IM5	P-0004662	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Oral Cavity	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		243	50
P-0004663-T01-IM5	P-0004663	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Biphasic Type	IMPACT410			Male	Note: The ERBB4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	711	70
P-0004664-T01-IM5	P-0004664	Salivary Carcinoma	Metastasis	Tumor	Colon	Soft Tissue	Myoepithelial Carcinoma	IMPACT410			Female		790	30
P-0004665-T01-IM5	P-0004665	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1, FGF19, FGF4, and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	702	50
P-0004666-T01-IM5	P-0004666	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		708	40
P-0004667-T01-IM5	P-0004667	Soft Tissue Sarcoma	Metastasis	Tumor	Muscle	Pelvis	Myxoid/Round-Cell Liposarcoma	IMPACT410			Female	Note: The RAD51, MGA, and BCL2L11 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	665	80
P-0004668-T01-IM5	P-0004668	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	460	20
P-0004669-T01-IM5	P-0004669	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		207	20
P-0004670-T01-IM5	P-0004670	Breast Carcinoma	Metastasis	Tumor	Bladder	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Variants in ERBB2, LATS1, and ANKRD11 genes indicate the presence of sub-clones      Note: The CCND1, FGF19, FGF4, and FGF3  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	565	50
P-0004671-T01-IM5	P-0004671	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	520	20
P-0004673-T01-IM5	P-0004673	Colorectal Cancer	Metastasis	Tumor	Sigmoid Colon	Cecum	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: The SMAD4 exon9 mutations occur on different alleles.	557	20
P-0004674-T01-IM5	P-0004674	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: The NOTCH1 exon7 mutations occur on different alleles.         Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 14q, 18q and 19q.	671	60
P-0004675-T01-IM5	P-0004675	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		742	30
P-0004676-T01-IM5	P-0004676	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		858	70
P-0004677-T01-IM5	P-0004677	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3q, 14q and 22q.	852	50
P-0004678-T01-IM5	P-0004678	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		693	40
P-0004679-T01-IM5	P-0004679	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		785	20
P-0004680-T01-IM5	P-0004680	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	GE Junction	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	478	30
P-0004680-T02-IM5	P-0004680	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	926	30
P-0004681-T01-IM5	P-0004681	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The RICTOR, MYC and RAD21 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	412	40
P-0004682-T01-IM5	P-0004682	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Adrenal Gland	Dedifferentiated Liposarcoma	IMPACT410			Male		841	40
P-0004683-T01-IM5	P-0004683	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p/19q and 18q and chromosomes 4 and 9.	688	60
P-0004684-T01-IM5	P-0004684	Ovarian Cancer	Metastasis	Tumor	Diaphragm	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	826	30
P-0004685-T02-IM5	P-0004685	Chondrosarcoma	Primary	Tumor	Not Applicable	Pelvis	Chondrosarcoma	IMPACT410			Male		538	30
P-0004686-T01-IM5	P-0004686	Melanoma	Primary	Tumor	Not Applicable	Anus	Anorectal Mucosal Melanoma	IMPACT410			Female		1057	40
P-0004687-T01-IM5	P-0004687	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The JAK2 and CD274 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	502	20
P-0004688-T01-IM5	P-0004688	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: The BCL2L11 exon4  mutations occur on different alleles.	912	10
P-0004689-T01-IM5	P-0004689	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Diffuse Type Stomach Adenocarcinoma	IMPACT410			Male		963	20
P-0004690-T01-IM5	P-0004690	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		740	30
P-0004691-T01-IM5	P-0004691	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		733	30
P-0004692-T01-IM5	P-0004692	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		815	30
P-0004693-T01-IM5	P-0004693	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		872	20
P-0004694-T01-IM5	P-0004694	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		778	50
P-0004696-T01-IM5	P-0004696	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		788	30
P-0004697-T01-IM5	P-0004697	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		687	40
P-0004698-T01-IM5	P-0004698	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		601	40
P-0004699-T01-IM5	P-0004699	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		815	40
P-0004700-T01-IM5	P-0004700	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	732	20
P-0004701-T01-IM5	P-0004701	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		595	20
P-0004702-T02-IM5	P-0004702	Breast Carcinoma	Metastasis	Tumor	Colon	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	500	30
P-0004702-T03-IM5	P-0004702	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		955	50
P-0004703-T01-IM5	P-0004703	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		802	60
P-0004704-T01-IM5	P-0004704	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		433	40
P-0004705-T01-IM5	P-0004705	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Female		665	50
P-0004706-T01-IM5	P-0004706	Melanoma	Metastasis	Tumor	Colon	Eye	Uveal Melanoma	IMPACT410			Male	Note: The RAD21, MYC and RECQL4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	577	60
P-0004707-T01-IM5	P-0004707	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		657	40
P-0004708-T01-IM5	P-0004708	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	599	20
P-0004709-T01-IM5	P-0004709	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		643	40
P-0004710-T01-IM5	P-0004710	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1006	10
P-0004711-T01-IM5	P-0004711	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Peripheral T-Cell Lymphoma	IMPACT410			Male	TET2 exon3 frameshift_deletion NM_001127208 c.2269delC p.L757fs 0.18724  TET2 exon3 frameshift_deletion NM_001127208 c.1450_1463delTGTGTGAACAGGAA p.C484fs 0.18153  found with unmatched calling	1005	50
P-0004712-T01-IM5	P-0004712	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		784	40
P-0004713-T01-IM5	P-0004713	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Female		652	40
P-0004714-T01-IM5	P-0004714	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The CCNE1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	828	30
P-0004716-T02-IM5	P-0004716	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses  on Chromosome arm 1p, 6p, 10, 11q, 15, and 18    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q	618	40
P-0004717-T01-IM5	P-0004717	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Endometrial Stromal Sarcoma	IMPACT410			Female		659	40
P-0004718-T01-IM5	P-0004718	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 5q11-24.	656	60
P-0004719-T01-IM5	P-0004719	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	501	20
P-0004720-T01-IM5	P-0004720	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female		727	50
P-0004721-T01-IM5	P-0004721	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,4q,13q and 19q.	534	40
P-0004722-T01-IM5	P-0004722	Ovarian Cancer	Metastasis	Tumor	Rectum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	669	50
P-0004723-T01-IM5	P-0004723	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female		657	40
P-0004725-T01-IM5	P-0004725	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	600	10
P-0004726-T01-IM5	P-0004726	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male	variants were matched against the normal run in run 152 for both this and T sample.	516	50
P-0004726-T02-IM5	P-0004726	Germ Cell Tumor	Metastasis	Tumor	Pelvis	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male	variants were matched against the normal run in run 152 for both this and the T2 sample.	455	50
P-0004727-T01-IM5	P-0004727	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	825	20
P-0005394-T01-IM5	P-0005409	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 1,2, 6, 10, 13, 17, 21 and 22.	606	60
P-0006224-T01-IM5	P-0006224	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Lung	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: The SPOP, RNF43, RAD51C, CD79B, CDK4 and AXIN2  copy number gains    fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. Note: The NF1, SDHA, SUZ12 and RAD51D copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	893	80
P-0006576-T01-IM5	P-0006576	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	888	10
P-0006900-T01-IM5	P-0006900	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		801	NA
P-0007008-T01-IM5	P-0007008	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		655	30
P-0001526-T02-IM5	P-0001526	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Pancreas	Neuroendocrine Tumor, NOS	IMPACT410			Male		503	80
P-0003264-T02-IM5	P-0003264	Embryonal Tumor	Metastasis	Tumor	Soft Tissue	Retroperitoneum	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.Note: Copy number profile is suggestive of broad copy number loss on Chromosome X.	893	80
P-0004524-T02-IM5	P-0004524	Ovarian Cancer	Metastasis	Tumor	Gallbladder	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7q.	952	90
P-0004909-T02-IM5	P-0004909	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		510	80
P-0007358-T02-IM5	P-0007358	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1028	90
P-0008544-T01-IM5	P-0008544	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	512	10
P-0008544-T02-IM5	P-0008544	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a slight copy number gain suggestive of the presence of i(12p).	708	60
P-0008625-T03-IM5	P-0008625	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female	Note: Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva and blood sample.	632	20
P-0008650-T02-IM5	P-0008650	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male		982	80
P-0008790-T01-IM5	P-0008790	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		827	60
P-0008791-T01-IM5	P-0008791	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Larynx	Spindle Cell Rhabdomyosarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	617	60
P-0008792-T01-IM5	P-0008792	Head and Neck Carcinoma	Metastasis	Tumor	Brain	Larynx	Larynx Squamous Cell Carcinoma	IMPACT410			Male		935	80
P-0008795-T01-IM5	P-0008795	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		953	20
P-0008796-T01-IM5	P-0008796	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male		1255	50
P-0008799-T01-IM5	P-0008799	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 3p.	893	50
P-0008817-T01-IM5	P-0008817	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Skin	Angiosarcoma	IMPACT410			Male		960	80
P-0008830-T01-IM5	P-0008830	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		561	60
P-0008831-T01-IM5	P-0008831	Adrenocortical Carcinoma	Metastasis	Tumor	Soft Tissue	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male		1079	90
P-0008832-T01-IM5	P-0008832	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		641	20
P-0008833-T01-IM5	P-0008833	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		967	40
P-0008834-T01-IM5	P-0008834	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9, 11p and 17p.	603	80
P-0008835-T01-IM5	P-0008835	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	493	20
P-0008837-T01-IM5	P-0008837	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		846	80
P-0008838-T01-IM5	P-0008838	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		644	40
P-0008839-T01-IM5	P-0008839	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1014	20
P-0008840-T01-IM5	P-0008840	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		978	30
P-0008841-T01-IM5	P-0008841	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1205	10
P-0008842-T01-IM5	P-0008842	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	776	90
P-0008843-T01-IM5	P-0008843	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Inflammatory Myofibroblastic Tumor	IMPACT410			Female		1025	90
P-0008844-T01-IM5	P-0008844	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		1012	20
P-0008845-T01-IM5	P-0008845	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		883	90
P-0008846-T01-IM5	P-0008846	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		788	30
P-0008847-T01-IM5	P-0008847	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Duodenum	B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patient's matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1073	80
P-0008849-T01-IM5	P-0008849	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		583	20
P-0008850-T01-IM5	P-0008850	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q26-3q28.	1002	70
P-0008851-T01-IM5	P-0008851	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male		1102	90
P-0008852-T01-IM5	P-0008852	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		507	90
P-0008853-T01-IM5	P-0008853	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		961	90
P-0008854-T01-IM5	P-0008854	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Spindle Cell Carcinoma of the Lung	IMPACT410			Female		1064	20
P-0008855-T01-IM5	P-0008855	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		684	50
P-0008856-T01-IM5	P-0008856	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1095	80
P-0008858-T01-IM5	P-0008858	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		482	80
P-0008860-T01-IM5	P-0008860	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Vulva	Epithelioid Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.	814	90
P-0008861-T01-IM5	P-0008861	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Male		924	60
P-0008862-T01-IM5	P-0008862	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1042	70
P-0008863-T01-IM5	P-0008863	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		908	30
P-0008865-T01-IM5	P-0008865	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		721	80
P-0008866-T01-IM5	P-0008866	Soft Tissue Sarcoma	Metastasis	Tumor	Vertebrate	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male		740	80
P-0008867-T01-IM5	P-0008867	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	846	20
P-0008869-T01-IM5	P-0008869	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		600	40
P-0008871-T01-IM5	P-0008871	Non-Small Cell Lung Cancer	Metastasis	Tumor	Cerebellum	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		724	80
P-0008872-T01-IM5	P-0008872	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Serous Cystadenoma of the Pancreas	IMPACT410			Female		644	80
P-0008874-T01-IM5	P-0008874	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		923	30
P-0008876-T01-IM5	P-0008876	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		1093	80
P-0008877-T01-IM5	P-0008877	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Leiomyosarcoma	IMPACT410			Male		689	80
P-0008878-T01-IM5	P-0008878	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		1059	40
P-0008879-T01-IM5	P-0008879	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		642	50
P-0008880-T01-IM5	P-0008880	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	745	20
P-0008882-T01-IM5	P-0008882	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Poorly Differentiated Carcinoma of the Stomach	IMPACT410			Male		822	40
P-0005950-T01-IM5	P-0005950	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		723	40
P-0008404-T01-IM5	P-0008404	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	227	80
P-0008881-T01-IM5	P-0008881	Salivary Carcinoma	Metastasis	Tumor	Lymph node	Parotid Gland	Salivary Duct Carcinoma	IMPACT410			Female		781	90
P-0008901-T01-IM5	P-0008901	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		625	50
P-0008902-T01-IM5	P-0008902	Non-Small Cell Lung Cancer	Metastasis	Tumor	Groin	Lung	Lung Adenocarcinoma	IMPACT410			Female		828	70
P-0008903-T01-IM5	P-0008903	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		908	50
P-0008904-T01-IM5	P-0008904	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female		978	30
P-0008905-T01-IM5	P-0008905	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patient's matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1274	40
P-0008906-T01-IM5	P-0008906	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		669	50
P-0008907-T01-IM5	P-0008907	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Gallbladder	Neuroendocrine Carcinoma, NOS	IMPACT410			Male		996	70
P-0008908-T01-IM5	P-0008908	Non-Small Cell Lung Cancer	Metastasis	Tumor	Spine	Lung	Lung Adenocarcinoma	IMPACT410			Male		468	80
P-0008909-T01-IM5	P-0008909	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		428	30
P-0008911-T01-IM5	P-0008911	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	708	25
P-0008913-T01-IM5	P-0008913	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	813	20
P-0008914-T01-IM5	P-0008914	Cancer of Unknown Primary	Metastasis	Tumor	Bone	Unknown	Neuroendocrine Tumor, NOS	IMPACT410			Male		911	90
P-0005602-T02-IM5	P-0005602	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q21-8q24.	1092	30
P-0005787-T02-IM5	P-0005787	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		777	40
P-0008350-T02-IM5	P-0008350	Colorectal Cancer	Metastasis	Tumor	Ovary	Cecum	Colon Adenocarcinoma	IMPACT410			Female		158	50
P-0008759-T02-IM5	P-0008759	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Female		1197	80
P-0008761-T03-IM5	P-0008761	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1151	40
P-0008769-T02-IM5	P-0008769	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		673	80
P-0008916-T01-IM5	P-0008916	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Marginal Zone Lymphoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1068	20
P-0008917-T01-IM5	P-0008917	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		855	25
P-0008919-T01-IM5	P-0008919	Pancreatic Cancer	Metastasis	Tumor	Pleura	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		752	30
P-0008920-T01-IM5	P-0008920	Prostate Cancer	Metastasis	Tumor	Testis	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		699	70
P-0008922-T01-IM5	P-0008922	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	832	40
P-0008922-T02-IM5	P-0008922	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		853	40
P-0008924-T01-IM5	P-0008924	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Male		1151	95
P-0008927-T01-IM5	P-0008927	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		757	60
P-0009000-T01-IM5	P-0009000	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1139	80
P-0009003-T01-IM5	P-0009003	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Scalp	Sebaceous Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	1229	90
P-0009004-T01-IM5	P-0009004	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1079	50
P-0002000-T02-IM5	P-0002000	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		792	60
P-0005088-T02-IM5	P-0005088	Mesothelioma	Metastasis	Tumor	Pleural Fluid	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	972	30
P-0006161-T02-IM5	P-0006161	Breast Carcinoma	Metastasis	Tumor	Femur	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1021	20
P-0008531-T02-IM5	P-0008531	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 14q23-14q32,  and 19q.	738	40
P-0008536-T02-IM5	P-0008536	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Gastroesophageal Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	668	40
P-0008857-T02-IM5	P-0008857	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female		1064	70
P-0008915-T01-IM5	P-0008915	Non-Small Cell Lung Cancer	Metastasis	Tumor	Stomach	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		939	20
P-0008928-T01-IM5	P-0008928	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1164	40
P-0008929-T01-IM5	P-0008929	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		1152	30
P-0008930-T01-IM5	P-0008930	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 16q, 19p , 9p and 11q22  .Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q11-13 and 16p13.	352	90
P-0008931-T01-IM5	P-0008931	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1097	50
P-0008932-T01-IM5	P-0008932	Head and Neck Carcinoma	Metastasis	Tumor	Cerebellum	Tongue	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		938	80
P-0008933-T01-IM5	P-0008933	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		840	80
P-0008934-T01-IM5	P-0008934	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		913	50
P-0008935-T01-IM5	P-0008935	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		543	80
P-0008936-T01-IM5	P-0008936	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT410			Female		913	60
P-0008937-T01-IM5	P-0008937	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 14q, 19q and 22q.	487	90
P-0008938-T01-IM5	P-0008938	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Follicular Lymphoma	IMPACT410			Male	Note: Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva and blood sample.	1279	95
P-0008939-T01-IM5	P-0008939	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1067	90
P-0008940-T01-IM5	P-0008940	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	754	30
P-0008941-T01-IM5	P-0008941	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		905	30
P-0008942-T01-IM5	P-0008942	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	794	80
P-0008944-T01-IM5	P-0008944	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		718	40
P-0008945-T01-IM5	P-0008945	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		621	80
P-0008947-T01-IM5	P-0008947	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		955	80
P-0008948-T01-IM5	P-0008948	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 3p.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q, 11q, 18q, and 16q.	382	50
P-0008949-T01-IM5	P-0008949	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	955	10
P-0008950-T01-IM5	P-0008950	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	639	20
P-0008951-T01-IM5	P-0008951	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	752	10
P-0008952-T01-IM5	P-0008952	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	725	40
P-0008953-T01-IM5	P-0008953	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1000	50
P-0008954-T01-IM5	P-0008954	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		919	95
P-0008956-T01-IM5	P-0008956	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		771	10
P-0008957-T01-IM5	P-0008957	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		743	25
P-0008958-T01-IM5	P-0008958	Germ Cell Tumor	Metastasis	Tumor	Vertebrate	Retroperitoneum	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	1002	90
P-0008959-T01-IM5	P-0008959	Mesothelioma	Primary	Tumor	Not Applicable	Chest Wall	Pleural Mesothelioma	IMPACT410			Male		736	40
P-0008960-T01-IM5	P-0008960	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		980	80
P-0008961-T01-IM5	P-0008961	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1056	90
P-0008963-T01-IM5	P-0008963	Melanoma	Metastasis	Tumor	Small Bowel	Skin	Cutaneous Melanoma	IMPACT410			Male		528	90
P-0008964-T01-IM5	P-0008964	Renal Cell Carcinoma	Metastasis	Tumor	Omentum	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		854	60
P-0008994-T01-IM5	P-0008994	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1114	30
P-0008995-T01-IM5	P-0008995	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	689	30
P-0008996-T01-IM5	P-0008996	Salivary Carcinoma	Primary	Tumor	Not Applicable	Mouth	Salivary Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1028	10
P-0008997-T01-IM5	P-0008997	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1223	80
P-0008998-T01-IM5	P-0008998	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		681	30
P-0008999-T01-IM5	P-0008999	Melanoma	Metastasis	Tumor	Spine	Skin	Cutaneous Melanoma	IMPACT410			Male		881	50
P-0009001-T01-IM5	P-0009001	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		919	50
P-0009002-T01-IM5	P-0009002	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	1058	20
P-0009005-T01-IM5	P-0009005	Bladder Cancer	Metastasis	Tumor	Brain	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1098	50
P-0009006-T01-IM5	P-0009006	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	253	30
P-0009008-T01-IM5	P-0009008	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	741	30
P-0009009-T01-IM5	P-0009009	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Mucinous Colorectal Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	829	10
P-0009011-T01-IM5	P-0009011	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Small Bowel	Ampullary Carcinoma	IMPACT410			Male		365	40
P-0009012-T01-IM5	P-0009012	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		891	40
P-0009013-T01-IM5	P-0009013	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	791	10
P-0009014-T01-IM5	P-0009014	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		1053	40
P-0009015-T01-IM5	P-0009015	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Carcinoma	IMPACT410			Female		764	90
P-0009017-T01-IM5	P-0009017	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		1097	40
P-0008965-T01-IM5	P-0008965	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9q12-9q31.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 11q22-11q24 and 18q.	991	80
P-0009098-T01-IM5	P-0009098	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p21.	920	15
P-0004770-T05-IM5	P-0004770	Histiocytosis	Primary	Tumor	Not Applicable	Soft Tissue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	939	10
P-0005283-T02-IM5	P-0005283	Embryonal Tumor	Metastasis	Tumor	Brain	Adrenal Gland	Neuroblastoma	IMPACT410			Male		880	90
P-0006410-T02-IM5	P-0006410	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3q21-23 and 3p.	919	90
P-0008142-T02-IM5	P-0008142	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female		855	10
P-0008794-T01-IM5	P-0008794	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Spleen	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		647	50
P-0009042-T01-IM5	P-0009042	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		698	30
P-0009043-T01-IM5	P-0009043	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Poorly Differentiated Carcinoma of the Stomach	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	988	10
P-0009044-T01-IM5	P-0009044	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		936	80
P-0009045-T01-IM5	P-0009045	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		932	90
P-0009046-T01-IM5	P-0009046	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		932	50
P-0009047-T01-IM5	P-0009047	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1053	20
P-0009048-T01-IM5	P-0009048	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1250	90
P-0009050-T01-IM5	P-0009050	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: No alterations identified in the context of high tumor content .More comprehensive testing could be valuable.	813	50
P-0009051-T01-IM5	P-0009051	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Female		302	80
P-0009052-T01-IM5	P-0009052	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm loss 9p21.	846	90
P-0009053-T01-IM5	P-0009053	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1044	15
P-0009054-T01-IM5	P-0009054	Retinoblastoma	Primary	Tumor	Not Applicable	Eye	Retinoblastoma	IMPACT410			Male		802	60
P-0009055-T01-IM5	P-0009055	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Poorly Differentiated Carcinoma	IMPACT410			Male		981	20
P-0009085-T01-IM5	P-0009085	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		842	50
P-0009086-T01-IM5	P-0009086	Bladder Cancer	Primary	Tumor	Not Applicable	Kidney/Upper tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female		720	50
P-0009088-T01-IM5	P-0009088	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male		971	60
P-0009089-T01-IM5	P-0009089	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT410			Female		1125	90
P-0009090-T01-IM5	P-0009090	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	801	10
P-0009091-T01-IM5	P-0009091	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		430	30
P-0009092-T01-IM5	P-0009092	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		992	10
P-0009093-T01-IM5	P-0009093	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		816	15
P-0008873-T01-IM5	P-0008873	Ovarian Cancer	Metastasis	Tumor	Pleural Fluid	Ovary	Mixed Ovarian Carcinoma	IMPACT410			Female	On hold to check with  Maria for the BRCA1 intragenic call.	854	90
P-0009094-T01-IM5	P-0009094	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female		1145	70
P-0009095-T01-IM5	P-0009095	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosomes 7, 12, 17 and 21.	961	40
P-0009096-T01-IM5	P-0009096	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1143	40
P-0009100-T01-IM5	P-0009100	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophagogastric Adenocarcinoma	IMPACT410			Male		1066	30
P-0009101-T01-IM5	P-0009101	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1138	15
P-0009103-T01-IM5	P-0009103	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Leg	Sarcoma, NOS	IMPACT410			Female	Mutation assessment: Mutations are called against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal. False negatives cannot be ruled out.	717	20
P-0009104-T01-IM5	P-0009104	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female		259	30
P-0009105-T01-IM5	P-0009105	Melanoma	Metastasis	Tumor	Omentum	Unknown	Melanoma of Unknown Primary	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	778	30
P-0009106-T01-IM5	P-0009106	Melanoma	Metastasis	Tumor	Liver	Anus	Anorectal Mucosal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 6p and 7p.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 16p, and 16q23-16q24.	894	60
P-0009107-T01-IM5	P-0009107	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Pancreas	Pancreatobiliary Ampullary Carcinoma	IMPACT410			Male		201	25
P-0009109-T01-IM5	P-0009109	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		458	50
P-0009110-T01-IM5	P-0009110	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1102	10
P-0009112-T01-IM5	P-0009112	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	350	10
P-0009113-T01-IM5	P-0009113	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 10 and Chromosome arms 14q and 22q .	1298	90
P-0009114-T01-IM5	P-0009114	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		480	20
P-0009115-T01-IM5	P-0009115	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Mutation assessment: Mutations are called against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal. False negatives cannot be ruled out.	769	10
P-0009116-T01-IM5	P-0009116	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Femoral Vein	Epithelioid Hemangioendothelioma	IMPACT410			Female		930	60
P-0009117-T01-IM5	P-0009117	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	269	20
P-0009119-T01-IM5	P-0009119	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		937	90
P-0009120-T01-IM5	P-0009120	Breast Carcinoma	Metastasis	Tumor	Vertebrate	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		568	50
P-0009121-T01-IM5	P-0009121	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	851	60
P-0009122-T01-IM5	P-0009122	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		895	80
P-0004728-T01-IM5	P-0004728	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	minor 1%	797	20
P-0004729-T01-IM5	P-0004729	Non-Small Cell Lung Cancer	Metastasis	Tumor	Epidural	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MLL, CBL, KDM5A, RAD52 and ETV6 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	632	NA
P-0004730-T01-IM5	P-0004730	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The PIK3R1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	766	40
P-0004731-T01-IM5	P-0004731	Uterine Sarcoma	Metastasis	Tumor	Soft Tissue	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: The IDH2 and BLM copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	352	50
P-0004732-T01-IM5	P-0004732	Germ Cell Tumor	Metastasis	Tumor	Paraspinal	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	647	30
P-0004733-T01-IM5	P-0004733	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA).  Negative results should be interpreted with caution.Note: Low sequencing depth of coverage of XXX, negative results should be interpreted with caution.	170	50
P-0004733-T02-IM5	P-0004733	Non-Small Cell Lung Cancer	Primary	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male		781	NA
P-0004734-T01-IM5	P-0004734	Thyroid Cancer	Metastasis	Tumor	Larynx	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Male		456	60
P-0004735-T01-IM5	P-0004735	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		581	20
P-0004736-T01-IM5	P-0004736	Colorectal Cancer	Metastasis	Tumor	Pelvis	Colon	Colon Adenocarcinoma	IMPACT410			Female		458	20
P-0004737-T01-IM5	P-0004737	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1009	30
P-0004738-T01-IM5	P-0004738	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		455	40
P-0004739-T01-IM5	P-0004739	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		910	20
P-0004740-T01-IM5	P-0004740	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: The MYC exons2 ( p.E54A , p.P72S)  mutations all occur in cis (same allele). Note: The MYC exons2 ( p.D100E, p.T110A)  mutations all occur in cis (same allele). Note: The MYC exons2 ( p.S218N, p.P220S)  mutations all occur in cis (same allele).	557	30
P-0004741-T01-IM5	P-0004741	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Male		532	20
P-0004742-T01-IM5	P-0004742	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	744	40
P-0004743-T01-IM5	P-0004743	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		545	50
P-0004744-T01-IM5	P-0004744	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	940	30
P-0004745-T01-IM5	P-0004745	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Esophagus	Leiomyosarcoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	846	40
P-0004746-T01-IM5	P-0004746	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Male		1212	60
P-0004747-T01-IM5	P-0004747	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		528	30
P-0004748-T01-IM5	P-0004748	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female		342	30
P-0004752-T01-IM5	P-0004752	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	580	30
P-0004753-T01-IM5	P-0004753	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	957	30
P-0004754-T01-IM5	P-0004754	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		559	40
P-0004755-T01-IM5	P-0004755	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		666	40
P-0004756-T01-IM5	P-0004756	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		384	70
P-0004757-T01-IM5	P-0004757	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		131	40
P-0004758-T01-IM5	P-0004758	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		762	20
P-0004759-T01-IM5	P-0004759	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		677	30
P-0004760-T01-IM5	P-0004760	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: A comparison of variant frequencies suggests the KIT p.Y823D mutation is subclonal.	182	60
P-0004761-T01-IM5	P-0004761	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Cervical Squamous Cell Carcinoma	IMPACT410			Female		849	20
P-0004762-T01-IM5	P-0004762	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the KRAS p.G12D mutation is subclonal.	321	20
P-0004763-T01-IM5	P-0004763	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male	Note: Due to marginal sample quality, all negative results should be interpreted with caution. Low sequencing depth of coverage of 89X, negative results should be interpreted with caution.	89	20
P-0004764-T01-IM5	P-0004764	Embryonal Tumor	Metastasis	Tumor	Epidural	Brain	Neuroblastoma	IMPACT410			Female		989	30
P-0004765-T01-IM5	P-0004765	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		827	50
P-0004766-T01-IM5	P-0004766	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	554	10
P-0004768-T01-IM5	P-0004768	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PIK3CA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	503	10
P-0004769-T01-IM5	P-0004769	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		600	30
P-0004770-T01-IM5	P-0004770	Histiocytosis	Primary	Tumor	Not Applicable	Bone	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	554	20
P-0004770-T02-IM5	P-0004770	Histiocytosis	Primary	Tumor	Not Applicable	Bone	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	713	20
P-0004771-T01-IM5	P-0004771	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	743	20
P-0004772-T01-IM5	P-0004772	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.        Note: MSK-IMPACT test panel does not cover CIC rearrangements.      Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 12p,16q and 19q	716	80
P-0004773-T01-IM5	P-0004773	Salivary Carcinoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Myoepithelial Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	992	60
P-0004774-T01-IM5	P-0004774	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Female	Note: The BAP1, CDKN2B, CDKN2Ap16INK4A, CDKN2Ap14ARF copy number loss fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	631	40
P-0004775-T01-IM5	P-0004775	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The AURKA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.        Note: The RUNX1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	743	40
P-0004776-T01-IM5	P-0004776	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	705	60
P-0004777-T01-IM5	P-0004777	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female		530	30
P-0004778-T01-IM5	P-0004778	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		732	40
P-0004779-T01-IM5	P-0004779	Biliary Cancer	Metastasis	Tumor	Lymph Node	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	695	10
P-0004780-T01-IM5	P-0004780	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Upper Extremity	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		510	20
P-0004781-T01-IM5	P-0004781	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		855	40
P-0004782-T01-IM5	P-0004782	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	588	60
P-0004783-T01-IM5	P-0004783	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		587	40
P-0004784-T01-IM5	P-0004784	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Abdomen	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q, 5, 7,and  8q.   Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 11q, 13,14,15, 21, and 22.	732	60
P-0004785-T01-IM5	P-0004785	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	486	40
P-0004786-T01-IM5	P-0004786	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		744	30
P-0004787-T01-IM5	P-0004787	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	980	50
P-0004788-T01-IM5	P-0004788	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		684	20
P-0004789-T01-IM5	P-0004789	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		688	40
P-0004790-T01-IM5	P-0004790	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MLL3 exon38 mutations all occur in cis (same allele).	883	50
P-0004791-T01-IM5	P-0004791	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		594	40
P-0004792-T01-IM5	P-0004792	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		903	40
P-0004793-T01-IM5	P-0004793	Endometrial Cancer	Metastasis	Tumor	Spleen	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: The ERBB2 and CDK12  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	573	70
P-0004794-T01-IM5	P-0004794	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		725	60
P-0004795-T01-IM5	P-0004795	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	minor at 1%	664	30
P-0004796-T01-IM5	P-0004796	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		716	40
P-0004797-T01-IM5	P-0004797	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	494	10
P-0004798-T01-IM5	P-0004798	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		694	60
P-0004799-T01-IM5	P-0004799	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Male		715	50
P-0004800-T01-IM5	P-0004800	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		774	70
P-0004801-T01-IM5	P-0004801	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	983	40
P-0004802-T01-IM5	P-0004802	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female		934	NA
P-0004803-T01-IM5	P-0004803	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The GNAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	532	60
P-0004804-T01-IM5	P-0004804	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: The CCND2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	638	70
P-0004805-T01-IM5	P-0004805	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..    Note: The ID3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	541	70
P-0004806-T01-IM5	P-0004806	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		664	30
P-0004807-T01-IM5	P-0004807	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		419	70
P-0004808-T01-IM5	P-0004808	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	422	50
P-0004809-T02-IM5	P-0004809	Appendiceal Cancer	Metastasis	Tumor	Small Bowel	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male		825	70
P-0004810-T01-IM5	P-0004810	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The CCND3 and VEGFA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	969	30
P-0004811-T01-IM5	P-0004811	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The AXL copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	605	70
P-0004812-T01-IM5	P-0004812	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 1p and 19q.	744	70
P-0004813-T02-IM5	P-0004813	Renal Cell Carcinoma	Primary	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		854	60
P-0004814-T01-IM5	P-0004814	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	802	30
P-0004815-T01-IM5	P-0004815	Melanoma	Metastasis	Tumor	Liver	Conjunctiva	Head and Neck Mucosal Melanoma	IMPACT410			Male		1296	80
P-0004816-T01-IM5	P-0004816	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 181X, negative results should be interpreted with caution.	181	40
P-0004817-T01-IM5	P-0004817	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Basal Cell Carcinoma	IMPACT410			Female		926	30
P-0004818-T01-IM5	P-0004818	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		917	60
P-0004819-T01-IM5	P-0004819	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male		836	70
P-0004820-T01-IM5	P-0004820	Germ Cell Tumor	Metastasis	Tumor	Mediastinum	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	202	30
P-0004821-T01-IM5	P-0004821	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	1125	30
P-0004822-T01-IM5	P-0004822	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		777	60
P-0004823-T01-IM5	P-0004823	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	425	40
P-0004824-T01-IM5	P-0004824	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		654	60
P-0004825-T01-IM5	P-0004825	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Mantle Cell Lymphoma	IMPACT410			Male		711	80
P-0004826-T01-IM5	P-0004826	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MLL3 p.N4854_V4856delinsS mutation is subclonal.	681	40
P-0004827-T01-IM5	P-0004827	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		662	20
P-0004828-T02-IM5	P-0004828	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The CD79B, AXIN2 and TERT copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	625	80
P-0004829-T01-IM5	P-0004829	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	521	60
P-0004830-T01-IM5	P-0004830	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		412	50
P-0004831-T01-IM5	P-0004831	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	847	30
P-0004832-T01-IM5	P-0004832	Melanoma	Metastasis	Tumor	In-transit	Skin	Acral Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	773	80
P-0004834-T01-IM5	P-0004834	Colorectal Cancer	Metastasis	Tumor	Pleura	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The APC exon15 mutations all occur in cis (same allele).	604	30
P-0004835-T01-IM5	P-0004835	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		823	50
P-0004836-T01-IM5	P-0004836	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..    Note: The PIM1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	526	70
P-0004837-T01-IM5	P-0004837	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The EGFR exon3 mutations occur on different alleles.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 10q.	683	60
P-0004838-T01-IM5	P-0004838	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		766	20
P-0004839-T01-IM5	P-0004839	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	950	30
P-0004840-T01-IM5	P-0004840	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	379	40
P-0004841-T01-IM5	P-0004841	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		309	30
P-0004842-T01-IM5	P-0004842	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		814	20
P-0004843-T01-IM5	P-0004843	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Carcinoid	IMPACT410			Female		881	60
P-0004844-T01-IM5	P-0004844	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		850	40
P-0004845-T01-IM5	P-0004845	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	854	40
P-0004846-T01-IM5	P-0004846	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	minor at 1%, ask about the TP53	491	30
P-0004847-T01-IM5	P-0004847	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		927	20
P-0004848-T01-IM5	P-0004848	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 6p and 8q      Note: The CARD11 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	874	50
P-0004849-T01-IM5	P-0004849	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		568	20
P-0004850-T01-IM5	P-0004850	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		1123	20
P-0004851-T01-IM5	P-0004851	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male		688	60
P-0004852-T01-IM5	P-0004852	Histiocytosis	Primary	Tumor	Not Applicable	Mesentery	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male		481	20
P-0004853-T01-IM5	P-0004853	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		764	60
P-0004854-T01-IM5	P-0004854	Chondrosarcoma	Primary	Tumor	Not Applicable	Leg	Mesenchymal Chondrosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12	826	80
P-0004855-T01-IM5	P-0004855	Melanoma	Primary	Tumor	Not Applicable	Anus	Anorectal Mucosal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p.	1010	70
P-0004856-T01-IM5	P-0004856	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	595	60
P-0004857-T01-IM5	P-0004857	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		851	70
P-0004858-T01-IM5	P-0004858	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		635	20
P-0004859-T01-IM5	P-0004859	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		415	30
P-0004860-T01-IM5	P-0004860	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	817	50
P-0004861-T01-IM5	P-0004861	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		899	60
P-0004862-T01-IM5	P-0004862	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20	734	60
P-0004863-T01-IM5	P-0004863	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		790	30
P-0004864-T01-IM5	P-0004864	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		279	30
P-0004865-T01-IM5	P-0004865	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		838	50
P-0004866-T01-IM5	P-0004866	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	488	20
P-0004867-T01-IM5	P-0004867	Ovarian Cancer	Metastasis	Tumor	Abdomen	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		651	30
P-0004868-T01-IM5	P-0004868	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		417	NA
P-0004869-T01-IM5	P-0004869	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MTOR p.G344R, NF1 p.G722*, BMPR1A exon6 splicing and ESR1 p.T4A  mutations are subclonal.    Note: The ERCC2, BBC3, POLD1, PPP2R1A, MET, SMO, BRAF, EZH2, RHEB, MLL3, XRCC2, and SH2D1A copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The PDCD1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	725	60
P-0004871-T01-IM5	P-0004871	Melanoma	Primary	Tumor	Not Applicable	Vagina	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		838	50
P-0004872-T01-IM5	P-0004872	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17p.	782	20
P-0004873-T01-IM5	P-0004873	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		720	40
P-0004874-T01-IM5	P-0004874	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		742	30
P-0004875-T01-IM5	P-0004875	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	890	20
P-0004876-T01-IM5	P-0004876	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	807	30
P-0004876-T02-IM5	P-0004876	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		382	80
P-0004878-T01-IM5	P-0004878	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Variant frequency of MET exon7 splicing mutation suggests that the mutation occurs on the non-amplified allele.	677	40
P-0004879-T01-IM5	P-0004879	Embryonal Tumor	Metastasis	Tumor	Lymph Node	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p, 11q and 21q.	782	50
P-0004880-T01-IM5	P-0004880	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	452	40
P-0004880-T02-IM5	P-0004880	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	708	40
P-0004881-T01-IM5	P-0004881	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	761	70
P-0004882-T01-IM5	P-0004882	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	667	30
P-0004883-T01-IM5	P-0004883	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	205	80
P-0004884-T01-IM5	P-0004884	Miscellaneous Neuroepithelial Tumor	Primary	Tumor	Not Applicable	Brain	Extraventricular Neurocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q	514	80
P-0004885-T01-IM5	P-0004885	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	359	80
P-0004886-T01-IM5	P-0004886	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT410			Female		494	40
P-0004887-T01-IM5	P-0004887	Salivary Carcinoma	Metastasis	Tumor	Lymph node	Parotid	Salivary Duct Carcinoma	IMPACT410			Male	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	759	50
P-0004888-T01-IM5	P-0004888	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 150X, negative results should be interpreted with caution.   Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	150	60
P-0004889-T01-IM5	P-0004889	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		660	60
P-0004890-T01-IM5	P-0004890	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		515	50
P-0004891-T01-IM5	P-0004891	Non-Small Cell Lung Cancer	Metastasis	Tumor	Neck	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The KEAP1 exon4 mutations all occur in cis (same allele).  Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q and 15q.	523	40
P-0004892-T01-IM5	P-0004892	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MLL3 exon36 mutations all occur in cis (same allele).	904	40
P-0004893-T01-IM5	P-0004893	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		926	40
P-0004894-T01-IM5	P-0004894	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female		367	30
P-0004895-T01-IM5	P-0004895	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The SMAD4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	303	30
P-0004896-T01-IM5	P-0004896	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		584	50
P-0004897-T01-IM5	P-0004897	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		668	NA
P-0004898-T01-IM5	P-0004898	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		878	40
P-0004899-T01-IM5	P-0004899	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	404	20
P-0004900-T01-IM5	P-0004900	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	447	10
P-0004901-T01-IM5	P-0004901	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q and 22q.	883	60
P-0004902-T01-IM5	P-0004902	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		786	30
P-0004903-T01-IM5	P-0004903	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		754	40
P-0004904-T01-IM5	P-0004904	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		496	60
P-0004905-T01-IM5	P-0004905	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Adenosquamous Carcinoma of the Pancreas	IMPACT410			Male		625	20
P-0004907-T01-IM5	P-0004907	Bladder Cancer	Metastasis	Tumor	Abdomen	Bladder	Bladder Squamous Cell Carcinoma	IMPACT410			Female	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA).  Negative results should be interpreted with caution.	578	20
P-0004908-T01-IM5	P-0004908	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The RIT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	632	10
P-0004909-T01-IM5	P-0004909	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1150	10
P-0004910-T01-IM5	P-0004910	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The CCND2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	531	50
P-0004910-T02-IM5	P-0004910	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		316	60
P-0004910-T03-IM5	P-0004910	Prostate Cancer	Metastasis	Tumor	Adrenal Gland	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The AR exon8 mutations all occur in cis (same allele).	518	50
P-0004910-T04-IM5	P-0004910	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The AR exon8 mutations all occur in cis (same allele).	637	20
P-0004911-T01-IM5	P-0004911	Endometrial Cancer	Metastasis	Tumor	Peritoneum	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q including PIK3CA.    Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	469	60
P-0004912-T01-IM5	P-0004912	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		575	60
P-0004913-T01-IM5	P-0004913	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.          Note: A comparison of variant frequencies suggests the FLT4  mutation is subclonal.	532	60
P-0004914-T01-IM5	P-0004914	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 12p including KRAS.	821	70
P-0004915-T01-IM5	P-0004915	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lower Extremity	Myxoid/Round-Cell Liposarcoma	IMPACT410			Female		233	80
P-0004916-T01-IM5	P-0004916	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		619	60
P-0004917-T01-IM5	P-0004917	Sex Cord Stromal Tumor	Metastasis	Tumor	Pelvis	Ovary	Granulosa Cell Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 14q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 22q.	692	80
P-0004918-T01-IM5	P-0004918	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		188	50
P-0004919-T01-IM5	P-0004919	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		798	40
P-0004920-T01-IM5	P-0004920	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		804	40
P-0004921-T01-IM5	P-0004921	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The HOXB13 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	778	NA
P-0004922-T01-IM5	P-0004922	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Scalp	Angiosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	804	60
P-0004923-T01-IM5	P-0004923	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		853	30
P-0004924-T01-IM5	P-0004924	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: The ARID1A exon1 mutations all occur in cis (same allele).	698	40
P-0004925-T01-IM5	P-0004925	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymic Carcinoma	IMPACT410			Male		931	20
P-0004926-T01-IM5	P-0004926	Embryonal Tumor	Metastasis	Tumor	Pleura	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: The H3F3B, SRSF2, and RPTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	846	60
P-0004928-T01-IM5	P-0004928	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The PIK3CA exon10 mutations occur on different alleles.	651	30
P-0004929-T01-IM5	P-0004929	Endometrial Cancer	Metastasis	Tumor	Peritoneum	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		621	20
P-0004929-T02-IM5	P-0004929	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The CXCR4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	394	70
P-0004930-T01-IM5	P-0004930	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		617	80
P-0004931-T02-IM5	P-0004931	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Male		482	60
P-0004932-T01-IM5	P-0004932	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p25.3-3p21.1 and 11q13.5-11q23.3.        Note: The POLD1 and  PPP2R1A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1008	90
P-0004933-T01-IM5	P-0004933	Melanoma	Metastasis	Tumor	Epidural	Skin	Cutaneous Melanoma	IMPACT410			Male		779	60
P-0004934-T01-IM5	P-0004934	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		952	40
P-0004935-T01-IM5	P-0004935	Cancer of Unknown Primary	Metastasis	Tumor	Bowel	Unknown	Cancer of Unknown Primary	IMPACT410			Female		898	40
P-0004936-T01-IM5	P-0004936	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Female		711	40
P-0004937-T01-IM5	P-0004937	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male		470	60
P-0004938-T01-IM5	P-0004938	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		599	60
P-0004939-T01-IM5	P-0004939	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		270	30
P-0004940-T01-IM5	P-0004940	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		428	70
P-0004941-T01-IM5	P-0004941	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		756	70
P-0004942-T01-IM5	P-0004942	Endometrial Cancer	Metastasis	Tumor	Vagina	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: The ARID1B, JAK2, PTPRD and CD274 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	265	30
P-0004943-T01-IM5	P-0004943	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Kidney	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Male		512	80
P-0004944-T02-IM5	P-0004944	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	924	60
P-0004945-T01-IM5	P-0004945	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		730	60
P-0004946-T01-IM5	P-0004946	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		565	40
P-0004947-T01-IM5	P-0004947	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 6, 12 and 19.    Note: The EPHA5 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	867	80
P-0004948-T01-IM5	P-0004948	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Fibrosarcoma	IMPACT410			Male	Note: The RNF43, RAD51C, H3F3B, SRSF2 and RPTOR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The STK11, DOT1L, TCF3, GNA11,  CCNE1, CEBPA, EP300, INPP4B, FBXW7 and FAT1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	862	80
P-0004949-T02-IM5	P-0004949	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: A comparison of variant frequencies suggests the EPHA7 p.E350G mutation is subclonal.	842	70
P-0004950-T01-IM5	P-0004950	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		828	40
P-0004951-T01-IM5	P-0004951	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the AKT1 p.E17K and PIK3CA p.E542K mutations are both subclonal.	277	60
P-0004952-T01-IM5	P-0004952	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The ANKRD11 and FANCA copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	876	60
P-0004953-T01-IM5	P-0004953	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	30
P-0004953-T02-IM5	P-0004953	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		965	50
P-0004954-T01-IM5	P-0004954	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		731	60
P-0004954-T02-IM5	P-0004954	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Male		883	60
P-0004955-T01-IM5	P-0004955	Biliary Cancer	Metastasis	Tumor	Peritoneum	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		981	30
P-0004956-T01-IM5	P-0004956	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		942	30
P-0004957-T01-IM5	P-0004957	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	1054	60
P-0004958-T01-IM5	P-0004958	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		892	60
P-0004959-T01-IM5	P-0004959	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female		153	70
P-0004960-T01-IM5	P-0004960	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colorectal Adenocarcinoma	IMPACT410			Male		1393	20
P-0004961-T01-IM5	P-0004961	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		855	10
P-0004962-T01-IM5	P-0004962	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	993	NA
P-0004963-T01-IM5	P-0004963	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1004	80
P-0004964-T01-IM5	P-0004964	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		1008	70
P-0004965-T01-IM5	P-0004965	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	626	60
P-0004966-T01-IM5	P-0004966	Histiocytosis	Primary	Tumor	Not Applicable	Bone	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.    Note: Low sequencing depth of coverage of 79X, negative results should be interpreted with caution.	79	10
P-0004967-T01-IM5	P-0004967	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the PIK3R1 p.E489* mutation is subclonal.	980	30
P-0004968-T01-IM5	P-0004968	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p36 and 18q.	944	60
P-0004969-T01-IM5	P-0004969	Chondrosarcoma	Metastasis	Tumor	Soft Tissue	Skull	Chondrosarcoma	IMPACT410			Male		488	40
P-0004970-T01-IM5	P-0004970	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		928	20
P-0004971-T01-IM5	P-0004971	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1106	60
P-0004972-T01-IM5	P-0004972	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	998	10
P-0004973-T01-IM5	P-0004973	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 2q.	790	80
P-0004974-T01-IM5	P-0004974	Breast Carcinoma	Metastasis	Tumor	Colon	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		1078	60
P-0004975-T01-IM5	P-0004975	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The FYN and ROS1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	395	50
P-0004976-T01-IM5	P-0004976	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Low-Grade Endometrial Stromal Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6p25.3-22.1, 6p21.2-6p21.1, 6q25.3 - 6q26, and 7p14.1-7p11.2	553	60
P-0004977-T01-IM5	P-0004977	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Male		599	40
P-0004978-T01-IM5	P-0004978	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	348	20
P-0004980-T01-IM5	P-0004980	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Ductal Carcinoma In Situ	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	433	10
P-0004981-T01-IM5	P-0004981	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The FLCN and NCOR1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	616	50
P-0004982-T01-IM5	P-0004982	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p	287	60
P-0004983-T01-IM5	P-0004983	Bladder Cancer	Primary	Tumor	Not Applicable	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	497	20
P-0004985-T01-IM5	P-0004985	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	586	NA
P-0004986-T01-IM5	P-0004986	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female		407	70
P-0004987-T01-IM5	P-0004987	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.    Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13 and 16q      Note: The EPHA7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	658	60
P-0004988-T01-IM5	P-0004988	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: A comparison of variant frequencies suggests the PIK3CA p.E542K mutation is subclonal.	539	10
P-0004989-T01-IM5	P-0004989	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	394	30
P-0004990-T01-IM5	P-0004990	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	346	10
P-0004991-T01-IM5	P-0004991	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: The STAT5A and STAT5B copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	423	80
P-0004993-T01-IM5	P-0004993	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	671	10
P-0004994-T01-IM5	P-0004994	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	T-Cell and Natural Killer Lymphoma	IMPACT410			Female		701	50
P-0004995-T01-IM5	P-0004995	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		370	40
P-0004997-T01-IM5	P-0004997	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		472	60
P-0004998-T01-IM5	P-0004998	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		341	10
P-0004999-T01-IM5	P-0004999	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PRKAR1A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	431	30
P-0005000-T01-IM5	P-0005000	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		643	60
P-0005002-T01-IM5	P-0005002	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm  Xp11.  Note: The BCOR, FGFR2 and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	496	60
P-0005003-T01-IM5	P-0005003	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		569	20
P-0005004-T01-IM5	P-0005004	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		455	70
P-0005005-T01-IM5	P-0005005	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		502	50
P-0005006-T01-IM5	P-0005006	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Blood Vessel	Rhabdomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 7, 15q13-15q22, and 16q. Note: The MAX copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	875	80
P-0005007-T01-IM5	P-0005007	Biliary Cancer	Metastasis	Tumor	Omentum	Bile Duct	Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	672	20
P-0005008-T01-IM5	P-0005008	Meningothelial Tumor	Primary	Tumor	Not Applicable	Bone	Meningioma	IMPACT410			Male		389	60
P-0005009-T01-IM5	P-0005009	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the PIK3CA p.H1047R mutation is subclonal.	507	60
P-0005009-T02-IM5	P-0005009	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1158	30
P-0005010-T01-IM5	P-0005010	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		726	30
P-0005011-T01-IM5	P-0005011	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	470	10
P-0005012-T01-IM5	P-0005012	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		940	70
P-0005013-T01-IM5	P-0005013	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Synovial Sarcoma	IMPACT410			Male		732	80
P-0005014-T01-IM5	P-0005014	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 5q11-5q13 and 6q15-6p22.   Note: The ETV6, CDKN1B, PMAIP1, and BCL2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	759	60
P-0005015-T01-IM5	P-0005015	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		493	50
P-0005016-T01-IM5	P-0005016	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		554	30
P-0005017-T02-IM5	P-0005017	Non-Small Cell Lung Cancer	Primary	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female		1166	50
P-0005018-T01-IM5	P-0005018	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female		1057	70
P-0005019-T01-IM5	P-0005019	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		956	80
P-0005020-T01-IM5	P-0005020	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	913	30
P-0005021-T01-IM5	P-0005021	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: The ATM exon7 mutations occur in trans	896	70
P-0005022-T01-IM5	P-0005022	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		998	20
P-0005023-T01-IM5	P-0005023	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	713	60
P-0005024-T01-IM5	P-0005024	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The MTOR exon5 mutations all occur in cis (same allele).    Note: The CDKN2Ap14ARF, CDKN2Ap16INK4A and CDKN2B  copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1266	60
P-0005025-T01-IM5	P-0005025	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		995	20
P-0005026-T01-IM5	P-0005026	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1100	40
P-0005028-T01-IM5	P-0005028	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Female		709	70
P-0005029-T01-IM5	P-0005029	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT410			Female		962	60
P-0005030-T02-IM5	P-0005030	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female		689	40
P-0005031-T01-IM5	P-0005031	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: The IRF4  exon2 mutations all occur in cis (same allele).	1032	50
P-0005032-T01-IM5	P-0005032	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PIK3CA exon8 mutations all occur in cis (same allele).	1062	30
P-0005033-T01-IM5	P-0005033	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	212	10
P-0005035-T01-IM5	P-0005035	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.	442	50
P-0005036-T01-IM5	P-0005036	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1304	60
P-0005037-T01-IM5	P-0005037	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The AURKA, GNAS and FGFR1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	981	70
P-0005038-T01-IM5	P-0005038	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		275	60
P-0005039-T01-IM5	P-0005039	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.   Note: The NRAS p.Q61L mutation frequency suggests that it is on the amplified allele.	434	40
P-0005040-T01-IM5	P-0005040	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution.  Note: Low sequencing depth of coverage of 82X, negative results should be interpreted with caution.	82	NA
P-0005041-T01-IM5	P-0005041	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	478	10
P-0005042-T01-IM5	P-0005042	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 6q.	643	60
P-0005043-T01-IM5	P-0005043	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	314	10
P-0005044-T01-IM5	P-0005044	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		648	70
P-0005045-T01-IM5	P-0005045	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The PIK3C2G copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	412	70
P-0005046-T01-IM5	P-0005046	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.      Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3q26-28 including PIK3CA, TP53 and SOX2.	695	50
P-0005047-T01-IM5	P-0005047	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		856	30
P-0005048-T01-IM5	P-0005048	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	965	20
P-0005049-T01-IM5	P-0005049	Chondrosarcoma	Primary	Tumor	Not Applicable	Pelvis	Chondrosarcoma	IMPACT410			Female		1142	80
P-0005050-T01-IM5	P-0005050	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		802	80
P-0005051-T01-IM5	P-0005051	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		824	70
P-0005052-T01-IM5	P-0005052	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male		712	40
P-0005052-T02-IM5	P-0005052	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		344	70
P-0005053-T01-IM5	P-0005053	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		998	30
P-0005054-T01-IM5	P-0005054	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: The RB1 exon12 mutations all occur in cis (same allele).	585	30
P-0005055-T01-IM5	P-0005055	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).        Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	593	30
P-0005057-T02-IM5	P-0005057	Biliary Cancer	Metastasis	Tumor	Lymph Node	Liver	Extrahepatic Cholangiocarcinoma	IMPACT410			Female		452	30
P-0005058-T01-IM5	P-0005058	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	843	10
P-0005060-T01-IM5	P-0005060	Esophagogastric Carcinoma	Metastasis	Tumor	Omentum	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: The CDKN2Ap16INK4A, SDHA, and TERT copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	948	50
P-0005061-T01-IM5	P-0005061	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		361	20
P-0005062-T01-IM5	P-0005062	Melanoma	Metastasis	Tumor	Adrenal Gland	Unknown	Melanoma of Unknown Primary	IMPACT410			Female		585	90
P-0005063-T01-IM5	P-0005063	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR  p.E746_S752delinsV mutation frequency suggests that the mutation occurs on the amplified allele	755	40
P-0005064-T01-IM5	P-0005064	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Small Cell Carcinoma	IMPACT410			Male		527	60
P-0005065-T02-IM5	P-0005065	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		395	60
P-0005065-T03-IM5	P-0005065	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		594	60
P-0005066-T01-IM5	P-0005066	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Pelvis	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: The AKT1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	780	90
P-0005067-T01-IM5	P-0005067	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3q.	469	40
P-0005068-T01-IM5	P-0005068	Embryonal Tumor	Metastasis	Tumor	Bone	Adrenal Gland	Neuroblastoma	IMPACT410			Female		414	40
P-0005069-T01-IM5	P-0005069	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		915	60
P-0005070-T01-IM5	P-0005070	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		587	60
P-0005073-T01-IM5	P-0005073	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Run matched with new normal, New normal on run 181 has 96x coverage, no more repeats, signed out the PIK3CA and CDKN1B ,MST1R, FAM175A and FAT1 CNV call.      Note: The MST1R  and FAT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The FAM175A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	234	30
P-0005074-T01-IM5	P-0005074	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: The HGF exon8 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of a fragmented genome.	887	60
P-0005075-T01-IM5	P-0005075	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		941	50
P-0005076-T01-IM5	P-0005076	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FOXP1,RYBP,SHQ1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	363	30
P-0005077-T01-IM5	P-0005077	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		398	40
P-0005078-T01-IM5	P-0005078	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		319	60
P-0005079-T01-IM5	P-0005079	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	413	70
P-0005080-T01-IM5	P-0005080	Non-Small Cell Lung Cancer	Metastasis	Tumor	Breast	Lung	Lung Adenocarcinoma	IMPACT410			Male		965	70
P-0005081-T01-IM5	P-0005081	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		319	40
P-0005082-T01-IM5	P-0005082	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Oral Cavity	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1183	10
P-0005083-T01-IM5	P-0005083	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Female		422	50
P-0005085-T01-IM5	P-0005085	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		1286	70
P-0005086-T01-IM5	P-0005086	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		226	60
P-0005087-T01-IM5	P-0005087	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FBXW7 exon10 mutations occur on different alleles.	607	20
P-0005089-T01-IM5	P-0005089	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		630	NA
P-0005090-T01-IM5	P-0005090	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	671	10
P-0005091-T01-IM5	P-0005091	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	1043	30
P-0005092-T01-IM5	P-0005092	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		1063	60
P-0005093-T01-IM5	P-0005093	Salivary Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Salivary Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p and 10q	1038	30
P-0005094-T01-IM5	P-0005094	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1208	20
P-0005095-T01-IM5	P-0005095	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The FGF3, FGF4, and FGF19  copy number gains  fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1183	30
P-0005096-T01-IM5	P-0005096	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q including NF2 and SMARCB1.	533	70
P-0005097-T01-IM5	P-0005097	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		448	30
P-0005098-T01-IM5	P-0005098	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		422	30
P-0005098-T02-IM5	P-0005098	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1242	30
P-0005099-T01-IM5	P-0005099	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.      Note: Assessment of the copy number profile is somewhat limited by increased background noise.	339	40
P-0005101-T01-IM5	P-0005101	Ewing Sarcoma	Metastasis	Tumor	Soft Tissue	Bone	Ewing Sarcoma	IMPACT410			Female		781	NA
P-0005102-T01-IM5	P-0005102	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		864	20
P-0005103-T01-IM5	P-0005103	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Male		549	60
P-0005104-T01-IM5	P-0005104	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		450	30
P-0005105-T01-IM5	P-0005105	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Epithelioid Hemangioendothelioma	IMPACT410			Male		366	40
P-0005106-T01-IM5	P-0005106	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	448	80
P-0005107-T01-IM5	P-0005107	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		776	40
P-0005108-T01-IM5	P-0005108	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	High-Grade Endometrial Stromal Sarcoma	IMPACT410			Female		541	40
P-0005109-T01-IM5	P-0005109	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 6p, 7q32.1-7q36.1, and 8q11.23-8q24.3	497	20
P-0005110-T01-IM5	P-0005110	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosomes 1,2,6,10, 13,17, and 21	576	80
P-0005111-T01-IM5	P-0005111	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		566	30
P-0005112-T01-IM5	P-0005112	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		505	70
P-0005113-T01-IM5	P-0005113	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		485	80
P-0005114-T01-IM5	P-0005114	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR  exon21 mutations all occur in cis (same allele).	411	30
P-0005115-T01-IM5	P-0005115	Non-Small Cell Lung Cancer	Metastasis	Tumor	Neck	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The ALK and CENPA copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	539	70
P-0005116-T01-IM5	P-0005116	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1009	40
P-0005117-T01-IM5	P-0005117	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Mons Pubis	Penis	Basal Cell Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 139X, negative results should be interpreted with caution.	139	50
P-0005117-T02-IM5	P-0005117	Penile Cancer	Metastasis	Tumor	Chest Wall	Penis	Basaloid Penile Squamous Cell Carcinoma	IMPACT410			Male		363	10
P-0005118-T01-IM5	P-0005118	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		813	80
P-0005119-T02-IM5	P-0005119	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female		405	NA
P-0005120-T01-IM5	P-0005120	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		330	50
P-0005121-T02-IM5	P-0005121	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Acral Melanoma	IMPACT410			Female		864	50
P-0005122-T01-IM5	P-0005122	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Male		945	60
P-0005123-T01-IM5	P-0005123	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: Low sequencing depth of coverage of 134X, negative results should be interpreted with caution.	134	10
P-0005124-T01-IM5	P-0005124	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The PIK3C3, SMAD2, SMAD4,MALT1, PMAIP1 and BCL2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	968	50
P-0005125-T01-IM5	P-0005125	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male		988	60
P-0005126-T01-IM5	P-0005126	Soft Tissue Sarcoma	Metastasis	Tumor	Prostate	Soft Tissue	Embryonal Rhabdomyosarcoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the AKT3 p.P206H mutation is subclonal.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8q and 13q.	827	80
P-0005127-T01-IM5	P-0005127	Cancer of Unknown Primary	Metastasis	Tumor	Soft Tissue	Unknown	Squamous Cell Carcinoma, NOS	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.    Note: The EPHA5 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	734	70
P-0005128-T01-IM5	P-0005128	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		804	60
P-0005129-T01-IM5	P-0005129	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: The STK11 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	617	60
P-0005130-T01-IM5	P-0005130	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Male		297	80
P-0005131-T01-IM5	P-0005131	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		909	30
P-0005131-T02-IM5	P-0005131	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The IFNGR1,  TNFAIP3 , LATS1  and ESR1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	690	60
P-0005132-T01-IM5	P-0005132	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		920	40
P-0005133-T01-IM5	P-0005133	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		740	70
P-0005134-T01-IM5	P-0005134	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		806	60
P-0005135-T01-IM5	P-0005135	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT410			Female		548	70
P-0005136-T01-IM5	P-0005136	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Female		600	80
P-0005137-T02-IM5	P-0005137	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arm 13q and Chromosome 20.	641	50
P-0005138-T01-IM5	P-0005138	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		787	60
P-0005139-T01-IM5	P-0005139	Non-Hodgkin Lymphoma	Metastasis	Tumor	Pelvis	Lymph Node	Mantle Cell Lymphoma	IMPACT410			Male		829	70
P-0005140-T01-IM5	P-0005140	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		487	40
P-0005141-T01-IM5	P-0005141	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q21-6q26 Note: The ERRFI1,  MTOR, and PIK3CD copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1015	80
P-0005142-T01-IM5	P-0005142	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		425	30
P-0005143-T01-IM5	P-0005143	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		542	70
P-0005144-T01-IM5	P-0005144	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A, CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	612	40
P-0005145-T01-IM5	P-0005145	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		653	10
P-0005146-T01-IM5	P-0005146	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: The KIT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	704	60
P-0005147-T01-IM5	P-0005147	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		512	60
P-0005149-T01-IM5	P-0005149	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		947	90
P-0005150-T01-IM5	P-0005150	Bladder Cancer	Primary	Tumor	Not Applicable	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Male		342	60
P-0005151-T01-IM5	P-0005151	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		423	30
P-0005152-T01-IM5	P-0005152	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PIK3CA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	522	NA
P-0005153-T01-IM5	P-0005153	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MAX, RAD51B, CDK12 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	624	50
P-0005154-T01-IM5	P-0005154	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		426	NA
P-0005155-T01-IM5	P-0005155	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.  Note: Low sequencing depth of coverage of 55X, negative results should be interpreted with caution.	55	40
P-0005156-T01-IM5	P-0005156	Uterine Sarcoma	Metastasis	Tumor	Soft Tissue	Uterus	Endometrial Stromal Sarcoma	IMPACT410			Female		762	80
P-0005157-T01-IM5	P-0005157	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Eye	Uveal Melanoma	IMPACT410			Male		869	80
P-0005158-T01-IM5	P-0005158	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		975	50
P-0005159-T01-IM5	P-0005159	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	844	70
P-0005160-T01-IM5	P-0005160	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	497	10
P-0005161-T01-IM5	P-0005161	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: The FGFR1 and BCL2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.         Note: The FGFR2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	861	90
P-0005162-T01-IM5	P-0005162	Embryonal Tumor	Primary	Tumor	Not Applicable	Pelvis	Neuroblastoma	IMPACT410			Female		859	60
P-0005163-T01-IM5	P-0005163	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	615	10
P-0005164-T01-IM5	P-0005164	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The CSF3R copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	657	30
P-0005165-T01-IM5	P-0005165	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		444	50
P-0005167-T01-IM5	P-0005167	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		732	40
P-0005168-T01-IM5	P-0005168	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	729	30
P-0005169-T01-IM5	P-0005169	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female		738	40
P-0005170-T01-IM5	P-0005170	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The FGFR4,NSD1 and FLT4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	765	60
P-0005171-T01-IM5	P-0005171	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Lymph node	Malignant Lymphoma	IMPACT410			Male		444	20
P-0005172-T01-IM5	P-0005172	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		529	50
P-0005173-T01-IM5	P-0005173	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The U2AF1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	850	20
P-0005174-T01-IM5	P-0005174	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	679	20
P-0005175-T01-IM5	P-0005175	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male		574	70
P-0005176-T01-IM5	P-0005176	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		419	50
P-0005177-T01-IM5	P-0005177	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		472	60
P-0005178-T01-IM5	P-0005178	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The CDK12, ERBB2, and RARA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	561	30
P-0005179-T01-IM5	P-0005179	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		596	50
P-0005180-T01-IM5	P-0005180	Melanoma	Primary	Tumor	Not Applicable	Foot	Acral Melanoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	334	60
P-0005181-T01-IM5	P-0005181	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		924	60
P-0005182-T01-IM5	P-0005182	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).        Note: The ARAF and RBM10 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	780	40
P-0005183-T01-IM5	P-0005183	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female		420	60
P-0005185-T01-IM5	P-0005185	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 115X, negative results should be interpreted with caution.	115	30
P-0005186-T01-IM5	P-0005186	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Female		584	50
P-0005187-T01-IM5	P-0005187	Renal Cell Carcinoma	Primary	Tumor	Lymph Node	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	825	30
P-0005189-T01-IM5	P-0005189	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	552	30
P-0005190-T01-IM5	P-0005190	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 19p.	621	60
P-0005191-T01-IM5	P-0005191	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		654	20
P-0005192-T01-IM5	P-0005192	Histiocytosis	Primary	Tumor	Not Applicable	Eye	Histiocytosis	IMPACT410			Male	Minor at 1%	259	10
P-0005193-T01-IM5	P-0005193	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	693	20
P-0005194-T01-IM5	P-0005194	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Variants in CIC gene indicates the presence of sub-clones	650	60
P-0005195-T01-IM5	P-0005195	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		550	60
P-0005196-T01-IM5	P-0005196	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	758	40
P-0005197-T01-IM5	P-0005197	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		798	50
P-0005198-T01-IM5	P-0005198	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13 and Chromosome arms 6p,12p,18q.	475	70
P-0005199-T01-IM5	P-0005199	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		721	30
P-0005200-T01-IM5	P-0005200	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		541	
P-0005201-T01-IM5	P-0005201	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Conjunctiva	Head and Neck Mucosal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p and chromosome 7.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and chromosome arms 9p, 16p.	587	70
P-0005202-T01-IM5	P-0005202	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		314	70
P-0005203-T01-IM5	P-0005203	Anal Cancer	Metastasis	Tumor	Lung	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14 and arms 3p, 16q.	537	70
P-0005204-T01-IM5	P-0005204	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p, 6q, 8p, 15q and Chromosomes 11 and 22.	749	80
P-0005205-T01-IM5	P-0005205	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		667	30
P-0005206-T01-IM5	P-0005206	Bladder Cancer	Primary	Tumor	Not Applicable	Urachus	Urachal Adenocarcinoma	IMPACT410			Female		484	30
P-0005207-T01-IM5	P-0005207	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		526	60
P-0005209-T01-IM5	P-0005209	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Soft Tissue	Head and Neck Neuroendocrine Carcinoma	IMPACT410			Female		681	50
P-0005210-T01-IM5	P-0005210	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		516	30
P-0005211-T01-IM5	P-0005211	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		460	20
P-0005212-T01-IM5	P-0005212	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male		418	60
P-0005213-T01-IM5	P-0005213	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	674	60
P-0005214-T01-IM5	P-0005214	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		667	80
P-0005215-T01-IM5	P-0005215	Penile Cancer	Primary	Tumor	Not Applicable	Penis	Penile Squamous Cell Carcinoma	IMPACT410			Male		728	30
P-0005216-T01-IM5	P-0005216	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		870	10
P-0005217-T02-IM5	P-0005217	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	577	30
P-0005217-T03-IM5	P-0005217	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	855	10
P-0005219-T01-IM5	P-0005219	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 126X, negative results should be interpreted with caution.	126	10
P-0005220-T01-IM5	P-0005220	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1119	60
P-0005221-T01-IM5	P-0005221	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 124X, negative results should be interpreted with caution.	124	30
P-0005222-T01-IM5	P-0005222	Melanoma	Metastasis	Tumor	Skin	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		681	60
P-0005223-T01-IM5	P-0005223	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		849	20
P-0005224-T01-IM5	P-0005224	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		314	60
P-0005225-T01-IM5	P-0005225	Bladder Cancer	Metastasis	Tumor	Lung	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Male		647	30
P-0005226-T01-IM5	P-0005226	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: The CDKN2Ap14ARF, CDKN2Ap16INK4A, and CDKN2B copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	945	50
P-0005227-T01-IM5	P-0005227	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male		298	40
P-0005228-T01-IM5	P-0005228	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	459	70
P-0005230-T01-IM5	P-0005230	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: The KRAS exon2 mutations occur on different alleles.	562	30
P-0005231-T01-IM5	P-0005231	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		466	50
P-0005232-T01-IM5	P-0005232	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9q.	451	30
P-0005233-T01-IM5	P-0005233	Embryonal Tumor	Metastasis	Tumor	Intercostal space	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: The MCL1 exon2 mutations all occur in cis (same allele).	501	30
P-0005234-T01-IM5	P-0005234	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	831	40
P-0005235-T01-IM5	P-0005235	Melanoma	Metastasis	Tumor	Lung	Foot	Acral Melanoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	804	60
P-0005235-T02-IM5	P-0005235	Melanoma	Metastasis	Tumor	Brain	Skin	Acral Melanoma	IMPACT410			Male		795	80
P-0005237-T01-IM5	P-0005237	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female		598	NA
P-0005239-T01-IM5	P-0005239	Cancer of Unknown Primary	Metastasis	Tumor	Retroperitoneum	Unknown	Squamous Cell Carcinoma, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	901	10
P-0005240-T01-IM5	P-0005240	Colorectal Cancer	Primary	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		860	NA
P-0005241-T01-IM5	P-0005241	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	742	40
P-0005242-T01-IM5	P-0005242	Breast Carcinoma	Metastasis	Tumor	Pelvis	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		775	30
P-0005243-T01-IM5	P-0005243	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: The  ATRX  exon9 mutations all occur in cis (same allele).	299	50
P-0005244-T01-IM5	P-0005244	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	989	70
P-0005245-T01-IM5	P-0005245	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		318	50
P-0005247-T01-IM5	P-0005247	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		318	40
P-0005249-T01-IM5	P-0005249	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male		177	40
P-0005250-T01-IM5	P-0005250	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		945	30
P-0005251-T01-IM5	P-0005251	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the CUL3  p.E172K and MLL3  p.S1154* mutations are subclonal.	495	50
P-0005252-T01-IM5	P-0005252	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	56	30
P-0005253-T01-IM5	P-0005253	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		165	40
P-0005254-T01-IM5	P-0005254	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		549	60
P-0005255-T01-IM5	P-0005255	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		696	50
P-0005256-T01-IM5	P-0005256	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male	Note: The NBN, RAD21 and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	566	40
P-0005257-T01-IM5	P-0005257	Pancreatic Cancer	Primary	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		402	40
P-0005258-T01-IM5	P-0005258	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Lymph node	Malignant Lymphoma	IMPACT410			Female		690	30
P-0005259-T01-IM5	P-0005259	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		837	30
P-0005260-T01-IM5	P-0005260	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female		271	50
P-0005261-T01-IM5	P-0005261	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		643	30
P-0005262-T01-IM5	P-0005262	Small Bowel Cancer	Metastasis	Tumor	Liver	Small Bowel	Small Bowel Cancer	IMPACT410			Male		846	60
P-0005263-T01-IM5	P-0005263	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PAK1 and EED copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	648	50
P-0005264-T01-IM5	P-0005264	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The MDM2 and EGFR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	546	10
P-0005265-T01-IM5	P-0005265	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	577	10
P-0005266-T01-IM5	P-0005266	Bladder Cancer	Metastasis	Tumor	Lymph node	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		588	40
P-0005267-T01-IM5	P-0005267	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The TP53  exon8 mutations all occur in cis (same allele).	572	30
P-0005268-T01-IM5	P-0005268	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by FISH has been performed	508	50
P-0005268-T02-IM5	P-0005268	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1000	70
P-0005269-T01-IM5	P-0005269	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	311	10
P-0005270-T01-IM5	P-0005270	Pheochromocytoma	Metastasis	Tumor	Lung	Adrenal Gland	Pheochromocytoma	IMPACT410			Male	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution.	300	80
P-0005271-T01-IM5	P-0005271	Renal Cell Carcinoma	Metastasis	Tumor	Skin	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		678	30
P-0005272-T01-IM5	P-0005272	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Ependymoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q,16q,17p and 22q.    Note: The MAP2K4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	726	20
P-0005273-T01-IM5	P-0005273	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	389	40
P-0005274-T01-IM5	P-0005274	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	685	40
P-0005275-T01-IM5	P-0005275	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The  FGFR3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	604	10
P-0005276-T01-IM5	P-0005276	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.   Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	649	20
P-0005277-T01-IM5	P-0005277	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	785	40
P-0005277-T02-IM5	P-0005277	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		753	40
P-0005278-T01-IM5	P-0005278	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	925	30
P-0005279-T01-IM5	P-0005279	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Female		976	40
P-0005280-T01-IM5	P-0005280	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		650	70
P-0005281-T01-IM5	P-0005281	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p , 13q14.11-21.1 and 19q.	783	40
P-0005282-T01-IM5	P-0005282	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		583	30
P-0005283-T01-IM5	P-0005283	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		342	60
P-0005284-T01-IM5	P-0005284	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		708	50
P-0005285-T01-IM5	P-0005285	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		487	30
P-0005285-T02-IM5	P-0005285	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	929	20
P-0005286-T01-IM5	P-0005286	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	512	10
P-0005288-T01-IM5	P-0005288	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		542	20
P-0005289-T01-IM5	P-0005289	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		202	90
P-0005290-T01-IM5	P-0005290	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q	580	50
P-0005291-T01-IM5	P-0005291	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	780	50
P-0005292-T01-IM5	P-0005292	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		771	30
P-0005293-T01-IM5	P-0005293	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		475	60
P-0005294-T01-IM5	P-0005294	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female		640	30
P-0005295-T01-IM5	P-0005295	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Male		839	50
P-0005297-T01-IM5	P-0005297	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Male	Note: The NBN and RAD21  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	734	30
P-0005298-T01-IM5	P-0005298	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		881	40
P-0005299-T01-IM5	P-0005299	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		882	60
P-0005300-T01-IM5	P-0005300	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		740	40
P-0005301-T01-IM5	P-0005301	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Blood Vessel	Leiomyosarcoma	IMPACT410			Female		865	70
P-0005302-T01-IM5	P-0005302	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q.	685	40
P-0005303-T01-IM5	P-0005303	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		861	30
P-0005304-T01-IM5	P-0005304	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT410			Female	Note: The NRAS  p.G12S mutation frequency (71%) suggests that the mutation occurs on the amplified allele	888	60
P-0005305-T01-IM5	P-0005305	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Male		897	30
P-0005306-T01-IM5	P-0005306	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		915	60
P-0005307-T01-IM5	P-0005307	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Female		1158	20
P-0005308-T01-IM5	P-0005308	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The TP53 exon 5  mutations occur on different alleles. Note: The TP53 exon 6  mutations occur on different alleles.	974	30
P-0005309-T01-IM5	P-0005309	Cancer of Unknown Primary	Metastasis	Tumor	Lymph node	Unknown	Adenocarcinoma, NOS	IMPACT410			Male		672	40
P-0005310-T01-IM5	P-0005310	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT gene.	265	50
P-0005311-T01-IM5	P-0005311	Colorectal Cancer	Metastasis	Tumor	Small Bowel	Colon	Colon Adenocarcinoma	IMPACT410			Male		439	20
P-0005311-T02-IM5	P-0005311	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		928	30
P-0005312-T01-IM5	P-0005312	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		827	30
P-0005313-T02-IM5	P-0005313	Adrenocortical Carcinoma	Metastasis	Tumor	Lung	Adrenal Gland	Adrenocortical Adenoma	IMPACT410			Female		1023	60
P-0005314-T01-IM5	P-0005314	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		426	30
P-0005315-T01-IM5	P-0005315	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8	656	30
P-0005316-T01-IM5	P-0005316	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		605	40
P-0005317-T01-IM5	P-0005317	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14 and Chromosome arms 1p and 3p	611	60
P-0005318-T01-IM5	P-0005318	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pleura	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Female		471	70
P-0005319-T01-IM5	P-0005319	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 9 and Chromosome arms 1p, 3p, 17p and 19p	733	30
P-0005320-T01-IM5	P-0005320	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	709	10
P-0005321-T01-IM5	P-0005321	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		537	40
P-0005322-T01-IM5	P-0005322	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low ALK mutant allele frequency due to low tumor content or possible sub-clonal mutation	645	20
P-0005322-T02-IM5	P-0005322	Embryonal Tumor	Metastasis	Tumor	Brain	Retroperitoneum	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p31-26 and 19p13.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 2p16-24, and17q.	944	70
P-0005323-T01-IM5	P-0005323	Soft Tissue Sarcoma	Metastasis	Tumor	Epidural	Groin	Dedifferentiated Liposarcoma	IMPACT410			Male	Note: The PAX5 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	952	30
P-0005324-T01-IM5	P-0005324	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	361	20
P-0005325-T01-IM5	P-0005325	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 7p, 16q and Chromosome 18.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1093	40
P-0005325-T02-IM5	P-0005325	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q.	700	70
P-0005326-T01-IM5	P-0005326	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The FOXP1	exon7 mutations all occur in cis (same allele).	772
P-0005327-T01-IM5	P-0005327	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female		1148	20
P-0005328-T01-IM5	P-0005328	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		718	30
P-0005329-T01-IM5	P-0005329	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	808	20
P-0005331-T01-IM5	P-0005331	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		747	70
P-0005332-T01-IM5	P-0005332	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		367	60
P-0005333-T01-IM5	P-0005333	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		629	30
P-0005334-T01-IM5	P-0005334	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The CRKL MAPK1 SMARCB1 CHEK2 NF2 EP300 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	931	40
P-0005335-T01-IM5	P-0005335	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18q including SMAD4.	579	30
P-0005336-T01-IM5	P-0005336	Embryonal Tumor	Primary	Tumor	Not Applicable	Mediastinum	Neuroblastoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	672	30
P-0005337-T01-IM5	P-0005337	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		797	20
P-0005338-T01-IM5	P-0005338	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 15q and 22q.	690	40
P-0005339-T01-IM5	P-0005339	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Small Cell Carcinoma of the Ovary	IMPACT410			Female	Note: The EPHA5 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The PMAIP1 and CD274 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	712	70
P-0005340-T01-IM5	P-0005340	Ovarian Cancer	Metastasis	Tumor	Cul-de-sac	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	549	30
P-0005341-T01-IM5	P-0005341	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		679	50
P-0005342-T01-IM5	P-0005342	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		163	70
P-0005343-T01-IM5	P-0005343	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	20
P-0005344-T01-IM5	P-0005344	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		607	60
P-0005345-T01-IM5	P-0005345	Biliary Cancer	Metastasis	Tumor	Peritoneum	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	835	30
P-0005346-T01-IM5	P-0005346	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		504	30
P-0005347-T01-IM5	P-0005347	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male	Note: The WT1 and B2M copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	217	40
P-0005348-T01-IM5	P-0005348	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		717	10
P-0005349-T01-IM5	P-0005349	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	666	10
P-0005350-T01-IM5	P-0005350	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Metaplastic Breast Cancer	IMPACT410			Female		776	50
P-0005351-T01-IM5	P-0005351	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		797	20
P-0005352-T01-IM5	P-0005352	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Female		1101	40
P-0005353-T01-IM5	P-0005353	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		775	30
P-0005354-T01-IM5	P-0005354	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		521	60
P-0005355-T01-IM5	P-0005355	Renal Cell Carcinoma	Primary	Tumor	Liver	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female		675	40
P-0005356-T01-IM5	P-0005356	Bladder Cancer	Primary	Tumor	Not Applicable	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	1041	30
P-0005357-T01-IM5	P-0005357	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		984	20
P-0005359-T01-IM5	P-0005359	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The STK11 exon1 mutations all occur in cis (same allele).    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	321	20
P-0005360-T01-IM5	P-0005360	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	596	50
P-0005361-T01-IM5	P-0005361	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the PTPN11 p.E76K  mutation is subclonal.	855	30
P-0005362-T02-IM5	P-0005362	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Pausity of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	436	70
P-0005363-T01-IM5	P-0005363	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male		791	10
P-0005364-T01-IM5	P-0005364	Bladder Cancer	Primary	Tumor	Not Applicable	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: The PIK3C2G copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1178	30
P-0005365-T01-IM5	P-0005365	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		783	10
P-0005366-T01-IM5	P-0005366	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The ERBB4 exon10 mutations occur on different alleles.     Note: The HNF1A  exon5 mutations all occur in cis (same allele).	693	70
P-0005367-T01-IM5	P-0005367	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		736	NA
P-0005368-T01-IM5	P-0005368	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1407	30
P-0005369-T01-IM5	P-0005369	Thyroid Cancer	Metastasis	Tumor	Chest Wall	Thyroid	Follicular Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 22q.	819	50
P-0005370-T01-IM5	P-0005370	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		875	50
P-0005371-T01-IM5	P-0005371	Melanoma	Primary	Tumor	Not Applicable	Foot	Acral Melanoma	IMPACT410			Female		906	20
P-0005372-T01-IM5	P-0005372	Bladder Cancer	Primary	Tumor	Prostate	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		957	30
P-0005373-T01-IM5	P-0005373	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		691	20
P-0005374-T01-IM5	P-0005374	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..    Note: The SF3B1 and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	2148	60
P-0005375-T01-IM5	P-0005375	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		1095	20
P-0005376-T01-IM5	P-0005376	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male		921	40
P-0005377-T01-IM5	P-0005377	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	862	60
P-0005378-T01-IM5	P-0005378	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The DNAJB1, MDC1, NOTCH4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1244	30
P-0005379-T01-IM5	P-0005379	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		554	80
P-0005380-T01-IM5	P-0005380	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male		509	30
P-0005381-T01-IM5	P-0005381	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise raising the risk of false negative results.	378	20
P-0005382-T01-IM5	P-0005382	Salivary Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 8p and 12q.	1154	60
P-0005383-T01-IM5	P-0005383	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		855	50
P-0005384-T01-IM5	P-0005384	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	875	10
P-0005385-T01-IM5	P-0005385	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The BRCA1 exon10 p.E649D, p.E648K mutations all occur in cis (same allele).	736	30
P-0005386-T01-IM5	P-0005386	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Sweat Gland Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 16p	900	50
P-0005387-T01-IM5	P-0005387	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Female		787	80
P-0005388-T01-IM5	P-0005388	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Lymph node	Malignant Lymphoma	IMPACT410			Male		714	50
P-0005390-T01-IM5	P-0005390	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		978	20
P-0005391-T01-IM5	P-0005391	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		521	20
P-0005392-T01-IM5	P-0005392	Salivary Carcinoma	Metastasis	Tumor	Liver	Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 1p, 6q23-6q26, and 9p.     Note: The ESR1, FGFR4, FLT4, LATS1, and NSD1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	750	80
P-0005393-T01-IM5	P-0005393	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1083	30
P-0005395-T01-IM5	P-0005395	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1245	40
P-0005396-T01-IM5	P-0005396	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Dedifferentiated Liposarcoma	IMPACT410			Male		377	60
P-0005397-T01-IM5	P-0005397	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16p13 and 19p13	736	60
P-0005398-T01-IM5	P-0005398	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		605	70
P-0005399-T01-IM5	P-0005399	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		953	50
P-0005400-T01-IM5	P-0005400	Biliary Cancer	Metastasis	Tumor	Lymph Node	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		812	40
P-0005404-T01-IM5	P-0005404	Cervical Cancer	Metastasis	Tumor	Lymph Node	Cervix	Small Cell Carcinoma of the Cervix	IMPACT410			Female		1089	50
P-0005404-T02-IM5	P-0005404	Cervical Cancer	Metastasis	Tumor	Lymph Node	Cervix	Small Cell Carcinoma of the Cervix	IMPACT410			Female		595	60
P-0005409-T02-IM5	P-0005409	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Note: Variants in ASXL1 gene indicates the presence of sub-clones   Note: The chromosomal copy number losses are the same as the previous specimen.	555	80
P-0005416-T01-IM5	P-0005416	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1806	50
P-0005417-T01-IM5	P-0005417	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		882	50
P-0005418-T01-IM5	P-0005418	Cervical Cancer	Metastasis	Tumor	Lung	Cervix	Cervical Adenosquamous Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3q	514	40
P-0005419-T01-IM5	P-0005419	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		465	30
P-0005420-T01-IM5	P-0005420	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	1101	50
P-0005421-T01-IM5	P-0005421	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		1404	30
P-0005422-T01-IM5	P-0005422	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	650	10
P-0005423-T01-IM5	P-0005423	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1282	10
P-0005424-T01-IM5	P-0005424	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		706	20
P-0005425-T01-IM5	P-0005425	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated. False negative results can not be ruled out.	438	70
P-0005426-T01-IM5	P-0005426	Breast Carcinoma	Metastasis	Tumor	Omentum	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	767	10
P-0005427-T01-IM5	P-0005427	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	581	20
P-0005428-T01-IM5	P-0005428	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.      Note: Copy number profile is suggestive of broad copy number gains on Chromosome X and  Chromosome arms 8q and17q	542	40
P-0005429-T01-IM5	P-0005429	Breast Carcinoma	Metastasis	Tumor	Peritoneum	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		542	50
P-0005430-T01-IM5	P-0005430	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		706	20
P-0005431-T01-IM5	P-0005431	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution.	349	10
P-0005432-T01-IM5	P-0005432	Cancer of Unknown Primary	Metastasis	Tumor	Uterus	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	845	10
P-0005434-T01-IM5	P-0005434	Pancreatic Cancer	Metastasis	Tumor	Gallbladder	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses  on Chromosomes 4,5, 6p, 17p,and  19p.	971	60
P-0005435-T01-IM5	P-0005435	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		895	30
P-0005436-T01-IM5	P-0005436	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		388	60
P-0005437-T01-IM5	P-0005437	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	648	70
P-0005438-T01-IM5	P-0005438	Germ Cell Tumor	Primary	Tumor	Not Applicable	Kidney	Teratoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	884	30
P-0005439-T01-IM5	P-0005439	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	741	30
P-0005440-T01-IM5	P-0005440	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male		902	70
P-0005441-T01-IM5	P-0005441	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	827	60
P-0005442-T01-IM5	P-0005442	Ewing Sarcoma	Metastasis	Tumor	Epidural	Bone	Ewing Sarcoma	IMPACT410			Female	Note: The LATS1,ESR1 and PARK2  copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	349	NA
P-0005443-T01-IM5	P-0005443	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	778	20
P-0005444-T01-IM5	P-0005444	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Retroperitoneum	Seminoma	IMPACT410			Male		471	60
P-0005445-T01-IM5	P-0005445	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		317	50
P-0005446-T01-IM5	P-0005446	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		946	20
P-0005447-T01-IM5	P-0005447	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female		455	NA
P-0005448-T01-IM5	P-0005448	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Adenosquamous Carcinoma of the Pancreas	IMPACT410			Male		812	30
P-0005449-T01-IM5	P-0005449	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the  PIK3CA (p.E726K),TP53 (p.R280T), ERBB2 (p.S310F),  PTPRD (p.E529K) and KDM6A (p.R549fs) mutations are subclonal.	705	60
P-0005450-T01-IM5	P-0005450	Gestational Trophoblastic Disease	Metastasis	Tumor	Brain	Testis	Choriocarcinoma	IMPACT410			Male		645	60
P-0005451-T01-IM5	P-0005451	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Non-Hodgkin Lymphoma	IMPACT410			Female		880	50
P-0005452-T01-IM5	P-0005452	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	948	20
P-0005453-T01-IM5	P-0005453	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The ETV1,CARD11,PMS2 and RAC1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	868	80
P-0005454-T01-IM5	P-0005454	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The MYC,  NBN, RAD21 and FAT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	967	60
P-0005455-T01-IM5	P-0005455	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		785	20
P-0005456-T01-IM5	P-0005456	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		713	30
P-0005457-T01-IM5	P-0005457	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Female		1096	60
P-0005458-T01-IM5	P-0005458	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		888	20
P-0005459-T01-IM5	P-0005459	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		907	60
P-0005460-T01-IM5	P-0005460	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		889	30
P-0005461-T02-IM5	P-0005461	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q including GNAS.    Note: The GNAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1517	40
P-0005462-T01-IM5	P-0005462	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.    Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	680	20
P-0005463-T01-IM5	P-0005463	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	716	20
P-0005464-T01-IM5	P-0005464	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		896	30
P-0005465-T01-IM5	P-0005465	Chondrosarcoma	Metastasis	Tumor	Lung	Upper Extremity	Chondrosarcoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.    Note: The KRAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	710	40
P-0005466-T01-IM5	P-0005466	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female		889	80
P-0005467-T01-IM5	P-0005467	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		867	30
P-0005468-T01-IM5	P-0005468	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	732	10
P-0005469-T01-IM5	P-0005469	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		935	60
P-0005470-T01-IM5	P-0005470	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male		1070	80
P-0005471-T01-IM5	P-0005471	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1160	50
P-0005472-T01-IM5	P-0005472	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		389	60
P-0005473-T01-IM5	P-0005473	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		915	20
P-0005474-T01-IM5	P-0005474	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 1p and 10q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q.	721	70
P-0005474-T02-IM5	P-0005474	Embryonal Tumor	Metastasis	Tumor	Lymph node	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1187	10
P-0005475-T01-IM5	P-0005475	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Mesonephric Carcinoma	IMPACT410			Female		749	10
P-0005475-T02-IM5	P-0005475	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Small Cell Carcinoma of the Cervix	IMPACT410			Female		702	80
P-0005476-T01-IM5	P-0005476	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p13-15 including TERT and SDHA and chromosome 19q13 including ERCC2.	540	50
P-0005477-T01-IM5	P-0005477	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1309	50
P-0005478-T01-IM5	P-0005478	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Female	Note: The FGFR4, FLT4 and NSD1  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	611	60
P-0005479-T01-IM5	P-0005479	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The SDHC, DDR2, ERBB2, RARA and CDK12 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	859	30
P-0005480-T01-IM5	P-0005480	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Abdomen	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: The PIK3CD and MTOR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	715	20
P-0005481-T01-IM5	P-0005481	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14 and 21.	830	70
P-0005482-T01-IM5	P-0005482	Cervical Cancer	Metastasis	Tumor	Lung	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female	Note: The CCNE1 and CEBPA copy number gain fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	721	20
P-0005483-T01-IM5	P-0005483	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		848	30
P-0005484-T01-IM5	P-0005484	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Fibrosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12p including KRAS.	714	80
P-0005485-T01-IM5	P-0005485	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female		894	70
P-0005486-T01-IM5	P-0005486	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Medullary Carcinoma	IMPACT410			Female		629	50
P-0005487-T01-IM5	P-0005487	Colorectal Cancer	Metastasis	Tumor	Paracolic Gutter	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	833	20
P-0005488-T01-IM5	P-0005488	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The ERBB2, RARA, and CDK12 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	755	30
P-0005489-T01-IM5	P-0005489	Bladder Cancer	Metastasis	Tumor	liver	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The ARID1A exon3 mutations all occur in cis (same allele).  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	739	10
P-0005490-T01-IM5	P-0005490	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		491	60
P-0005492-T01-IM5	P-0005492	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		701	30
P-0005493-T01-IM5	P-0005493	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		1474	NA
P-0005494-T01-IM5	P-0005494	Renal Cell Carcinoma	Metastasis	Tumor	Pancreas	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	314	40
P-0005495-T01-IM5	P-0005495	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		671	50
P-0005496-T01-IM5	P-0005496	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		915	40
P-0005497-T01-IM5	P-0005497	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The ARID1A exon 20 mutations all occur in cis (same allele).  Note: The TP53 exon 8  mutations all occur in cis (same allele).	664	10
P-0005498-T01-IM5	P-0005498	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Appendix	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female		594	40
P-0005499-T01-IM5	P-0005499	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Female	Note: The MED12 mutation is suggestive of uterine leiomyosarcoma.  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p,3p, 10, 11, and 19q.	893	70
P-0005500-T01-IM5	P-0005500	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male		501	30
P-0005501-T01-IM5	P-0005501	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1133	30
P-0005502-T01-IM5	P-0005502	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male		1267	20
P-0005503-T01-IM5	P-0005503	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	841	10
P-0005504-T01-IM5	P-0005504	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution. Positive results should be confirmed with an alternate method if clinically indicated.	488	30
P-0005505-T01-IM5	P-0005505	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 14q and 22q.	1005	60
P-0005506-T01-IM5	P-0005506	Head and Neck Carcinoma	Metastasis	Tumor	Lymph Node	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution. Positive results should be confirmed with an alternate method if clinically indicated.	523	40
P-0005507-T01-IM5	P-0005507	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		723	60
P-0005508-T01-IM5	P-0005508	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		694	40
P-0005509-T01-IM5	P-0005509	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: The EPHA5  exon3 mutations all occur in cis (same allele).    Note: The CCND1,FGF19,FGF4,FGF3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1012	70
P-0005510-T01-IM5	P-0005510	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1384	30
P-0005511-T01-IM5	P-0005511	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The JAK1,MYCL1 and E2F3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1246	30
P-0005511-T02-IM5	P-0005511	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1101	70
P-0005512-T01-IM5	P-0005512	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Male	RUN UNMATCHED	1159	NA
P-0005513-T01-IM5	P-0005513	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	810	30
P-0005514-T01-IM5	P-0005514	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Bone	Schwannoma	IMPACT410			Female		755	50
P-0005515-T01-IM5	P-0005515	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	769	20
P-0005516-T01-IM5	P-0005516	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		699	60
P-0005517-T01-IM5	P-0005517	Osteosarcoma	Primary	Tumor	Not Applicable	Epidural	Secondary Osteosarcoma	IMPACT410			Female		958	70
P-0005518-T01-IM5	P-0005518	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		824	40
P-0005519-T01-IM5	P-0005519	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	582	20
P-0005520-T01-IM5	P-0005520	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 111X, negative results should be interpreted with caution.	111	40
P-0005520-T02-IM5	P-0005520	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 151X, negative results should be interpreted with caution.	151	NA
P-0005521-T01-IM5	P-0005521	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution.	714	30
P-0005522-T01-IM5	P-0005522	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female		656	40
P-0005523-T01-IM5	P-0005523	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		990	30
P-0005525-T01-IM5	P-0005525	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		476	30
P-0005526-T01-IM5	P-0005526	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	293	50
P-0005527-T01-IM5	P-0005527	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		701	10
P-0005528-T01-IM5	P-0005528	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		916	20
P-0005529-T01-IM5	P-0005529	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q21-11q23.	856	30
P-0005530-T02-IM5	P-0005530	Cancer of Unknown Primary	Metastasis	Tumor	Bone	Unknown	Cancer of Unknown Primary	IMPACT410			Male		1334	NA
P-0005531-T01-IM5	P-0005531	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		821	60
P-0005532-T01-IM5	P-0005532	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	997	10
P-0005533-T01-IM5	P-0005533	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		896	40
P-0005534-T01-IM5	P-0005534	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and Chromosome 12	910	NA
P-0005535-T01-IM5	P-0005535	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.   Note: The CDKN1B exon 1 mutations all occur in cis (same allele).	910	50
P-0005536-T02-IM5	P-0005536	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	830	10
P-0005537-T01-IM5	P-0005537	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	859	50
P-0005538-T01-IM5	P-0005538	Biliary Cancer	Metastasis	Tumor	Brain	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		1008	70
P-0005539-T01-IM5	P-0005539	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1071	60
P-0005540-T01-IM5	P-0005540	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Male	reference TFE3 FISH results	821	30
P-0005541-T01-IM5	P-0005541	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1004	NA
P-0005542-T01-IM5	P-0005542	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The RB1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1022	60
P-0005543-T02-IM5	P-0005543	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The TP53 exon5 mutations occur on different alleles.	635	30
P-0005544-T01-IM5	P-0005544	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		967	NA
P-0005544-T02-IM5	P-0005544	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		881	NA
P-0005545-T01-IM5	P-0005545	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Alveolar Rhabdomyosarcoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover PAX3 and introns of FOXO1 gene.	746	60
P-0005546-T01-IM5	P-0005546	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		861	20
P-0005547-T02-IM5	P-0005547	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		825	60
P-0005548-T01-IM5	P-0005548	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		786	30
P-0005549-T01-IM5	P-0005549	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosomes 7 and 20.	979	60
P-0005550-T01-IM5	P-0005550	Embryonal Tumor	Primary	Tumor	Not Applicable	Mediastinum	Neuroblastoma	IMPACT410			Female	Note: Paucity of somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1056	10
P-0005551-T02-IM5	P-0005551	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 6,9,14, and 15.	774	60
P-0005552-T01-IM5	P-0005552	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		667	30
P-0005553-T01-IM5	P-0005553	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The RAD21 and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1033	60
P-0005554-T01-IM5	P-0005554	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		952	60
P-0005555-T01-IM5	P-0005555	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The CDK12 exon1 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q including BRCA2 and RB1.	1119	60
P-0005556-T01-IM5	P-0005556	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	978	10
P-0005557-T01-IM5	P-0005557	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		762	20
P-0005558-T01-IM5	P-0005558	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	807	10
P-0005560-T01-IM5	P-0005560	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		1004	30
P-0005561-T01-IM5	P-0005561	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	491	40
P-0005562-T01-IM5	P-0005562	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Male		982	40
P-0005563-T02-IM5	P-0005563	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		979	NA
P-0005564-T01-IM5	P-0005564	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The PTEN exon5 mutations occur on different alleles.	667	60
P-0005565-T01-IM5	P-0005565	Leukemia	Primary	Tumor	Not Applicable	Skin	T-Cell Acute Lymphoid Leukemia	IMPACT410			Female		742	NA
P-0005566-T01-IM5	P-0005566	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Atypical Meningioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,6q,10q,16p, 18q and 22q.	793	20
P-0005567-T01-IM5	P-0005567	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		838	NA
P-0005568-T01-IM5	P-0005568	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	998	10
P-0005569-T01-IM5	P-0005569	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p,14q,17p and 18q.   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	988	30
P-0005570-T01-IM5	P-0005570	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise. False negatives cannot be ruled out.	529	40
P-0005571-T01-IM5	P-0005571	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Negative results should be interpreted with caution.	291	60
P-0005572-T03-IM5	P-0005572	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	895	20
P-0005573-T01-IM5	P-0005573	Non-Small Cell Lung Cancer	Primary	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 5p and 3p	829	NA
P-0005574-T01-IM5	P-0005574	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	707	10
P-0005575-T01-IM5	P-0005575	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	207	30
P-0005576-T01-IM5	P-0005576	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		779	60
P-0005577-T01-IM5	P-0005577	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		569	30
P-0005578-T01-IM5	P-0005578	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: The CDKN2B,  CDKN2Ap14ARF	and  CDKN2Ap16INK4A copy number loss fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.     Note: The CARD11, INPP4A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	827
P-0005579-T01-IM5	P-0005579	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	936	30
P-0005580-T01-IM5	P-0005580	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		661	NA
P-0005581-T01-IM5	P-0005581	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		474	60
P-0005582-T01-IM5	P-0005582	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	.Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 11q, 14q31, 14q32 and 22q	811	90
P-0005583-T01-IM5	P-0005583	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		864	NA
P-0005584-T01-IM5	P-0005584	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		800	80
P-0005585-T01-IM5	P-0005585	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female		788	40
P-0005586-T01-IM5	P-0005586	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The TBX3 exon7 mutations all occur in cis (same allele).      Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	856	10
P-0005587-T01-IM5	P-0005587	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The NOTCH4 exon12 mutations all occur in cis (same allele).    Note: The MLL2 exon31 mutations occur on different alleles.	387	10
P-0005588-T01-IM5	P-0005588	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female		380	50
P-0005589-T01-IM5	P-0005589	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20 and Chromosome arm 8q	751	30
P-0005590-T01-IM5	P-0005590	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	97	10
P-0005591-T01-IM5	P-0005591	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	771	20
P-0005592-T01-IM5	P-0005592	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		681	30
P-0005593-T01-IM5	P-0005593	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		499	60
P-0005594-T01-IM5	P-0005594	Anal Cancer	Metastasis	Tumor	Liver	Rectum	Anal Squamous Cell Carcinoma	IMPACT410			Female		1009	30
P-0005595-T01-IM5	P-0005595	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		1241	80
P-0005596-T01-IM5	P-0005596	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The RET, RB1, FOXO1, PLCG2 and FANCA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	937	50
P-0005597-T01-IM5	P-0005597	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: The SMAD4 exon9 mutations occur on different alleles.  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	918	10
P-0005598-T01-IM5	P-0005598	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male		1046	50
P-0005599-T01-IM5	P-0005599	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT410			Female		885	60
P-0005600-T01-IM5	P-0005600	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	913	50
P-0005600-T02-IM5	P-0005600	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	854	20
P-0005601-T01-IM5	P-0005601	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 9p including CDKN2Ap16INK4A.	1365	80
P-0005602-T01-IM5	P-0005602	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The PRKAR1A,  SOX9, RARA and H3F3B copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	767	10
P-0005603-T01-IM5	P-0005603	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10, 14q, 15q and 22q.	744	30
P-0005604-T01-IM5	P-0005604	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		1073	80
P-0005605-T01-IM5	P-0005605	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		1005	60
P-0005606-T01-IM5	P-0005606	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FGFR1 and NKX3-1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	642	30
P-0005607-T01-IM5	P-0005607	Chondrosarcoma	Metastasis	Tumor	Lung	Upper Extremity	Extraskeletal Myxoid Chondrosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	505	40
P-0005608-T01-IM5	P-0005608	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Non-Seminomatous Germ Cell Tumor	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	925	40
P-0005609-T01-IM5	P-0005609	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p/19q.	1076	20
P-0005610-T01-IM5	P-0005610	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 9.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14q.	392	60
P-0005611-T01-IM5	P-0005611	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The SRSF2 exon2 mutations all occur in cis (same allele).    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	966	20
P-0005612-T01-IM5	P-0005612	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1110	30
P-0005613-T01-IM5	P-0005613	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosomes 6q16-26, 13q including BRCA2 and RB1 and 11q21-23.	1223	50
P-0005614-T01-IM5	P-0005614	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	483	70
P-0005615-T03-IM5	P-0005615	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of CDKN2Ap14ARF, CDKN2Ap16INK4A, and CDKN2B loss, but does not meet the criteria for deletion.	723	30
P-0005616-T02-IM5	P-0005616	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q	325	30
P-0005617-T02-IM5	P-0005617	Penile Cancer	Primary	Tumor	Not Applicable	Penis	Penile Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	915	10
P-0005618-T02-IM5	P-0005618	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		831	40
P-0005619-T02-IM5	P-0005619	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.       Note: Copy number profile is suggestive of broad copy number loss on Chromosome 15	785	20
P-0005620-T02-IM5	P-0005620	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The CDK12 p.D214N, p.R219K,  p.D235Y, and  p.D245N mutations all occur in cis (same allele).    Note: The CDK12 p.R300T, p.E314Q and p.R329L mutations in cis mutations all occur in cis (same allele).	619	40
P-0005621-T02-IM5	P-0005621	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	625	20
P-0005622-T03-IM5	P-0005622	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female		708	30
P-0005623-T02-IM5	P-0005623	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female		1109	50
P-0005624-T02-IM5	P-0005624	Salivary Carcinoma	Primary	Tumor	Lung	Salivary Gland	Salivary Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q23-6q26    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 22	957	70
P-0005625-T02-IM5	P-0005625	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q12-13q14 and 19p.         Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	616	40
P-0005626-T02-IM5	P-0005626	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	846	60
P-0005627-T02-IM5	P-0005627	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	864	20
P-0005628-T02-IM5	P-0005628	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Desmoid/Aggressive Fibromatosis	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	767	40
P-0005629-T02-IM5	P-0005629	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	472	10
P-0005630-T01-IM5	P-0005630	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		542	30
P-0005631-T01-IM5	P-0005631	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 138X, negative results should be interpreted with caution.	138	20
P-0005632-T01-IM5	P-0005632	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover FUS gene.	776	20
P-0005633-T01-IM5	P-0005633	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1151	NA
P-0005634-T01-IM5	P-0005634	Colorectal Cancer	Primary	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		823	30
P-0005635-T01-IM5	P-0005635	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		869	40
P-0005636-T01-IM5	P-0005636	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The EPHA3 and AR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1073	40
P-0005637-T01-IM5	P-0005637	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male		331	20
P-0005638-T01-IM5	P-0005638	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	673	60
P-0005639-T01-IM5	P-0005639	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		346	30
P-0005640-T01-IM5	P-0005640	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		732	60
P-0005641-T01-IM5	P-0005641	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		694	60
P-0005642-T01-IM5	P-0005642	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		651	30
P-0005643-T01-IM5	P-0005643	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	617	30
P-0005644-T01-IM5	P-0005644	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	937	30
P-0005645-T01-IM5	P-0005645	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The NFKBIA and NKX2-1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	893	NA
P-0005646-T01-IM5	P-0005646	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Mantle Cell Lymphoma	IMPACT410			Male		1408	70
P-0005647-T01-IM5	P-0005647	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1140	10
P-0005648-T01-IM5	P-0005648	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 19q12-13.    Note: The SOX17 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	505	60
P-0005649-T01-IM5	P-0005649	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	627	10
P-0005650-T01-IM5	P-0005650	Bladder Cancer	Metastasis	Tumor	Epidural	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 95X, negative results should be interpreted with caution.	95	20
P-0005651-T01-IM5	P-0005651	Thyroid Cancer	Metastasis	Tumor	Bone	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	281	60
P-0005652-T01-IM5	P-0005652	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1031	20
P-0005655-T01-IM5	P-0005655	Melanoma	Primary	Tumor	Not Applicable	Urethra	Mucosal Melanoma of the Urethra	IMPACT410			Female		661	40
P-0005656-T01-IM5	P-0005656	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Female	Note: The RUNX1,ERG,TMPRSS2,SOX17,TCEB1,NBN,RAD21,MYC,RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1327	80
P-0005662-T01-IM5	P-0005662	Pancreatic Cancer	Metastasis	Tumor	Pancreas	Esophagus	Pancreatic Adenocarcinoma	IMPACT410			Female		482	20
P-0005664-T01-IM5	P-0005664	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		774	30
P-0005666-T01-IM5	P-0005666	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Lobular Carcinoma In Situ	IMPACT410			Female	Note: The  MLL3  exon13 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q and 16p..	575	10
P-0005670-T01-IM5	P-0005670	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		838	30
P-0005671-T01-IM5	P-0005671	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		803	40
P-0005672-T01-IM5	P-0005672	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	Low-Grade Neuroepithelial Tumor	IMPACT410			Male		475	50
P-0005673-T01-IM5	P-0005673	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Male		839	40
P-0005674-T01-IM5	P-0005674	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover SYT gene.	654	60
P-0005675-T01-IM5	P-0005675	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	824	20
P-0005676-T01-IM5	P-0005676	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Pleomorphic Rhabdomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosomes 5, 18, 20, 21, and 22	881	80
P-0005677-T01-IM5	P-0005677	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	695	60
P-0005678-T01-IM5	P-0005678	Sex Cord Stromal Tumor	Metastasis	Tumor	Bladder	Ovary	Granulosa Cell Tumor	IMPACT410			Female		941	60
P-0005679-T01-IM5	P-0005679	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Medullary Carcinoma	IMPACT410			Male		724	30
P-0005680-T01-IM5	P-0005680	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male		780	60
P-0005681-T01-IM5	P-0005681	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Male		993	60
P-0005682-T01-IM5	P-0005682	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		740	30
P-0005683-T01-IM5	P-0005683	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	503	20
P-0005684-T01-IM5	P-0005684	Germ Cell Tumor	Primary	Tumor	Lung	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	989	70
P-0005685-T01-IM5	P-0005685	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	633	30
P-0005687-T01-IM5	P-0005687	Melanoma	Metastasis	Tumor	Retroperitoneum	Nailbed	Acral Melanoma	IMPACT410			Male		564	50
P-0005688-T01-IM5	P-0005688	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	342	50
P-0005689-T01-IM5	P-0005689	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		973	60
P-0005690-T01-IM5	P-0005690	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	449	10
P-0005691-T01-IM5	P-0005691	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		673	50
P-0005692-T01-IM5	P-0005692	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		965	20
P-0005693-T01-IM5	P-0005693	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Ependymoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9p and 11q.	519	60
P-0005694-T01-IM5	P-0005694	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		959	40
P-0005695-T01-IM5	P-0005695	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		738	30
P-0005696-T01-IM5	P-0005696	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		530	60
P-0005697-T03-IM5	P-0005697	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The ZFHX3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	654	80
P-0005698-T01-IM5	P-0005698	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		687	30
P-0005699-T01-IM5	P-0005699	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Seminoma	IMPACT410			Male		299	70
P-0005700-T01-IM5	P-0005700	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male		621	70
P-0005701-T01-IM5	P-0005701	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		832	80
P-0005702-T01-IM5	P-0005702	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	325	20
P-0005703-T01-IM5	P-0005703	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	556	40
P-0005704-T01-IM5	P-0005704	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q21.	881	50
P-0005705-T01-IM5	P-0005705	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Rectum	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male		768	80
P-0005707-T01-IM5	P-0005707	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The STK11 exon8 mutations all occur in cis (same allele).	639	60
P-0005708-T01-IM5	P-0005708	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		532	60
P-0005709-T01-IM5	P-0005709	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		767	50
P-0005710-T01-IM5	P-0005710	Soft Tissue Sarcoma	Metastasis	Tumor	Peritoneum	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Female		759	10
P-0005711-T01-IM5	P-0005711	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Cancer of Unknown Primary	IMPACT410			Male		723	60
P-0005712-T01-IM5	P-0005712	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		719	70
P-0005713-T01-IM5	P-0005713	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	324	80
P-0005714-T01-IM5	P-0005714	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		195	70
P-0005715-T01-IM5	P-0005715	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: The GATA3 and SHQ1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The FGFR1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	717	70
P-0005716-T01-IM5	P-0005716	Ewing Sarcoma	Metastasis	Tumor	Lung	Bone	Ewing Sarcoma	IMPACT410			Male		489	90
P-0005717-T01-IM5	P-0005717	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The MYOD1, PTPRD, and ROS1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	796	70
P-0005718-T01-IM5	P-0005718	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		529	30
P-0005719-T01-IM5	P-0005719	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		435	80
P-0005720-T01-IM5	P-0005720	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	2176	20
P-0005721-T01-IM5	P-0005721	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		622	20
P-0005722-T01-IM5	P-0005722	Cancer of Unknown Primary	Metastasis	Tumor	Testis	Unknown	Cancer of Unknown Primary	IMPACT410			Male		1046	70
P-0005723-T01-IM5	P-0005723	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		1324	70
P-0005724-T01-IM5	P-0005724	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1625	80
P-0005725-T01-IM5	P-0005725	Melanoma	Metastasis	Tumor	Bone	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	924	80
P-0005726-T02-IM5	P-0005726	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female		819	40
P-0005727-T01-IM5	P-0005727	Bladder Cancer	Metastasis	Tumor	Liver	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		933	70
P-0005728-T01-IM5	P-0005728	Anal Cancer	Metastasis	Tumor	Lymph node	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Male		524	30
P-0005729-T01-IM5	P-0005729	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lymph Node	Histiocytic Dendritic Cell Sarcoma	IMPACT410			Male	Note: The CDKN1B  exon1 mutations all occur in cis (same allele).	824	70
P-0005730-T02-IM5	P-0005730	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The NCOA3, AURKA, CARD11, PMS2 and RAC1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	676	60
P-0005731-T01-IM5	P-0005731	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		851	80
P-0005732-T01-IM5	P-0005732	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: The 3p, 5q and 17p copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The RB1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	621	30
P-0005733-T01-IM5	P-0005733	Melanoma	Metastasis	Tumor	Lung	Unknown	Melanoma of Unknown Primary	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	636	80
P-0005733-T02-IM5	P-0005733	Melanoma	Metastasis	Tumor	Lung	Unknown	Melanoma of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	778	75
P-0005734-T02-IM5	P-0005734	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	455	10
P-0005735-T01-IM5	P-0005735	Breast Carcinoma	Primary	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	798	30
P-0005736-T01-IM5	P-0005736	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		196	20
P-0005737-T02-IM5	P-0005737	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: The copy number analysis is suggestive of an intragenic gain of PIK3CB exons 13-22.	678	90
P-0005738-T02-IM5	P-0005738	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		473	70
P-0005739-T02-IM5	P-0005739	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Assessment of the gene copy number data is limited by low tumor content. Negative results should be interpreted with caution.	525	10
P-0005740-T02-IM5	P-0005740	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		648	80
P-0005741-T01-IM5	P-0005741	Ampullary Carcinoma	Metastasis	Tumor	Liver	Pancreas	Pancreatobiliary Ampullary Carcinoma	IMPACT410			Male		937	40
P-0005742-T01-IM5	P-0005742	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		902	30
P-0005743-T02-IM5	P-0005743	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		488	30
P-0005744-T01-IM5	P-0005744	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The SPOP copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	785	30
P-0005745-T01-IM5	P-0005745	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 15.     Note: The DNMT1 and KEAP1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.     Note: The EPHA5 and MED12 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	366	70
P-0005746-T01-IM5	P-0005746	Thymic Tumor	Primary	Tumor	Not Applicable	Thymus	Thymoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p12-1p31, 2p23 -2p24, 3p13-3p25, 5q13-5q22, 5q32-5q35, and chromosome 22.         Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q22-1q44, 3q and 5p.      Note: The RUNX1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1211	60
P-0005747-T01-IM5	P-0005747	Renal Cell Carcinoma	Metastasis	Tumor	Mediastinum	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		457	NA
P-0005748-T01-IM5	P-0005748	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		410	NA
P-0005749-T01-IM5	P-0005749	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 4q12, 6q, 11q22-11q24, and 16q.	643	70
P-0005750-T01-IM5	P-0005750	Renal Cell Carcinoma	Metastasis	Tumor	Pancreas	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		698	60
P-0005751-T01-IM5	P-0005751	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		681	80
P-0005752-T01-IM5	P-0005752	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		846	50
P-0005753-T01-IM5	P-0005753	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		1146	40
P-0005754-T01-IM5	P-0005754	Germ Cell Tumor	Metastasis	Tumor	Sinonasal	Testis	Yolk Sac Tumor	IMPACT410			Male		1147	30
P-0005755-T01-IM5	P-0005755	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Male		281	20
P-0005756-T01-IM5	P-0005756	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 17p13 including TP53.    Note: The ATRX and MED12 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1188	NA
P-0005757-T01-IM5	P-0005757	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	886	90
P-0005758-T01-IM5	P-0005758	Pancreatic Cancer	Metastasis	Tumor	Ovary	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1016	20
P-0005759-T01-IM5	P-0005759	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	820	20
P-0005760-T01-IM5	P-0005760	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		675	50
P-0005761-T01-IM5	P-0005761	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		936	20
P-0005762-T01-IM5	P-0005762	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q.    Note: Copy number profile is suggestive of a fragmented genome.	1744	NA
P-0005763-T01-IM5	P-0005763	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		950	30
P-0005765-T01-IM5	P-0005765	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	No extra mutations in unmatched analysis	659	70
P-0005766-T01-IM5	P-0005766	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	Mixed Ovarian Carcinoma	IMPACT410			Female		719	40
P-0005767-T02-IM5	P-0005767	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		620	50
P-0005768-T02-IM5	P-0005768	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		527	70
P-0005769-T01-IM5	P-0005769	Melanoma	Metastasis	Tumor	Small Bowel	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7q.	552	90
P-0005770-T02-IM5	P-0005770	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		412	20
P-0005771-T02-IM5	P-0005771	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The FGFR1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6p22-25.	548	50
P-0005772-T01-IM5	P-0005772	Cervical Cancer	Metastasis	Tumor	Soft Tissue	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 2q26-28 including PIK3CA. Comparison of variant frequencies suggests the PIK3CA exon10 mutation is on the gained allele.	492	30
P-0005773-T02-IM5	P-0005773	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male		581	70
P-0005774-T01-IM5	P-0005774	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		475	20
P-0005775-T02-IM5	P-0005775	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q including MYC.	277	70
P-0005776-T02-IM5	P-0005776	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		475	50
P-0005777-T02-IM5	P-0005777	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 4q, 5q, 9p, 13q and 16p.	312	30
P-0005778-T01-IM5	P-0005778	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		645	80
P-0005779-T01-IM5	P-0005779	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		508	80
P-0005780-T01-IM5	P-0005780	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 14q including MAX.	793	80
P-0005781-T01-IM5	P-0005781	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.    Note: The FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	907	40
P-0005782-T01-IM5	P-0005782	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arms 8p and 17p.	519	80
P-0005782-T02-IM5	P-0005782	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 17p including TP53.	216	80
P-0005783-T01-IM5	P-0005783	Cancer of Unknown Primary	Metastasis	Tumor	Chest Wall	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage.	1005	30
P-0005784-T01-IM5	P-0005784	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		850	50
P-0005785-T01-IM5	P-0005785	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		1019	90
P-0005786-T01-IM5	P-0005786	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		759	70
P-0005787-T01-IM5	P-0005787	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		735	80
P-0005788-T01-IM5	P-0005788	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		716	20
P-0005789-T01-IM5	P-0005789	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p/19q and 14q.	612	50
P-0005790-T01-IM5	P-0005790	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		570	70
P-0005791-T01-IM5	P-0005791	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Nasopharynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		788	60
P-0005792-T01-IM5	P-0005792	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 19p    Note: Copy number profile is suggestive of a fragmented genome.	1406	10
P-0005793-T01-IM5	P-0005793	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		83	50
P-0005794-T01-IM5	P-0005794	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	335	70
P-0005795-T01-IM5	P-0005795	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	794	50
P-0005797-T01-IM5	P-0005797	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female	Note: The TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	526	70
P-0005799-T01-IM5	P-0005799	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		691	20
P-0005800-T01-IM5	P-0005800	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male		830	80
P-0005801-T01-IM5	P-0005801	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		841	50
P-0005802-T01-IM5	P-0005802	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		854	50
P-0005803-T01-IM5	P-0005803	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: The HLA-A exon2 mutations all occur in cis (same allele).   Note: The PIM1 exon2 (p.Q37_Y38delinsH) and  (c.83-19G_85del)  mutations  all occur in cis .  Note: The PIM1 exon2 (p.E32K) mutation  is on a different allele than the(p.Q37_Y38delinsH) and ( c.83-19G_85del) mutations.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	1070	70
P-0005804-T01-IM5	P-0005804	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		699	60
P-0005805-T01-IM5	P-0005805	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female		686	50
P-0005806-T01-IM5	P-0005806	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		484	50
P-0005807-T01-IM5	P-0005807	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1036	30
P-0005808-T01-IM5	P-0005808	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		770	30
P-0005810-T01-IM5	P-0005810	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		974	30
P-0005811-T01-IM5	P-0005811	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1069	80
P-0005812-T01-IM5	P-0005812	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Epithelioid Sarcoma	IMPACT410			Male		649	70
P-0005813-T01-IM5	P-0005813	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		881	60
P-0005814-T01-IM5	P-0005814	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	B-Cell Lymphoma	IMPACT410			Male		580	10
P-0005815-T01-IM5	P-0005815	Pancreatic Cancer	Metastasis	Tumor	Ovary	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		773	80
P-0005816-T01-IM5	P-0005816	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The SPOP copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The PARK2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	724	40
P-0005818-T01-IM5	P-0005818	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female		698	50
P-0005819-T01-IM5	P-0005819	Esophagogastric Carcinoma	Metastasis	Tumor	Liver	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		879	60
P-0005820-T01-IM5	P-0005820	Soft Tissue Sarcoma	Metastasis	Tumor	Small Bowel	Leg	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		870	90
P-0005821-T01-IM5	P-0005821	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	534	NA
P-0005822-T01-IM5	P-0005822	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on several chromosome arms including 3p.	662	70
P-0005823-T01-IM5	P-0005823	Colorectal Cancer	Metastasis	Tumor	Mesentery	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		751	70
P-0005824-T01-IM5	P-0005824	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		964	60
P-0005825-T01-IM5	P-0005825	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 13q and 17p (including TP53).	959	90
P-0005826-T01-IM5	P-0005826	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Pharynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MSH2 p.Q288L mutation is subclonal.	1095	70
P-0005827-T01-IM5	P-0005827	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Female		669	20
P-0005828-T01-IM5	P-0005828	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p, 6q, 10q and 22q.    Note: A comparison of variant frequencies suggests the IRS1 p.R439Q mutation is subclonal.	1057	90
P-0005829-T01-IM5	P-0005829	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The YES1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	256	50
P-0005830-T01-IM5	P-0005830	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Carcinoid	IMPACT410			Male	Note: The hight variant frequency of MEN1 exon5 mutation is consistent with copy neutral LOH.	1105	80
P-0005831-T01-IM5	P-0005831	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		1282	80
P-0005832-T01-IM5	P-0005832	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		260	70
P-0005833-T01-IM5	P-0005833	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.    Note: A comparison of variant frequencies suggests the LATS2 p.P514L mutation is subclonal.	669	60
P-0005834-T01-IM5	P-0005834	Glioma	Primary	Tumor	Not Applicable	Brain	Pleomorphic Xanthoastrocytoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A and  CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1063	80
P-0005835-T01-IM5	P-0005835	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: The CDKN2B, CDKN2Ap16INK4A and  CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	867	80
P-0005836-T01-IM5	P-0005836	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		295	30
P-0005837-T01-IM5	P-0005837	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	991	70
P-0005838-T01-IM5	P-0005838	Thyroid Cancer	Metastasis	Tumor	Liver	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		378	20
P-0005839-T01-IM5	P-0005839	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male	Note: The CDK4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	648	30
P-0005840-T01-IM5	P-0005840	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Bladder	Stomach	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female		909	70
P-0005841-T01-IM5	P-0005841	Ewing Sarcoma	Metastasis	Tumor	Lung	Bone	Ewing Sarcoma	IMPACT410			Male		964	50
P-0005842-T01-IM5	P-0005842	Bladder Cancer	Metastasis	Tumor	Kidney	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may represent APOBEC signature.	836	80
P-0005843-T01-IM5	P-0005843	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	1448	90
P-0005844-T01-IM5	P-0005844	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	906	40
P-0005845-T01-IM5	P-0005845	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		768	10
P-0005846-T01-IM5	P-0005846	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p , 11q  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7q , 17q	823	60
P-0005847-T01-IM5	P-0005847	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		843	20
P-0005848-T01-IM5	P-0005848	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Female		248	60
P-0005849-T01-IM5	P-0005849	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		730	50
P-0005850-T01-IM5	P-0005850	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	901	10
P-0005851-T01-IM5	P-0005851	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male	High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage	608	30
P-0005853-T01-IM5	P-0005853	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosomes 9 and 18	1585	70
P-0005854-T01-IM5	P-0005854	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: The FGFR1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q, 6p, Xq22 and Xq25.     Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q	468	80
P-0005855-T01-IM5	P-0005855	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female	minor contamination normal	772	10
P-0005856-T01-IM5	P-0005856	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Angiosarcoma	IMPACT410			Female	Note: The CDKN2B,  CDKN2Ap14ARF, CDKN2Ap16INK4A, CD274, PTPRD, and JAK2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	245	50
P-0005858-T01-IM5	P-0005858	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  arm 20q	1732	30
P-0005859-T01-IM5	P-0005859	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The PIK3CA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	501	40
P-0005860-T01-IM5	P-0005860	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	379	20
P-0005862-T01-IM5	P-0005862	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Female		415	40
P-0005863-T01-IM5	P-0005863	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1092	10
P-0005864-T01-IM5	P-0005864	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		907	30
P-0005865-T01-IM5	P-0005865	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		929	20
P-0005866-T01-IM5	P-0005866	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Follicular Thyroid Cancer	IMPACT410			Female		271	70
P-0005867-T01-IM5	P-0005867	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		843	20
P-0005868-T02-IM5	P-0005868	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9p21.      Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	869	80
P-0005869-T01-IM5	P-0005869	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male		790	30
P-0005870-T01-IM5	P-0005870	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The CDKN2C and NF1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	947	30
P-0005871-T01-IM5	P-0005871	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		713	70
P-0005872-T01-IM5	P-0005872	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	816	20
P-0005873-T01-IM5	P-0005873	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		749	30
P-0005874-T01-IM5	P-0005874	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		819	30
P-0005875-T02-IM5	P-0005875	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: The SDHD copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	961	90
P-0005876-T01-IM5	P-0005876	Small Bowel Cancer	Primary	Tumor	Not Applicable	Duodenum	Small Bowel Cancer	IMPACT410			Female	Note: A comparison of variant frequencies suggests the ERBB2 p.S310Y mutation is subclonal.	926	50
P-0005877-T01-IM5	P-0005877	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		706	60
P-0005878-T01-IM5	P-0005878	Gestational Trophoblastic Disease	Metastasis	Tumor	Lung	Testis	Choriocarcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: The KDM5A and RAD52 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	656	40
P-0005879-T01-IM5	P-0005879	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		680	60
P-0005881-T02-IM5	P-0005881	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		838	60
P-0005882-T01-IM5	P-0005882	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		656	60
P-0005883-T01-IM5	P-0005883	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The PTEN exon5 mutations occur on different alleles.	562	30
P-0005884-T01-IM5	P-0005884	Melanoma	Primary	Tumor	Not Applicable	Rectum	Anorectal Mucosal Melanoma	IMPACT410			Male		735	60
P-0005885-T01-IM5	P-0005885	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Ependymoma	IMPACT410			Male		563	80
P-0005886-T01-IM5	P-0005886	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		1072	60
P-0005887-T02-IM5	P-0005887	Ampullary Carcinoma	Metastasis	Tumor	Liver	Pancreatobiliary	Pancreatobiliary Ampullary Carcinoma	IMPACT410			Male		753	30
P-0005888-T01-IM5	P-0005888	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		834	50
P-0005889-T01-IM5	P-0005889	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Seminoma	IMPACT410			Male		619	30
P-0005890-T01-IM5	P-0005890	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	723	20
P-0005891-T01-IM5	P-0005891	Gastrointestinal Stromal Tumor	Primary	Tumor	Liver	Colon	Gastrointestinal Stromal Tumor	IMPACT410			Female		365	90
P-0005893-T01-IM5	P-0005893	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		619	70
P-0005895-T01-IM5	P-0005895	Non-Small Cell Lung Cancer	Primary	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		824	70
P-0005896-T01-IM5	P-0005896	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female		607	70
P-0005897-T02-IM5	P-0005897	Non-Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Lung Adenocarcinoma	IMPACT410			Male		1061	20
P-0005898-T01-IM5	P-0005898	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		921	30
P-0005899-T01-IM5	P-0005899	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male	Note: The NCOA3, GNAS, IL7R, and RICTOR copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	976	20
P-0005900-T01-IM5	P-0005900	Breast Carcinoma	Primary	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		653	80
P-0005901-T01-IM5	P-0005901	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Oncocytoma	IMPACT410			Male		752	90
P-0005901-T02-IM5	P-0005901	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		730	80
P-0005902-T01-IM5	P-0005902	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the CTNNB1 (p.S33A), CDK12 (p.T1463fs), and MLL2 (p.R5154Q) mutations are subclonal.	385	80
P-0005903-T01-IM5	P-0005903	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		955	20
P-0005904-T01-IM5	P-0005904	Breast Carcinoma	Primary	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Male		1069	70
P-0005905-T01-IM5	P-0005905	Bladder Cancer	Primary	Tumor	Not Applicable	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	498	10
P-0005906-T01-IM5	P-0005906	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Atypical Meningioma	IMPACT410			Male		647	90
P-0005907-T01-IM5	P-0005907	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1, FGF19, FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	762	10
P-0005908-T01-IM5	P-0005908	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		836	70
P-0005909-T01-IM5	P-0005909	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	866	50
P-0005910-T01-IM5	P-0005910	Colorectal Cancer	Primary	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		808	40
P-0005911-T01-IM5	P-0005911	Cancer of Unknown Primary	Metastasis	Tumor	Pelvis	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	634	70
P-0005912-T01-IM5	P-0005912	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The copy number analysis is suggestive of an intragenic gain of BRIP1 exons 2-6.	909	50
P-0005913-T01-IM5	P-0005913	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		367	80
P-0005914-T01-IM5	P-0005914	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	646	10
P-0005915-T01-IM5	P-0005915	Breast Carcinoma	Primary	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1129	50
P-0005916-T01-IM5	P-0005916	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	624	10
P-0005917-T01-IM5	P-0005917	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bladder	Angiosarcoma	IMPACT410			Male		772	30
P-0005918-T01-IM5	P-0005918	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		698	70
P-0005919-T01-IM5	P-0005919	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male		965	20
P-0005920-T01-IM5	P-0005920	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Carcinoid	IMPACT410			Female		912	70
P-0005921-T01-IM5	P-0005921	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		729	30
P-0005922-T01-IM5	P-0005922	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	831	80
P-0005923-T01-IM5	P-0005923	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Esophagus	Gastrointestinal Stromal Tumor	IMPACT410			Male		724	90
P-0005924-T01-IM5	P-0005924	Embryonal Tumor	Metastasis	Tumor	Soft Tissue	Retroperitoneum	Neuroblastoma	IMPACT410			Female	Note: The APC copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	630	60
P-0005925-T02-IM5	P-0005925	Non-Small Cell Lung Cancer	Metastasis	Tumor	Infrahilar mass	Lung	Lung Adenocarcinoma	IMPACT410			Male		846	50
P-0005926-T01-IM5	P-0005926	Non-Hodgkin Lymphoma	Metastasis	Tumor	Skin	Neck	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		963	60
P-0005927-T01-IM5	P-0005927	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		861	70
P-0005928-T01-IM5	P-0005928	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		549	10
P-0005929-T01-IM5	P-0005929	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		771	50
P-0005930-T01-IM5	P-0005930	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q12 -17q24 including ERBB2.	752	70
P-0005931-T01-IM5	P-0005931	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The CCND1, FGF19, FGF4, FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	737	40
P-0005932-T01-IM5	P-0005932	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		252	40
P-0005933-T01-IM5	P-0005933	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The APC and RASA1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The ZRSR2 and EIF1AX copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	836	70
P-0005934-T01-IM5	P-0005934	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		400	80
P-0005935-T01-IM5	P-0005935	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	574	30
P-0005937-T01-IM5	P-0005937	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		597	20
P-0005938-T01-IM5	P-0005938	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		932	10
P-0005939-T01-IM5	P-0005939	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	169	80
P-0005940-T01-IM5	P-0005940	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The ERBB2 p.A37T mutation frequency suggests that the mutation occurs on the amplified allele	440	20
P-0005941-T01-IM5	P-0005941	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18	662	60
P-0005942-T01-IM5	P-0005942	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1178	20
P-0005943-T01-IM5	P-0005943	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		790	70
P-0005945-T01-IM5	P-0005945	Non-Hodgkin Lymphoma	Metastasis	Tumor	Soft Tissue	Lymph Node	Follicular Lymphoma	IMPACT410			Male		1099	90
P-0005946-T01-IM5	P-0005946	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	829	80
P-0005947-T01-IM5	P-0005947	Bladder Cancer	Primary	Tumor	Not Applicable	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p, 10q, 11q, 12p and 16p.	648	80
P-0005948-T01-IM5	P-0005948	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female	Note: The PAK7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	677	60
P-0005949-T01-IM5	P-0005949	Colorectal Cancer	Metastasis	Tumor	Sigmoid colon	Cecum	Colon Adenocarcinoma	IMPACT410			Male		604	40
P-0005951-T01-IM5	P-0005951	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q .	807	20
P-0005952-T01-IM5	P-0005952	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	889	40
P-0005953-T01-IM5	P-0005953	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		982	70
P-0005953-T02-IM5	P-0005953	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Small Cell Carcinoma	IMPACT410			Male		610	80
P-0005954-T01-IM5	P-0005954	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		498	80
P-0005955-T01-IM5	P-0005955	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	675	10
P-0005956-T01-IM5	P-0005956	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		785	80
P-0005957-T01-IM5	P-0005957	Adrenocortical Carcinoma	Metastasis	Tumor	Lung	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female		988	80
P-0005958-T01-IM5	P-0005958	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		642	90
P-0005959-T01-IM5	P-0005959	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		899	30
P-0005960-T01-IM5	P-0005960	Small Bowel Cancer	Primary	Tumor	Not Applicable	Duodenum	Small Bowel Cancer	IMPACT410			Male		447	10
P-0005961-T01-IM5	P-0005961	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Male		875	30
P-0005962-T01-IM5	P-0005962	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	733	10
P-0005963-T01-IM5	P-0005963	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1318	80
P-0005964-T01-IM5	P-0005964	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Teratoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12p.	691	20
P-0005965-T01-IM5	P-0005965	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		430	50
P-0005966-T01-IM5	P-0005966	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		737	60
P-0005967-T01-IM5	P-0005967	Non-Hodgkin Lymphoma	Metastasis	Tumor	Kidney	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: The BCL2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	622	90
P-0005969-T01-IM5	P-0005969	Chondrosarcoma	Metastasis	Tumor	Lung	Bone	Chondrosarcoma	IMPACT410			Female		843	70
P-0005970-T01-IM5	P-0005970	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		925	50
P-0005971-T01-IM5	P-0005971	Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Melanoma	IMPACT410			Female		706	50
P-0005971-T02-IM5	P-0005971	Melanoma	Metastasis	Tumor	Ovary	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 and Chromosome arm 20q.	628	90
P-0005972-T01-IM5	P-0005972	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q.	841	70
P-0005973-T01-IM5	P-0005973	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		602	70
P-0005974-T01-IM5	P-0005974	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		818	60
P-0005975-T01-IM5	P-0005975	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		742	40
P-0005976-T01-IM5	P-0005976	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1409	80
P-0005977-T01-IM5	P-0005977	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Female		531	60
P-0005979-T01-IM5	P-0005979	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome 12, 16, and Chromosome arm 5q.   Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 11q and 22q.	643	80
P-0005980-T01-IM5	P-0005980	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		625	90
P-0005981-T01-IM5	P-0005981	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The NKX2-1 p.H37fs mutation frequency  suggests that the mutation occurs on the amplified allele	1121	70
P-0005983-T01-IM5	P-0005983	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q.	573	90
P-0005984-T01-IM5	P-0005984	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.      Note: The TMPRSS2, ICOSLG, and  ZRSR2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	763	90
P-0005985-T01-IM5	P-0005985	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Female		851	NA
P-0005986-T01-IM5	P-0005986	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		278	70
P-0005987-T01-IM5	P-0005987	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		860	50
P-0005988-T01-IM5	P-0005988	Thyroid Cancer	Primary	Tumor	Bone	Thyroid	Follicular Thyroid Cancer	IMPACT410			Male		599	80
P-0005989-T01-IM5	P-0005989	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Small Bowel	Clear Cell Sarcoma	IMPACT410			Male		1056	80
P-0005990-T01-IM5	P-0005990	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	922	20
P-0005991-T01-IM5	P-0005991	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		932	60
P-0005992-T01-IM5	P-0005992	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male	Note: Paucity of somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	886	40
P-0005993-T01-IM5	P-0005993	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The MDC1, NOTCH4, TCEB1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1127	60
P-0005994-T01-IM5	P-0005994	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		1135	20
P-0005995-T01-IM5	P-0005995	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: The CALR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1036	10
P-0005996-T01-IM5	P-0005996	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		786	60
P-0005997-T01-IM5	P-0005997	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		955	60
P-0005998-T01-IM5	P-0005998	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		849	20
P-0005999-T01-IM5	P-0005999	Esophagogastric Carcinoma	Primary	Tumor	Lymph Node	Stomach	Poorly Differentiated Carcinoma of the Stomach	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	921	20
P-0006000-T02-IM5	P-0006000	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	877	20
P-0006001-T01-IM5	P-0006001	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Malignant Peripheral Nerve Sheath Tumor	IMPACT410			Male	Note: The SMAD4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	883	70
P-0006002-T01-IM5	P-0006002	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	547	40
P-0006003-T01-IM5	P-0006003	Non-Small Cell Lung Cancer	Metastasis	Tumor	Abdomen	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: The EGFR exon18 mutations all occur in cis (same allele).    Note: The ARID5B copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	995	80
P-0006004-T01-IM5	P-0006004	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Male		757	70
P-0006005-T01-IM5	P-0006005	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Male		625	70
P-0006006-T01-IM5	P-0006006	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Sinonasal	Head and Neck Carcinoma, Other	IMPACT410			Female		908	70
P-0006007-T01-IM5	P-0006007	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female		460	70
P-0006008-T01-IM5	P-0006008	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		963	60
P-0006009-T01-IM5	P-0006009	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	708	10
P-0006011-T01-IM5	P-0006011	Embryonal Tumor	Primary	Tumor	Not Applicable	Bone	Neuroblastoma	IMPACT410			Female		810	30
P-0006012-T01-IM5	P-0006012	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	757	10
P-0006013-T01-IM5	P-0006013	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The YES1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	686	10
P-0006014-T01-IM5	P-0006014	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female	Note: The ASXL2 and DNMT3A copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	703	50
P-0006015-T01-IM5	P-0006015	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The FBXW7 exon10 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q14-34 including RB1.	609	70
P-0006016-T01-IM5	P-0006016	Ampullary Carcinoma	Metastasis	Tumor	Duodenum	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	809	70
P-0006017-T01-IM5	P-0006017	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male		536	90
P-0006018-T01-IM5	P-0006018	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	564	90
P-0006019-T01-IM5	P-0006019	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: The TP53  exon5 mutations occur on different alleles.	476	30
P-0006020-T01-IM5	P-0006020	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		627	60
P-0006021-T01-IM5	P-0006021	Non-Small Cell Lung Cancer	Metastasis	Tumor	Epidural	Lung	Lung Adenocarcinoma	IMPACT410			Male		202	50
P-0006022-T01-IM5	P-0006022	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q12- 18q21.      Note: The GATA3,RET,ARID1A,CDKN2B copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	698	70
P-0006023-T02-IM5	P-0006023	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	798	40
P-0006024-T01-IM5	P-0006024	Chondrosarcoma	Primary	Tumor	Not Applicable	Mediastinum	Chondrosarcoma	IMPACT410			Female	Silent mutations called in APC,KL4 and AR.	564	80
P-0006025-T01-IM5	P-0006025	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: A comparison of variant frequencies suggests the ATRX p.P995L mutation is subclonal.   Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p,4q,5q,13q and 17p.    Note: The PTPRD copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	2778	60
P-0006026-T01-IM5	P-0006026	Esophagogastric Carcinoma	Metastasis	Tumor	Falciform Ligament	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: The RICTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	821	10
P-0006027-T01-IM5	P-0006027	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	706	30
P-0006028-T01-IM5	P-0006028	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		917	20
P-0006029-T01-IM5	P-0006029	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		713	60
P-0006030-T01-IM5	P-0006030	Small Bowel Cancer	Metastasis	Tumor	Periumbilical mass	Jejunum	Small Bowel Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	187	10
P-0006031-T01-IM5	P-0006031	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	512	70
P-0006032-T01-IM5	P-0006032	Salivary Carcinoma	Metastasis	Tumor	Liver	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Female		887	50
P-0006033-T01-IM5	P-0006033	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.      Note: The NPM1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	709	80
P-0006034-T01-IM5	P-0006034	Melanoma	Metastasis	Tumor	Lymph node	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.    Note: The FGF19 exon3 mutations all occur in cis (same allele).	752	60
P-0006035-T01-IM5	P-0006035	Sex Cord Stromal Tumor	Primary	Tumor	Not Applicable	Testis	Sex Cord Stromal Tumors	IMPACT410			Male		627	80
P-0006036-T01-IM5	P-0006036	Mesothelioma	Primary	Tumor	Not Applicable	Diaphragm	Pleural Mesothelioma	IMPACT410			Female		315	30
P-0006037-T01-IM5	P-0006037	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		564	60
P-0006038-T01-IM5	P-0006038	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		864	30
P-0006040-T01-IM5	P-0006040	Ewing Sarcoma	Primary	Tumor	Not Applicable	Mediastinum	Ewing Sarcoma	IMPACT410			Female		951	90
P-0006042-T01-IM5	P-0006042	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	690	80
P-0006043-T01-IM5	P-0006043	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		604	20
P-0006044-T01-IM5	P-0006044	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female		437	70
P-0006045-T01-IM5	P-0006045	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		904	70
P-0006046-T01-IM5	P-0006046	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	The FGFR2 p.M1 mutation disrupts translation start. It is uncertain if this mutation is inactivating.	716	70
P-0006048-T02-IM5	P-0006048	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 14q.	332	70
P-0006049-T01-IM5	P-0006049	Skin Cancer, Non-Melanoma	Primary	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arms 4q, 5q, 11q, 13q and Xq13      Note: The CTLA4,  IDH1 , ERBB4, BARD1, INHA , CUL3, IRS1 and PDCD1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1088	90
P-0006050-T01-IM5	P-0006050	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The TGFBR2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1001	40
P-0006051-T01-IM5	P-0006051	Breast Carcinoma	Metastasis	Tumor	Small Bowel	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		610	40
P-0006052-T01-IM5	P-0006052	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Female		785	90
P-0006053-T01-IM5	P-0006053	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14q.      Note: The FLT4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	169	70
P-0006054-T01-IM5	P-0006054	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The E2F3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	945	60
P-0006055-T01-IM5	P-0006055	Renal Cell Carcinoma	Metastasis	Tumor	Brain	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: The TGFBR2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	985	80
P-0006056-T01-IM5	P-0006056	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		332	70
P-0006057-T01-IM5	P-0006057	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	872	20
P-0006058-T02-IM5	P-0006058	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Anorectal Junction	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		666	20
P-0006059-T01-IM5	P-0006059	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Dendritic Cell Sarcoma	IMPACT410			Male	Note: The NFKBIA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	914	30
P-0006060-T01-IM5	P-0006060	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		807	30
P-0006062-T01-IM5	P-0006062	Cancer of Unknown Primary	Metastasis	Tumor	Ovary	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: The PHOX2B, CDKN1B, FGFR3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1090	90
P-0006063-T01-IM5	P-0006063	Non-Small Cell Lung Cancer	Metastasis	Tumor	Colon	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Comparison of variant frequencies suggests the KRAS exon2 mutation occurs on the amplified allele.	1075	80
P-0006064-T01-IM5	P-0006064	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1002	60
P-0006065-T01-IM5	P-0006065	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		891	70
P-0006066-T01-IM5	P-0006066	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		895	30
P-0006067-T01-IM5	P-0006067	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		941	50
P-0006068-T01-IM5	P-0006068	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CDK12, MDM2, ERBB3, SPOP, ERBB2 and RARA copy number gains fall slightly below the cut off criteria for deletion. Confirmatory FISH is suggested, if clinically indicated.	1147	30
P-0006069-T01-IM5	P-0006069	Anal Cancer	Metastasis	Tumor	Liver	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q including MYC.    Note: The RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	859	70
P-0006071-T01-IM5	P-0006071	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The SMAD4 exon9 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of an intrangenic gain of NCOA3 exons 2-17.	752	70
P-0006072-T01-IM5	P-0006072	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		973	30
P-0006073-T01-IM5	P-0006073	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The KRAS exon2 mutations occur on different alleles.	972	10
P-0006074-T01-IM5	P-0006074	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		568	40
P-0006076-T01-IM5	P-0006076	Small Bowel Cancer	Primary	Tumor	Not Applicable	Ileocecal Valve	Small Bowel Cancer	IMPACT410			Female		727	70
P-0006077-T01-IM5	P-0006077	Esophagogastric Carcinoma	Metastasis	Tumor	Thyroid	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1239	40
P-0006078-T01-IM5	P-0006078	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		821	30
P-0006079-T01-IM5	P-0006079	Cancer of Unknown Primary	Metastasis	Tumor	Skin	Unknown	Cancer of Unknown Primary	IMPACT410			Female		925	30
P-0006080-T01-IM5	P-0006080	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	577	30
P-0006081-T01-IM5	P-0006081	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female		541	60
P-0006082-T01-IM5	P-0006082	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  False negatives cannot be ruled out.	405	80
P-0006083-T01-IM5	P-0006083	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	941	10
P-0006084-T01-IM5	P-0006084	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The SDHA and TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	885	70
P-0006085-T01-IM5	P-0006085	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The SDHA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	845	20
P-0006086-T01-IM5	P-0006086	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		815	60
P-0006087-T01-IM5	P-0006087	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT410			Female		854	70
P-0006088-T01-IM5	P-0006088	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		923	60
P-0006089-T01-IM5	P-0006089	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the MET p.I1118T mutation is subclonal.	531	30
P-0006090-T01-IM5	P-0006090	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1007	70
P-0006091-T01-IM5	P-0006091	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the HNF1A p.G181E mutation is subclonal.	1177	60
P-0006092-T01-IM5	P-0006092	Soft Tissue Sarcoma	Metastasis	Tumor	Lymph Node	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: The KDM5A and RAD52 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The DIS3 and ERCC5 copy number losses fall slightly below the cut off criteria for deletion.  Confirmatory testing by an alternate method is suggested, if clinically indicated.	930	80
P-0006093-T01-IM5	P-0006093	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 13q and 20q	848	30
P-0006094-T01-IM5	P-0006094	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The ATRX exon9 p.D896H and p.E892K mutations all occur in cis (same allele).	860	70
P-0006095-T01-IM5	P-0006095	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		698	60
P-0006096-T01-IM5	P-0006096	Cancer of Unknown Primary	Metastasis	Tumor	Stomach	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	170	10
P-0006097-T01-IM5	P-0006097	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		703	50
P-0006098-T01-IM5	P-0006098	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p, 14q, 16q22-16q24, and 18q    Note: The PAX5 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	793	70
P-0006099-T01-IM5	P-0006099	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	818	10
P-0006101-T01-IM5	P-0006101	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	792	30
P-0006102-T01-IM5	P-0006102	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	601	90
P-0006103-T01-IM5	P-0006103	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT410			Female		809	40
P-0006104-T01-IM5	P-0006104	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Colon	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p	923	90
P-0006106-T01-IM5	P-0006106	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		733	30
P-0006107-T01-IM5	P-0006107	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		648	20
P-0006108-T01-IM5	P-0006108	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		954	30
P-0006108-T02-IM5	P-0006108	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	691	15
P-0006109-T01-IM5	P-0006109	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Female		720	80
P-0006110-T01-IM5	P-0006110	Colorectal Cancer	Primary	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		889	50
P-0006111-T01-IM5	P-0006111	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.    Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	803	70
P-0006112-T01-IM5	P-0006112	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		941	80
P-0006112-T02-IM5	P-0006112	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		829	NA
P-0006113-T01-IM5	P-0006113	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Alveolar Rhabdomyosarcoma	IMPACT410			Male	Note: Copy number gain of FOXO1 may be suggestive of a rearrangement. However, MSK-IMPACT test panel does not completely cover intronic region of FOX01 gene.   Note: The RAD51B and MAX copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	949	80
P-0006114-T01-IM5	P-0006114	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		1179	30
P-0006115-T01-IM5	P-0006115	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		999	20
P-0006116-T01-IM5	P-0006116	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	609	10
P-0006118-T02-IM5	P-0006118	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		666	40
P-0006119-T01-IM5	P-0006119	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The FAT1 exon7 mutations all occur in cis (same allele).	838	20
P-0006120-T01-IM5	P-0006120	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Duodenum	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: The MCL1,  RIT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The NOTCH2, CDKN2B, CDKN2Ap16INK4A, CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	384	70
P-0006121-T01-IM5	P-0006121	Melanoma	Metastasis	Tumor	Lung	Vagina	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		551	NA
P-0006122-T01-IM5	P-0006122	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: The CCND1, FGF19, FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	694	70
P-0006123-T01-IM5	P-0006123	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1084	NA
P-0006124-T01-IM5	P-0006124	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  False negative cannot be ruled out.      Note: Copy number profile is suggestive of a fragmented genome..    Note: The FANCA exon3, PBRM1 exon17 mutations all occur in cis (same allele).	662	80
P-0006125-T01-IM5	P-0006125	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  False negative cannot be ruled out.	673	30
P-0006126-T01-IM5	P-0006126	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  arms 7q and 17q.    Note: The TP53,  PMS2 and RAC1 copy number gains fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	871	90
P-0006127-T01-IM5	P-0006127	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The PMS2 and RAC1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The FAT1 exon10 mutations (c.6659T>C and c.6547G>A) all occur in cis (same allele).	995	50
P-0006128-T01-IM5	P-0006128	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		996	20
P-0006129-T01-IM5	P-0006129	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		665	60
P-0006129-T02-IM5	P-0006129	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	621	10
P-0006130-T01-IM5	P-0006130	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	B-Cell Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 18q, including BCL2.   Note: The KIT, TET2,  INPP4B, and FBXW7 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	837	80
P-0006131-T01-IM5	P-0006131	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Female		697	30
P-0006132-T01-IM5	P-0006132	Hepatocellular Carcinoma	Metastasis	Tumor	Ovary	Liver	Fibrolamellar Carcinoma	IMPACT410			Female		669	80
P-0006133-T01-IM5	P-0006133	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EP300 exon19 mutations all occur in cis (same allele).	684	30
P-0006134-T01-IM5	P-0006134	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1077	30
P-0006135-T01-IM5	P-0006135	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The KDM5A copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	743	70
P-0006136-T01-IM5	P-0006136	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	900	20
P-0006137-T01-IM5	P-0006137	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		402	40
P-0006138-T01-IM5	P-0006138	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		934	20
P-0006139-T01-IM5	P-0006139	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The NFKBIA, NKX2-1, and FOXA1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	920	30
P-0006140-T01-IM5	P-0006140	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	951	10
P-0006141-T01-IM5	P-0006141	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Adenosquamous Carcinoma of the Pancreas	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	685	20
P-0006142-T01-IM5	P-0006142	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9q21.33-9q31	814	50
P-0006144-T01-IM5	P-0006144	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Adenosquamous Carcinoma of the Pancreas	IMPACT410			Male		867	10
P-0006145-T01-IM5	P-0006145	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Breast	Angiosarcoma	IMPACT410			Female		940	70
P-0006148-T01-IM5	P-0006148	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		783	30
P-0006149-T02-IM5	P-0006149	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		593	30
P-0006150-T01-IM5	P-0006150	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		1060	30
P-0006151-T01-IM5	P-0006151	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Female		801	70
P-0006152-T01-IM5	P-0006152	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Female		612	30
P-0006153-T01-IM5	P-0006153	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Male		904	70
P-0006154-T01-IM5	P-0006154	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		883	20
P-0006155-T02-IM5	P-0006155	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: The MLL2  exon10 mutations all occur in cis (same allele).        Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.      Note: The BLM copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF  copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	327	50
P-0006156-T01-IM5	P-0006156	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The RAD51D and MAPK3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	766	40
P-0006157-T01-IM5	P-0006157	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Conjunctiva	Head and Neck Mucosal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  arm 1q.	396	50
P-0006158-T01-IM5	P-0006158	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		560	70
P-0006159-T01-IM5	P-0006159	Chondrosarcoma	Primary	Tumor	Not Applicable	Perineal mass	Extraskeletal Myxoid Chondrosarcoma	IMPACT410			Male		516	50
P-0006160-T01-IM5	P-0006160	Soft Tissue Sarcoma	Metastasis	Tumor	Abdomen	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female		674	70
P-0006161-T01-IM5	P-0006161	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	581	10
P-0006162-T01-IM5	P-0006162	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: A comparison of variant frequencies suggests the PIK3CB  p.E552K mutation is subclonal.	784	60
P-0006163-T01-IM5	P-0006163	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Assessment of the copy number profile is limited by increased background noise.  Negative results should be interpreted with caution.	256	70
P-0006164-T01-IM5	P-0006164	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		738	60
P-0006165-T01-IM5	P-0006165	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1044	10
P-0006166-T01-IM5	P-0006166	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		237	10
P-0006167-T01-IM5	P-0006167	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		681	20
P-0006169-T01-IM5	P-0006169	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The ESR1 exon9 mutations occur on different alleles.	754	60
P-0006170-T01-IM5	P-0006170	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		740	20
P-0006172-T01-IM5	P-0006172	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		923	20
P-0006173-T01-IM5	P-0006173	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male		1130	30
P-0006174-T01-IM5	P-0006174	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		884	40
P-0006175-T01-IM5	P-0006175	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male	Note: The KEAP1 exon2 mutations all occur in cis (same allele).    Note: The CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1002	70
P-0006176-T01-IM5	P-0006176	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT410			Female		864	30
P-0006177-T01-IM5	P-0006177	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		1145	60
P-0006178-T01-IM5	P-0006178	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		550	20
P-0006179-T01-IM5	P-0006179	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Schwannoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	660	10
P-0006180-T01-IM5	P-0006180	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Dermatofibrosarcoma Protuberans	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	675	10
P-0006181-T01-IM5	P-0006181	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		849	30
P-0006182-T01-IM5	P-0006182	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The RIT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.     Note: The FAT1 and BRAF copy number losses fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1086	70
P-0006183-T01-IM5	P-0006183	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		819	30
P-0006184-T01-IM5	P-0006184	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		985	20
P-0006185-T01-IM5	P-0006185	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	835	40
P-0006186-T01-IM5	P-0006186	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	553	10
P-0006187-T01-IM5	P-0006187	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	523	70
P-0006188-T01-IM5	P-0006188	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Adenosquamous Carcinoma of the Pancreas	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	866	10
P-0006189-T01-IM5	P-0006189	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		762	40
P-0006190-T01-IM5	P-0006190	Bladder Cancer	Primary	Tumor	Not Applicable	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests APOBEC signature.	735	50
P-0006191-T01-IM5	P-0006191	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		949	40
P-0006192-T01-IM5	P-0006192	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1088	80
P-0006193-T01-IM5	P-0006193	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		548	30
P-0006194-T01-IM5	P-0006194	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	MYC and POLD1 germline gain (1.53 and 1.43)	738	80
P-0006195-T01-IM5	P-0006195	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female		831	60
P-0006196-T02-IM5	P-0006196	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	614	70
P-0006197-T01-IM5	P-0006197	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the SETD2 p.N261fs mutation is subclonal.	565	80
P-0006198-T01-IM5	P-0006198	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female		889	70
P-0006199-T01-IM5	P-0006199	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		895	20
P-0006199-T02-IM5	P-0006199	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		524	30
P-0006199-T03-IM5	P-0006199	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 8q	644	70
P-0006200-T01-IM5	P-0006200	Melanoma	Metastasis	Tumor	Lung	Foot	Acral Melanoma	IMPACT410			Male	Note: A comparison with histological tumor content suggests that the AURKB exon9 variant is subclonal.	921	70
P-0006201-T01-IM5	P-0006201	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		594	70
P-0006202-T01-IM5	P-0006202	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		745	60
P-0006203-T01-IM5	P-0006203	Endometrial Cancer	Metastasis	Tumor	Colon	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1088	80
P-0006204-T01-IM5	P-0006204	Chordoma	Primary	Tumor	Not Applicable	Bone	Chordoma	IMPACT410			Male		499	20
P-0006205-T01-IM5	P-0006205	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The NOTCH2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	869	20
P-0006206-T01-IM5	P-0006206	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		988	60
P-0006207-T01-IM5	P-0006207	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		801	40
P-0006208-T01-IM5	P-0006208	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female		1014	90
P-0006209-T01-IM5	P-0006209	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: The ARID1A exon1 mutations all occur in cis (same allele).	940	30
P-0006210-T01-IM5	P-0006210	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1157	40
P-0006211-T01-IM5	P-0006211	Cancer of Unknown Primary	Metastasis	Tumor	Peritoneum	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	796	10
P-0006213-T01-IM5	P-0006213	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		937	20
P-0006214-T01-IM5	P-0006214	Embryonal Tumor	Metastasis	Tumor	Lung	Abdomen	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q21.33-17q25.      Note: The DICER1, AKT1, AKT3, and FH copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1335	70
P-0006215-T01-IM5	P-0006215	Embryonal Tumor	Metastasis	Tumor	Lymph node	Mediastinum	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 and Chromosome arm 17q.	712	70
P-0006215-T02-IM5	P-0006215	Embryonal Tumor	Metastasis	Tumor	Soft Tissue	Mediastinum	Neuroblastoma	IMPACT410			Female		903	10
P-0006216-T01-IM5	P-0006216	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	976	70
P-0006217-T01-IM5	P-0006217	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		456	30
P-0006218-T01-IM5	P-0006218	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.  Note: Low sequencing depth of coverage of 160X, negative results should be interpreted with caution.	159	70
P-0006219-T01-IM5	P-0006219	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female		549	20
P-0006220-T01-IM5	P-0006220	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		708	70
P-0006221-T01-IM5	P-0006221	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	753	10
P-0006221-T02-IM5	P-0006221	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	add back SCNA	957	70
P-0006222-T01-IM5	P-0006222	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	287	50
P-0006223-T02-IM5	P-0006223	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Non-Hodgkin Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.	736	70
P-0006225-T01-IM5	P-0006225	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		786	50
P-0006226-T01-IM5	P-0006226	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		919	20
P-0006226-T02-IM5	P-0006226	Cancer of Unknown Primary	Metastasis	Tumor	Brain	Unknown	Cancer of Unknown Primary	IMPACT410			Male		864	70
P-0006227-T01-IM5	P-0006227	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: The AKT1 p.E17K mutation frequency suggests that the mutation occurs on the amplified allele	487	70
P-0006228-T01-IM5	P-0006228	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20.	835	60
P-0006229-T01-IM5	P-0006229	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	425	70
P-0006230-T01-IM5	P-0006230	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Female		776	20
P-0006231-T01-IM5	P-0006231	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1089	20
P-0006232-T01-IM5	P-0006232	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Peritoneum	Fibrosarcoma	IMPACT410			Female	Note: The GLI1 p.P869A mutation frequency suggests that the mutation occurs on the amplified allele	652	30
P-0006233-T01-IM5	P-0006233	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The TERT promoter mutations all occur in cis (same allele).  Note: The MDC1 exon8 mutations all occur in cis (same allele).	664	10
P-0006234-T01-IM5	P-0006234	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		540	70
P-0006236-T01-IM5	P-0006236	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	504	10
P-0006237-T01-IM5	P-0006237	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT gene.        Note: Copy number profile is suggestive of broad copy number losses on Chromosome 18 and Chromosome arm 22q11-22q12.      Note: The ID3, ARID1A, FAT1, PRDM1, and FYN copy number losses falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1023	80
P-0006238-T01-IM5	P-0006238	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p and 6q.	1039	70
P-0006239-T01-IM5	P-0006239	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		709	30
P-0006240-T01-IM5	P-0006240	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Female	Note: The TET2 (NM_001127208) exon 3 p.S774* mutation is observed  upon manual review at low frequency.	947	30
P-0006241-T01-IM5	P-0006241	Melanoma	Primary	Tumor	Not Applicable	Conjunctiva	Head and Neck Mucosal Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	735	20
P-0006243-T01-IM5	P-0006243	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Female		1051	90
P-0006244-T01-IM5	P-0006244	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		778	70
P-0006245-T01-IM5	P-0006245	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	700	NA
P-0006245-T02-IM5	P-0006245	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	657	20
P-0006246-T01-IM5	P-0006246	Anal Cancer	Primary	Tumor	Not Applicable	Rectum	Anal Squamous Cell Carcinoma	IMPACT410			Male		1036	30
P-0006246-T02-IM5	P-0006246	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		800	NA
P-0006247-T01-IM5	P-0006247	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		730	30
P-0006248-T01-IM5	P-0006248	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female	Note: The CCND1,FGF19,FGF4,FGF3 and GNAS copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	737	10
P-0006248-T02-IM5	P-0006248	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The PPM1D, BRIP1, CD79B and NCOA3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	639	10
P-0006249-T01-IM5	P-0006249	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 19p.	546	30
P-0006250-T01-IM5	P-0006250	Biliary Cancer	Metastasis	Tumor	Peritoneum	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: The SMAD4 exon12 mutations all occur in cis (same allele).    Note: Low sequencing depth of coverage of 111x, negative results should be interpreted with caution.	111	10
P-0006251-T01-IM5	P-0006251	Anal Cancer	Metastasis	Tumor	Liver	Rectum	Anal Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3q including SOX2.      Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	870	20
P-0006252-T01-IM5	P-0006252	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	414	10
P-0006253-T01-IM5	P-0006253	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The DDR2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	506	70
P-0006254-T01-IM5	P-0006254	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	158	10
P-0006256-T01-IM5	P-0006256	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	623	10
P-0006257-T01-IM5	P-0006257	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p13-15 gain including TERT and SDHA.	521	20
P-0006258-T01-IM5	P-0006258	Soft Tissue Sarcoma	Primary	Tumor	Colon	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Male		758	80
P-0006259-T01-IM5	P-0006259	Thyroid Cancer	Metastasis	Tumor	Mediastinum	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9p and 22q including CDKN2A and NF2, respectively.	853	70
P-0006260-T01-IM5	P-0006260	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise but is indicative of a loss in CDKN2A and TP53.  Confirmation of copy number loss by alternate methods is suggested if clinically indicated.	478	30
P-0006261-T01-IM5	P-0006261	Colorectal Cancer	Metastasis	Tumor	Retroperitoneum	Colon	Colon Adenocarcinoma	IMPACT410			Female		918	NA
P-0006262-T01-IM5	P-0006262	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The CDK12 and ERBB2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	709	10
P-0006264-T01-IM5	P-0006264	Cancer of Unknown Primary	Metastasis	Tumor	Lymph node	Unknown	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		943	20
P-0006265-T01-IM5	P-0006265	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	712	50
P-0006266-T01-IM5	P-0006266	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The MALT1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	666	20
P-0006267-T01-IM5	P-0006267	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	651	70
P-0006268-T01-IM5	P-0006268	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	591	20
P-0006269-T01-IM5	P-0006269	Endometrial Cancer	Metastasis	Tumor	Diaphragm	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		842	70
P-0006270-T01-IM5	P-0006270	Bladder Cancer	Primary	Tumor	Not Applicable	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	749	20
P-0006271-T01-IM5	P-0006271	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	390	10
P-0006272-T01-IM5	P-0006272	Colorectal Cancer	Metastasis	Tumor	Lymph Node	Rectum	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	904	10
P-0006273-T01-IM5	P-0006273	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female	Note: The MYC,RECQL4 and  YES1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	706	30
P-0006274-T01-IM5	P-0006274	Soft Tissue Sarcoma	Metastasis	Tumor	Ovary	Soft Tissue	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Female		660	50
P-0006275-T01-IM5	P-0006275	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: The BCL2L1,ASXL1,DNMT3B,SRC,TOP1,PTPRT,NCOA3,AURKA,GNAS,RECQL4,LATS2 and CDK8 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	704	50
P-0006276-T01-IM5	P-0006276	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	333	10
P-0006277-T01-IM5	P-0006277	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the  BCL2L11 p.S104fs mutation is subclonal.	721	70
P-0006279-T01-IM5	P-0006279	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 10% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	413	10
P-0006282-T02-IM5	P-0006282	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		676	40
P-0006283-T01-IM5	P-0006283	Breast Carcinoma	Metastasis	Tumor	Mediastinum	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		401	30
P-0006284-T01-IM5	P-0006284	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Dedifferentiated Liposarcoma	IMPACT410			Male		244	30
P-0006289-T01-IM5	P-0006289	Non-Small Cell Lung Cancer	Metastasis	Tumor	Omentum	Lung	Lung Adenocarcinoma	IMPACT410			Female		809	30
P-0006291-T01-IM5	P-0006291	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		765	70
P-0006292-T01-IM5	P-0006292	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	541	10
P-0006294-T01-IM5	P-0006294	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		586	20
P-0006295-T01-IM5	P-0006295	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 15q.	559	80
P-0006296-T01-IM5	P-0006296	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: The ATRX exon9 mutations all occur in cis (same allele).      Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 14q.	480	30
P-0006297-T01-IM5	P-0006297	Uterine Sarcoma	Metastasis	Tumor	Abdomen	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 3q, 6p, 9p, 10q, 12q12, 12q13, 13q12,15q13, 15q 15 and 15q21.	574	90
P-0006299-T01-IM5	P-0006299	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Ependymoma	IMPACT410			Female		657	50
P-0006300-T01-IM5	P-0006300	Penile Cancer	Primary	Tumor	Not Applicable	Penis	Penile Squamous Cell Carcinoma	IMPACT410			Male	Note: The ASXL2 exon12 mutations occur on different alleles. Note:  Copy number profile is suggestive of broad copy number loss on Chromosome arm of 3p	478	20
P-0006301-T01-IM5	P-0006301	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	538	60
P-0006302-T01-IM5	P-0006302	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	518	20
P-0006303-T01-IM5	P-0006303	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Angiosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 10q, 17p, 18q and 22q.	276	70
P-0006304-T01-IM5	P-0006304	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		821	50
P-0006305-T01-IM5	P-0006305	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Neck	Cellular Schwannoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	780	80
P-0006306-T01-IM5	P-0006306	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	819	20
P-0006307-T01-IM5	P-0006307	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT410			Male		982	70
P-0006308-T01-IM5	P-0006308	Cancer of Unknown Primary	Metastasis	Tumor	Omentum	Unknown	Cancer of Unknown Primary	IMPACT410			Female		261	60
P-0006309-T01-IM5	P-0006309	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		1061	20
P-0006310-T01-IM5	P-0006310	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		856	20
P-0006311-T01-IM5	P-0006311	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	905	30
P-0006312-T01-IM5	P-0006312	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pericardium	Lung	Lung Adenocarcinoma	IMPACT410			Female		149	70
P-0006313-T01-IM5	P-0006313	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		862	30
P-0006314-T01-IM5	P-0006314	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	685	10
P-0006315-T01-IM5	P-0006315	Breast Carcinoma	Metastasis	Tumor	Colon	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		721	40
P-0006316-T01-IM5	P-0006316	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female		611	60
P-0006317-T01-IM5	P-0006317	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 106X, negative results should be interpreted with caution.	106	20
P-0006318-T01-IM5	P-0006318	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female		891	70
P-0006319-T01-IM5	P-0006319	Embryonal Tumor	Primary	Tumor	Not Applicable	Neck	Neuroblastoma	IMPACT410			Male		946	70
P-0006320-T01-IM5	P-0006320	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Duodenum	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p           Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	729	80
P-0006321-T01-IM5	P-0006321	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p        Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q	351	70
P-0006322-T01-IM5	P-0006322	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	871	20
P-0006323-T01-IM5	P-0006323	Chordoma	Primary	Tumor	Not Applicable	Neck	Chordoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	422	80
P-0006324-T01-IM5	P-0006324	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		598	30
P-0006325-T01-IM5	P-0006325	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		1243	70
P-0006326-T01-IM5	P-0006326	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		378	30
P-0006327-T01-IM5	P-0006327	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	700	30
P-0006329-T01-IM5	P-0006329	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colorectal Adenocarcinoma	IMPACT410			Male		918	20
P-0006330-T01-IM5	P-0006330	Cancer of Unknown Primary	Metastasis	Tumor	Mediastinum	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low sequencing depth of coverage of 178X, negative results should be interpreted with caution.	178	10
P-0006331-T01-IM5	P-0006331	Bladder Cancer	Metastasis	Tumor	Lymph node	Bladder	Bladder Adenocarcinoma	IMPACT410			Male		1252	20
P-0006332-T01-IM5	P-0006332	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	982	10
P-0006333-T01-IM5	P-0006333	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		506	40
P-0006334-T01-IM5	P-0006334	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		688	60
P-0006335-T01-IM5	P-0006335	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms pf 1p, 6q, 13q, 16q and 11	790	NA
P-0006336-T01-IM5	P-0006336	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Small Bowel	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9 and 18	753	70
P-0006337-T01-IM5	P-0006337	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 122X, negative results should be interpreted with caution.	122	30
P-0006338-T01-IM5	P-0006338	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		395	60
P-0006339-T01-IM5	P-0006339	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Female		1647	70
P-0006340-T01-IM5	P-0006340	Ovarian Cancer	Metastasis	Tumor	Rectum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: The CRKL, MAPK1,  SMARCB1, CHEK2,  NF2 and EP300 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	750	70
P-0006341-T01-IM5	P-0006341	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		920	40
P-0006342-T01-IM5	P-0006342	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		448	50
P-0006343-T01-IM5	P-0006343	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	747	NA
P-0006344-T01-IM5	P-0006344	Endometrial Cancer	Metastasis	Tumor	Chest Wall	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		280	70
P-0006345-T01-IM5	P-0006345	Colorectal Cancer	Metastasis	Tumor	Abdominal Wall	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 12p	618	20
P-0006346-T01-IM5	P-0006346	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		525	30
P-0006347-T01-IM5	P-0006347	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q and copy number loss on chromosome arm 11q.	561	50
P-0006348-T01-IM5	P-0006348	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		868	20
P-0006349-T01-IM5	P-0006349	Cancer of Unknown Primary	Metastasis	Tumor	Pleura	Unknown	Cancer of Unknown Primary	IMPACT410			Female		685	60
P-0006350-T01-IM5	P-0006350	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Immature Teratoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q and 10.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome Xq22-25 including STAG2.	553	20
P-0006350-T02-IM5	P-0006350	Germ Cell Tumor	Metastasis	Tumor	Bone	Mediastinum	Immature Teratoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and chromosome 10.    Note: The SH2D1A, STAG2, XIAP and BTK copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	712	50
P-0006351-T01-IM5	P-0006351	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TERT and SDHA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	636	20
P-0006353-T01-IM5	P-0006353	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female		780	20
P-0006354-T01-IM5	P-0006354	Retinoblastoma	Primary	Tumor	Not Applicable	Eye	Retinoblastoma	IMPACT410			Male	Note: The LATS1, ESR1, ARID1B and PARK2  copy number losses fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	621	60
P-0006355-T01-IM5	P-0006355	Breast Carcinoma	Metastasis	Tumor	Bladder	Breast	Breast Carcinoma	IMPACT410			Female	Note: The PIK3CA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	744	50
P-0006356-T01-IM5	P-0006356	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Liver	Epithelioid Hemangioendothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1395	10
P-0006357-T01-IM5	P-0006357	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the SETD2 p.K1074N and MLL2 p.Q4219* mutations are subclonal.	799	30
P-0006358-T01-IM5	P-0006358	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1016	70
P-0006359-T01-IM5	P-0006359	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The CTNNB1 splicing variant is potentially an in frame deletion which skips exon 3.	1068	70
P-0006360-T01-IM5	P-0006360	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	875	50
P-0006361-T01-IM5	P-0006361	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		638	30
P-0006362-T01-IM5	P-0006362	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	813	10
P-0006363-T01-IM5	P-0006363	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: The EGFR exon7 mutations occur on different alleles.	791	70
P-0006364-T01-IM5	P-0006364	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1288	30
P-0006365-T01-IM5	P-0006365	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		524	60
P-0006366-T01-IM5	P-0006366	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Follicular Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood, saliva, and nail samples and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood, saliva, and nail samples.	726	20
P-0006367-T01-IM5	P-0006367	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	464	20
P-0006368-T01-IM5	P-0006368	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The KEAP1 exon3 mutations occur on different alleles.	1319	60
P-0006369-T01-IM5	P-0006369	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Leg	Perivascular Epithelioid Cell Tumor	IMPACT410			Male	Note: A comparison of variant frequencies suggests the TSC1 p.E478Q  mutation is subclonal.   Note: A comparison of variant frequencies suggests the CIC  p.A782D  mutation is subclonal	780	70
P-0006370-T01-IM5	P-0006370	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		762	80
P-0006371-T01-IM5	P-0006371	Pancreatic Cancer	Metastasis	Tumor	Lymph Node	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		621	20
P-0006372-T01-IM5	P-0006372	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	679	10
P-0006373-T01-IM5	P-0006373	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Ascending Colon	Dedifferentiated Liposarcoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 106X, negative results should be interpreted with caution.	106	30
P-0006374-T01-IM5	P-0006374	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		588	20
P-0006375-T01-IM5	P-0006375	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Non-Hodgkin Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patient matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	721	50
P-0006376-T01-IM5	P-0006376	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1150	40
P-0006377-T02-IM5	P-0006377	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Arm	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3 and chromosome arm 18q.    Note: The CDKN2Ap16INK4A copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	714	10
P-0006378-T01-IM5	P-0006378	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		818	30
P-0006379-T01-IM5	P-0006379	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	620	50
P-0006380-T01-IM5	P-0006380	Ovarian Cancer	Metastasis	Tumor	Vagina	Ovary	Endometrioid Ovarian Cancer	IMPACT410			Female		1064	60
P-0006381-T01-IM5	P-0006381	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		608	70
P-0006381-T02-IM5	P-0006381	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	730	90
P-0006382-T01-IM5	P-0006382	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		684	60
P-0006383-T01-IM5	P-0006383	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.	812	60
P-0006384-T01-IM5	P-0006384	Soft Tissue Sarcoma	Metastasis	Tumor	Mediastinum	Soft Tissue	Epithelioid Sarcoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MGA p.D582fs  mutation is subclonal.  Note: Low sequencing depth of coverage of 113X, negative results should be interpreted with caution.	113	30
P-0006387-T01-IM5	P-0006387	Renal Cell Carcinoma	Metastasis	Tumor	Pleura	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		913	50
P-0006388-T01-IM5	P-0006388	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The POLE,  SRC, TOP1 , PTPRT, NCOA3,  PIK3CB and FOXL2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	608	50
P-0006389-T01-IM5	P-0006389	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 111, negative results should be interpreted with caution.	111	20
P-0006390-T01-IM5	P-0006390	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		933	30
P-0006392-T01-IM5	P-0006392	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note:  A comparison of variant frequencies suggests the ANKRD11 and KDM5C mutations are subclonal.	666	70
P-0006393-T01-IM5	P-0006393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 78X, negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	78	70
P-0006394-T01-IM5	P-0006394	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note:  Copy number profile is suggestive of broad copy number gains on chromosomes 7, 13q, and 20q.	741	40
P-0006395-T01-IM5	P-0006395	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	900	20
P-0006396-T01-IM5	P-0006396	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male		652	30
P-0006397-T01-IM5	P-0006397	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	835	20
P-0006398-T01-IM5	P-0006398	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		517	20
P-0006399-T01-IM5	P-0006399	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	445	20
P-0006400-T01-IM5	P-0006400	Cervical Cancer	Metastasis	Tumor	Abdomen	Cervix	Cervical Adenosquamous Carcinoma	IMPACT410			Female		479	10
P-0006402-T01-IM5	P-0006402	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR exon18 mutations all occur in cis (same allele).	1303	40
P-0006403-T01-IM5	P-0006403	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	347	10
P-0006404-T01-IM5	P-0006404	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.	892	70
P-0006406-T01-IM5	P-0006406	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		822	10
P-0006407-T01-IM5	P-0006407	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	951	50
P-0006408-T01-IM5	P-0006408	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female		1302	60
P-0006409-T01-IM5	P-0006409	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		813	30
P-0006410-T01-IM5	P-0006410	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of copy number gain on Chromosome 9q34 and loss on chromosome 21q22.	696	70
P-0006411-T01-IM5	P-0006411	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female	Note: The PDGFRA p.G390D mutation frequency  suggests that the mutation occurs on the amplified allele	1220	70
P-0006412-T01-IM5	P-0006412	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the EPHA3 p.R305S mutation is subclonal.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	952	40
P-0006413-T01-IM5	P-0006413	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Yolk Sac Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	721	20
P-0006414-T01-IM5	P-0006414	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female	Note: The TET2 exon3 mutations all occur in cis (same allele).	998	50
P-0006415-T01-IM5	P-0006415	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		301	30
P-0006416-T01-IM5	P-0006416	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		752	40
P-0006417-T01-IM5	P-0006417	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	917	NA
P-0006418-T01-IM5	P-0006418	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	702	20
P-0006419-T01-IM5	P-0006419	Mesothelioma	Primary	Tumor	Not Applicable	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 14q and 19q.	560	30
P-0006421-T01-IM5	P-0006421	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	825	10
P-0006422-T01-IM5	P-0006422	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Extramammary Paget Disease	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	366	10
P-0006423-T01-IM5	P-0006423	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		1288	60
P-0006425-T01-IM5	P-0006425	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Meningioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19p13.3.     Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 19p13.11-19p13.12 and 19q	914	80
P-0006427-T01-IM5	P-0006427	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	626	20
P-0006428-T01-IM5	P-0006428	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female		234	20
P-0006429-T01-IM5	P-0006429	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		409	80
P-0006430-T01-IM5	P-0006430	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	684	10
P-0006431-T01-IM5	P-0006431	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.	787	80
P-0006432-T01-IM5	P-0006432	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		1064	40
P-0006433-T01-IM5	P-0006433	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		878	20
P-0006434-T01-IM5	P-0006434	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Sigmoid colon	Colorectal Adenocarcinoma	IMPACT410			Female		469	50
P-0006436-T01-IM5	P-0006436	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		517	40
P-0006437-T01-IM5	P-0006437	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Skin Adnexal Carcinoma	IMPACT410			Male	Note: The PTPRS exon22 mutations all occur in cis (same allele).  Note: The NF2 exon14 mutations all occur in cis (same allele).  Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	695	50
P-0006439-T01-IM5	P-0006439	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Larynx	Larynx Squamous Cell Carcinoma	IMPACT410			Male		722	30
P-0006440-T01-IM5	P-0006440	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		898	30
P-0006441-T01-IM5	P-0006441	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1164	50
P-0006442-T01-IM5	P-0006442	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		881	50
P-0006443-T01-IM5	P-0006443	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Axilla	Sarcoma, NOS	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover introns of CIC gene.	848	40
P-0006444-T01-IM5	P-0006444	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		733	40
P-0006445-T01-IM5	P-0006445	Cervical Cancer	Metastasis	Tumor	Abdominal Wall	Cervix	Cervical Clear Cell Carcinoma	IMPACT410			Female		361	30
P-0006446-T01-IM5	P-0006446	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 9p, 16q and 17p	563	40
P-0006447-T01-IM5	P-0006447	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		516	80
P-0006448-T01-IM5	P-0006448	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		1051	30
P-0006449-T01-IM5	P-0006449	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		755	90
P-0006450-T01-IM5	P-0006450	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Cholangiocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 149X, negative results should be interpreted with caution.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	149	10
P-0006450-T02-IM5	P-0006450	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	848	10
P-0006451-T01-IM5	P-0006451	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Liver	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		976	30
P-0006452-T01-IM5	P-0006452	Mesothelioma	Primary	Tumor	Not Applicable	Omentum	Peritoneal Mesothelioma	IMPACT410			Female		750	50
P-0006453-T01-IM5	P-0006453	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: The ERRFI1 , ID3  and ARID1A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	922	30
P-0006454-T01-IM5	P-0006454	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Fibrolamellar Carcinoma	IMPACT410			Male		579	60
P-0006455-T01-IM5	P-0006455	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		749	70
P-0006456-T01-IM5	P-0006456	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 6q, 16q and 17p.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 7p and 16p	386	30
P-0006457-T01-IM5	P-0006457	Non-Small Cell Lung Cancer	Metastasis	Tumor	Skin	Lung	Lung Adenocarcinoma	IMPACT410			Female		599	40
P-0006458-T01-IM5	P-0006458	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		960	30
P-0006459-T01-IM5	P-0006459	Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: The YES1, EPHA3 , MITF , FOXP1,  RYBP . SHQ1  and PBRM1  copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1071	30
P-0006460-T01-IM5	P-0006460	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colon Adenocarcinoma	IMPACT410			Male		1101	20
P-0006461-T01-IM5	P-0006461	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The NBN, RAD21, MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	799	30
P-0006462-T01-IM5	P-0006462	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Supraclavicular Mass	Skin	Basal Cell Carcinoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	716	10
P-0006463-T01-IM5	P-0006463	Small Cell Lung Cancer	Metastasis	Tumor	Trachea	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p and 4q.      Note: The MAP3K1, PLK2, PIK3R1, RASA1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	990	50
P-0006464-T01-IM5	P-0006464	Miscellaneous Neuroepithelial Tumor	Primary	Tumor	Not Applicable	Brain	Rosette-forming Glioneuronal Tumor of the Fourth Ventricle	IMPACT410			Male		666	20
P-0006465-T01-IM5	P-0006465	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the PIK3C2G p.R273H mutation is subclonal.	234	20
P-0006467-T01-IM5	P-0006467	Melanoma	Metastasis	Tumor	Liver	Foot	Cutaneous Melanoma	IMPACT410			Male		818	40
P-0006468-T01-IM5	P-0006468	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		875	60
P-0006469-T01-IM5	P-0006469	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Mucinous Colorectal Carcinoma	IMPACT410			Male		752	60
P-0006470-T01-IM5	P-0006470	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male		759	50
P-0006471-T01-IM5	P-0006471	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The RICTOR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	622	20
P-0006472-T01-IM5	P-0006472	Cancer of Unknown Primary	Metastasis	Tumor	Vagina	Unknown	Cancer of Unknown Primary	IMPACT410			Female		771	60
P-0006473-T01-IM5	P-0006473	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		616	30
P-0006474-T01-IM5	P-0006474	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		463	60
P-0006475-T01-IM5	P-0006475	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female		873	20
P-0006476-T01-IM5	P-0006476	Melanoma	Metastasis	Tumor	Small Bowel	Skin	Cutaneous Melanoma	IMPACT410			Male		638	70
P-0006477-T01-IM5	P-0006477	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Ampulla of Vater	Pancreatobiliary Ampullary Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	155	10
P-0006479-T01-IM5	P-0006479	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 65X, negative results should be interpreted with caution.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	65	10
P-0006480-T01-IM5	P-0006480	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Salivary Carcinoma, Other	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	240	60
P-0006481-T01-IM5	P-0006481	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p/19q and chromosome 9.	702	70
P-0006482-T01-IM5	P-0006482	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		826	50
P-0006484-T01-IM5	P-0006484	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	906	90
P-0006485-T01-IM5	P-0006485	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1062	30
P-0006486-T01-IM5	P-0006486	Head and Neck Carcinoma	Metastasis	Tumor	Skin	Sinonasal	Head and Neck Carcinoma, Other	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: Low sequencing depth of coverage of 137X, negative results should be interpreted with caution.	137	10
P-0006488-T01-IM5	P-0006488	Melanoma	Metastasis	Tumor	Spleen	Skin	Cutaneous Melanoma	IMPACT410			Female		839	70
P-0006489-T01-IM5	P-0006489	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		741	30
P-0006490-T01-IM5	P-0006490	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bone	Myxofibrosarcoma	IMPACT410			Female	Note: Assessment of the gene copy number data is limited by (increased noise due to low input DNA). Negative results should be interpreted with caution.        Note: Low sequencing depth of coverage of 129X, negative results should be interpreted with caution.	129	60
P-0006491-T01-IM5	P-0006491	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1097	10
P-0006492-T01-IM5	P-0006492	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		512	40
P-0006493-T01-IM5	P-0006493	Breast Carcinoma	Metastasis	Tumor	Axilla	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND2, PLK2, MAP3K1 and PIK3R1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The H3F3A, MAPK3, PALB2, H3F3C, GNAQ, RECQL4, XPO1 and REL copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	989	20
P-0006494-T01-IM5	P-0006494	Pancreatic Cancer	Metastasis	Tumor	Adrenal Gland	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		946	80
P-0006494-T02-IM5	P-0006494	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Pancreas	Neuroendocrine Tumor, NOS	IMPACT410			Male		769	60
P-0006495-T01-IM5	P-0006495	Cancer of Unknown Primary	Metastasis	Tumor	Thigh	Unknown	Adenocarcinoma, NOS	IMPACT410			Male		1180	20
P-0006496-T01-IM5	P-0006496	Sex Cord Stromal Tumor	Metastasis	Tumor	Liver	Testis	Granulosa Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	574	10
P-0006497-T01-IM5	P-0006497	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		738	50
P-0006498-T01-IM5	P-0006498	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	216	20
P-0006499-T01-IM5	P-0006499	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1037	60
P-0006500-T01-IM5	P-0006500	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 10 and Chromosome arm 15q21-24	674	70
P-0006501-T01-IM5	P-0006501	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 14q, 15q, 21q, and 22q	777	90
P-0006502-T01-IM5	P-0006502	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	912	10
P-0006503-T01-IM5	P-0006503	Renal Cell Carcinoma	Metastasis	Tumor	Chest Wall	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		687	70
P-0006504-T02-IM5	P-0006504	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		870	70
P-0006505-T01-IM5	P-0006505	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Solid Pseudopapillary Neoplasm of the Pancreas	IMPACT410			Male		738	80
P-0006506-T01-IM5	P-0006506	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome  arm 16q and Chromosome 16.	615	20
P-0006507-T01-IM5	P-0006507	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male		965	50
P-0006508-T01-IM5	P-0006508	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	217	70
P-0006509-T01-IM5	P-0006509	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		1061	60
P-0006510-T01-IM5	P-0006510	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		587	80
P-0006511-T01-IM5	P-0006511	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		1096	20
P-0006512-T01-IM5	P-0006512	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		827	10
P-0006514-T01-IM5	P-0006514	Histiocytosis	Primary	Tumor	Not Applicable	Brain	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	450	10
P-0006515-T01-IM5	P-0006515	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		678	30
P-0006516-T01-IM5	P-0006516	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	888	10
P-0006517-T01-IM5	P-0006517	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The JAK1 exon7 mutations all occur in cis (same allele).	1028	20
P-0006518-T01-IM5	P-0006518	Salivary Carcinoma	Metastasis	Tumor	Lung	Sinonasal	Adenoid Cystic Carcinoma	IMPACT410			Male		1001	60
P-0006519-T01-IM5	P-0006519	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		549	20
P-0006520-T01-IM5	P-0006520	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male		874	50
P-0006522-T01-IM5	P-0006522	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Mesonephric Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.        Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	754	70
P-0006523-T01-IM5	P-0006523	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1006	10
P-0006525-T01-IM5	P-0006525	Head and Neck Carcinoma	Metastasis	Tumor	Bone	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Female		339	30
P-0006526-T01-IM5	P-0006526	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 136X, negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	136	30
P-0006527-T01-IM5	P-0006527	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		793	50
P-0006528-T01-IM5	P-0006528	Cancer of Unknown Primary	Metastasis	Tumor	Larynx	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Low sequencing depth of coverage of 166X, negative results should be interpreted with caution.	166	10
P-0006529-T01-IM5	P-0006529	Soft Tissue Sarcoma	Metastasis	Tumor	Kidney	Soft Tissue	Well-Differentiated Liposarcoma	IMPACT410			Female		218	90
P-0006530-T02-IM5	P-0006530	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	Hemangioblastoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	521	30
P-0006531-T01-IM5	P-0006531	Ovarian Cancer	Metastasis	Tumor	Lung	Ovary	Endometrioid Ovarian Cancer	IMPACT410			Female		860	20
P-0006532-T01-IM5	P-0006532	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		806	70
P-0006533-T01-IM5	P-0006533	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		178	60
P-0006535-T01-IM5	P-0006535	Bladder Cancer	Metastasis	Tumor	Pelvis	Bladder	Sarcomatoid Carcinoma of the Urinary Bladder	IMPACT410			Female	Dx: Urothelial Sarcomatoid Carcinoma	899	50
P-0006536-T01-IM5	P-0006536	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1126	20
P-0006537-T01-IM5	P-0006537	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Ascending Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Female		1046	70
P-0006538-T01-IM5	P-0006538	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		190	80
P-0006539-T01-IM5	P-0006539	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		943	50
P-0006540-T01-IM5	P-0006540	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	483	10
P-0006541-T01-IM5	P-0006541	Melanoma	Metastasis	Tumor	Axilla	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: The RAD51, MGA and B2M copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	863	70
P-0006542-T01-IM5	P-0006542	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		1061	60
P-0006543-T01-IM5	P-0006543	Breast Sarcoma	Primary	Tumor	Not Applicable	Breast	Malignant Phyllodes Tumor of the Breast	IMPACT410			Female	Note: A comparison of variant frequencies suggests the LATS1 p.L743del mutation is subclonal.	837	70
P-0006544-T01-IM5	P-0006544	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1013	10
P-0006545-T01-IM5	P-0006545	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		681	80
P-0006546-T01-IM5	P-0006546	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 4q,12p and 22q.    Note: The IRS2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	816	80
P-0006546-T02-IM5	P-0006546	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1046	80
P-0006547-T01-IM5	P-0006547	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male		659	20
P-0006548-T01-IM5	P-0006548	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Mucinous Colorectal Carcinoma	IMPACT410			Female		682	20
P-0006549-T01-IM5	P-0006549	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female	Note: Paucity of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	461	20
P-0006550-T01-IM5	P-0006550	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		683	60
P-0006551-T01-IM5	P-0006551	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	389	30
P-0006552-T01-IM5	P-0006552	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	566	50
P-0006553-T01-IM5	P-0006553	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		879	20
P-0006554-T01-IM5	P-0006554	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p/19q and 9p including CDKN2A.	479	60
P-0006555-T01-IM5	P-0006555	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pancreas	Perivascular Epithelioid Cell Tumor	IMPACT410			Male		597	70
P-0006556-T01-IM5	P-0006556	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1041	10
P-0006557-T01-IM5	P-0006557	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		916	50
P-0006558-T01-IM5	P-0006558	Breast Carcinoma	Primary	Tumor	Pleura	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q23-25 and 11q13 including CCND1.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q, 10q, 16q and 22q.	1015	
P-0006559-T01-IM5	P-0006559	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1308	20
P-0006560-T01-IM5	P-0006560	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1064	30
P-0006561-T02-IM5	P-0006561	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		455	NA
P-0006562-T01-IM5	P-0006562	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1105	10
P-0006563-T01-IM5	P-0006563	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8 and arm of 16p.   Note: The FGFR1 and RECQL4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	804	70
P-0006564-T01-IM5	P-0006564	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	740	10
P-0006565-T01-IM5	P-0006565	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	919	30
P-0006566-T01-IM5	P-0006566	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	706	10
P-0006567-T01-IM5	P-0006567	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Subungual Toe	Acral Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	790	70
P-0006568-T01-IM5	P-0006568	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		608	20
P-0006569-T01-IM5	P-0006569	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	583	10
P-0006570-T01-IM5	P-0006570	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 9q and 21q.	662	80
P-0006571-T01-IM5	P-0006571	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Major Salivary Gland	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by smoking induced damage.	1015	20
P-0006572-T01-IM5	P-0006572	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	501	10
P-0006573-T01-IM5	P-0006573	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		235	70
P-0006574-T01-IM5	P-0006574	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		589	70
P-0006575-T01-IM5	P-0006575	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The BCL2L1, ASXL1,  DNMT3B,  SRC, TOP1, PTPRT  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	824	70
P-0006577-T01-IM5	P-0006577	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Muscle	Dedifferentiated Liposarcoma	IMPACT410			Female		1031	70
P-0006579-T01-IM5	P-0006579	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Marginal Zone Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	552	30
P-0006580-T01-IM5	P-0006580	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		648	40
P-0006581-T01-IM5	P-0006581	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		926	40
P-0006582-T01-IM5	P-0006582	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		814	30
P-0006583-T01-IM5	P-0006583	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		986	30
P-0006584-T01-IM5	P-0006584	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		618	10
P-0006585-T01-IM5	P-0006585	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Leg	Merkel Cell Carcinoma	IMPACT410			Female	Note: The  CDK6, PIK3C2G,  and MET copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	383	70
P-0006586-T01-IM5	P-0006586	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: The STK11, TCF3, DOT1L, GNA11 and MAP2K2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	595	80
P-0006587-T01-IM5	P-0006587	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		1110	20
P-0006588-T01-IM5	P-0006588	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	818	10
P-0006589-T01-IM5	P-0006589	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 13q12-13.	370	10
P-0006590-T01-IM5	P-0006590	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		873	80
P-0006591-T01-IM5	P-0006591	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.      Note: The TP53 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	339	80
P-0006592-T01-IM5	P-0006592	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		908	NA
P-0006593-T01-IM5	P-0006593	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		787	30
P-0006594-T01-IM5	P-0006594	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Female	Note: The DIS3 and SDHA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	778	80
P-0006595-T01-IM5	P-0006595	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 13q and 16q.    Note: The ERBB4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1175	70
P-0006596-T01-IM5	P-0006596	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		311	10
P-0006597-T01-IM5	P-0006597	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		719	60
P-0006598-T01-IM5	P-0006598	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		1088	30
P-0006599-T01-IM5	P-0006599	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		609	70
P-0006600-T01-IM5	P-0006600	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	842	80
P-0006601-T01-IM5	P-0006601	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 120X, negative results should be interpreted with caution.	120	70
P-0006602-T02-IM5	P-0006602	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		199	30
P-0006603-T01-IM5	P-0006603	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		658	
P-0006604-T01-IM5	P-0006604	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	GLI1 1.44 FC in normal, germline gain	564	40
P-0006605-T01-IM5	P-0006605	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Testis	Dedifferentiated Liposarcoma	IMPACT410			Male		913	20
P-0006606-T01-IM5	P-0006606	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		796	50
P-0006607-T01-IM5	P-0006607	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	699	20
P-0006608-T01-IM5	P-0006608	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20.	952	30
P-0006610-T01-IM5	P-0006610	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: The CDKN2Ap16INK4A copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	702	50
P-0006611-T01-IM5	P-0006611	Melanoma	Primary	Tumor	Not Applicable	Vulva	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female	Note: The RPTOR and XIAP copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	769	50
P-0006612-T01-IM5	P-0006612	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		865	60
P-0006613-T02-IM5	P-0006613	Pancreatic Cancer	Metastasis	Tumor	Abdomen	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	425	15
P-0006615-T01-IM5	P-0006615	Esophagogastric Carcinoma	Metastasis	Tumor	Pleural Fluid	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		894	60
P-0006616-T01-IM5	P-0006616	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		801	40
P-0006617-T01-IM5	P-0006617	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	759	20
P-0006618-T01-IM5	P-0006618	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The SMAD4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	793	50
P-0006619-T01-IM5	P-0006619	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1047	30
P-0006620-T01-IM5	P-0006620	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		1016	50
P-0006620-T02-IM5	P-0006620	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	965	10
P-0006621-T01-IM5	P-0006621	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		819	80
P-0006622-T01-IM5	P-0006622	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The MYC, RAD21 and CARD11 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	985	50
P-0006623-T01-IM5	P-0006623	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		472	30
P-0006624-T01-IM5	P-0006624	Melanoma	Metastasis	Tumor	Subcutaneous Tissue	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	738	60
P-0006625-T01-IM5	P-0006625	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male		1068	50
P-0006626-T01-IM5	P-0006626	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		854	60
P-0006627-T01-IM5	P-0006627	Colorectal Cancer	Primary	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	920	10
P-0006628-T01-IM5	P-0006628	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		219	80
P-0006629-T01-IM5	P-0006629	Small Bowel Cancer	Metastasis	Tumor	Liver	Jejunum	Small Bowel Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	803	20
P-0006630-T01-IM5	P-0006630	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Male		1236	60
P-0006631-T02-IM5	P-0006631	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Lobular Carcinoma In Situ	IMPACT410			Female		277	60
P-0006632-T01-IM5	P-0006632	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Nasopharynx	Rhabdomyosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: MSK-IMPACT test panel does not cover the PAX3, PAX7 and FOXO1 genes.	862	20
P-0006633-T01-IM5	P-0006633	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	752	70
P-0006634-T01-IM5	P-0006634	Ampullary Carcinoma	Metastasis	Tumor	Pancreas	Ampulla of Vater	Ampullary Carcinoma	IMPACT410			Male	Note: The KRAS exon2 mutations occur on different alleles.  Note: A comparison of variant frequencies suggests the KRAS p.G13D mutation is subclonal.	855	60
P-0006635-T01-IM5	P-0006635	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The TP53 exon4 mutations occur on different alleles.	879	70
P-0006636-T01-IM5	P-0006636	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1000	10
P-0006637-T01-IM5	P-0006637	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The TCEB1 and NBN copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	963	20
P-0006638-T01-IM5	P-0006638	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p36, 4q, 9, 13q, 14q, and 22q.	909	80
P-0006639-T01-IM5	P-0006639	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		586	60
P-0006640-T01-IM5	P-0006640	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		965	30
P-0006641-T01-IM5	P-0006641	Head and Neck Carcinoma	Metastasis	Tumor	Liver	Oral Cavity	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female	Note: The PIK3CA p.R88Q mutation frequency suggests that the mutation occurs on the amplified allele	869	30
P-0006642-T01-IM5	P-0006642	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		1100	40
P-0006643-T01-IM5	P-0006643	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Sarcomatoid Carcinoma of the Lung	IMPACT410			Male	Note: The copy number profile is suggestive of an intragenic gain of CDK12 exons2-6.	870	30
P-0006644-T01-IM5	P-0006644	Cancer of Unknown Primary	Metastasis	Tumor	Duodenum	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	767	10
P-0006645-T01-IM5	P-0006645	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		893	50
P-0006646-T01-IM5	P-0006646	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		813	NA
P-0006647-T01-IM5	P-0006647	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18q21.	929	40
P-0006648-T01-IM5	P-0006648	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7p22.	995	50
P-0006649-T01-IM5	P-0006649	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	512	40
P-0006650-T01-IM5	P-0006650	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		912	60
P-0006651-T01-IM5	P-0006651	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Signet Ring Cell Carcinoma of the Stomach	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	723	20
P-0006652-T01-IM5	P-0006652	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		742	30
P-0006653-T01-IM5	P-0006653	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		889	40
P-0006654-T01-IM5	P-0006654	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1025	10
P-0006655-T01-IM5	P-0006655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		625	60
P-0006656-T01-IM5	P-0006656	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1019	70
P-0006657-T01-IM5	P-0006657	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		1001	60
P-0006658-T01-IM5	P-0006658	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	966	
P-0006659-T01-IM5	P-0006659	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		1143	
P-0006660-T01-IM5	P-0006660	Breast Carcinoma	Metastasis	Tumor	Endometrium	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	985	10
P-0006661-T01-IM5	P-0006661	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		379	20
P-0006662-T01-IM5	P-0006662	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		985	60
P-0006663-T01-IM5	P-0006663	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female		830	10
P-0006664-T01-IM5	P-0006664	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Lung	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	887	10
P-0006665-T01-IM5	P-0006665	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	805	60
P-0006666-T01-IM5	P-0006666	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called  against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched nail and saliva sample.	812	50
P-0006667-T01-IM5	P-0006667	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		788	40
P-0006668-T01-IM5	P-0006668	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The SMARCB1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	999	30
P-0006669-T01-IM5	P-0006669	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	887	40
P-0006670-T01-IM5	P-0006670	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		395	60
P-0006671-T01-IM5	P-0006671	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q.    Note: The BARD1,EPHA7,PRDM1,FYN and NOTCH2  copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	715	20
P-0006672-T01-IM5	P-0006672	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		705	40
P-0006673-T01-IM5	P-0006673	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male		737	70
P-0006674-T01-IM5	P-0006674	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female		723	50
P-0006675-T01-IM5	P-0006675	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1172	60
P-0006676-T01-IM5	P-0006676	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		938	50
P-0006677-T01-IM5	P-0006677	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	908	NA
P-0006678-T01-IM5	P-0006678	Glioma	Primary	Tumor	Not Applicable	Brain	Pilocytic Astrocytoma	IMPACT410			Male	Note: The TP53 exon7 mutations all occur in cis (same allele).	296	60
P-0006679-T01-IM5	P-0006679	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		794	30
P-0006680-T01-IM5	P-0006680	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		754	50
P-0006681-T01-IM5	P-0006681	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q.	730	NA
P-0006682-T01-IM5	P-0006682	Anal Cancer	Metastasis	Tumor	Liver	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female		368	40
P-0006683-T01-IM5	P-0006683	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	488	NA
P-0006684-T01-IM5	P-0006684	Prostate Cancer	Metastasis	Tumor	Pancreas	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		832	60
P-0006685-T01-IM5	P-0006685	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1054	NA
P-0006686-T01-IM5	P-0006686	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	574	10
P-0006687-T01-IM5	P-0006687	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		1390	20
P-0006688-T01-IM5	P-0006688	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Pancreas	Ampullary Carcinoma	IMPACT410			Female		436	20
P-0006689-T01-IM5	P-0006689	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		617	40
P-0006690-T01-IM5	P-0006690	Salivary Carcinoma	Metastasis	Tumor	Lung	Major Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MITF exon2 and NOTCH1 exon25 mutations are subclonal.  Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	445	60
P-0006691-T01-IM5	P-0006691	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	745	30
P-0006692-T01-IM5	P-0006692	Prostate Cancer	Metastasis	Tumor	Mediastinum	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q12 and 20q13	831	70
P-0006693-T01-IM5	P-0006693	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		777	30
P-0006694-T01-IM5	P-0006694	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1374	70
P-0006694-T02-IM5	P-0006694	Non-Hodgkin Lymphoma	Metastasis	Tumor	Skin	Lymph Node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female		961	30
P-0006695-T01-IM5	P-0006695	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Pelvis	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: The SOCS1 exon2 p.M1I, p.A3R, p.Q6H, and p.A16T  mutations all occur in cis (same allele).       Note: The SOCS1 exon2 p.L200F and p.A192G mutations all occur in cis (same allele).	561	60
P-0006696-T01-IM5	P-0006696	Small Cell Lung Cancer	Metastasis	Tumor	Mediastinum	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 3q.    Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q12-13q22, 16p and 17p.	520	70
P-0006697-T01-IM5	P-0006697	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		854	60
P-0006698-T03-IM5	P-0006698	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1092	40
P-0006699-T01-IM5	P-0006699	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		816	30
P-0006700-T01-IM5	P-0006700	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		328	20
P-0006701-T01-IM5	P-0006701	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	694	20
P-0006702-T01-IM5	P-0006702	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		948	20
P-0006703-T01-IM5	P-0006703	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The CCNE1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1122	50
P-0006704-T01-IM5	P-0006704	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		662	20
P-0006705-T01-IM5	P-0006705	Bladder Cancer	Primary	Tumor	Not Applicable	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Female		520	40
P-0006706-T01-IM5	P-0006706	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: The APC exon16 p.A1347fs and p.K1350T mutations all occur in cis (same allele).	984	40
P-0006707-T01-IM5	P-0006707	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 13q and 20q	705	60
P-0006708-T01-IM5	P-0006708	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		779	30
P-0006709-T01-IM5	P-0006709	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		562	20
P-0006710-T01-IM5	P-0006710	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	516	50
P-0006711-T01-IM5	P-0006711	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 13q and 20q	681	30
P-0006712-T01-IM5	P-0006712	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	519	60
P-0006713-T01-IM5	P-0006713	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		946	50
P-0006713-T02-IM5	P-0006713	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		670	40
P-0006714-T01-IM5	P-0006714	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		904	60
P-0006715-T01-IM5	P-0006715	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q   Note: Copy number profile is suggestive of a fragmented genome.	854	30
P-0006716-T01-IM5	P-0006716	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		759	40
P-0006717-T01-IM5	P-0006717	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		783	50
P-0006718-T01-IM5	P-0006718	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		486	20
P-0006719-T01-IM5	P-0006719	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	927	70
P-0006720-T01-IM5	P-0006720	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	888	10
P-0006721-T01-IM5	P-0006721	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The MGA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	767	20
P-0006722-T01-IM5	P-0006722	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		1135	30
P-0006723-T01-IM5	P-0006723	Breast Carcinoma	Metastasis	Tumor	Epidural	Breast	Breast Carcinoma	IMPACT410			Female		737	50
P-0006724-T01-IM5	P-0006724	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		704	60
P-0006725-T01-IM5	P-0006725	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		707	70
P-0006726-T01-IM5	P-0006726	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	799	30
P-0006727-T01-IM5	P-0006727	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p and gain on Chromosome arm 17q .	809	60
P-0006729-T01-IM5	P-0006729	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	789	20
P-0006730-T01-IM5	P-0006730	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		798	30
P-0006731-T01-IM5	P-0006731	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Female		933	50
P-0006732-T01-IM5	P-0006732	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	377	20
P-0006733-T01-IM5	P-0006733	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female	Mutation assessment Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample	756	70
P-0006734-T01-IM5	P-0006734	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The CDK12,  ERBB2, RARA, STAT5B, STAT5A,  STAT3 and MDC1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The CDKN2B,  CDKN2Ap16INK4A  and  CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	873	60
P-0006735-T01-IM5	P-0006735	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 20q.	823	80
P-0006736-T01-IM5	P-0006736	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Retroperitoneum	Leiomyosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	582	10
P-0006737-T01-IM5	P-0006737	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		807	20
P-0006738-T01-IM5	P-0006738	Renal Cell Carcinoma	Metastasis	Tumor	Adrenal Gland	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		1022	80
P-0006740-T01-IM5	P-0006740	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm  20q.	739	50
P-0006741-T01-IM5	P-0006741	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The PPM1D,  BRIP1, CD79B and AXIN2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1383	50
P-0006742-T01-IM5	P-0006742	Renal Cell Carcinoma	Metastasis	Tumor	Neck	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	626	80
P-0006743-T01-IM5	P-0006743	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		825	50
P-0006744-T01-IM5	P-0006744	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q and 20q.	902	70
P-0006745-T01-IM5	P-0006745	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Leg	Soft Tissue Myoepithelial Carcinoma	IMPACT410			Female		690	NA
P-0006746-T01-IM5	P-0006746	Renal Cell Carcinoma	Metastasis	Tumor	Lymph Node	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1141	20
P-0006747-T01-IM5	P-0006747	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		872	40
P-0006748-T01-IM5	P-0006748	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.      Note: The KRAS and H3F3C copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	993	20
P-0006749-T01-IM5	P-0006749	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	672	10
P-0006750-T01-IM5	P-0006750	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male		820	10
P-0006751-T01-IM5	P-0006751	Prostate Cancer	Metastasis	Tumor	Epidural	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		879	70
P-0006752-T01-IM5	P-0006752	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		634	20
P-0006753-T01-IM5	P-0006753	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		804	10
P-0006754-T01-IM5	P-0006754	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1009	20
P-0006755-T01-IM5	P-0006755	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Female		812	60
P-0006756-T01-IM5	P-0006756	Endometrial Cancer	Metastasis	Tumor	Vagina	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		1080	70
P-0006757-T01-IM5	P-0006757	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		644	30
P-0006758-T01-IM5	P-0006758	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Mucinous Colorectal Carcinoma	IMPACT410			Male	Note: The APC exon16 mutations all occur in cis (same allele).	847	50
P-0006759-T01-IM5	P-0006759	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 20q	898	30
P-0006760-T01-IM5	P-0006760	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1168	40
P-0006761-T01-IM5	P-0006761	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colorectal Adenocarcinoma	IMPACT410			Female		780	30
P-0006762-T02-IM5	P-0006762	Renal Cell Carcinoma	Metastasis	Tumor	Pancreatic Head	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is  limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	176	80
P-0006763-T01-IM5	P-0006763	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		224	50
P-0006764-T01-IM5	P-0006764	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	320	20
P-0006765-T01-IM5	P-0006765	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1373	10
P-0006766-T01-IM5	P-0006766	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 20q	936	40
P-0006767-T01-IM5	P-0006767	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Male		971	60
P-0006768-T01-IM5	P-0006768	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1424	50
P-0006769-T01-IM5	P-0006769	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		545	40
P-0006770-T01-IM5	P-0006770	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		845	50
P-0006771-T01-IM5	P-0006771	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: The NF1 exon14 mutations all occur in cis (same allele).	643	30
P-0006772-T01-IM5	P-0006772	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		669	40
P-0006773-T01-IM5	P-0006773	Melanoma	Primary	Tumor	Not Applicable	Anus	Anorectal Mucosal Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	756	10
P-0006775-T01-IM5	P-0006775	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		676	40
P-0006776-T01-IM5	P-0006776	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The MDM2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	941	30
P-0006777-T01-IM5	P-0006777	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Basal Cell Carcinoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	942	40
P-0006778-T01-IM5	P-0006778	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		628	20
P-0006779-T01-IM5	P-0006779	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	763	20
P-0006780-T01-IM5	P-0006780	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		766	70
P-0006781-T01-IM5	P-0006781	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Thigh	Pleomorphic Liposarcoma	IMPACT410			Male		810	70
P-0006782-T01-IM5	P-0006782	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		339	30
P-0006783-T01-IM5	P-0006783	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	770	20
P-0006784-T01-IM5	P-0006784	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Triceps	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		1129	60
P-0006785-T01-IM5	P-0006785	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	695	50
P-0006786-T01-IM5	P-0006786	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		856	30
P-0006786-T02-IM5	P-0006786	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1088	20
P-0006787-T01-IM5	P-0006787	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	551	50
P-0006788-T01-IM5	P-0006788	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		894	50
P-0006789-T01-IM5	P-0006789	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR exon19 mutations all occur in cis (same allele).	977	40
P-0006790-T01-IM5	P-0006790	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1138	20
P-0006791-T01-IM5	P-0006791	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Sarcoma, NOS	IMPACT410			Female		1156	70
P-0006792-T01-IM5	P-0006792	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Female		1251	50
P-0006793-T01-IM5	P-0006793	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1094	20
P-0006794-T01-IM5	P-0006794	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		498	20
P-0006796-T01-IM5	P-0006796	Melanoma	Metastasis	Tumor	Bone	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p and 11q.    Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1301	80
P-0006797-T01-IM5	P-0006797	Ovarian Cancer	Metastasis	Tumor	Breast	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		1231	30
P-0006798-T02-IM5	P-0006798	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	760	10
P-0006799-T01-IM5	P-0006799	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 9q21-22, 19p13 and Xp22.	772	80
P-0006800-T01-IM5	P-0006800	Bladder Cancer	Metastasis	Tumor	Liver	Ureter	Upper Tract Urothelial Carcinoma	IMPACT410			Male		645	30
P-0006801-T01-IM5	P-0006801	Embryonal Tumor	Metastasis	Tumor	Lymph node	Paraspinal	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome X.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q.	1493	60
P-0006802-T01-IM5	P-0006802	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Medullary Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3, 11q, 12q12-13 and 13q.	1043	60
P-0006804-T01-IM5	P-0006804	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	929	40
P-0006805-T01-IM5	P-0006805	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	924	10
P-0006806-T01-IM5	P-0006806	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	856	40
P-0006807-T01-IM5	P-0006807	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	762	30
P-0006808-T01-IM5	P-0006808	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		893	10
P-0006809-T01-IM5	P-0006809	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		743	70
P-0006810-T01-IM5	P-0006810	Non-Small Cell Lung Cancer	Metastasis	Tumor	Paraspinal	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the GRIN2A p.K453N mutation is subclonal.	805	30
P-0006811-T01-IM5	P-0006811	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 17q.	1118	40
P-0006811-T02-IM5	P-0006811	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment Mutations are called against the patients matched nail and saliva  samples and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched nail and saliva samples.	1361	40
P-0006812-T01-IM5	P-0006812	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Male	Note: The CCND3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	802	30
P-0006813-T01-IM5	P-0006813	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	933	20
P-0006814-T01-IM5	P-0006814	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	604	NA
P-0006815-T01-IM5	P-0006815	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		413	60
P-0006816-T01-IM5	P-0006816	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		669	30
P-0006817-T01-IM5	P-0006817	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	243	20
P-0006818-T01-IM5	P-0006818	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p including KRAS.	1082	50
P-0006819-T01-IM5	P-0006819	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		362	10
P-0006821-T01-IM5	P-0006821	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		646	30
P-0006822-T01-IM5	P-0006822	Colorectal Cancer	Metastasis	Tumor	Pleura	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q including MYC.	642	50
P-0006823-T01-IM5	P-0006823	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		354	50
P-0006824-T01-IM5	P-0006824	Histiocytosis	Metastasis	Tumor	Brain	Lung	Histiocytosis	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1031	20
P-0006825-T01-IM5	P-0006825	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	987	10
P-0006826-T01-IM5	P-0006826	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3q.	822	50
P-0006827-T01-IM5	P-0006827	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The SPEN exon11 mutations all occur in cis (same allele).  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	997	10
P-0006828-T01-IM5	P-0006828	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		829	40
P-0006829-T01-IM5	P-0006829	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 3p, 11q22-24, 14q, 16q and 22q.   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 11q13, 15q and 16p.	796	80
P-0006830-T01-IM5	P-0006830	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1099	30
P-0006831-T01-IM5	P-0006831	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		939	20
P-0006833-T01-IM5	P-0006833	Non-Hodgkin Lymphoma	Metastasis	Tumor	Lymph Node	Bone Marrow	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	332	60
P-0006834-T01-IM5	P-0006834	Small Bowel Cancer	Primary	Tumor	Not Applicable	Duodenum-Jejunum	Small Bowel Cancer	IMPACT410			Female		692	10
P-0006835-T01-IM5	P-0006835	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	810	20
P-0006836-T01-IM5	P-0006836	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	855	30
P-0006837-T01-IM5	P-0006837	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		668	50
P-0006838-T01-IM5	P-0006838	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male	Note: The NRAS and IRF4 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	975	60
P-0006839-T01-IM5	P-0006839	Bladder Cancer	Metastasis	Tumor	Adrenal Gland	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		1035	70
P-0006842-T01-IM5	P-0006842	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		961	20
P-0006843-T01-IM5	P-0006843	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The GATA1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The LATS2,CDK8,FLT3,FLT1 and BRCA2  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1131	20
P-0006844-T01-IM5	P-0006844	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		868	30
P-0006844-T02-IM5	P-0006844	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1028	20
P-0006845-T01-IM5	P-0006845	Melanoma	Metastasis	Tumor	Liver	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	553	10
P-0006846-T01-IM5	P-0006846	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: A comparison of variant frequencies suggests the EGFR p.A289V mutation is subclonal.	942	30
P-0006847-T01-IM5	P-0006847	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: The CCND1,FGF19,FGF4,FGF3,FGFR1 and GNAS  copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	663	60
P-0006848-T01-IM5	P-0006848	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT410			Female		902	40
P-0006849-T01-IM5	P-0006849	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Undifferentiated Carcinoma	IMPACT410			Female		671	40
P-0006850-T01-IM5	P-0006850	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Female		877	30
P-0006851-T01-IM5	P-0006851	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Testis	Embryonal Rhabdomyosarcoma	IMPACT410			Male		1228	50
P-0006852-T01-IM5	P-0006852	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 11q,16q,9p and 22q.	842	20
P-0006853-T01-IM5	P-0006853	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female		792	20
P-0006854-T01-IM5	P-0006854	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9p loss including CDKN2B,  CDKN2Ap16INK4A and CDKN2Ap14ARF.  Note: The MAP2K4,NCOR1,GPS2,TP53,ALOX12B and AURKB copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	874	30
P-0006855-T01-IM5	P-0006855	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		978	50
P-0006856-T01-IM5	P-0006856	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	779	40
P-0006857-T01-IM5	P-0006857	Breast Carcinoma	Metastasis	Tumor	Brain	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The MALT1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	685	30
P-0006858-T01-IM5	P-0006858	Germ Cell Tumor	Metastasis	Tumor	Pelvis	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	776	10
P-0006859-T01-IM5	P-0006859	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	642	40
P-0006860-T01-IM5	P-0006860	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		763	40
P-0006861-T01-IM5	P-0006861	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT410			Female		775	30
P-0006862-T02-IM5	P-0006862	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Pancreas	Ampullary Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	514	40
P-0006863-T01-IM5	P-0006863	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Mucinous Colorectal Carcinoma	IMPACT410			Female	Note: The PIK3CD exon4 mutations all occur in cis (same allele).	730	30
P-0006865-T01-IM5	P-0006865	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Mucinous Colorectal Carcinoma	IMPACT410			Male		799	30
P-0006866-T01-IM5	P-0006866	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 11q13 including CCND1, FGF19, FGF4, FGF3, and PAK1.       Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 17q21-17q24 and 20q.	912	20
P-0006867-T01-IM5	P-0006867	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Mucinous Colorectal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	606	10
P-0006868-T01-IM5	P-0006868	Small Bowel Cancer	Metastasis	Tumor	Liver	Duodenum	Small Bowel Cancer	IMPACT410			Male		796	30
P-0006869-T01-IM5	P-0006869	Esophagogastric Carcinoma	Metastasis	Tumor	Abdomen	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		647	50
P-0006870-T01-IM5	P-0006870	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		539	20
P-0006872-T01-IM5	P-0006872	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the FLT1 p.G1116A mutation is subclonal.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	1052	20
P-0006873-T01-IM5	P-0006873	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1106	20
P-0006875-T01-IM5	P-0006875	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Stromal Tumor	IMPACT410			Male		878	70
P-0006877-T01-IM5	P-0006877	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The CDK12,ERBB2 and RARA  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	895	20
P-0006878-T01-IM5	P-0006878	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Male		1065	
P-0006879-T01-IM5	P-0006879	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		668	50
P-0006880-T01-IM5	P-0006880	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		958	10
P-0006881-T01-IM5	P-0006881	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	837	20
P-0006882-T01-IM5	P-0006882	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Heart	Sarcoma, NOS	IMPACT410			Female		998	60
P-0006883-T01-IM5	P-0006883	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		781	10
P-0006884-T01-IM5	P-0006884	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Maxilla	Rhabdomyosarcoma	IMPACT410			Male		1228	20
P-0006886-T01-IM5	P-0006886	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p12-1p31, 6q, 10q23-10q25, and Chromosome 18.         Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p, including EGFR.	690	NA
P-0006887-T01-IM5	P-0006887	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		1102	30
P-0006888-T01-IM5	P-0006888	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	886	50
P-0006889-T01-IM5	P-0006889	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	885	30
P-0006890-T01-IM5	P-0006890	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1078	10
P-0006891-T01-IM5	P-0006891	Sex Cord Stromal Tumor	Primary	Tumor	Not Applicable	Ovary	Granulosa Cell Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	264	60
P-0006892-T01-IM5	P-0006892	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	725	50
P-0006893-T01-IM5	P-0006893	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3q22 -3q28, 7q, 10q11, and 10q24-10q26.	1003	60
P-0006894-T01-IM5	P-0006894	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	406	10
P-0006895-T01-IM5	P-0006895	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	882	NA
P-0006896-T01-IM5	P-0006896	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		573	NA
P-0006897-T01-IM5	P-0006897	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Unknown	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Male		1227	50
P-0006898-T01-IM5	P-0006898	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Female		959	20
P-0006899-T01-IM5	P-0006899	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	B-Cell Lymphoma	IMPACT410			Male		288	80
P-0006901-T01-IM5	P-0006901	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male		813	30
P-0006902-T01-IM5	P-0006902	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17p and gain on chromosome arm 17q.	698	50
P-0006904-T01-IM5	P-0006904	Renal Cell Carcinoma	Metastasis	Tumor	Brain	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	378	20
P-0006905-T01-IM5	P-0006905	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		981	10
P-0006906-T01-IM5	P-0006906	Colorectal Cancer	Metastasis	Tumor	Abdominal Wall	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		877	40
P-0006907-T01-IM5	P-0006907	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	689	10
P-0006908-T01-IM5	P-0006908	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q including ERBB2.	874	40
P-0006909-T01-IM5	P-0006909	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		780	40
P-0006910-T01-IM5	P-0006910	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q, 13q, 16q and 17p.        Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1q and chromosome 8.       Note: The ERBB2	exon19 mutation frequency suggests that the mutation occurs on the amplified allele      Note: A comparison of variant frequencies suggests the ALK p.R179H mutation is subclonal.	687
P-0006912-T01-IM5	P-0006912	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		975	20
P-0006913-T01-IM5	P-0006913	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The ETV1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.   Note: The CDKN2B,  CDKN2Ap16INK4A  and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	674	30
P-0006914-T01-IM5	P-0006914	Small Cell Lung Cancer	Metastasis	Tumor	Trachea	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 7q.	863	10
P-0006915-T01-IM5	P-0006915	Non-Small Cell Lung Cancer	Metastasis	Tumor	Femur	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm of 18q.	809	30
P-0006916-T01-IM5	P-0006916	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		914	10
P-0006917-T01-IM5	P-0006917	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	830	60
P-0006918-T01-IM5	P-0006918	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Renal Medullary Carcinoma	IMPACT410			Female		1056	40
P-0006919-T01-IM5	P-0006919	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A  and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	745	20
P-0006920-T01-IM5	P-0006920	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The TP52 exon 7 mutations all occur in cis (same allele).     Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	876	20
P-0006921-T01-IM5	P-0006921	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		1005	30
P-0006922-T02-IM5	P-0006922	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		541	30
P-0006923-T01-IM5	P-0006923	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The RPS6KB2,  FGF19 , FGF19 , FGF4  and FGF3  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1022	10
P-0006924-T01-IM5	P-0006924	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		685	10
P-0006925-T01-IM5	P-0006925	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male		817	30
P-0006926-T01-IM5	P-0006926	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	719	10
P-0006926-T02-IM5	P-0006926	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: ATR (NM_001184) exon6 p.S472F (c.1415C>T) and p.I487F (c.1459A>T) occur in cis.	773	20
P-0006927-T01-IM5	P-0006927	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p and 20q11.	251	20
P-0006928-T01-IM5	P-0006928	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		699	40
P-0006929-T01-IM5	P-0006929	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Marginal Zone Lymphoma	IMPACT410			Male		1043	40
P-0006930-T01-IM5	P-0006930	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1030	10
P-0006931-T01-IM5	P-0006931	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	650	20
P-0006932-T01-IM5	P-0006932	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Pelvis	Abdomen	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p34, 14q and 22q.	835	50
P-0006933-T01-IM5	P-0006933	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p and 18q.	659	30
P-0006934-T01-IM5	P-0006934	Bladder Cancer	Primary	Tumor	Not Applicable	Urethra	Urethral Urothelial Carcinoma	IMPACT410			Male		893	30
P-0006935-T01-IM5	P-0006935	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		914	50
P-0006936-T01-IM5	P-0006936	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	396	10
P-0006937-T01-IM5	P-0006937	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		329	30
P-0006938-T01-IM5	P-0006938	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	840	10
P-0006939-T01-IM5	P-0006939	Salivary Carcinoma	Primary	Tumor	Not Applicable	Breast	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome X.	1015	50
P-0006940-T01-IM5	P-0006940	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	540	30
P-0006941-T01-IM5	P-0006941	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: The KRAS copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1068	10
P-0006942-T01-IM5	P-0006942	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	863	NA
P-0006945-T01-IM5	P-0006945	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Pancreas	Ampullary Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	888	40
P-0006946-T01-IM5	P-0006946	Melanoma	Primary	Tumor	Not Applicable	Skin	Acral Melanoma	IMPACT410			Male		666	50
P-0006947-T01-IM5	P-0006947	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q.	448	30
P-0006948-T01-IM5	P-0006948	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	965	10
P-0006949-T01-IM5	P-0006949	Cervical Cancer	Metastasis	Tumor	Diaphragm	Cervix	Intestinal Type Mucinous Carcinoma	IMPACT410			Female		968	30
P-0006950-T01-IM5	P-0006950	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q and 11q.	941	NA
P-0006953-T01-IM5	P-0006953	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		864	NA
P-0006954-T01-IM5	P-0006954	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	691	NA
P-0006958-T01-IM5	P-0006958	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male		898	60
P-0006959-T01-IM5	P-0006959	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		793	40
P-0006960-T01-IM5	P-0006960	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: B2M (NM_004048) exon1 p.L12P (c.35T>C) and p.E19* (c.55G>T) occur in trans.       BRCA2 (NM_000059) exon11 p.A1564T (c.4690G>A) and p.D1575Y (c.4723G>T) occur in cis.       INPP4B (NM_001101669) exon5 p.P36Q (c.107C>A) and p.Q40* (c.118C>T) occur in trans.       PTPRT (NM_133170) exon3 p.D99G (c.296A>G) and p.V124M (c.370G>A) occur in trans. TP53 exon5 p.H168R and p.R175H occur in trans.	812	30
P-0006961-T01-IM5	P-0006961	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Chest Wall	Myofibroma	IMPACT410			Female		753	50
P-0006962-T01-IM5	P-0006962	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	790	20
P-0006963-T01-IM5	P-0006963	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		887	20
P-0006964-T01-IM5	P-0006964	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The MCL1, RIT1, NTRK1 and SDHC  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1012	30
P-0006965-T01-IM5	P-0006965	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		743	30
P-0006966-T01-IM5	P-0006966	Uterine Sarcoma	Metastasis	Tumor	Pelvis	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT410			Female	Note: The PLK2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	801	40
P-0006967-T01-IM5	P-0006967	Colorectal Cancer	Metastasis	Tumor	Ovary	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		1172	30
P-0006968-T01-IM5	P-0006968	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	800	60
P-0006969-T01-IM5	P-0006969	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	855	30
P-0006970-T01-IM5	P-0006970	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		881	20
P-0006970-T02-IM5	P-0006970	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		895	60
P-0006971-T01-IM5	P-0006971	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male		893	50
P-0006972-T01-IM5	P-0006972	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	High-Grade Neuroepithelial Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 19p.       Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 4q, 9p21, 9p24, 13q12-13q14, 14q23-14q32, 17p, 18, and 19q.	796	40
P-0006973-T01-IM5	P-0006973	Melanoma	Metastasis	Tumor	Pelvis	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q.	812	50
P-0006974-T01-IM5	P-0006974	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Female		955	30
P-0006975-T01-IM5	P-0006975	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Leiomyosarcoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	599	50
P-0006976-T01-IM5	P-0006976	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p   . Note: The PAK1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The SMAD2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1004	20
P-0006977-T01-IM5	P-0006977	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		668	70
P-0006978-T01-IM5	P-0006978	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	537	40
P-0006979-T01-IM5	P-0006979	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	836	40
P-0006980-T01-IM5	P-0006980	Thyroid Cancer	Metastasis	Tumor	Pelvis	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p36, 9p21, and 9p24.	788	30
P-0006981-T01-IM5	P-0006981	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: The ERBB2 p.V777L mutation frequency suggests that the mutation occurs on the amplified allele.        Note: Low tumor content (approximately 20% or less). Negative mutation, and structural variant results should be interpreted with caution.      Note: The FLT1 and FLT3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	891	10
P-0006982-T01-IM5	P-0006982	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Abdomen	Dedifferentiated Liposarcoma	IMPACT410			Male		628	30
P-0006984-T01-IM5	P-0006984	Ovarian Cancer	Metastasis	Tumor	Sigmoid Colon	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		727	20
P-0006985-T01-IM5	P-0006985	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Male		802	30
P-0006986-T01-IM5	P-0006986	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Follicular Lymphoma	IMPACT410			Female	Note: The NSD1 exon19 mutations all occur in cis (same allele).	866	30
P-0006987-T01-IM5	P-0006987	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1057	10
P-0006988-T01-IM5	P-0006988	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		655	30
P-0006989-T01-IM5	P-0006989	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9q.        Note: The MLL2 exon15 mutations all occur in cis (same allele).      Note: A comparison of variant frequencies suggests the PPP2R1A p.E297K mutation is subclonal.   Note: The PTCH1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	707	50
P-0006990-T01-IM5	P-0006990	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	724	20
P-0006991-T01-IM5	P-0006991	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.	786	30
P-0006992-T01-IM5	P-0006992	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1029	30
P-0006993-T01-IM5	P-0006993	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		597	30
P-0006994-T01-IM5	P-0006994	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		852	40
P-0006995-T01-IM5	P-0006995	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		811	30
P-0006996-T01-IM5	P-0006996	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		1044	20
P-0006997-T01-IM5	P-0006997	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		537	20
P-0006999-T02-IM5	P-0006999	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female		347	20
P-0007000-T01-IM5	P-0007000	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		602	30
P-0007001-T01-IM5	P-0007001	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		997	50
P-0007002-T01-IM5	P-0007002	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 2q.	889	30
P-0007003-T01-IM5	P-0007003	Ovarian Cancer	Metastasis	Tumor	Omentum	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	351	10
P-0007004-T01-IM5	P-0007004	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		775	30
P-0007005-T01-IM5	P-0007005	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		814	40
P-0007006-T01-IM5	P-0007006	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		578	20
P-0007007-T01-IM5	P-0007007	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: The FGFR1, CCND1, FGF3, FGF4 and FGF19 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1059	10
P-0007009-T01-IM5	P-0007009	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		776	60
P-0007009-T02-IM5	P-0007009	Breast Carcinoma	Metastasis	Tumor	Infraclavicular	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		971	50
P-0007010-T01-IM5	P-0007010	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.	908	70
P-0007011-T01-IM5	P-0007011	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	609	40
P-0007012-T01-IM5	P-0007012	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: The MPL and MYCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1009	10
P-0007014-T01-IM5	P-0007014	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		521	40
P-0007015-T01-IM5	P-0007015	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		984	20
P-0007016-T01-IM5	P-0007016	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 124X, negative results should be interpreted with caution.      Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	124	10
P-0007017-T01-IM5	P-0007017	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 20q11 and 20q12.        Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 2q, 10q, 17p, and 22q.	1135	30
P-0007018-T01-IM5	P-0007018	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p including EGFR.	380	30
P-0007019-T01-IM5	P-0007019	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	934	10
P-0007020-T01-IM5	P-0007020	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 17p11-13 and Xp.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 3q, 5p13 and 5p15	1126	30
P-0007023-T01-IM5	P-0007023	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	799	20
P-0007024-T01-IM5	P-0007024	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		847	30
P-0007025-T01-IM5	P-0007025	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 10q21 and 17p12-13  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 5q32 and  5q35	981	10
P-0007026-T01-IM5	P-0007026	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1014	10
P-0007027-T01-IM5	P-0007027	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1059	30
P-0007029-T01-IM5	P-0007029	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		841	70
P-0007030-T01-IM5	P-0007030	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	887	10
P-0007031-T01-IM5	P-0007031	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		828	20
P-0007032-T01-IM5	P-0007032	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1035	10
P-0007033-T01-IM5	P-0007033	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Female		620	40
P-0007034-T01-IM5	P-0007034	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 17p, 18q and 19q.	729	
P-0007035-T01-IM5	P-0007035	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		763	30
P-0007036-T01-IM5	P-0007036	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	795	30
P-0007036-T02-IM5	P-0007036	Breast Carcinoma	Metastasis	Tumor	Spine	Breast	Breast Carcinoma	IMPACT410			Female		977	10
P-0007037-T01-IM5	P-0007037	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The SOX9 exon1 mutations all occur in cis (same allele).	343	20
P-0007039-T01-IM5	P-0007039	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		810	40
P-0007040-T01-IM5	P-0007040	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		906	20
P-0007041-T01-IM5	P-0007041	Biliary Cancer	Metastasis	Tumor	Peritoneum	Liver	Cholangiocarcinoma	IMPACT410			Male	Note: The TP53 exon5 mutations all occur in cis (same allele).	147	30
P-0007042-T01-IM5	P-0007042	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		759	30
P-0007043-T01-IM5	P-0007043	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		470	30
P-0007044-T01-IM5	P-0007044	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		875	10
P-0007045-T01-IM5	P-0007045	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		956	60
P-0007046-T01-IM5	P-0007046	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		823	50
P-0007047-T01-IM5	P-0007047	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	948	10
P-0007048-T01-IM5	P-0007048	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample, matched nail sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1459	20
P-0007049-T01-IM5	P-0007049	Melanoma	Metastasis	Tumor	Lymph Node	Oral Cavity	Head and Neck Mucosal Melanoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1037	30
P-0007050-T01-IM5	P-0007050	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		767	20
P-0007051-T01-IM5	P-0007051	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 1p32-34 and 19q13.	715	30
P-0007052-T01-IM5	P-0007052	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 17q15 and 17q22-25.	631	60
P-0007053-T01-IM5	P-0007053	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 5p, 11p13, 11p15 and 11q   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 12p.	479	50
P-0007054-T01-IM5	P-0007054	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		514	40
P-0007055-T01-IM5	P-0007055	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		653	50
P-0007056-T01-IM5	P-0007056	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	822	30
P-0007057-T01-IM5	P-0007057	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	651	10
P-0007058-T01-IM5	P-0007058	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	1182	20
P-0007059-T01-IM5	P-0007059	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Perivascular Epithelioid Cell Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 14q31-32.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 3p11 and 3p13.	710	40
P-0007060-T01-IM5	P-0007060	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		962	20
P-0007061-T01-IM5	P-0007061	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female		928	20
P-0007062-T01-IM5	P-0007062	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: The CDKN2B, CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	614	40
P-0007063-T01-IM5	P-0007063	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1096	30
P-0007064-T01-IM5	P-0007064	Ovarian Cancer	Metastasis	Tumor	Colon	Ovary	Low-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.    Note: The ID3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1062	40
P-0007065-T01-IM5	P-0007065	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	933	10
P-0007066-T01-IM5	P-0007066	Colorectal Cancer	Primary	Tumor	Not available	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q including SMAD4.      Note: The  H3F3B and SRSF2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	814	30
P-0007067-T01-IM5	P-0007067	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the AKT1 p.L213fs mutation is subclonal.  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	993	10
P-0007068-T01-IM5	P-0007068	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the PIK3R3 p.A397V and p.R309*mutatios are subclonal.	931	30
P-0007069-T01-IM5	P-0007069	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		1023	20
P-0007070-T01-IM5	P-0007070	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		580	30
P-0007071-T01-IM5	P-0007071	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female		799	20
P-0007072-T01-IM5	P-0007072	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	524	40
P-0007073-T01-IM5	P-0007073	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	Miscellaneous Brain Tumor	IMPACT410			Male		745	50
P-0007074-T01-IM5	P-0007074	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	819	20
P-0007075-T01-IM5	P-0007075	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	887	10
P-0007076-T02-IM5	P-0007076	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.	887	75
P-0007076-T03-IM5	P-0007076	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Liver	Neuroendocrine Carcinoma, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1255	75
P-0007077-T02-IM5	P-0007077	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	306	10
P-0007078-T02-IM5	P-0007078	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1341	50
P-0007079-T01-IM5	P-0007079	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		952	NA
P-0007080-T02-IM5	P-0007080	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		1286	NA
P-0007081-T02-IM5	P-0007081	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20.	1146	40
P-0007082-T01-IM5	P-0007082	Non-Small Cell Lung Cancer	Metastasis	Tumor	Spine	Lung	Lung Adenocarcinoma	IMPACT410			Female		390	10
P-0007084-T02-IM5	P-0007084	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p.	263	NA
P-0007085-T02-IM5	P-0007085	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosimoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female		1173	NA
P-0007086-T02-IM5	P-0007086	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1653	70
P-0007087-T01-IM5	P-0007087	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		728	20
P-0007088-T02-IM5	P-0007088	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		919	40
P-0007089-T02-IM5	P-0007089	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		434	60
P-0007090-T02-IM5	P-0007090	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		758	NA
P-0007091-T01-IM5	P-0007091	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p,4q, 10q,13q,15q,16p and 17p.	1128	90
P-0007092-T01-IM5	P-0007092	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q and broad loss on 18q.    Note: The H3F3B and SRSF2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	876	35
P-0007093-T01-IM5	P-0007093	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the PIK3CA p.E545K mutation is subclonal.  Note: The ERBB2  p.S310F suggests that the mutation occurs on the amplified allele	1131	60
P-0007096-T01-IM5	P-0007096	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Salivary Duct Carcinoma	IMPACT410			Male		731	20
P-0007097-T01-IM5	P-0007097	Colorectal Cancer	Primary	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The CCND3 and VEGFA  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	408	20
P-0007098-T01-IM5	P-0007098	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	487	25
P-0007099-T01-IM5	P-0007099	Non-Small Cell Lung Cancer	Metastasis	Tumor	Back	Lung	Lung Adenocarcinoma	IMPACT410			Female		963	30
P-0007100-T01-IM5	P-0007100	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		854	50
P-0007101-T02-IM5	P-0007101	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		513	15
P-0007102-T01-IM5	P-0007102	Salivary Carcinoma	Primary	Tumor	Not Applicable	Parotid	Salivary Duct Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	886	15
P-0007103-T01-IM5	P-0007103	Embryonal Tumor	Primary	Tumor	Not Applicable	Mediastinum	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.	843	NA
P-0007104-T01-IM5	P-0007104	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: The  PDGFRA exon9 mutations all occur in cis (same allele).	1003	80
P-0007109-T01-IM5	P-0007109	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: The CDKN2B,  CDKN2Ap16INK4A and CDKN2Ap14ARF copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	786	20
P-0007110-T01-IM5	P-0007110	Germ Cell Tumor	Metastasis	Tumor	Soft Tissue	Testis	Yolk Sac Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	872	40
P-0007111-T01-IM5	P-0007111	Soft Tissue Sarcoma	Metastasis	Tumor	Pelvis	Thigh	Dedifferentiated Liposarcoma	IMPACT410			Female	Note: The MCL1,RIT1,NTRK1,SDHC,DDR2 and RFWD2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	880	50
P-0007112-T01-IM5	P-0007112	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1077	15
P-0007113-T01-IM5	P-0007113	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		638	NA
P-0007114-T01-IM5	P-0007114	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male		970	10
P-0007115-T01-IM5	P-0007115	Colorectal Cancer	Primary	Tumor	Colon	Colon	Colon Adenocarcinoma	IMPACT410			Female		1028	35
P-0007116-T01-IM5	P-0007116	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	887	10
P-0007117-T01-IM5	P-0007117	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1216	80
P-0007118-T01-IM5	P-0007118	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The CDKN2B,  CDKN2Ap14ARF, and CDKN2Ap16INK4A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1232	50
P-0007119-T01-IM5	P-0007119	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage	562	20
P-0007120-T01-IM5	P-0007120	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 5q.          Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20.        Note: The APC and RAD50 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1264	60
P-0007120-T02-IM5	P-0007120	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male		987	60
P-0007121-T01-IM5	P-0007121	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	851	15
P-0007122-T01-IM5	P-0007122	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample is highly recommended.	936	10
P-0007123-T01-IM5	P-0007123	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		861	20
P-0007124-T01-IM5	P-0007124	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		311	80
P-0007125-T01-IM5	P-0007125	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		988	40
P-0007126-T01-IM5	P-0007126	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	911	40
P-0007127-T01-IM5	P-0007127	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		601	20
P-0007128-T01-IM5	P-0007128	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		510	30
P-0007129-T01-IM5	P-0007129	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		281	20
P-0007129-T02-IM5	P-0007129	Breast Carcinoma	Metastasis	Tumor	Abdomen	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		1040	90
P-0007130-T01-IM5	P-0007130	Sex Cord Stromal Tumor	Metastasis	Tumor	Lymph Node	Ovary	Granulosa Cell Tumor	IMPACT410			Female		782	70
P-0007131-T01-IM5	P-0007131	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The CDK12 and ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	509	N/A
P-0007131-T02-IM5	P-0007131	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The GATA2, EPHA3 ,  CDKN2Ap16INK4A	and  CDKN2Ap14ARF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	500
P-0007132-T01-IM5	P-0007132	Colorectal Cancer	Metastasis	Tumor	Lung	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	980	20
P-0007133-T01-IM5	P-0007133	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	754	20
P-0007134-T01-IM5	P-0007134	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		552	10
P-0007135-T01-IM5	P-0007135	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	785	20
P-0007136-T01-IM5	P-0007136	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: The ASXL1, DNMT3B, SRC, and BCL2L1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	829	10
P-0007137-T01-IM5	P-0007137	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	788	10
P-0007138-T01-IM5	P-0007138	Colorectal Cancer	Metastasis	Tumor	Retroperitoneum	Cecum	Mucinous Colorectal Carcinoma	IMPACT410			Male		737	30
P-0007139-T01-IM5	P-0007139	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1049	70
P-0007140-T01-IM5	P-0007140	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male		1108	20
P-0007141-T01-IM5	P-0007141	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	556	10
P-0007141-T02-IM5	P-0007141	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		575	40
P-0007142-T01-IM5	P-0007142	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	368	10
P-0007143-T01-IM5	P-0007143	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	756	50
P-0007144-T01-IM5	P-0007144	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colon Adenocarcinoma	IMPACT410			Male		1032	30
P-0007145-T01-IM5	P-0007145	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms of 1p, 3p, 5q, 14q, 15q and 17p	988	60
P-0007146-T01-IM5	P-0007146	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1042	50
P-0007147-T01-IM5	P-0007147	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		706	30
P-0007148-T01-IM5	P-0007148	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Metaplastic Squamous Cell Carcinoma	IMPACT410			Female		762	30
P-0007149-T01-IM5	P-0007149	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Mutation assessment: Mutations are called against an unmatched normal sample. This assay may not distinguish between somatic mutations and rare germline variants.  Note: The DICER1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	865	80
P-0007150-T01-IM5	P-0007150	Ovarian Cancer	Metastasis	Tumor	Peritoneum	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number alterations by alternate methods is suggested if clinically indicated.	579	30
P-0007151-T01-IM5	P-0007151	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Male		966	60
P-0007152-T01-IM5	P-0007152	Meningothelial Tumor	Primary	Tumor	Not Applicable	Sinus	Meningioma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	448	50
P-0007153-T01-IM5	P-0007153	Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Mediastinum	Hodgkin Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.            Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1269	20
P-0007154-T01-IM5	P-0007154	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	785	70
P-0007155-T01-IM5	P-0007155	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: The AKT3, FH, KDM5A and RAD52 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	601	50
P-0007156-T02-IM5	P-0007156	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 135X, negative results should be interpreted with caution.	135	10
P-0007157-T01-IM5	P-0007157	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the CTNNB1 p.T41A mutation is subclonal.   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 6p and 8q.     Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.    Note: The FGFR1, NKX3-1, CDKN2B,  CDKN2Ap14ARF and CDKN2Ap16INK4A copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	613	60
P-0007158-T01-IM5	P-0007158	Melanoma	Primary	Tumor	Not Applicable	Foot	Acral Melanoma	IMPACT410			Male		990	30
P-0007159-T01-IM5	P-0007159	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Intestinal Type Stomach Adenocarcinoma	IMPACT410			Male		919	20
P-0007160-T01-IM5	P-0007160	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 2q.	755	100
P-0007161-T01-IM5	P-0007161	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		350	40
P-0007162-T01-IM5	P-0007162	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male		897	20
P-0007163-T01-IM5	P-0007163	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Poorly Differentiated Carcinoma of the Stomach	IMPACT410			Male	Note: The FGFR2 and MDM2 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	568	30
P-0007165-T01-IM5	P-0007165	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	973	10
P-0007166-T01-IM5	P-0007166	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1096	10
P-0007167-T01-IM5	P-0007167	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The CDKN2Ap16INK4A copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	937	30
P-0007168-T01-IM5	P-0007168	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 20q12 and 20q13.	1079	30
P-0007169-T01-IM5	P-0007169	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male		1001	20
P-0007170-T01-IM5	P-0007170	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		971	40
P-0007171-T01-IM5	P-0007171	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	862	10
P-0007172-T01-IM5	P-0007172	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Medullary Thyroid Cancer	IMPACT410			Female		757	50
P-0007173-T01-IM5	P-0007173	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		770	70
P-0007174-T01-IM5	P-0007174	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		949	10
P-0007175-T01-IM5	P-0007175	Colorectal Cancer	Metastasis	Tumor	Lung	Descending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 13q and 20q.	886	30
P-0007176-T01-IM5	P-0007176	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Myxofibrosarcoma	IMPACT410			Male	Note: The ATRX exon 27 mutations all occur in cis (same allele).	1292	40
P-0007177-T01-IM5	P-0007177	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The PTEN and SMAD3 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	732	N/A
P-0007178-T01-IM5	P-0007178	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		916	20
P-0007179-T02-IM5	P-0007179	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	382	65
P-0007180-T01-IM5	P-0007180	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 20q.	1091	N/A
P-0007181-T01-IM5	P-0007181	Colorectal Cancer	Metastasis	Tumor	Lung	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 8q, 20q and chrX.	445	40
P-0007182-T01-IM5	P-0007182	Prostate Cancer	Metastasis	Tumor	Spine	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 8q    Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arm of 17p	387	70
P-0007183-T01-IM5	P-0007183	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Mixed Ductal and Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 1q and 16p.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 11q, 16q and 17p    Note: The RNF43 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	853	60
P-0007184-T01-IM5	P-0007184	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The CCND1, FGF19, FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	700	30
P-0007185-T01-IM5	P-0007185	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm of 18q.	1047	20
P-0007186-T01-IM5	P-0007186	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Small Lymphocytic Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q.	1258	90
P-0007202-T01-IM5	P-0007202	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1787	35
P-0007203-T01-IM5	P-0007203	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1100	10
P-0007204-T01-IM5	P-0007204	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Mucinous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	667	15
P-0007205-T01-IM5	P-0007205	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	880	50
P-0007206-T01-IM5	P-0007206	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Mantle Cell Lymphoma	IMPACT410			Female		1243	95
P-0007207-T01-IM5	P-0007207	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		696	15
P-0007208-T01-IM5	P-0007208	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		569	40
P-0007209-T01-IM5	P-0007209	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Sinus	Alveolar Rhabdomyosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	875	10
P-0007210-T01-IM5	P-0007210	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		766	40
P-0007211-T01-IM5	P-0007211	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The CDKN2Ap16INK4A, CDKN2Ap14ARF and CDKN2B copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	642	50
P-0007213-T01-IM5	P-0007213	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Cholangiocarcinoma	IMPACT410			Female	Note: The CDKN2Ap16INK4A, CDKN2Ap14ARF and CDKN2B copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	836	20
P-0007214-T01-IM5	P-0007214	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		1270	25
P-0007215-T01-IM5	P-0007215	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		456	15
P-0007216-T01-IM5	P-0007216	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum and Colon	Colorectal Adenocarcinoma	IMPACT410			Male		923	40
P-0007217-T01-IM5	P-0007217	Appendiceal Cancer	Primary	Tumor	Not Applicable	Ileum	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	734	10
P-0007218-T01-IM5	P-0007218	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	664	40
P-0007219-T01-IM5	P-0007219	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	757	15
P-0007220-T01-IM5	P-0007220	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Maxilla	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		1013	20
P-0007221-T01-IM5	P-0007221	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT410			Female	Note: The MYCL1 and TCEB1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	908	30
P-0007222-T01-IM5	P-0007222	Colorectal Cancer	Metastasis	Tumor	Abdomen	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		397	10
P-0007223-T01-IM5	P-0007223	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Atypical Lung Carcinoid	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3q and 11q.	1111	50
P-0007224-T01-IM5	P-0007224	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p.	595	NA
P-0007225-T01-IM5	P-0007225	Cancer of Unknown Primary	Metastasis	Tumor	Stomach	Unknown	Small Cell Carcinoma of Unknown Primary	IMPACT410			Male	Note: Assessment of the copy number profile is limited by increased background noise.	707	90
P-0007226-T01-IM5	P-0007226	Colorectal Cancer	Metastasis	Tumor	Brain	Rectum and Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	933	80
P-0007227-T01-IM5	P-0007227	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		482	30
P-0007228-T01-IM5	P-0007228	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The copy number profile is suggestive of an intragenic gain of CDK12 exons7-14.	535	30
P-0007231-T01-IM5	P-0007231	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		839	90
P-0007232-T01-IM5	P-0007232	Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	753	10
P-0007233-T01-IM5	P-0007233	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		347	50
P-0007234-T01-IM5	P-0007234	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome	12q15-24 and chromosome arm 6q .	1048
P-0007235-T01-IM5	P-0007235	Melanoma	Primary	Tumor	Not Applicable	Esophagus	Mucosal Melanoma of the Esophagus	IMPACT410			Female	Note: The BRCA2 p.S1632R and p.K1638E mutations all occur in cis (same allele).	924	80
P-0007236-T01-IM5	P-0007236	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		534	20
P-0007237-T01-IM5	P-0007237	Germ Cell Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Mixed Germ Cell Tumor	IMPACT410			Male		913	20
P-0007238-T01-IM5	P-0007238	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Male		571	80
P-0007239-T01-IM5	P-0007239	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p12-32, 6q16-22 and 12p13 (except KDM5A on 12p13).          Note: The MAX, DICER1,  RAD51B and ARID1B copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	380	50
P-0007240-T01-IM5	P-0007240	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	708	10
P-0007241-T01-IM5	P-0007241	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		790	50
P-0007266-T01-IM5	P-0007266	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1055	NA
P-0007267-T01-IM5	P-0007267	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		874	60
P-0007268-T01-IM5	P-0007268	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and loss on 13q12-22.   Note: The MAP2K1,SMAD3 and RICTOR  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1085	80
P-0007269-T01-IM5	P-0007269	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female		589	40
P-0007271-T01-IM5	P-0007271	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	852	15
P-0007272-T01-IM5	P-0007272	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		990	10
P-0007273-T01-IM5	P-0007273	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1127	60
P-0007274-T01-IM5	P-0007274	Bladder Cancer	Metastasis	Tumor	Lung	Urethra	Urethral Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	854	20
P-0007275-T01-IM5	P-0007275	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p,16p and 18q.	899	50
P-0007276-T01-IM5	P-0007276	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		739	25
P-0007277-T01-IM5	P-0007277	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: The TERT promoter mutations all occur in cis (same allele).	901	15
P-0007278-T01-IM5	P-0007278	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The CCND1,FGF19,FGF4 and FGF3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	760	15
P-0007279-T01-IM5	P-0007279	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male		629	20
P-0007280-T01-IM5	P-0007280	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		748	40
P-0007281-T01-IM5	P-0007281	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male		939	20
P-0007282-T01-IM5	P-0007282	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: The Chromosome arm 12q  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1134	90
P-0007283-T01-IM5	P-0007283	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		498	20
P-0007284-T01-IM5	P-0007284	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and  17q21-17q25.      Note: The PRDM1 and FYN  copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	594	80
P-0007285-T01-IM5	P-0007285	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.	816	70
P-0007286-T01-IM5	P-0007286	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	883	20
P-0007286-T02-IM5	P-0007286	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		754	40
P-0007287-T01-IM5	P-0007287	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	438	30
P-0007288-T01-IM5	P-0007288	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		453	60
P-0007289-T02-IM5	P-0007289	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q14-22 including RB1.    Note: Copy number profile is suggestive of a fragmented genome.	657	80
P-0007290-T02-IM5	P-0007290	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	844	20
P-0007291-T01-IM5	P-0007291	Melanoma	Primary	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 6q, 11q and 14q.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	676	NA
P-0007293-T01-IM5	P-0007293	Melanoma	Metastasis	Tumor	Abdominal Wall	Cervix	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p including KRAS.	1621	10
P-0007294-T01-IM5	P-0007294	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q including SMAD4.	917	NA
P-0007295-T01-IM5	P-0007295	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Copy number profile is suggestive of broad copy number gains on chromosomes 3,7,10,12,17q, and 22.	850	50
P-0007296-T01-IM5	P-0007296	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The RPS6KA4 exon17 mutations all occur in cis (same allele). Note: The ERCC2 exon7  mutations all occur in cis (same allele).	516	NA
P-0007297-T01-IM5	P-0007297	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1039	NA
P-0007298-T01-IM5	P-0007298	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		826	20
P-0007299-T01-IM5	P-0007299	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		161	25
P-0007300-T01-IM5	P-0007300	Pancreatic Cancer	Primary	Tumor	Not Applicable	Peritoneum	Mucinous Cystic Neoplasm	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	904	NA
P-0007302-T01-IM5	P-0007302	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	439	20
P-0007303-T01-IM5	P-0007303	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	1118	30
P-0007304-T01-IM5	P-0007304	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	949	20
P-0007305-T01-IM5	P-0007305	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		532	20
P-0007306-T01-IM5	P-0007306	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: The BCL6 exon5  mutations ( p.S349G andp.K351*) all occur in cis (same allele).	432	95
P-0007307-T01-IM5	P-0007307	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		857	60
P-0007308-T01-IM5	P-0007308	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Chest Wall	Synovial Sarcoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the ABL1 p.K765fs mutation is subclonal.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 12.	838	90
P-0007309-T01-IM5	P-0007309	Non-Small Cell Lung Cancer	Metastasis	Tumor	Femur	Lung	Lung Adenocarcinoma	IMPACT410			Female		563	50
P-0007310-T01-IM5	P-0007310	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		624	40
P-0007311-T01-IM5	P-0007311	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the MLL p.R2659Q, GNAS  p.R265H , BRD4  p.A40T , PDCD1 p.G119S,PTPRS p.T327M   mutations are  subclonal.	574	60
P-0007312-T01-IM5	P-0007312	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the FLT1  p.S412* mutation is subclonal.	640	80
P-0007313-T01-IM5	P-0007313	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: A comparison of variant frequencies suggests the IRF4 p.C255Y mutation is subclonal.   Note: The HGF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	624	80
P-0007314-T01-IM5	P-0007314	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		981	70
P-0007315-T01-IM5	P-0007315	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	720	30
P-0007316-T01-IM5	P-0007316	Embryonal Tumor	Metastasis	Tumor	Lymph node	Abdomen	Neuroblastoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	50
P-0007317-T01-IM5	P-0007317	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	896	10
P-0007318-T01-IM5	P-0007318	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p.    Note: The CDKN2B, CDKN2Ap16INK4A, and CDKN2Ap14AR copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	960	30
P-0007319-T01-IM5	P-0007319	Penile Cancer	Primary	Tumor	Not Applicable	Penis	Basaloid Penile Squamous Cell Carcinoma	IMPACT410			Male		985	35
P-0007320-T01-IM5	P-0007320	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The MCL and  KRAS copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The KRAS p.G12C mutation frequency  suggests that the mutation occurs on the amplified allele	922	NA
P-0007321-T01-IM5	P-0007321	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		1353	60
P-0007322-T01-IM5	P-0007322	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	921	10
P-0007323-T01-IM5	P-0007323	Embryonal Tumor	Primary	Tumor	Not Applicable	Mediastinum	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.	722	40
P-0007324-T01-IM5	P-0007324	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Breast	Angiosarcoma	IMPACT410			Female		850	50
P-0007325-T01-IM5	P-0007325	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 2p, 8q, 16p, and 21q.       Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q, 8p, and 16q.	821	80
P-0007327-T01-IM5	P-0007327	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 16p.     Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 16q and 22q	813	80
P-0007328-T01-IM5	P-0007328	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The MET copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	952	20
P-0007329-T01-IM5	P-0007329	Embryonal Tumor	Metastasis	Tumor	Lymph node	Abdomen	Neuroblastoma	IMPACT410			Female		995	15
P-0007330-T01-IM5	P-0007330	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: The CTNNB1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	672	50
P-0007331-T01-IM5	P-0007331	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lung	Mediastinal Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	836	90
P-0007332-T01-IM5	P-0007332	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		231	50
P-0007333-T01-IM5	P-0007333	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	834	15
P-0007334-T01-IM5	P-0007334	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		658	NA
P-0007335-T01-IM5	P-0007335	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		845	60
P-0007335-T02-IM5	P-0007335	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		834	60
P-0007336-T01-IM5	P-0007336	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		515	20
P-0007337-T01-IM5	P-0007337	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 15q.	810	80
P-0007338-T01-IM5	P-0007338	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		639	50
P-0007339-T01-IM5	P-0007339	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male		716	90
P-0007340-T01-IM5	P-0007340	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1791	60
P-0007341-T01-IM5	P-0007341	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	725	NA
P-0007342-T01-IM5	P-0007342	Colorectal Cancer	Metastasis	Tumor	Omentum	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female		711	50
P-0007343-T01-IM5	P-0007343	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	644	30
P-0007344-T01-IM5	P-0007344	Soft Tissue Sarcoma	Metastasis	Tumor	Soft Tissue	Soft Tissue	Sarcoma, NOS	IMPACT410			Male	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out.	672	60
P-0007345-T01-IM5	P-0007345	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		601	40
P-0007346-T01-IM5	P-0007346	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	725	30
P-0007347-T01-IM5	P-0007347	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		603	30
P-0007348-T01-IM5	P-0007348	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	462	50
P-0007349-T01-IM5	P-0007349	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		691	60
P-0007350-T01-IM5	P-0007350	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	656	20
P-0007351-T01-IM5	P-0007351	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	656	40
P-0007352-T01-IM5	P-0007352	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female		649	30
P-0007353-T01-IM5	P-0007353	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 6p and 8q.	1142	40
P-0007354-T01-IM5	P-0007354	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched normal sample.	499	90
P-0007355-T01-IM5	P-0007355	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	1164	90
P-0007356-T01-IM5	P-0007356	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		628	15
P-0007357-T01-IM5	P-0007357	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum and Colon	Colorectal Adenocarcinoma	IMPACT410			Male		720	30
P-0007359-T01-IM5	P-0007359	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	570	40
P-0007361-T01-IM5	P-0007361	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum and Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	374	15
P-0007362-T01-IM5	P-0007362	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	583	60
P-0007363-T01-IM5	P-0007363	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Buttock	Sarcoma, NOS	IMPACT410			Female		789	40
P-0007364-T01-IM5	P-0007364	Breast Carcinoma	Metastasis	Tumor	Pericardium	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	762	50
P-0007365-T01-IM5	P-0007365	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female		390	30
P-0007366-T01-IM5	P-0007366	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		656	50
P-0007368-T01-IM5	P-0007368	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		589	NA
P-0007369-T01-IM5	P-0007369	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female		583	90
P-0007370-T01-IM5	P-0007370	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor	IMPACT410			Female		694	60
P-0007371-T01-IM5	P-0007371	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 10q and Chromosome 16.	620	50
P-0007372-T01-IM5	P-0007372	Non-Hodgkin Lymphoma	Metastasis	Tumor	Kidney	Lymph node	Follicular Lymphoma	IMPACT410			Male		680	90
P-0007373-T01-IM5	P-0007373	Colorectal Cancer	Metastasis	Tumor	Liver	Rectosigmoid Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q.	505	NA
P-0007374-T01-IM5	P-0007374	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		444	80
P-0007375-T01-IM5	P-0007375	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		594	40
P-0007376-T01-IM5	P-0007376	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Sarcoma, NOS	IMPACT410			Male		721	30
P-0007377-T02-IM5	P-0007377	Colorectal Cancer	Metastasis	Tumor	Bladder	Colon	Colon Adenocarcinoma	IMPACT410			Male		793	90
P-0007379-T01-IM5	P-0007379	Non-Hodgkin Lymphoma	Metastasis	Tumor	Soft Tissue	Lymph node	Follicular Lymphoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the BRAF p.G469A mutation is subclonal.	536	90
P-0007380-T01-IM5	P-0007380	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome Xp11- Xp22 and 20q.	421	40
P-0007381-T01-IM5	P-0007381	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	792	40
P-0007382-T01-IM5	P-0007382	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		407	60
P-0007383-T01-IM5	P-0007383	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 2q11, 3, 4q, 6q, 8p, 13q and 19p.	910	60
P-0007384-T01-IM5	P-0007384	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Tongue	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		798	20
P-0007385-T01-IM5	P-0007385	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Extrahepatic Cholangiocarcinoma	IMPACT410			Female		731	15
P-0007386-T01-IM5	P-0007386	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		1317	60
P-0007387-T01-IM5	P-0007387	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Porto-cava mass	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  False negatives can not be ruled out.      Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	912	80
P-0007388-T01-IM5	P-0007388	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Tongue	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female	Note: The FGF3, FGF4, FGF19, and CCND1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	633	20
P-0007389-T01-IM5	P-0007389	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		716	40
P-0007390-T01-IM5	P-0007390	Embryonal Tumor	Primary	Tumor	Not Applicable	Abdomen	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 11q, and 16q.	860	90
P-0007391-T01-IM5	P-0007391	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1176	30
P-0007392-T01-IM5	P-0007392	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		769	90
P-0007393-T01-IM5	P-0007393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		853	80
P-0007394-T01-IM5	P-0007394	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	748	60
P-0007395-T01-IM5	P-0007395	Ependymomal Tumor	Primary	Tumor	Not Applicable	Thoracic Spine	Ependymoma	IMPACT410			Male		792	90
P-0007396-T01-IM5	P-0007396	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		792	50
P-0007397-T01-IM5	P-0007397	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		603	NA
P-0007398-T01-IM5	P-0007398	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		515	40
P-0007398-T02-IM5	P-0007398	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	1062	80
P-0007399-T01-IM5	P-0007399	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	868	50
P-0007400-T01-IM5	P-0007400	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p, 7p, 15q, 16q, 17p, and 22q.	778	95
P-0007401-T01-IM5	P-0007401	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		810	50
P-0007402-T01-IM5	P-0007402	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		763	25
P-0007403-T01-IM5	P-0007403	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Basaloid Large Cell Carcinoma of the Lung	IMPACT410			Male	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	851	25
P-0007404-T01-IM5	P-0007404	Sellar Tumor	Primary	Tumor	Not Applicable	Skull	Craniopharyngioma, Adamantinomatous Type	IMPACT410			Male		762	60
P-0007405-T01-IM5	P-0007405	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		639	35
P-0007406-T01-IM5	P-0007406	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Spleen	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		859	90
P-0007407-T01-IM5	P-0007407	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Larynx	Larynx Squamous Cell Carcinoma	IMPACT410			Male		544	15
P-0007408-T01-IM5	P-0007408	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	949	10
P-0007409-T01-IM5	P-0007409	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Translocation-Associated Renal Cell Carcinoma	IMPACT410			Male		931	40
P-0007410-T01-IM5	P-0007410	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	565	25
P-0007412-T01-IM5	P-0007412	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Esophagogastric Adenocarcinoma	IMPACT410			Female		604	30
P-0007413-T01-IM5	P-0007413	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		856	50
P-0007414-T01-IM5	P-0007414	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	582	15
P-0007415-T01-IM5	P-0007415	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Anaplastic Ependymoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p and 13q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5 and 7.	684	80
P-0007416-T01-IM5	P-0007416	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		361	95
P-0007418-T01-IM5	P-0007418	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	519	70
P-0007419-T01-IM5	P-0007419	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		661	50
P-0007420-T01-IM5	P-0007420	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		673	NA
P-0007421-T01-IM5	P-0007421	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		905	50
P-0007422-T01-IM5	P-0007422	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		773	30
P-0007423-T01-IM5	P-0007423	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 101X, negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	101	60
P-0007424-T01-IM5	P-0007424	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	938	10
P-0007424-T02-IM5	P-0007424	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	835	50
P-0007425-T01-IM5	P-0007425	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		628	10
P-0007427-T01-IM5	P-0007427	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Male		789	90
P-0007428-T01-IM5	P-0007428	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		1381	30
P-0007483-T01-IM5	P-0007483	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Male		854	NA
P-0007484-T01-IM5	P-0007484	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Urethral Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	493	80
P-0007485-T01-IM5	P-0007485	Cervical Cancer	Metastasis	Tumor	Lymph node	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	715	30
P-0007486-T01-IM5	P-0007486	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	550	NA
P-0007487-T01-IM5	P-0007487	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1014	NA
P-0007488-T01-IM5	P-0007488	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	637	NA
P-0007489-T01-IM5	P-0007489	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colorectal Adenocarcinoma	IMPACT410			Female		355	NA
P-0007490-T01-IM5	P-0007490	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	749	NA
P-0007491-T01-IM5	P-0007491	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	544	NA
P-0007492-T01-IM5	P-0007492	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female		628	NA
P-0007494-T01-IM5	P-0007494	Pancreatic Cancer	Metastasis	Tumor	Appendix	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	725	10
P-0007495-T01-IM5	P-0007495	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		793	25
P-0007496-T01-IM5	P-0007496	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		890	60
P-0007497-T01-IM5	P-0007497	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		392	60
P-0007498-T01-IM5	P-0007498	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		999	60
P-0007499-T01-IM5	P-0007499	Salivary Carcinoma	Metastasis	Tumor	Pleura	Maxilla	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MYB and NFIB genes.	756	90
P-0007500-T01-IM5	P-0007500	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	834	50
P-0007501-T01-IM5	P-0007501	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		923	80
P-0007502-T01-IM5	P-0007502	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		825	20
P-0007503-T01-IM5	P-0007503	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		826	90
P-0007504-T01-IM5	P-0007504	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		909	90
P-0007505-T01-IM5	P-0007505	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		890	30
P-0007506-T01-IM5	P-0007506	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 14q13-23.	818	80
P-0007507-T01-IM5	P-0007507	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pericardium	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	187	10
P-0007508-T01-IM5	P-0007508	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		942	60
P-0007509-T01-IM5	P-0007509	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		1154	40
P-0007510-T01-IM5	P-0007510	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		793	60
P-0007511-T01-IM5	P-0007511	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	985	20
P-0007512-T01-IM5	P-0007512	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Female		1224	60
P-0007513-T01-IM5	P-0007513	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Pelvis	Gastrointestinal Stromal Tumor	IMPACT410			Female		736	80
P-0007514-T01-IM5	P-0007514	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		606	30
P-0007515-T01-IM5	P-0007515	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		924	95
P-0007516-T01-IM5	P-0007516	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Adenosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	862	90
P-0007517-T01-IM5	P-0007517	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		832	90
P-0007518-T01-IM5	P-0007518	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		830	50
P-0007519-T01-IM5	P-0007519	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6p22.	913	70
P-0007520-T01-IM5	P-0007520	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female		785	95
P-0007521-T01-IM5	P-0007521	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		177	60
P-0007522-T01-IM5	P-0007522	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT gene.	1094	95
P-0007523-T01-IM5	P-0007523	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Female		863	90
P-0007524-T01-IM5	P-0007524	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Seminoma	IMPACT410			Male		591	80
P-0007525-T01-IM5	P-0007525	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p13-15 including TERT and SDHA.	413	15
P-0007526-T02-IM5	P-0007526	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pelvis	Angiosarcoma	IMPACT410			Male		864	40
P-0007527-T01-IM5	P-0007527	Soft Tissue Sarcoma	Metastasis	Tumor	Skin	Brain	Solitary Fibrous Tumor/Hemangiopericytoma	IMPACT410			Female		573	80
P-0007528-T01-IM5	P-0007528	Thyroid Cancer	Metastasis	Tumor	Rib	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		437	NA
P-0007529-T01-IM5	P-0007529	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		721	40
P-0007530-T01-IM5	P-0007530	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q including MYC.      Note: The EPHA5, GSK3B and GATA2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by alternative method is suggested, if clinically indicated.	1153	NA
P-0007531-T01-IM5	P-0007531	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Esophagogastric Adenocarcinoma	IMPACT410			Female		200	NA
P-0007532-T01-IM5	P-0007532	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	937	NA
P-0007533-T01-IM5	P-0007533	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		811	80
P-0007534-T01-IM5	P-0007534	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	93	NA
P-0007535-T01-IM5	P-0007535	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q including MYC.	582	30
P-0007536-T01-IM5	P-0007536	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Dedifferentiated Liposarcoma	IMPACT410			Female		770	60
P-0007538-T01-IM5	P-0007538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		234	25
P-0007539-T01-IM5	P-0007539	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		315	80
P-0007540-T01-IM5	P-0007540	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		479	60
P-0007541-T01-IM5	P-0007541	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		885	25
P-0007542-T01-IM5	P-0007542	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1020	20
P-0007543-T01-IM5	P-0007543	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male		908	70
P-0007544-T01-IM5	P-0007544	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	958	70
P-0007545-T01-IM5	P-0007545	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		946	50
P-0007546-T01-IM5	P-0007546	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	793	30
P-0007547-T01-IM5	P-0007547	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		674	80
P-0007548-T01-IM5	P-0007548	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		1039	40
P-0007549-T01-IM5	P-0007549	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1062	45
P-0007550-T01-IM5	P-0007550	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		182	40
P-0007551-T01-IM5	P-0007551	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p, 10q,13q and 17q.	414	80
P-0007552-T01-IM5	P-0007552	Nerve Sheath Tumor	Primary	Tumor	Not Applicable	Soft Tissue	Malignant Peripheral Nerve Sheath Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 19p.	1041	50
P-0007554-T01-IM5	P-0007554	Colorectal Cancer	Metastasis	Tumor	Liver	Cecum	Colorectal Adenocarcinoma	IMPACT410			Female		726	NA
P-0007555-T01-IM5	P-0007555	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Colorectal Adenocarcinoma	IMPACT410			Male		1011	20
P-0007556-T01-IM5	P-0007556	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		731	60
P-0007557-T01-IM5	P-0007557	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Skin	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		838	NA
P-0007558-T01-IM5	P-0007558	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	924	30
P-0007559-T01-IM5	P-0007559	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: ESR1 p.Y537C is a resistance mutation.	426	70
P-0007560-T01-IM5	P-0007560	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1023	60
P-0007561-T01-IM5	P-0007561	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Female		759	NA
P-0007562-T01-IM5	P-0007562	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	998	80
P-0007563-T01-IM5	P-0007563	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		864	30
P-0007564-T01-IM5	P-0007564	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8q and 16p.  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-22, 8p, 16q and 22q.  Note: ESR1 p.D538G is a resistance mutation.	686	50
P-0007565-T01-IM5	P-0007565	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		921	NA
P-0007566-T01-IM5	P-0007566	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		715	90
P-0007568-T01-IM5	P-0007568	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Anaplastic Large Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	802	NA
P-0007570-T02-IM5	P-0007570	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Male		840	60
P-0007571-T01-IM5	P-0007571	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Endometrioid Ovarian Cancer	IMPACT410			Female		829	80
P-0007572-T01-IM5	P-0007572	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Esophagogastric Adenocarcinoma	IMPACT410			Male		682	40
P-0007573-T01-IM5	P-0007573	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		485	80
P-0007575-T01-IM5	P-0007575	Head and Neck Carcinoma	Metastasis	Tumor	Liver	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT410			Male		890	70
P-0007576-T01-IM5	P-0007576	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		691	80
P-0007577-T01-IM5	P-0007577	Breast Carcinoma	Metastasis	Tumor	Small Bowel	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		925	70
P-0007578-T01-IM5	P-0007578	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Male		776	NA
P-0007579-T01-IM5	P-0007579	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		787	70
P-0007580-T01-IM5	P-0007580	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		191	50
P-0007581-T01-IM5	P-0007581	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		585	30
P-0007582-T01-IM5	P-0007582	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		780	50
P-0007583-T01-IM5	P-0007583	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft tissue back	Lung	Lung Adenocarcinoma	IMPACT410			Female		744	70
P-0007584-T01-IM5	P-0007584	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	505	30
P-0007585-T01-IM5	P-0007585	Chordoma	Primary	Tumor	Not Applicable	Soft Tissue	Chordoma	IMPACT410			Female		399	40
P-0007586-T01-IM5	P-0007586	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosimoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise and false negatives cannot be ruled out.	507	15
P-0007587-T01-IM5	P-0007587	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1042	10
P-0007588-T01-IM5	P-0007588	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Female		774	30
P-0007589-T01-IM5	P-0007589	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		412	40
P-0007590-T01-IM5	P-0007590	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		669	NA
P-0007591-T01-IM5	P-0007591	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	939	NA
P-0007592-T01-IM5	P-0007592	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise and false negatives cannot be ruled out.	856	NA
P-0007593-T01-IM5	P-0007593	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		600	NA
P-0007594-T01-IM5	P-0007594	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma	IMPACT410			Female		291	90
P-0007595-T01-IM5	P-0007595	Renal Cell Carcinoma	Metastasis	Tumor	Abdomen	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		1101	80
P-0007596-T01-IM5	P-0007596	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		834	70
P-0007597-T01-IM5	P-0007597	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p and 6p.    A comparison of the variant frequencies suggests that the KRAS G12A mutation occurs on the amplified allele.	1213	80
P-0007598-T01-IM5	P-0007598	Esophagogastric Carcinoma	Metastasis	Tumor	Retroperitoneum	Stomach	Esophagogastric Adenocarcinoma	IMPACT410			Male		534	50
P-0007599-T01-IM5	P-0007599	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Male		126	25
P-0007600-T01-IM5	P-0007600	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	965	30
P-0007601-T01-IM5	P-0007601	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		989	70
P-0007602-T01-IM5	P-0007602	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 19q.	1211	50
P-0007604-T01-IM5	P-0007604	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		1082	25
P-0007605-T01-IM5	P-0007605	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Groin	Epithelioid Sarcoma	IMPACT410			Male		509	70
P-0007606-T01-IM5	P-0007606	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		350	40
P-0007607-T01-IM5	P-0007607	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1088	10
P-0007608-T01-IM5	P-0007608	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		802	30
P-0007619-T01-IM5	P-0007619	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		785	40
P-0007620-T01-IM5	P-0007620	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p.	554	NA
P-0007622-T01-IM5	P-0007622	Head and Neck Carcinoma	Metastasis	Tumor	Chest Wall	Tongue	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		598	30
P-0007623-T01-IM5	P-0007623	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	752	20
P-0007624-T01-IM5	P-0007624	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	788	25
P-0007625-T01-IM5	P-0007625	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		451	60
P-0007626-T01-IM5	P-0007626	Cancer of Unknown Primary	Metastasis	Tumor	Lymph node	Unknown	Cancer of Unknown Primary	IMPACT410			Female		927	60
P-0007627-T01-IM5	P-0007627	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 16p and 17q.	984	80
P-0007628-T01-IM5	P-0007628	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	798	50
P-0007629-T01-IM5	P-0007629	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		455	20
P-0007630-T01-IM5	P-0007630	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Liver	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		869	70
P-0007631-T01-IM5	P-0007631	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p.	740	NA
P-0007632-T01-IM5	P-0007632	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		500	20
P-0007633-T01-IM5	P-0007633	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		719	40
P-0007634-T01-IM5	P-0007634	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	696	20
P-0007635-T01-IM5	P-0007635	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	841	NA
P-0007637-T01-IM5	P-0007637	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 10% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	857	40
P-0007638-T01-IM5	P-0007638	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		864	NA
P-0007639-T02-IM5	P-0007639	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female		304	60
P-0007640-T01-IM5	P-0007640	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Sarcoma, NOS	IMPACT410			Male		920	NA
P-0007641-T01-IM5	P-0007641	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Soft Tissue	Sclerosing Epithelioid Fibrosarcoma	IMPACT410			Male	H3F3C gain in normal , 1.50fc	211	80
P-0007642-T01-IM5	P-0007642	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male		887	50
P-0007643-T01-IM5	P-0007643	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		778	70
P-0007644-T01-IM5	P-0007644	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Maxilla	Sarcoma, NOS	IMPACT410			Female		971	80
P-0007645-T01-IM5	P-0007645	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Colon	Stomach Adenocarcinoma	IMPACT410			Male		378	50
P-0007646-T01-IM5	P-0007646	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		850	80
P-0007647-T01-IM5	P-0007647	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		875	NA
P-0007648-T01-IM5	P-0007648	Small Bowel Cancer	Metastasis	Tumor	Liver	Duodenum	Small Bowel Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses  on Chromosome 9 and Chromosome arms 17p and 18q.	944	70
P-0007649-T01-IM5	P-0007649	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p and 22q including SMARCB1.	840	90
P-0007650-T01-IM5	P-0007650	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Female	(Tumor content okay - slide reviewed.)	324	70
P-0007651-T01-IM5	P-0007651	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Abdomen	Leiomyosarcoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 86X, negative results should be interpreted with caution.	86	60
P-0007652-T01-IM5	P-0007652	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Oncocytoma	IMPACT410			Male	(Reviewed slide - tumor present)	569	70
P-0007653-T01-IM5	P-0007653	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	718	10
P-0007654-T01-IM5	P-0007654	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 13q.	833	55
P-0007655-T01-IM5	P-0007655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	517	25
P-0007656-T01-IM5	P-0007656	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		735	30
P-0007657-T01-IM5	P-0007657	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		709	60
P-0007658-T01-IM5	P-0007658	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1063	80
P-0007660-T01-IM5	P-0007660	Osteosarcoma	Metastasis	Tumor	Lung	Soft Tissue	Osteosarcoma	IMPACT410			Male		962	70
P-0007661-T01-IM5	P-0007661	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1184	60
P-0007662-T01-IM5	P-0007662	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 18q.	898	80
P-0007663-T01-IM5	P-0007663	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p including TERT.	646	20
P-0007664-T01-IM5	P-0007664	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		1089	NA
P-0007665-T01-IM5	P-0007665	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.    Note: Low sequencing depth of coverage of 118X, negative results should be interpreted with caution.	118	30
P-0007666-T01-IM5	P-0007666	Thyroid Cancer	Metastasis	Tumor	Pleura	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female		1021	35
P-0007667-T01-IM5	P-0007667	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Larynx	Angiosarcoma	IMPACT410			Male		774	30
P-0007668-T01-IM5	P-0007668	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		1069	80
P-0007669-T01-IM5	P-0007669	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	FH structural variants	1505	NA
P-0007670-T01-IM5	P-0007670	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		560	30
P-0007671-T01-IM5	P-0007671	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1011	15
P-0007672-T01-IM5	P-0007672	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Male		320	90
P-0007673-T01-IM5	P-0007673	Appendiceal Cancer	Metastasis	Tumor	Sigmoid colon	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1035	10
P-0007674-T01-IM5	P-0007674	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Tubular Stomach Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	689	10
P-0007675-T01-IM5	P-0007675	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		619	50
P-0007676-T01-IM5	P-0007676	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	533	10
P-0007677-T01-IM5	P-0007677	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Carcinoid	IMPACT410			Male		246	80
P-0007678-T01-IM5	P-0007678	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		684	40
P-0007679-T01-IM5	P-0007679	Gastrointestinal Neuroendocrine Tumor	Metastasis	Tumor	Liver	Sigmoid Colon	Gastrointestinal Neuroendocrine Tumors	IMPACT410			Male		710	30
P-0007680-T01-IM5	P-0007680	Endometrial Cancer	Metastasis	Tumor	Soft Tissue	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		927	NA
P-0007681-T01-IM5	P-0007681	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1003	NA
P-0007682-T01-IM5	P-0007682	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		811	80
P-0007683-T01-IM5	P-0007683	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q and 20q.	789	50
P-0007684-T01-IM5	P-0007684	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Male		520	40
P-0007685-T01-IM5	P-0007685	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		551	60
P-0007685-T02-IM5	P-0007685	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1115	60
P-0007686-T01-IM5	P-0007686	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	848	60
P-0007687-T01-IM5	P-0007687	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	826	10
P-0007688-T01-IM5	P-0007688	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		722	40
P-0007689-T01-IM5	P-0007689	Cancer of Unknown Primary	Metastasis	Tumor	Not Applicable	Eyelid	Cancer of Unknown Primary	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p.	731	70
P-0007691-T01-IM5	P-0007691	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		533	20
P-0007692-T01-IM5	P-0007692	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Leg	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 18 Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 20q12-20q13	602	80
P-0007693-T01-IM5	P-0007693	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		673	80
P-0007694-T01-IM5	P-0007694	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	686	NA
P-0007695-T01-IM5	P-0007695	Cancer of Unknown Primary	Metastasis	Tumor	Spine	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	750	20
P-0007696-T01-IM5	P-0007696	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male	Note: High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage.	214	25
P-0007697-T01-IM5	P-0007697	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1024	90
P-0007698-T01-IM5	P-0007698	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		863	80
P-0007699-T01-IM5	P-0007699	Salivary Carcinoma	Primary	Tumor	Not Applicable	Parotid	Salivary Duct Carcinoma	IMPACT410			Male		653	25
P-0007699-T02-IM5	P-0007699	Salivary Carcinoma	Metastasis	Tumor	Liver	Parotid	Salivary Adenocarcinoma	IMPACT410			Male		470	70
P-0007700-T01-IM5	P-0007700	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Male		878	60
P-0007701-T01-IM5	P-0007701	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	896	NA
P-0007702-T01-IM5	P-0007702	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		1031	90
P-0007703-T01-IM5	P-0007703	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Cholangiocarcinoma	IMPACT410			Male		801	60
P-0007705-T01-IM5	P-0007705	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7p including EGFR.	886	20
P-0007734-T01-IM5	P-0007734	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		131	80
P-0007735-T01-IM5	P-0007735	Soft Tissue Sarcoma	Metastasis	Tumor	Soft Tissue	Leg	Pleomorphic Liposarcoma	IMPACT410			Male		956	NA
P-0007736-T01-IM5	P-0007736	Melanoma	Metastasis	Tumor	Brain	Skin	Cutaneous Melanoma	IMPACT410			Female		795	90
P-0007737-T01-IM5	P-0007737	Small Bowel Cancer	Metastasis	Tumor	Liver	Duodenum	Small Bowel Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17p.	846	NA
P-0007738-T01-IM5	P-0007738	Ovarian Cancer	Metastasis	Tumor	Muscle	Uterus	Low-Grade Serous Ovarian Cancer	IMPACT410			Female		895	NA
P-0007739-T01-IM5	P-0007739	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		893	NA
P-0007740-T01-IM5	P-0007740	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		951	NA
P-0007741-T01-IM5	P-0007741	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		699	50
P-0007742-T01-IM5	P-0007742	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	626	50
P-0007743-T01-IM5	P-0007743	Chondrosarcoma	Metastasis	Tumor	Larynx	Cricoid Cartilage	Chondrosarcoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 114x, negative results should be interpreted with caution.  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	114	NA
P-0007744-T01-IM5	P-0007744	Glioma	Primary	Tumor	Not Applicable	Brain	Pleomorphic Xanthoastrocytoma	IMPACT410			Male		600	80
P-0007745-T01-IM5	P-0007745	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		765	NA
P-0007746-T01-IM5	P-0007746	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	921	30
P-0007747-T01-IM5	P-0007747	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		365	80
P-0007748-T01-IM5	P-0007748	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		337	20
P-0007749-T01-IM5	P-0007749	Prostate Cancer	Metastasis	Tumor	Omentum	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		884	40
P-0007750-T01-IM5	P-0007750	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		511	80
P-0007751-T01-IM5	P-0007751	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		715	90
P-0007752-T01-IM5	P-0007752	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1095	90
P-0007753-T01-IM5	P-0007753	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		438	10
P-0007754-T01-IM5	P-0007754	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		298	10
P-0007755-T01-IM5	P-0007755	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		970	40
P-0007756-T01-IM5	P-0007756	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		839	70
P-0007758-T01-IM5	P-0007758	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		801	70
P-0007759-T01-IM5	P-0007759	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1154	20
P-0007770-T01-IM5	P-0007770	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1170	60
P-0007771-T01-IM5	P-0007771	Colorectal Cancer	Metastasis	Tumor	Adrenal	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 13q and 20q.	646	80
P-0007772-T01-IM5	P-0007772	Salivary Carcinoma	Metastasis	Tumor	Neck	Thyroid	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	IMPACT410			Male		696	80
P-0007772-T02-IM5	P-0007772	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		426	80
P-0007772-T03-IM5	P-0007772	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		235	80
P-0007773-T01-IM5	P-0007773	Hepatocellular Carcinoma	Metastasis	Tumor	Spine	Liver	Hepatocellular Carcinoma	IMPACT410			Male		651	70
P-0007774-T01-IM5	P-0007774	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		912	50
P-0007775-T01-IM5	P-0007775	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		297	10
P-0007776-T01-IM5	P-0007776	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1167	60
P-0007777-T01-IM5	P-0007777	Salivary Carcinoma	Primary	Tumor	Not Applicable	Trachea	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3q13, 3q21-3q23, 5q22-5q32	1000	60
P-0007778-T01-IM5	P-0007778	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	388	30
P-0007779-T01-IM5	P-0007779	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1201	30
P-0007780-T01-IM5	P-0007780	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		897	80
P-0007781-T01-IM5	P-0007781	Colorectal Cancer	Metastasis	Tumor	Lung	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		341	70
P-0007782-T01-IM5	P-0007782	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		797	70
P-0007783-T01-IM5	P-0007783	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Thigh	Synovial Sarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	900	40
P-0007784-T01-IM5	P-0007784	Biliary Cancer	Metastasis	Tumor	Peritoneum	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		911	50
P-0007785-T01-IM5	P-0007785	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Spine	Sarcoma, NOS	IMPACT410			Female		422	80
P-0007786-T01-IM5	P-0007786	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	639	40
P-0007787-T01-IM5	P-0007787	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		738	40
P-0007788-T01-IM5	P-0007788	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female		302	60
P-0007788-T02-IM5	P-0007788	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		794	NA
P-0007789-T01-IM5	P-0007789	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Skin	Embryonal Rhabdomyosarcoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	171	70
P-0007790-T01-IM5	P-0007790	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		886	50
P-0007791-T01-IM5	P-0007791	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	717	30
P-0007792-T01-IM5	P-0007792	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18.	347	90
P-0007793-T01-IM5	P-0007793	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		786	70
P-0007794-T01-IM5	P-0007794	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		865	80
P-0007804-T01-IM5	P-0007804	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		910	25
P-0007805-T01-IM5	P-0007805	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		937	85
P-0007806-T01-IM5	P-0007806	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female	CBL germline gain (1.43 in normal,1.21 in tumor)	951	70
P-0007807-T01-IM5	P-0007807	Embryonal Tumor	Primary	Tumor	Not Applicable	Retroperitoneum	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	976	70
P-0007808-T01-IM5	P-0007808	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		922	NA
P-0007809-T01-IM5	P-0007809	Colorectal Cancer	Metastasis	Tumor	Brain	Colon	Colon Adenocarcinoma	IMPACT410			Male		770	60
P-0007810-T02-IM5	P-0007810	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	836	10
P-0007811-T01-IM5	P-0007811	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Retroperitoneum	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1044	70
P-0007813-T01-IM5	P-0007813	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		946	60
P-0007814-T01-IM5	P-0007814	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14q and 6q.	639	70
P-0007815-T01-IM5	P-0007815	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Pancreas	Rhabdomyosarcoma	IMPACT410			Male		800	55
P-0007816-T01-IM5	P-0007816	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		794	60
P-0007821-T02-IM5	P-0007821	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood and saliva samples and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood and saliva samples.	1129	NA
P-0007831-T01-IM5	P-0007831	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		497	40
P-0007832-T01-IM5	P-0007832	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		657	15
P-0007833-T01-IM5	P-0007833	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		924	90
P-0007834-T01-IM5	P-0007834	Renal Cell Carcinoma	Metastasis	Tumor	Pleura	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		840	80
P-0007835-T01-IM5	P-0007835	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		791	80
P-0007836-T01-IM5	P-0007836	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		814	40
P-0007837-T01-IM5	P-0007837	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	212	60
P-0007838-T01-IM5	P-0007838	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		901	40
P-0007839-T01-IM5	P-0007839	Head and Neck Carcinoma	Metastasis	Tumor	Periaortic Mass	Tonsil	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male		867	20
P-0007840-T01-IM5	P-0007840	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	995	10
P-0007841-T01-IM5	P-0007841	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		1073	90
P-0007842-T01-IM5	P-0007842	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		669	80
P-0007843-T01-IM5	P-0007843	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		605	55
P-0007844-T01-IM5	P-0007844	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13p.	618	50
P-0007845-T01-IM5	P-0007845	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male		840	50
P-0007846-T01-IM5	P-0007846	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	851	50
P-0007847-T01-IM5	P-0007847	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		900	NA
P-0007848-T01-IM5	P-0007848	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		654	60
P-0007849-T01-IM5	P-0007849	Salivary Carcinoma	Metastasis	Tumor	Lung	Submandibular Gland	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1850	60
P-0007850-T01-IM5	P-0007850	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		932	70
P-0007851-T01-IM5	P-0007851	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Male		775	60
P-0007852-T01-IM5	P-0007852	Melanoma	Metastasis	Tumor	Lymph node	Oral Cavity	Head and Neck Mucosal Melanoma	IMPACT410			Male	add back CDH12 and TERT SVs	608	50
P-0007852-T02-IM5	P-0007852	Melanoma	Metastasis	Tumor	Liver	Oral Cavity	Head and Neck Mucosal Melanoma	IMPACT410			Male	running unmatched	1022	70
P-0007853-T01-IM5	P-0007853	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	880	15
P-0007854-T01-IM5	P-0007854	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		397	45
P-0007855-T01-IM5	P-0007855	Ovarian Cancer	Metastasis	Tumor	Lymph Node	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		672	65
P-0007856-T01-IM5	P-0007856	Prostate Cancer	Metastasis	Tumor	Pelvic Nodule	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		724	30
P-0007857-T01-IM5	P-0007857	Salivary Carcinoma	Metastasis	Tumor	Lung	Tonsil	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes	848	50
P-0007858-T01-IM5	P-0007858	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood and saliva samples and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood and saliva samples	956	80
P-0007859-T01-IM5	P-0007859	Renal Cell Carcinoma	Metastasis	Tumor	Tibia	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		692	85
P-0007860-T01-IM5	P-0007860	Colorectal Cancer	Metastasis	Tumor	Liver	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	921	NA
P-0007861-T01-IM5	P-0007861	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		712	75
P-0007862-T01-IM5	P-0007862	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Skin	Peripheral T-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood and saliva samples and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood and saliva samples.	855	NA
P-0007863-T01-IM5	P-0007863	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		326	50
P-0007864-T01-IM5	P-0007864	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		846	60
P-0007865-T01-IM5	P-0007865	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		805	5
P-0007866-T01-IM5	P-0007866	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	752	65
P-0007867-T01-IM5	P-0007867	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	806	NA
P-0007868-T01-IM5	P-0007868	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	527	NA
P-0007869-T01-IM5	P-0007869	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	622	NA
P-0007870-T01-IM5	P-0007870	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		685	NA
P-0007871-T01-IM5	P-0007871	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Adnexa	Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	529	NA
P-0007872-T01-IM5	P-0007872	Endometrial Cancer	Metastasis	Tumor	Lymph node	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		794	20
P-0007873-T01-IM5	P-0007873	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	622	50
P-0007874-T01-IM5	P-0007874	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		619	50
P-0007875-T01-IM5	P-0007875	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		861	50
P-0007876-T01-IM5	P-0007876	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	591	70
P-0007877-T01-IM5	P-0007877	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	617	30
P-0007879-T01-IM5	P-0007879	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Female		827	NA
P-0007880-T01-IM5	P-0007880	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1264	40
P-0007881-T01-IM5	P-0007881	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	415	30
P-0007882-T01-IM5	P-0007882	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		991	65
P-0007883-T01-IM5	P-0007883	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female		1036	NA
P-0007884-T01-IM5	P-0007884	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated. However, Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	559	70
P-0007885-T01-IM5	P-0007885	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Sinus	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		975	NA
P-0007887-T01-IM5	P-0007887	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		589	40
P-0007888-T01-IM5	P-0007888	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		617	70
P-0007889-T01-IM5	P-0007889	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	614	70
P-0007890-T01-IM5	P-0007890	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Pleura	Soft Tissue	Gastrointestinal Stromal Tumor	IMPACT410			Male		897	85
P-0007891-T01-IM5	P-0007891	Uterine Sarcoma	Primary	Tumor	Not Applicable	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		536	85
P-0007892-T01-IM5	P-0007892	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1417	NA
P-0007893-T01-IM5	P-0007893	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male		1060	20
P-0007894-T01-IM5	P-0007894	Pancreatic Cancer	Primary	Tumor	Not Applicable	Liver	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Female		563	60
P-0007895-T01-IM5	P-0007895	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		791	70
P-0007896-T01-IM5	P-0007896	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		824	NA
P-0007897-T01-IM5	P-0007897	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 16p13 and 16q22-24.	718	80
P-0007898-T01-IM5	P-0007898	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		941	NA
P-0007899-T01-IM5	P-0007899	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Clear Cell Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	744	60
P-0007900-T01-IM5	P-0007900	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Neuroendocrine Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	844	70
P-0007901-T01-IM5	P-0007901	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		867	NA
P-0007902-T01-IM5	P-0007902	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and 16p.	915	20
P-0007903-T01-IM5	P-0007903	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		935	50
P-0007904-T01-IM5	P-0007904	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of an intragenic copy number gain of KDM6A exons 19-27.	902	30
P-0007905-T01-IM5	P-0007905	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		355	40
P-0007906-T01-IM5	P-0007906	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		598	30
P-0007907-T01-IM5	P-0007907	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Female		862	70
P-0007908-T01-IM5	P-0007908	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Small Intestine	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male		1044	80
P-0007909-T01-IM5	P-0007909	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Male		236	70
P-0007910-T01-IM5	P-0007910	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Pelvic Nodule	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		810	90
P-0007911-T01-IM5	P-0007911	Cancer of Unknown Primary	Metastasis	Tumor	Skin	Neck	Cancer of Unknown Primary	IMPACT410			Female		1337	NA
P-0007911-T02-IM5	P-0007911	Thyroid Cancer	Metastasis	Tumor	Skin	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Female		587	40
P-0007912-T01-IM5	P-0007912	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Female		494	50
P-0007913-T01-IM5	P-0007913	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	449	70
P-0007914-T01-IM5	P-0007914	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female		152	80
P-0007915-T01-IM5	P-0007915	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Myxopapillary Ependymoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 21q and 18q and chromosome 9.	668	75
P-0007916-T01-IM5	P-0007916	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	699	NA
P-0007917-T01-IM5	P-0007917	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1153	80
P-0007917-T02-IM5	P-0007917	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Subclonal (PTEN)?	1115	90
P-0007918-T01-IM5	P-0007918	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	972	NA
P-0007919-T01-IM5	P-0007919	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	wait for clinicians response  this patient passed away and should NOT be signed out but we will need to generate the report.	1012	50
P-0007920-T01-IM5	P-0007920	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		638	40
P-0007921-T01-IM5	P-0007921	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Poorly Differentiated Non-Small Cell Lung Cancer	IMPACT410			Male		562	40
P-0007922-T01-IM5	P-0007922	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Cervical Adenosquamous Carcinoma	IMPACT410			Female		741	90
P-0007923-T01-IM5	P-0007923	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		668	50
P-0007924-T01-IM5	P-0007924	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q27-3q28.	829	70
P-0007925-T01-IM5	P-0007925	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Skin	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		611	60
P-0007926-T01-IM5	P-0007926	Breast Carcinoma	Metastasis	Tumor	Sacral Mass	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		681	NA
P-0007927-T01-IM5	P-0007927	Melanoma	Primary	Tumor	Not Applicable	Skin	Acral Melanoma	IMPACT410			Male		633	30
P-0007929-T01-IM5	P-0007929	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		724	40
P-0007930-T01-IM5	P-0007930	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	301	30
P-0007931-T01-IM5	P-0007931	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		281	90
P-0007932-T01-IM5	P-0007932	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 2 and chromosome arm 10q.	1353	70
P-0007965-T01-IM5	P-0007965	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	703	30
P-0007966-T01-IM5	P-0007966	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 11q-22-24 and 9q.	851	80
P-0007967-T01-IM5	P-0007967	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Rectum	Gastrointestinal Stromal Tumor	IMPACT410			Female		1064	90
P-0007968-T01-IM5	P-0007968	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		468	80
P-0007969-T01-IM5	P-0007969	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	651	60
P-0007970-T01-IM5	P-0007970	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	806	60
P-0007971-T01-IM5	P-0007971	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Neck	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3q21-28.	867	60
P-0007972-T01-IM5	P-0007972	Pancreatic Cancer	Metastasis	Tumor	Ovary	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		776	65
P-0007973-T01-IM5	P-0007973	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	720	60
P-0007974-T01-IM5	P-0007974	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Submandibular Gland	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Minor contamination (1.3%) - Call above 10% VF	945	70
P-0007975-T01-IM5	P-0007975	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	941	25
P-0007976-T01-IM5	P-0007976	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	omentum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 14q, 15q and 22q.	974	NA
P-0007977-T01-IM5	P-0007977	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		420	10
P-0007978-T01-IM5	P-0007978	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		707	10
P-0007979-T01-IM5	P-0007979	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	700	10
P-0007980-T01-IM5	P-0007980	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Male		793	80
P-0007981-T01-IM5	P-0007981	Renal Cell Carcinoma	Metastasis	Tumor	Liver	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		948	30
P-0007982-T01-IM5	P-0007982	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.	1067	80
P-0007983-T01-IM5	P-0007983	Soft Tissue Sarcoma	Primary	Tumor	Lung	Soft Tissue	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male		566	10
P-0007984-T01-IM5	P-0007984	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 16p.     Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q and 16q.	1072	75
P-0007985-T01-IM5	P-0007985	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p, 6q23-6q26, 13q, 14q, 15q, 18q, and 22q.	569	85
P-0007986-T01-IM5	P-0007986	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female		862	15
P-0007987-T01-IM5	P-0007987	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		801	60
P-0007988-T01-IM5	P-0007988	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		415	75
P-0007989-T01-IM5	P-0007989	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p36, 5q13-5q22,  and 10q including PTEN.	830	75
P-0007990-T01-IM5	P-0007990	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q and 13q.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	914	75
P-0007991-T01-IM5	P-0007991	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 including PTEN.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7q including BRAF.	678	50
P-0007992-T01-IM5	P-0007992	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Teratoma	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).   Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q14-11q24.	843	85
P-0007993-T01-IM5	P-0007993	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	922	75
P-0007994-T01-IM5	P-0007994	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		973	30
P-0007995-T01-IM5	P-0007995	Esophagogastric Carcinoma	Metastasis	Tumor	Lymph node	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Female		896	45
P-0007996-T01-IM5	P-0007996	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 113X, negative results should be interpreted with caution.	113	30
P-0007997-T01-IM5	P-0007997	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		600	40
P-0007998-T01-IM5	P-0007998	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 13q.	792	30
P-0007999-T01-IM5	P-0007999	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		868	30
P-0008000-T01-IM5	P-0008000	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Male		707	20
P-0008001-T01-IM5	P-0008001	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male	Note: i(12p) gain cannot be verified from the data. Alternate testing is suggested, if clinically indicated.	909	85
P-0008002-T01-IM5	P-0008002	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		823	80
P-0008003-T01-IM5	P-0008003	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q22-24.	814	30
P-0008004-T01-IM5	P-0008004	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	911	10
P-0008005-T01-IM5	P-0008005	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		824	60
P-0008006-T01-IM5	P-0008006	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		723	30
P-0008007-T01-IM5	P-0008007	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		625	50
P-0008008-T01-IM5	P-0008008	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	511	20
P-0008009-T01-IM5	P-0008009	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	747	50
P-0008010-T01-IM5	P-0008010	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	678	10
P-0008011-T01-IM5	P-0008011	Endometrial Cancer	Metastasis	Tumor	Lymph node	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	655	40
P-0008012-T01-IM5	P-0008012	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Skin	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		579	15
P-0008013-T01-IM5	P-0008013	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		772	80
P-0008014-T01-IM5	P-0008014	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		653	60
P-0008015-T01-IM5	P-0008015	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Ileum	Neuroendocrine Carcinoma, NOS	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q and 18q.	812	80
P-0008016-T01-IM5	P-0008016	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	693	75
P-0008017-T01-IM5	P-0008017	Germ Cell Tumor	Metastasis	Tumor	Retroperitoneum	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		619	20
P-0008018-T01-IM5	P-0008018	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3.	690	70
P-0008019-T01-IM5	P-0008019	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	670	75
P-0008021-T01-IM5	P-0008021	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1181	10
P-0008022-T02-IM5	P-0008022	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	730	60
P-0008023-T01-IM5	P-0008023	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		597	40
P-0008025-T01-IM5	P-0008025	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Cholangiocarcinoma	IMPACT410			Male		501	35
P-0008027-T01-IM5	P-0008027	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		405	25
P-0008028-T01-IM5	P-0008028	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 127X, negative results should be interpreted with caution.    Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	127	20
P-0008029-T01-IM5	P-0008029	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	630	75
P-0008030-T01-IM5	P-0008030	Ewing Sarcoma	Primary	Tumor	Not Applicable	Leg	Ewing Sarcoma	IMPACT410			Female		552	30
P-0008031-T01-IM5	P-0008031	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	799	30
P-0008032-T01-IM5	P-0008032	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Male		569	85
P-0008033-T01-IM5	P-0008033	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		760	80
P-0008034-T01-IM5	P-0008034	Ampullary Carcinoma	Primary	Tumor	Not Applicable	Duodenum	Ampullary Carcinoma	IMPACT410			Male		557	35
P-0008035-T01-IM5	P-0008035	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male	Note: Low sequencing depth of coverage of 56X, negative results should be interpreted with caution.	56	50
P-0008036-T01-IM5	P-0008036	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Hypopharynx	Hypopharynx Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 3q26-3q28 and 15q26.	768	65
P-0008037-T01-IM5	P-0008037	Ovarian Cancer	Metastasis	Tumor	Liver	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		482	40
P-0008038-T01-IM5	P-0008038	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Female		881	50
P-0008039-T01-IM5	P-0008039	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		677	20
P-0008040-T01-IM5	P-0008040	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	862	20
P-0008041-T01-IM5	P-0008041	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.       Note: Low sequencing depth of coverage of 134X, negative results should be interpreted with caution.	134	10
P-0008042-T01-IM5	P-0008042	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		823	25
P-0008043-T01-IM5	P-0008043	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		705	30
P-0008044-T01-IM5	P-0008044	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	676	25
P-0008045-T01-IM5	P-0008045	Salivary Carcinoma	Primary	Tumor	Not Applicable	Ear Canal	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.     Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes.	298	70
P-0008046-T01-IM5	P-0008046	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		996	45
P-0008047-T01-IM5	P-0008047	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	680	70
P-0008048-T01-IM5	P-0008048	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	918	20
P-0008049-T01-IM5	P-0008049	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		842	35
P-0008050-T01-IM5	P-0008050	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		437	25
P-0008051-T01-IM5	P-0008051	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Rectum	Rhabdomyosarcoma	IMPACT410			Male		413	70
P-0008052-T01-IM5	P-0008052	Ovarian Cancer	Metastasis	Tumor	Colon	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		839	75
P-0008053-T01-IM5	P-0008053	Renal Cell Carcinoma	Metastasis	Tumor	Peritoneum	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	768	25
P-0008054-T01-IM5	P-0008054	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		833	25
P-0008055-T01-IM5	P-0008055	Histiocytosis	Primary	Tumor	Not Applicable	Testis	Histiocytosis	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.     Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	205	20
P-0008056-T01-IM5	P-0008056	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		105	10
P-0008057-T01-IM5	P-0008057	Prostate Cancer	Metastasis	Tumor	Skull	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		846	25
P-0008058-T01-IM5	P-0008058	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage.	1000	60
P-0008059-T01-IM5	P-0008059	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	215	70
P-0008060-T01-IM5	P-0008060	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q	682	90
P-0008061-T01-IM5	P-0008061	Renal Cell Carcinoma	Metastasis	Tumor	Brain	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		567	80
P-0008063-T01-IM5	P-0008063	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	605	10
P-0008064-T01-IM5	P-0008064	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Pharynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		735	40
P-0008065-T01-IM5	P-0008065	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	718	40
P-0008066-T01-IM5	P-0008066	Salivary Carcinoma	Metastasis	Tumor	Lung	Salivary Gland	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p, 11p, 13q, 16q, 17p, 19p, and 20p.  Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes	1108	90
P-0008067-T01-IM5	P-0008067	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	231	30
P-0008068-T01-IM5	P-0008068	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	1327	50
P-0008069-T01-IM5	P-0008069	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	895	15
P-0008071-T01-IM5	P-0008071	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Pelvis	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		998	80
P-0008072-T01-IM5	P-0008072	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male		751	70
P-0008073-T01-IM5	P-0008073	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Tonsil	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6q23-26 13q13-34 and 17q25.	910	70
P-0008074-T01-IM5	P-0008074	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	862	70
P-0008075-T01-IM5	P-0008075	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	614	70
P-0008076-T01-IM5	P-0008076	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Rectum	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	436	10
P-0008077-T01-IM5	P-0008077	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		243	40
P-0008077-T02-IM5	P-0008077	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		303	65
P-0008078-T01-IM5	P-0008078	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		967	60
P-0008079-T01-IM5	P-0008079	Colorectal Cancer	Metastasis	Tumor	Omentum	Colon	Colon Adenocarcinoma	IMPACT410			Male		707	40
P-0008080-T01-IM5	P-0008080	Melanoma	Metastasis	Tumor	Stomach	Skin	Cutaneous Melanoma	IMPACT410			Male		720	90
P-0008081-T01-IM5	P-0008081	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female		385	70
P-0008082-T01-IM5	P-0008082	Breast Carcinoma	Metastasis	Tumor	Trachea	Breast	Breast Carcinoma	IMPACT410			Female		217	60
P-0008083-T01-IM5	P-0008083	Colorectal Cancer	Metastasis	Tumor	Lymph node	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	369	35
P-0008084-T01-IM5	P-0008084	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Duodenum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 3p, 15q and 22q.	510	35
P-0008085-T01-IM5	P-0008085	Meningothelial Tumor	Primary	Tumor	Not Applicable	Brain	Meningioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.	640	80
P-0008094-T01-IM5	P-0008094	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	539	25
P-0008095-T01-IM5	P-0008095	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number change by alternate methods is suggested if clinically indicated.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q.	246	70
P-0008097-T01-IM5	P-0008097	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Hypopharynx Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	993	30
P-0008098-T01-IM5	P-0008098	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: The copy number profile is suggestive of an intragenic gain of MLL3 exons 1-42 and 47-59.	882	20
P-0008099-T01-IM5	P-0008099	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		929	20
P-0008100-T01-IM5	P-0008100	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Neck	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		939	70
P-0008101-T01-IM5	P-0008101	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		674	60
P-0008102-T01-IM5	P-0008102	Ewing Sarcoma	Metastasis	Tumor	Lung	Bone	Ewing Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1268	90
P-0008103-T01-IM5	P-0008103	Thyroid Cancer	Metastasis	Tumor	Mediastinum	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		1195	90
P-0008104-T01-IM5	P-0008104	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		768	30
P-0008105-T01-IM5	P-0008105	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Palate	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	745	40
P-0008106-T01-IM5	P-0008106	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bladder	Sarcoma, NOS	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1129	70
P-0008124-T01-IM5	P-0008124	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Mixed Mucinous Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	489	40
P-0008125-T01-IM5	P-0008125	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Bone	Sarcoma, NOS	IMPACT410			Male		1076	90
P-0008126-T01-IM5	P-0008126	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		1231	40
P-0008127-T01-IM5	P-0008127	Mesothelioma	Primary	Tumor	Not available	Peritoneum	Peritoneal Mesothelioma	IMPACT410			Female		764	30
P-0008128-T01-IM5	P-0008128	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q and 20q.	855	60
P-0008129-T01-IM5	P-0008129	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female		1112	90
P-0008130-T01-IM5	P-0008130	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Peripheral T-Cell Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 11q and 17p.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 9q.	1011	90
P-0008131-T01-IM5	P-0008131	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q11-12 and 13q.	1013	90
P-0008132-T01-IM5	P-0008132	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female	.	729	80
P-0008133-T01-IM5	P-0008133	Colorectal Cancer	Metastasis	Tumor	Brain	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	1016	70
P-0008134-T01-IM5	P-0008134	Non-Small Cell Lung Cancer	Metastasis	Tumor	pericardial Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		1185	70
P-0008136-T01-IM5	P-0008136	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	803	40
P-0008137-T01-IM5	P-0008137	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1269	60
P-0008138-T01-IM5	P-0008138	Melanoma	Metastasis	Tumor	Abdominal Wall	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 17q23-34.	1152	80
P-0008139-T01-IM5	P-0008139	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		256	10
P-0008140-T01-IM5	P-0008140	Pancreatic Cancer	Metastasis	Tumor	Lymph node	Pancreas	Acinar Cell Carcinoma of the Pancreas	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	843	60
P-0008141-T01-IM5	P-0008141	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		814	75
P-0008143-T01-IM5	P-0008143	Cervical Cancer	Metastasis	Tumor	Ovary	Cervix	Mucinous Carcinoma	IMPACT410			Female		794	80
P-0008144-T01-IM5	P-0008144	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Perineum	Marginal Zone Lymphoma	IMPACT410			Female		1163	40
P-0008145-T01-IM5	P-0008145	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		703	85
P-0008146-T01-IM5	P-0008146	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		680	50
P-0008147-T01-IM5	P-0008147	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	730	30
P-0008148-T01-IM5	P-0008148	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	835	20
P-0008149-T01-IM5	P-0008149	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Small Cell Bladder Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 13q22-34 and 14q.	675	80
P-0008150-T01-IM5	P-0008150	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Atypical Lung Carcinoid	IMPACT410			Female		992	85
P-0008151-T01-IM5	P-0008151	Salivary Carcinoma	Primary	Tumor	Not Applicable	Soft Palate	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes	868	90
P-0008152-T01-IM5	P-0008152	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	709	10
P-0008153-T01-IM5	P-0008153	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q	743	90
P-0008154-T01-IM5	P-0008154	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1012	20
P-0008155-T01-IM5	P-0008155	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1128	30
P-0008156-T01-IM5	P-0008156	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	perineum	Poorly Differentiated Carcinoma, NOS	IMPACT410			Female		1061	40
P-0008157-T01-IM5	P-0008157	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		645	60
P-0008158-T01-IM5	P-0008158	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	634	20
P-0008159-T01-IM5	P-0008159	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 140X, negative results should be interpreted with caution.	140	35
P-0008160-T01-IM5	P-0008160	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male		867	50
P-0008161-T01-IM5	P-0008161	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1182	20
P-0008161-T02-IM5	P-0008161	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Male		756	30
P-0008162-T01-IM5	P-0008162	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	603	35
P-0008162-T02-IM5	P-0008162	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	883	60
P-0008163-T01-IM5	P-0008163	Thyroid Cancer	Metastasis	Tumor	Neck	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		1087	30
P-0008164-T01-IM5	P-0008164	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		797	40
P-0008165-T01-IM5	P-0008165	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	543	20
P-0008166-T01-IM5	P-0008166	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		583	90
P-0008167-T01-IM5	P-0008167	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	451	50
P-0008168-T01-IM5	P-0008168	Bladder Cancer	Metastasis	Tumor	Lymph Node	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		1067	40
P-0008169-T01-IM5	P-0008169	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p, including KRAS.	416	50
P-0008171-T01-IM5	P-0008171	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	520	40
P-0008172-T01-IM5	P-0008172	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1088	10
P-0008173-T01-IM5	P-0008173	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	1015	50
P-0008174-T01-IM5	P-0008174	Cancer of Unknown Primary	Metastasis	Tumor	Pleura	Unknown	Cancer of Unknown Primary	IMPACT410			Female		1307	NA
P-0008175-T01-IM5	P-0008175	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		740	40
P-0008176-T01-IM5	P-0008176	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		698	NA
P-0008177-T01-IM5	P-0008177	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		714	90
P-0008178-T01-IM5	P-0008178	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		345	70
P-0008179-T01-IM5	P-0008179	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	1145	90
P-0008180-T01-IM5	P-0008180	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Male		836	50
P-0008181-T01-IM5	P-0008181	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	784	40
P-0008182-T01-IM5	P-0008182	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		952	65
P-0008184-T01-IM5	P-0008184	Small Bowel Cancer	Metastasis	Tumor	Peritoneum	Duodenum	Small Bowel Cancer	IMPACT410			Female		611	20
P-0008185-T01-IM5	P-0008185	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Nasopharynx	Nasopharyngeal Carcinoma	IMPACT410			Male		1095	90
P-0008186-T01-IM5	P-0008186	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Femoral Tendon	Glomangiosarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arm 1q and 9q.  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 1p ,14q,19q, 21q and 22q.	639	90
P-0008187-T01-IM5	P-0008187	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 13q12-13.	860	60
P-0008188-T01-IM5	P-0008188	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		370	30
P-0008189-T01-IM5	P-0008189	Glioma	Primary	Tumor	Not Applicable	Brain	Pleomorphic Xanthoastrocytoma	IMPACT410			Female		785	90
P-0008190-T01-IM5	P-0008190	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	868	10
P-0008191-T01-IM5	P-0008191	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17q including NF1.    Note: Low sequencing depth of coverage of 145X, negative results should be interpreted with caution.	145	90
P-0008192-T01-IM5	P-0008192	Mesothelioma	Metastasis	Tumor	Lung	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	998	40
P-0008204-T01-IM5	P-0008204	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	828	10
P-0008205-T01-IM5	P-0008205	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Kidney	Leiomyosarcoma	IMPACT410			Male		683	50
P-0008206-T01-IM5	P-0008206	Prostate Cancer	Metastasis	Tumor	Neck	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome..	1141	70
P-0008207-T01-IM5	P-0008207	Endometrial Cancer	Metastasis	Tumor	Diaphragm	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q14-23.	849	80
P-0008209-T01-IM5	P-0008209	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	B-Cell Lymphoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1154	10
P-0008210-T01-IM5	P-0008210	Salivary Carcinoma	Metastasis	Tumor	Skull	Minor Salivary Gland	Salivary Carcinoma, Other	IMPACT410			Male		158	50
P-0008211-T01-IM5	P-0008211	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	552	20
P-0008212-T01-IM5	P-0008212	Anal Cancer	Primary	Tumor	Not Applicable	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female		847	70
P-0008213-T02-IM5	P-0008213	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		521	70
P-0008214-T01-IM5	P-0008214	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		676	60
P-0008215-T01-IM5	P-0008215	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		778	70
P-0008224-T01-IM5	P-0008224	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		424	20
P-0008225-T01-IM5	P-0008225	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male		670	80
P-0008227-T01-IM5	P-0008227	Salivary Carcinoma	Metastasis	Tumor	Lung	Submandibular Gland	Adenoid Cystic Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 5q11 and 6q23.    Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes	822	70
P-0008228-T01-IM5	P-0008228	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	565	70
P-0008229-T01-IM5	P-0008229	Head and Neck Carcinoma	Metastasis	Tumor	Femur	Larynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		764	25
P-0008230-T01-IM5	P-0008230	Chondrosarcoma	Metastasis	Tumor	Lung	Spine	Chondrosarcoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	347	45
P-0008231-T01-IM5	P-0008231	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Yolk Sac Tumor	IMPACT410			Male		1059	70
P-0008232-T01-IM5	P-0008232	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	373	60
P-0008234-T01-IM5	P-0008234	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		555	15
P-0008235-T01-IM5	P-0008235	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		788	35
P-0008236-T01-IM5	P-0008236	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		958	30
P-0008237-T01-IM5	P-0008237	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female		170	60
P-0008238-T01-IM5	P-0008238	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	625	10
P-0008239-T01-IM5	P-0008239	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		465	30
P-0008240-T01-IM5	P-0008240	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		581	70
P-0008241-T01-IM5	P-0008241	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Leiomyosarcoma	IMPACT410			Male		854	40
P-0008242-T01-IM5	P-0008242	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 19q.	591	80
P-0008243-T01-IM5	P-0008243	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	655	10
P-0008244-T01-IM5	P-0008244	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses  on Chromosome arms 1p and 19q.	707	90
P-0008245-T01-IM5	P-0008245	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		722	65
P-0008246-T02-IM5	P-0008246	Melanoma	Metastasis	Tumor	Colon	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1101	80
P-0008247-T01-IM5	P-0008247	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		469	70
P-0008248-T01-IM5	P-0008248	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Trachea	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		778	70
P-0008249-T01-IM5	P-0008249	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		1028	70
P-0008257-T01-IM5	P-0008257	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 10q, including PTEN.	782	80
P-0008258-T01-IM5	P-0008258	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and Chromosome arms 22q and 9p.	1040	80
P-0008259-T01-IM5	P-0008259	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		926	20
P-0008260-T01-IM5	P-0008260	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	912	20
P-0008261-T01-IM5	P-0008261	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number amplification on Chromosome arms 17q22-24.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9p21-24.	837	90
P-0008262-T01-IM5	P-0008262	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10, including PTEN.	880	70
P-0008263-T01-IM5	P-0008263	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Colon	Sarcoma, NOS	IMPACT410			Female		997	60
P-0008264-T01-IM5	P-0008264	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Groin	Proximal-Type Epithelioid Sarcoma	IMPACT410			Female		669	50
P-0008265-T01-IM5	P-0008265	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Parotid Gland	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male		821	50
P-0008266-T01-IM5	P-0008266	Chondrosarcoma	Metastasis	Tumor	Pleura	Femur	Dedifferentiated Chondrosarcoma	IMPACT410			Female		448	65
P-0008267-T01-IM5	P-0008267	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		796	60
P-0008268-T01-IM5	P-0008268	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Female		967	60
P-0008269-T01-IM5	P-0008269	Uterine Sarcoma	Metastasis	Tumor	Lung	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female		795	70
P-0008270-T01-IM5	P-0008270	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	723	80
P-0008271-T01-IM5	P-0008271	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		613	50
P-0008282-T01-IM5	P-0008282	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		628	40
P-0008283-T01-IM5	P-0008283	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		518	40
P-0008285-T01-IM5	P-0008285	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	889	10
P-0008286-T01-IM5	P-0008286	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Female		702	60
P-0008287-T01-IM5	P-0008287	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		872	25
P-0008288-T01-IM5	P-0008288	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q	1240	70
P-0008289-T01-IM5	P-0008289	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1050	60
P-0008290-T01-IM5	P-0008290	Bladder Cancer	Metastasis	Tumor	Liver	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		937	80
P-0008291-T01-IM5	P-0008291	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1006	70
P-0008292-T01-IM5	P-0008292	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1002	NA
P-0008293-T01-IM5	P-0008293	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	263	10
P-0008294-T01-IM5	P-0008294	Prostate Cancer	Metastasis	Tumor	Femur	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	523	10
P-0008295-T01-IM5	P-0008295	Non-Small Cell Lung Cancer	Metastasis	Tumor	Spine	Lung	Lung Adenocarcinoma	IMPACT410			Male		1118	30
P-0008296-T01-IM5	P-0008296	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood, saliva and nail samples.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 16p13.	2075	70
P-0008297-T01-IM5	P-0008297	Non-Small Cell Lung Cancer	Metastasis	Tumor	Spleen	Lung	Lung Adenocarcinoma	IMPACT410			Male		844	50
P-0008299-T01-IM5	P-0008299	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Colon	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood and saliva samples.	805	90
P-0008299-T02-IM5	P-0008299	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		1387	80
P-0008300-T01-IM5	P-0008300	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		903	20
P-0008301-T01-IM5	P-0008301	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	916	10
P-0008302-T01-IM5	P-0008302	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		928	40
P-0008303-T01-IM5	P-0008303	Thyroid Cancer	Metastasis	Tumor	Brain	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Female		769	90
P-0008304-T01-IM5	P-0008304	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		615	60
P-0008305-T01-IM5	P-0008305	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male	Note: The copy number profile is suggestive of an intragenic gain of PTPRT exons 2-7.	982	60
P-0008306-T01-IM5	P-0008306	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1013	70
P-0008307-T01-IM5	P-0008307	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		577	20
P-0008308-T01-IM5	P-0008308	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		837	NA
P-0008309-T01-IM5	P-0008309	Germ Cell Tumor	Primary	Tumor	Not Applicable	Mediastinum	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	778	50
P-0008310-T01-IM5	P-0008310	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		840	NA
P-0008311-T01-IM5	P-0008311	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	301	30
P-0008312-T01-IM5	P-0008312	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Knee	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma	IMPACT410			Female		819	80
P-0008313-T01-IM5	P-0008313	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		783	80
P-0008314-T01-IM5	P-0008314	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Arm	Merkel Cell Carcinoma	IMPACT410			Male		857	60
P-0008315-T01-IM5	P-0008315	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q.	987	60
P-0008316-T01-IM5	P-0008316	Cervical Cancer	Metastasis	Tumor	Muscle	Cervix	Cervical Adenosquamous Carcinoma	IMPACT410			Female		204	35
P-0008317-T01-IM5	P-0008317	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		373	60
P-0008318-T01-IM5	P-0008318	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	734	20
P-0008319-T01-IM5	P-0008319	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Kidney Renal Clear Cell Papillary Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	829	60
P-0008320-T01-IM5	P-0008320	Ewing Sarcoma	Primary	Tumor	Not Applicable	Fibula	Ewing Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	596	40
P-0008321-T01-IM5	P-0008321	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 9p and 13q.	800	75
P-0008322-T01-IM5	P-0008322	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		788	30
P-0008323-T01-IM5	P-0008323	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Pancreas	Neuroendocrine Carcinoma, NOS	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 6p21-22.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm  8p and 16q.	789	90
P-0008324-T01-IM5	P-0008324	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		1033	40
P-0008325-T01-IM5	P-0008325	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Rhabdomyosarcoma	IMPACT410			Female		929	80
P-0008326-T01-IM5	P-0008326	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	478	20
P-0008327-T01-IM5	P-0008327	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	503	10
P-0008328-T01-IM5	P-0008328	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Tongue	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		869	30
P-0008329-T01-IM5	P-0008329	Soft Tissue Sarcoma	Metastasis	Tumor	Not Applicable	Soft Tissue	Myxoid/Round-Cell Liposarcoma	IMPACT410			Female		353	80
P-0008330-T01-IM5	P-0008330	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		961	60
P-0008330-T02-IM5	P-0008330	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 10% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	807	10
P-0008331-T01-IM5	P-0008331	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		473	40
P-0008332-T01-IM5	P-0008332	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		509	90
P-0008333-T01-IM5	P-0008333	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p/19q.	372	80
P-0008334-T01-IM5	P-0008334	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		918	10
P-0008335-T01-IM5	P-0008335	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		855	40
P-0008336-T01-IM5	P-0008336	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Urethral Urothelial Carcinoma	IMPACT410			Male		822	80
P-0008337-T01-IM5	P-0008337	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	612	70
P-0008338-T01-IM5	P-0008338	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1123	30
P-0008339-T01-IM5	P-0008339	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	505	10
P-0008340-T01-IM5	P-0008340	Renal Cell Carcinoma	Metastasis	Tumor	Colon	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		799	90
P-0008340-T02-IM5	P-0008340	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		875	90
P-0008341-T01-IM5	P-0008341	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female		801	NA
P-0008342-T01-IM5	P-0008342	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT410			Male		405	60
P-0008343-T01-IM5	P-0008343	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	332	40
P-0008344-T01-IM5	P-0008344	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1035	20
P-0008345-T01-IM5	P-0008345	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		964	80
P-0008346-T01-IM5	P-0008346	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		977	70
P-0008347-T01-IM5	P-0008347	Adrenocortical Carcinoma	Primary	Tumor	Not Applicable	Adrenal Gland	Adrenocortical Carcinoma	IMPACT410			Female		666	60
P-0008348-T01-IM5	P-0008348	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Relatively low tumor content (approximately 20% or less). Negative  copy number results should be interpreted with caution.	519	30
P-0008349-T01-IM5	P-0008349	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched nail and blood sample.  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	596	10
P-0008351-T01-IM5	P-0008351	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		632	40
P-0008352-T01-IM5	P-0008352	Ewing Sarcoma	Metastasis	Tumor	Skull	Bone	Ewing Sarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8q and loss 16q.	526	70
P-0008353-T01-IM5	P-0008353	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Tonsil	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		1027	40
P-0008354-T01-IM5	P-0008354	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Neuroendocrine Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p,13q,16q,17p and Xp.	839	80
P-0008355-T01-IM5	P-0008355	Ewing Sarcoma	Primary	Tumor	Not Applicable	Bone	Ewing Sarcoma	IMPACT410			Male		365	70
P-0008356-T01-IM5	P-0008356	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	464	20
P-0008357-T01-IM5	P-0008357	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		647	30
P-0008358-T01-IM5	P-0008358	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	788	20
P-0008359-T01-IM5	P-0008359	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		440	30
P-0008360-T01-IM5	P-0008360	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Male		945	30
P-0008369-T01-IM5	P-0008369	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		741	40
P-0008370-T01-IM5	P-0008370	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Undifferentiated Carcinoma of the Pancreas	IMPACT410			Female		876	50
P-0008370-T02-IM5	P-0008370	Cancer of Unknown Primary	Metastasis	Tumor	Lymph node	Pancreas	Adenocarcinoma, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p21, including CDKN2Ap16INK4A, CDKN2Ap14ARF, and CDKN2B.	737	50
P-0008371-T01-IM5	P-0008371	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		643	40
P-0008372-T01-IM5	P-0008372	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Solid Pseudopapillary Neoplasm of the Pancreas	IMPACT410			Female		822	80
P-0008373-T01-IM5	P-0008373	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		890	30
P-0008374-T01-IM5	P-0008374	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	556	10
P-0008375-T01-IM5	P-0008375	Melanoma	Metastasis	Tumor	Omentum	Anus	Anorectal Mucosal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3, 6q and 11q22-24..   .	811	70
P-0008376-T01-IM5	P-0008376	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Male		1076	50
P-0008377-T01-IM5	P-0008377	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		692	60
P-0008378-T01-IM5	P-0008378	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Large Cell Neuroendocrine Carcinoma	IMPACT410			Female		835	60
P-0008379-T01-IM5	P-0008379	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Foot	Epithelioid Hemangioendothelioma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover WWTR1 nor CAMTA1 genes    Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.Note: The MSK-IMPACT test panel does not cover FOSB or SERPINE1 genes.	457	10
P-0008380-T01-IM5	P-0008380	Glioma	Primary	Tumor	Not Applicable	Brain	Gliosarcoma	IMPACT410			Male		828	70
P-0008381-T01-IM5	P-0008381	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 11q12-13.	1191	80
P-0008382-T01-IM5	P-0008382	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 10q including PTEN and 4q13-35.      Note: Copy number profile is suggestive of broad copy number gain on Chromosome 9p24.	1006	80
P-0008383-T01-IM5	P-0008383	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	878	10
P-0008384-T01-IM5	P-0008384	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligoastrocytoma	IMPACT410			Male		336	80
P-0008385-T01-IM5	P-0008385	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Adenoid Cystic Breast Cancer	IMPACT410			Female		629	90
P-0008386-T01-IM5	P-0008386	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.       Note: Low sequencing depth of coverage of 142X, negative results should be interpreted with caution.	142	80
P-0008388-T01-IM5	P-0008388	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 4 and Chromosome arms 1p and 19q.	908	80
P-0008389-T01-IM5	P-0008389	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		1025	55
P-0008390-T01-IM5	P-0008390	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 15q and 16q.    Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p.	1331	70
P-0008391-T01-IM5	P-0008391	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 14.	1057	85
P-0008391-T02-IM5	P-0008391	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		1050	80
P-0008392-T01-IM5	P-0008392	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	895	35
P-0008393-T01-IM5	P-0008393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	463	50
P-0008394-T01-IM5	P-0008394	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		695	20
P-0008395-T01-IM5	P-0008395	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.     Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 7q21-22,31	872	80
P-0008396-T01-IM5	P-0008396	Colorectal Cancer	Metastasis	Tumor	Brain	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 12p, 13q, 20q     Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q.	916	40
P-0008397-T01-IM5	P-0008397	Embryonal Tumor	Primary	Tumor	Not Applicable	Brain	Medulloblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 17q and 21q	844	90
P-0008398-T01-IM5	P-0008398	Breast Carcinoma	Metastasis	Tumor	Ovary	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1125	80
P-0008399-T01-IM5	P-0008399	Renal Cell Carcinoma	Metastasis	Tumor	Lung	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		664	70
P-0008400-T01-IM5	P-0008400	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	810	40
P-0008402-T01-IM5	P-0008402	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms  1p, 19q.	804	70
P-0008403-T01-IM5	P-0008403	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	718	70
P-0008405-T01-IM5	P-0008405	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	394	20
P-0008406-T01-IM5	P-0008406	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		989	70
P-0008407-T01-IM5	P-0008407	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	963	20
P-0008408-T01-IM5	P-0008408	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patients matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.	1086	10
P-0008416-T01-IM5	P-0008416	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	757	60
P-0008417-T01-IM5	P-0008417	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	417	40
P-0008418-T01-IM5	P-0008418	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male		833	30
P-0008419-T01-IM5	P-0008419	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q.	849	50
P-0008420-T01-IM5	P-0008420	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1185	80
P-0008421-T01-IM5	P-0008421	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Follicular Dendritic Cell Sarcoma	IMPACT410			Male		880	80
P-0008422-T01-IM5	P-0008422	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1014	20
P-0008424-T01-IM5	P-0008424	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		845	30
P-0008425-T01-IM5	P-0008425	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	842	20
P-0008426-T01-IM5	P-0008426	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		527	10
P-0008427-T01-IM5	P-0008427	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female		1163	30
P-0008428-T01-IM5	P-0008428	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	952	20
P-0008429-T01-IM5	P-0008429	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		436	20
P-0008429-T02-IM5	P-0008429	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		1056	20
P-0008430-T01-IM5	P-0008430	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	181	10
P-0008431-T01-IM5	P-0008431	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	840	10
P-0008432-T01-IM5	P-0008432	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Female		867	60
P-0008433-T01-IM5	P-0008433	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		134	60
P-0008434-T01-IM5	P-0008434	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	891	60
P-0008435-T01-IM5	P-0008435	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 100X, negative results should be interpreted with caution.	100	10
P-0008436-T01-IM5	P-0008436	Pancreatic Cancer	Metastasis	Tumor	Lung	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		999	30
P-0008437-T01-IM5	P-0008437	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Liver	Neuroendocrine Tumor, NOS	IMPACT410			Female		825	60
P-0008438-T01-IM5	P-0008438	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		737	70
P-0008439-T01-IM5	P-0008439	Bladder Cancer	Metastasis	Tumor	Bone	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		384	10
P-0008440-T01-IM5	P-0008440	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		863	30
P-0008441-T01-IM5	P-0008441	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		960	70
P-0008442-T01-IM5	P-0008442	Non-Small Cell Lung Cancer	Primary	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13 and Chromosome arm 3p13-21.	501	30
P-0008443-T01-IM5	P-0008443	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		380	10
P-0008444-T01-IM5	P-0008444	Endometrial Cancer	Metastasis	Tumor	Lung	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		639	20
P-0008445-T01-IM5	P-0008445	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		321	40
P-0008446-T01-IM5	P-0008446	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	581	10
P-0008447-T01-IM5	P-0008447	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Alveolar Soft Part Sarcoma	IMPACT410			Male		387	70
P-0008448-T01-IM5	P-0008448	Breast Carcinoma	Metastasis	Tumor	Bone	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 17p13, including TP53.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	630	20
P-0008449-T01-IM5	P-0008449	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		608	80
P-0008450-T01-IM5	P-0008450	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		522	50
P-0008451-T01-IM5	P-0008451	Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	350	10
P-0008452-T01-IM5	P-0008452	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		540	60
P-0008453-T01-IM5	P-0008453	Head and Neck Carcinoma	Metastasis	Tumor	Lymph node	Oral Cavity	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Female		556	20
P-0008456-T01-IM5	P-0008456	Ovarian Cancer	Metastasis	Tumor	Diaphragm	Ovary	Mucinous Ovarian Cancer	IMPACT410			Female		661	30
P-0008457-T02-IM5	P-0008457	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		975	60
P-0008458-T02-IM5	P-0008458	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	442	30
P-0008459-T02-IM5	P-0008459	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.	906	60
P-0008460-T02-IM5	P-0008460	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched normal blood sample.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3q13-3q22.	908	80
P-0008461-T01-IM5	P-0008461	Prostate Cancer	Metastasis	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		716	40
P-0008462-T02-IM5	P-0008462	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Female		594	80
P-0008464-T02-IM5	P-0008464	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		614	30
P-0008465-T02-IM5	P-0008465	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1015	40
P-0008466-T01-IM5	P-0008466	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Merkel Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1p32 -1p36 and 17p.	840	25
P-0008467-T01-IM5	P-0008467	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		1142	40
P-0008468-T01-IM5	P-0008468	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Soft Tissue	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 13q,14q,15q and 22q.	986	90
P-0008469-T01-IM5	P-0008469	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	11q gains?	1343	30
P-0008470-T01-IM5	P-0008470	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		441	80
P-0008471-T01-IM5	P-0008471	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 17q21-17q24, and 20q13.	520	60
P-0008472-T01-IM5	P-0008472	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male		693	80
P-0008474-T01-IM5	P-0008474	Ovarian Cancer	Metastasis	Tumor	Soft Tissue	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		1034	70
P-0008475-T01-IM5	P-0008475	Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Classical Hodgkin Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patient's matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	969	NA
P-0008476-T01-IM5	P-0008476	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		943	20
P-0008477-T01-IM5	P-0008477	Anal Cancer	Metastasis	Tumor	Lung	Anus	Anal Squamous Cell Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome  arm 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p22-1p32, 3p21-24, 7q36, 11q13.5-11q23.1, and 16q	1055	20
P-0008478-T01-IM5	P-0008478	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		635	60
P-0008479-T01-IM5	P-0008479	Miscellaneous Brain Tumor	Primary	Tumor	Not Applicable	Brain	Hemangioblastoma	IMPACT410			Male		690	40
P-0008480-T01-IM5	P-0008480	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	508	60
P-0008481-T02-IM5	P-0008481	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	301	40
P-0008482-T01-IM5	P-0008482	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		871	20
P-0008483-T01-IM5	P-0008483	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Colon	Colon Adenocarcinoma	IMPACT410			Female		720	60
P-0008484-T02-IM5	P-0008484	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Hurthle Cell Thyroid Cancer	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	966	60
P-0008485-T01-IM5	P-0008485	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		628	40
P-0008486-T01-IM5	P-0008486	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 14q	630	90
P-0008487-T01-IM5	P-0008487	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		584	30
P-0008488-T02-IM5	P-0008488	Breast Carcinoma	Metastasis	Tumor	Soft Tissue	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		989	10
P-0008489-T01-IM5	P-0008489	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		763	20
P-0008490-T01-IM5	P-0008490	Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female		754	60
P-0008494-T01-IM5	P-0008494	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Gallbladder	Adenocarcinoma, NOS	IMPACT410			Male		886	60
P-0008514-T01-IM5	P-0008514	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		1119	60
P-0008515-T01-IM5	P-0008515	Embryonal Tumor	Metastasis	Tumor	Lung	Adrenal Gland	Neuroblastoma	IMPACT410			Female		1016	60
P-0008516-T01-IM5	P-0008516	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		620	40
P-0008517-T01-IM5	P-0008517	Chondrosarcoma	Metastasis	Tumor	Soft Tissue	Bone	Mesenchymal Chondrosarcoma	IMPACT410			Male		1004	80
P-0008518-T01-IM5	P-0008518	Head and Neck Carcinoma	Metastasis	Tumor	Brain	Tonsil	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p.  Note: Assessment of the copy number profile is limited by increased background noise.  False negative results cannot be ruled out.	708	70
P-0008519-T01-IM5	P-0008519	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1117	10
P-0008520-T01-IM5	P-0008520	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT gene.	757	80
P-0008521-T01-IM5	P-0008521	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		895	30
P-0008522-T01-IM5	P-0008522	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		784	60
P-0008523-T01-IM5	P-0008523	Soft Tissue Sarcoma	Metastasis	Tumor	Soft Tissue	Liver	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 7q.	920	60
P-0008524-T01-IM5	P-0008524	Melanoma	Primary	Tumor	Not Applicable	Vulva	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		959	40
P-0008525-T01-IM5	P-0008525	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1014	20
P-0008526-T01-IM5	P-0008526	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Male		878	60
P-0008527-T01-IM5	P-0008527	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		998	30
P-0008528-T01-IM5	P-0008528	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Tongue	Oropharynx Squamous Cell Carcinoma	IMPACT410			Male		1061	60
P-0008529-T01-IM5	P-0008529	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	855	10
P-0008530-T01-IM5	P-0008530	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male		860	20
P-0008533-T01-IM5	P-0008533	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Merkel Cell Carcinoma	IMPACT410			Female		913	60
P-0008534-T01-IM5	P-0008534	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	993	20
P-0008535-T01-IM5	P-0008535	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		951	30
P-0008537-T01-IM5	P-0008537	Renal Cell Carcinoma	Metastasis	Tumor	Lymph node	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	915	10
P-0008538-T01-IM5	P-0008538	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		612	10
P-0008539-T01-IM5	P-0008539	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Female		860	60
P-0008540-T01-IM5	P-0008540	Colorectal Cancer	Metastasis	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		440	20
P-0008541-T01-IM5	P-0008541	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		858	60
P-0008542-T01-IM5	P-0008542	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1108	10
P-0008543-T01-IM5	P-0008543	Soft Tissue Sarcoma	Metastasis	Tumor	Maxillary Sinus	Neck	Alveolar Rhabdomyosarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q.	1030	60
P-0008545-T01-IM5	P-0008545	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched normal  blood sample.	1184	20
P-0008546-T01-IM5	P-0008546	Sex Cord Stromal Tumor	Metastasis	Tumor	Pelvis	Ovary	Granulosa Cell Tumor	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 21q and 22q.	882	60
P-0008547-T01-IM5	P-0008547	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7.	503	80
P-0008548-T01-IM5	P-0008548	Gastrointestinal Stromal Tumor	Primary	Tumor	Not available	Small Bowel	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms  1p, 10q, 11q, 13q, 14q, 15q and 22q.	1050	80
P-0008549-T02-IM5	P-0008549	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		916	10
P-0008551-T01-IM5	P-0008551	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q11-20q12.	793	30
P-0008552-T01-IM5	P-0008552	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Gallbladder	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		772	80
P-0008552-T02-IM5	P-0008552	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	246	80
P-0008553-T01-IM5	P-0008553	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		837	10
P-0008554-T01-IM5	P-0008554	Salivary Carcinoma	Primary	Tumor	Not Applicable	Parotid Gland	Myoepithelial Carcinoma	IMPACT410			Female		703	40
P-0008555-T01-IM5	P-0008555	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		669	90
P-0008556-T01-IM5	P-0008556	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patient's matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.	720	80
P-0008557-T02-IM5	P-0008557	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	948	70
P-0008558-T02-IM5	P-0008558	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		969	60
P-0008559-T01-IM5	P-0008559	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		704	80
P-0008560-T01-IM5	P-0008560	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		711	20
P-0008561-T01-IM5	P-0008561	Soft Tissue Sarcoma	Metastasis	Tumor	Bone	Thigh	Myxoid/Round-Cell Liposarcoma	IMPACT410			Female		697	80
P-0008562-T01-IM5	P-0008562	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		935	50
P-0008563-T01-IM5	P-0008563	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Angiomyolipoma	IMPACT410			Male		1056	20
P-0008564-T01-IM5	P-0008564	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Male		866	80
P-0008565-T01-IM5	P-0008565	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Female		689	70
P-0008566-T01-IM5	P-0008566	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		872	50
P-0008567-T01-IM5	P-0008567	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Papillary Thyroid Cancer	IMPACT410			Male		766	60
P-0008568-T01-IM5	P-0008568	Colorectal Cancer	Metastasis	Tumor	Omentum	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1003	10
P-0008569-T01-IM5	P-0008569	Germ Cell Tumor	Metastasis	Tumor	Soft Tissue	Unknown	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	944	20
P-0008570-T01-IM5	P-0008570	Breast Carcinoma	Metastasis	Tumor	Spine	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		803	70
P-0008571-T01-IM5	P-0008571	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1282	10
P-0008571-T02-IM5	P-0008571	Breast Carcinoma	Metastasis	Tumor	Lymph Node	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		1121	10
P-0008572-T01-IM5	P-0008572	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		721	30
P-0008573-T01-IM5	P-0008573	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Anaplastic Thyroid Cancer	IMPACT410			Female		573	60
P-0008574-T01-IM5	P-0008574	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	921	50
P-0008575-T01-IM5	P-0008575	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		876	60
P-0008576-T01-IM5	P-0008576	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		887	10
P-0008577-T01-IM5	P-0008577	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		676	50
P-0008578-T01-IM5	P-0008578	Soft Tissue Sarcoma	Metastasis	Tumor	Tibia	Calf	Sarcoma, NOS	IMPACT410			Female		563	80
P-0008579-T01-IM5	P-0008579	Colorectal Cancer	Metastasis	Tumor	Omentum	Colon	Colon Adenocarcinoma	IMPACT410			Female		755	20
P-0008580-T01-IM5	P-0008580	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against the patient's matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.| |	827	10
P-0008581-T01-IM5	P-0008581	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		660	50
P-0008582-T01-IM5	P-0008582	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		1012	10
P-0008583-T01-IM5	P-0008583	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female		836	10
P-0008584-T01-IM5	P-0008584	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		694	20
P-0008586-T01-IM5	P-0008586	Cancer of Unknown Primary	Metastasis	Tumor	Soft Tissue	Unknown	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	886	10
P-0008587-T01-IM5	P-0008587	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	565	20
P-0008588-T01-IM5	P-0008588	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		1030	10
P-0008589-T01-IM5	P-0008589	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		872	60
P-0008590-T01-IM5	P-0008590	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		716	20
P-0008591-T01-IM5	P-0008591	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		794	70
P-0008592-T01-IM5	P-0008592	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		732	60
P-0008593-T01-IM5	P-0008593	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched normal blood sample.	750	40
P-0008594-T01-IM5	P-0008594	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female		809	30
P-0008595-T01-IM5	P-0008595	Breast Carcinoma	Metastasis	Tumor	Bladder	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		976	40
P-0008596-T01-IM5	P-0008596	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Leiomyosarcoma	IMPACT410			Female	Note: No alterations identified in the context of high tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.	868	80
P-0008597-T01-IM5	P-0008597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		913	60
P-0008598-T01-IM5	P-0008598	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		966	10
P-0008599-T01-IM5	P-0008599	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1089	20
P-0008600-T01-IM5	P-0008600	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female		910	60
P-0008601-T01-IM5	P-0008601	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		955	20
P-0008602-T01-IM5	P-0008602	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		894	60
P-0008643-T01-IM5	P-0008643	Histiocytosis	Primary	Tumor	Not Applicable	Soft Tissue	Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	867	30
P-0008644-T01-IM5	P-0008644	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		870	20
P-0008645-T01-IM5	P-0008645	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Male		884	80
P-0008646-T01-IM5	P-0008646	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		1019	10
P-0008647-T01-IM5	P-0008647	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Lobular Carcinoma	IMPACT410			Female		1109	30
P-0008648-T01-IM5	P-0008648	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		1118	20
P-0008649-T01-IM5	P-0008649	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		976	80
P-0008650-T01-IM5	P-0008650	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	776	20
P-0008651-T01-IM5	P-0008651	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		454	70
P-0008652-T01-IM5	P-0008652	Colorectal Cancer	Metastasis	Tumor	Lymph node	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female		426	40
P-0008653-T01-IM5	P-0008653	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		952	60
P-0008654-T01-IM5	P-0008654	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	877	10
P-0008655-T01-IM5	P-0008655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	689	30
P-0008656-T01-IM5	P-0008656	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		676	80
P-0008657-T01-IM5	P-0008657	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male		908	70
P-0008659-T01-IM5	P-0008659	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q and 13q (except RB1); also broad copy number loss on 3q.	735	90
P-0008660-T01-IM5	P-0008660	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	745	10
P-0008661-T01-IM5	P-0008661	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		854	40
P-0008662-T01-IM5	P-0008662	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	680	10
P-0008664-T01-IM5	P-0008664	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		950	30
P-0008665-T01-IM5	P-0008665	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		813	30
P-0008666-T01-IM5	P-0008666	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1323	60
P-0008667-T01-IM5	P-0008667	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	663	30
P-0008668-T01-IM5	P-0008668	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		776	20
P-0008669-T01-IM5	P-0008669	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1117	20
P-0008671-T01-IM5	P-0008671	Colorectal Cancer	Metastasis	Tumor	Soft Tissue	Rectosigmoid Colon	Colorectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	200	10
P-0008672-T01-IM5	P-0008672	Thyroid Cancer	Metastasis	Tumor	Lung	Thyroid	Poorly Differentiated Thyroid Cancer	IMPACT410			Male		737	20
P-0008673-T01-IM5	P-0008673	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	816	10
P-0008674-T01-IM5	P-0008674	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		838	60
P-0008675-T01-IM5	P-0008675	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		1059	80
P-0008676-T01-IM5	P-0008676	Retinoblastoma	Primary	Tumor	Not Applicable	Eye	Retinoblastoma	IMPACT410			Female		899	80
P-0008677-T01-IM5	P-0008677	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1017	70
P-0008678-T01-IM5	P-0008678	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Female		1066	60
P-0008679-T01-IM5	P-0008679	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	373	80
P-0008680-T01-IM5	P-0008680	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Lung	Epithelioid Hemangioendothelioma	IMPACT410			Female		960	30
P-0008682-T01-IM5	P-0008682	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		664	80
P-0008683-T01-IM5	P-0008683	Colorectal Cancer	Metastasis	Tumor	Liver	Descending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	676	10
P-0008684-T01-IM5	P-0008684	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		776	80
P-0008685-T01-IM5	P-0008685	Endometrial Cancer	Metastasis	Tumor	Ascites	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410			Female		952	20
P-0008686-T01-IM5	P-0008686	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Pancreas	Skin	Merkel Cell Carcinoma	IMPACT410			Female		543	80
P-0008687-T01-IM5	P-0008687	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	598	80
P-0008688-T01-IM5	P-0008688	Salivary Carcinoma	Primary	Tumor	Not Applicable	Hard palate	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 138X, negative results should be interpreted with caution.  Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out.	138	60
P-0008689-T01-IM5	P-0008689	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Colon	Mantle Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patient's matched saliva sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched saliva sample.	763	90
P-0008690-T01-IM5	P-0008690	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		686	20
P-0008691-T01-IM5	P-0008691	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		980	70
P-0008692-T01-IM5	P-0008692	Appendiceal Cancer	Metastasis	Tumor	Soft Tissue	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male		786	60
P-0008693-T01-IM5	P-0008693	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	835	40
P-0008694-T01-IM5	P-0008694	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		855	80
P-0008695-T01-IM5	P-0008695	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Male		675	90
P-0008705-T01-IM5	P-0008705	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		824	30
P-0008706-T01-IM5	P-0008706	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	614	10
P-0008707-T01-IM5	P-0008707	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Female		305	60
P-0008708-T01-IM5	P-0008708	Soft Tissue Sarcoma	Metastasis	Tumor	Not Applicable	Soft Tissue	Dedifferentiated Liposarcoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 181X, negative results should be interpreted with caution.	181	50
P-0008709-T01-IM5	P-0008709	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		833	30
P-0008710-T01-IM5	P-0008710	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	370	20
P-0008711-T01-IM5	P-0008711	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q26-3q28.	755	60
P-0008712-T01-IM5	P-0008712	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		719	80
P-0008713-T01-IM5	P-0008713	Uterine Sarcoma	Metastasis	Tumor	Retroperitoneum	Uterus	Uterine Smooth Muscle Tumor of Uncertain Malignant Potential	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 22q.	358	80
P-0008714-T01-IM5	P-0008714	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		413	70
P-0008715-T01-IM5	P-0008715	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		636	35
P-0008716-T01-IM5	P-0008716	Chondrosarcoma	Primary	Tumor	Not Applicable	Larynx	Chondrosarcoma	IMPACT410			Male		565	60
P-0008717-T01-IM5	P-0008717	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		877	80
P-0008718-T01-IM5	P-0008718	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		888	40
P-0008719-T01-IM5	P-0008719	Cancer of Unknown Primary	Metastasis	Tumor	Lymph node	Pancreas	Adenocarcinoma, NOS	IMPACT410			Female		793	20
P-0008720-T01-IM5	P-0008720	Osteosarcoma	Primary	Tumor	Not Applicable	Humerus	Osteosarcoma	IMPACT410			Male		855	60
P-0008721-T01-IM5	P-0008721	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		978	80
P-0008722-T01-IM5	P-0008722	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	685	30
P-0008723-T01-IM5	P-0008723	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Non-Small Cell Lung Cancer	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1132	10
P-0008724-T01-IM5	P-0008724	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	915	70
P-0008725-T01-IM5	P-0008725	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p/19q.	958	80
P-0008727-T01-IM5	P-0008727	Colorectal Cancer	Metastasis	Tumor	Lung	Rectum	Rectal Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	325	30
P-0008728-T01-IM5	P-0008728	Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	337	10
P-0008729-T01-IM5	P-0008729	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		976	60
P-0008730-T01-IM5	P-0008730	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female		901	40
P-0008731-T01-IM5	P-0008731	Ewing Sarcoma	Primary	Tumor	Not Applicable	Kidney	Ewing Sarcoma	IMPACT410			Male		584	40
P-0008734-T01-IM5	P-0008734	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1262	90
P-0008735-T01-IM5	P-0008735	Colorectal Cancer	Metastasis	Tumor	Peritonuem	Colon	Colorectal Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.  Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	1163	30
P-0008736-T01-IM5	P-0008736	Pancreatic Cancer	Metastasis	Tumor	Ovary	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		1068	60
P-0008737-T01-IM5	P-0008737	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Sarcoma, NOS	IMPACT410			Male		993	80
P-0008744-T01-IM5	P-0008744	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Male		1054	20
P-0008747-T01-IM5	P-0008747	Colorectal Cancer	Primary	Tumor	Not Applicable	Cecum	Colon Adenocarcinoma	IMPACT410			Female		933	80
P-0008748-T01-IM5	P-0008748	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Undifferentiated Carcinoma of the Pancreas	IMPACT410			Female		975	70
P-0008749-T01-IM5	P-0008749	Ewing Sarcoma	Metastasis	Tumor	Lymph node	Bone	Ewing Sarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	1184	40
P-0008750-T01-IM5	P-0008750	Hepatocellular Carcinoma	Metastasis	Tumor	Mediastinum	Liver	Hepatocellular Carcinoma	IMPACT410			Female		1114	90
P-0008751-T01-IM5	P-0008751	Breast Carcinoma	Metastasis	Tumor	Iliac Bone	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	808	20
P-0008752-T01-IM5	P-0008752	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Leiomyosarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	903	90
P-0008753-T01-IM5	P-0008753	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Male		1078	20
P-0008754-T01-IM5	P-0008754	Pancreatic Cancer	Metastasis	Tumor	Mesentery	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1145	10
P-0008755-T01-IM5	P-0008755	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	856	20
P-0008756-T01-IM5	P-0008756	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		1079	40
P-0008757-T01-IM5	P-0008757	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Variant frequencies of EGFR exon21 and EGFR exon19 variants are identical. These 2 mutations may be in cis (same allele).	1014	80
P-0008760-T01-IM5	P-0008760	Breast Carcinoma	Metastasis	Tumor	Peritoneum	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 11q and 16q.	802	90
P-0008763-T01-IM5	P-0008763	Cancer of Unknown Primary	Metastasis	Tumor	Soft Tissue	Unknown	Adenocarcinoma, NOS	IMPACT410			Female		985	70
P-0008764-T01-IM5	P-0008764	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Male		1030	70
P-0008765-T01-IM5	P-0008765	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		1040	20
P-0008766-T01-IM5	P-0008766	Cancer of Unknown Primary	Metastasis	Tumor	Unknown	Unknown	Adenocarcinoma, NOS	IMPACT410			Female		1047	90
P-0008767-T01-IM5	P-0008767	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		688	90
P-0008768-T01-IM5	P-0008768	Salivary Carcinoma	Primary	Tumor	Not Applicable	Maxillary Sinus	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MIB/AFIB	1006	30
P-0008770-T01-IM5	P-0008770	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 and Chromosome arms 6p22, 6q15-16, 6q22-26, 9p, and 13q14-34.	745	90
P-0008771-T01-IM5	P-0008771	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		826	80
P-0008772-T01-IM5	P-0008772	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		834	70
P-0008773-T01-IM5	P-0008773	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Squamous Cell Carcinoma	IMPACT410			Female		758	50
P-0008774-T01-IM5	P-0008774	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	729	70
P-0008775-T01-IM5	P-0008775	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Female		769	70
P-0008776-T01-IM5	P-0008776	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Papillary Renal Cell Carcinoma	IMPACT410			Male		959	80
P-0008777-T01-IM5	P-0008777	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 10q, 14q and 22q.	876	80
P-0008778-T01-IM5	P-0008778	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Male		860	80
P-0008779-T01-IM5	P-0008779	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Periurethra	Extramammary Paget Disease	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	915	10
P-0008781-T01-IM5	P-0008781	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Follicular Lymphoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p21.  Mutation assessment: Mutations are called against the patient's matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1093	40
P-0008782-T01-IM5	P-0008782	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Rectal Adenocarcinoma	IMPACT410			Female		913	30
P-0008783-T01-IM5	P-0008783	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p13.	558	80
P-0008785-T01-IM5	P-0008785	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Female		854	80
P-0008786-T01-IM5	P-0008786	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	1174	30
P-0008787-T01-IM5	P-0008787	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Mixed Ovarian Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3p21	652	80
P-0008788-T01-IM5	P-0008788	Esophagogastric Carcinoma	Metastasis	Tumor	Pleura	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		789	60
P-0008809-T01-IM5	P-0008809	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	848	60
P-0008810-T01-IM5	P-0008810	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		877	60
P-0008811-T01-IM5	P-0008811	Germ Cell Tumor	Metastasis	Tumor	Soft Tissue	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	1108	90
P-0008812-T01-IM5	P-0008812	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		961	80
P-0008813-T01-IM5	P-0008813	Germ Cell Tumor	Primary	Tumor	Not Applicable	Ovary	Mixed Germ Cell Tumor	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	930	60
P-0008813-T02-IM5	P-0008813	Germ Cell Tumor	Primary	Tumor	Not Applicable	Ovary	Mature Teratoma	IMPACT410			Female	Note: No alterations identified in the context of high tumor content .More comprehensive testing could be valuable.	833	90
P-0008814-T01-IM5	P-0008814	Germ Cell Tumor	Metastasis	Tumor	Liver	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	348	50
P-0008815-T01-IM5	P-0008815	Cancer of Unknown Primary	Metastasis	Tumor	Omentum	Unknown	Cancer of Unknown Primary	IMPACT410			Female		749	10
P-0008816-T01-IM5	P-0008816	Bladder Cancer	Primary	Tumor	Not Applicable	Renal Pelvis	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	742	70
P-0008818-T01-IM5	P-0008818	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1094	10
P-0008819-T01-IM5	P-0008819	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 77X, negative results should be interpreted with caution.	77	10
P-0008923-T01-IM5	P-0008923	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 7p14-7p22 and 10q24-10q26.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q22-1q31.	974	90
P-0000913-T02-IM5	P-0000913	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female		979	20
P-0001157-T02-IM5	P-0001157	Gastrointestinal Stromal Tumor	Metastasis	Tumor	Liver	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	917	80
P-0001296-T02-IM5	P-0001296	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	844	20
P-0001442-T02-IM5	P-0001442	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male		792	25
P-0001581-T02-IM5	P-0001581	Appendiceal Cancer	Primary	Tumor	Omentum	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female		512	30
P-0002085-T02-IM5	P-0002085	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR exon21 mutations all occur in cis (same allele).  Note: The SMARCA4 exon24 mutations all occur in cis (same allele).	751	30
P-0002653-T01-IM3	P-0002653	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Signet Ring Cell Adenocarcinoma of the Colon and Rectum	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	738	20
P-0002673-T01-IM3	P-0002673	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341			Male	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	504	30
P-0002678-T01-IM3	P-0002678	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341			Male	Note: The MYC and RECQL4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1028	20
P-0002748-T02-IM5	P-0002748	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		547	40
P-0002749-T02-IM3	P-0002749	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Signet Ring Cell Type of the Appendix	IMPACT341			Female	Note: The CDK4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	784	20
P-0002768-T01-IM3	P-0002768	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT341			Female		565	30
P-0002780-T01-IM3	P-0002780	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female		146	40
P-0002783-T01-IM3	P-0002783	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT341			Male		572	30
P-0002890-T01-IM3	P-0002890	Non-Small Cell Lung Cancer	Metastasis	Tumor	Retroperitoneum	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	678	40
P-0002902-T01-IM3	P-0002902	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT341			Male		688	20
P-0002907-T01-IM3	P-0002907	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT341			Male		600	70
P-0003009-T01-IM3	P-0003009	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Oropharynx Squamous Cell Carcinoma	IMPACT341			Female		628	20
P-0003012-T01-IM3	P-0003012	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	725	20
P-0003013-T01-IM3	P-0003013	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		539	50
P-0003015-T01-IM3	P-0003015	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	904	80
P-0003074-T01-IM5	P-0003074	Appendiceal Cancer	Metastasis	Tumor	Liver	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female		417	20
P-0003135-T04-IM5	P-0003135	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Male		945	40
P-0003143-T01-IM5	P-0003143	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	487	10
P-0003251-T01-IM5	P-0003251	Appendiceal Cancer	Metastasis	Tumor	Spleen	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	478	10
P-0003254-T01-IM5	P-0003254	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT410			Male	Note: The SMAD4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	579	40
P-0003274-T01-IM5	P-0003274	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Female		421	20
P-0003284-T01-IM5	P-0003284	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Mucinous Adenocarcinoma of the Colon and Rectum	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	560	20
P-0003289-T02-IM5	P-0003289	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	477	30
P-0003311-T01-IM5	P-0003311	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		488	20
P-0003334-T02-IM5	P-0003334	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 13.	381	40
P-0003371-T01-IM5	P-0003371	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	wait for sanger results for KRAS from Navid and then sign out	407	10
P-0003542-T01-IM5	P-0003542	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	538	20
P-0003638-T01-IM5	P-0003638	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female		223	60
P-0003657-T01-IM5	P-0003657	Appendiceal Cancer	Metastasis	Tumor	Colon	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Female		597	40
P-0003705-T01-IM5	P-0003705	Appendiceal Cancer	Metastasis	Tumor	Colon	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male		526	10
P-0003768-T01-IM5	P-0003768	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female		463	30
P-0003923-T01-IM5	P-0003923	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR exon20 p.S768I and p.C775Y  mutations occur in different alleles.  Note: The EGFR exon20 p.S768I and p.T790M mutations occur in cis (same alleles).	635	40
P-0004134-T01-IM5	P-0004134	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	561	10
P-0004156-T01-IM5	P-0004156	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Malignant Carcinoid of the Appendix	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	500	10
P-0004188-T01-IM5	P-0004188	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	791	10
P-0004192-T01-IM5	P-0004192	Appendiceal Cancer	Metastasis	Tumor	Colon	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	656	20
P-0004390-T01-IM5	P-0004390	Appendiceal Cancer	Metastasis	Tumor	Ovary	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	364	10
P-0004496-T01-IM5	P-0004496	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Female		546	50
P-0004534-T01-IM5	P-0004534	Biliary Cancer	Metastasis	Tumor	Liver	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		951	30
P-0004624-T01-IM5	P-0004624	Appendiceal Cancer	Metastasis	Tumor	Lung	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male		677	20
P-0004672-T01-IM5	P-0004672	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	10
P-0004695-T01-IM5	P-0004695	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		835	20
P-0004724-T01-IM5	P-0004724	Appendiceal Cancer	Metastasis	Tumor	Ileum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: The SMAD4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	840	30
P-0004809-T01-IM5	P-0004809	Appendiceal Cancer	Metastasis	Tumor	Ileum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male		586	20
P-0004906-T01-IM5	P-0004906	Pancreatic Cancer	Metastasis	Tumor	Peritoneum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	625	20
P-0004927-T01-IM5	P-0004927	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: A comparison of variant frequencies suggests the EGFR p.T790M mutation is subclonal.        Note: The NBN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1009	50
P-0005027-T01-IM5	P-0005027	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	560	40
P-0005034-T01-IM5	P-0005034	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: The EGFR p.L858R mutation frequency suggests that it is on the amplified allele.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q including BRCA2 and RB1 and Chromosome arm 3p including BAP1.  .	979	70
P-0005056-T01-IM5	P-0005056	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	903	10
P-0005059-T01-IM5	P-0005059	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	968	10
P-0005148-T01-IM5	P-0005148	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Male		868	20
P-0005208-T01-IM5	P-0005208	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	369	10
P-0005296-T01-IM5	P-0005296	Appendiceal Cancer	Metastasis	Tumor	Sigmoid Colon	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female		826	20
P-0005361-T02-IM5	P-0005361	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Female		700	60
P-0005524-T03-IM5	P-0005524	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Leg	Pleomorphic Liposarcoma	IMPACT410			Female		690	70
P-0005796-T01-IM5	P-0005796	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	334	10
P-0005817-T01-IM5	P-0005817	Small Bowel Cancer	Metastasis	Tumor	Liver	Ileum	Small Bowel Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 11q,16q and 18q.	832	60
P-0005944-T01-IM5	P-0005944	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		443	20
P-0006105-T01-IM5	P-0006105	Non-Small Cell Lung Cancer	Primary	Tumor	Lung	Lung	Lung Adenocarcinoma	IMPACT410			Male		800	40
P-0006171-T01-IM5	P-0006171	Non-Small Cell Lung Cancer	Metastasis	Tumor	Omentum	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The EGFR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1072	50
P-0006235-T01-IM5	P-0006235	Biliary Cancer	Metastasis	Tumor	Lung	Liver	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		447	40
P-0006242-T01-IM5	P-0006242	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		894	20
P-0006255-T01-IM5	P-0006255	Leukemia	Metastasis	Tumor	Lymph Node	Breast	Acute Myeloid Leukemia	IMPACT410			Female		914	20
P-0006328-T01-IM5	P-0006328	Biliary Cancer	Metastasis	Tumor	Soft Tissue	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Female		817	20
P-0006352-T01-IM5	P-0006352	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Extrahepatic Cholangiocarcinoma	IMPACT410			Female		1814	20
P-0006426-T01-IM5	P-0006426	Melanoma	Primary	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Female		856	70
P-0006438-T01-IM5	P-0006438	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Goblet Cell Carcinoid of the Appendix	IMPACT410			Male	SLIDE REVIEWED (DSR) - TUMOR CONTENT OK.	708	30
P-0006466-T01-IM5	P-0006466	Cancer of Unknown Primary	Metastasis	Tumor	Breast	Unknown	Cancer of Unknown Primary	IMPACT410			Female		783	
P-0006478-T01-IM5	P-0006478	Appendiceal Cancer	Metastasis	Tumor	Mesentery	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	321	10
P-0006609-T01-IM5	P-0006609	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Ductal Carcinoma	IMPACT410			Female		708	60
P-0006795-T01-IM5	P-0006795	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		596	30
P-0006841-T01-IM5	P-0006841	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: The KLF4 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	662	40
P-0006885-T01-IM5	P-0006885	Biliary Cancer	Metastasis	Tumor	Liver	Gallbladder	Gallbladder Cancer	IMPACT410			Male		551	10
P-0006903-T01-IM5	P-0006903	Biliary Cancer	Metastasis	Tumor	Lymph Node	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	654	20
P-0006911-T01-IM5	P-0006911	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	no silent mutation	621	40
P-0007094-T01-IM5	P-0007094	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	837	10
P-0007095-T01-IM5	P-0007095	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		829	20
P-0007105-T01-IM5	P-0007105	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male		916	10
P-0007106-T01-IM5	P-0007106	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Merkel Cell Carcinoma	IMPACT410			Male		924	40
P-0007107-T01-IM5	P-0007107	Biliary Cancer	Metastasis	Tumor	Lymph Node	Gallbladder	Cholangiocarcinoma	IMPACT410			Female		742	30
P-0007108-T01-IM5	P-0007108	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT410			Male		1028	45
P-0007179-T01-IM5	P-0007179	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		829	10
P-0007326-T01-IM5	P-0007326	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Gallbladder Cancer	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	874	10
P-0007360-T01-IM5	P-0007360	Biliary Cancer	Metastasis	Tumor	Pelvis	Gallbladder	Gallbladder Cancer	IMPACT410			Female		916	30
P-0007417-T01-IM5	P-0007417	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		1068	40
P-0007426-T01-IM5	P-0007426	Biliary Cancer	Metastasis	Tumor	Diaphragm	Bile Duct	Intrahepatic Cholangiocarcinoma	IMPACT410			Male		572	30
P-0007981-T02-IM5	P-0007981	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms  4q13-4q35, 7, 12, and 17.	904	70
P-0008490-T02-IM5	P-0008490	Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	756	25
P-0008492-T02-IM5	P-0008492	Melanoma	Metastasis	Tumor	Lymph Node	Scalp	Cutaneous Melanoma	IMPACT410			Male		696	60
P-0008542-T02-IM5	P-0008542	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	643	20
P-0008542-T03-IM5	P-0008542	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	514	20
P-0008670-T01-IM5	P-0008670	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	479	10
P-0008670-T02-IM5	P-0008670	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Embryonal Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	592	10
P-0008732-T01-IM5	P-0008732	Endometrial Cancer	Metastasis	Tumor	Lymph Node	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		984	70
P-0008733-T01-IM5	P-0008733	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 6p, and Chromosome 20.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 21.	807	90
P-0008784-T02-IM5	P-0008784	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: Low sequencing depth of coverage of 147X, negative results should be interpreted with caution.  Note: Assessment of the copy number profile is limited by increased background noise. Assessment of mutations and structural variants is also limited by the sample quality. False negatives cannot be ruled out.	179	N/A
P-0008789-T01-IM5	P-0008789	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Male		758	40
P-0008857-T01-IM5	P-0008857	Melanoma	Metastasis	Tumor	In-transit	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p36, 16q, and 17p.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	781	90
P-0008859-T01-IM5	P-0008859	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	923	20
P-0008870-T01-IM5	P-0008870	Melanoma	Metastasis	Tumor	Soft Tissue	Eye	Uveal Melanoma	IMPACT410			Female		700	80
P-0008912-T01-IM5	P-0008912	Melanoma	Metastasis	Tumor	Lymph Node, Non-Regional	Unknown	Melanoma of Unknown Primary	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p21-3p25, 3q, 5, 6q, 8p, 9, 10, 11p15, 11q13-11q24, 14, 15, 17p13, 18, 22, and X. Confirmatory testing by an alternate method is suggested, if clinically indicated.	917	80
P-0008932-T02-IM5	P-0008932	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Tongue	Oral Cavity Squamous Cell Carcinoma	IMPACT410			Male		567	20
P-0008946-T01-IM5	P-0008946	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	758	30
P-0009010-T01-IM5	P-0009010	Renal Cell Carcinoma	Metastasis	Tumor	Pleura	Kidney	Unclassified Renal Cell Carcinoma	IMPACT410			Male		891	40
P-0009018-T01-IM5	P-0009018	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Female		976	40
P-0009019-T01-IM5	P-0009019	Melanoma	Local Recurrence	Tumor	Not Applicable	Eye	Uveal Melanoma	IMPACT410			Male		950	80
P-0009020-T01-IM5	P-0009020	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		449	20
P-0009021-T01-IM5	P-0009021	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		1206	70
P-0009023-T01-IM5	P-0009023	Small Bowel Cancer	Metastasis	Tumor	Liver	Duodenum	Small Bowel Cancer	IMPACT410			Male		1119	40
P-0009024-T01-IM5	P-0009024	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		938	75
P-0009025-T01-IM5	P-0009025	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Skin	Angiosarcoma	IMPACT410			Male		940	15
P-0009026-T01-IM5	P-0009026	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		927	60
P-0009027-T01-IM5	P-0009027	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Thigh	Sarcoma, NOS	IMPACT410			Female		940	80
P-0009028-T01-IM5	P-0009028	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	911	10
P-0009029-T01-IM5	P-0009029	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 3 and 15.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9q21-9q34.13 .	730	30
P-0009056-T01-IM5	P-0009056	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1107	10
P-0009057-T01-IM5	P-0009057	Esophagogastric Carcinoma	Metastasis	Tumor	Ovary	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		987	50
P-0009058-T01-IM5	P-0009058	Colorectal Cancer	Primary	Tumor	Not Applicable	Sigmoid colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	953	40
P-0009059-T01-IM5	P-0009059	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	937	10
P-0009060-T01-IM5	P-0009060	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	687	60
P-0009061-T01-IM5	P-0009061	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	High-Grade Serous Ovarian Cancer	IMPACT410			Female		683	20
P-0009062-T01-IM5	P-0009062	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		826	50
P-0009063-T01-IM5	P-0009063	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		781	15
P-0009064-T01-IM5	P-0009064	Embryonal Tumor	Metastasis	Tumor	Brain	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.  Note: The ALK amplification is an intragenic gain of exons2-12.	826	70
P-0009065-T01-IM5	P-0009065	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Adenocarcinoma of the Gastroesophageal Junction	IMPACT410			Male		1043	20
P-0009066-T01-IM5	P-0009066	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		764	30
P-0009067-T01-IM5	P-0009067	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Male		946	30
P-0009068-T01-IM5	P-0009068	Cancer of Unknown Primary	Metastasis	Tumor	Adrenal Gland	Unknown	Cancer of Unknown Primary	IMPACT410			Female		1030	50
P-0009069-T01-IM5	P-0009069	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	856	30
P-0009072-T01-IM5	P-0009072	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 6p, 7 and 10p.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6q, 9, 10q, 11 and 22q.	806	100
P-0009073-T01-IM5	P-0009073	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	597	50
P-0009074-T01-IM5	P-0009074	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3, 6p, 8q, 12q and 16q.	1036	80
P-0009075-T01-IM5	P-0009075	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Endometrioid Ovarian Cancer	IMPACT410			Female		568	40
P-0009076-T01-IM5	P-0009076	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Female		1141	90
P-0009077-T01-IM5	P-0009077	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	634	40
P-0009078-T01-IM5	P-0009078	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p, 11q and 22q.	1065	95
P-0009079-T01-IM5	P-0009079	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female		812	30
P-0009080-T01-IM5	P-0009080	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q and 22q.	973	80
P-0009081-T01-IM5	P-0009081	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	738	30
P-0009082-T01-IM5	P-0009082	Prostate Cancer	Metastasis	Tumor	Iliac Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		838	90
P-0009083-T01-IM5	P-0009083	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1093	20
P-0009084-T01-IM5	P-0009084	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Anus	Anorectal Mucosal Melanoma	IMPACT410			Male		778	20
P-0009099-T01-IM5	P-0009099	Bladder Cancer	Primary	Tumor	Not Applicable	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 10q.	774	80
P-0009102-T01-IM5	P-0009102	Non-Small Cell Lung Cancer	Metastasis	Tumor	Chest Wall	Lung	Lung Adenocarcinoma	IMPACT410			Female		604	60
P-0009108-T01-IM5	P-0009108	Melanoma	Metastasis	Tumor	Brain	Unknown	Melanoma of Unknown Primary	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	1098	90
P-0009111-T01-IM5	P-0009111	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		457	10
P-0009161-T01-IM5	P-0009161	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		912	60
P-0009162-T01-IM5	P-0009162	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Female		883	20
P-0009163-T01-IM5	P-0009163	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		956	30
P-0009164-T01-IM5	P-0009164	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1021	20
P-0009166-T01-IM5	P-0009166	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Soft Tissue	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1231	50
P-0009167-T01-IM5	P-0009167	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q	835	30
P-0009168-T01-IM5	P-0009168	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1044	20
P-0009169-T01-IM5	P-0009169	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		829	40
P-0009171-T01-IM5	P-0009171	Non-Small Cell Lung Cancer	Metastasis	Tumor	Bone	Lung	Lung Adenocarcinoma	IMPACT410			Female		869	80
P-0009172-T01-IM5	P-0009172	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		975	20
P-0009173-T01-IM5	P-0009173	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	909	10
P-0002209-T02-IM5	P-0002209	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male		578	60
P-0002676-T01-IM3	P-0002676	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.   Note: The TP63 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	592	40
P-0002881-T01-IM3	P-0002881	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT341			Male		455	NA
P-0003262-T01-IM5	P-0003262	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male		462	40
P-0004239-T01-IM5	P-0004239	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	364	20
P-0008401-T01-IM5	P-0008401	Skin Cancer, Non-Melanoma	Metastasis	Tumor	Lymph Node	Neck	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	894	40
P-0009071-T01-IM5	P-0009071	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Sinus	Sinonasal Adenocarcinoma	IMPACT410			Male	Tumor Type: Sinonasal Adenocarcinoma (Tumor type to be added)Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	989	40
P-0009087-T01-IM5	P-0009087	Cancer of Unknown Primary	Metastasis	Tumor	Vagina	Unknown	Neuroendocrine Tumor, NOS	IMPACT410			Female		1097	90
P-0009170-T01-IM5	P-0009170	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	This sample was discussed in the consensus meeting on 02/4, and it was decide to sign out both the mutations, as there is no additional material left.	481	90
P-0000449-T02-IM5	P-0000449	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		873	80
P-0000739-T02-IM5	P-0000739	Colorectal Cancer	Metastasis	Tumor	Brain	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q, including SMAD4.	936	25
P-0001654-T02-IM5	P-0001654	Glioma	Primary	Tumor	Not available	Brain	Glioblastoma Multiforme	IMPACT410			Female		871	80
P-0008595-T02-IM5	P-0008595	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: The NOTCH4 exon 30 p.R1793P and p.E1820K mutations occur in cis (same allele).	565	60
P-0008679-T03-IM5	P-0008679	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 11q13.5-11q24.	1165	80
P-0009070-T01-IM5	P-0009070	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage. Repeat testing on a separate sample is recommended.	133	10
P-0009084-T02-IM5	P-0009084	Melanoma	Metastasis	Tumor	Liver	Anus	Anorectal Mucosal Melanoma	IMPACT410			Male		926	60
P-0009137-T01-IM5	P-0009137	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	673	30
P-0009138-T01-IM5	P-0009138	Appendiceal Cancer	Metastasis	Tumor	Peritoneum	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male		924	20
P-0009139-T01-IM5	P-0009139	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	629	10
P-0009141-T01-IM5	P-0009141	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Relatively low tumor content (approximately 20%). Negative copy number and structural variant results should be interpreted with caution.	788	15
P-0009142-T01-IM5	P-0009142	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		1083	25
P-0009144-T01-IM5	P-0009144	Chondrosarcoma	Primary	Tumor	Not Applicable	Chest Wall	Chondrosarcoma	IMPACT410			Male	Note: No alterations identified in the context of high tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.	719	70
P-0009145-T01-IM5	P-0009145	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	909	30
P-0009146-T01-IM5	P-0009146	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		301	40
P-0009149-T01-IM5	P-0009149	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Male		838	30
P-0009151-T01-IM5	P-0009151	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		339	30
P-0009152-T01-IM5	P-0009152	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	972	60
P-0009153-T01-IM5	P-0009153	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male	Note: Low sequencing depth of coverage of 68X, negative results should be interpreted with caution.  Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	77	70
P-0009155-T01-IM5	P-0009155	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female		1074	80
P-0009156-T01-IM5	P-0009156	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		1135	40
P-0009157-T01-IM5	P-0009157	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		428	70
P-0009158-T01-IM5	P-0009158	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		1040	60
P-0009160-T01-IM5	P-0009160	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female		1397	50
P-0009194-T01-IM5	P-0009194	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q.	710	40
P-0009195-T01-IM5	P-0009195	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q32-1q44  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 5p15 and 13q.	551	80
P-0009196-T01-IM5	P-0009196	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	726	10
P-0009197-T01-IM5	P-0009197	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q14-11q24.  Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 7q and 17q12-17q25.	816	90
P-0009198-T01-IM5	P-0009198	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		638	35
P-0009200-T01-IM5	P-0009200	Colorectal Cancer	Metastasis	Tumor	Peritoneum	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	830	40
P-0009201-T01-IM5	P-0009201	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		549	70
P-0009202-T01-IM5	P-0009202	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Trachea	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q22-13q34.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q26-3q28.	649	30
P-0009203-T01-IM5	P-0009203	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p21.	686	25
P-0009205-T01-IM5	P-0009205	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma	IMPACT410			Male		600	70
P-0009206-T01-IM5	P-0009206	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	801	20
P-0009215-T01-IM5	P-0009215	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	872	25
P-0009218-T01-IM5	P-0009218	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	320	90
P-0009219-T01-IM5	P-0009219	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p and 19q.	876	80
P-0009220-T01-IM5	P-0009220	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Soft Tissue	Angiosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	907	25
P-0009221-T01-IM5	P-0009221	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		873	30
P-0009223-T01-IM5	P-0009223	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		881	10
P-0009225-T01-IM5	P-0009225	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Mucinous Cystic Neoplasm	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	320	20
P-0009228-T01-IM5	P-0009228	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		959	20
P-0009150-T01-IM5	P-0009150	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	258	10
P-0009154-T01-IM5	P-0009154	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	1116	10
P-0009222-T01-IM5	P-0009222	Appendiceal Cancer	Metastasis	Tumor	Soft Tissue	Appendix	Appendiceal Adenocarcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	943	10
P-0009227-T01-IM5	P-0009227	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	859	10
P-0001495-T03-IM5	P-0001495	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male		777	75
P-0002451-T02-IM5	P-0002451	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Variants in SMARCA4 gene indicates the presence of sub-clones	666	40
P-0002837-T01-IM3	P-0002837	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		671	30
P-0002846-T01-IM3	P-0002846	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	839	20
P-0002849-T01-IM3	P-0002849	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	352	40
P-0002850-T01-IM3	P-0002850	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Male		777	30
P-0002851-T01-IM3	P-0002851	Chondrosarcoma	Metastasis	Tumor	Bone	Lung	Chondrosarcoma	IMPACT341			Female		778	30
P-0002859-T01-IM3	P-0002859	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Female		633	20
P-0002861-T01-IM3	P-0002861	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		770	20
P-0002865-T01-IM3	P-0002865	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Female		384	60
P-0002869-T01-IM3	P-0002869	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Male	Note  :The EGFR exon 19 variant is a complex event which includes the 9bp deletion in EGFR as well as three SNVs.	526	40
P-0002871-T01-IM3	P-0002871	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	663	20
P-0002873-T01-IM3	P-0002873	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		560	50
P-0002876-T01-IM3	P-0002876	Non-Small Cell Lung Cancer	Primary	Tumor	Lymph Node	Lung	Lung Adenocarcinoma	IMPACT341			Female		602	40
P-0002877-T01-IM3	P-0002877	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		681	NA
P-0002879-T01-IM3	P-0002879	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT341			Female		788	20
P-0002893-T01-IM3	P-0002893	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Male		386	20
P-0002896-T01-IM3	P-0002896	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Seminoma	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	666	50
P-0002904-T01-IM3	P-0002904	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		774	60
P-0002921-T01-IM3	P-0002921	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		438	30
P-0002947-T01-IM3	P-0002947	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).	806	20
P-0002966-T01-IM3	P-0002966	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).      Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	219	20
P-0002968-T01-IM3	P-0002968	Germ Cell Tumor	Metastasis	Tumor	Lymph Node	Testis	Seminoma	IMPACT341			Male	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	815	20
P-0002973-T01-IM3	P-0002973	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT341			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).    Note: The PAK1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.  Note: The RPS6KB2 and CCND1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	480	50
P-0002980-T01-IM3	P-0002980	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT341			Female		831	60
P-0003038-T01-IM5	P-0003038	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		737	70
P-0003138-T01-IM5	P-0003138	Uterine Sarcoma	Metastasis	Tumor	Omentum	Uterus	Uterine Adenosarcoma	IMPACT410			Female		829	80
P-0003309-T01-IM5	P-0003309	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph Node	Waldenstrom Macroglobulinemia	IMPACT410			Male		537	90
P-0003321-T01-IM5	P-0003321	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		299	50
P-0003322-T01-IM5	P-0003322	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	745	10
P-0003323-T01-IM5	P-0003323	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		185	40
P-0003324-T01-IM5	P-0003324	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		623	40
P-0003324-T02-IM5	P-0003324	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		594	30
P-0003344-T01-IM5	P-0003344	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		708	50
P-0003822-T02-IM5	P-0003822	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female		844	90
P-0005330-T02-IM5	P-0005330	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Female		682	NA
P-0006061-T01-IM5	P-0006061	Biliary Cancer	Primary	Tumor	Not Applicable	Bile Duct	Extrahepatic Cholangiocarcinoma	IMPACT410			Male		821	40
P-0006405-T01-IM5	P-0006405	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The copy number result is indicative of an intragenic gain of BRAF exons 10-18, which includes the protein kinase domain.  Note: The TERT, SDHA and CCNE1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	899	20
P-0006544-T02-IM5	P-0006544	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q.	1242	80
P-0006864-T01-IM5	P-0006864	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Colon Adenocarcinoma	IMPACT410			Female		838	30
P-0006871-T01-IM5	P-0006871	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male		1114	20
P-0006876-T01-IM5	P-0006876	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		1135	50
P-0007013-T01-IM5	P-0007013	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p and 19q	794	30
P-0007021-T01-IM5	P-0007021	Soft Tissue Sarcoma	Metastasis	Tumor	Scalp	Unknown	Sarcoma, NOS	IMPACT410			Male		871	50
P-0007022-T01-IM5	P-0007022	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Neuroendocrine Carcinoma, NOS	IMPACT410			Male		842	40
P-0007028-T01-IM5	P-0007028	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Unknown	Sarcoma, NOS	IMPACT410			Female		1346	50
P-0007164-T01-IM5	P-0007164	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1070	10
P-0007229-T01-IM5	P-0007229	Cancer of Unknown Primary	Metastasis	Tumor	Scalp	Unknown	Neuroendocrine Carcinoma, NOS	IMPACT410			Female	Note: The AKT1 and SRC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	872	70
P-0007230-T01-IM5	P-0007230	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Omentum	Gastrointestinal Stromal Tumor	IMPACT410			Male	Note: The GNA11 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 9p, 14q, 15q, 16q and 22q.     Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm Xq.	882	90
P-0007270-T01-IM5	P-0007270	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Adrenal Gland	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: Assessment of the gene copy number data is limited by (low tumor content / increased noise due to low input DNA). Negative results should be interpreted with caution.	258	75
P-0007301-T01-IM5	P-0007301	Chondrosarcoma	Primary	Tumor	Not Applicable	Chest Wall	Dedifferentiated Chondrosarcoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 112X, negative results should be interpreted with caution.	112	40
P-0007567-T01-IM5	P-0007567	Colorectal Cancer	Primary	Tumor	Not Applicable	Transverse Colon	Colon Adenocarcinoma	IMPACT410			Male		741	80
P-0007690-T01-IM5	P-0007690	Melanoma	Metastasis	Tumor	Liver	Eye	Uveal Melanoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 21q.	748	60
P-0007886-T01-IM5	P-0007886	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Well-Differentiated Liposarcoma	IMPACT410			Female		437	70
P-0008020-T01-IM5	P-0008020	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Cancer of Unknown Primary	IMPACT410			Male		722	50
P-0008026-T01-IM5	P-0008026	Embryonal Tumor	Metastasis	Tumor	Liver	Adrenal Gland	Neuroblastoma	IMPACT410			Male		710	90
P-0008055-T02-IM5	P-0008055	Anal Cancer	Primary	Tumor	Not Applicable	Rectum	Anal Squamous Cell Carcinoma	IMPACT410			Male		884	40
P-0008123-T01-IM5	P-0008123	Thyroid Cancer	Primary	Tumor	Not available	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female	Note: Low sequencing depth of coverage of 192X, negative results should be interpreted with caution.  Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	192	80
P-0008135-T01-IM5	P-0008135	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Angiosarcoma	IMPACT410			Male		778	80
P-0008233-T01-IM5	P-0008233	Endometrial Cancer	Metastasis	Tumor	Pelvis	Uterus	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor	IMPACT410			Female		853	80
P-0008455-T01-IM5	P-0008455	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Abdomen	Leiomyosarcoma	IMPACT410			Female		438	50
P-0008658-T01-IM5	P-0008658	Biliary Cancer	Metastasis	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Male		913	80
P-0008663-T01-IM5	P-0008663	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Male		1098	80
P-0008726-T01-IM5	P-0008726	Cancer of Unknown Primary	Metastasis	Tumor	Brain	Ampulla of Vater	Neuroendocrine Carcinoma, NOS	IMPACT410			Female		757	80
P-0008745-T01-IM5	P-0008745	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female		1087	80
P-0008746-T01-IM5	P-0008746	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 19q.	942	80
P-0008780-T02-IM5	P-0008780	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		142	30
P-0008797-T01-IM5	P-0008797	Renal Cell Carcinoma	Metastasis	Tumor	Mediastinum	Kidney	Renal Cell Carcinoma	IMPACT410			Male		987	80
P-0008848-T01-IM5	P-0008848	Cancer of Unknown Primary	Metastasis	Tumor	Peritoneum	Unknown	Neuroendocrine Carcinoma, NOS	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q21-1q32 and 3q13-3q23.	1029	60
P-0008868-T01-IM5	P-0008868	Colorectal Cancer	Primary	Tumor	Not Applicable	Descending Colon	Colon Adenocarcinoma	IMPACT410			Female		761	50
P-0008875-T01-IM5	P-0008875	Colorectal Cancer	Primary	Tumor	Not Applicable	Ascending Colon	Colon Adenocarcinoma	IMPACT410			Male		628	90
P-0008926-T01-IM5	P-0008926	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	GE Junction	Esophagogastric Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	933	10
P-0008943-T01-IM5	P-0008943	Cancer of Unknown Primary	Metastasis	Tumor	Neck	Unknown	Cancer of Unknown Primary	IMPACT410			Male		932	30
P-0008973-T01-IM5	P-0008973	Cancer of Unknown Primary	Metastasis	Tumor	Neck	Unknown	Cancer of Unknown Primary	IMPACT410			Female		924	10
P-0009007-T01-IM5	P-0009007	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Neuroendocrine Tumor, NOS	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	940	20
P-0009016-T01-IM5	P-0009016	Cancer of Unknown Primary	Metastasis	Tumor	Liver	Unknown	Adenocarcinoma, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	973	10
P-0009022-T01-IM5	P-0009022	Cancer of Unknown Primary	Metastasis	Tumor	Pelvis	Unknown	Adenocarcinoma, NOS	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	432	20
P-0009097-T01-IM5	P-0009097	Glioma	Primary	Tumor	Not Applicable	Brain	Pilocytic Astrocytoma	IMPACT410			Male		997	60
P-0009118-T01-IM5	P-0009118	Gastrointestinal Neuroendocrine Tumor	Primary	Tumor	Not Applicable	Ascending Colon	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number losses on Chromosome 16 and Chromosome arms 5q, 9q21-9q22, 11q22-11q23, and 15q.  Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 5p, 20q, and Xp11.	535	80
P-0009143-T01-IM5	P-0009143	Endometrial Cancer	Metastasis	Tumor	Abdomen	Uterus	Uterine Mixed Endometrial Carcinoma	IMPACT410			Female		1288	80
P-0009145-T02-IM5	P-0009145	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	962	30
P-0009174-T01-IM5	P-0009174	Salivary Carcinoma	Metastasis	Tumor	Lung	Oropharynx	Adenoid Cystic Carcinoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover MYB nor NFIB genes  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6q.	1018	80
P-0009176-T01-IM5	P-0009176	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Carcinoma	IMPACT410			Female	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	997	20
P-0009177-T01-IM5	P-0009177	Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Melanoma	IMPACT410			Female		1217	70
P-0009178-T01-IM5	P-0009178	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	678	40
P-0009179-T01-IM5	P-0009179	Germ Cell Tumor	Primary	Tumor	Not Applicable	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Chromosome arm 12p shows a broad range of copy number gain suggestive of the presence of i(12p).  Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	657	40
P-0009180-T01-IM5	P-0009180	Melanoma	Metastasis	Tumor	Lymph Node, Regional	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	750	10
P-0009182-T01-IM5	P-0009182	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 16q.	997	60
P-0009183-T01-IM5	P-0009183	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Squamous Cell Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1036	40
P-0009184-T01-IM5	P-0009184	Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p, 5q and 18.	1136	95
P-0009185-T01-IM5	P-0009185	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 13q and 20q.	967	30
P-0009186-T01-IM5	P-0009186	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1057	25
P-0009187-T01-IM5	P-0009187	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female		1055	50
P-0009188-T01-IM5	P-0009188	Head and Neck Carcinoma	Metastasis	Tumor	Lymph node	Tongue	Head and Neck Squamous Cell Carcinoma	IMPACT410			Male		242	60
P-0009189-T01-IM5	P-0009189	Melanoma	Local Recurrence	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	254	80
P-0009190-T01-IM5	P-0009190	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		975	30
P-0009191-T01-IM5	P-0009191	Biliary Cancer	Primary	Tumor	Not Applicable	Liver	Cholangiocarcinoma	IMPACT410			Female		867	35
P-0009192-T01-IM5	P-0009192	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		991	30
P-0009193-T01-IM5	P-0009193	Glioma	Primary	Tumor	Not Applicable	Brain	Astrocytoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q24.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome 5p.	204	80
P-0009204-T01-IM5	P-0009204	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Testis	Pleomorphic Liposarcoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9 and Chromosome arm 16q.	631	80
P-0009214-T01-IM5	P-0009214	Cancer of Unknown Primary	Metastasis	Tumor	Lymph Node	Unknown	Cancer of Unknown Primary	IMPACT410			Male		1006	NA
P-0001484-T02-IM5	P-0001484	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	915	30
P-0001551-T02-IM5	P-0001551	Esophagogastric Carcinoma	Metastasis	Tumor	Lung	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		1804	25
P-0001961-T02-IM5	P-0001961	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: The NBN, RAD21, and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	831	30
P-0001961-T03-IM5	P-0001961	Colorectal Cancer	Metastasis	Tumor	Liver	Sigmoid Colon	Colon Adenocarcinoma	IMPACT410			Female	Note:  A comparison of variant frequencies suggests the RPTOR mutation is subclonal.	440	20
P-0003491-T02-IM5	P-0003491	Cancer of Unknown Primary	Metastasis	Tumor	Breast	Bowel	Neuroendocrine Carcinoma, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q, 16q, and 18q.	1162	70
P-0005852-T02-IM5	P-0005852	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		809	40
P-0006614-T01-IM5	P-0006614	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Abdomen	Diffuse Large B-Cell Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome X.    Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6q.	1014	30
P-0006840-T01-IM5	P-0006840	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1001	20
P-0006952-T01-IM5	P-0006952	Melanoma	Primary	Tumor	Not Applicable	Mandible	Melanoma	IMPACT410			Male		1130	NA
P-0006983-T01-IM5	P-0006983	Colorectal Cancer	Metastasis	Tumor	Liver	Rectum	Colorectal Adenocarcinoma	IMPACT410			Male		843	20
P-0007227-T02-IM5	P-0007227	Esophagogastric Carcinoma	Metastasis	Tumor	Peritoneum	Stomach	Esophageal Adenocarcinoma	IMPACT410			Male	reviewed slide - tumor content ok (DSR)	890	50
P-0008062-T01-IM5	P-0008062	Bladder Cancer	Metastasis	Tumor	Lymph Node	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female		752	70
P-0008532-T01-IM5	P-0008532	Bladder Cancer	Metastasis	Tumor	Retroperitoneum	Upper Tract	Upper Tract Urothelial Carcinoma	IMPACT410			Male		842	50
P-0008663-T02-IM5	P-0008663	Osteosarcoma	Metastasis	Tumor	Lung	Bone	Osteosarcoma	IMPACT410			Male		897	70
P-0008689-T02-IM5	P-0008689	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Colon	Mantle Cell Lymphoma	IMPACT410			Male	Mutation assessment: Mutations are called against the patient's matched blood sample and against pooled unmatched normal. This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched blood sample.	1026	90
P-0008798-T01-IM5	P-0008798	Head and Neck Carcinoma	Metastasis	Tumor	Lung	Larynx	Head and Neck Carcinoma, Other	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover NUT gene.	987	40
P-0008864-T01-IM5	P-0008864	Cancer of Unknown Primary	Primary	Tumor	Not Applicable	Bladder, Upper Tract	Poorly Differentiated Carcinoma, NOS	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	566	80
P-0009061-T02-IM5	P-0009061	Biliary Cancer	Primary	Tumor	Not Applicable	Gallbladder	Cholangiocarcinoma	IMPACT410			Female		908	40
P-0009147-T01-IM5	P-0009147	Soft Tissue Sarcoma	Metastasis	Tumor	Abdomen	Kidney	Dedifferentiated Liposarcoma	IMPACT410			Female		428	40
P-0009148-T01-IM5	P-0009148	Melanoma	Metastasis	Tumor	Brain	Skin	Melanoma	IMPACT410			Male		593	90
P-0009181-T01-IM5	P-0009181	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	519	60
P-0009207-T02-IM5	P-0009207	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Neck	Synovial Sarcoma	IMPACT410			Male	Note: MSK-IMPACT test panel does not cover SYT  and SYX genes.	832	90
P-0009216-T01-IM5	P-0009216	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		951	90
P-0009217-T01-IM5	P-0009217	Embryonal Tumor	Primary	Tumor	Not Applicable	Adrenal Gland	Neuroblastoma	IMPACT410			Female		583	40
P-0009239-T01-IM5	P-0009239	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	946	50
P-0009240-T01-IM5	P-0009240	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		1050	80
P-0009242-T01-IM5	P-0009242	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Solid Pseudopapillary Neoplasm of the Pancreas	IMPACT410			Female		679	80
P-0009243-T01-IM5	P-0009243	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome..	515	90
P-0009245-T01-IM5	P-0009245	Melanoma	Metastasis	Tumor	Lung	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.  Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 6p.	610	90
P-0009246-T01-IM5	P-0009246	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Abdomen	Dedifferentiated Liposarcoma	IMPACT410			Female		821	80
P-0009248-T01-IM5	P-0009248	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		962	40
P-0009249-T01-IM5	P-0009249	Breast Carcinoma	Metastasis	Tumor	Lung	Breast	Breast Carcinoma	IMPACT410			Female		855	30
P-0009250-T02-IM5	P-0009250	Gastrointestinal Stromal Tumor	Primary	Tumor	Not Applicable	Stomach	Gastrointestinal Stromal Tumor	IMPACT410			Male		788	90
P-0009251-T01-IM5	P-0009251	Pancreatic Cancer	Metastasis	Tumor	Liver	Pancreas	Pancreatic Neuroendocrine Tumor	IMPACT410			Male		1008	80
P-0009252-T01-IM5	P-0009252	Colorectal Cancer	Metastasis	Tumor	Lymph node	Cecum	Colon Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	808	10
P-0009253-T01-IM5	P-0009253	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal	Lung	Lung Adenocarcinoma	IMPACT410			Male		905	80
P-0009254-T01-IM5	P-0009254	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	836	20
P-0009255-T01-IM5	P-0009255	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		648	70
P-0009256-T01-IM5	P-0009256	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		828	NA
P-0009257-T01-IM5	P-0009257	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female		1613	40
P-0009258-T01-IM5	P-0009258	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Squamous Cell Carcinoma	IMPACT410			Male	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	936	30
P-0009259-T01-IM5	P-0009259	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1144	10
P-0009260-T01-IM5	P-0009260	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1004	NA
P-0009261-T01-IM5	P-0009261	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		774	50
P-0009262-T01-IM5	P-0009262	Bladder Cancer	Metastasis	Tumor	Lung	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male	slide reviewed - tumor content ok (DSR)	987	10
P-0009263-T01-IM5	P-0009263	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Male		1150	70
P-0009264-T01-IM5	P-0009264	Glioma	Primary	Tumor	Not Applicable	Brain	Oligodendroglioma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p and 19q.	638	70
P-0009265-T01-IM5	P-0009265	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		433	NA
P-0009266-T01-IM5	P-0009266	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		841	60
P-0009267-T01-IM5	P-0009267	Endometrial Cancer	Metastasis	Tumor	Omentum	Uterus	Uterine Clear Cell Carcinoma	IMPACT410			Female		1429	40
P-0009268-T01-IM5	P-0009268	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1347	50
P-0009269-T01-IM5	P-0009269	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Female		984	10
P-0009270-T01-IM5	P-0009270	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		937	20
P-0009271-T01-IM5	P-0009271	Pancreatic Cancer	Metastasis	Tumor	Arm	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		985	60
P-0009272-T01-IM5	P-0009272	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		728	NA
P-0009273-T01-IM5	P-0009273	Cervical Cancer	Primary	Tumor	Not Applicable	Cervix	Endocervical Adenocarcinoma	IMPACT410			Female		784	NA
P-0009274-T01-IM5	P-0009274	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 18q21 and gain on 1q21-44.	1002	NA
P-0009275-T01-IM5	P-0009275	Non-Small Cell Lung Cancer	Metastasis	Tumor	Brain	Lung	Lung Adenocarcinoma	IMPACT410			Female		934	20
P-0009277-T01-IM5	P-0009277	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1149	40
P-0009288-T01-IM5	P-0009288	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note:  Relatively low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	998	20
P-0009289-T01-IM5	P-0009289	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		998	70
P-0009290-T01-IM5	P-0009290	Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT410			Male		755	50
P-0009291-T01-IM5	P-0009291	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Cell Carcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by FISH is highly suggested.	559	40
P-0009292-T01-IM5	P-0009292	Melanoma	Metastasis	Tumor	Soft Tissue	Skin	Cutaneous Melanoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p and 22q.	1020	70
P-0009293-T01-IM5	P-0009293	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		558	40
P-0009294-T01-IM5	P-0009294	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		1222	40
P-0009295-T01-IM5	P-0009295	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Non-Small Cell Lung Cancer	IMPACT410			Female		1036	30
P-0009296-T01-IM5	P-0009296	Thyroid Cancer	Primary	Tumor	Not Applicable	Thyroid	Papillary Thyroid Cancer	IMPACT410			Female		405	60
P-0009297-T01-IM5	P-0009297	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Carcinoma	IMPACT410			Female		670	50
P-0009299-T01-IM5	P-0009299	Pancreatic Cancer	Primary	Tumor	Not Applicable	Unknown	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	1095	10
P-0009300-T01-IM5	P-0009300	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Atypical Lung Carcinoid	IMPACT410			Male	Note: No alterations identified in the context of high tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.	1008	50
P-0009301-T01-IM5	P-0009301	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Male		841	50
P-0009302-T01-IM5	P-0009302	Colorectal Cancer	Metastasis	Tumor	Peritoneal Implant	Colon	Colon Adenocarcinoma	IMPACT410			Male		286	50
P-0009303-T01-IM5	P-0009303	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Male		825	30
P-0009304-T01-IM5	P-0009304	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		1124	50
P-0009305-T01-IM5	P-0009305	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	815	10
P-0009307-T01-IM5	P-0009307	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		916	50
P-0009308-T01-IM5	P-0009308	Melanoma	Metastasis	Tumor	Lymph node	Skin	Melanoma	IMPACT410			Female		1046	60
P-0009309-T01-IM5	P-0009309	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 5p and 13q.	917	60
P-0009310-T01-IM5	P-0009310	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		523	40
P-0009311-T01-IM5	P-0009311	Melanoma	Metastasis	Tumor	Lymph node	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by UV exposure/Radiation induced damage.	905	70
P-0009312-T01-IM5	P-0009312	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		959	30
P-0009313-T01-IM5	P-0009313	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Unknown	Lung Adenocarcinoma	IMPACT410			Female		906	20
P-0009314-T01-IM5	P-0009314	Uterine Sarcoma	Metastasis	Tumor	Rectum	Uterus	Uterine Leiomyosarcoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	1050	80
P-0009315-T01-IM5	P-0009315	Head and Neck Carcinoma	Primary	Tumor	Not Applicable	Oropharynx	Head and Neck Squamous Cell Carcinoma	IMPACT410			Female		893	30
P-0009316-T01-IM5	P-0009316	Endometrial Cancer	Primary	Tumor	Not Applicable	Uterus	Uterine Endometrioid Carcinoma	IMPACT410			Female		621	50
P-0009318-T01-IM5	P-0009318	Non-Hodgkin Lymphoma	Primary	Tumor	Not Applicable	Lymph node	Mantle Cell Lymphoma	IMPACT410			Male	Note: Copy number profile is suggestive of copy number losses on Chromosome arms 6q25-6q26, 7q31-7q36, 11q22-11q23, 13q12-13q14, and 13q34.  Note: Copy number profile is suggestive of copy number gain on Chromosome arm 3q26-3q28.	1016	90
P-0009320-T01-IM5	P-0009320	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	884	90
P-0009321-T01-IM5	P-0009321	Appendiceal Cancer	Primary	Tumor	Not Applicable	Appendix	Mucinous Adenocarcinoma of the Appendix	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	798	20
P-0009322-T01-IM5	P-0009322	Skin Cancer, Non-Melanoma	Primary	Tumor	Not Applicable	Unknown	Cutaneous Squamous Cell Carcinoma	IMPACT410			Female		1110	50
P-0009323-T01-IM5	P-0009323	Thyroid Cancer	Metastasis	Tumor	Lymph node	Thyroid	Medullary Thyroid Cancer	IMPACT410			Male		744	NA
P-0009326-T01-IM5	P-0009326	Unknown	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Male		979	80
P-0009327-T01-IM5	P-0009327	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Male		973	80
P-0009328-T01-IM5	P-0009328	Melanoma	Primary	Tumor	Not Applicable	Vulva	Mucosal Melanoma of the Vulva/Vagina	IMPACT410			Female		1073	50
P-0009330-T01-IM5	P-0009330	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		953	40
P-0009331-T01-IM5	P-0009331	Hepatocellular Carcinoma	Primary	Tumor	Not Applicable	Liver	Hepatocellular Carcinoma	IMPACT410			Female		906	30
P-0009333-T01-IM5	P-0009333	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 11q13 and 20q.	1061	70
P-0009334-T01-IM5	P-0009334	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Female		940	50
P-0009335-T01-IM5	P-0009335	Pancreatic Cancer	Metastasis	Tumor	Omentum	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	830	10
P-0009336-T01-IM5	P-0009336	Cancer of Unknown Primary	Metastasis	Tumor	Bone	Cancer of Unknown Primary	Cancer of Unknown Primary	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	256	10
P-0009337-T01-IM5	P-0009337	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male		711	10
P-0009338-T01-IM5	P-0009338	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: No alterations identified in the context of moderate tumor content . No silent mutations identified. More comprehensive testing could be valuable.	908	30
P-0009339-T01-IM5	P-0009339	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Female		999	90
P-0009341-T01-IM5	P-0009341	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q.	1215	30
P-0009343-T01-IM5	P-0009343	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1034	30
P-0009344-T01-IM5	P-0009344	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		939	40
P-0009345-T01-IM5	P-0009345	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	798	10
P-0009346-T01-IM5	P-0009346	Non-Small Cell Lung Cancer	Metastasis	Tumor	Liver	Lung	Lung Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q21-23.	868	90
P-0009347-T01-IM5	P-0009347	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Cell Carcinoma	IMPACT410			Male		1440	30
P-0009348-T01-IM5	P-0009348	Renal Cell Carcinoma	Metastasis	Tumor	Soft Tissue	Kidney	Renal Clear Cell Carcinoma	IMPACT410			Male		727	80
P-0009350-T01-IM5	P-0009350	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1101	30
P-0009351-T01-IM5	P-0009351	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 89X, negative results should be interpreted with caution.	89	30
P-0009352-T01-IM5	P-0009352	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		998	25
P-0009353-T01-IM5	P-0009353	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	185	20
P-0001319-T05-IM5	P-0001319	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		1206	80
P-0001795-T02-IM5	P-0001795	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		808	10
P-0002190-T02-IM5	P-0002190	Osteosarcoma	Primary	Tumor	Not Applicable	Bone	Osteosarcoma	IMPACT410			Female		933	40
P-0006312-T02-IM5	P-0006312	Non-Small Cell Lung Cancer	Metastasis	Tumor	Adrenal Gland	Lung	Lung Adenocarcinoma	IMPACT410			Female		923	60
P-0007299-T02-IM5	P-0007299	Renal Cell Carcinoma	Metastasis	Tumor	Bone	Kidney	Renal Cell Carcinoma	IMPACT410			Female		374	70
P-0008563-T02-IM5	P-0008563	Renal Cell Carcinoma	Metastasis	Tumor	Retroperitoneum	Kidney	Renal Angiomyolipoma	IMPACT410			Male		1107	30
P-0009159-T02-IM5	P-0009159	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	882	20
P-0009355-T01-IM5	P-0009355	Colorectal Cancer	Metastasis	Tumor	Omentum	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	858	10
P-0009356-T01-IM5	P-0009356	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	542	80
P-0009357-T01-IM5	P-0009357	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		892	NA
P-0009359-T01-IM5	P-0009359	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Brain	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male		848	80
P-0009360-T01-IM5	P-0009360	Soft Tissue Sarcoma	Metastasis	Tumor	Lung	Retroperitoneum	Leiomyosarcoma	IMPACT410			Female		941	70
P-0009362-T01-IM5	P-0009362	Colorectal Cancer	Primary	Tumor	Not Applicable	Rectum	Rectal Adenocarcinoma	IMPACT410			Male		762	30
P-0009364-T01-IM5	P-0009364	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		1086	60
P-0009366-T01-IM5	P-0009366	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Renal Cell Carcinoma	IMPACT410			Male		943	50
P-0009368-T01-IM5	P-0009368	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Stomach	Stomach Adenocarcinoma	IMPACT410			Male	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	261	25
P-0009370-T01-IM5	P-0009370	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		827	30
P-0009371-T01-IM5	P-0009371	Bladder Cancer	Primary	Tumor	Not Applicable	Bladder	Bladder Urothelial Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9.	398	70
P-0009372-T01-IM5	P-0009372	Ovarian Cancer	Primary	Tumor	Not Applicable	Ovary	Serous Ovarian Cancer	IMPACT410			Female		1136	10
P-0009373-T01-IM5	P-0009373	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Well-Differentiated Liposarcoma	IMPACT410			Male		806	20
P-0009379-T01-IM5	P-0009379	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Male		1224	N/A
P-0009393-T01-IM5	P-0009393	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	201	60
P-0009394-T01-IM5	P-0009394	Ovarian Cancer	Metastasis	Tumor	Lymph node	Ovary	Serous Ovarian Cancer	IMPACT410			Female		744	30
P-0009395-T01-IM5	P-0009395	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	674	10
P-0009396-T01-IM5	P-0009396	Pancreatic Cancer	Metastasis	Tumor	Lymph node	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1172	10
P-0009398-T01-IM5	P-0009398	Glioma	Primary	Tumor	Not Applicable	Brain	Diffuse Glioma	IMPACT410			Male		807	80
P-0009399-T01-IM5	P-0009399	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of a fragmented genome.	1211	80
P-0009400-T01-IM5	P-0009400	Esophagogastric Carcinoma	Primary	Tumor	Not Applicable	Esophagus	Esophageal Adenocarcinoma	IMPACT410			Female		361	30
P-0009401-T01-IM5	P-0009401	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Low sequencing depth of coverage of 184X, negative results should be interpreted with caution.	184	60
P-0009403-T01-IM5	P-0009403	Cancer of Unknown Primary	Metastasis	Tumor	Lung	Unknown	Cancer of Unknown Primary	IMPACT410			Female		822	20
P-0009404-T01-IM5	P-0009404	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	566	10
P-0009405-T01-IM5	P-0009405	Breast Carcinoma	Metastasis	Tumor	Chest Wall	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	916	80
P-0009406-T01-IM5	P-0009406	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		884	20
P-0009407-T01-IM5	P-0009407	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	419	10
P-0009408-T01-IM5	P-0009408	Embryonal Tumor	Metastasis	Tumor	Retroperitoneum	Adrenal Gland	Neuroblastoma	IMPACT410			Male		734	60
P-0009409-T01-IM5	P-0009409	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		511	30
P-0009410-T01-IM5	P-0009410	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Ependymoma	IMPACT410			Male		755	60
P-0009411-T01-IM5	P-0009411	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Oligodendroglioma	IMPACT410			Female	Note: Abundance of G>A,C>T transitions suggests mutations may be caused by TMZ treatment induced damage.  Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p, 14q23-32, and 19q.	770	60
P-0009412-T01-IM5	P-0009412	Melanoma	Metastasis	Tumor	Lung	Skin	Melanoma	IMPACT410			Male		907	50
P-0003495-T01-IM5	P-0003495	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		530	30
P-0004817-T02-IM5	P-0004817	Unknown	Primary	Tumor	Not Applicable	Lymph node	Angioimmunoblastic T-Cell Lymphoma	IMPACT410			Female	Mutation assessment: Mutations are called against pooled unmatched normal . This assay reports variants confirmed to be absent in the pooled unmatched normal and also confirmed to be somatic based on comparison of variant allele frequencies in the matched  blood sample.	1033	50
P-0006278-T01-IM5	P-0006278	Renal Cell Carcinoma	Primary	Tumor	Not Applicable	Kidney	Chromophobe Renal Cell Carcinoma	IMPACT410			Male		411	90
P-0006280-T01-IM5	P-0006280	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The IL7R, SDHA, RICTOR and TERT copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	536	40
P-0006286-T01-IM5	P-0006286	Breast Carcinoma	Metastasis	Tumor	Pleural Fluid	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		505	40
P-0006287-T01-IM5	P-0006287	Colorectal Cancer	Metastasis	Tumor	Lung	Colon	Colon Adenocarcinoma	IMPACT410			Female	Note: Low sequencing depth of coverage of 123X, negative results should be interpreted with caution.    Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	123	20
P-0006290-T01-IM5	P-0006290	Non-Small Cell Lung Cancer	Metastasis	Tumor	Soft Tissue	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: The KRAS p.G12D mutation frequency suggests that the mutation occurs on the amplified allele	150	30
P-0006728-T01-IM5	P-0006728	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		647	20
P-0007411-T02-IM5	P-0007411	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of copy number loss on Chromosome arm 6q16-6q22.  Note: Copy number profile is suggestive of copy number gain on Chromosome arm 8q21-8q24.	854	40
P-0008404-T02-IM5	P-0008404	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Male		931	80
P-0009224-T02-IM5	P-0009224	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male		638	30
P-0009319-T01-IM5	P-0009319	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleural Fluid	Lung	Lung Adenocarcinoma	IMPACT410			Male		919	60
P-0009324-T02-IM5	P-0009324	Melanoma	Primary	Tumor	Not Applicable	Skin	Cutaneous Melanoma	IMPACT410			Male		699	80
P-0009351-T02-IM5	P-0009351	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Female		257	30
P-0009354-T01-IM5	P-0009354	Pancreatic Cancer	Metastasis	Tumor	Peritoneal Implant	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	968	10
P-0009358-T01-IM5	P-0009358	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of copy number losses on Chromosome arms 6q23 and 9p21-9p24, including CDKN2Ap14ARF andCDKN2AP16INK4A.	885	50
P-0009361-T01-IM5	P-0009361	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		816	10
P-0009363-T01-IM5	P-0009363	Colorectal Cancer	Primary	Tumor	Not Applicable	Colon	Colon Adenocarcinoma	IMPACT410			Female		886	30
P-0009365-T01-IM5	P-0009365	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female	Note: Copy number profile is suggestive of copy number gain on Chromosome arm 7p22.  Note: Copy number profile is suggestive of copy number losses on Chromosome arms 9p13-9p24 and 12p12-12p13.	913	90
P-0009367-T01-IM5	P-0009367	Breast Carcinoma	Metastasis	Tumor	Lymph node	Breast	Breast Carcinoma	IMPACT410			Female		341	80
P-0009369-T01-IM5	P-0009369	Breast Carcinoma	Metastasis	Tumor	Liver	Breast	Breast Carcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	1205	60
P-0009375-T01-IM5	P-0009375	Breast Carcinoma	Metastasis	Tumor	Pleura	Breast	Breast Carcinoma	IMPACT410			Female		770	20
P-0009376-T01-IM5	P-0009376	Non-Small Cell Lung Cancer	Metastasis	Tumor	Left Lung	Right Lung	Lung Adenocarcinoma	IMPACT410			Female	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.	965	20
P-0009377-T01-IM5	P-0009377	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Colon Adenocarcinoma	IMPACT410			Male	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.  Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p34, 17p, 18q, and 21q22.	1023	20
P-0009449-T01-IM5	P-0009449	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Female		590	70
P-0009450-T01-IM5	P-0009450	Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Small Cell Lung Cancer	IMPACT410			Female	Note: Copy number profile is suggestive of a fragmented genome.	778	40
P-0009451-T01-IM5	P-0009451	Glioma	Primary	Tumor	Not Applicable	Brain	Glioblastoma Multiforme	IMPACT410			Male		834	80
P-0009452-T01-IM5	P-0009452	Soft Tissue Sarcoma	Metastasis	Tumor	Liver	Unknown	Desmoplastic Small-Round-Cell Tumor	IMPACT410			Male		717	80
P-0009453-T01-IM5	P-0009453	Glioma	Primary	Tumor	Not Applicable	Brain	Anaplastic Astrocytoma	IMPACT410			Female		769	60
P-0009454-T01-IM5	P-0009454	Unknown	Metastasis	Tumor	Parotid	Unknown	NotOnTree	IMPACT410			Male		693	70
P-0009455-T01-IM5	P-0009455	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Leg	Myxoid/Round-Cell Liposarcoma	IMPACT410			Male		810	60
P-0009456-T01-IM5	P-0009456	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Soft Tissue	Angiosarcoma	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	583	70
P-0009457-T01-IM5	P-0009457	Salivary Carcinoma	Primary	Tumor	Not Applicable	Submandibular Gland	Adenoid Cystic Carcinoma	IMPACT410			Male		666	60
P-0009458-T01-IM5	P-0009458	Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Small Cell Lung Cancer	IMPACT410			Female		806	80
P-0009459-T01-IM5	P-0009459	Germ Cell Tumor	Metastasis	Tumor	Lymph node	Testis	Mixed Germ Cell Tumor	IMPACT410			Male	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	824	10
P-0009460-T01-IM5	P-0009460	Breast Carcinoma	Primary	Tumor	Not Applicable	Breast	Breast Carcinoma	IMPACT410			Female		831	30
P-0009462-T01-IM5	P-0009462	Unknown	Primary	Tumor	Not Applicable	Unknown	Unknown	IMPACT410			Male		718	0
P-0009463-T01-IM5	P-0009463	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410			Male		758	20
P-0009464-T01-IM5	P-0009464	Colorectal Cancer	Metastasis	Tumor	Liver	Colon	Mucinous Colorectal Carcinoma	IMPACT410			Female	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	497	20
P-0009465-T01-IM5	P-0009465	Pancreatic Cancer	Primary	Tumor	Not Applicable	Pancreas	Pancreatic Adenocarcinoma	IMPACT410			Male		805	60
P-0009466-T01-IM5	P-0009466	Non-Small Cell Lung Cancer	Metastasis	Tumor	Pleura	Lung	Lung Adenocarcinoma	IMPACT410			Male		1116	20
P-0009467-T01-IM5	P-0009467	Non-Small Cell Lung Cancer	Metastasis	Tumor	Lymph node	Lung	Lung Adenocarcinoma	IMPACT410			Female		842	20
P-0009468-T01-IM5	P-0009468	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Squamous Cell Carcinoma	IMPACT410			Male		1160	20
P-0009469-T01-IM5	P-0009469	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	lung	Lung Adenocarcinoma	IMPACT410			Female		696	60
P-0009470-T01-IM5	P-0009470	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenocarcinoma	IMPACT410			Female		1024	20
P-0009471-T01-IM5	P-0009471	Soft Tissue Sarcoma	Primary	Tumor	Not Applicable	Retroperitoneum	Dedifferentiated Liposarcoma	IMPACT410			Female		676	50
P-0009472-T01-IM5	P-0009472	Ependymomal Tumor	Primary	Tumor	Not Applicable	Brain	Ependymoma	IMPACT410			Female	Note: No alterations identified in the context of high tumor content .Review of histology and copy number profile indicates adequate tumor.	947	50
P-0009473-T01-IM5	P-0009473	Non-Small Cell Lung Cancer	Primary	Tumor	Not Applicable	Lung	Lung Adenosquamous Carcinoma	IMPACT410			Male		709	20
P-0009474-T01-IM5	P-0009474	Breast Carcinoma	Metastasis	Tumor	Skin	Breast	Breast Invasive Cancer, NOS	IMPACT410			Female		968	20
P-0009476-T01-IM5	P-0009476	Cancer of Unknown Primary	Metastasis	Tumor	Spine	Unknown	Adenocarcinoma, NOS	IMPACT410			Female		717	60
